Citrus Sinensis ID: 039895
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 284 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.940 | 0.370 | 0.302 | 1e-28 | |
| O80795 | 372 | Probable inactive recepto | no | no | 0.908 | 0.693 | 0.290 | 2e-28 | |
| O64798 | 389 | Inactive serine/threonine | no | no | 0.852 | 0.622 | 0.316 | 4e-27 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.602 | 0.190 | 0.393 | 3e-26 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.651 | 0.210 | 0.363 | 4e-26 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.609 | 0.198 | 0.370 | 4e-26 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.630 | 0.239 | 0.391 | 5e-26 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.637 | 0.369 | 0.364 | 8e-26 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.637 | 0.367 | 0.359 | 8e-26 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.609 | 0.192 | 0.376 | 2e-25 |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 126 bits (317), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 102/337 (30%), Positives = 160/337 (47%), Gaps = 70/337 (20%)
Query: 4 CLRSRKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVI 63
C +RK +KRKF NG +LL++ + +G N + FS+++L+ ATD F+ +++
Sbjct: 337 CKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRIL 396
Query: 64 MKCLFYKLYKGFLQDR-------------------------------------------- 79
+ +YKG L+D
Sbjct: 397 GQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLET 456
Query: 80 --PISVMKF-------------EDTFPFSVS-KLKIAIEIASAVAYLHVGFSRPVVSRDI 123
PI V +F + FP S +L IA E+A A++YLH S P+ RD+
Sbjct: 457 EVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDV 516
Query: 124 KPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDV 183
K T I+L E++ A++ DF +S S+ +TH+ + V GT G++ PEY + F+ KSDV
Sbjct: 517 KSTNILLDEKHRAKVSDFGISRSVAIDDTHL--TTIVQGTIGYVDPEYLQSNHFTGKSDV 574
Query: 184 YSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWP 243
YSFG LL+ELLTG+K S E L + + N+ EI+D A + EE
Sbjct: 575 YSFGVLLIELLTGEKP--VSLLRRQEVRMLGAYFLEAMRNDRLHEILD-ARIKEEC---- 627
Query: 244 EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280
+++L +LA +CLS + RPT+ V +L ++
Sbjct: 628 -DREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRM 663
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O80795|Y1652_ARATH Probable inactive receptor-like protein kinase At1g65250 OS=Arabidopsis thaliana GN=At1g65250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 126 bits (316), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 95/327 (29%), Positives = 157/327 (48%), Gaps = 69/327 (21%)
Query: 24 GKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKC-LFYKLYKGFLQDRPIS 82
G LLE+LI +GK NPI+ FSADE+ AT+DF +++ + +K Y G ++ P+
Sbjct: 19 GAKLLEELIECCDGKSNPIKFFSADEILKATNDFSDSNFVLRLEVPFKWYSGKNENHPMI 78
Query: 83 VMK-------------------------------------FEDTFPFSV----------- 94
++K E +P V
Sbjct: 79 LIKKDVGWWSGLRVDRLCRDIAVSSMVSGHKNFMKLVGCCLELDYPVMVYHSVKKHYKLE 138
Query: 95 -------SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147
++KIA +IA+A+AYLH F RP V R + I+L E+ VA+L DF+ +SI
Sbjct: 139 ISEQPWKKRMKIAEDIATALAYLHTAFPRPFVYRILSHWNILLDEDGVAKLTDFSHCVSI 198
Query: 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF-- 205
PEGET + +R +G + + A Y +G S+K+DV++FG + L Y H+
Sbjct: 199 PEGETFVR-VDRDVGLYSYFADNYVRSGLVSDKTDVFAFGIFMGHRLLLGYEYYFEHYRG 257
Query: 206 -----DDGEDYRL----QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELA 256
+DG D + ++L+ E+ +EI D ++ + G + ++ Q+ +L+
Sbjct: 258 EEEESEDGFDSLMKRHARNLLSTLKEDRPMEEIADSKMIEKMGQISEQERCQMKAFLKLS 317
Query: 257 FKCLSESEGDRPTIVQVAKQLRQIYQS 283
+C SE + PT+V+VAK+L +I +S
Sbjct: 318 LRCTGPSE-EVPTMVEVAKELNKIQRS 343
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O64798|Y1747_ARATH Inactive serine/threonine-protein kinase At1g67470 OS=Arabidopsis thaliana GN=At1g67470 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 100/316 (31%), Positives = 148/316 (46%), Gaps = 74/316 (23%)
Query: 24 GKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLF---YKLYKG------ 74
G LL+ LI +GK NPI+ FSADE++ AT++F ++ + YK Y G
Sbjct: 19 GAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFGVSNLVSELSHDFDYKWYSGKNENHD 78
Query: 75 -----------------FLQDRPISVM---------------KFEDTFPFSV-------- 94
F +D +S M +FE+ P V
Sbjct: 79 MILVRKAFSQSVYYKDTFFRDIAVSSMVSGHKNFLKLIGYCLEFEE--PVMVYHGVKKHY 136
Query: 95 ----------SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144
++KIA +IA+A+AYLH F RP V R + T I+L E+ VA+L DF+
Sbjct: 137 HLESSEQPWKRRMKIAEDIATALAYLHTAFPRPFVYRCLSLTNILLDEDGVAKLMDFSFC 196
Query: 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
+SIPEGET + + + GT ++ P Y G SE++DV++ G + LL G+KI
Sbjct: 197 VSIPEGETFVQ-VDYIAGTVDYLKPNYLKHGVVSEETDVFAVGHSMQMLLMGEKI----- 250
Query: 205 FDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESE 264
FD R K++E EI DP E G + E+ Q+ L+ +C
Sbjct: 251 FD--RIMRRPFPTSKFMEEPKMDEIADP----EMGEISEEELCQMKAFLLLSLRCTGHV- 303
Query: 265 GDRPTIVQVAKQLRQI 280
G+ PT+V+VAK+L+ I
Sbjct: 304 GEVPTMVEVAKELKSI 319
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (297), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 74/188 (39%), Positives = 103/188 (54%), Gaps = 17/188 (9%)
Query: 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP-EGETH 153
++LKI +E A + YLH G P+V RD+K T I+L E A+L DF LS S P EGETH
Sbjct: 690 TRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETH 749
Query: 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
+ S V GT G++ PEY T +EKSDVYSFG +LLE++T + + S E +
Sbjct: 750 V--STVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR----EKPHI 803
Query: 214 QDLVKKYIENESFKEIVDPAIVG--EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIV 271
+ V + + I+DP + G + G +W ELA CL+ S RPT+
Sbjct: 804 AEWVGLMLTKGDIQNIMDPKLYGDYDSGSVWR--------AVELAMSCLNPSSARRPTMS 855
Query: 272 QVAKQLRQ 279
QV +L +
Sbjct: 856 QVVIELNE 863
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 118 bits (296), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 76/209 (36%), Positives = 117/209 (55%), Gaps = 24/209 (11%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
+L + S++ +E+ +L+I+++ A + YLH G P+V RD+KPT I++ E+
Sbjct: 652 YLSGKNSSILSWEE-------RLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKL 704
Query: 135 VAQLFDFTLSLSIP-EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLEL 193
A++ DF LS S EG++ + S V GT G++ PE+ + FSEKSDVYSFG +LLE+
Sbjct: 705 QAKIADFGLSRSFTLEGDSQV--STEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEV 762
Query: 194 LTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE---GLMWPEKEQQLL 250
+TG+ + S + E+ + D V + K IVDP + GE GL W
Sbjct: 763 ITGQPVISRSRTE--ENRHISDRVSLMLSKGDIKSIVDPKL-GERFNAGLAWK------- 812
Query: 251 ICTELAFKCLSESEGDRPTIVQVAKQLRQ 279
TE+A C SES R T+ QV +L++
Sbjct: 813 -ITEVALACASESTKTRLTMSQVVAELKE 840
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (296), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 69/186 (37%), Positives = 104/186 (55%), Gaps = 13/186 (6%)
Query: 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP-EGETH 153
++++IA+E A + YLH G + P+V RD+K T I+L E A+L DF LS S P +GE+H
Sbjct: 663 NRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESH 722
Query: 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
+ S V GT G++ PEY T SEKSDVYSFG +LLE++T + ++ + E +
Sbjct: 723 V--STVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR----ERTHI 776
Query: 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ V + K I+DP ++G+ K ELA C++ S RPT+ V
Sbjct: 777 NEWVGSMLTKGDIKSILDPKLMGDYDTNGAWK------IVELALACVNPSSNRRPTMAHV 830
Query: 274 AKQLRQ 279
+L +
Sbjct: 831 VTELNE 836
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (295), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 74/189 (39%), Positives = 108/189 (57%), Gaps = 10/189 (5%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+L IAIEIA A++YLH S P+ RDIK T I+L E N A++ DF S S+ +TH+
Sbjct: 515 RLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHL- 573
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ +V GTFG++ PEY + F+EKSDVYSFG +L+ELLTG+K SS E+ L
Sbjct: 574 -TTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAA 630
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
+ ++ +IVD I E + Q++ LA +CL+ RP + +V+
Sbjct: 631 HFVEAVKENRVLDIVDDRIKDECNM------DQVMSVANLARRCLNRKGKKRPNMREVSI 684
Query: 276 QLRQIYQSN 284
+L I S+
Sbjct: 685 ELEMIRSSH 693
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 117 bits (293), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 70/192 (36%), Positives = 112/192 (58%), Gaps = 11/192 (5%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP- 148
P+S+ ++KIA+ A +++LH +PV+ RD K + I+L E A+L DF L+ P
Sbjct: 238 LPWSI-RMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPD 296
Query: 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDG 208
EG+TH+ S RV+GT+G+ APEY TG + KSDVYSFG +LLE+LTG++ S + +G
Sbjct: 297 EGKTHV--STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNG 353
Query: 209 EDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP 268
E ++ ++ F ++DP + G + +K T+LA +CLS RP
Sbjct: 354 EHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQK------VTQLAAQCLSRDSKIRP 407
Query: 269 TIVQVAKQLRQI 280
+ +V + L+ +
Sbjct: 408 KMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 117 bits (293), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 69/192 (35%), Positives = 111/192 (57%), Gaps = 11/192 (5%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP- 148
P+S+ ++KIA+ A +++LH +PV+ RD K + I+L + A+L DF L+ P
Sbjct: 244 LPWSI-RMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPD 302
Query: 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDG 208
EG+TH+ S RV+GT+G+ APEY TG + KSDVYSFG +LLE+LTG++ S + +G
Sbjct: 303 EGKTHV--STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNG 359
Query: 209 EDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP 268
E ++ ++ F ++DP + G + +K T+LA +CLS RP
Sbjct: 360 EHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQK------VTQLAAQCLSRDPKIRP 413
Query: 269 TIVQVAKQLRQI 280
+ V + L+ +
Sbjct: 414 KMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 116 bits (290), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 102/186 (54%), Gaps = 13/186 (6%)
Query: 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG-ETH 153
++L+IA E A + YLH+G P++ RDIK I+L A+L DF LS S P G ETH
Sbjct: 689 NRLRIAAETAQGLEYLHIGCKPPMIHRDIKSMNILLDNNFQAKLGDFGLSRSFPVGSETH 748
Query: 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
+ S V G+ G++ PEY T +EKSDV+SFG +LLE++T + + + E +
Sbjct: 749 V--STNVAGSPGYLDPEYYRTNWLTEKSDVFSFGVVLLEIITSQPVIDQTR----EKSHI 802
Query: 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ V + N K IVDP++ G+ L ELA C+S S RP + QV
Sbjct: 803 GEWVGFKLTNGDIKNIVDPSMNGD------YDSSSLWKALELAMSCVSPSSSGRPNMSQV 856
Query: 274 AKQLRQ 279
A +L++
Sbjct: 857 ANELQE 862
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 284 | ||||||
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.919 | 0.788 | 0.409 | 4e-52 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.971 | 0.802 | 0.375 | 3e-50 | |
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.637 | 0.546 | 0.524 | 4e-45 | |
| 255542668 | 307 | serine-threonine protein kinase, plant-t | 0.947 | 0.876 | 0.411 | 6e-43 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.968 | 0.772 | 0.364 | 3e-42 | |
| 255539344 | 340 | receptor protein kinase, putative [Ricin | 0.936 | 0.782 | 0.362 | 2e-39 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.651 | 0.560 | 0.476 | 2e-39 | |
| 359495254 | 331 | PREDICTED: wall-associated receptor kina | 0.915 | 0.785 | 0.352 | 4e-37 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.904 | 0.800 | 0.352 | 6e-37 | |
| 62320087 | 351 | protein kinase - like protein [Arabidops | 0.936 | 0.757 | 0.295 | 2e-36 |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 211 bits (536), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 131/320 (40%), Positives = 171/320 (53%), Gaps = 59/320 (18%)
Query: 18 KFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFLQ 77
K ++ NG+ LLEK +A +NG+ NP+R FS EL+ AT+ + V +LYKG ++
Sbjct: 12 KALMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFYIDGTCRLYKGLIR 71
Query: 78 DRPISVMKF---------------------------------EDTFPFSV---------- 94
DRP+ V K+ E P V
Sbjct: 72 DRPVIVKKYDYKHPSEDPVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAEKGTLE 131
Query: 95 -----------SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143
+LKIA+++AS +AYLH F RP+V RDI +I+L E+ A++ F+L
Sbjct: 132 DYVQKTALLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDEDCAAKVTGFSL 191
Query: 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203
S+SIPEGETHI D V GT G++APEY F+EK DVYSFG +LL LLTG S
Sbjct: 192 SISIPEGETHIED--EVAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLLTGHGPILRS 249
Query: 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSES 263
+ E + L V+ I+NE F EI+DPAI+ EEG WPEKEQQL LA +C +
Sbjct: 250 PTTN-ESHALVVFVEAKIKNERFNEIIDPAIL-EEG-PWPEKEQQLKSFLTLAMQCTRKD 306
Query: 264 EGDRPTIVQVAKQLRQIYQS 283
E DRP I VAKQLR IY S
Sbjct: 307 EEDRPEITDVAKQLRHIYHS 326
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 204 bits (519), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 129/344 (37%), Positives = 191/344 (55%), Gaps = 68/344 (19%)
Query: 1 MGSCLRSRKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGG 60
M +C ++K +K K + NG LLEKL+ +GK N IRSFSA ELK AT+++D
Sbjct: 1 MSTCWETKKD-KKVNKETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQ 59
Query: 61 KVIMKCLFYKL-------------------------------------YKGF-------L 76
K++ YKL +K F L
Sbjct: 60 KILTGDSGYKLYKGFLQGRPVSVKKFKDDDEQYEYCFNDIVYASKMSVHKSFMKLLGCCL 119
Query: 77 QDR-PISVMKFEDTFPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVV 119
+ R PI V ++ + S + + KIA+++A+AVA+LH FS+P+V
Sbjct: 120 EARIPILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIV 179
Query: 120 SRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSE 179
R+IKP I+L + + A+L DF++S+SIP+GE+H+ DS V G G +APEY TTG+F+E
Sbjct: 180 FRNIKPLNILLDDNHEAKLSDFSISISIPKGESHVRDS--VAGATGLIAPEYLTTGNFNE 237
Query: 180 KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239
K DV++FG LL LL+G+ + S + ++ LQD VKK IE++ F +++D I+ E
Sbjct: 238 KQDVFNFGVFLLVLLSGQMVVDFSRPE--KEILLQDHVKKCIEDDRFNKVIDSTIIAEG- 294
Query: 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
WP KEQQL T L+ +C+SE DRPT++ V+K+LR+IY S
Sbjct: 295 -TWPGKEQQLQAYTALSLRCISELAEDRPTMIDVSKELRKIYWS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 187 bits (476), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 97/185 (52%), Positives = 132/185 (71%), Gaps = 4/185 (2%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+LKIA+EIA+AV+YLH FSRP+V R+IKP I L E +VA+L DF+L++SIPEGE+H+
Sbjct: 149 RLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAKLSDFSLAVSIPEGESHVK 208
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
D + G +G +APEY T F+E DVY+FG LL LLTG+K+ S GE+ L D
Sbjct: 209 D--MLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQKVVDSYRPQAGEELGLVD 266
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
VKK+I ++ F E VD I+GE L PEK+QQL T L+F+C+SE++ DRP ++ VAK
Sbjct: 267 HVKKFIADDRFYETVDSIILGEGSL--PEKDQQLQAFTLLSFRCISEADEDRPMMIDVAK 324
Query: 276 QLRQI 280
+LR+I
Sbjct: 325 ELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 180 bits (457), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 124/301 (41%), Positives = 172/301 (57%), Gaps = 32/301 (10%)
Query: 1 MGSCLRSRKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDF--- 57
M SC + +K +L NG LLEK IA +NG+ + + A +++ +D
Sbjct: 16 MFSCFKGKKD------ETVLLRNGSRLLEKSIALNNGRVIVKKYYWASDMEDPINDIVFA 69
Query: 58 -------DGGKVIMKCLFYKL--------YKGFLQDRPISVMKFEDTFPFSVSKLKIAIE 102
+ K++ CL K+ KG L+D K + +L+IA++
Sbjct: 70 SEMSVHKNVLKLLGCCLESKIPILVFECAQKGILKDY---FYKTDSASLLWQIRLRIAVD 126
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+AS ++YLH F RP+V RDI + I+L E+ +A++ F+LS+SIPEG+THI D V+G
Sbjct: 127 VASVISYLHSAFPRPIVHRDITLSNILLDEDYIAKVTGFSLSMSIPEGKTHIED--EVVG 184
Query: 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222
T G++AP Y T F+EK DVYSFG LLL LLTG++ S Y L + VK+ IE
Sbjct: 185 TPGYLAPAYFKTLMFNEKIDVYSFGVLLLVLLTGQQPILHSPTTTAR-YSLVNFVKEKIE 243
Query: 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282
+E F EI+DP I+ EEG WPEKE+QL I LA +C E+E DRP I VAKQLR IY
Sbjct: 244 DERFDEIIDPVIL-EEG-PWPEKERQLEIFLTLAMQCTHENEEDRPEITDVAKQLRHIYH 301
Query: 283 S 283
S
Sbjct: 302 S 302
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 178 bits (451), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 132/362 (36%), Positives = 175/362 (48%), Gaps = 87/362 (24%)
Query: 1 MGSCLRSRKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGG 60
M SC R E ++ NG ILLEK IA +NG+ NPIR FS DEL+TAT+ +
Sbjct: 1 MFSCFRDNMD----ENETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQN 56
Query: 61 KVIMKCLFYKL--------------YKGFLQDR--PISVMKF------------------ 86
VI + ++ L Y+ + +R PI+ + F
Sbjct: 57 NVIYEGGWHTLYKGFLRDRPVIVKRYRNNIHERVCPINDIVFASEMSRHKNVLKLLGCCL 116
Query: 87 EDTFPFSV---------------------------SKLKIAIEIASAVAYLHVGFSRPVV 119
E P V S+LKIA++ A+ +AYLH RPVV
Sbjct: 117 ESEIPILVFEYAEKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVV 176
Query: 120 SRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSE 179
RDI + I L E+ VA++ DFT+S+SI EGETHI D V+GT G+ APEY +G F+E
Sbjct: 177 HRDITLSNIWLDEDYVAKVTDFTVSMSILEGETHIEDF--VLGTCGYAAPEYVRSGIFNE 234
Query: 180 KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI-------ENESFKEI--- 229
K DV+SFG LLL LLT +K + + +D R +++ I E E +
Sbjct: 235 KIDVFSFGVLLLVLLTDQKPFQGNWENILKDARFDEIIGSLIVEKGLWSEKEQLETFLTR 294
Query: 230 --------VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281
+DP IV EEG WPEKEQQL L +C+ E +RP I VAKQLR Y
Sbjct: 295 TRQKLDLTIDPIIV-EEG-PWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFY 352
Query: 282 QS 283
S
Sbjct: 353 LS 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539344|ref|XP_002510737.1| receptor protein kinase, putative [Ricinus communis] gi|223551438|gb|EEF52924.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 169 bits (427), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 107/295 (36%), Positives = 170/295 (57%), Gaps = 29/295 (9%)
Query: 15 EKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKG 74
E++K L NG LLE+ IA NG NPI++FSAD+L A +DF + + + KG
Sbjct: 46 ERQKCWLENGSKLLEERIAFGNGGGNPIKTFSADKLHEAIEDFRKKHPLNSIIDFTWCKG 105
Query: 75 FLQDRPISVMKF----EDTFPFSV---------SKLKI----------AIEIASAVAYLH 111
+ R I + K+ ++ + +V + LK+ A+E+ASAVAYLH
Sbjct: 106 IMDGRLILIKKYFKSCKEAYQDNVITSHMSTHNNVLKLLGCCLELPGPALEVASAVAYLH 165
Query: 112 VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEY 171
FS+ +V RD+KP I L A+L DF+L +SIPEGE+ + D + + GT+GF+ P Y
Sbjct: 166 TAFSKRIVHRDVKPENIFLDHNFAAKLSDFSLCISIPEGESRVKDCS-ITGTWGFLDPNY 224
Query: 172 RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231
T +EK+DV+SFG +L LLT ++ +++ H+ + + D V+ +E + F E+
Sbjct: 225 VLTEFVTEKTDVFSFGVFMLVLLT-EQPAFTRHYSENGG-SVVDHVEYLVERDRFDEVPG 282
Query: 232 PAIVGEEGL--MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284
P I+ E G + P+ +L TELA +C + DRP+I++VA+QL++IY ++
Sbjct: 283 PGIL-ENGRTEIEPQLRSELQAFTELALRCTHLTGEDRPSILEVAQQLQKIYSTS 336
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 168 bits (426), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 90/189 (47%), Positives = 127/189 (67%), Gaps = 4/189 (2%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+LKI +IA+ V Y+H F RP+V R+IK + I+L E+ VA+L DF+L +SIPEG++ +
Sbjct: 143 RLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDEDYVAKLSDFSLCVSIPEGKSRVR 202
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
D + GT G +A E TG F+EKSDVYSFG +LL +LTG++ S + GE + L +
Sbjct: 203 DI--MAGTMGLIASESLATGYFNEKSDVYSFGVVLLVVLTGQRSFDFSRTETGEQFLLVN 260
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
VKK+IE FKE+VDP IV EE K Q+L +LA +C+ +S +RPT+++VAK
Sbjct: 261 HVKKHIETGGFKEMVDPIIVAEEA--GNRKGQELEDFRDLALRCIHDSAEERPTMIEVAK 318
Query: 276 QLRQIYQSN 284
QLR IY S+
Sbjct: 319 QLRHIYLSS 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495254|ref|XP_002271826.2| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 160 bits (406), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 115/326 (35%), Positives = 173/326 (53%), Gaps = 66/326 (20%)
Query: 13 KAEKRKFMLGNGKILLEKLIASSNGKH-NPIRSFSADELKTATDDFDGGKV----IMKCL 67
K K++ ML NG +LL++ I+ NGK+ NPIRSF EL+ ATDD++ G + + C+
Sbjct: 7 KEMKKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCI 66
Query: 68 FYK-------------LYKGF--------------------------LQDR-PISVMKFE 87
+YK Y+G L+ R PI V +F
Sbjct: 67 WYKGSLEGRTISVRTNFYEGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFP 126
Query: 88 D-----------TFPFSV-SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV 135
P S S+L+IA +IA+ +AYLH+ F R ++ DIKP++ L ++
Sbjct: 127 SGGSLIDRIFSPPNPLSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQDCA 186
Query: 136 AQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
A+L DF+LS+++PEGE H+ D R GTFG++APE +G ++EK+DV+SFG LLLELL
Sbjct: 187 AKLSDFSLSITLPEGEMHVEDEIR--GTFGYLAPETLISGVYTEKNDVFSFGILLLELLI 244
Query: 196 GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE-EGLMWPEKEQQLLICTE 254
GK+ H E +QD + ++ IVDP I+ + G+ +E Q +
Sbjct: 245 GKRAHSIMH---EERASIQDYAQSFVNTYDINGIVDPIILAQPRGI---HEELQFQAIFD 298
Query: 255 LAFKCLSESEGDRPTIVQVAKQLRQI 280
LA +C + +RPTIV AK++R+I
Sbjct: 299 LAMRCSMKDMDERPTIVNAAKEVRRI 324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 160 bits (405), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 114/323 (35%), Positives = 172/323 (53%), Gaps = 66/323 (20%)
Query: 16 KRKFMLGNGKILLEKLIASSNGKH-NPIRSFSADELKTATDDFDGGKV----IMKCLFYK 70
K++ ML NG +LL++ I+ NGK+ NPIRSF EL+ ATDD++ G + + C++YK
Sbjct: 2 KKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIWYK 61
Query: 71 -------------LYKGF--------------------------LQDR-PISVMKFED-- 88
Y+G L+ R PI V +F
Sbjct: 62 GSLEGRTISVRTNFYEGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFPSGG 121
Query: 89 ---------TFPFSV-SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138
P S S+L+IA +IA+ +AYLH+ F R ++ DIKP++ L ++ A+L
Sbjct: 122 SLIDRIFSPPNPLSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQDCAAKL 181
Query: 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198
DF+LS+++PEGE H+ D R GTFG++APE +G ++EK+DV+SFG LLLELL GK+
Sbjct: 182 SDFSLSITLPEGEMHVEDEIR--GTFGYLAPETLISGVYTEKNDVFSFGILLLELLIGKR 239
Query: 199 ISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE-EGLMWPEKEQQLLICTELAF 257
H E +QD + ++ IVDP I+ + G+ +E Q +LA
Sbjct: 240 AHSIMH---EERASIQDYAQSFVNTYDINGIVDPIILAQPRGI---HEELQFQAIFDLAM 293
Query: 258 KCLSESEGDRPTIVQVAKQLRQI 280
+C + +RPTIV AK++R+I
Sbjct: 294 RCSMKDMDERPTIVNAAKEVRRI 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62320087|dbj|BAD94258.1| protein kinase - like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 158 bits (400), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 100/338 (29%), Positives = 165/338 (48%), Gaps = 72/338 (21%)
Query: 12 EKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLFYKL 71
EK + +++ L NG I L +L+A NGK PIRSFS +++ AT++FD + + ++YK
Sbjct: 15 EKDKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDVYYKW 74
Query: 72 YKGFLQDRPISVMKFED-------------------------------------TFPFSV 94
Y+G ++DR + +F + FPF V
Sbjct: 75 YRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQPLGCCLEFPFPV 134
Query: 95 SKLKIA-------------------------IEIASAVA----YLHVGFSRPVVSRDIKP 125
+ A ++I +A YLH F + ++ RD+KP
Sbjct: 135 LVFEFAEHGAMNQRGGVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRDVKP 194
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYS 185
+ L + A+L D + S+S+PEG++ I ++ V+GTFG++ P Y T +E +DVYS
Sbjct: 195 MHVFLDKNWTAKLSDLSFSISLPEGKSRI-EAEWVLGTFGYIDPLYHKTCFVTEYTDVYS 253
Query: 186 FGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEK 245
FG LL ++TGK + DG+ + LV++ EN E++DP ++ + + +
Sbjct: 254 FGICLLVIITGKPAIMT--ISDGDLQGILSLVRELCENGKLDEVIDPRLMKD---ITSGQ 308
Query: 246 EQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
Q+ C LA +C E + DRP ++QVAK+L+QI S
Sbjct: 309 RLQVEACVVLALRCCKERDEDRPKMIQVAKELKQIEAS 346
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 284 | ||||||
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.669 | 0.541 | 0.385 | 5.3e-47 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.707 | 0.559 | 0.360 | 1.8e-44 | |
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.658 | 0.55 | 0.386 | 5.9e-44 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.679 | 0.543 | 0.37 | 1.4e-42 | |
| TAIR|locus:2076646 | 334 | AT3G57750 [Arabidopsis thalian | 0.644 | 0.547 | 0.374 | 1.5e-41 | |
| TAIR|locus:2206235 | 372 | AT1G65250 [Arabidopsis thalian | 0.647 | 0.494 | 0.348 | 1.3e-34 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.630 | 0.239 | 0.391 | 1.1e-32 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.633 | 0.25 | 0.395 | 2.9e-32 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.626 | 0.243 | 0.377 | 4.3e-32 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.626 | 0.237 | 0.393 | 6.1e-32 |
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 346 (126.9 bits), Expect = 5.3e-47, Sum P(2) = 5.3e-47
Identities = 76/197 (38%), Positives = 119/197 (60%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146
E P+SV +LKI EIA+AV YLH F + ++ RD+KP + L + A+L D + S+S
Sbjct: 157 ESLLPWSV-RLKIGKEIANAVTYLHTAFPKIIIHRDVKPMHVFLDKNWTAKLSDLSFSIS 215
Query: 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD 206
+PEG++ I ++ V+GTFG++ P Y T +E +DVYSFG LL ++TGK +
Sbjct: 216 LPEGKSRI-EAEWVLGTFGYIDPLYHKTCFVTEYTDVYSFGICLLVIITGKPAIMT--IS 272
Query: 207 DGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD 266
DG+ + LV++ EN E++DP ++ + + + Q+ C LA +C E + D
Sbjct: 273 DGDLQGILSLVRELCENGKLDEVIDPRLMKD---ITSGQRLQVEACVVLALRCCKERDED 329
Query: 267 RPTIVQVAKQLRQIYQS 283
RP ++QVAK+L+QI S
Sbjct: 330 RPKMIQVAKELKQIEAS 346
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 320 (117.7 bits), Expect = 1.8e-44, Sum P(2) = 1.8e-44
Identities = 75/208 (36%), Positives = 121/208 (58%)
Query: 74 GFLQDRPISVMKFEDTF-PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE 132
G L R ++ E+ P S+ +LKI EIA+AV YLH+ F + ++ R IKP + L E
Sbjct: 151 GVLNHRGGVIVNGEEVILPLSL-RLKIGKEIANAVTYLHMAFPKILIHRHIKPRNVFLDE 209
Query: 133 ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLE 192
+L DF++S+++PEG++ I + V GT G++ P Y TT +E +DVYSFG L+
Sbjct: 210 NWTPKLSDFSISINLPEGKSRI-EVECVQGTIGYLDPVYYTTKMVTEYTDVYSFGVFLMV 268
Query: 193 LLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252
+LTGK + +S DG+ + VK + EN ++DP ++ E + +K + C
Sbjct: 269 ILTGKP-ALASTSSDGDYKHIASYVKGFHENGQLDGVIDPKVM--EDITSAQKVH-VEAC 324
Query: 253 TELAFKCLSESEGDRPTIVQVAKQLRQI 280
LA +C + +RP ++Q+AK+L+QI
Sbjct: 325 VVLALRCCELRDENRPKMIQIAKELKQI 352
|
|
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 303 (111.7 bits), Expect = 5.9e-44, Sum P(2) = 5.9e-44
Identities = 75/194 (38%), Positives = 114/194 (58%)
Query: 89 TFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148
+FP++V +L+IA EIA AVAYLH F R ++ RD+K I L E A+L F+LS+ +P
Sbjct: 148 SFPWNV-RLRIAKEIADAVAYLHTEFPRTIIHRDLKLANIFLDENWSAKLSSFSLSIVLP 206
Query: 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDG 208
EGET +ND V T ++ P+Y TG +E D+YS G ++L +LTGK Y+S
Sbjct: 207 EGETGVNDM--VCRTSSYIEPDYFNTGLVTENVDIYSLGIIMLIILTGKS-EYNSEVAVY 263
Query: 209 EDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ-QLLICTELAFKCLSESEGDR 267
L V K++E E++DP+I+ P+ + Q+ ELAF+C+ G+
Sbjct: 264 LPV-LPVYVGKFLERGLLTELIDPSILDSTSDDIPKHSRLQMEAFIELAFRCVRFRPGEN 322
Query: 268 -PTIVQVAKQLRQI 280
P ++ VAK+L++I
Sbjct: 323 VPRMIDVAKELKKI 336
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 318 (117.0 bits), Expect = 1.4e-42, Sum P(2) = 1.4e-42
Identities = 74/200 (37%), Positives = 116/200 (58%)
Query: 81 ISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140
I+V E P S+ +LKI EIA+A+AYLH+ F + ++ RD+KP + L A+L D
Sbjct: 156 ITVNGEESLLPLSL-RLKIGKEIANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAKLSD 214
Query: 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKIS 200
+ S+S+ EG++ I ++ V+GT+G++ P Y T +E +DVYSFG L+ ++TG +
Sbjct: 215 LSFSISLEEGKSQI-EAEDVLGTYGYLDPLYFATRIVTEYTDVYSFGVFLMVVITGISVY 273
Query: 201 YSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCL 260
++ DG + +K EN EIV P I+ E M + Q+ C LA +C
Sbjct: 274 FTG--SDGYPVGILGYMKGLAENGKLNEIVYPMIMKE---MTSAQRLQVEACVLLALRCC 328
Query: 261 SESEGDRPTIVQVAKQLRQI 280
E DRP ++QVAK+L++I
Sbjct: 329 EERVEDRPKMIQVAKELKRI 348
|
|
| TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 286 (105.7 bits), Expect = 1.5e-41, Sum P(2) = 1.5e-41
Identities = 73/195 (37%), Positives = 110/195 (56%)
Query: 91 PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150
P+ V +LKIA EIAS+V YLH F +V R+I PT I + E A+L DF ++IPEG
Sbjct: 143 PWKV-RLKIAKEIASSVTYLHTAFPETIVHRNINPTNIFIDENWTAKLSDFWFCVAIPEG 201
Query: 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210
E ++ D V G GF+ P+Y T +EK D+YSFG ++L LL+G+ ++ D
Sbjct: 202 ELYVEDD--VKGVIGFVDPDYYWTMKVTEKVDIYSFGVVMLVLLSGRAAVFNG--PDEAP 257
Query: 211 YRLQDLVKKYIENESFKEIVDPAIV----GEEGLMWPEKEQQLLICTELAFKCLSESEGD 266
L D V + +E F EIVD I G++ L+ + Q+ LA +C+ + D
Sbjct: 258 MSLNDHVSEVMEKGEFDEIVDKEIWNDLGGDDDLVL--RRSQVKAFLRLALRCVRYKKED 315
Query: 267 RPT-IVQVAKQLRQI 280
+ +++VAK+L+ I
Sbjct: 316 PVSGMLEVAKELKLI 330
|
|
| TAIR|locus:2206235 AT1G65250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 269 (99.8 bits), Expect = 1.3e-34, Sum P(2) = 1.3e-34
Identities = 70/201 (34%), Positives = 116/201 (57%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
++KIA +IA+A+AYLH F RP V R + I+L E+ VA+L DF+ +SIPEGET +
Sbjct: 147 RMKIAEDIATALAYLHTAFPRPFVYRILSHWNILLDEDGVAKLTDFSHCVSIPEGETFVR 206
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALL-LELLTGKKISYSSHFDDGEDYRLQ 214
+R +G + + A Y +G S+K+DV++FG + LL G + Y H+ GE+ +
Sbjct: 207 -VDRDVGLYSYFADNYVRSGLVSDKTDVFAFGIFMGHRLLLGYEY-YFEHYR-GEEEESE 263
Query: 215 D----LVKKYIEN--------ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSE 262
D L+K++ N +EI D ++ + G + ++ Q+ +L+ +C
Sbjct: 264 DGFDSLMKRHARNLLSTLKEDRPMEEIADSKMIEKMGQISEQERCQMKAFLKLSLRCTGP 323
Query: 263 SEGDRPTIVQVAKQLRQIYQS 283
SE + PT+V+VAK+L +I +S
Sbjct: 324 SE-EVPTMVEVAKELNKIQRS 343
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 1.1e-32, Sum P(2) = 1.1e-32
Identities = 74/189 (39%), Positives = 107/189 (56%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+L IAIEIA A++YLH S P+ RDIK T I+L E N A++ DF S S+ +TH+
Sbjct: 515 RLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHL- 573
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ +V GTFG++ PEY + F+EKSDVYSFG +L+ELLTG+K S ++
Sbjct: 574 -TTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAH- 631
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
V+ EN +IVD I E + Q++ LA +CL+ RP + +V+
Sbjct: 632 FVEAVKENRVL-DIVDDRIKDECNM------DQVMSVANLARRCLNRKGKKRPNMREVSI 684
Query: 276 QLRQIYQSN 284
+L I S+
Sbjct: 685 ELEMIRSSH 693
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 270 (100.1 bits), Expect = 2.9e-32, Sum P(2) = 2.9e-32
Identities = 76/192 (39%), Positives = 112/192 (58%)
Query: 87 EDTFPFSVS-KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145
ED FP S +L IA E+A A++YLH S P+ RD+K T I+L E++ A++ DF +S
Sbjct: 480 ED-FPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISR 538
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF 205
S+ +TH+ + V GT G++ PEY + F+ KSDVYSFG LL+ELLTG+K S
Sbjct: 539 SVAIDDTHL--TTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPV--SLL 594
Query: 206 DDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEG 265
E L + + N+ EI+D A + EE ++E+ L + +LA +CLS +
Sbjct: 595 RRQEVRMLGAYFLEAMRNDRLHEILD-ARIKEEC----DREEVLAVA-KLARRCLSLNSE 648
Query: 266 DRPTIVQVAKQL 277
RPT+ V +L
Sbjct: 649 HRPTMRDVFIEL 660
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 287 (106.1 bits), Expect = 4.3e-32, Sum P(2) = 4.3e-32
Identities = 71/188 (37%), Positives = 108/188 (57%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+L+IAIEIA A+ Y+H S P+ RDIK T I+L E+ A++ DF S S+ +TH+
Sbjct: 528 RLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHL- 586
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ V GTFG+M PEY + ++ KSDVYSFG +L+EL+TG+K ++G
Sbjct: 587 -TTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHF 645
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
L + EN +I+D I E L +Q++ +LA KCL+ +RP + +V+
Sbjct: 646 L-EAMKENRVI-DIIDIRIKDESKL------EQVMAVAKLARKCLNRKGKNRPNMKEVSN 697
Query: 276 QLRQIYQS 283
+L +I S
Sbjct: 698 ELERIRSS 705
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 289 (106.8 bits), Expect = 6.1e-32, Sum P(2) = 6.1e-32
Identities = 74/188 (39%), Positives = 112/188 (59%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+L+I++EIA A+AYLH S PV RD+K T I+L E+ A++ DF S SI +TH+
Sbjct: 520 RLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHL- 578
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ V GTFG++ PEY T F++KSDVYSFG +L+EL+TG+K +S + E+ L
Sbjct: 579 -TTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEK-PFSVMRPE-ENRGLVS 635
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
+ ++ +IVD I +EG +Q+L +LA +CLS RP + +V+
Sbjct: 636 HFNEAMKQNRVLDIVDSRI--KEGCTL----EQVLAVAKLARRCLSLKGKKRPNMREVSV 689
Query: 276 QLRQIYQS 283
+L +I S
Sbjct: 690 ELERIRSS 697
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pm.C_LG_XIII000087 | hypothetical protein (344 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 284 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-16 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-15 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-15 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-08 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.001 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.002 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHI 154
L+I ++I + YLH S ++ RD+KP I+L +N +L DF LS + +
Sbjct: 94 ILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--- 147
Query: 155 NDSNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLEL 193
+ ++GT +MAPE G +SEKSD++S G +L EL
Sbjct: 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-16
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 25/177 (14%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
KIA++I + YLH S ++ RD+KP I+L E V ++ DF L+ + +
Sbjct: 102 KIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLA-KKLLKSSSSLTT 157
Query: 158 NRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+GT +MAPE + K DV+S G +L ELLTGK + D
Sbjct: 158 --FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD--------- 206
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ + + I+ P + P+ +L KCL++ RPT ++
Sbjct: 207 -----QLQLIRRILGPPL----EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 6e-16
Identities = 46/208 (22%), Positives = 79/208 (37%), Gaps = 31/208 (14%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE 132
+L+ E + L AI+IA + YL S+ V RD+ ++ E
Sbjct: 84 LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGE 140
Query: 133 ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLE 192
+ V ++ DF LS + + + + + + +MAPE G F+ KSDV+SFG LL E
Sbjct: 141 DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWE 199
Query: 193 LLTGKKISYSSHFDDGEDYRLQDLVKKYIENE--SFKEIVDPAIVGEEGLMWPEKEQQLL 250
+ T Y +++++ + E +
Sbjct: 200 IFTLGATPY-------PGLSNEEVLEYLRKGYRLPKPEYCPDEL---------------- 236
Query: 251 ICTELAFKCLSESEGDRPTIVQVAKQLR 278
EL C DRPT ++ ++L
Sbjct: 237 --YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-15
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
+I +AYLH S +V RDIK I++ + V +L DF + + + ET +
Sbjct: 107 TRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET-GEGTGS 162
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V GT +MAPE ++ +D++S G ++E+ TGK
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-15
Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
++K ++ +I SA+ YLH S+ +V RD+KP I+L E+ +L DF
Sbjct: 86 DLLKKRGRLSEDEAR-FYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADF 141
Query: 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
L+ + GE +GT +MAPE + + D++S G +L ELLTGK
Sbjct: 142 GLARQLDPGEKL----TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 6e-15
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 28/182 (15%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
L A++IA + YL S+ + RD+ ++ E V ++ DF LS + + + +
Sbjct: 104 LLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK 160
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
++ +MAPE G F+ KSDV+SFG LL E+ T + Y E+
Sbjct: 161 RGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPG--MSNEE----- 211
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
V +Y++N P + +L +C +E DRPT ++ +
Sbjct: 212 -VLEYLKNGYRLPQPPNC---------PPE------LYDLMLQCWAEDPEDRPTFSELVE 255
Query: 276 QL 277
L
Sbjct: 256 IL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 91 PFSVSKLKIAI-EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
FS ++K I EI A+ YLH S+ ++ RDIKP I+L E+ + DF ++ +
Sbjct: 96 KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198
+ GT G+MAPE +S D +S G E L GK+
Sbjct: 153 DTL----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 5e-14
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 12/130 (9%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE 132
+L+ + D L A++IA + YL S+ + RD+ ++ E
Sbjct: 89 LDYLRKNRPKELSLSD-------LLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGE 138
Query: 133 ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLE 192
V ++ DF LS + + + + ++ +MAPE G F+ KSDV+SFG LL E
Sbjct: 139 NLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWE 196
Query: 193 LLTGKKISYS 202
+ T + Y
Sbjct: 197 IFTLGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (171), Expect = 7e-14
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 42/186 (22%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L +++ A+ YLH SR ++ RDIKP I L + +L DF +S + + ++
Sbjct: 106 LDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDL 159
Query: 157 SNRVIGTFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210
+ V+GT +++PE Y + KSD++S G +L EL T K +
Sbjct: 160 AKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGEN------ 207
Query: 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270
L +L K I + I P+ E L L L + +RP+I
Sbjct: 208 --LLELALK-ILKGQYPPI--PSQYSSE-----------LR--NLVSSLLQKDPEERPSI 249
Query: 271 VQVAKQ 276
Q+ +
Sbjct: 250 AQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 9e-14
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 14/151 (9%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
S + E F ++ A EI A+ YLH S ++ RD+KP I+L + +L DF
Sbjct: 82 SHLSKEGRFSEERARFYAA-EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDF 137
Query: 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
L+ + + N GT ++APE + + D +S G LL E+LTGK
Sbjct: 138 GLAKELSSEGSRTNT---FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK---- 190
Query: 202 SSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232
F + + + + K + F E + P
Sbjct: 191 -PPFYAEDRKEIYEKILK--DPLRFPEFLSP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 52/182 (28%), Positives = 74/182 (40%), Gaps = 39/182 (21%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ E+ + YLH S ++ RDIK I+L + +L DF LS + + N
Sbjct: 103 VCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL----SDTKARN 155
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218
++GT +MAPE + K+D++S G +EL GK
Sbjct: 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK--------------------P 195
Query: 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTEL-AF--KCLSESEGDRPTIVQVAK 275
Y E K + A G GL PEK E F KCL ++ RPT A+
Sbjct: 196 PYSELPPMKALFKIATNGPPGLRNPEK-----WSDEFKDFLKKCLQKNPEKRPT----AE 246
Query: 276 QL 277
QL
Sbjct: 247 QL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 56/183 (30%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
KIAI IA A+ +LH S VV ++ P I++ ++ L LS+P D+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLPG--LLCTDT 836
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217
I + ++APE R T D +EKSD+Y FG +L+ELLTGK + D E +V
Sbjct: 837 KCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA------DAEFGVHGSIV 889
Query: 218 K--KYIENESFKEI-VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274
+ +Y ++ ++ +DP+I G+ + + +++ LA C + RP V
Sbjct: 890 EWARYCYSDCHLDMWIDPSIRGDVSV----NQNEIVEVMNLALHCTATDPTARPCANDVL 945
Query: 275 KQL 277
K L
Sbjct: 946 KTL 948
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 36/116 (31%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
++K FP S+ + + ++ +AYLH + V+ RDIK I+ ++ V +L DF
Sbjct: 88 QIIKKFGPFPESLVAVYVY-QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADF 143
Query: 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
++ + + D V+GT +MAPE S SD++S G ++ELLTG
Sbjct: 144 GVATKLNDVS---KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
KIA + ++YLH SR ++ RDIKP+ I+L + +L DF +S GE + +
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF---DDGEDYRLQ 214
GT +MAPE +S SDV+S G LLE+ + F +GE
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR-------FPFPPEGEPPLGP 213
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT 269
+ YI N E+ D G+ W E+ + + CL + RPT
Sbjct: 214 IELLSYIVNMPNPELKDEP---GNGIKWSEEFKDFIKQ------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 7e-13
Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
L++A++IA + YL S+ V RD+ ++ E V ++ DF LS I E + +
Sbjct: 104 LLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK 160
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS--------SHFDD 207
+ +MAPE G F+ KSDV+SFG LL E+ T + Y +D
Sbjct: 161 RGGGKLPIK-WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
Query: 208 GEDYRL 213
G YRL
Sbjct: 220 G--YRL 223
|
Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 13/173 (7%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
S+++ + V+++ IA EI A+ YLH S ++ RD+KP I++ +L DF
Sbjct: 82 SLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDF 137
Query: 142 TLSLSIPEGET-----HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
LS + R++GT ++APE S+ D +S G +L E L G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 197 KKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQL 249
+ + Q+++ IE E+ D AI L+ P+ E++L
Sbjct: 198 ----IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRL 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 27/176 (15%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND- 156
KIA+ + + YL+ ++ RDIKP+ I++ +L DF +S GE IN
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GEL-INSI 158
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK-KISYSSHFDDGEDYRLQ- 214
++ +GT +M+PE G ++ KSDV+S G ++EL GK ++S+ DDG+D +
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 215 -DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT 269
DL+++ IV E P + CL + +RPT
Sbjct: 219 LDLLQQ--------------IVQEPPPRLP-SSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 34 SSNGKHNP--IRSFSADELKTATDDFDGGKVIMKCL----FYKLYKGFLQDRPISVMKFE 87
+S GK P ++ +D+L DDF IM L +LY G + P+ +M E
Sbjct: 18 TSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY-GVVLTHPL-MMVTE 75
Query: 88 --------DTF------PFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE 132
D F +S L A++IA+ + YL S+ + RD+ I+L
Sbjct: 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLAS 132
Query: 133 ENVAQLFDFTLSLSIPEGETH-INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLL 191
++ ++ DF L ++P+ E H + + + + F + APE T FS SDV+ FG L
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLW 191
Query: 192 ELLT 195
E+ T
Sbjct: 192 EMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 62.8 bits (151), Expect = 3e-11
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 23/217 (10%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
L + G + + + + S + I +I SA+ YLH S+ ++ RDIKP
Sbjct: 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALEYLH---SKGIIHRDIKPE 130
Query: 127 TIVLQEE-NVAQLFDFTLSLSIPEGETHIND---SNRVIGTFGFMAPEY---RTTGDFSE 179
I+L + V +L DF L+ +P+ + + + +GT G+MAPE + S
Sbjct: 131 NILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASS 190
Query: 180 KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239
SD++S G L ELLTG F+ ++ K I + P
Sbjct: 191 SSDIWSLGITLYELLTGL-----PPFEGEKNSSATSQTLKIILELPTPSLASPLS----- 240
Query: 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
E ++L K L++ +R +
Sbjct: 241 --PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 4e-11
Identities = 36/163 (22%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF-------- 141
++ A EI A+ YLH S+ ++ RD+KP I+L ++ ++ DF
Sbjct: 99 LDEKCTRFYAA-EILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154
Query: 142 -TLSLSIPEGETHINDSNRV--------IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLE 192
+ S T+I+ +GT +++PE + SD+++ G ++ +
Sbjct: 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQ 214
Query: 193 LLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235
+LTGK F +Y + K SF P
Sbjct: 215 MLTGK-----PPFRGSNEYLTFQKILK--LEYSFPPNFPPDAK 250
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS-N 158
+++ +AYLH S +V RDIKP I L V +L DF ++ + T + +
Sbjct: 105 TLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 159 RVIGTFGFMAPEYRTTGDFSEK---SDVYSFGALLLELLTGKK 198
+ GT +MAPE T G +D++S G ++LE+ TGK+
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 28/158 (17%)
Query: 68 FYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTT 127
K +G + +R + KIA+ + + YLH ++ RD+KP+
Sbjct: 89 ILKEVQGRIPERILG---------------KIAVAVLKGLTYLHE--KHKIIHRDVKPSN 131
Query: 128 IVLQEENVAQLFDFTLSLSIPEGETHIND-SNRVIGTFGFMAPEYRTTGDFSEKSDVYSF 186
I++ +L DF +S G+ +N + +GT +MAPE D+S KSD++S
Sbjct: 132 ILVNSRGQIKLCDFGVS-----GQL-VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSL 185
Query: 187 GALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224
G L+EL TG + Y +D D + L +YI NE
Sbjct: 186 GLSLIELATG-RFPYPPE-NDPPDGIFELL--QYIVNE 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 37/186 (19%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
IA +I + YLH R ++ RDIKP+ +++ + ++ DF +S + E ++
Sbjct: 103 YIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQC 157
Query: 158 NRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
N +GT +M+PE R G+ +S +D++S G LLE GK +
Sbjct: 158 NTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLECALGK-------------FPFLPP 203
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTEL-AF--KCLSESEGDRPTIVQV 273
SF E++ AI P +E E F CL + RP+
Sbjct: 204 -----GQPSFFELMQ-AICDGPPPSLPAEE----FSPEFRDFISACLQKDPKKRPS---- 249
Query: 274 AKQLRQ 279
A +L Q
Sbjct: 250 AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 101 IEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160
+I SAV+Y+H ++ RDIK I L + + +L DF +S + + + + V
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETV 161
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198
+GT +M+PE ++ KSD+++ G +L ELLT K+
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 27/138 (19%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L I +I + + Y+H S+ V+ RD+KP I+L + D+ ++ E + D
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 157 SN---------------RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT------ 195
+ +++GT +MAPE SE +D+Y+ G +L ++LT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 196 ---GKKISYSSHFDDGED 210
G+KISY +
Sbjct: 233 RKKGRKISYRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
E+A A+ +LH S ++ RD+KP I+L EE +L DF LS E H +
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFC 159
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
GT +MAPE ++ +D +SFG L+ E+LTG
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 18/131 (13%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
+LQ +K + +A ++AS +AYL ++ + RD+ +++ E N
Sbjct: 91 YLQGGAGRALKLPQ-------LIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENN 140
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGT---FGFMAPEYRTTGDFSEKSDVYSFGALLL 191
+ ++ DF L+ I E + G + APE FS KSDV+SFG LL
Sbjct: 141 ICKVADFGLARVIKE-----DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195
Query: 192 ELLTGKKISYS 202
E++T ++ Y
Sbjct: 196 EIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+A +IA +AYL SR + RD+ I++ E V ++ DF L+ I + E +
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203
+ + APE G F+ KSDV+SFG LL E++T ++ Y
Sbjct: 165 KF--PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 5/103 (4%)
Query: 97 LKIAIEIASAVAYLHVGF--SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154
+I ++ A+ H V+ RD+KP I L N +L DF L+ +
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDS 164
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ + +GT +M+PE + EKSD++S G L+ EL
Sbjct: 165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 33/105 (31%), Positives = 60/105 (57%), Gaps = 6/105 (5%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +A ++A +AYL + + RD+ I++ E+ V ++ DF L+ I E + +++
Sbjct: 107 IDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSS 162
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
++ + + APE + G FS KSDV+SFG LL E+ T ++ Y
Sbjct: 163 DKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 42/128 (32%), Positives = 65/128 (50%), Gaps = 15/128 (11%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSK---LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIV 129
K FLQ + E P ++S + +AI+IA ++YLH R V+ +DI V
Sbjct: 97 KLFLQQCRLG----EANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCV 149
Query: 130 LQEENVAQLFDFTLSLSIPEGETHI--NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFG 187
+ EE ++ D LS + + H ++ NR + +MA E ++S SDV+SFG
Sbjct: 150 IDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALESLVNKEYSSASDVWSFG 206
Query: 188 ALLLELLT 195
LL EL+T
Sbjct: 207 VLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN--- 158
+I VAYLH + VV RDIK ++L + +L DF + + H SN
Sbjct: 110 QILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ GT +MAPE + KSD++S G + E+ TGK
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L+ ++++A + YL S+ +V RD+ I++ E+ VA++ DF L+ G D
Sbjct: 103 LQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----D 155
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
++++ + APE FS KSDV+S+G LL E+ + + Y
Sbjct: 156 NSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L A +I +AYLH S+ + RD+ ++L + + ++ DF L+ ++PEG +
Sbjct: 110 LLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ A E FS SDV+SFG L ELLT
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 26 ILLEKLIASSNGKHNPI----RSF-SADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRP 80
I+ E+ + N KH + SF + ++L D +GG+ LF+ L +
Sbjct: 42 IMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE-----LFFHLQR------- 89
Query: 81 ISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140
E +FP ++ A EIASA+ YLH S +V RD+KP I+L + L D
Sbjct: 90 ------ERSFPEPRARFYAA-EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTD 139
Query: 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKIS 200
F L EG + + GT ++APE + D + GA+L E+L G
Sbjct: 140 FGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
Query: 201 YS 202
Y
Sbjct: 197 YC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 11/122 (9%)
Query: 82 SVMKFEDTFPFSVSKLKIAI----EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ 137
+MK ++P I E+ + YLH S + RDIK I+L E+ +
Sbjct: 88 DIMKS--SYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVK 142
Query: 138 LFDFTLSLSIPEGETHINDS-NRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLT 195
+ DF +S S+ +G +GT +MAPE + K+D++SFG +EL T
Sbjct: 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202
Query: 196 GK 197
G
Sbjct: 203 GA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 12/121 (9%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + +LH R ++ RD+K ++L E ++ DF + EG ++
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTST 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD-DGEDYRLQDLVK 218
GT ++APE + + D ++ G LL E+L G+ S F+ D ED Q +++
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ-----SPFEGDDEDELFQSILE 210
Query: 219 K 219
Sbjct: 211 D 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 45/221 (20%)
Query: 70 KLYKGFLQ-DRPISVMKFEDTFP--------------FSVSKL-KIAIEIASAVAYLHVG 113
+ YK FL+ DR VM + P F+ ++ I +++ A+ YLH
Sbjct: 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK- 131
Query: 114 FSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT 173
+ +V RD+ P I+L E++ + DF L+ + V+GT + PE
Sbjct: 132 -EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS----VVGTILYSCPEIVK 186
Query: 174 TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233
+ EK+DV++FG +L ++ T + YS++ + L K +E +P
Sbjct: 187 NEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEAV-----YEPL 233
Query: 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274
EG M+ E T++ CL+ RP I+QV+
Sbjct: 234 ---PEG-MYSED------VTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 27/143 (18%)
Query: 63 IMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRD 122
+M K YK V T P + KIA+ I A+ YLH S V+ RD
Sbjct: 81 VMDTSLDKFYK--------KVYDKGLTIPEDILG-KIAVSIVKALEYLHSKLS--VIHRD 129
Query: 123 IKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS---NRVIGTFGFMAPEYRTTGD--- 176
+KP+ +++ +L DF +S ++ DS G +MAPE R +
Sbjct: 130 VKPSNVLINRNGQVKLCDFGIS-------GYLVDSVAKTIDAGCKPYMAPE-RINPELNQ 181
Query: 177 --FSEKSDVYSFGALLLELLTGK 197
+ KSDV+S G ++EL TG+
Sbjct: 182 KGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 92 FSVSKLKI-AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150
FS ++++ A EI + ++H F VV RD+KP I+L E ++ D L+ +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150
Query: 151 ETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTG 196
+ H + +GT G+MAPE G + +D +S G +L +LL G
Sbjct: 151 KPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L A+++ + YL + V RD+ +++ E+ VA++ DF L+ +G+
Sbjct: 105 LGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157
Query: 157 SNRVIGTF--GFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
G + APE FS KSDV+SFG LL E+ + ++ Y
Sbjct: 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A +I + +LH R +V RD+KP ++L + ++ D L++ + G+
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----IKG 153
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT G+MAPE + D ++ G L E++ G+
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 26/160 (16%)
Query: 44 SF-SADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIE 102
SF +AD+L D +GG+ LF+ L + E +FP ++ A E
Sbjct: 64 SFQTADKLYFVLDYVNGGE-----LFFHLQR-------------ERSFPEPRARF-YAAE 104
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
IASA+ YLH S ++ RD+KP I+L + L DF L EG H ++ G
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEGIEHSKTTSTFCG 158
Query: 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
T ++APE + D + GA+L E+L G YS
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG-ETHIN 155
L + +I + YL S+ + RD+ I+++ E++ ++ DF L+ +PE + +
Sbjct: 112 LLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
F + APE T FS SDV+SFG L EL T
Sbjct: 169 KEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + LH +V RD+KP I+L + ++ D L++ +PEG+T R
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 161
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V GT G+MAPE ++ D ++ G LL E++ G+
Sbjct: 162 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 92 FSVSKLKI-AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150
FS +++ A EI + ++H +R VV RD+KP I+L E ++ D L+ +
Sbjct: 94 FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150
Query: 151 ETHINDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTG 196
+ H + +GT G+MAPE G + +D +S G +L +LL G
Sbjct: 151 KPHAS-----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 90 FPFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148
F+ S++K ++ + YLH S ++ RDIK + I++ + V +L DF L+
Sbjct: 95 VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY- 150
Query: 149 EGETHINDSNRVIGTFGFMAPEYRT-TGDFSEKSDVYSFGALLLELLTGKKI 199
+ +NRVI T + PE + + D++S G +L EL GK I
Sbjct: 151 TKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K+ + I A+ YL V+ RD+KP+ I+L +L DF +S + + +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171
Query: 158 NRVIGTFGFMAPEYRT----TGDFSEKSDVYSFGALLLELLTGK 197
R G +MAPE + ++DV+S G L+EL TG+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 40/112 (35%), Positives = 57/112 (50%), Gaps = 16/112 (14%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SL 145
EDT F +S EI+ A+ +LH + ++ RD+KP I+L + +L DF L
Sbjct: 99 EDTACFYLS------EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149
Query: 146 SIPEGE-THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
SI EG TH GT +MAPE + D +S GAL+ ++LTG
Sbjct: 150 SIHEGTVTHT-----FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + LH +V RD+KP I+L + ++ D L++ IPEGET R
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGR 161
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V GT G+MAPE ++ D + G L+ E++ GK
Sbjct: 162 V-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+A +I S +AYLH R +V RDIKP+ +++ ++ DF +S + + N S
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 159 RVIGTFGFMAPEYRTTGDFSE------KSDVYSFGALLLELLTGK 197
+GT +M+PE R D + D++S G +LE G+
Sbjct: 229 --VGTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
KI+I + + YL ++ RD+KP+ I++ +L DF +S G+ + +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N +GT +M+PE ++ +SD++S G L+E+ G+
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-08
Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 6/119 (5%)
Query: 84 MKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFT 142
+K + +++KL +A +IA +A++ + + RD++ I++ E ++ DF
Sbjct: 91 LKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFG 147
Query: 143 LSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
L+ I + E + + + APE G F+ KSDV+SFG LL E++T +I Y
Sbjct: 148 LARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 9/105 (8%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
LK ++++ A+ YL + V RD+ +++ E+NVA++ DF L+ + D
Sbjct: 105 LKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQD 157
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ ++ + APE FS KSDV+SFG LL E+ + ++ Y
Sbjct: 158 TGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-08
Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K++I + +AYL ++ RD+KP+ I++ +L DF +S G+ + +
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 159
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N +GT +M+PE +S +SD++S G L+EL G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 3/100 (3%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K +I V YLH S +V RDIK I+ +L DF S + +
Sbjct: 108 KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM 164
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V GT +M+PE + + K+DV+S G ++E+LT K
Sbjct: 165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 108 AYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFM 167
YLH S + RDIK I+L EE A+L DF +S + + N VIGT +M
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTVIGTPFWM 166
Query: 168 APEYRTTGDFSEKSDVYSFGALLLELLTGK 197
APE ++ K+D++S G +E+ GK
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-08
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + LH V RD+KP I+L + ++ D L++ IPEGE+ R
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGR 161
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V GT G+MAPE ++ D + G L+ E++ G+
Sbjct: 162 V-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 118 VVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDF 177
+V RD+KP I+L + ++ D L++ IPEGET RV GT G+MAPE +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRV-GTVGYMAPEVINNEKY 178
Query: 178 SEKSDVYSFGALLLELLTGK 197
+ D + G L+ E++ G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+A +IAS +AY+ V RD++ I++ E V ++ DF L+ I + E
Sbjct: 107 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ + APE G F+ KSDV+SFG LL EL T ++ Y
Sbjct: 164 KF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 8/108 (7%)
Query: 92 FSVSKLKIAI-EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150
F+ S++++ I EI A+ +LH ++ RDIK I+L E L DF LS
Sbjct: 102 FTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158
Query: 151 ETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTG 196
E + GT +MAPE G + D +S G L ELLTG
Sbjct: 159 EE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 37/190 (19%)
Query: 93 SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152
S L ++IA ++YL + +V RD+ ++++ ++ DF L+ + E
Sbjct: 108 SQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
Query: 153 HIN-DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY 211
+ + +V +MA E ++ KSDV+S+G + EL+T Y
Sbjct: 165 EYHAEGGKV--PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY---------- 212
Query: 212 RLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT----ELAFKCLSESEGDR 267
E EI D GE L P ICT + KC R
Sbjct: 213 ----------EGIPAVEIPDLLEKGER-LPQPP------ICTIDVYMVLVKCWMIDAESR 255
Query: 268 PTIVQVAKQL 277
PT ++ +
Sbjct: 256 PTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 40/202 (19%)
Query: 8 RKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPI----RSF-SADELKTATDDFDGGKV 62
+K++ K ++ K ++ +LL+ N KH + SF +AD+L D +GG+
Sbjct: 30 KKAILKKKEEKHIMSERNVLLK------NVKHPFLVGLHFSFQTADKLYFVLDYINGGE- 82
Query: 63 IMKCLFYKLYKG--FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVS 120
LFY L + FL+ R +F A EIASA+ YLH S +V
Sbjct: 83 ----LFYHLQRERCFLEPRA----RF------------YAAEIASALGYLH---SLNIVY 119
Query: 121 RDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEK 180
RD+KP I+L + L DF L E H ++ GT ++APE +
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLC---KENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 181 SDVYSFGALLLELLTGKKISYS 202
D + GA+L E+L G YS
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+ I+I +A+LH S+ ++ RDIK + L + ++ D ++ + + N +
Sbjct: 105 RFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFA 158
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N ++GT +++PE ++EKSDV++ G +L E TGK
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ E+ + YLH S+ V+ RDIK I+L ++ +L DF + + + ++ N
Sbjct: 121 VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK---RN 174
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
V+GT +MAPE D+ K D++S G + +E+ G
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI-NDSNR- 159
+I + YLH +R ++ RDIK I++ + ++ DF +S + + R
Sbjct: 114 QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 160 -VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ G+ +MAPE ++ K+D++S G L++E+LTGK
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 10/99 (10%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+ E+ V LH R ++ RDIKP +++ + +L DF LS + E +
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------N 150
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+ +GT ++APE + SD +S G ++ E L G
Sbjct: 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 46/239 (19%)
Query: 44 SFSAD-ELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIE 102
SF D EL + D G + ++K K + +R + K ++
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV---------------WKYFVQ 114
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ SAV ++H SR V+ RDIKP + + V +L D L T ++ ++G
Sbjct: 115 LCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVG 168
Query: 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222
T +M+PE ++ KSD++S G LL E+ + Y G+ L L +K IE
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLFSLCQK-IE 221
Query: 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI---VQVAKQLR 278
+ P + E + EK + EL C+ RP I Q+AKQ+
Sbjct: 222 QCDY-----PPLPTEH---YSEKLR------ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+I I++ + LH + ++ RD+K I+L ++ ++ D +S + +
Sbjct: 107 RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----- 158
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
IGT +MAPE +S KSD++S G LL E+ T
Sbjct: 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 10/105 (9%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFTLSLSIP----EGETHI 154
++ A+A H ++ +V RD+KP I++ + V A++ DF + +P +
Sbjct: 87 QVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKI 199
+ V+GT + APE + SD+Y++G + LE LTG+++
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 6/103 (5%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A E+ASA+ YLH S ++ RD+KP I+L + L DF L EG ++
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEGVEPEETTST 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
GT ++APE + D + GA+L E+L G YS
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L IAI+IA+ + YL S V RD+ ++ E ++ DF LS I + +
Sbjct: 127 LHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLEL 193
S ++ +M PE G F+ +SD++SFG +L E+
Sbjct: 184 SKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 4/100 (4%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+++A EIA +AYL ++ V RD+ ++ E+ ++ DF ++ I E + +
Sbjct: 121 FIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
++ +MAPE G F+ KSDV+SFG +L E+ T
Sbjct: 178 GGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 12/122 (9%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K +++ SA+ ++H SR V+ RDIKP + + V +L D L T +
Sbjct: 110 KYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---A 163
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217
+ ++GT +M+PE ++ KSD++S G LL E+ + Y G+ L L
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC 217
Query: 218 KK 219
KK
Sbjct: 218 KK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 35/103 (33%), Positives = 47/103 (45%), Gaps = 15/103 (14%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS--LSIPEGETHINDSNR 159
E +AYLH V+ RDIK I+L + +L DF +S L G N
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR-----NT 172
Query: 160 VIGTFGFMAPE-----YRTTGDFSEKSDVYSFGALLLELLTGK 197
IGT +MAPE + + +SDV+S G +EL GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 24/138 (17%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE-THINDSNRVI 161
+ A YLH +R ++ RD+KP ++L +L DF + + G+ T
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-----FC 153
Query: 162 GTFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
GT ++APE Y DFS D +S G LL ELLTG + + DD + + +
Sbjct: 154 GTPEYVAPEIILNKGY----DFS--VDYWSLGILLYELLTG-RPPFGE--DDEDPMEIYN 204
Query: 216 LVKKYIENESFKEIVDPA 233
+ K F +D A
Sbjct: 205 DILKGNGKLEFPNYIDKA 222
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
+IA +AY+ + + RD++ +++ E + ++ DF L+ I + E + +
Sbjct: 111 QIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF- 166
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ APE G F+ KSDV+SFG LL E++T KI Y
Sbjct: 167 -PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 33/181 (18%)
Query: 101 IEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160
++IA A+ YLH + ++ RD+K + L N+ ++ D ++ + E + ++ +
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTL 162
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220
IGT +M+PE + ++ KSDV++ G + E+ T K H + +D + LV +
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK------HAFNAKD--MNSLVYRI 214
Query: 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280
IE G+ M + +L EL LS+ RP++ + LRQ
Sbjct: 215 IE-------------GKLPPMPKDYSPEL---GELIATMLSKRPEKRPSVKSI---LRQP 255
Query: 281 Y 281
Y
Sbjct: 256 Y 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-07
Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 5/105 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +A +IA +AY+ + RD++ I++ + V ++ DF L+ I + E
Sbjct: 105 VDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ + APE G F+ KSDV+SFG LL EL+T ++ Y
Sbjct: 162 GAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 101 IEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160
I++ AV ++H S+ ++ RDIK I+L + +L DF S T +D R
Sbjct: 150 IQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY--AATVSDDVGRT 204
Query: 161 I-GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198
GT ++APE +S+K+D++S G LL ELLT K+
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + +IA +A++ R + RD++ I++ V ++ DF L+ I + E +
Sbjct: 105 IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ + APE G F+ KSDV+SFG LL+E++T +I Y
Sbjct: 162 GAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-07
Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 12/102 (11%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND- 156
+IA+ + + YL +S ++ RD+KP+ +++ +L DF +S + +N
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSI 149
Query: 157 SNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGK 197
+ +GT +MAPE R +G+ + SDV+S G +EL G+
Sbjct: 150 AKTYVGTNAYMAPE-RISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-07
Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+A ++A+ +AY+ + RD++ I++ + V ++ DF L+ I + E
Sbjct: 107 MAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ + APE G F+ KSDV+SFG LL EL+T ++ Y
Sbjct: 164 KF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-07
Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 11/123 (8%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
+I + +LH S +V RD+KP ++L ++ +L D L++ + +G+T +
Sbjct: 103 QITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----ITQRA 155
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI 221
GT G+MAPE +S D ++ G + E++ G+ + D E ++L ++ +
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR----TPFKDHKEKVAKEELKRRTL 211
Query: 222 ENE 224
E+E
Sbjct: 212 EDE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 51/216 (23%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKI-AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE 133
+L+ R VS LK A ++A +AYL S+ V RD+ ++L
Sbjct: 85 YLKKRRE----------IPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNR 131
Query: 134 NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLEL 193
+ A++ DF +S ++ G + + + APE G FS KSDV+S+G L E
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191
Query: 194 LT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG--EEGLMWPEKEQQLL 250
+ G K + E+ ++ E G P E+
Sbjct: 192 FSYGAK--------------------------PYGEMKGAEVIAMLESGERLPRPEE--- 222
Query: 251 ICTE----LAFKCLSESEGDRPTIVQVAKQLRQIYQ 282
C + + C DRPT ++ R+ +
Sbjct: 223 -CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI-PEGETHINDSNRV 160
E A+ +LH S V+ RDIK I+L + +L DF I PE + + +
Sbjct: 123 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTM 175
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+GT +MAPE T + K D++S G + +E++ G+
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV- 160
E+ A+ Y+H V+ RDIK I++ +L DF ++ + + N S R
Sbjct: 109 EVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRST 160
Query: 161 -IGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTG 196
+GT +MAPE T G + K+D++S G + E+ TG
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K++I + + YL ++ RD+KP+ I++ +L DF +S G+ + +
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 159
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N +GT +M+PE +S +SD++S G L+E+ G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L+++++ A+ + YL S+ + RD+ ++ E NV ++ DF +S G ++D
Sbjct: 96 LQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
+ I + APE G ++ +SDV+S+G LL E + Y
Sbjct: 153 GLKQI-PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 13/122 (10%)
Query: 88 DTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146
++S+L +IA++IAS + YL S+ V RD+ ++ + V ++ DF +S
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171
Query: 147 IPEGETHINDSNRVIGT----FGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
+ + D RV G +M PE F+ +SDV+SFG +L E+ T K +
Sbjct: 172 V-----YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
Query: 203 SH 204
Sbjct: 227 GL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 93 SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152
+V L +A +I+SA+ YL + + RD+ ++ E ++ ++ DF LS + G+T
Sbjct: 103 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDT 158
Query: 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ + + APE FS KSDV++FG LL E+ T
Sbjct: 159 YTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 31/143 (21%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI A+ YLH S+ +V RD+KP I+L +E +L DF + + + +
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWT 157
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK------------------KISY 201
+ GT ++APE + ++ D ++ G L+ E+L G K+ +
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF 217
Query: 202 SSHFDDGEDYRLQDLVKKYIENE 224
H D +DL+KK + +
Sbjct: 218 PRHL----DLYAKDLIKKLLVVD 236
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 21/139 (15%)
Query: 62 VIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSR 121
VI + Y FL+ + S + ED FS ++A +A+L S+ + R
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY-------QVAKGMAFLA---SKNCIHR 165
Query: 122 DIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGD 176
D+ ++L + ++ DF L+ I +NDSN V+ MAPE
Sbjct: 166 DLAARNVLLTHGKIVKICDFGLARDI------MNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 177 FSEKSDVYSFGALLLELLT 195
++ +SDV+S+G LL E+ +
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
I E+ + YLH + RDIK I+L EE +L DF +S G+ S
Sbjct: 103 ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSK 154
Query: 159 R--VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
R +GT +MAPE + EK+D++S G +EL G+
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
LK A++I + YL SR V RD+ ++++ E+ ++ DF L+ +I + +
Sbjct: 112 LKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
+ + + APE F SDV+SFG L ELLT S
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS--LSIPEGETHIN 155
K +++ SA+ ++H S+ ++ RDIKP + + V +L D L S H
Sbjct: 110 KYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-- 164
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
++GT +M+PE ++ KSD++S G LL E+ + Y G+ L
Sbjct: 165 ---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYS 215
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP---TIVQ 272
L KK IE + + PA E L +L +C++ RP ++Q
Sbjct: 216 LCKK-IEKCDYPPL--PADHYSEEL------------RDLVSRCINPDPEKRPDISYVLQ 260
Query: 273 VAKQL 277
VAK++
Sbjct: 261 VAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 28/105 (26%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + ++ A+ YL S + RD+ ++ E+NV ++ DF L+ + + + +
Sbjct: 103 LDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ + PE FS KSDV+SFG L+ E+ + K+ Y
Sbjct: 160 GTKF--PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI SA+ YLH SR VV RDIK ++L ++ ++ DF L EG +
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFC 156
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
GT ++APE D+ D + G ++ E++ G+ Y+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 34/135 (25%), Positives = 66/135 (48%), Gaps = 5/135 (3%)
Query: 62 VIMKCLFYKLYKGFLQD-RPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVS 120
V+M+ + + K +L+ RP + P +++A EIA +AYL+ ++ V
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVH 142
Query: 121 RDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEK 180
RD+ ++ + ++ DF ++ I E + + ++ MAPE G F+
Sbjct: 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW-MAPESLKDGVFTTS 201
Query: 181 SDVYSFGALLLELLT 195
SD++SFG +L E+ +
Sbjct: 202 SDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 9/117 (7%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
++K +FP V +L +I + YLH R V RDIK I++ V +L DF
Sbjct: 91 KLLKKYGSFPEPVIRLYTR-QILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADF 146
Query: 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEY-RTTGDFSEKSDVYSFGALLLELLTGK 197
++ + E + G+ +MAPE G + +D++S G +LE+ TGK
Sbjct: 147 GMAKQVVEFSF----AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 15/133 (11%)
Query: 87 EDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145
ED++P + L + + ++A + +L S+ + RD+ ++L + VA++ DF L+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 146 SIPEGETHINDSNRVIG-----TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKIS 200
I +NDSN V+ +MAPE ++ +SDV+S+G LL E+ + K
Sbjct: 261 DI------MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
Query: 201 YSSHFDDGEDYRL 213
Y + + Y++
Sbjct: 315 YPGILVNSKFYKM 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174
SR + RD+ I+L E NV ++ DF L+ I + ++ + + +MAPE
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-PLKWMAPESIFD 250
Query: 175 GDFSEKSDVYSFGALLLELLT 195
++ +SDV+SFG LL E+ +
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 26/96 (27%), Positives = 54/96 (56%), Gaps = 14/96 (14%)
Query: 106 AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF----TLSLSIPEGETHINDSNRVI 161
A+++LH ++ V+ RDIK +I+L + +L DF +S +P ++ ++
Sbjct: 127 ALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-------LV 176
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE + + + D++S G +++E++ G+
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 32/116 (27%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 80 PISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLF 139
P + F+D + A ++A + YL S+ + RD+ +++ E+NV ++
Sbjct: 133 PEEQLSFKDL-------VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIA 182
Query: 140 DFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
DF L+ I + + +N + +MAPE ++ +SDV+SFG LL E+ T
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 34/130 (26%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 74 GFLQDRPISVMKFEDTFPFSVSKLKIAIE--------IASAVAYLHVGFSRPVVSRDIKP 125
GF++++ +S ++ E+ + K + +E +A + +L SR + RD+
Sbjct: 151 GFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAA 207
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYS 185
I+L E NV ++ DF L+ I + ++ + + +MAPE ++ +SDV+S
Sbjct: 208 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWS 266
Query: 186 FGALLLELLT 195
FG LL E+ +
Sbjct: 267 FGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 25/96 (26%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
+I S + +LH R ++ RD+KP ++L + ++ D L++ + +G+ + +
Sbjct: 105 QIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYA 158
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT GFMAPE ++ D ++ G L E++ +
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 89 TFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148
+F VS A ++A + YL SR + RD+ +++ E+NV ++ DF L+ +
Sbjct: 132 SFKDLVS---CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ + + SN + +MAPE ++ +SDV+SFG L+ E+ T
Sbjct: 186 DIDYYKKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 5/125 (4%)
Query: 72 YKGFLQDRPISVMKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
Y G +R S + D ++ L A +I+ + YL +V RD+ +++
Sbjct: 104 YLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV 160
Query: 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALL 190
E ++ DF LS + E ++++ S I +MA E ++ +SDV+SFG LL
Sbjct: 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLL 219
Query: 191 LELLT 195
E++T
Sbjct: 220 WEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 20/103 (19%)
Query: 101 IEIA-------SAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153
+EIA +AYLH S + RDIK I+L E +L DF S S+
Sbjct: 115 VEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFG-SASL------ 164
Query: 154 INDSNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLEL 193
++ +N +GT +MAPE G + K DV+S G +EL
Sbjct: 165 VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-06
Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 11/125 (8%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI+ A+ YLH R ++ RD+K ++L E +L D+ + EG + ++
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFC 157
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK----ISYSSHFD-DGEDYRLQDL 216
GT ++APE D+ D ++ G L+ E++ G+ + S + D + EDY Q +
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
Query: 217 VKKYI 221
++K I
Sbjct: 218 LEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 15/131 (11%)
Query: 74 GFLQDRPISVMKFEDTFPFSVSKLKIAIE--------IASAVAYLHVGFSRPVVSRDIKP 125
GF++D+ +S ++ ED + K + +E +A + +L SR + RD+
Sbjct: 146 GFIEDKSLSDVE-EDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAA 201
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHI-NDSNRVIGTFGFMAPEYRTTGDFSEKSDVY 184
I+L E NV ++ DF L+ I + ++ R+ +MAPE ++ +SDV+
Sbjct: 202 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVW 259
Query: 185 SFGALLLELLT 195
SFG LL E+ +
Sbjct: 260 SFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 29/117 (24%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 85 KFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144
+FE+ ++ ++ +AYLH S+ ++ RD+K +++ + + ++ DF +S
Sbjct: 104 RFEEQLVRFFTE-----QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155
Query: 145 LSIPEGETHINDSNRVI-GTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKK 198
+ + ND N + G+ +MAPE + +S K D++S G ++LE+ G++
Sbjct: 156 KK--SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ A+ YLH S+ V+ RDIK +I+L + +L DF I + + ++G
Sbjct: 126 VLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKSLVG 179
Query: 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
T +MAPE + + + D++S G +++E++ G+ +S
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 8e-06
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
E A+ +LH S V+ RDIK I+L + +L DF I ++ + ++
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMV 177
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE T + K D++S G + +E++ G+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 101 IEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH-INDSNR 159
+++A + YL S+ V RD+ +L E ++ DF L+ I + E + +++
Sbjct: 105 LQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+MA E T F+ KSDV+SFG LL EL+T
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 25/99 (25%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ + + A++YLH ++ V+ RDIK +I+L + +L DF + + +
Sbjct: 123 VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK---EVPKRK 176
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
++GT +MAPE + + + D++S G +++E++ G+
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 23/98 (23%), Positives = 47/98 (47%), Gaps = 5/98 (5%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEGETHIND-SNR 159
++ ++YLH ++ RD+K +++ ++ DF + + T + +
Sbjct: 111 QLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
++GT FMAPE + DV+S G +++E+ T K
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L IAI+IA+ + YL F V +D+ I++ E+ ++ D LS I + +
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
++ +M PE G FS SD++SFG +L E+ +
Sbjct: 184 PKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 30/90 (33%), Positives = 42/90 (46%), Gaps = 11/90 (12%)
Query: 108 AYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH-INDSNRVIGTFGF 166
AYLH + RDIK I+L E+ +L DF +S + T I IGT +
Sbjct: 115 AYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYW 167
Query: 167 MAPEY---RTTGDFSEKSDVYSFGALLLEL 193
MAPE G + K D+++ G +EL
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 42/137 (30%), Positives = 64/137 (46%), Gaps = 14/137 (10%)
Query: 92 FSVSKLKIAI-EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150
F +++I EI A+ +LH ++ RDIK I+L L DF LS E
Sbjct: 102 FKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158
Query: 151 ETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFD-D 207
E + GT +MAP+ GD + D +S G L+ ELLTG +S F D
Sbjct: 159 EVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG-----ASPFTVD 211
Query: 208 GEDYRLQDLVKKYIENE 224
GE ++ ++ +++E
Sbjct: 212 GEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-05
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI + YLH S + RDIK ++L E +L DF ++ + + + N +
Sbjct: 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFV 162
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE + K+D++S G +EL G+
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 6/103 (5%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI + YLH S + RDIK ++L E+ +L DF ++ + + + N +
Sbjct: 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV 162
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
GT +MAPE + K+D++S G +EL G+ + H
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 14/118 (11%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
FP V+K A E+ A YLH S+ ++ RD+KP ++L + ++ DF + +P+
Sbjct: 115 FPNDVAKFYHA-ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207
+ + GT ++APE + + D ++ G LL E + G Y FDD
Sbjct: 171 ------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG----YPPFFDD 218
|
Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 37/96 (38%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI A+ +LH +V RDIK I+L E L DF LS E S
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FC 167
Query: 162 GTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTG 196
GT +MAPE R G + D +S G L+ ELLTG
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
E A+ +LH S V+ RDIK I+L + +L DF I ++ + ++
Sbjct: 123 ECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMV 176
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE T + K D++S G + +E++ G+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 24/99 (24%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ + + A++ LH ++ V+ RDIK +I+L + +L DF + + +
Sbjct: 121 VCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---EVPRRK 174
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
++GT +MAPE + + + D++S G +++E++ G+
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 91 PFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
P S+ K+ ++A EIA +AYL+ + V RD+ ++ E+ ++ DF ++ I E
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ + + + +M+PE G F+ SDV+SFG +L E+ T
Sbjct: 172 TD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 13/124 (10%)
Query: 85 KFEDTFPFSVSKLKIAIEIASAVAYLH-VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143
KFED P +++ +A E+ A+ +H +G+ V RDIKP ++L + +L DF
Sbjct: 94 KFEDRLPEDMARFYLA-EMVLAIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGS 148
Query: 144 SLSIPEGETHINDSNRVIGTFGFMAPEY-----RTTGDFSEKSDVYSFGALLLELLTGKK 198
L + T SN +GT +++PE G + + D +S G + E+L G+
Sbjct: 149 CLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206
Query: 199 ISYS 202
Y+
Sbjct: 207 PFYA 210
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 28/96 (29%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A ++A + YL S+ + RD+ +++ E+NV ++ DF L+ + + + +N
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ +MAPE ++ +SDV+SFG LL E+ T
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 21/128 (16%)
Query: 85 KFEDTFP-----FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLF 139
KFED P F ++++ IAI+ + Y+H RDIKP I++ +L
Sbjct: 94 KFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLA 144
Query: 140 DFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELL 194
DF L + E T S+ +GT +++PE G + + D +S G + E+L
Sbjct: 145 DFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
Query: 195 TGKKISYS 202
G+ Y+
Sbjct: 203 YGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 27/96 (28%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
E A+ +LH + V+ RDIK ++L + +L DF I ++ + ++
Sbjct: 123 ECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMV 176
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE T + K D++S G + +E++ G+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI + YLH S + RDIK ++L E+ +L DF ++ + + + N +
Sbjct: 109 EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV 162
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE + K+D++S G +EL G+
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 33/137 (24%), Positives = 56/137 (40%), Gaps = 32/137 (23%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLH-VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145
+D FP ++ IA E+ A+ +H +GF + RDIKP I++ + +L DF L
Sbjct: 95 KDVFPEETARFYIA-ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCK 149
Query: 146 SIPEGETHINDSNR--------------------------VIGTFGFMAPEYRTTGDFSE 179
+ + + N +GT ++APE +
Sbjct: 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL 209
Query: 180 KSDVYSFGALLLELLTG 196
+ D +S G +L E+L G
Sbjct: 210 ECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI SA+ YLH G +V RD+K ++L ++ ++ DF L EG T
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKTFC 156
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT ++APE D+ D + G ++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 10/111 (9%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + +LH + ++ RD+K ++L ++ ++ DF + GE ++
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKAST 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210
GT ++APE ++E D +SFG LL E+L G+ S + ED
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ----SPFHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 28/181 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + +++ +AYL S V+ RD+ ++ E V ++ DF ++ + + + +
Sbjct: 103 LGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ + +PE + +S KSDV+SFG L+ E+ + K Y
Sbjct: 160 GTKF--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY--------------- 202
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
EN S E+V+ G L P Q + EL C E DRP+ + Q
Sbjct: 203 -----ENRSNSEVVETINAGFR-LYKPRLASQSVY--ELMQHCWKERPEDRPSFSLLLHQ 254
Query: 277 L 277
L
Sbjct: 255 L 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 11/123 (8%)
Query: 85 KFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144
KFED P +++ IA E+ A+ +H V RDIKP ++L +L DF
Sbjct: 94 KFEDRLPEDMARFYIA-EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSC 149
Query: 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKI 199
L + + T S+ +GT +++PE G + + D +S G + E+L G+
Sbjct: 150 LKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
Query: 200 SYS 202
Y+
Sbjct: 208 FYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+K A++ A+ +AYL S+ + RD+ ++ E NV ++ DF +S +G +
Sbjct: 96 VKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
++ + APE G +S +SDV+S+G LL E +
Sbjct: 153 LKQI--PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154
+L IA ++A+ +AYL R V RD+ ++ E V ++ DF LS +I + +
Sbjct: 131 EQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
N I +M PE ++ +SDV+++G +L E+ +
Sbjct: 188 ASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + +LH S+ +V RD+K I+L + ++ DF + G+ +
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCT 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT ++APE ++ D +SFG LL E+L G+
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
++A + YL S+ + RD+ +++ E NV ++ DF L+ + + + +N +
Sbjct: 145 QVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+MAPE ++ +SDV+SFG L+ E+ T
Sbjct: 202 -PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L IA +IAS + YL S V RD+ ++ + V ++ DF +S I + D
Sbjct: 125 LAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-----YSTD 176
Query: 157 SNRVIG----TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISY 201
RV G +M PE F+ +SD++SFG +L E+ T GK+ Y
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 31/152 (20%)
Query: 61 KVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVS 120
+++M+ L Y + +LQ K + L A +I + YL S+ V
Sbjct: 83 RLVMEYLPYGSLRDYLQ-------KHRERLDHR-KLLLYASQICKGMEYLG---SKRYVH 131
Query: 121 RDIKPTTIVLQEENVAQLFDFTLSLSIPE----------GETHINDSNRVIGTFGFMAPE 170
RD+ I+++ EN ++ DF L+ +P+ GE+ I F + APE
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---------FWY-APE 181
Query: 171 YRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
T FS SDV+SFG +L EL T S S
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
I EI +A+LH V+ RDIK ++L E +L DF +S + + + N
Sbjct: 126 ICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRN 179
Query: 159 RVIGTFGFMAPEY-----RTTGDFSEKSDVYSFGALLLELLTG 196
IGT +MAPE + +SD++S G +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 32/125 (25%), Positives = 68/125 (54%), Gaps = 15/125 (12%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL-QEE 133
++Q R S++ EDT L ++I A+ ++H ++ ++ RD+K I+L + +
Sbjct: 89 YIQKRCNSLLD-EDTI------LHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHK 138
Query: 134 NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLEL 193
V ++ DF +S + + + V+GT +++PE +++KSD+++ G +L EL
Sbjct: 139 MVVKIGDFGISKILSSK----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
Query: 194 LTGKK 198
+ K+
Sbjct: 195 ASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 27/109 (24%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 91 PFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
PFS S++K + +++ + YLH F ++ RD+K + ++L ++ ++ DF L+ +
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-- 158
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKS-DVYSFGALLLELLTGK 197
+ T + APE + D+++ G +L ELL K
Sbjct: 159 -GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174
SR ++ RD+K I L + +L DF S + ++ ++ GT ++APE
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD-SVSLDVASSFCGTPYYLAPELWER 245
Query: 175 GDFSEKSDVYSFGALLLELLT 195
+S+K+D++S G +L ELLT
Sbjct: 246 KRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
EI SA+ YLH S VV RD+K ++L ++ ++ DF L EG +
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFC 156
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202
GT ++APE D+ D + G ++ E++ G+ Y+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 39/141 (27%), Positives = 57/141 (40%), Gaps = 23/141 (16%)
Query: 63 IMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRD 122
+M K YK + P + KIA+ A+ YL ++ RD
Sbjct: 84 LMDISLDKFYK-------YVYEVLKSVIPEEILG-KIAVATVKALNYLKEELK--IIHRD 133
Query: 123 IKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS---NRVIGTFGFMAPEYRTTGD--- 176
+KP+ I+L +L DF +S + DS R G +MAPE
Sbjct: 134 VKPSNILLDRNGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 177 FSEKSDVYSFGALLLELLTGK 197
+ +SDV+S G L E+ TGK
Sbjct: 187 YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 8e-05
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
I EI +++LH V+ RDIK ++L E +L DF +S + + + N
Sbjct: 116 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRN 169
Query: 159 RVIGTFGFMAPEY-------RTTGDFSEKSDVYSFGALLLELLTG 196
IGT +MAPE T DF KSD++S G +E+ G
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDF--KSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 22/112 (19%)
Query: 166 FMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225
++APE DFS KSDV+SFG L+ E+ T ++ + D+
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------------------ 225
Query: 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277
E++ + L P E +L +C + + DRP+ ++ L
Sbjct: 226 --EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-05
Identities = 26/97 (26%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 101 IEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160
++I A+ ++H R ++ RDIK I L ++ +L DF ++ + + + +
Sbjct: 108 VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTC 161
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
IGT +++PE ++ KSD+++ G +L E+ T K
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-05
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 93 SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152
SV++ K +I ++YLH S +V RDIK I+ +L DF S +
Sbjct: 106 SVTR-KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161
Query: 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V GT +M+PE + + K+DV+S G ++E+LT K
Sbjct: 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SL 145
E F S ++ A E+ A+ LH V+ RD+KP I+L + L DF L L
Sbjct: 87 EGRFDLSRARFYTA-ELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
++ + + +N GT ++APE +++ D ++ G LL E+LTG
Sbjct: 143 NMKDDDK----TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 9e-05
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 24/117 (20%)
Query: 91 PFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS--LSI 147
P S + +K I ++ +AY H S ++ RD+KP I++ + V +L DF L+ I
Sbjct: 94 PLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI 150
Query: 148 PEGETHINDSNRVIGTFGFMAPE-------YRTTGDFSEKSDVYSFGALLLELLTGK 197
P ++ V+ T + APE Y S D++S G + E++TGK
Sbjct: 151 PL----RTYTHEVV-TLWYRAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 29/209 (13%)
Query: 7 SRKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSAD-ELKTATDDFDGGKVIMK 65
S+K + ++ +G IL+ L+ S SF D +L TD GG+
Sbjct: 27 SKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGE---- 82
Query: 66 CLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKP 125
LF+ L K E F +K IA E+ A+ +LH +V RD+KP
Sbjct: 83 -LFWHLQK-------------EGRFSEDRAKFYIA-ELVLALEHLH---KYDIVYRDLKP 124
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE-YRTTGDFSEKSDVY 184
I+L L DF LS + T +N GT ++APE +++ D +
Sbjct: 125 ENILLDATGHIALCDFGLSKA---NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181
Query: 185 SFGALLLELLTGKKISYSSHFDDGEDYRL 213
S G L+ E+ G Y+ D + YR
Sbjct: 182 SLGVLVFEMCCGWSPFYAE--DTQQMYRN 208
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 27/181 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+++ A+ + YL S+ + RD+ ++ E+NV ++ DF +S +G
Sbjct: 97 IQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ I + APE G +S +SDV+SFG LL E + + Y++
Sbjct: 154 GMKQI-PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN------------- 199
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ N+ +E + E+G+ P E L +C G RP+ V ++
Sbjct: 200 ----LSNQQTREAI------EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249
Query: 277 L 277
L
Sbjct: 250 L 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 3/96 (3%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
+I V+YLH S +V RDIK I+ +L DF S I V
Sbjct: 114 QILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +M+PE + + K+DV+S ++E+LT K
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 106 AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFG 165
A+ +LH S V+ RD+K I+L + +L DF +S + ++ + + IGT
Sbjct: 115 ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS---AKNKSTLQKRDTFIGTPY 168
Query: 166 FMAPEYRTTGDFSE-----KSDVYSFGALLLEL 193
+MAPE F + K+D++S G L+EL
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 24/74 (32%), Positives = 37/74 (50%)
Query: 119 VSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFS 178
V RD+ ++L ++ A++ DF LS ++ E + + APE FS
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 179 EKSDVYSFGALLLE 192
KSDV+SFG L+ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L IA +IAS + YL S+ V RD+ ++ + ++ DF +S + + D
Sbjct: 126 LHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-----YSTD 177
Query: 157 SNRVIG----TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKK 198
RV G +M PE F+ +SDV+SFG +L E+ T GK+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 28/120 (23%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
++++ + P V K+ I + +H +V RDIKP +++ +V +L DF
Sbjct: 85 NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDF 144
Query: 142 TLSLSIPEGETHINDSN--RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKI 199
+ ++ EG +++N + T + +PE + + D++S G +L EL G+ +
Sbjct: 145 GFARNLSEG----SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SLSIPEGETHINDSNRV 160
EI SA+ YLH + VV RD+K ++L ++ ++ DF L I +G T
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTF 156
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT ++APE D+ D + G ++ E++ G+
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 36/104 (34%), Positives = 50/104 (48%), Gaps = 22/104 (21%)
Query: 101 IEIAS-------AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF-TLSLSIPEGET 152
+EIA+ +AYLH S ++ RDIK I+L E +L DF + S S P
Sbjct: 121 VEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173
Query: 153 HINDSNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLEL 193
+N +GT +MAPE G + K DV+S G +EL
Sbjct: 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 35/128 (27%), Positives = 65/128 (50%), Gaps = 13/128 (10%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SLSIPEGETHINDSN 158
+ EI+ A+ +LH R ++ RD+K ++L E +L D+ + I G+T ++
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT----TS 154
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK----ISYSSHFD-DGEDYRL 213
GT ++APE D+ D ++ G L+ E++ G+ + S + D + EDY
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
Query: 214 QDLVKKYI 221
Q +++K I
Sbjct: 215 QVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 34/137 (24%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
++ + +LH S ++ RD+KP+ IV++ + ++ DF L+ + T+ + V+
Sbjct: 131 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---ACTNFMMTPYVV 184
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKI-SYSSHFDDGEDY--------- 211
+ + APE + E D++S G ++ EL+ G I + H D
Sbjct: 185 TRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 212 ----RLQDLVKKYIENE 224
RLQ V+ Y+EN
Sbjct: 244 EFMNRLQPTVRNYVENR 260
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 20/102 (19%)
Query: 106 AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV----I 161
A+ Y+H S V+ RD+KP+ I+L + +L DF L+ S+ E E N N V +
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE--ENPENPVLTDYV 173
Query: 162 GTFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTGK 197
T + APE T G D++S G +L E+L GK
Sbjct: 174 ATRWYRAPEILLGSTRYTKG-----VDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 12/100 (12%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A ++A + +L S+ + RD+ +++ E++V ++ DF L+ I H D R
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYYR 189
Query: 160 VIGT----FGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+MAPE ++ +SDV+SFG LL E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 34/130 (26%), Positives = 62/130 (47%), Gaps = 19/130 (14%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI A+ +LH R ++ RD+K ++L + +L D+ + EG + ++
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMC---KEGLGPGDTTST 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD--------DGEDY 211
GT ++APE ++ D ++ G L+ E++ G+ S FD + EDY
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR-----SPFDIITDNPDMNTEDY 210
Query: 212 RLQDLVKKYI 221
Q +++K I
Sbjct: 211 LFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 22/104 (21%)
Query: 101 IEIAS-------AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF-TLSLSIPEGET 152
+EIA+ +AYLH S ++ RDIK I+L E +L DF + S++ P
Sbjct: 125 VEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177
Query: 153 HINDSNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLEL 193
+N +GT +MAPE G + K DV+S G +EL
Sbjct: 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 42/194 (21%)
Query: 92 FSVSKL-KIAIEIASAVAYL-HVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
F+V +L + IAS + YL + + V RD+ I++ V ++ DF LS
Sbjct: 103 FTVGQLVGMLRGIASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLS----- 153
Query: 150 GETHINDSNRVIGTFG------FMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203
+ DS T G + APE F+ SDV+SFG ++ E+++ + Y
Sbjct: 154 --RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY-- 209
Query: 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSES 263
D QD++K E+G P +L C +
Sbjct: 210 -----WDMSNQDVIKAV----------------EDGYRLPPPMDCPSALYQLMLDCWQKD 248
Query: 264 EGDRPTIVQVAKQL 277
+RPT Q+ L
Sbjct: 249 RNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 15/102 (14%)
Query: 101 IEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHINDSNR 159
++I+ + ++H R ++ RDIK I L + VA+L DF ++ + NDS
Sbjct: 108 VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSME 157
Query: 160 V----IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ +GT +++PE ++ K+D++S G +L EL T K
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 93 SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152
S + + ++++A+AYL S+ V RDI +++ + +L DF LS + +
Sbjct: 106 LASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162
Query: 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKK 198
+ ++ +MAPE F+ SDV+ FG + E+L G K
Sbjct: 163 YKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 3/96 (3%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
+I V+YLH S +V RDIK I+ +L DF S + V
Sbjct: 114 QILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +M+PE + + K+D++S G ++E+LT K
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 16/130 (12%)
Query: 80 PISVMKFEDTFPFSVSK---LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136
P +V+ E P +++ L IA +IA+ + YL S+ V RD+ ++ E +
Sbjct: 103 PDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 159
Query: 137 QLFDFTLSLSIPEGETHINDSNRVIG----TFGFMAPEYRTTGDFSEKSDVYSFGALLLE 192
++ DF +S + + D RV G +M PE F+ +SDV+S G +L E
Sbjct: 160 KIGDFGMSRDV-----YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214
Query: 193 LLT-GKKISY 201
+ T GK+ Y
Sbjct: 215 IFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SLSIPEGETHINDSN 158
A EI SA+ +LH + ++ RD+K ++L E +L DF + I G+T ++
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT----TS 154
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
GT ++APE + D ++ G LL E+L G
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG-ETHIND 156
++ A+AY H S ++ RDIKP I++ E V +L DF + ++ + + D
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 157 SNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTG 196
+ T + APE GD + + DV++ G ++ ELL G
Sbjct: 161 ---YVATRWYRAPEL-LVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A E+ A+ LH +V RD+ P I+L + QL F+ + + D
Sbjct: 91 AAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEA 143
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKIS 200
V + APE + +E D +S GA+L ELLTGK +
Sbjct: 144 VENMY--CAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 87 EDTFPFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145
D S S L +A +IAS + YL S V RD+ ++ + ++ DF +S
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF 205
++ G+ + R + +M+ E G F+ SDV++FG L E+LT K S
Sbjct: 179 NLYSGD-YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237
Query: 206 DDGEDYRLQDLVKKYIEN--ESFKEIVDPAIVGEEGLMWPEKEQQLL----ICTELAFK- 258
D ++ IEN E F++ + Q L +C + +K
Sbjct: 238 SD----------EQVIENTGEFFRD---------------QGRQVYLPKPALCPDSLYKL 272
Query: 259 ---CLSESEGDRPTIVQVAKQLRQ 279
C + +RP+ ++ L +
Sbjct: 273 MLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 20/103 (19%)
Query: 101 IEIAS-------AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153
+EIA+ +AYLH S ++ RD+K I+L E + +L DF S SI
Sbjct: 115 VEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG-SASI------ 164
Query: 154 INDSNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLEL 193
+ +N +GT +MAPE G + K DV+S G +EL
Sbjct: 165 MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 30/194 (15%)
Query: 91 PFSVSK---LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147
PF++ ++ I+IAS + YL S+ + RD+ +L E + DF LS I
Sbjct: 107 PFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163
Query: 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207
G+ + + ++A E ++ SDV++FG + E++T + Y+
Sbjct: 164 YSGDYYRQGCASKL-PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG---- 218
Query: 208 GEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR 267
+EN EI + I G P+ + + EL +C S R
Sbjct: 219 -------------VEN---SEIYNYLIKGNRLKQPPDCLEDVY---ELMCQCWSPEPKCR 259
Query: 268 PTIVQVAKQLRQIY 281
P+ + QL I+
Sbjct: 260 PSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-04
Identities = 35/148 (23%), Positives = 65/148 (43%), Gaps = 32/148 (21%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
FP V++ A ++ A+ YLH S +V RD+KP ++L + ++ DF + +
Sbjct: 98 FPEPVARFYAA-QVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG------------- 196
T+ + GT ++APE + + + D ++ G L+ E+L G
Sbjct: 154 R-TYT-----LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207
Query: 197 KKI-----SYSSHFDDGEDYRLQDLVKK 219
+KI + S F +DL++
Sbjct: 208 EKILEGKVRFPSFFSP----DAKDLIRN 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 10/111 (9%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A EI + +LH S+ ++ RD+K ++L + ++ DF + G+ N ++
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NRAST 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210
GT ++APE ++ D +SFG LL E+L G+ S D ED
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ----SPFHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 11/98 (11%)
Query: 100 AIEIASAVAYLH-VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
E+ AV LH +G+ + RD+KP ++ +L DF LS I + +N
Sbjct: 107 MAEMFEAVDALHELGY----IHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYAN 156
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
V+G+ +MAPE + D +S G +L E L G
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 11/86 (12%)
Query: 118 VVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD- 176
++ RD+KPT +++ +L DF +S ++ + +N IG +MAPE +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTN--IGCQSYMAPERIKSGGP 178
Query: 177 -----FSEKSDVYSFGALLLELLTGK 197
++ +SDV+S G +LE+ G+
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A + + YLH +V RD+K ++L E ++ DF L EG + ++
Sbjct: 107 AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTST 160
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
GT F+APE T ++ D + G L+ E+L G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L +A++IAS + YL S V RD+ ++ E ++ DF +S ++ G+ +
Sbjct: 141 LHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRI 196
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELL 194
R + +MA E G F+ SDV++FG L E+L
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 40/177 (22%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SLSIPEGETHINDSN 158
A EIA + +LH S+ ++ RD+K ++L E ++ DF + ++ +G T +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT----TK 159
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218
GT ++APE + + D ++FG LL E+L G+ + F +GED
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ-----APF-EGED-------- 205
Query: 219 KYIENESFKEIVDPAIVGEEGLMWPE--KEQQLLICTELAFK-------CLSESEGD 266
E+E F+ I+ E + +P+ ++ + IC L K C E E D
Sbjct: 206 ---EDELFQSIM------EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 253
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 25/133 (18%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SLSIPEGETHINDSN 158
A EIA + +LH S+ ++ RD+K ++L E ++ DF + +I G+T +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT----TR 159
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218
GT ++APE + + D ++FG LL E+L G+ F DGED
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ-----PPF-DGED-------- 205
Query: 219 KYIENESFKEIVD 231
E+E F+ I++
Sbjct: 206 ---EDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS--LSIPEGETHI 154
L ++IA ++YL +V RD+ ++++ N ++ DF L+ L I E E H
Sbjct: 112 LNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
D +V +MA E F+ +SDV+S+G + EL+T
Sbjct: 169 -DGGKV--PIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 38/150 (25%), Positives = 55/150 (36%), Gaps = 38/150 (25%)
Query: 74 GFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHV-GFSRPVVSRDIKPTTIVLQE 132
LQ +P V++ A E+ A+ YLH+ G V RD+KP I+L E
Sbjct: 90 RLLQRQPGKC------LSEEVARFYAA-EVLLALEYLHLLGI----VYRDLKPENILLHE 138
Query: 133 ENVAQLFDFTLSLSIPEGETHIND--------------------------SNRVIGTFGF 166
L DF LS ++ SN +GT +
Sbjct: 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEY 198
Query: 167 MAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+APE + D ++ G LL E+L G
Sbjct: 199 IAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 17/117 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-----VAQLFDFTLSLSIPEGE 151
L I +++A YL + RD+ ++ E+ V ++ DF L+ I
Sbjct: 109 LDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---- 161
Query: 152 THINDSNRVIGT----FGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
+ +D R G +MAPE G F+ +SDV+SFG L+ E+LT + Y +
Sbjct: 162 -YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 16/127 (12%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
+++K P ++++ A E A+ YLH + +V RD+KP +++ +L DF
Sbjct: 90 TLLKNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDF 145
Query: 142 TLS------LSIPEGETHINDSNR------VIGTFGFMAPEYRTTGDFSEKSDVYSFGAL 189
LS L+ E HI R V GT ++APE + + D ++ G +
Sbjct: 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII 205
Query: 190 LLELLTG 196
L E L G
Sbjct: 206 LYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 14/104 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + ++A +++L S+ + RD+ I+L + ++ DF L+ I ND
Sbjct: 217 LSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR------ND 267
Query: 157 SNRVIG-----TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
SN V+ +MAPE ++ +SDV+S+G LL E+ +
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
I ++ A+ YLH S ++ RD+K ++L + +L DF +S + + +
Sbjct: 115 ICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRD 168
Query: 159 RVIGTFGFMAPEY---RTTGD--FSEKSDVYSFGALLLEL 193
IGT +MAPE T D + K+D++S G L+E+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 9e-04
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV- 160
+I + Y+H S VV RD+KP+ I++ E ++ DF L+ I D
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA--------RIQDPQMTG 164
Query: 161 -IGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGK 197
+ T + APE T + + D++S G + E+L GK
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 12/106 (11%)
Query: 94 VSKLKIAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150
+S+L+IA E +AYLH S+ + RDIK I+L + +L DF ++ I
Sbjct: 103 LSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI--- 156
Query: 151 ETHINDSNRVIGTFGFMAPE---YRTTGDFSEKSDVYSFGALLLEL 193
I IGT +MAPE G +++ D+++ G +EL
Sbjct: 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 13/128 (10%)
Query: 73 KGFL-QDRPISVMKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
K FL ++RP + E ++ L A ++A YL + RDI +L
Sbjct: 97 KSFLRENRP----RPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLL 149
Query: 131 Q---EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFG 187
VA++ DF ++ I ++ R + +M PE G F+ K+DV+SFG
Sbjct: 150 TCKGPGRVAKIADFGMARDI-YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFG 208
Query: 188 ALLLELLT 195
LL E+ +
Sbjct: 209 VLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS-NRV 160
+I + Y+H S ++ RD+KP+ + + E+ ++ DF L+ H +D
Sbjct: 128 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGY 177
Query: 161 IGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKI 199
+ T + APE +++ D++S G ++ ELLTG+ +
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 16/113 (14%)
Query: 91 PFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL--SLSI 147
S +K ++ +A+ H S ++ RD+KP +++ E V +L DF L S
Sbjct: 94 GLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS 150
Query: 148 PEGE-THINDSNRVIGTFGFMAPE--YRTTGDFSEKSDVYSFGALLLELLTGK 197
P TH + T + APE G +S D++S G + ELL+ +
Sbjct: 151 PVRPYTH------YVVTRWYRAPELLLGDKG-YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 75 FLQDRPI-SVMKFEDTFPFSVSK---LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
FL R I S + P SVS L +A++IAS + YL S V RD+ ++
Sbjct: 107 FLSQREIESTFTHANNIP-SVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLV 162
Query: 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALL 190
++ DF +S ++ G+ + R + +MA E G F+ SDV++FG L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 191 LELLT-GKKISYSSHFDD------GEDYRLQ 214
E+ T K+ YS D+ GE +R Q
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ 252
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 47/192 (24%), Positives = 80/192 (41%), Gaps = 36/192 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L +A +IAS + YL S V RD+ ++ + ++ DF +S ++ + +D
Sbjct: 133 LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-----YSSD 184
Query: 157 SNRVIGT----FGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDY 211
RV G +MA E G F+ KSDV++FG L E+LT ++ Y H D
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY-EHLTD--QQ 241
Query: 212 RLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIV 271
+++ + ++ + P ++ EL +C E DRPT
Sbjct: 242 VIENAGHFFRDDGRQIYLPRPPNCPKD-------------IYELMLECWRRDEEDRPT-- 286
Query: 272 QVAKQLRQIYQS 283
R+I+
Sbjct: 287 -----FREIHLF 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 10/109 (9%)
Query: 89 TFPFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147
T P S S++ ++ E + YLH S+ + RDIK I+L + +L DF +S I
Sbjct: 100 TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156
Query: 148 PEGETHINDSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLEL 193
I IGT +MAPE G +++ D+++ G +EL
Sbjct: 157 ---TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 35/149 (23%), Positives = 61/149 (40%), Gaps = 46/149 (30%)
Query: 90 FPFSVSKLKIAIEIASAVAYLH-VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL----- 143
F +++ IA E+ A+ +H +GF + RDIKP I++ + +L DF L
Sbjct: 98 FEEDLARFYIA-ELTCAIESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152
Query: 144 ----SLSIPEGETHINDS-------------------------------NRVIGTFGFMA 168
S +G+ H DS + ++GT ++A
Sbjct: 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212
Query: 169 PEYRTTGDFSEKSDVYSFGALLLELLTGK 197
PE +++ D +S G +L E+L G+
Sbjct: 213 PEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 35/133 (26%), Positives = 62/133 (46%), Gaps = 25/133 (18%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL-SLSIPEGETHINDSN 158
A EI+ + +LH R ++ RD+K ++L E ++ DF + + +G T +
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT----TR 159
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218
GT ++APE + + D +++G LL E+L G+ DGED
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF------DGED-------- 205
Query: 219 KYIENESFKEIVD 231
E+E F+ I++
Sbjct: 206 ---EDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 42/196 (21%)
Query: 62 VIMKCLFYKLYKGFL------------QDRPISVMKFEDTFPFSVSKLKIAIEIASAVAY 109
V+MKC+ +K G L QD I VM+ D V ++++ E S + Y
Sbjct: 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI-VMELMDANLCQVIQMELDHERMSYLLY 133
Query: 110 --------LHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
LH S ++ RD+KP+ IV++ + ++ DF L+ + G + + V
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV- 187
Query: 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED----------- 210
T + APE + E D++S G ++ E++ G + + D +
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 211 ---YRLQDLVKKYIEN 223
+LQ V+ Y+EN
Sbjct: 247 EFMKKLQPTVRTYVEN 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN- 155
L ++IA + YL R +V RD+ ++++ N ++ DF L+ + E N
Sbjct: 112 LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
D ++ +MA E F+ +SDV+S+G + EL+T
Sbjct: 169 DGGKM--PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 14/107 (13%)
Query: 106 AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV--IGT 163
A+AYLH R ++ RD+K I L E A L DF + + H + GT
Sbjct: 197 ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQCYGWSGT 250
Query: 164 FGFMAPEYRTTGDFSEKSDVYSFGALLLEL------LTGKKISYSSH 204
+PE + K+D++S G +L E+ L GK++ SS
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 6/98 (6%)
Query: 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159
A E+ A+ +LH V+ RD+K I+L E +L DF + EG + +
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMC---KEGILNGVTTTT 155
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
GT ++APE ++ D ++ G L+ E++ G+
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 29/113 (25%), Positives = 54/113 (47%), Gaps = 11/113 (9%)
Query: 83 VMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFT 142
+ + D FS ++A+ + +L S+ V RD+ +++ E + ++ DF
Sbjct: 235 ALSYMDLVGFS-------YQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFG 284
Query: 143 LSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
L+ I +I+ + + +MAPE ++ SDV+SFG LL E+ T
Sbjct: 285 LARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 85 KFEDTFPFSVSKLKIAIEIASAVAYLH-VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143
++ED F +++ +A E+ A+ +H +G+ V RDIKP +++ +L DF
Sbjct: 94 RYEDQFDEDMAQFYLA-ELVLAIHSVHQMGY----VHRDIKPENVLIDRTGHIKLADFGS 148
Query: 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKS------DVYSFGALLLELLTGK 197
+ + +N S +GT ++APE TT + K D +S G + E++ G+
Sbjct: 149 AARL-TANKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 14/116 (12%)
Query: 85 KFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL--FDFT 142
K+ + S + K +I + + H S ++ RDIKP I++ + V +L F F
Sbjct: 92 KYPNGLDESRVR-KYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 147
Query: 143 LSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTG 196
+L+ P GE + + + T + APE GD + D+++ G L+ E+LTG
Sbjct: 148 RTLAAP-GEVYTD----YVATRWYRAPEL-LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 41/189 (21%), Positives = 82/189 (43%), Gaps = 37/189 (19%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-LSIPEGETHIN 155
L ++IA + YL +V R++ I+L+ +++ Q+ DF ++ L P+ + +
Sbjct: 112 LNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF- 167
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ +MA E G ++ +SDV+S+G + E+++ Y+ R +
Sbjct: 168 -YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-------MRPHE 219
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT----ELAFKCLSESEGDRPTIV 271
+ P ++ E+G E+ Q ICT + KC E RPT
Sbjct: 220 V---------------PDLL-EKG----ERLAQPQICTIDVYMVMVKCWMIDENVRPTFK 259
Query: 272 QVAKQLRQI 280
++A + ++
Sbjct: 260 ELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 14/120 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L ++A + +L S+ V RD+ ++L + + ++ DF L+ I ++D
Sbjct: 240 LSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDI------MHD 290
Query: 157 SNRVI--GTF---GFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY 211
SN V TF +MAPE ++ SDV+S+G LL E+ + Y D Y
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 33/119 (27%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 93 SVSKLKIAI-EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL--SIPE 149
S+ +KI + +I +AY H R V+ RD+KP +++ E +L DF L+ S+P
Sbjct: 102 SMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158
Query: 150 GETHINDSNRVIGTFGFMAPEYRT-TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207
+T+ SN V+ T + P+ + ++S + D++ G + E+ +G+ + S +D
Sbjct: 159 -KTY---SNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 17/104 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L+ A ++A+ + YL + + RD+ +++ E +++ DF LS GE
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS----RGE----- 169
Query: 157 SNRVIGTFG-----FMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
V T G +MA E ++ KSDV+SFG LL E+++
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 8/109 (7%)
Query: 91 PFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
PF S++K + +++ S VA+LH ++ RD+K + ++L + ++ DF L+
Sbjct: 102 PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
Query: 150 GETHINDSNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGK 197
+++ T + APE ++S D++S G + ELLT K
Sbjct: 159 PLKPYT---QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 284 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.68 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.67 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.48 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.45 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.41 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.28 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.25 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.25 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.25 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.25 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.66 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.58 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.31 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.92 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.52 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 96.95 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 96.85 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 96.76 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.32 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.15 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.44 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.89 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.69 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.64 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.3 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.57 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.51 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 93.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.04 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 92.81 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.23 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 91.93 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.68 | |
| PLN02236 | 344 | choline kinase | 91.67 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.3 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.09 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 90.29 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 90.17 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 87.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 87.84 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 87.03 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.01 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=331.75 Aligned_cols=231 Identities=41% Similarity=0.678 Sum_probs=197.0
Q ss_pred CcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------CC
Q 039895 41 PIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------FP 91 (284)
Q Consensus 41 ~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------~~ 91 (284)
..+.|++.||.+||++|+..++||+|+||.||+|.. +|..||||++... ||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 788999999999999999999999999999999999 6689999987652 33
Q ss_pred Cc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeec
Q 039895 92 FS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 92 ~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
.+ ..|++||.++|+||+|||+.+..+||||||||+|||+|+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 32 45889999999999999998888999999999999999999999999
Q ss_pred cccccccCC-CCccccCCCCc-ccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 141 FTLSLSIPE-GETHINDSNRV-IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 141 fg~a~~~~~-~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
||+|+.... ...... . .||.+|+|||+...+..+.++|||||||+++|++||+.+.+... ......+..|..
T Consensus 221 FGLa~~~~~~~~~~~~----~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVST----TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAK 294 (361)
T ss_pred ccCcccCCccccceee----ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHH
Confidence 999966654 221111 2 79999999999999999999999999999999999998876543 334445899998
Q ss_pred HHhhcCcccccccccccC-CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 219 KYIENESFKEIVDPAIVG-EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.....+.+.+++|+.+.. .. + ...+...+..++.+|++.+|..||+|.||+++|+.+..
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~----~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEY----P-DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHCcchhheeCCCccCCCC----C-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 888888999999999873 31 1 11567779999999999999999999999999977653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=295.12 Aligned_cols=195 Identities=28% Similarity=0.391 Sum_probs=154.6
Q ss_pred CCCeeeecCCceEEEEEeCCcc-eEEEeecCCC------------------------------CCc--------------
Q 039895 59 GGKVIMKCLFYKLYKGFLQDRP-ISVMKFEDTF------------------------------PFS-------------- 93 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~------------------------------~~~-------------- 93 (284)
..+.||+|+||+||+|.+.|.. ||||++.... |.+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3456999999999999999988 9999998631 000
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCC-eeecccccCcEEEecCC-cceeeccccccccCCCCccc
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRP-VVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~~ 154 (284)
..++++|.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--- 198 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--- 198 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---
Confidence 456899999999999999 888 99999999999999998 99999999998776432
Q ss_pred cCCCCcccCcccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRT--TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
...+...||+.|||||++. ...|+.|+||||||+++|||+||..||.... ..............+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--------~~~~~~~v~~~~~Rp----- 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--------PVQVASAVVVGGLRP----- 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCCC-----
Confidence 1112267999999999999 5689999999999999999999999997543 111122221111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+..++..+..||.+||+.||+.||++.+++..|+.+..
T Consensus 266 ----------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 ----------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ----------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1122355668899999999999999999999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=275.36 Aligned_cols=197 Identities=25% Similarity=0.337 Sum_probs=156.5
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|...++||.|+||+||++.. +|..||.|.++-.
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 455567899999999999998 9999999998744
Q ss_pred -CCCc-------------------hhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEecCCcceeecccccccc
Q 039895 90 -FPFS-------------------VSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 -~~~~-------------------~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
+|.. ....+++.|++.||..+|... .. |+||||||.||+|+.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 2211 567789999999999999321 44 999999999999999999999999999998
Q ss_pred CCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
.+..+... +.+|||.||+||.+...+|+.+|||||+||++|||..-++||++.. +..+ ...+.++.++
T Consensus 179 ~s~~tfA~---S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L-~~KI~qgd~~ 246 (375)
T KOG0591|consen 179 SSKTTFAH---SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSL-CKKIEQGDYP 246 (375)
T ss_pred cchhHHHH---hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHH-HHHHHcCCCC
Confidence 77655433 3799999999999999999999999999999999999999998643 2222 2333444433
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.+. ....+..+..|+..|+..||+.||+...++..++.
T Consensus 247 ~~p--------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PLP--------------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCc--------------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 322 13445558899999999999999986555555443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.34 Aligned_cols=195 Identities=22% Similarity=0.295 Sum_probs=152.9
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------C----------------------CCc--
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------F----------------------PFS-- 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------~----------------------~~~-- 93 (284)
+...+.||+|..|+||++.+ ++..+|+|.+... - |.+
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 33457899999999999999 7999999999433 0 111
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
...-+++.++++||.|||+ ..+||||||||+|||+++.|.+||||||.+..+..+.
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~----- 233 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI----- 233 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh-----
Confidence 3345799999999999994 4999999999999999999999999999998876551
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
..+++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .......+.......... +.
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~pp-P~-------- 301 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEPP-PR-------- 301 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCCC-CC--------
Confidence 223899999999999999999999999999999999999999987641 222333333333332111 11
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.|.. .+++++.+++..||+.||.+|||+.|++++
T Consensus 302 -----lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 -----LPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----CCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 356669999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.08 Aligned_cols=190 Identities=21% Similarity=0.300 Sum_probs=155.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
..|..+++||+|||+.||+++. .|..||+|++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588899999999999999999 8999999999764
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
.|.. .....++.||+.||.||| +.+|+|||||..|++++++.++||+|||+|..+......
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 2222 567789999999999999 999999999999999999999999999999988754322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. .+.+|||-|.|||++....++..+||||+||++|-|+.|++||.... +.+........ +
T Consensus 175 k---~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~~----~----- 234 (592)
T KOG0575|consen 175 K---KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKLN----E----- 234 (592)
T ss_pred c---ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHhc----C-----
Confidence 2 23799999999999999999999999999999999999999997543 22222221111 1
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+..+.....+..+||.++|+.+|.+|||+++|+.
T Consensus 235 --------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 --------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112233445789999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=271.26 Aligned_cols=210 Identities=20% Similarity=0.284 Sum_probs=153.8
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
.|+...++|+|+||.||+++. +|+.||||+|... |
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 456667899999999999999 8999999999765 3
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC-CCCccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP-EGETHI 154 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~~~ 154 (284)
|.. ....+++.|++.|+.|+| ++++|||||||+||||+.+|.+||||||+|+.+. .+..+.
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 332 456689999999999999 9999999999999999999999999999999987 333332
Q ss_pred cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHH---------HhhcC
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK---------YIENE 224 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~ 224 (284)
. .+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+.. +-+....+..... +..++
T Consensus 160 D----YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 160 D----YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred h----hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2 678999999999887 589999999999999999999999887644 2111111111110 00111
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
-+.-+.-|....-... ....+.....+++++..||+.||++|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epL-e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPL-ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccch-hhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1221111111111000 0001223335789999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=294.35 Aligned_cols=215 Identities=24% Similarity=0.324 Sum_probs=160.3
Q ss_pred eecHHHHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------
Q 039895 44 SFSADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---------------------------------- 89 (284)
..+.+++....+.+.....||+|+||+||+|.|.|. ||||++...
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 334455555556666778999999999999999875 999999866
Q ss_pred --------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 90 --------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 90 --------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
+|.. .+.+.||.|||+|+.||| .++|||||||+.||++.+++++||+|||++.
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence 2222 456789999999999999 9999999999999999999999999999985
Q ss_pred ccCCCCccccCCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
.-..- ..........|...|||||++.. .+|+..+|||||||++|||+||..|+.... . +.+--.+.
T Consensus 537 vk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~------dqIifmVG 606 (678)
T KOG0193|consen 537 VKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---R------DQIIFMVG 606 (678)
T ss_pred eeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---h------hheEEEec
Confidence 43211 11111122568889999999864 379999999999999999999999986322 0 00000001
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+- +.+.+ ......++.++.+|+..||..++++||++.+|+..|+.+..+
T Consensus 607 rG~----l~pd~-------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 RGY----LMPDL-------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccc----cCccc-------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 110 00111 112456677799999999999999999999999999988763
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.28 Aligned_cols=195 Identities=27% Similarity=0.366 Sum_probs=157.9
Q ss_pred CCeeeecCCceEEEEEeCCc-ceEEEeecCC---------------------------CCCc------------------
Q 039895 60 GKVIMKCLFYKLYKGFLQDR-PISVMKFEDT---------------------------FPFS------------------ 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~---------------------------~~~~------------------ 93 (284)
.+.||+|-||+||.|.+++. .||+|.++.. .|..
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~ 290 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD 290 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence 46799999999999999776 9999999875 1111
Q ss_pred ------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 94 ------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 94 ------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
.+.+.++.|||+|++||. ++++|||||-++|||++++..+||+|||+|+...++.+..... ..
T Consensus 291 yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~--~k 365 (468)
T KOG0197|consen 291 YLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG--GK 365 (468)
T ss_pred HhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC--CC
Confidence 567889999999999999 9999999999999999999999999999999665554433322 33
Q ss_pred cCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
-+..|.|||.+..+.++.+||||||||+|||++| |+.|+.... ..+.+...- .+.
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------n~ev~~~le----------------~Gy 421 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------NEEVLELLE----------------RGY 421 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------HHHHHHHHh----------------ccC
Confidence 4678999999999999999999999999999999 555544322 222222211 233
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.|.+..|++.+.+||..||+.+|++|||+..+...|+++..+
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 4455667888899999999999999999999999999998765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=282.07 Aligned_cols=198 Identities=21% Similarity=0.346 Sum_probs=155.4
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCCc-----------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPFS----------------------------------- 93 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----------------------------------- 93 (284)
+...++|..++.||+|+|++|++|+. .++.+|||++.+.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44457899999999999999999999 89999999997761100
Q ss_pred -------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 94 -------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 94 -------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
.....++.+|+.||+||| +.|||||||||+|||+|.+|.++|+|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 334568999999999999 9999999999999999999999999999999886
Q ss_pred CCCcc----------ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 149 EGETH----------INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 149 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
..... .....+++||..|.+||++.....+..+|+|+|||++|+|+.|.+||.... ...+-+-+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliFqkI~ 300 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIFQKIQ 300 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHHHHHH
Confidence 43222 111245899999999999999999999999999999999999999997543 111111111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.. .-.+ ++..++.+.+|+.+.|..||.+|+|+.+|.++
T Consensus 301 ~l--~y~f------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 AL--DYEF------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred Hh--cccC------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 10 0011 11122347899999999999999999888653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=270.67 Aligned_cols=145 Identities=24% Similarity=0.406 Sum_probs=126.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
...+|...+.||+|+||+||+|++ ++..||||.+...
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 346788888899999999999999 8899999998655
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC------Ccceeeccccccc
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE------NVAQLFDFTLSLS 146 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~------~~~kl~Dfg~a~~ 146 (284)
||.. .....++.|||.||++|| +++||||||||+||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 5553 456679999999999999 9999999999999999865 4579999999999
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
+..+.... +.+|++.|||||++....|+.|+|+||+|+++|++++|+.||....
T Consensus 165 L~~~~~a~----tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQPGSMAE----TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCchhHHH----HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98654332 2789999999999999999999999999999999999999997543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=268.16 Aligned_cols=185 Identities=26% Similarity=0.324 Sum_probs=147.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCCc--------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPFS-------------------------------------- 93 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-------------------------------------- 93 (284)
.++|+..++||+|+||.||.++. +++.+|+|++++..+.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 47899999999999999999998 89999999998772222
Q ss_pred ---------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 94 ---------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 94 ---------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
....-++.+|+.||.||| +++||||||||+|||+|.+|.++|+|||+++..-....
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 334558999999999999 99999999999999999999999999999986543322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. +.+++||+.|||||++....|+..+|.||+|+++|||++|.+||+... ...+........ ... .
T Consensus 181 ~---t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k-~~~--~- 245 (357)
T KOG0598|consen 181 A---TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGK-LPL--P- 245 (357)
T ss_pred c---cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCc-CCC--C-
Confidence 2 123799999999999999999999999999999999999999998644 233333322221 000 0
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP 268 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 268 (284)
+........+++...|..||++|.
T Consensus 246 ------------p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 ------------PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------------CccCCHHHHHHHHHHhccCHHHhc
Confidence 111223378999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=256.71 Aligned_cols=211 Identities=16% Similarity=0.164 Sum_probs=153.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCC-----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPF----------------------------------------- 92 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----------------------------------------- 92 (284)
.|...++||+|.||.||+|.+ +|+.||||+++...-.
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 355678999999999999999 8999999999765110
Q ss_pred -----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 93 -----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 93 -----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
......++.++++||+||| .+.|+||||||.|+|++++|.+||+|||+|+.+.+......
T Consensus 83 m~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 83 MPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred ccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 1557789999999999999 99999999999999999999999999999999876543322
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh--cCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE--NESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (284)
. .+-|.+|+|||.+.+. .|+..+||||.||++.||+.|.+.|.+.. +-.++....+.... ...++++..-
T Consensus 160 ~---~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s----DidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 160 H---QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS----DIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc----hHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 3679999999988765 69999999999999999999987765433 11122222222111 1223322110
Q ss_pred c----ccCCCCC-CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 A----IVGEEGL-MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~----~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. +...+.. .-.....+....++|+..+|.+||.+|+|++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0000000 000122344456899999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=273.94 Aligned_cols=193 Identities=21% Similarity=0.252 Sum_probs=149.6
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---CCC--------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---FPF-------------------------------------- 92 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~-------------------------------------- 92 (284)
.|-..+.||+|+||.|-+|.. +|+.||||++.+. -|.
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 455678899999999999998 9999999999866 111
Q ss_pred ----------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC---Ccceeecccccccc
Q 039895 93 ----------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE---NVAQLFDFTLSLSI 147 (284)
Q Consensus 93 ----------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfg~a~~~ 147 (284)
+..-..++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 0233458999999999999 9999999999999999866 78999999999988
Q ss_pred CCCCccccCCCCcccCccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGD---FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
..... . .+.+|||.|.|||++.+.. +..++|+||+||+||-+++|.+||.... ....+.+.+..
T Consensus 330 g~~sf--m--~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~eQI~~----- 396 (475)
T KOG0615|consen 330 GEGSF--M--KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLKEQILK----- 396 (475)
T ss_pred cccee--h--hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHHHHHhc-----
Confidence 64322 2 2379999999999998764 3358899999999999999999997543 11223332221
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.+...++.......+.++|+.+||..||++|||+.|+++
T Consensus 397 -----------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 -----------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111122334455666889999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=277.45 Aligned_cols=210 Identities=17% Similarity=0.226 Sum_probs=155.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPF---------------------------------------- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---------------------------------------- 92 (284)
+.|...+.||.|.||.||+|+. .|..||||.++..+-.
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4555667899999999999998 8899999999877111
Q ss_pred -------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 93 -------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 93 -------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+.....|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.+.+....
T Consensus 90 E~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 90 EFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred HhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence 1567789999999999999 999999999999999999999999999999998766544
Q ss_pred ccCCCCcccCcccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---ccc-
Q 039895 154 INDSNRVIGTFGFMAPEYRT-TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES---FKE- 228 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 228 (284)
.. .+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|.+.. +...+.... ..+.... +.+
T Consensus 167 Te----YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s----E~Dqi~KIc-~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 167 TE----YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS----EIDQIYKIC-EVLGTPDKDSWPEG 237 (538)
T ss_pred ch----hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc----HHHHHHHHH-HHhCCCccccchhH
Confidence 33 68899999999865 5679999999999999999999999887643 111111111 1111111 111
Q ss_pred -----cccccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 229 -----IVDPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 229 -----~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+.-.+....+... .....+..++.+++.+|+++||++||||.|++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111000 0112356678899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.83 Aligned_cols=211 Identities=20% Similarity=0.215 Sum_probs=154.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|+...+||+|.||.||+|.. +|+.||+|++...
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4577778999999999999999 8999999998755
Q ss_pred -----------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -----------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -----------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
...+.+...++.|++.||.|+| +++|+|||||.+|||||.+|.+||+|||+|+.+.....
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 1111678889999999999999 99999999999999999999999999999998765543
Q ss_pred cccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc---Cccc-
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN---ESFK- 227 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 227 (284)
...+. .+-|++|+|||++.+. .|+.++|+||.|||+.||++|+++|.+.. +...+. .+-..... ..|.
T Consensus 274 ~~~T~--rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t----EveQl~-kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 274 APYTS--RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT----EVEQLH-KIFKLCGSPTEDYWPV 346 (560)
T ss_pred ccccc--ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc----HHHHHH-HHHHHhCCCChhcccc
Confidence 33222 5679999999998876 69999999999999999999999887543 111111 11111111 1111
Q ss_pred -cccccc-ccCCCCC--CCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 -EIVDPA-IVGEEGL--MWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 -~~~~~~-~~~~~~~--~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.... +...... ... .....+...++|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000000 0000000 000 01223445789999999999999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=265.25 Aligned_cols=191 Identities=21% Similarity=0.285 Sum_probs=151.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~ 91 (284)
.|....+||+|+||.||+|.+ .++.||+|++.-. +|
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466668999999999999999 8899999999755 11
Q ss_pred Cc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 FS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
.. ....-++.+++.||.||| ..+.+|||||+.|||+..+|.+|++|||.+..+.......
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-- 168 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence 11 223347899999999999 9999999999999999999999999999998887655443
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
.+++||+.|||||++....|+.++||||||++.+||.+|.+|+..... .... --+++-..|.+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvl------------flIpk~~PP~L-- 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVL------------FLIPKSAPPRL-- 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEE------------EeccCCCCCcc--
Confidence 338999999999999988999999999999999999999999865431 0000 00111111222
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.....+.+.+++..||+.||+.||||.++++.
T Consensus 232 --------~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 --------DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --------ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 12444558899999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=271.07 Aligned_cols=161 Identities=23% Similarity=0.394 Sum_probs=122.3
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......... .....+++.|+|||++.+..
T Consensus 177 ~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 252 (338)
T cd05102 177 ICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGSARLPLKWMAPESIFDKV 252 (338)
T ss_pred HHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhc-ccCCCCCccccCcHHhhcCC
Confidence 457889999999999 99999999999999999999999999999987643322211 11234678899999998889
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHH
Q 039895 177 FSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTEL 255 (284)
Q Consensus 177 ~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (284)
++.++|||||||++|||++ |..||..... .. ... .....+.... .+...+..+.+|
T Consensus 253 ~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~---~~~-~~~~~~~~~~---------------~~~~~~~~l~~l 309 (338)
T cd05102 253 YTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NE---EFC-QRLKDGTRMR---------------APENATPEIYRI 309 (338)
T ss_pred CCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cH---HHH-HHHhcCCCCC---------------CCCCCCHHHHHH
Confidence 9999999999999999997 8888864321 00 111 1111111100 011223457899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 256 AFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 256 ~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+.+||+.||++|||+.|+++.|+++.++|
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~~~ 338 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQEN 338 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhcC
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.12 Aligned_cols=198 Identities=21% Similarity=0.232 Sum_probs=150.2
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
...++|+....||+|+||.||.++- +|..+|+|++++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3568999999999999999999998 8999999999876
Q ss_pred -------------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -------------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -------------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
...+.....++.+++.|+.-|| ..|+|||||||+|+|||..|.+||+|||++..+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 1111556678999999999999 999999999999999999999999999998644210
Q ss_pred ---------------------Cccc----cCC-------------------CCcccCccccccccccCCCCCcchhHHHH
Q 039895 151 ---------------------ETHI----NDS-------------------NRVIGTFGFMAPEYRTTGDFSEKSDVYSF 186 (284)
Q Consensus 151 ---------------------~~~~----~~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwS~ 186 (284)
.... ... -..+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 000 03689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC
Q 039895 187 GALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD 266 (284)
Q Consensus 187 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 266 (284)
|||+|||+.|.+||.+... .....-+..+.. ...+|.......+..+||.+|+. ||++
T Consensus 375 G~ImyEmLvGyPPF~s~tp-----~~T~rkI~nwr~----------------~l~fP~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETP-----QETYRKIVNWRE----------------TLKFPEEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred HHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhh----------------hccCCCcCcccHHHHHHHHHHhc-CHHH
Confidence 9999999999999986541 111111111100 01122233334568899999999 9999
Q ss_pred CCC---HHHHH
Q 039895 267 RPT---IVQVA 274 (284)
Q Consensus 267 Rps---~~ev~ 274 (284)
|.. +.||.
T Consensus 433 RLG~~G~~EIK 443 (550)
T KOG0605|consen 433 RLGSKGAEEIK 443 (550)
T ss_pred hcCcccHHHHh
Confidence 975 55553
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.60 Aligned_cols=205 Identities=21% Similarity=0.264 Sum_probs=156.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCCc-------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPFS------------------------------------- 93 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------------------------------- 93 (284)
.-.+|+....||.|..++||+|.. .+..||||++.-..|..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346788889999999999999999 78999999998663333
Q ss_pred ----------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 94 ----------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 94 ----------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
..+..|+.++++||.||| .+|.||||||+.||||+.+|.+||+|||.+..+.+..
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 455678999999999999 9999999999999999999999999999887765544
Q ss_pred ccccCC-CCcccCccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 152 THINDS-NRVIGTFGFMAPEYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 152 ~~~~~~-~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
...... .+++||+.|||||++... .|+.|+||||||++..|+.+|..||.... ........+.+ ..+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--------PmkvLl~tLqn-~pp~ 251 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP--------PMKVLLLTLQN-DPPT 251 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC--------hHHHHHHHhcC-CCCC
Confidence 333322 557999999999996543 69999999999999999999999996432 11222222211 1111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..-..+ ...........+.+++..||..||.+|||++++++
T Consensus 252 ~~t~~~------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGL------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccC------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111 11223334446889999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=276.40 Aligned_cols=190 Identities=25% Similarity=0.335 Sum_probs=154.9
Q ss_pred CCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------CCCc------------
Q 039895 60 GKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------------------FPFS------------ 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------------------~~~~------------ 93 (284)
.+-||+|+.|.||.|++.++.||||+++.- ||..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~ 208 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP 208 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc
Confidence 457999999999999999999999998643 3433
Q ss_pred ---hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccc
Q 039895 94 ---VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE 170 (284)
Q Consensus 94 ---~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 170 (284)
...+.+..+||.|+.||| .+.|||||||+-||||..+..+||+|||.++......+. ..+.||..|||||
T Consensus 209 itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk----MSFaGTVaWMAPE 281 (904)
T KOG4721|consen 209 ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK----MSFAGTVAWMAPE 281 (904)
T ss_pred cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh----hhhhhhHhhhCHH
Confidence 445678999999999999 999999999999999999999999999999877654322 2278999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHH
Q 039895 171 YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLL 250 (284)
Q Consensus 171 ~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (284)
++...+.+.|+|||||||+||||+||..|+.... .. .+ ++. .+......|.+..|+.
T Consensus 282 vIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd-----ss-AI--IwG---------------VGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 282 VIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD-----SS-AI--IWG---------------VGSNSLHLPVPSTCPD 338 (904)
T ss_pred HhhcCCcccccceehhHHHHHHHHhcCCCccccc-----hh-ee--EEe---------------ccCCcccccCcccCch
Confidence 9999999999999999999999999999985422 00 00 000 0111222345667777
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 251 ICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 251 ~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.+.-|+..||+..|.+||++.+++.+|.-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 88899999999999999999999998863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=261.49 Aligned_cols=198 Identities=25% Similarity=0.348 Sum_probs=149.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
.++...+.||+|+||+||.+.. +|...|||.+...
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4567788999999999999999 5899999987652
Q ss_pred CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCCCc
Q 039895 90 FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|+ .+.....+..||++||.||| +++||||||||+|||++. ++.+||+|||+++.......
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 11 11456789999999999999 999999999999999999 79999999999987764222
Q ss_pred cccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.........||+.|||||++..+ ....++||||+||++.||+||++||... ......+-........+.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~P~i-- 244 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSLPEI-- 244 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCCCCC--
Confidence 21222237899999999999854 3345999999999999999999998642 1111111111111112211
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
+...+....+++.+|+..+|+.||||.++++..
T Consensus 245 -------------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 245 -------------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -------------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 222344478999999999999999999998754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=255.12 Aligned_cols=211 Identities=18% Similarity=0.208 Sum_probs=153.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.|++|+||.||+|.+ ++..||+|+++..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35677788999999999999999 8999999999765
Q ss_pred ---CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
||.. .+...++.|+++|++||| ...|+||||||+|+|++..|.+||+|||+|+.+.+..
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 2211 456679999999999999 9999999999999999999999999999999987663
Q ss_pred ccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh--cCcccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE--NESFKE 228 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 228 (284)
... +..+-|.+|+|||.+.+. .|+++.|+||+|||+.|++++++.|.+.. +...+...+..... ...++.
T Consensus 232 k~~---T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s----E~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 232 KPY---TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS----EIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred ccC---cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc----hHHHHHHHHHHhCCCccccCCC
Confidence 221 225679999999998876 59999999999999999999999887543 22222222222111 111221
Q ss_pred cccccccC------C-CC---CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 IVDPAIVG------E-EG---LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~------~-~~---~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+ . ++ ..++... ....-.+|+...|.+||.+|.|+.|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111000 0 00 0011110 2244678999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=267.15 Aligned_cols=192 Identities=21% Similarity=0.309 Sum_probs=154.9
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|..-.+||+|..|.||.+.. .+..||||.+...
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 55556899999999999998 8889999998755
Q ss_pred ----------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 90 ----------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 90 ----------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
...+.+...|+.+++.||+||| .++|+|||||.+|||++.+|.+||+|||++..+..... ...+
T Consensus 355 gsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---KR~T 428 (550)
T KOG0578|consen 355 GSLTDVVTKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---KRST 428 (550)
T ss_pred CchhhhhhcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC---cccc
Confidence 1122677889999999999999 99999999999999999999999999999988765544 3344
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
.+|||.|||||+.....|++++||||||++++||+-|.+||..+. .+.... ....++ .+++
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAly-LIa~ng-~P~l---------- 489 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALY-LIATNG-TPKL---------- 489 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHH-HHhhcC-CCCc----------
Confidence 899999999999999999999999999999999999999997432 111111 111111 1111
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.........+.+++.+||+.|+++||++.|+|++
T Consensus 490 ---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 ---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1234555668999999999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.07 Aligned_cols=206 Identities=17% Similarity=0.249 Sum_probs=157.3
Q ss_pred CCcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------------
Q 039895 40 NPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------ 89 (284)
Q Consensus 40 ~~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------ 89 (284)
..++.++.+++ +......||+|++|.||+|.++|+.||||.+...
T Consensus 10 ~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 10 NDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred CcceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34556677776 3334478999999999999999999999998643
Q ss_pred ------------------CCCc---------------hhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCc
Q 039895 90 ------------------FPFS---------------VSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENV 135 (284)
Q Consensus 90 ------------------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~ 135 (284)
+|.. ...+.++.+++.||.||| . .+++||||||+|||++.++.
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCc
Confidence 1110 456789999999999999 6 48899999999999999999
Q ss_pred ceeeccccccccCCCCccccCCCCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 136 AQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 136 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
+||+|||+++....... ...|++.|+|||++.+ ..++.++|||||||++|||++|..||.... .
T Consensus 162 ~kl~dfg~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~ 227 (283)
T PHA02988 162 LKIICHGLEKILSSPPF------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------T 227 (283)
T ss_pred EEEcccchHhhhccccc------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------H
Confidence 99999999876643322 1468899999999876 678999999999999999999999986432 1
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
............ . ++.+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 228 ~~~~~~i~~~~~-~--------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 228 KEIYDLIINKNN-S--------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHhcCC-C--------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111111111110 0 00111234458899999999999999999999999998753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=266.54 Aligned_cols=216 Identities=18% Similarity=0.178 Sum_probs=151.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------CC------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------FP------ 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------~~------ 91 (284)
++|+..+.||+|+||.||++.. +++.||+|..... ++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~ 171 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC 171 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHH
Confidence 5688899999999999999998 7889999987543 00
Q ss_pred --------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccC
Q 039895 92 --------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGT 163 (284)
Q Consensus 92 --------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 163 (284)
.....+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......... ......||
T Consensus 172 ~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt 246 (391)
T PHA03212 172 YLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN--KYYGWAGT 246 (391)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc--ccccccCc
Confidence 01456789999999999999 999999999999999999999999999998654322111 11225799
Q ss_pred ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc---cccHHHHHHHHhh-cCccc--------ccc-
Q 039895 164 FGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE---DYRLQDLVKKYIE-NESFK--------EIV- 230 (284)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~--------~~~- 230 (284)
+.|+|||++.+..++.++|||||||++|||++|..|+......+.. ...+...+..... ...+. ...
T Consensus 247 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~ 326 (391)
T PHA03212 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYI 326 (391)
T ss_pred cCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHH
Confidence 9999999999889999999999999999999999887643211111 0111111111000 00000 000
Q ss_pred ----cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 ----DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...........+......+..+.+|+.+||+.||++|||+.|+++
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 327 GLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000001112222234556889999999999999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=257.31 Aligned_cols=208 Identities=20% Similarity=0.288 Sum_probs=150.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--CCCc--------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--FPFS-------------------------------------- 93 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~-------------------------------------- 93 (284)
.|...+++|.|+||.||+|.. ++..||||+.... ++..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 355678999999999999999 7789999988655 1100
Q ss_pred --------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-CcceeeccccccccCCCCc
Q 039895 94 --------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 94 --------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~~ 152 (284)
....-+..||.+||.||| +.+|+||||||+|+|+|.+ |.+||||||.|+.+..+..
T Consensus 105 P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 105 PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 122347999999999999 9999999999999999965 9999999999999866543
Q ss_pred cccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--------
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-------- 223 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (284)
.. +...|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.. ....+...+.-...+
T Consensus 182 ni----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s----~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 182 NI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS----SVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ce----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC----HHHHHHHHHHHhCCCCHHHHhhc
Confidence 32 25679999999988765 69999999999999999999999987633 222222222221111
Q ss_pred -CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 -ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+...+.+....... -......++..+|+.++|.++|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011111122222211000 012233445789999999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=258.82 Aligned_cols=211 Identities=20% Similarity=0.251 Sum_probs=149.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4678889999999999999999 6789999988643
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 110 1456779999999999999 9999999999999999999999999999998765432221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH------------hh
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY------------IE 222 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~ 222 (284)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.. +... ..
T Consensus 158 ~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 158 Y--TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE----IDQLFT-IQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred c--cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHHhhCCCCHHHHHhhhc
Confidence 1 125689999999999888899999999999999999999999865321 000100 0000 00
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.........+................+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=254.86 Aligned_cols=215 Identities=17% Similarity=0.195 Sum_probs=153.1
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC--------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF-------------------------------------- 90 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------------------------------------- 90 (284)
-.+...|...+.||+|+||.|..+.. +|..||||++...+
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 33445566678899999999999999 89999999987430
Q ss_pred ------------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 91 ------------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 91 ------------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
..+.....++.|++.||.|+| +.+|+||||||+|+|++.+..+||+|||+|+.
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 011334568999999999999 99999999999999999999999999999999
Q ss_pred cCCCCccccCCCCcccCcccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRT-TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
.... ......+..+.|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+... ......+......+.
T Consensus 175 ~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-----v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 175 LDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-----VHQLQLILELLGTPS 248 (359)
T ss_pred cccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-----HHHHHHHHHhcCCCC
Confidence 8654 2222324477899999999865 45799999999999999999999999876431 111111111111110
Q ss_pred -----------ccccccccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 -----------FKEIVDPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 -----------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+. .+.......+ ...+...+..++|+.+||..||.+|+|++|+++
T Consensus 249 ~e~l~~i~s~~ar~yi~-slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIK-SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhccHHHHHHHH-hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 0000111111 011233445789999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=253.19 Aligned_cols=209 Identities=16% Similarity=0.203 Sum_probs=149.1
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------CC-Cc------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------FP-FS------------------ 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------~~-~~------------------ 93 (284)
|...++||+|+||+||+|.. +|+.||+|++.-. .| ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44445799999999999999 8999999998644 11 00
Q ss_pred ---------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 94 ---------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 94 ---------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
.....++.||+.||+||| +.+|+||||||+||||+++|.+||+|||+|+.
T Consensus 93 ~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 93 YLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 246789999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh---
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE--- 222 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 222 (284)
..-.... .+..++|.+|+|||++.+. .|++..||||+||++.||+++++.|.+.. + ......+-....
T Consensus 170 ~~ip~~~---yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s----e-~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 170 FSIPMRT---YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS----E-IDQLFRIFRLLGTPN 241 (323)
T ss_pred hcCCccc---ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc----H-HHHHHHHHHHcCCCC
Confidence 6532221 1226789999999998877 69999999999999999999998887643 1 111111111111
Q ss_pred cCcccccccccccCCCCCCCh----hhH---HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWP----EKE---QQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...++....-.-....-..+. ... .......+++.+||+++|.+|.|+..++.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 122222211000000000111 001 111357899999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.02 Aligned_cols=192 Identities=22% Similarity=0.313 Sum_probs=145.4
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
.|...+.||+|+||+||+|.. +|+.||+|.+...
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366678999999999999998 7899999987532
Q ss_pred CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 110 1355678999999999999 99999999999999999999999999999977643322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......... . .
T Consensus 158 ~----~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~-~-~-- 224 (285)
T cd05631 158 V----RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-----RVKREEVDRRVKEDQE-E-Y-- 224 (285)
T ss_pred e----cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc-----chhHHHHHHHhhcccc-c-C--
Confidence 1 125689999999999998999999999999999999999999975331 1111111111111000 0 0
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
.......+.+|+.+||+.||.+||+ ++++++
T Consensus 225 ------------~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 ------------SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ------------CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1112334789999999999999997 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=274.10 Aligned_cols=146 Identities=17% Similarity=0.268 Sum_probs=120.0
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------- 89 (284)
++...+++|...++||+|+||+||+|.. .+..||||++...
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3444567888889999999999999998 6789999998531
Q ss_pred ----------CC--------------CchhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCC----------
Q 039895 90 ----------FP--------------FSVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEEN---------- 134 (284)
Q Consensus 90 ----------~~--------------~~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~---------- 134 (284)
++ .......++.||+.||.||| . .+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 00 00345678999999999999 7 5999999999999998765
Q ss_pred ------cceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 135 ------VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 135 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~~------~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHSR------TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cCCCCceEEECCCCccccCcccc------ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 48999999875432221 2267999999999999999999999999999999999999999653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=272.21 Aligned_cols=200 Identities=22% Similarity=0.260 Sum_probs=152.7
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------- 89 (284)
+.....+.|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444557899999999999999999998 8899999987532
Q ss_pred --------------CCCc-------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 --------------FPFS-------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 --------------~~~~-------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
++.. .....++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence 0000 234568899999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 216 (284)
||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ....
T Consensus 183 kL~DFGls~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~ 253 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDD-VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEV 253 (496)
T ss_pred EEEecccCeecccccccc-ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHH
Confidence 999999997764332211 1123679999999999999899999999999999999999999986432 1222
Q ss_pred HHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...... +... +.+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 254 ~~~~~~-~~~~---------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 MHKTLA-GRYD---------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHhc-CCCC---------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222111 1110 0111223458899999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=253.68 Aligned_cols=209 Identities=19% Similarity=0.236 Sum_probs=147.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC---------------------------------CC-------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT---------------------------------FP------- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---------------------------------~~------- 91 (284)
+.|...+.||+|+||.||+|.. ++..||+|++... .|
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3577788999999999999987 4678999987532 00
Q ss_pred ---------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 92 ---------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 92 ---------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
.......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 00355779999999999999 999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh--
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE-- 222 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 222 (284)
........ .....||+.|+|||++....++.++|||||||++|||++|.+||.... .......+.....
T Consensus 158 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~-----~~~~~~~i~~~~~~~ 228 (290)
T cd07862 158 RIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIGLP 228 (290)
T ss_pred EeccCCcc----cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCCC
Confidence 76643311 122568999999999988889999999999999999999999986532 1111111111110
Q ss_pred -cCcccccc---cccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 -NESFKEIV---DPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 -~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...++... ...+......... ........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00010000 0000000000000 01123345779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=255.85 Aligned_cols=200 Identities=21% Similarity=0.340 Sum_probs=150.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc----ceEEEeecCC-----------------------------CCC-------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR----PISVMKFEDT-----------------------------FPF------- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~-----------------------------~~~------- 92 (284)
++|+..+.||+|+||.||+|.+ ++. .||+|++... +|.
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 5688899999999999999987 444 3899998633 000
Q ss_pred ---------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 93 ---------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 93 ---------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
....+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 0345688999999999999 9999999999999999999999999999998775433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
..... ....++..|+|||++....++.++|||||||++||+++ |..||.... ..... ........
T Consensus 164 ~~~~~-~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~---- 229 (316)
T cd05108 164 KEYHA-EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEIS-SILEKGER---- 229 (316)
T ss_pred cceec-cCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHH-HHHhCCCC----
Confidence 22111 11234678999999998899999999999999999998 888875422 11111 11111100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
++.+..+...+.+++.+||+.+|++|||+.+++..|..+..
T Consensus 230 -----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 -----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00111222347899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=253.48 Aligned_cols=162 Identities=15% Similarity=0.160 Sum_probs=117.9
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc----ccCCCCcccCcccccccc
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH----INDSNRVIGTFGFMAPEY 171 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~ 171 (284)
...++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.+...... ........||+.|+|||+
T Consensus 128 ~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~ 204 (294)
T PHA02882 128 IKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDA 204 (294)
T ss_pred HHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHH
Confidence 4568999999999999 999999999999999999999999999999876432211 111122469999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHH
Q 039895 172 RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI 251 (284)
Q Consensus 172 ~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
..+..++.++|||||||+++||++|..||..... . ........... ...+....+. ...++..
T Consensus 205 ~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~--~--~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~~ 267 (294)
T PHA02882 205 HNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH--N--GNLIHAAKCDF----IKRLHEGKIK---------IKNANKF 267 (294)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc--c--hHHHHHhHHHH----HHHhhhhhhc---------cCCCCHH
Confidence 9999999999999999999999999999965421 1 11111000000 0000000000 0112345
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 252 CTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 252 ~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
+.+++..||..+|++||++.++++.|
T Consensus 268 ~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 268 IYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 88999999999999999999998876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=241.63 Aligned_cols=178 Identities=21% Similarity=0.284 Sum_probs=143.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||.|+||+|..++. +|..+|+|++...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5677788999999999999998 8999999999876
Q ss_pred ----------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 ----------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ----------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
...+....-+|.||+.||+||| +.+|++|||||+|||+|.+|.+||+|||+|+.......
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~- 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW- 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEE-
Confidence 1111455679999999999999 99999999999999999999999999999988765422
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh-cCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE-NESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (284)
+.+|||.|+|||++...+|+.++|-|||||++|||+.|.+||+... . ......... .-.++..+
T Consensus 200 -----TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~-----~---~~iY~KI~~~~v~fP~~f-- 264 (355)
T KOG0616|consen 200 -----TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN-----P---IQIYEKILEGKVKFPSYF-- 264 (355)
T ss_pred -----EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC-----h---HHHHHHHHhCcccCCccc--
Confidence 2789999999999999999999999999999999999999998654 1 111222211 11222222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCC
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR 267 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 267 (284)
...+.+|+...|+.|-.+|
T Consensus 265 ----------------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 ----------------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------------CHHHHHHHHHHHhhhhHhh
Confidence 2236789999999988888
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=277.18 Aligned_cols=198 Identities=25% Similarity=0.334 Sum_probs=161.9
Q ss_pred CCCCeeeecCCceEEEEEeC-------CcceEEEeecCC-----------------------------C-----------
Q 039895 58 DGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT-----------------------------F----------- 90 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~-----------------------------~----------- 90 (284)
...+.||+|.||.||+|... ...||||.++.. .
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 34568999999999999982 356999999876 0
Q ss_pred -------------------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceee
Q 039895 91 -------------------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLF 139 (284)
Q Consensus 91 -------------------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 139 (284)
....+.+.||.|||.|+.||- +..+|||||-.+|+|+.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEec
Confidence 111578999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHH
Q 039895 140 DFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 140 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
|||+++...+..++..... ..-+..|||||.+..++|+++||||||||+|||+++ |+.|+++.. -. .+-
T Consensus 646 DfGLsRdiYssDYYk~~~~-t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--------n~-EVI 715 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGN-TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--------NQ-EVI 715 (774)
T ss_pred ccccchhhhhhhhhcccCC-ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------hH-HHH
Confidence 9999999887776654422 234789999999999999999999999999999998 788887543 11 122
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..+..+.+ ++-+..|+.++.+||..||+.+|.+||+++||-..|+..-+.
T Consensus 716 e~i~~g~l---------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 ECIRAGQL---------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHcCCc---------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 22233332 233567888899999999999999999999999999987653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=260.15 Aligned_cols=211 Identities=18% Similarity=0.255 Sum_probs=145.5
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 56678999999999999998 7899999987532
Q ss_pred ---CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 ---FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ---~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 82 VFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 1100 445678999999999999 99999999999999999999999999999976533222
Q ss_pred cccCCCCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-------
Q 039895 153 HINDSNRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN------- 223 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (284)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHH
Confidence 1111122578999999999865 5789999999999999999999999864321 1111111110000
Q ss_pred ----CcccccccccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ----ESFKEIVDPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......+.. +......... ........+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 0000000000 001123447899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.50 Aligned_cols=162 Identities=23% Similarity=0.383 Sum_probs=123.0
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++..+........ .....++..|+|||++.+.
T Consensus 175 ~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 250 (337)
T cd05054 175 LISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPESIFDK 250 (337)
T ss_pred HHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhh-ccCCCCCccccCcHHhcCC
Confidence 4568899999999999 99999999999999999999999999999987644332211 1124567789999999999
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++|||||||++|||++ |..||..... . .. .......+.... .+......+.+
T Consensus 251 ~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~--~~----~~~~~~~~~~~~---------------~~~~~~~~~~~ 307 (337)
T cd05054 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--D--EE----FCRRLKEGTRMR---------------APEYATPEIYS 307 (337)
T ss_pred CCCccccHHHHHHHHHHHHHcCCCCCCCCCc--c--HH----HHHHHhccCCCC---------------CCccCCHHHHH
Confidence 99999999999999999998 8888754220 0 00 111111111000 01122344789
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
++.+||+.+|++||++.||++.|+++++.|
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~~ 337 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQEN 337 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhcC
Confidence 999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=254.93 Aligned_cols=208 Identities=14% Similarity=0.213 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|+||.||+|.. ++..||+|++... +
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4678888999999999999998 7889999988632 1
Q ss_pred C---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 P---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
| .......++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-- 159 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-- 159 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--
Confidence 1 01345678999999999999 999999999999999999999999999998765432211
Q ss_pred CCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc---Ccccc---
Q 039895 156 DSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN---ESFKE--- 228 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 228 (284)
.....|++.|+|||++.+ ..++.++||||+||++|+|++|..||.... .......+...... ..++.
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 160 -YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-----VKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHHhhcccc
Confidence 112467999999998865 468999999999999999999999986532 11111111111110 00111
Q ss_pred ------cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 ------IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+..... ............+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQ--PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCC--chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111100000 000000112334789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=267.56 Aligned_cols=210 Identities=17% Similarity=0.246 Sum_probs=145.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
..+|...+.||+|+||.||+|.. +++.||||++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 35688899999999999999998 7889999987532
Q ss_pred ---CCCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeecccccccc
Q 039895 90 ---FPFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSI 147 (284)
Q Consensus 90 ---~~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~ 147 (284)
+|.. .....++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.+
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 0000 234567889999999999 99999999999999999665 7999999999876
Q ss_pred CCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc---
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN--- 223 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 223 (284)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.. ....+...+......
T Consensus 222 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 222 LAGQRS----VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS----SVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cCCCCc----ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCHH
Confidence 543221 125689999999987654 68999999999999999999999986532 111111111110000
Q ss_pred ------CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 ------ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+..+.-+..... ......+...+..+.+|+.+||..||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~-~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPK-DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCch-hHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000000000 0000001112345889999999999999999999984
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=253.77 Aligned_cols=200 Identities=21% Similarity=0.317 Sum_probs=155.8
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------- 89 (284)
.+..|.|.....||+|.||.|-+|+. +++.||+|++.+.
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34567899999999999999999999 8999999999765
Q ss_pred ------------------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 ------------------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 ------------------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
||.. .+..+++.+++.||.||| .++||||||||+|+|++++|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 2211 567889999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCcc--ccCCCCcccCccccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 137 QLFDFTLSLSIPEGETH--INDSNRVIGTFGFMAPEYRTTGD----FSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
||+|||.+.....+... .......+|||.|+|||.+.++. .+.+.||||+||+||.++.|+-||.+..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~------ 323 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF------ 323 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch------
Confidence 99999999877443211 11112368999999999987732 3578999999999999999999997543
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......... .. ...+|..++....+.+|+.++|+.||+.|.++.+|..+
T Consensus 324 --~~~l~~KIv---------n~------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 324 --ELELFDKIV---------ND------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred --HHHHHHHHh---------cC------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 122221111 11 12233344555668899999999999999999998643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=259.22 Aligned_cols=159 Identities=20% Similarity=0.363 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
.++++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......... .....+++.|+|||++...
T Consensus 214 ~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 289 (374)
T cd05106 214 LLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV-KGNARLPVKWMAPESIFDC 289 (374)
T ss_pred HHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee-ccCCCCccceeCHHHhcCC
Confidence 3578999999999999 99999999999999999999999999999977644322111 1113456789999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++|||||||++|||++ |..||..... ....... ...+ . .... +...+..+.+
T Consensus 290 ~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~~----~~~~-~-~~~~-------------~~~~~~~l~~ 346 (374)
T cd05106 290 VYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYKM----VKRG-Y-QMSR-------------PDFAPPEIYS 346 (374)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHHH----HHcc-c-CccC-------------CCCCCHHHHH
Confidence 99999999999999999997 9998864320 0011111 1110 0 0000 0011234789
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
++.+||+.||++|||+.+|++.|+++.
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.80 Aligned_cols=188 Identities=22% Similarity=0.292 Sum_probs=145.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3677889999999999999998 6899999998532
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~- 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW- 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc-
Confidence 1111 345678999999999999 99999999999999999999999999999877643221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......... ... .
T Consensus 157 -----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~-~~~------~ 216 (291)
T cd05612 157 -----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILA-GKL------E 216 (291)
T ss_pred -----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCc------C
Confidence 2568999999999998889999999999999999999999986432 1111111111 110 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~~ 276 (284)
+ +......+.+|+.+||+.||.+||+ +.++++.
T Consensus 217 ~----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 F----------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C----------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 0111234789999999999999995 8887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=255.58 Aligned_cols=191 Identities=25% Similarity=0.310 Sum_probs=151.2
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
...+.|...+.||+|+||.|+.|.. ++..||+|++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456888999999999999999988 8899999976552
Q ss_pred -------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-Ccceeeccccccc
Q 039895 90 -------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLS 146 (284)
Q Consensus 90 -------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~ 146 (284)
||.. .....++.|++.|++||| +.+|+||||||+|||++.+ +.+||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 1211 356679999999999999 9999999999999999999 9999999999988
Q ss_pred cC-CCCccccCCCCcccCccccccccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh-
Q 039895 147 IP-EGETHINDSNRVIGTFGFMAPEYRTTGD-FS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE- 222 (284)
Q Consensus 147 ~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 222 (284)
.. ... ...+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.... ..........
T Consensus 171 ~~~~~~----~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~ 238 (370)
T KOG0583|consen 171 SPGEDG----LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKG 238 (370)
T ss_pred cCCCCC----cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcC
Confidence 74 221 122378999999999999877 86 78999999999999999999997522 2222222111
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
.-.++.+++ ...+..|+.+||..+|.+|+|+.+|+
T Consensus 239 ~~~~p~~~~-----------------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFKIPSYLL-----------------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CccCCCCcC-----------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111222221 34478999999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=264.29 Aligned_cols=187 Identities=21% Similarity=0.260 Sum_probs=149.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------CCCc------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------FPFS------ 93 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------~~~~------ 93 (284)
..++|....+||+|+||.|+.+.. +++.+|||++++. .|+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 447888899999999999999999 8889999999887 1111
Q ss_pred ----------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 94 ----------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 94 ----------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
....-+|..|+.||+||| +++||+||||.+|||+|..|.+||+|||+++...-..
T Consensus 446 fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 445568999999999999 9999999999999999999999999999997654221
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
..+.+++|||.|||||++.+..|+.++|-|||||++|||+.|..||.+.. + . +++|
T Consensus 523 ---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----E----e-------------e~Fd 578 (694)
T KOG0694|consen 523 ---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD----E----E-------------EVFD 578 (694)
T ss_pred ---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC----H----H-------------HHHH
Confidence 12344899999999999999999999999999999999999999997643 1 1 1111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
..+..+. .-+...+.+..+|+.++|..+|++|..+
T Consensus 579 sI~~d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVNDEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcCCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111110 0122334457899999999999999865
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=248.28 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=174.0
Q ss_pred CchHHHHHHHHhh--CCCCCCcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC-----------
Q 039895 23 NGKILLEKLIASS--NGKHNPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------- 89 (284)
Q Consensus 23 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------- 89 (284)
.+...+.+++... +|+.++++.+-...+... ....+.||+|.||.||+|.|.|..||||+|...
T Consensus 180 ~~~stl~Dll~~~~tSGSGSGlplLVQRTiarq---I~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEI 256 (513)
T KOG2052|consen 180 AGDSTLKDLLDDLETSGSGSGLPLLVQRTIARQ---IVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEI 256 (513)
T ss_pred cCCccHHHHHHhhccCCCCCCchhHhHHhhhhe---eEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHH
Confidence 3445566666444 566677776655555443 345678999999999999999999999999766
Q ss_pred -----------------------C------------------------CCchhHHHHHHHHHHHHHHhcc-----CCCCC
Q 039895 90 -----------------------F------------------------PFSVSKLKIAIEIASAVAYLHV-----GFSRP 117 (284)
Q Consensus 90 -----------------------~------------------------~~~~~~~~i~~~i~~gL~~LH~-----~~~~~ 117 (284)
. -.....++++..+|.||++||. +..+.
T Consensus 257 YqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 257 YQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred HHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 0 0005678999999999999993 33678
Q ss_pred eeecccccCcEEEecCCcceeeccccccccCCC-CccccCCCCcccCccccccccccCCC----C--CcchhHHHHHHHH
Q 039895 118 VVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG-ETHINDSNRVIGTFGFMAPEYRTTGD----F--SEKSDVYSFGALL 190 (284)
Q Consensus 118 ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwS~G~il 190 (284)
|.|||||+.|||+.+++++.|+|+|+|....+. ..........+||..|||||++...- + -..+||||||.++
T Consensus 337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 999999999999999999999999999877654 33333344578999999999986542 2 1469999999999
Q ss_pred HHHHhC----------CCCCCCCCCCCCccccHHHHHHHHhhcCccccc-ccccccCCCCCCChhhHHHHHHHHHHHHHh
Q 039895 191 LELLTG----------KKISYSSHFDDGEDYRLQDLVKKYIENESFKEI-VDPAIVGEEGLMWPEKEQQLLICTELAFKC 259 (284)
Q Consensus 191 ~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 259 (284)
||+... +.||++.-..+.. .. .+.++ ....+....+.+|.. .+.+..+.+||..|
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs---~e----------eMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeC 482 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPS---FE----------EMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKEC 482 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCC---HH----------HHhcceeecccCCCCCccccc-CHHHHHHHHHHHHh
Confidence 998753 2344432211111 10 11111 122233333333433 35566688999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 260 LSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 260 l~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
|..+|..|.|+--+.+.|.++.++
T Consensus 483 W~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 483 WYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred hcCCchhhhHHHHHHHHHHHHhcC
Confidence 999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=259.34 Aligned_cols=190 Identities=24% Similarity=0.384 Sum_probs=154.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||||+. +.+.||+|.+.+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 3566667899999999999998 7889999998755
Q ss_pred CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 90 FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 90 ~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
||.. .....++.+++.||.||| +.+|+|||+||.|||++.+|.+|+||||+|+....... ..
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-vl 157 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-VL 157 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCce-ee
Confidence 2221 567789999999999999 99999999999999999999999999999988765322 22
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
+...|||.|||||+..+.+|+..+|.||+||++||+++|++||+... +...+........
T Consensus 158 --tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v---------- 217 (808)
T KOG0597|consen 158 --TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPV---------- 217 (808)
T ss_pred --eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCC----------
Confidence 23789999999999999999999999999999999999999998543 3444444332211
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.|| ......+..++...|..||..|.|-.+++.
T Consensus 218 -----~~p--~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 -----KPP--STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -----CCc--ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 111 134445889999999999999999988764
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=247.52 Aligned_cols=200 Identities=22% Similarity=0.334 Sum_probs=149.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc----ceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR----PISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ +|. .||+|++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 5677788999999999999987 554 4899988643
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 00 01456789999999999999 9999999999999999999999999999998765432
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
..... ....+++.|+|||...+..++.++|||||||++||+++ |..||.... ...+...+ ......
T Consensus 164 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~----~~~~~~--- 230 (279)
T cd05109 164 TEYHA-DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLL----EKGERL--- 230 (279)
T ss_pred ceeec-CCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCCcC---
Confidence 22111 11234678999999988889999999999999999998 778775322 11111111 111100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.....+..+.+++.+||+.||+.||++.++++.|+.+..
T Consensus 231 ------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 ------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0011223347899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=258.30 Aligned_cols=187 Identities=19% Similarity=0.295 Sum_probs=144.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5678888999999999999999 7889999988532
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF- 173 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc-
Confidence 1111 344568899999999999 99999999999999999999999999999977644322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... .+...
T Consensus 174 -----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~-~~~~~------ 233 (329)
T PTZ00263 174 -----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKIL-AGRLK------ 233 (329)
T ss_pred -----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHh-cCCcC------
Confidence 2568999999999998889999999999999999999999986432 111111111 11100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
+ +......+.+|+.+||+.||.+||+ +.+++.
T Consensus 234 ~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 F----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0011223779999999999999997 577764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=248.85 Aligned_cols=198 Identities=24% Similarity=0.378 Sum_probs=150.0
Q ss_pred cCCCCCCeeeecCCceEEEEEeCC-------cceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQD-------RPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~-------------------------------------- 89 (284)
++|+..+.||+|+||.||+|...+ ..||+|.+...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467778899999999999999822 46999988643
Q ss_pred ----CCC-------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC
Q 039895 90 ----FPF-------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134 (284)
Q Consensus 90 ----~~~-------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 134 (284)
++. ....+.++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 110 0234579999999999999 99999999999999999999
Q ss_pred cceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccH
Q 039895 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 135 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~ 213 (284)
.++|+|||++........... .....+++.|+|||.+....++.++|||||||++|||++ |..||.... ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-----~~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRV-QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-----NQEV 235 (283)
T ss_pred cEEECCCcceeeccccccccc-cCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence 999999999976644332211 112456888999999988889999999999999999998 988886432 1111
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
... +..+... +.+..++..+.+|+.+||+.+|++||++.||++.|+.+
T Consensus 236 ~~~----i~~~~~~---------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEM----IRSRQLL---------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH----HHcCCcC---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111 1111111 11223445688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.75 Aligned_cols=211 Identities=14% Similarity=0.214 Sum_probs=145.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|+||.||+|.. +++.||+|++... +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 6788889999999999999999 7889999998633 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 159 (303)
T cd07869 85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT-- 159 (303)
T ss_pred CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc--
Confidence 10 0346678999999999999 999999999999999999999999999998754322211
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccccc--
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEI-- 229 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 229 (284)
.....||+.|+|||++.+. .++.++||||+||++|+|++|..||.... ........+....... .+...
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 160 -YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK----DIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhCCCChhhccchhh
Confidence 1125689999999987654 58899999999999999999999996532 0001111111111000 00000
Q ss_pred ---cccc-ccCCCCCCChh---hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 ---VDPA-IVGEEGLMWPE---KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ---~~~~-~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+. ........... .......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000000000 0011234779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=244.69 Aligned_cols=192 Identities=21% Similarity=0.304 Sum_probs=145.4
Q ss_pred eeeecCCceEEEEEe----CCcceEEEeecCC------------------------------------------C-----
Q 039895 62 VIMKCLFYKLYKGFL----QDRPISVMKFEDT------------------------------------------F----- 90 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~------------------------------------------~----- 90 (284)
.||+|+||.||+|.+ ++..+|+|++... +
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999976 5788999988543 0
Q ss_pred ----------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 91 ----------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 91 ----------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
........++.|++.||.||| +++|+|+||||+||+++.++.++|+|||++................
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 011466789999999999999 9999999999999999999999999999998765443322222223
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
.+++.|+|||.+....++.++|||||||++||+++ |..||.... .......+ ..+....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~i----~~~~~~~----------- 218 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GNEVTQMI----ESGERME----------- 218 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----HCCCCCC-----------
Confidence 44678999999988889999999999999999998 888886432 11111111 1111110
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+...+..+.+++.+||+.||++||++.+|+..|++.
T Consensus 219 ----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 ----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0112334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=278.21 Aligned_cols=200 Identities=24% Similarity=0.350 Sum_probs=155.5
Q ss_pred CCCCCeeeecCCceEEEEEe---CCc----ceEEEeecCC-----------------------------CCCc-------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL---QDR----PISVMKFEDT-----------------------------FPFS------- 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~---~~~----~vavK~~~~~-----------------------------~~~~------- 93 (284)
....+.||+|.||.||+|.+ .|. .||+|.+... .|..
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 34467899999999999999 443 3899988765 0100
Q ss_pred ----------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 94 ----------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 94 ----------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
...+.++.|||+|+.||+ +++.|||||..+|+|++....+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 677899999999999999 9999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
.+....++..... ..-+..|||||.+..+.|+.|+|||||||++||++|...++++.. . ..+........+
T Consensus 851 Diy~~~yyr~~~~-a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~----~---n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGE-AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR----S---NFEVLLDVLEGG- 921 (1025)
T ss_pred hhhhchheeccCc-cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc----c---hHHHHHHHHhCC-
Confidence 7666555544332 234578999999999999999999999999999999544443322 1 111122122222
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+.+..|+..+.++|..||+.+|++||++..+++++..+...
T Consensus 922 ---------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 ---------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ---------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1233556777789999999999999999999999999988754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=255.90 Aligned_cols=184 Identities=20% Similarity=0.259 Sum_probs=140.7
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCCc-
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPFS- 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~~- 93 (284)
+.||+|+||.||++.. +|+.||+|++... +|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999998 7899999988643 1111
Q ss_pred --------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 94 --------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 94 --------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~ 154 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKT 154 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cccc
Confidence 345668899999999999 99999999999999999999999999999875422211 1122
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
..||+.|+|||++.+..++.++|||||||++|||++|..||.... ......... .... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~-~~~~------~~----- 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELIL-MEEI------RF----- 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHH-cCCC------CC-----
Confidence 579999999999998899999999999999999999999996432 111111111 1110 00
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111233478999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=255.81 Aligned_cols=145 Identities=20% Similarity=0.262 Sum_probs=122.3
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------C--------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------F-------- 90 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------~-------- 90 (284)
...++|...+.||+|+||.||++.. .++.||+|++... +
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3557898899999999999999998 7889999988643 0
Q ss_pred ----------C------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 91 ----------P------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 91 ----------~------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
| .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 0 00334568999999999999 9999999999999999999999999999997654
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
..... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 171 TSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred Ccccc----CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 33221 1256899999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=251.38 Aligned_cols=162 Identities=23% Similarity=0.317 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
.+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+........ .....++..|+|||++...
T Consensus 140 ~~~i~~~i~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 140 LLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI-QGRAVLPIRWMAWECILMG 215 (304)
T ss_pred HHHHHHHHHHHHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEe-cCcCCCCccccCHHHHhcC
Confidence 4579999999999999 99999999999999999999999999999977644332211 1124567889999999888
Q ss_pred CCCcchhHHHHHHHHHHHHhC--CCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLTG--KKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT 253 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
.++.++|||||||++|||+++ ..||.... .......+......... ... . ..+..++..+.
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~-~~~-~----------~~~~~~~~~~~ 278 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELT-----DEQVIENAGEFFRDQGR-QVY-L----------FRPPPCPQGLY 278 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCC-----HHHHHHHHHHHhhhccc-ccc-c----------cCCCCCCHHHH
Confidence 899999999999999999874 44554321 11122222111111100 000 0 00112234588
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 254 ELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 254 ~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
+|+.+||+.+|++|||+.+|.+.|+
T Consensus 279 ~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 279 ELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHccCCchhCcCHHHHHHHHh
Confidence 9999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=243.82 Aligned_cols=200 Identities=26% Similarity=0.375 Sum_probs=153.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. ++..||+|.+...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788889999999999999998 8899999976432
Q ss_pred -CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 00 01345678999999999999 99999999999999999999999999999877654
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
..... ....|++.|+|||.+.+..++.++||||||+++||+++|..||.... .......... .....+..
T Consensus 159 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~-~~~~~~~~ 228 (267)
T cd08228 159 KTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKI-EQCDYPPL 228 (267)
T ss_pred hhHHH---hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHH-hcCCCCCC
Confidence 32211 12468889999999988889999999999999999999999986432 1112222111 11111110
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
........+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 229 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 --------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01123345889999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=246.06 Aligned_cols=197 Identities=19% Similarity=0.316 Sum_probs=148.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ .+..||+|.+...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 4677888999999999999986 3568999988754
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.|++.||+||| +.+++||||||+|||++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 11 01456789999999999999 9999999999999999999999999999876543222
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... .....++..|+|||++.+..++.++|||||||++||+++ |..||.... ........ ..+..
T Consensus 162 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~~-~~~~~---- 226 (266)
T cd05064 162 IYT--TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKAV-EDGFR---- 226 (266)
T ss_pred hhc--ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHH-HCCCC----
Confidence 111 111345678999999988899999999999999999775 988886432 11111111 11100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+.+..++..+.+++..||+.+|++|||+.+|++.|+++
T Consensus 227 -----------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -----------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011223344578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=250.84 Aligned_cols=141 Identities=23% Similarity=0.375 Sum_probs=113.7
Q ss_pred CCeeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------CC---
Q 039895 60 GKVIMKCLFYKLYKGFL----QDRPISVMKFEDT-----------------------------------------FP--- 91 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-----------------------------------------~~--- 91 (284)
+.+||+|+||+||+|.. ++..||+|.+... ++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 46899999999999986 4578999988643 00
Q ss_pred --------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE----ecCCcceeecccccccc
Q 039895 92 --------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL----QEENVAQLFDFTLSLSI 147 (284)
Q Consensus 92 --------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfg~a~~~ 147 (284)
.......++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 00224578999999999999 9999999999999999 45678999999999876
Q ss_pred CCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
..............||+.|+|||++.+. .++.++||||+||++|+|++|.+||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 5433222222336789999999998764 5889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=245.61 Aligned_cols=197 Identities=23% Similarity=0.334 Sum_probs=150.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~- 91 (284)
.+|...+.||+|+||.||+|.+ .+..||+|++... ++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3567778999999999999998 6889999998654 00
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
....++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 00445778999999999999 99999999999999999999999999999877654332211
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
. ...++..|+|||.+.+..++.++|||||||++|||++ |..|+.... ........ ... .. +
T Consensus 163 ~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~-~~~-~~----~-- 224 (263)
T cd05052 163 A--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELL-EKG-YR----M-- 224 (263)
T ss_pred C--CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHH-HCC-CC----C--
Confidence 1 1234678999999988899999999999999999998 888875422 11111111 111 00 0
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+.+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 --------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00112234588999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=258.57 Aligned_cols=158 Identities=21% Similarity=0.325 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
.+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......... .....++..|+|||++.+.
T Consensus 216 ~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 291 (375)
T cd05104 216 LLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV-KGNARLPVKWMAPESIFNC 291 (375)
T ss_pred HHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc-cCCCCCCcceeChhHhcCC
Confidence 3468899999999999 99999999999999999999999999999987654332211 1113456789999999988
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++|||||||++|||++ |..||..... .......+ ..+.... . +...+.++.+
T Consensus 292 ~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~~~----~~~~~~~--~-------------~~~~~~~l~~ 348 (375)
T cd05104 292 VYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYKMI----KEGYRML--S-------------PECAPSEMYD 348 (375)
T ss_pred CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHHHH----HhCccCC--C-------------CCCCCHHHHH
Confidence 99999999999999999998 7777754220 01111111 1110000 0 0111234789
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
|+.+||+.||++|||+.||++.|++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=258.61 Aligned_cols=211 Identities=18% Similarity=0.219 Sum_probs=146.5
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|+..+.||+|+||.||++.. +|+.||+|++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578889999999999999997 7899999987532
Q ss_pred ----CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ----FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ----~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 00 00345678999999999999 9999999999999999999999999999997654332
Q ss_pred ccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc--
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE-- 228 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 228 (284)
.... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...........
T Consensus 158 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 158 SKHM--TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-----IQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cccC--CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcCCCCHHHHH
Confidence 2211 124678999999998764 478999999999999999999999865331 111111111110000000
Q ss_pred --------cccccc--cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 229 --------IVDPAI--VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 229 --------~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+.... .......+.........+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 000000000011123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=255.90 Aligned_cols=144 Identities=20% Similarity=0.244 Sum_probs=121.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..+.|...+.||+|+||.||++.. .|..||+|++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457888899999999999999998 7899999998532
Q ss_pred --------CC------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 --------FP------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --------~~------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 00 00334568999999999999 99999999999999999999999999999876533
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 176 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 NFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CccC----CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 2211 1256899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=256.01 Aligned_cols=144 Identities=19% Similarity=0.270 Sum_probs=122.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF---------------------------------------- 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---------------------------------------- 90 (284)
..++|...+.||+|+||.||++.. .++.||||++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899899999999999999998 78899999986420
Q ss_pred ---------C------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 91 ---------P------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 91 ---------~------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+ .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 0 00345568999999999999 99999999999999999999999999999976543
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 179 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 179 SFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCcc----cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 3221 1256899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=245.20 Aligned_cols=200 Identities=20% Similarity=0.337 Sum_probs=148.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc----ceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR----PISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ ++. .+++|.+...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 4567778999999999999998 555 4777777432
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++. ....+.++.||+.||.||| +.+++|+||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 000 0356779999999999999 9999999999999999999999999999998664332
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.... .....+.+ ..+....
T Consensus 164 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~----~~~~~~~-- 231 (279)
T cd05111 164 KKY-FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLL----EKGERLA-- 231 (279)
T ss_pred ccc-ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCCcCC--
Confidence 211 1112456788999999988889999999999999999998 888875432 11111111 1111100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+ ..+...+.+++.+||..+|+.|||+.|+++.|..+.+
T Consensus 232 ~~-------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QP-------------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC-------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00 1122346789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=234.51 Aligned_cols=205 Identities=19% Similarity=0.222 Sum_probs=154.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|||+-||.++. +++.+|+|++...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 35688889999999999999997 8999999988644
Q ss_pred -----------------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 -----------------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 -----------------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+-++.+.+.|+.+|++||.+||+. ..+.+||||||.|||+.+.+.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 222267889999999999999943 33499999999999999999999999999876
Q ss_pred cCCCCcc------ccCCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 147 IPEGETH------INDSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 147 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
..-.... .........|..|+|||.+.- ...+.++|||||||++|+|+.|..||..... .
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~---------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-Q---------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-c----------
Confidence 6421111 111112457899999998864 3578999999999999999999999964321 1
Q ss_pred HHHhhcCcccc-cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 218 KKYIENESFKE-IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.+.+.- +....+ .+|.....+..+.+++.+|++.||.+||++.+++..++++.
T Consensus 248 -----GgSlaLAv~n~q~------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQI------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----CCeEEEeeecccc------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 111111 12222234556889999999999999999999999998874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=260.39 Aligned_cols=139 Identities=22% Similarity=0.300 Sum_probs=119.6
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CCCc-
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FPFS- 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~~~- 93 (284)
|...++||+|+||.|-+|.+ ++..||||+++.. .|.-
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf 267 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF 267 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence 45567899999999999999 8999999999877 1110
Q ss_pred ---------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC--cceeeccccccccCCC
Q 039895 94 ---------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN--VAQLFDFTLSLSIPEG 150 (284)
Q Consensus 94 ---------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~--~~kl~Dfg~a~~~~~~ 150 (284)
.....++.||+.||.+|| ..+|||+||||+||||...+ .+||+|||.|......
T Consensus 268 ELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 268 ELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred hhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 456679999999999999 99999999999999997543 7899999999887665
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
... ..-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..
T Consensus 345 vyt------YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 345 VYT------YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cee------eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 442 567889999999999999999999999999999999988776543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=256.76 Aligned_cols=196 Identities=19% Similarity=0.220 Sum_probs=147.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3677888999999999999999 6889999998632
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~--- 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--- 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence 111 1455678999999999999 999999999999999999999999999999765441
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+.........+...++
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~- 225 (333)
T cd05600 155 ---ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETWENLKYWKETLQRPVYDDP- 225 (333)
T ss_pred ---cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHHHHHHhccccccCCCCCcc-
Confidence 122578999999999998899999999999999999999999986432 11111111110000000000000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++.+||..+|++||++.++++.
T Consensus 226 -----------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 -----------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01233457899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=255.00 Aligned_cols=195 Identities=21% Similarity=0.247 Sum_probs=143.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
.+|+..+.||+|+||.||+|.+ +++.||||++... +
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3455567899999999999998 7899999998543 1
Q ss_pred CC-----------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 91 PF-----------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 91 ~~-----------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+...... ...
T Consensus 154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~---~~~ 227 (353)
T PLN00034 154 MDGGSLEGTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNS 227 (353)
T ss_pred CCCCcccccccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc---ccc
Confidence 11 1345679999999999999 999999999999999999999999999999876433211 112
Q ss_pred cccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 160 VIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
..||..|+|||++.. ...+.++|||||||++|||++|+.||.... ...+........... ..
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~-~~------- 294 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-----QGDWASLMCAICMSQ-PP------- 294 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhccC-CC-------
Confidence 578999999998743 234568999999999999999999986322 111111111111000 00
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.........+.+|+.+||+.||++|||+.|+++.
T Consensus 295 --------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 --------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011223448899999999999999999999864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=247.29 Aligned_cols=208 Identities=15% Similarity=0.168 Sum_probs=145.8
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||+||+|.. +++.||+|.+...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 66778999999999999998 7889999987532
Q ss_pred ------CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 ------FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 ------~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
++ .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 82 VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 00 00345678999999999999 999999999999999999999999999998766
Q ss_pred CCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh--cCc
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE--NES 225 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 225 (284)
...... ....||+.|+|||++.+..++.++||||+||++|+|++|.+||.... ....+......... ...
T Consensus 159 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 159 SCQMAL----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cCcccC----CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC----HHHHHHHHHHHhCCCChhh
Confidence 432221 12568999999999988889999999999999999999999885432 11111111111000 000
Q ss_pred cccccc---ccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVD---PAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+..... ........... .........+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 100000 00000000000 001123345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=252.80 Aligned_cols=184 Identities=21% Similarity=0.279 Sum_probs=139.9
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467788999999999999998 6678999988632
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 1111 455678999999999999 99999999999999999999999999999865322111
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
......||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ... .
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~-~~~------~ 219 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIME-HNV------S 219 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-CCC------C
Confidence 1112568999999999999999999999999999999999999986432 1111111111 100 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+ +......+.+++.+||+.+|++|++.
T Consensus 220 ~----------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 Y----------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 01122347799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=231.69 Aligned_cols=190 Identities=21% Similarity=0.270 Sum_probs=151.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|+.++.||+|.||.||.|.. ++..||+|++.+.
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 37899999999999999999999 7889999998765
Q ss_pred -------------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -------------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -------------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
.-.+.....+..|+|.||.|+| .++|+||||||+|+|++..+.+||+|||.+...+.+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 0111445578999999999999 999999999999999999999999999998776532
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
. ..+.+||..|.|||+..+..++..+|+|++|++.||++.|.+||.+.. . ... .+.... .++.
T Consensus 178 k-----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~---~et---YkrI~k----~~~~ 240 (281)
T KOG0580|consen 178 K-----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--H---SET---YKRIRK----VDLK 240 (281)
T ss_pred C-----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--h---HHH---HHHHHH----cccc
Confidence 2 233789999999999999999999999999999999999999997543 1 111 111111 0111
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+| ......+.+++.+|+..+|.+|.+..|++..
T Consensus 241 ~p-------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FP-------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CC-------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11 1222337899999999999999999999864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.85 Aligned_cols=157 Identities=24% Similarity=0.316 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
...++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++.......... .....+++.|+|||...+.
T Consensus 114 ~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~ 189 (272)
T cd05075 114 LVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ-GRIAKMPVKWIAIESLADR 189 (272)
T ss_pred HHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcccccCcccceec-CCcccCCcccCCHHHccCC
Confidence 5678999999999999 89999999999999999999999999999987654332211 1123467789999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++|||||||++||+++ |..||.... ...+.. ....+.... .....+..+.+
T Consensus 190 ~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~----~~~~~~~~~---------------~~~~~~~~~~~ 245 (272)
T cd05075 190 VYTTKSDVWSFGVTMWEIATRGQTPYPGVE-----NSEIYD----YLRQGNRLK---------------QPPDCLDGLYS 245 (272)
T ss_pred CcChHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH----HHHcCCCCC---------------CCCCCCHHHHH
Confidence 89999999999999999999 677775321 111111 111111100 01122334789
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
++.+||+.+|++|||+.++++.|+++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 246 LMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=252.78 Aligned_cols=184 Identities=21% Similarity=0.273 Sum_probs=141.3
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477788999999999999998 6789999987643
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 111 0456779999999999999 999999999999999999999999999998754322211
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... .... +
T Consensus 158 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~-~~~~--~--- 220 (323)
T cd05616 158 ---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIME-HNVA--Y--- 220 (323)
T ss_pred ---cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCCC--C---
Confidence 122578999999999999999999999999999999999999986432 1111111111 1100 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+......+.+++.+||+.+|++|++.
T Consensus 221 -----------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 -----------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122347899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=250.73 Aligned_cols=183 Identities=21% Similarity=0.315 Sum_probs=138.5
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||.||+|.. ++..||+|++... +|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 6788999988532 1110
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---KAS 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---ccc
Confidence 445668999999999999 99999999999999999999999999999876533221 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... ............ +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-------~~~---- 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILNDR-------PHF---- 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-------CCC----
Confidence 2578999999999998899999999999999999999999986432 111111111100 000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIV-QVA 274 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-ev~ 274 (284)
+......+.+++.+||+.+|++||++. +++
T Consensus 216 ------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 ------PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111223467899999999999999875 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=252.76 Aligned_cols=188 Identities=19% Similarity=0.272 Sum_probs=139.0
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||.||++.. +++.||+|++... +|..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999998 7789999998643 1110
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~---~~ 154 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TS 154 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc---cc
Confidence 455678999999999999 999999999999999999999999999998754222111 12
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||...............++.......... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~-------- 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I-------- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--C--------
Confidence 257899999999999989999999999999999999999999643211111112222222211111100 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+......+.+++.+||+.||++|||+
T Consensus 225 ------p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ------PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11122347799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=282.02 Aligned_cols=222 Identities=26% Similarity=0.395 Sum_probs=170.7
Q ss_pred eecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------
Q 039895 44 SFSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------- 89 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------- 89 (284)
.++++++. ..|...+.||+|+||.||+|.. +|..||||++...
T Consensus 682 ~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 682 SITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 34555554 4577788999999999999997 7899999988543
Q ss_pred -----CCC------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -----FPF------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -----~~~------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|+. ...+..++.|++.||+|||+.++.+|+||||||+||+++.++.+++. ||.+......
T Consensus 759 ~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred EEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 111 14567899999999999997777899999999999999998888876 6654332211
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....||+.|+|||++.+..++.++|||||||++|||+||+.||+... ........|............++|+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCc
Confidence 11467899999999999899999999999999999999999985432 2234455666555444445556666
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+... .+....+...+.+++.+||+.+|++||||.||++.|+++..+
T Consensus 908 ~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 908 SIRGD----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cccCC----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 55432 122345566788999999999999999999999999998753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=244.69 Aligned_cols=197 Identities=21% Similarity=0.338 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCCc
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPFS 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~~ 93 (284)
++|...++||+|+||.||+|.. ++..||+|.+... ++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 5677788999999999999998 6778999987643 1110
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++...........
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~- 161 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR- 161 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc-
Confidence 345678999999999999 89999999999999999999999999999987654332211
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
....++..|+|||++....++.++|||||||++|+|++ |..||.... .......+ .... .
T Consensus 162 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~----~~~~-~-------- 222 (261)
T cd05072 162 -EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMSAL----QRGY-R-------- 222 (261)
T ss_pred -CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHHHH----HcCC-C--------
Confidence 11346778999999988889999999999999999998 888875322 11111111 1110 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+.....+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000112233478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=254.18 Aligned_cols=194 Identities=23% Similarity=0.234 Sum_probs=142.6
Q ss_pred CCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC-----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~----------------------------------------- 89 (284)
+|...+.||+|+||.||++.. ++..||+|++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467778999999999999876 5788999998532
Q ss_pred -----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 1111 445678899999999999 99999999999999999999999999999876543
Q ss_pred CCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|..||..... . ............ .
T Consensus 158 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~--~~~~~~~~~~~~-~---- 226 (332)
T cd05614 158 EEKERT--YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE--R--NTQSEVSRRILK-C---- 226 (332)
T ss_pred cCCCcc--ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC--C--CCHHHHHHHHhc-C----
Confidence 322111 125789999999998765 478899999999999999999999864321 1 111111111111 0
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
++.+ +......+.+++.+||+.||++|| ++.++++
T Consensus 227 --~~~~----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 --DPPF----------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCC----------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0000 111223478999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=245.16 Aligned_cols=209 Identities=22% Similarity=0.270 Sum_probs=149.8
Q ss_pred CCCCeeeecCCceEEEEEe------CCcceEEEeecCC------------------------------------------
Q 039895 58 DGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~------------------------------------------ 89 (284)
...+.||+|+||+||.+.+ ++..||+|.+...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988653 5678999998643
Q ss_pred --CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 --FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 --~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
++ ....+..++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++.........
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 00 01556789999999999999 999999999999999999999999999999876543322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh---hcCcccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI---ENESFKEIV 230 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (284)
........++..|+|||.+....++.++||||||+++|||++|..|+..... .......... ....+.+..
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK------KFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc------hhhhhhcccccccchhhhhhhh
Confidence 1111123456779999999888899999999999999999999998753220 0000000000 000011111
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
+... ..+.+...+..+.+++..||+.+|++|||+++|++.|+++.
T Consensus 238 ~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1110 01112233456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=247.51 Aligned_cols=141 Identities=22% Similarity=0.371 Sum_probs=113.5
Q ss_pred CCeeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------CCC--
Q 039895 60 GKVIMKCLFYKLYKGFL----QDRPISVMKFEDT-----------------------------------------FPF-- 92 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-----------------------------------------~~~-- 92 (284)
+.+||+|+||.||+|.. ++..||+|.+... ++.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 46899999999999997 3468999987643 000
Q ss_pred ---------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE----ecCCcceeecccccccc
Q 039895 93 ---------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL----QEENVAQLFDFTLSLSI 147 (284)
Q Consensus 93 ---------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfg~a~~~ 147 (284)
......++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 0235578999999999999 9999999999999999 56678999999999876
Q ss_pred CCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
..............||+.|+|||++.+. .++.++|||||||++|||+||..||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 5443322222335789999999998764 5889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.72 Aligned_cols=218 Identities=15% Similarity=0.143 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------C-------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------F------- 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------~------- 90 (284)
.+|...+.||+|+||.||++.. .++.||||..... +
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~ 248 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYT 248 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHH
Confidence 4688888999999999999999 6788999964321 0
Q ss_pred --------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCccc
Q 039895 91 --------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162 (284)
Q Consensus 91 --------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g 162 (284)
.....++.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++........ .......|
T Consensus 249 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~~G 324 (461)
T PHA03211 249 YLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST-PFHYGIAG 324 (461)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-ccccccCC
Confidence 111456789999999999999 999999999999999999999999999999766432211 11122569
Q ss_pred CccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc---cHHHHHHHHhh-cCcccccccccc----
Q 039895 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY---RLQDLVKKYIE-NESFKEIVDPAI---- 234 (284)
Q Consensus 163 t~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~---- 234 (284)
|+.|+|||++.+..++.++|||||||++|||++|..+++.......... .+...+..... ...+.......+
T Consensus 325 T~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~ 404 (461)
T PHA03211 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQY 404 (461)
T ss_pred CcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHH
Confidence 9999999999998999999999999999999999877654331111111 11111111100 000110000000
Q ss_pred ---------cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 235 ---------VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 235 ---------~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......|.........+.+|+.+||+.||.+|||+.|+++.
T Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 405 RHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000111111222357899999999999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=261.95 Aligned_cols=198 Identities=20% Similarity=0.289 Sum_probs=147.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||++.. ++..||+|++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456788889999999999999998 7889999988531
Q ss_pred ---CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 ---FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ---~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 1211 345568899999999999 99999999999999999999999999999977643322
Q ss_pred cccCCCCcccCccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTG----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
... ....||+.|+|||++.+. .++.++|||||||++|||++|..||.... ..............
T Consensus 198 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~-- 265 (370)
T cd05596 198 VRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHKNS-- 265 (370)
T ss_pred ccC--CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCc--
Confidence 111 225799999999988653 37899999999999999999999997533 11111111111000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAKQ 276 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~~ 276 (284)
..++.....+..+.+++.+||+.+|.+ |||+.|+++.
T Consensus 266 -----------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 -----------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001111123345789999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=251.39 Aligned_cols=193 Identities=19% Similarity=0.274 Sum_probs=142.0
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||.||++.. ++..||+|++... +|..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999998 7889999998642 1111
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~ 154 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTS 154 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---ccc
Confidence 456678999999999999 99999999999999999999999999999865322111 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...............+........... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I---- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C----
Confidence 257899999999999989999999999999999999999999643321211111222222222111110 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCC------HHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPT------IVQVAK 275 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps------~~ev~~ 275 (284)
+......+.+++.+||+.||.+||| +.++++
T Consensus 225 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 ------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0112234789999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=251.70 Aligned_cols=185 Identities=19% Similarity=0.259 Sum_probs=141.2
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCC--
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPF-- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~-- 92 (284)
+.||+|+||.||++.. +|+.||+|++... +|.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 7899999998643 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
+.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~---~~~ 154 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MKT 154 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc---ccc
Confidence 1456678999999999999 999999999999999999999999999998754322111 122
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... .... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~-~~~~------~~----- 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELIL-MEDI------KF----- 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhc-cCCc------cC-----
Confidence 568999999999998889999999999999999999999986432 111111111 0000 00
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
+......+.+++.+||+.||++|| ++.++++.
T Consensus 215 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111223478999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=254.00 Aligned_cols=210 Identities=14% Similarity=0.225 Sum_probs=147.4
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------C---------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------F--------- 90 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------~--------- 90 (284)
...+.|...+.||+|+||.||+|.. ++..||||++... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457788889999999999999998 7789999998642 0
Q ss_pred -----------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 91 -----------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 91 -----------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
........++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 001445678999999999999 999999999999999999999999999999776
Q ss_pred CCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+...... ..
T Consensus 169 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~-~~ 236 (343)
T cd07878 169 DDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQLKRIMEVVGT-PS 236 (343)
T ss_pred CCCc------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHhCC-CC
Confidence 4322 12578999999999876 4688999999999999999999999864321 0000000000000 00
Q ss_pred ccccc-----------ccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 227 KEIVD-----------PAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 227 ~~~~~-----------~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+... ..+.......+. ......+.+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000000000 000112346799999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=249.89 Aligned_cols=140 Identities=24% Similarity=0.286 Sum_probs=119.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|+..+.||+|+||.||++.. +|..+|+|++... +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 6788889999999999999999 6888999987643 1
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
|.. .....++.|++.||.||| +. +|+||||||+|||++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 159 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 159 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc--
Confidence 111 345678999999999999 64 699999999999999999999999999876643221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 160 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 160 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 125689999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=242.15 Aligned_cols=196 Identities=22% Similarity=0.312 Sum_probs=146.5
Q ss_pred CCCCCeeeecCCceEEEEEe--C---CcceEEEeecCCC------------------------------C----------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--Q---DRPISVMKFEDTF------------------------------P---------- 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~~------------------------------~---------- 91 (284)
|...+.||+|+||.||+|.. + +..||+|++.... +
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678999999999999997 2 2679999886430 0
Q ss_pred ------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 92 ------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 92 ------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
.......++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 00234568999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHH
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
|+++.......... .....++..|+|||++....++.++|||||||++||+++ |..||.... .... ....
T Consensus 158 g~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~---~~~~ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQ-GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEI---YDYL 228 (273)
T ss_pred cceeeccccccccc-cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHH---HHHH
Confidence 99987654432211 111235678999999988889999999999999999999 777775322 1111 1111
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
..+.... .+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 -~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 -RHGNRLK---------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HcCCCCC---------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111110 0112334588999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=249.99 Aligned_cols=183 Identities=22% Similarity=0.300 Sum_probs=138.4
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||.||+|.. +|..||+|++... +|..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999 7889999988632 1111
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++....... ...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RAS 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---cee
Confidence 455678999999999999 99999999999999999999999999999865322111 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... .. +.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~~~~~~~-~~------~~~---- 215 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDELFESIRV-DT------PHY---- 215 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CC------CCC----
Confidence 2578999999999998899999999999999999999999986432 1111111110 00 000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIV-QVA 274 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-ev~ 274 (284)
+......+.+++.+||+.||++||++. +++
T Consensus 216 ------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 ------PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 001223477999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.93 Aligned_cols=193 Identities=24% Similarity=0.358 Sum_probs=149.1
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------------CCC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------------------------FPF-- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------------------------~~~-- 92 (284)
.+|...+.||+|+||.||++...|..||+|.+... ++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 46777889999999999999999999999998654 110
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
....+.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----- 157 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----- 157 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC-----
Confidence 0345789999999999999 99999999999999999999999999999876543221
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
...++..|+|||++....++.++|||||||++|+|++ |..||.... ........ ..+....
T Consensus 158 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~~~-------- 219 (256)
T cd05082 158 -TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV-EKGYKMD-------- 219 (256)
T ss_pred -CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCCCCC--------
Confidence 1345678999999988889999999999999999998 888875322 12221111 1110000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
....++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 220 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=250.11 Aligned_cols=184 Identities=22% Similarity=0.276 Sum_probs=140.3
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCC--
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPF-- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~-- 92 (284)
+.||+|+||.||++.. +|..||+|++... +|.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999998 7899999998642 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~ 154 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKT 154 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc---ccc
Confidence 1456678999999999999 999999999999999999999999999998754222111 112
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
..||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~-~~~------~~----- 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM-EEI------RF----- 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCC------CC-----
Confidence 568999999999998899999999999999999999999986432 1111111110 000 00
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 011233478999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=259.23 Aligned_cols=196 Identities=23% Similarity=0.324 Sum_probs=147.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +|+.||+|++...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3677888999999999999999 6899999998632
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC--
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE-- 151 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-- 151 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 1111 455678999999999999 9999999999999999999999999999997765432
Q ss_pred ------------------------ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 039895 152 ------------------------THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207 (284)
Q Consensus 152 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~ 207 (284)
..........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--- 234 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT--- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC---
Confidence 00011123578999999999999999999999999999999999999986532
Q ss_pred CccccHHHHHHHHhhc-CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 039895 208 GEDYRLQDLVKKYIEN-ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-IVQVAKQ 276 (284)
Q Consensus 208 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~ev~~~ 276 (284)
........... .... .+.....+..+.+++.+||. +|.+||+ +.++++.
T Consensus 235 -----~~~~~~~i~~~~~~~~--------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -----LQETYNKIINWKESLR--------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHHHhccCCccc--------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111110 0000 00011123447899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=241.57 Aligned_cols=193 Identities=23% Similarity=0.336 Sum_probs=147.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|+....||+|.|+.||++.. +|+.+|+|++...
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4455567899999999999998 8999999887644
Q ss_pred ------CCCc---------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC---CcceeeccccccccCCCC
Q 039895 90 ------FPFS---------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE---NVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ------~~~~---------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfg~a~~~~~~~ 151 (284)
.|.+ ...-..+.||+.+|.|+| .++|||||+||.|+|+.+. .-+||+|||+|..+.++.
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 1111 223347899999999999 9999999999999999643 357999999999988444
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.... ..|||+|||||++...+|+..+|||+.||+||-++.|..||++.. ...+.+.+..
T Consensus 168 ~~~G----~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~rlye~I~~------------ 226 (355)
T KOG0033|consen 168 AWHG----FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYEQIKA------------ 226 (355)
T ss_pred cccc----ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHHHHHHHhc------------
Confidence 3322 689999999999999999999999999999999999999998633 1222222211
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.+....|......++..+|+.+||..||.+|.|+.|.++
T Consensus 227 ----g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 227 ----GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111111122233445789999999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=250.86 Aligned_cols=182 Identities=23% Similarity=0.289 Sum_probs=138.0
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCC----
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPF---- 92 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~---- 92 (284)
||+|+||.||+|.. ++..||+|++... +|.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999 6889999988642 111
Q ss_pred -----------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 93 -----------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 93 -----------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
......++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 154 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFC 154 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccccc
Confidence 1455678999999999999 99999999999999999999999999999875432221 112257
Q ss_pred cCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCC
Q 039895 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLM 241 (284)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ... .
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~-~~~------~-------- 211 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQ-EPL------R-------- 211 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHc-CCC------C--------
Confidence 8999999999999899999999999999999999999986432 1222222111 100 0
Q ss_pred ChhhHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 039895 242 WPEKEQQLLICTELAFKCLSESEGDRPT---IVQVAK 275 (284)
Q Consensus 242 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~ev~~ 275 (284)
.+......+.+++.+||+.||++||+ +.|++.
T Consensus 212 --~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 --FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 01112234789999999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=248.96 Aligned_cols=161 Identities=23% Similarity=0.401 Sum_probs=119.7
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........... .....+++.|+|||++.+..
T Consensus 182 ~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 257 (343)
T cd05103 182 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDRV 257 (343)
T ss_pred HHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh-cCCCCCCcceECcHHhcCCC
Confidence 457889999999999 99999999999999999999999999999876543322111 11134567899999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHH
Q 039895 177 FSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTEL 255 (284)
Q Consensus 177 ~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (284)
++.++||||||+++|++++ |..|+..... . .... .....+..... +......+.++
T Consensus 258 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~-~~~~~~~~~~~---------------~~~~~~~~~~~ 314 (343)
T cd05103 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKI----D---EEFC-RRLKEGTRMRA---------------PDYTTPEMYQT 314 (343)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCCccc----c---HHHH-HHHhccCCCCC---------------CCCCCHHHHHH
Confidence 9999999999999999997 8777753220 0 0111 11111110000 00112347899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 256 AFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 256 ~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+..||+.+|++|||+.||++.|+.+++.+
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~~~~ 343 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 343 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhcC
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=257.13 Aligned_cols=190 Identities=19% Similarity=0.217 Sum_probs=153.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+-|+.++-||.|+.|.|-.|++ +|+.+|||++.+.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688899999999999999999 9999999998765
Q ss_pred ----------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 ----------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ----------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
-..+....+++.||+.|+.|+| ..+|+||||||+|+|+|.++.+||+|||+|..-..+...
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 0111667889999999999999 999999999999999999999999999999665443322
Q ss_pred ccCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.+.+|+|.|.|||++.+.+|. .++||||+|||||.|+||+-||++.+ +.. +...+..+.+.
T Consensus 169 ----eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------ir~-LLlKV~~G~f~----- 230 (786)
T KOG0588|consen 169 ----ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------IRV-LLLKVQRGVFE----- 230 (786)
T ss_pred ----cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------HHH-HHHHHHcCccc-----
Confidence 226899999999999999986 79999999999999999999997433 222 22222233221
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+...+.++++|+.+|+..||+.|.|+.||+++
T Consensus 231 -----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 -----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 123334458899999999999999999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.31 Aligned_cols=186 Identities=18% Similarity=0.249 Sum_probs=138.2
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCC-
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPF- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~- 92 (284)
+.||+|+||.||+|.. +++.||+|++... +|.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999998 7789999998743 111
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---~~ 154 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TS 154 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc---ee
Confidence 1456679999999999999 999999999999999999999999999998753221111 11
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||..... .................... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~--~-------- 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD--NPDMNTEDYLFQVILEKPIR--I-------- 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCC--CcccccHHHHHHHHHhCCCC--C--------
Confidence 25789999999999988999999999999999999999999964321 11111112222211111100 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+......+.+++.+||+.||++||++
T Consensus 223 ------p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 ------PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122336799999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=255.59 Aligned_cols=217 Identities=17% Similarity=0.156 Sum_probs=150.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe----CCcceEEEeecCC------------------------------------CC---
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL----QDRPISVMKFEDT------------------------------------FP--- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~------------------------------------~~--- 91 (284)
..|.....||+|+||.||++.. .+..||+|.+... ++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 171 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCC
Confidence 4688889999999999999976 3567999988654 00
Q ss_pred -----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 92 -----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 92 -----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
.....+.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++..+....... .....
T Consensus 172 l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~-~~~~~ 247 (392)
T PHA03207 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP-QCYGW 247 (392)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc-ccccc
Confidence 01466789999999999999 9999999999999999999999999999997665432221 11225
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccccccc------
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVDPA------ 233 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------ 233 (284)
.||+.|+|||++....++.++|||||||++|||++|..||....... ....+...+...... ..+.......
T Consensus 248 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 326 (392)
T PHA03207 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK 326 (392)
T ss_pred ccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCCccchhHHHHHH
Confidence 79999999999998899999999999999999999999997654211 111111111111000 0000000000
Q ss_pred -ccCCCCCCChhh-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 -IVGEEGLMWPEK-----EQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 -~~~~~~~~~~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
........++.+ ......+.+++.+||..||++|||+.|++..
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 327 QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 1123347789999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=255.73 Aligned_cols=146 Identities=22% Similarity=0.294 Sum_probs=121.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||++.. +++.||+|++...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688889999999999999998 7889999998642
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 2211 456678999999999999 999999999999999999999999999998765321100
Q ss_pred --------------------------------ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039895 154 --------------------------------INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201 (284)
Q Consensus 154 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~ 201 (284)
........||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 000112579999999999998899999999999999999999999996
Q ss_pred CC
Q 039895 202 SS 203 (284)
Q Consensus 202 ~~ 203 (284)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.30 Aligned_cols=179 Identities=22% Similarity=0.268 Sum_probs=137.0
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||.||+|.. +++.||+|++... +|..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999998 6889999988632 1111
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......... ..
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~---~~ 154 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TS 154 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc---cc
Confidence 445678999999999999 999999999999999999999999999998754322111 12
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... .... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~-~~~~---~~------- 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAIL-NDEV---VY------- 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHh-cCCC---CC-------
Confidence 2578999999999998889999999999999999999999986432 111111111 1110 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+......+.+++.+||+.||++||++
T Consensus 216 ------~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 ------PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 01122347899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.60 Aligned_cols=199 Identities=19% Similarity=0.320 Sum_probs=148.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~------------------------------------ 89 (284)
+.++|+..+.||+|+||.||+|.+. +..||+|++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999863 356999987532
Q ss_pred ------CCCc-------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ------FPFS-------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ------~~~~-------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
++.. ...+.++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 1110 134668899999999999 899999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||++............ ....+++.|+|||++.+..++.++|||||||++||+++ |..||.... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (277)
T cd05062 161 GDFGMTRDIYETDYYRKG-GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVL 231 (277)
T ss_pred CCCCCccccCCcceeecC-CCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 999998766543332211 11345788999999988889999999999999999999 677765322 11111
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.... ....... +...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 ~~~~-~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVM-EGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHH-cCCcCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 1111110 11123357899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=245.99 Aligned_cols=156 Identities=21% Similarity=0.325 Sum_probs=117.5
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
...++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......... .....+++.|+|||.+.+.
T Consensus 126 ~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05091 126 FVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL-MGNSLLPIRWMSPEAIMYG 201 (283)
T ss_pred HHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCceEecccccccccccchheee-ccCccCCccccCHHHHhcC
Confidence 4568899999999999 99999999999999999999999999999876643322111 1123467889999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++|||||||++|||++ |..||.... ......... ...... .+..++..+.+
T Consensus 202 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~i~-~~~~~~---------------~~~~~~~~~~~ 257 (283)
T cd05091 202 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQDVIEMIR-NRQVLP---------------CPDDCPAWVYT 257 (283)
T ss_pred CCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHH-cCCcCC---------------CCCCCCHHHHH
Confidence 89999999999999999998 777765322 112222111 111110 01223344789
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
++..||+.+|++||++.+|+..|+.
T Consensus 258 li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 258 LMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHhCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=248.30 Aligned_cols=188 Identities=18% Similarity=0.240 Sum_probs=142.1
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||.||+|.. +++.||||++...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45567899999999999998 7899999998532
Q ss_pred --CCC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 --FPF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 --~~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD- 156 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-
Confidence 111 1456779999999999999 99999999999999999999999999999865432211
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
......|++.|+|||++.+..++.++|||||||++|||++|..||.... ........... ... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~-~~~--~--- 220 (324)
T cd05589 157 --RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVND-EVR--Y--- 220 (324)
T ss_pred --cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCC--C---
Confidence 1123578999999999998899999999999999999999999986432 11111111111 000 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+...+..+.+++.+||+.||++|| ++.++++
T Consensus 221 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 -----------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011223477999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=240.34 Aligned_cols=198 Identities=22% Similarity=0.356 Sum_probs=149.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CC-
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FP- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~- 91 (284)
.++|...+.||+|++|.||+|.+ +++.||+|.+... ++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 35678889999999999999998 6678999998753 11
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 01456789999999999999 99999999999999999999999999999987753322111
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.....+..|+|||++.+..++.++||||||+++||+++ |..||.... ....... .... ...
T Consensus 162 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~-~~~~-~~~------ 223 (261)
T cd05068 162 --EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAEVLQQ-VDQG-YRM------ 223 (261)
T ss_pred --CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHH-HHcC-CCC------
Confidence 11223467999999988889999999999999999999 888875422 1111111 1111 000
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+.....+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00112234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=247.29 Aligned_cols=183 Identities=21% Similarity=0.304 Sum_probs=138.6
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCC-
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPF- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~- 92 (284)
+.||+|+||.||+|.. ++..||+|++... +|.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 6788999987542 111
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......... ..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~ 154 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TC 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc---ee
Confidence 0455678999999999999 999999999999999999999999999998754322111 11
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... ............ +..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~-------~~~---- 215 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMDN-------PCY---- 215 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-------CCC----
Confidence 2568999999999998899999999999999999999999986432 111111111100 000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIV-QVA 274 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-ev~ 274 (284)
+......+.+++.+||+.+|++||++. ++.
T Consensus 216 ------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 ------PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 001123377999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.73 Aligned_cols=184 Identities=19% Similarity=0.248 Sum_probs=139.8
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
++||+|+||.||+|.. +++.||+|++... +|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999998 6789999988642 1111
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~ 154 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TT 154 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc---cc
Confidence 345678999999999999 999999999999999999999999999998754322211 12
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~-~~~---~~------- 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILH-DDV---LY------- 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHc-CCC---CC-------
Confidence 2568999999999998899999999999999999999999986432 1111111111 110 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCC-------CHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRP-------TIVQVAK 275 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-------s~~ev~~ 275 (284)
+......+.+++.+||+.||++|| ++.++++
T Consensus 216 ------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 ------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 001123478999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=233.83 Aligned_cols=198 Identities=21% Similarity=0.294 Sum_probs=157.1
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------- 89 (284)
....+.|...++||.|..++|.++.. .|...|+|++...
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788889999999999999988 8899999998654
Q ss_pred --------------------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccc
Q 039895 90 --------------------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143 (284)
Q Consensus 90 --------------------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~ 143 (284)
..++....+|+.|+..|+.||| ..+||||||||+|||++++..++|+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 1111456789999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+..+..+..... .+|||+|.|||.+.- ..|+..+|+||+||++|.++.|.+||.-.. +...
T Consensus 170 a~~l~~GekLre----lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---------QmlM 236 (411)
T KOG0599|consen 170 ACQLEPGEKLRE----LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---------QMLM 236 (411)
T ss_pred eeccCCchhHHH----hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---------HHHH
Confidence 999987765443 789999999998653 247889999999999999999999997321 2222
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...+..+. +....|...+......+|+.+||+.||.+|.|+.|+++.
T Consensus 237 LR~ImeGk------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 LRMIMEGK------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHhcc------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 22332322 112223334555567899999999999999999999853
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=250.12 Aligned_cols=143 Identities=19% Similarity=0.230 Sum_probs=118.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------C-----
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------F----- 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------~----- 90 (284)
...+|...+.||+|+||.||+|.. ++..||+|+.... +
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l 143 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDL 143 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcH
Confidence 346799999999999999999999 6678999975433 0
Q ss_pred ----------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 91 ----------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 91 ----------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
.....+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......... ...
T Consensus 144 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~----~~~ 216 (357)
T PHA03209 144 YTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF----LGL 216 (357)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc----ccc
Confidence 011456789999999999999 999999999999999999999999999998754322111 125
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
.||+.|+|||++.+..++.++|||||||++|||+++..++..
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 689999999999988999999999999999999997666543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=255.81 Aligned_cols=188 Identities=24% Similarity=0.339 Sum_probs=148.7
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
-|+..+-||.|+||.||.+.+ +...||||++.-.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 356667899999999999999 8899999998633
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
||.. ..+..|+.+.+.||+||| +.+.||||||..|||+++.|.+||+|||.|....+..+
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns-- 181 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS-- 181 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchhc--
Confidence 4443 456678999999999999 99999999999999999999999999999876654333
Q ss_pred cCCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
++|||.|||||++. .+.|+-++||||+|+++.|+.-.++|.+..+ ..........+. .
T Consensus 182 -----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--------AMSALYHIAQNe------s 242 (948)
T KOG0577|consen 182 -----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE------S 242 (948)
T ss_pred -----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--------HHHHHHHHHhcC------C
Confidence 79999999999875 5679999999999999999999999987543 111111111111 1
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
|.+. ..+....+..++..||+.-|.+|||..+++..
T Consensus 243 PtLq---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 12344558899999999999999999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.96 Aligned_cols=200 Identities=20% Similarity=0.300 Sum_probs=147.1
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------- 89 (284)
....++|...+.||+|+||.||++.. +++.+|+|++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 33457788899999999999999998 6889999988532
Q ss_pred -----CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -----FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -----~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. .....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 2211 446678999999999999 999999999999999999999999999999876443
Q ss_pred CccccCCCCcccCccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTG----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
..... ....||+.|+|||++... .++.++||||+||++|||++|..||.... ..............
T Consensus 196 ~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~ 265 (370)
T cd05621 196 GMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDHKNS 265 (370)
T ss_pred Cceec--ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcc
Confidence 22211 236799999999998654 37889999999999999999999996532 11111111111100
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAKQ 276 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~~ 276 (284)
..+|........+.+++..||..+|.+ |||+.|++++
T Consensus 266 -------------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 -------------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001111223344778999999855543 8999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.05 Aligned_cols=194 Identities=18% Similarity=0.232 Sum_probs=145.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||++.. +|+.||+|++...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4678889999999999999998 7899999998643
Q ss_pred -CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 1110 344568899999999999 99999999999999999999999999999987654332
Q ss_pred cccCCCCcccCcccccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 153 HINDSNRVIGTFGFMAPEYRT------TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
... ....||+.|+|||++. ...++.++|||||||++|||++|..||.... ..............
T Consensus 158 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~ 227 (330)
T cd05601 158 VNS--KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQRF 227 (330)
T ss_pred eee--ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCCc
Confidence 211 1246899999999986 4567899999999999999999999986432 11111111111110
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.. ++........+.+|+..||+ +|.+|||+.+++.
T Consensus 228 ~~-------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LK-------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cC-------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 01111223347889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=241.43 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=153.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-C-----CcceEEEeecCC--------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-Q-----DRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~-----~~~vavK~~~~~-------------------------------------- 89 (284)
.++|...+.||+|+||.||+|.+ + +..|++|.+...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 35677889999999999999998 4 578999987643
Q ss_pred -----CC-----------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 90 -----FP-----------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 90 -----~~-----------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
++ .......++.|++.||+||| +.+++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 00 01345678999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHH
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
|+++.+......... ....++..|+|||++.+..++.++|||||||++||+++ |..||.... ...+.....
T Consensus 162 g~~~~~~~~~~~~~~-~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~-- 233 (280)
T cd05043 162 ALSRDLFPMDYHCLG-DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLK-- 233 (280)
T ss_pred CCcccccCCceEEeC-CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHH--
Confidence 999876443322111 11346778999999988889999999999999999999 888885422 111111111
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..... +....++..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 234 -~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 -DGYRL----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -cCCCC----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11000 00112234578999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=243.16 Aligned_cols=161 Identities=24% Similarity=0.348 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
.+.++.|++.||.||| +.+++||||||+|||+++++.++|+|||+++.......... .....++..|+|||.+.+.
T Consensus 129 ~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 129 LISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred HHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhc-ccCCCCCccccCHHHHccC
Confidence 3688999999999999 99999999999999999999999999999876543322211 1123457789999998888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++||||||++++||++ |..||.... ...+... ..... . ++.+......+.+
T Consensus 205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~----~~~~~-----~----------~~~~~~~~~~~~~ 260 (290)
T cd05045 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-----PERLFNL----LKTGY-----R----------MERPENCSEEMYN 260 (290)
T ss_pred CcchHhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH----HhCCC-----C----------CCCCCCCCHHHHH
Confidence 89999999999999999998 888875322 1111111 11110 0 0001122335889
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
++..||+.+|++||++.++++.|+++..+|
T Consensus 261 ~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~~ 290 (290)
T cd05045 261 LMLTCWKQEPDKRPTFADISKELEKMMVKS 290 (290)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHHHhcC
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=251.96 Aligned_cols=188 Identities=21% Similarity=0.297 Sum_probs=143.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--C-CcceEEEeecCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--Q-DRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~-~~~vavK~~~~~------------------------------------------ 89 (284)
++|...+.||+|+||.||+|.+ . +..||+|++...
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 5688889999999999999987 2 357999988532
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~ 186 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence 1111 345678999999999999 99999999999999999999999999999977643221
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... . ........ .+... +.
T Consensus 187 ------~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~---~~~~~~i~-~~~~~--~p- 248 (340)
T PTZ00426 187 ------TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----P---LLIYQKIL-EGIIY--FP- 248 (340)
T ss_pred ------eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----H---HHHHHHHh-cCCCC--CC-
Confidence 2578999999999988889999999999999999999999996432 1 11111111 11100 00
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
......+.+++.+||+.+|++|+ |+.++++.
T Consensus 249 -------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 -------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11122367999999999999995 88888753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=257.19 Aligned_cols=196 Identities=20% Similarity=0.269 Sum_probs=144.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.. +|+.||||++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688889999999999999999 7899999998632
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 111 1456678999999999999 999999999999999999999999999998765322110
Q ss_pred c-----------------------------------cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 039895 154 I-----------------------------------NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198 (284)
Q Consensus 154 ~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~ 198 (284)
. .......||+.|+|||++....++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 00012469999999999998899999999999999999999999
Q ss_pred CCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 039895 199 ISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT---IVQVAK 275 (284)
Q Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~ev~~ 275 (284)
||.... ............. ... .+........+.+++.+|+. +|.+|++ +.|+++
T Consensus 238 Pf~~~~--------~~~~~~~i~~~~~--~~~-----------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDN--------PQETYRKIINWKE--TLQ-----------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCC--------HHHHHHHHHcCCC--ccC-----------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 996432 1111111111000 000 00011122347789999996 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=266.81 Aligned_cols=220 Identities=21% Similarity=0.338 Sum_probs=174.5
Q ss_pred CCCCCcceecHHHHHHHhcCCC---------CCCeeeecCCceEEEEEe--CC---cceEEEeecCCCCCc---------
Q 039895 37 GKHNPIRSFSADELKTATDDFD---------GGKVIMKCLFYKLYKGFL--QD---RPISVMKFEDTFPFS--------- 93 (284)
Q Consensus 37 ~~~~~~~~~~~~~l~~~~~~f~---------~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~~~~~--------- 93 (284)
|...=+.-++|+|-.+|...|. ++++||.|.||.|++|.+ .| ..||||-++..+...
T Consensus 602 G~k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EA 681 (996)
T KOG0196|consen 602 GTKTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEA 681 (996)
T ss_pred CceeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhh
Confidence 3444556678888877776663 467899999999999999 34 579999998772211
Q ss_pred -------------------------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccc
Q 039895 94 -------------------------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIK 124 (284)
Q Consensus 94 -------------------------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlk 124 (284)
.+.+.++.+||.|+.||- +.+.|||||.
T Consensus 682 sIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLA 758 (996)
T KOG0196|consen 682 SIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLA 758 (996)
T ss_pred hhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhh
Confidence 456778999999999999 9999999999
Q ss_pred cCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 039895 125 PTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSS 203 (284)
Q Consensus 125 p~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~ 203 (284)
.+|||++++-.+|++|||+++.+.++.........-.-+..|.|||.+...+++.++||||||+++||+++ |.+|+...
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 99999999999999999999988665422222211122568999999999999999999999999999876 88887643
Q ss_pred CCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. .++.+... +.+.+.|.+++|+..+.+||+.||+.|..+||.+.||+..|.++..+
T Consensus 839 S--------NQdVIkaI----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 839 S--------NQDVIKAI----------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred c--------hHHHHHHH----------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3 22222221 12345566889999999999999999999999999999999999754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=240.57 Aligned_cols=196 Identities=26% Similarity=0.325 Sum_probs=142.4
Q ss_pred CeeeecCCceEEEEEe-----CCcceEEEeecCC-----------------------------CCC--------------
Q 039895 61 KVIMKCLFYKLYKGFL-----QDRPISVMKFEDT-----------------------------FPF-------------- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~-----------------------------~~~-------------- 92 (284)
+.||+|+||.||+|.+ .+..||+|.+... .|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4689999999999987 2347999987532 010
Q ss_pred ----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc-
Q 039895 93 ----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN- 155 (284)
Q Consensus 93 ----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~- 155 (284)
....+.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 0345678899999999999 89999999999999999999999999999876543221111
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
......++..|+|||.+....++.++|||||||++|||++|..|++... . ......... .+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~---~~~~~~~~~-~~~~~-------- 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----D---SFDITVYLL-QGRRL-------- 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----C---HHHHHHHHh-cCCCC--------
Confidence 1112346778999999988889999999999999999999655443211 1 111111111 11000
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+...+..+.+++..||+.+|++||++.+|++.|+++..
T Consensus 222 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 -------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011123358899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=239.00 Aligned_cols=198 Identities=23% Similarity=0.330 Sum_probs=149.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--C---CcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--Q---DRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~---------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.+ . ...||+|.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5688899999999999999998 2 347999988644
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 11 01456788999999999999 9999999999999999999999999999998775221
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... .....+++.|+|||.+.+..++.++||||||+++|++++ |..||.... ........ ......
T Consensus 161 ~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~~--- 227 (266)
T cd05033 161 ATYT-TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAV-EDGYRL--- 227 (266)
T ss_pred ccee-ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHH-HcCCCC---
Confidence 1111 111345678999999988889999999999999999998 888875322 11111111 111000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112234578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=238.71 Aligned_cols=194 Identities=19% Similarity=0.290 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCC-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPF- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~- 92 (284)
++|+..+.||+|+||.||++.+ ++..+|+|.+... ++.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4577778999999999999999 6668999987643 111
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+...........
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~-- 158 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-- 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc--
Confidence 0345779999999999999 99999999999999999999999999999876643322211
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ....+........ ...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~~---- 223 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFR---LYRP---- 223 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCC---CCCC----
Confidence 11345678999999988889999999999999999999 888875422 1122222111110 0001
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
......+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ---------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ---------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11123478999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=239.18 Aligned_cols=200 Identities=25% Similarity=0.356 Sum_probs=152.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.. ++..+|||.+...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999997 8899999977532
Q ss_pred -CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .+.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 00 01345678999999999999 99999999999999999999999999999876643
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
..... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ........... ...
T Consensus 159 ~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~---- 224 (267)
T cd08229 159 KTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE-QCD---- 224 (267)
T ss_pred CCccc---ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhh-cCC----
Confidence 32211 12468899999999988889999999999999999999999986432 11111111111 000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.+.. ........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 225 -~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 -YPPL---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CCCC---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000 01123445889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=242.20 Aligned_cols=201 Identities=19% Similarity=0.271 Sum_probs=151.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||.||++.. ++..+|+|.+...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999985 2356899987643
Q ss_pred ---CC----------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ---FP----------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ---~~----------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
++ .....+.++.|++.||+||| +.+++||||||+|||++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 11 11345679999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||++........... .....+++.|+|||++.+..++.++|||||||++++|++ |..||.... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~~~ 232 (288)
T cd05093 162 GDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI 232 (288)
T ss_pred ccCCccccccCCceeec-CCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence 99999976644322111 112345788999999988889999999999999999998 888875432 11111
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
... ..+..... ....+..+.+|+.+||+.+|.+|||+.+|++.|+++...
T Consensus 233 ~~i-~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECI-TQGRVLQR---------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHH-HcCCcCCC---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 11111110 011223488999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=238.39 Aligned_cols=196 Identities=21% Similarity=0.256 Sum_probs=147.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|++|.||.+.. ++..||+|.+...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999987 7899999987532
Q ss_pred ---CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++. ......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 110 0345678999999999999 9999999999999999999999999999987654322
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
..........|+..|+|||++.+..++.++||||||+++||+++|+.||.... . ..............
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~---~~~~~~~~~~~~~~---- 226 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----A---MAAIFKIATQPTNP---- 226 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----h---HHHHHHHhccCCCC----
Confidence 21111122467889999999998889999999999999999999999985422 0 11111111110000
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
..+......+.+++.+||..+|++|||+.++++.
T Consensus 227 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -----------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011223347899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=247.03 Aligned_cols=184 Identities=19% Similarity=0.263 Sum_probs=141.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|+..+.||+|+||+||+|.. +|+.||+|++...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467778999999999999998 7889999988632
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 111 1556779999999999999 999999999999999999999999999998754322211
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ....
T Consensus 158 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~-~~~~------ 219 (323)
T cd05615 158 ---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIME-HNVS------ 219 (323)
T ss_pred ---ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCCC------
Confidence 122568999999999998899999999999999999999999986432 1111111111 1100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
. +......+.+++.+||+.+|.+|++.
T Consensus 220 ~----------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 Y----------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 01122347799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=251.17 Aligned_cols=185 Identities=21% Similarity=0.271 Sum_probs=140.3
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCC--
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPF-- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~-- 92 (284)
+.||+|+||.||++.. +|..||+|++... +|.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 7899999998643 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
+.....++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~ 154 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MK 154 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc---cc
Confidence 1456678999999999999 7 79999999999999999999999999998754322111 11
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... .... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~-~~~~------~~---- 215 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELIL-MEEI------RF---- 215 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHh-cCCC------CC----
Confidence 2568999999999998899999999999999999999999986432 111111111 1100 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 ------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 011223478999999999999996 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=238.12 Aligned_cols=193 Identities=19% Similarity=0.296 Sum_probs=143.7
Q ss_pred eeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------CC-----
Q 039895 62 VIMKCLFYKLYKGFL----QDRPISVMKFEDT-----------------------------------------FP----- 91 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-----------------------------------------~~----- 91 (284)
.||+|+||.||+|.+ .+..||+|++... ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 389999999999987 3446999988644 00
Q ss_pred -----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 92 -----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 92 -----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
....++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++................
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 11456789999999999999 8999999999999999999999999999997664433222111112
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
.+++.|+|||++....++.++|||||||++||+++ |..||.... ..... .....+...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~~------------ 217 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPEVM-SFIEQGKRL------------ 217 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHHHH-HHHHCCCCC------------
Confidence 34578999999988889999999999999999996 888886432 11111 111111100
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
+.+..++.++.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 218 ---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 218 ---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 001123345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=237.63 Aligned_cols=194 Identities=23% Similarity=0.337 Sum_probs=145.9
Q ss_pred CeeeecCCceEEEEEe--CC---cceEEEeecCC-----------------------------------------C----
Q 039895 61 KVIMKCLFYKLYKGFL--QD---RPISVMKFEDT-----------------------------------------F---- 90 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~-----------------------------------------~---- 90 (284)
+.||+|+||.||+|.+ .+ ..+|+|.+... +
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 4799999999999987 22 67999987644 1
Q ss_pred -----------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 91 -----------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 91 -----------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
..+..+..++.|++.||.||| ..+++|+||||+|||++.++.+||+|||+++..............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 111556789999999999999 899999999999999999999999999999876544332222212
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
..++..|+|||.+.+..++.++||||||+++|++++ |..||.... .......+. .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~---~~~~~------------ 217 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLE---SGERL------------ 217 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHH---cCCcC------------
Confidence 234568999999988889999999999999999998 888875322 111111111 11100
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
+.+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=240.81 Aligned_cols=197 Identities=21% Similarity=0.316 Sum_probs=146.5
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~ 91 (284)
+|...++||+|+||.||+|.. ++..||+|++... ++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 566778999999999999998 7889999987533 11
Q ss_pred C-----------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 92 F-----------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 92 ~-----------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
. +.....++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++........ ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~-----~~~ 153 (279)
T cd06619 82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-----KTY 153 (279)
T ss_pred CCCChHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc-----cCC
Confidence 1 0345679999999999999 99999999999999999999999999999876543221 125
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
.||..|+|||++.+..++.++|||||||++|++++|..||......... ........... .... +.+.
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-~~~~-----~~~~----- 221 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIV-DEDP-----PVLP----- 221 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHh-ccCC-----CCCC-----
Confidence 7899999999999888999999999999999999999998653211111 11111111111 1100 0000
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01122347899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=239.55 Aligned_cols=196 Identities=22% Similarity=0.340 Sum_probs=150.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CC---
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FP--- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~--- 91 (284)
++|...++||+|+||.||+|.. ++..||+|.+... ++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENG 85 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCC
Confidence 5677788999999999999998 7889999988754 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++...........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~-- 160 (260)
T cd05067 86 SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-- 160 (260)
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc--
Confidence 01445678999999999999 99999999999999999999999999999977653322111
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||++....++.++||||||+++||+++ |..||.... . ....... ......
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~~-~~~~~~--------- 222 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----N---PEVIQNL-ERGYRM--------- 222 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----h---HHHHHHH-HcCCCC---------
Confidence 11346778999999988889999999999999999999 888885432 1 1111111 111000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
+.....+..+.+++.+||+.+|++|||++++...|++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011123348899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=248.78 Aligned_cols=210 Identities=16% Similarity=0.216 Sum_probs=145.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|+||.||+|.. ++..||+|.+... +
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4577788999999999999998 7888999988633 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
+. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 161 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY- 161 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc-
Confidence 10 0345668899999999999 9999999999999999999999999999987653322111
Q ss_pred CCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEIVD 231 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (284)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+....... .++.+..
T Consensus 162 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 162 --SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-----EDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred --ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHhhhcc
Confidence 12467899999998765 4688999999999999999999999865431 11111111111000 0000000
Q ss_pred ------ccccCCC-CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 ------PAIVGEE-GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ------~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....... .............+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 0000001123345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.53 Aligned_cols=180 Identities=25% Similarity=0.313 Sum_probs=137.9
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||+||+|.. +|+.||+|++... +|..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999 7899999998632 1111
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~ 154 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTS 154 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---ccc
Confidence 345668999999999999 99999999999999999999999999999865422211 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... .... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~-~~~~--~~------- 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILN-KPLR--LK------- 216 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHc-CCCC--CC-------
Confidence 2568999999999998899999999999999999999999986432 1122211111 1000 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIV 271 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 271 (284)
......+.+++.+||+.||.+||++.
T Consensus 217 -------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 -------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11133478999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=253.57 Aligned_cols=195 Identities=24% Similarity=0.282 Sum_probs=160.1
Q ss_pred CCCeeeecCCceEEEEEeC----C--cceEEEeecCCC-----------------------------CCc----------
Q 039895 59 GGKVIMKCLFYKLYKGFLQ----D--RPISVMKFEDTF-----------------------------PFS---------- 93 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~----~--~~vavK~~~~~~-----------------------------~~~---------- 93 (284)
..++||.|-||.||+|.+. | -.||||..+..+ |.+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~ 472 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELA 472 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecc
Confidence 4568999999999999992 2 258999888751 111
Q ss_pred ------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 94 ------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 94 ------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
...+.++.||+.||+||| +...|||||-.+|||+.+.-.+|++|||+++.+.+...+..
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 455678999999999999 99999999999999999999999999999999987765543
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.. ..-+..|||||.+....++.++|||-|||++||+++ |..||.+-.. . |-..
T Consensus 550 S~--~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------------------s------DVI~ 603 (974)
T KOG4257|consen 550 SR--GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------------------S------DVIG 603 (974)
T ss_pred cc--cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------------------c------ceEE
Confidence 32 344678999999999999999999999999999876 8889875431 1 1111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.-+.+.+.|.++.|++.+..|+.+||+++|.+||++.++...|.++++
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 222344566778888999999999999999999999999999999886
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=241.33 Aligned_cols=195 Identities=24% Similarity=0.312 Sum_probs=145.6
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
.+++.|+..+.||+|+||.||+|.. +++.||+|++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567788889999999999999998 7889999998533
Q ss_pred -------CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 90 -------FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 90 -------~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
+|. +.....++.|++.||+||| +.+|+|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 000 0345668999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
....... ......|++.|+|||++. ...++.++|||||||++|||++|..||.... . ..... .
T Consensus 160 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-----~--~~~~~-~- 227 (272)
T cd06637 160 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----P--MRALF-L- 227 (272)
T ss_pred ecccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----H--HHHHH-H-
Confidence 6543221 112257899999999875 3357889999999999999999999985422 0 01100 0
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......... ....+..+.+|+.+||+.+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNPAPRLK--------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCCCCCCC--------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011101110 0112234789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=256.61 Aligned_cols=204 Identities=18% Similarity=0.283 Sum_probs=148.9
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------
Q 039895 47 ADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------- 89 (284)
Q Consensus 47 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------- 89 (284)
+.++....++|...+.||+|+||.||++.. +++.+|+|++...
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 334444568899999999999999999999 7889999997531
Q ss_pred ---------CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 ---------FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 ---------~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 2211 345668999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTG----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
......... ....||+.|+|||++... .++.++|||||||++|||++|..||.... ..........
T Consensus 192 ~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~ 261 (371)
T cd05622 192 MNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMN 261 (371)
T ss_pred cCcCCcccc--cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHHHHc
Confidence 654322211 225799999999998654 37899999999999999999999997533 1111122111
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAKQ 276 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~~ 276 (284)
...... ++........+.+++..||..++.+ ||++.++++.
T Consensus 262 ~~~~~~-------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLT-------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCccc-------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111000 1111223344778999999844433 7899998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=236.73 Aligned_cols=200 Identities=25% Similarity=0.374 Sum_probs=153.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.. +|+.||+|.+...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788899999999999999999 7899999987531
Q ss_pred -CCC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FPF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ...+..++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 111 1345678999999999999 99999999999999999999999999999876543
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... .....+++.|+|||.+.+..++.++|||||||++|++++|..||.... ........... .+.....
T Consensus 159 ~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~~ 228 (267)
T cd08224 159 KTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE-KCDYPPL 228 (267)
T ss_pred CCcc---cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhh-cCCCCCC
Confidence 3211 112468889999999988889999999999999999999999986432 12222221111 1111100
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
+ .......+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 229 -------------~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 -------------P-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -------------C-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 1123345789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=246.25 Aligned_cols=184 Identities=20% Similarity=0.270 Sum_probs=140.0
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCC-
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPF- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~- 92 (284)
+.||+|+||.||+|.. ++..||+|++... +|.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999 6789999988632 111
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
+.....++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++........ ..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~ 154 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TS 154 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc---cc
Confidence 1455678999999999999 999999999999999999999999999998653222111 11
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... ..... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~-~~~~~--~-------- 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSIL-EDEVR--Y-------- 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHH-cCCCC--C--------
Confidence 2568999999999999999999999999999999999999986432 111111111 11100 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTI-----VQVAK 275 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~ev~~ 275 (284)
+......+.+|+.+||+.||++|||+ .++++
T Consensus 216 ------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 ------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01122347899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=238.74 Aligned_cols=200 Identities=20% Similarity=0.341 Sum_probs=149.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCc---ceEEEeecCC---------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDR---PISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~--------------------------------------- 89 (284)
.++|+..+.||+|+||.||+|.. ++. .+|+|.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 35788889999999999999998 333 6999987643
Q ss_pred ---CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ---FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
++ .......++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 00 00356789999999999999 999999999999999999999999999998766543
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
............++.|+|||++....++.++|||||||++||+++ |..||.... ..............
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~~~--- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGFRL--- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCCCC---
Confidence 222111111233567999999988889999999999999999997 998885432 11111111111000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+.....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 -------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112334578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=237.58 Aligned_cols=198 Identities=22% Similarity=0.312 Sum_probs=150.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF-- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~-- 92 (284)
+.|...+.||+|+||.||+|.+ ++..||+|++... ++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 85 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCC
Confidence 4577888999999999999998 5567999988753 010
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
....+.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+..+........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~-- 160 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-- 160 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc--
Confidence 1345778999999999999 99999999999999999999999999999976654332211
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||+..+..++.++|||||||++|++++ |..||.... . ............
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~---~~~~~~~~~~~~----------- 221 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N---REVLDQVERGYR----------- 221 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----h---HHHHHHHhcCCC-----------
Confidence 11346778999999988889999999999999999999 666764321 1 111111110000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.+.....+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 222 -----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0111233445889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.16 Aligned_cols=183 Identities=25% Similarity=0.291 Sum_probs=138.5
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
+.||+|+||.||+|.. +++.||+|++... +|..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999998 6788999998532 1110
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~~~ 154 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTS 154 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---Ccc
Confidence 344568999999999999 99999999999999999999999999999875432211 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......... ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~-~~~--~~~------- 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILN-KPL--QLK------- 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHh-CCc--CCC-------
Confidence 2579999999999999899999999999999999999999996432 1111111111 100 001
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
......+.+++.+||+.+|.+||++.+.+
T Consensus 217 -------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 -------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11223478999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=240.94 Aligned_cols=190 Identities=29% Similarity=0.449 Sum_probs=139.8
Q ss_pred CCeeeecCCceEEEEEeC------CcceEEEeecCC------------------------------------------CC
Q 039895 60 GKVIMKCLFYKLYKGFLQ------DRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~------------------------------------------~~ 91 (284)
.+.||.|.||.||+|.+. +..|+||.++.. +|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 357999999999999996 678999999653 11
Q ss_pred C-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 92 F-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 ~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
. ...+..++.||+.||.||| +.+++|+||+++|||++.++.+||+|||++..........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence 1 1567889999999999999 8999999999999999999999999999998773332221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
......+...|+|||.+....++.++||||||+++||+++ |..|+... ......... ..+.....
T Consensus 161 -~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~~~~~~~---- 226 (259)
T PF07714_consen 161 -NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQGQRLPI---- 226 (259)
T ss_dssp -ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HTTEETTS----
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-ccccccee----
Confidence 1112456788999999988889999999999999999999 56776432 122222222 11111110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
+..++..+.+++..||+.+|++|||+.++++.|
T Consensus 227 -----------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -----------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112233478999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=238.27 Aligned_cols=196 Identities=22% Similarity=0.338 Sum_probs=148.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CC---
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FP--- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~--- 91 (284)
++|...+.||+|+||.||+|.. ++..+|+|.+... ++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG 85 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence 4577788999999999999998 6678999998753 00
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
....+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~- 161 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ- 161 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc-
Confidence 01346789999999999999 899999999999999999999999999999776443222111
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
...++..|+|||++.+..++.++||||||+++|++++ |..||.... ..............
T Consensus 162 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~---------- 222 (260)
T cd05070 162 -GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVERGYRM---------- 222 (260)
T ss_pred -CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCC----------
Confidence 1345678999999988889999999999999999999 777775422 11111111111000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
+.+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223458899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=255.55 Aligned_cols=197 Identities=19% Similarity=0.224 Sum_probs=140.9
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
.|...+.||+|+||+||+|.. ++..||+|++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577788999999999999998 7889999998542
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc-
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH- 153 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 153 (284)
+|.. .....++.||+.||.||| ..+|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 2211 344567889999999999 999999999999999999999999999997543210000
Q ss_pred -------------------------------------------ccCCCCcccCccccccccccCCCCCcchhHHHHHHHH
Q 039895 154 -------------------------------------------INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALL 190 (284)
Q Consensus 154 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il 190 (284)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0001125799999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHH--hhcCCCCCCC
Q 039895 191 LELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFK--CLSESEGDRP 268 (284)
Q Consensus 191 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~~p~~Rp 268 (284)
|||++|..||.... . ............... .+........+.+++.+ |+..+|..||
T Consensus 239 ~elltG~~Pf~~~~-----~---~~~~~~i~~~~~~~~-------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 239 FEMLVGQPPFLAPT-----P---TETQLKVINWENTLH-------------IPPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred HHHHhCCCCCcCCC-----H---HHHHHHHHccccccC-------------CCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 99999999996532 0 111111110000000 01111122346678877 5566677799
Q ss_pred CHHHHHHH
Q 039895 269 TIVQVAKQ 276 (284)
Q Consensus 269 s~~ev~~~ 276 (284)
++.++++.
T Consensus 298 ~~~~~l~h 305 (381)
T cd05626 298 GADDIKAH 305 (381)
T ss_pred CHHHHhcC
Confidence 99999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=240.72 Aligned_cols=201 Identities=21% Similarity=0.279 Sum_probs=151.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
.+|...+.||+|+||.||+|.. ++..+++|.+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3567778999999999999985 2346889987643
Q ss_pred ---CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc
Q 039895 90 ---FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV 135 (284)
Q Consensus 90 ---~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 135 (284)
++ ....++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 11 01245789999999999999 999999999999999999999
Q ss_pred ceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHH
Q 039895 136 AQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQ 214 (284)
Q Consensus 136 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 214 (284)
++|+|||++........... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~ 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--------NT 232 (291)
T ss_pred EEECCCCcccccCCCceeec-CCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HH
Confidence 99999999976644332111 112456788999999988889999999999999999999 888875432 11
Q ss_pred HHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.... ....+..... ....+..+.+++.+||+.+|++|||+.+|++.|+++..+
T Consensus 233 ~~~~-~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 EVIE-CITQGRVLER---------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHH-HHhCCCCCCC---------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111 1111111111 111233478999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=267.96 Aligned_cols=155 Identities=25% Similarity=0.374 Sum_probs=111.9
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC----C-----------CCccccCCCC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP----E-----------GETHINDSNR 159 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~----~-----------~~~~~~~~~~ 159 (284)
...+++.+|++||.|+| ++|||||||||.||++++++.+||+|||+|.... . ........+.
T Consensus 698 ~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts 774 (1351)
T KOG1035|consen 698 EAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS 774 (1351)
T ss_pred HHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence 34578999999999999 9999999999999999999999999999998721 0 1111223345
Q ss_pred cccCccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 160 VIGTFGFMAPEYRTTGD---FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~---~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
.+||..|+|||++.+.. |+.|+|+||+||+++||+. ||.... .-...+ ..+..+.++.- +.+
T Consensus 775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------ERa~iL-~~LR~g~iP~~--~~f-- 839 (1351)
T KOG1035|consen 775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------ERASIL-TNLRKGSIPEP--ADF-- 839 (1351)
T ss_pred ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-------HHHHHH-HhcccCCCCCC--ccc--
Confidence 78999999999987654 9999999999999999975 443321 111111 12223333332 000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+.-..++.++++.||++||||.|+++
T Consensus 840 --------~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 840 --------FDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0111122358999999999999999999985
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=239.84 Aligned_cols=197 Identities=21% Similarity=0.315 Sum_probs=147.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe-C------CcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-Q------DRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~------~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. + +..||+|++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 4577778999999999999987 2 368999998654
Q ss_pred ----CCC-----------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 ----FPF-----------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 ----~~~-----------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
++. ......++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 110 0234668999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
+|+|||++........... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.... ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~~~~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----NEEVIE 235 (280)
T ss_pred EECCcccceecccCcceec-CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Confidence 9999999876543322111 112346788999999999999999999999999999998 998886432 111111
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.+. .+..... +...+..+.+++.+||+.+|++|||+.||++.|++
T Consensus 236 ~~~----~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CIT----QGRLLQR---------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH----cCCcCCC---------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 1111100 11223447899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=242.21 Aligned_cols=212 Identities=22% Similarity=0.250 Sum_probs=148.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||.||++.. ++..||+|.+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677788999999999999974 5778999998543
Q ss_pred ----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ ....+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 00 00445678999999999999 99999999999999999999999999999987654
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
............++..|+|||++.+..++.++|||||||+++||++|..++..... .+.............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 231 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---------EFMRMMGNDKQGQMI 231 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---------hhhhhcccccccccc
Confidence 33221111112345569999999888899999999999999999998776532210 000000000000000
Q ss_pred cc---ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 230 VD---PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 230 ~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.. ..+.. ....+.....+..+.+|+.+||+.+|++|||+.||++.|+++
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKN--NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhc--CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 00000 000111122334588999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=250.15 Aligned_cols=160 Identities=19% Similarity=0.352 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
+.++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||+++.......... .....+++.|+|||++.+..
T Consensus 240 ~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 315 (400)
T cd05105 240 LSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGSTFLPVKWMAPESIFDNL 315 (400)
T ss_pred HHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccc-cCCcCCCcceEChhhhcCCC
Confidence 468899999999999 99999999999999999999999999999986643322111 11245678899999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHH
Q 039895 177 FSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTEL 255 (284)
Q Consensus 177 ~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (284)
++.++|||||||++|||++ |..||..... ..........+.. ++.....+..+.++
T Consensus 316 ~~~~~DiwSlGvil~ellt~g~~P~~~~~~--------~~~~~~~~~~~~~---------------~~~~~~~~~~l~~l 372 (400)
T cd05105 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIV--------DSTFYNKIKSGYR---------------MAKPDHATQEVYDI 372 (400)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCcccch--------hHHHHHHHhcCCC---------------CCCCccCCHHHHHH
Confidence 9999999999999999997 8888754220 0001111111100 00112234458899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 256 AFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 256 ~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+||+.+|++|||+.+|.+.|+++.++
T Consensus 373 i~~cl~~dP~~RPt~~~l~~~l~~l~~~ 400 (400)
T cd05105 373 MVKCWNSEPEKRPSFLHLSDIVESLLPS 400 (400)
T ss_pred HHHHCccCHhHCcCHHHHHHHHHHHcCC
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=236.95 Aligned_cols=193 Identities=20% Similarity=0.283 Sum_probs=144.8
Q ss_pred CCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CC---
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FP--- 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~--- 91 (284)
+|...+.||+|+||.||+|.+ .+..+|+|++... ++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 467788999999999999998 6668999998653 11
Q ss_pred -------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 92 -------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 92 -------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....+.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++...........
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~-- 159 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-- 159 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccC--
Confidence 01345789999999999999 999999999999999999999999999998766433222111
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...++..|+|||.+.+..++.++||||||+++|++++ |..||.... . ........ .. . ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~---~~~~~~~~-~~-~----~~----- 220 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-----N---SEVVESVS-AG-Y----RL----- 220 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-----H---HHHHHHHH-cC-C----cC-----
Confidence 1234567999999988889999999999999999999 777775322 1 11111111 11 0 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
+.+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 221 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00112334588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=249.49 Aligned_cols=192 Identities=24% Similarity=0.299 Sum_probs=157.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.+|+|+||.++.... ++..+++|.+...
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4677788999999999988877 8889999998655
Q ss_pred -CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
||.. .....++.|++.|+.||| +..|+|||||+.||+++.++.++|+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 3322 556789999999999999 9999999999999999999999999999999987765
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
... .+.+||+.||+||++.+.+|+.|+|||||||++|||++-+++|.... ....+...... ..
T Consensus 161 ~~a---~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~-----~~- 223 (426)
T KOG0589|consen 161 SLA---STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRG-----LY- 223 (426)
T ss_pred hhh---heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhc-----cC-
Confidence 222 23789999999999999999999999999999999999999997543 23333322211 11
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.|.+.....++..++..||..+|..||++.+++.+
T Consensus 224 ----------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 ----------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 13345556668999999999999999999999876
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.74 Aligned_cols=194 Identities=26% Similarity=0.370 Sum_probs=150.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------------CC--
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------------------------FP-- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------------------------~~-- 91 (284)
.++|...+.||.|+||.||+|...|+.||+|.+... ++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 356788899999999999999999999999998755 11
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
.......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 11456789999999999999 99999999999999999999999999999977643222
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
...++..|+|||.+....++.++||||||+++|++++ |..||.... ....... ........
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~~~~------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPH-VEKGYRME------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHH-HhcCCCCC-------
Confidence 1334678999999988889999999999999999997 888875322 1111111 11110000
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 220 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 --------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0111234578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=238.95 Aligned_cols=197 Identities=20% Similarity=0.281 Sum_probs=145.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||+|+||.||+|.. ++..||+|++... ++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5688889999999999999998 7889999988643 11
Q ss_pred C---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 F---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
. ......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.........
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--- 162 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--- 162 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccc---
Confidence 1 1355678999999999999 999999999999999999999999999999766432211
Q ss_pred CCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....|++.|+|||.+. ...++.++|||||||++|||++|..|+........ .. ...... ...+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~-~~~~~~---~~~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LF-LMSKSN---FQPPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------he-eeecCC---CCCCC
Confidence 11256889999999874 34578899999999999999999999853320000 00 000000 00000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
. ......+..+.+++.+||+.+|++|||++++++.|
T Consensus 231 ~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00112234578999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=239.72 Aligned_cols=186 Identities=19% Similarity=0.294 Sum_probs=138.8
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCC----
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPF---- 92 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~---- 92 (284)
||+|+||.||++.. +|+.+|+|.+... +|.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999998 7899999988532 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
......++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~----~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI----TQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee----ec
Confidence 0334678899999999999 999999999999999999999999999998776543221 12
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
..|++.|+|||++.+..++.++||||+||++|||++|..||.... ............. ...... .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~-~~~~~~-~--------- 218 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTL-EDEVKF-E--------- 218 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhh-cccccc-c---------
Confidence 468999999999988889999999999999999999999986432 1011111111111 111000 0
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+.+|+.+||+.||++||++.|+++
T Consensus 219 -----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 -----HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred -----cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0112334789999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=240.95 Aligned_cols=202 Identities=20% Similarity=0.284 Sum_probs=150.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe---------CCcceEEEeecCC-----------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL---------QDRPISVMKFEDT----------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~----------------------------------- 89 (284)
.++|...+.||+|+||.||+|.. ++..||+|.+...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 46678889999999999999975 2346999988643
Q ss_pred --------CCCc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE
Q 039895 90 --------FPFS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130 (284)
Q Consensus 90 --------~~~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl 130 (284)
+|.. ..++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 1110 124567899999999999 9999999999999999
Q ss_pred ecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 039895 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGE 209 (284)
Q Consensus 131 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~ 209 (284)
+.++.+||+|||+++.......... .....+++.|+|||++.+..++.++||||||+++|++++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred cCCCcEEECCCccceeccccccccc-ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 9999999999999987654332211 111345678999999988889999999999999999998 666664321
Q ss_pred cccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
......... ...... .+..++..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 245 ---~~~~~~~~~-~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ---VEELFKLLK-EGHRMD---------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHHHHH-cCCcCC---------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 222222111 111000 0112334588999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=240.58 Aligned_cols=200 Identities=23% Similarity=0.358 Sum_probs=148.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc----ceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR----PISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ +|. .||+|.+...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 4567778999999999999997 554 4688877643
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 00 01356788999999999999 9999999999999999999999999999998765332
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... ......++..|+|||++.+..++.++|||||||++||+++ |..||.... ......++ ......
T Consensus 164 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~----~~~~~~--- 230 (303)
T cd05110 164 KEY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLL----EKGERL--- 230 (303)
T ss_pred ccc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----HCCCCC---
Confidence 211 1112345778999999988889999999999999999998 888875322 11111111 111000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+....+...+.+++..||..+|++||++.++++.|+++.+
T Consensus 231 ------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 231 ------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0011122347899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=240.15 Aligned_cols=186 Identities=18% Similarity=0.274 Sum_probs=139.8
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CC-----
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FP----- 91 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~----- 91 (284)
||+|+||+||++.. +++.||+|++... +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999998 7889999998532 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.+.....++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++..+...... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---T 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc---c
Confidence 11345678999999999999 999999999999999999999999999999766543221 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....||+.|+|||++.+..++.++|||||||++|||++|..||..... ............ ....
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~-~~~~----------- 218 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRIL-NDSV----------- 218 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc----chhHHHHHHhhc-ccCC-----------
Confidence 125689999999999999999999999999999999999999864321 001111111110 0000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
..+...+..+.+++.+||+.||++|| |++++++
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 -----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00112334478999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=244.94 Aligned_cols=184 Identities=22% Similarity=0.288 Sum_probs=138.8
Q ss_pred CeeeecCCceEEEEEe-----CCcceEEEeecCC---------------------------------------------C
Q 039895 61 KVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------------F 90 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------------~ 90 (284)
+.||+|+||.||++.. .++.||+|++... +
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999986 5678999988632 1
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-- 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence 111 344567899999999999 999999999999999999999999999998754322211
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... ......... .+.. . +
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~-~~~~-~-~----- 219 (323)
T cd05584 157 -THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKIL-KGKL-N-L----- 219 (323)
T ss_pred -ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCC-C-C-----
Confidence 112568999999999988889999999999999999999999986432 111111111 1110 0 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 220 ---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 ---------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111223478999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=242.34 Aligned_cols=201 Identities=22% Similarity=0.317 Sum_probs=149.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~------------------------------------ 89 (284)
..++|+..+.||+|+||.||++... ...+|+|.+...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4466888889999999999999872 257899987643
Q ss_pred -------CCCc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -------FPFS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -------~~~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|.. ...+.++.|++.||+||| +.+|+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 1100 234568999999999999 99999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~ 210 (284)
.++.+||+|||+++.+......... ....++..|+|||++.+..++.++|||||||++||+++ |..||....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 239 (293)
T ss_pred CCCeEEeCccccccccccccceecc-CCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC------
Confidence 9999999999999876543322111 11335678999999988889999999999999999998 888875322
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
........ ..+.... .+......+.+|+.+||+.+|++|||+.|+++.|+++.
T Consensus 240 --~~~~~~~~-~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 --VEELFKLL-KEGYRME---------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHHH-HcCCcCC---------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111 1111000 01122344789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=244.90 Aligned_cols=220 Identities=20% Similarity=0.280 Sum_probs=152.0
Q ss_pred CCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------------CC----------------
Q 039895 58 DGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------FP---------------- 91 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------~~---------------- 91 (284)
....+||+|+||.||+|.++++.||||+|... .+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred hhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 34568999999999999999999999999654 00
Q ss_pred ------------CchhHHHHHHHHHHHHHHhccC------CCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 92 ------------FSVSKLKIAIEIASAVAYLHVG------FSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ------------~~~~~~~i~~~i~~gL~~LH~~------~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+.....+++..+++||+|||+. ..++|+|||||++|||+.+|+++.|+|||+|..+..+...
T Consensus 293 GsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~ 372 (534)
T KOG3653|consen 293 GSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQ 372 (534)
T ss_pred CcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCC
Confidence 0055678999999999999953 3578999999999999999999999999999988755433
Q ss_pred ccCCCCcccCccccccccccCCC-CC-----cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGD-FS-----EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
... ...+||..|||||++.+.. +. .+.||||+|.++||++++...+++.. .+.....+..-+.. ...+.
T Consensus 373 ~d~-~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp~Yqlpfe~evG~---hPt~e 447 (534)
T KOG3653|consen 373 GDT-HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VPEYQLPFEAEVGN---HPTLE 447 (534)
T ss_pred cch-hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CCcccCchhHHhcC---CCCHH
Confidence 222 2378999999999987642 21 46899999999999999876554311 11111111111111 11111
Q ss_pred ccccccccCCCCCCChh---hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 228 EIVDPAIVGEEGLMWPE---KEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
++..-.......+.+|. ......-+.+.+..||..||+.|.|+.=|.+++.++..
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11100000001111111 11233447899999999999999999999888887753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=240.50 Aligned_cols=193 Identities=24% Similarity=0.339 Sum_probs=145.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|...++||+|+||+||++.. +++.||+|++...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 366678999999999999998 7899999988532
Q ss_pred CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ......++.|++.||.||| +.+|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 110 0345678999999999999 99999999999999999999999999999877543322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ....|++.|+|||++.+..++.++||||+||++||+++|..||.... .......+........ ..
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~--~~--- 223 (285)
T cd05605 158 I----RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQ--EE--- 223 (285)
T ss_pred c----ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhhcc--cc---
Confidence 1 12468999999999988889999999999999999999999986432 1111111111111100 00
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
.+...+..+.+|+.+||+.||++|| ++.++++.
T Consensus 224 -----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 -----------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112233478999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=238.97 Aligned_cols=198 Identities=22% Similarity=0.362 Sum_probs=151.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC-----------------------------------------C
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----------------------------------------~ 90 (284)
...+|...+.||.|+||.||+|.. ++..+|+|++... +
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 345688889999999999999999 7789999998654 1
Q ss_pred CC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
|. ......++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 11 0345779999999999999 899999999999999999999999999999776543222
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.. ...++..|+|||.+....++.++||||||++++++++ |..||.... .............
T Consensus 161 ~~---~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------- 222 (261)
T cd05148 161 SS---DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGYR------- 222 (261)
T ss_pred cc---CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhCCc-------
Confidence 11 1346778999999988889999999999999999998 788875322 1111111111000
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+.+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ---------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011122334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=236.80 Aligned_cols=194 Identities=20% Similarity=0.260 Sum_probs=145.4
Q ss_pred CCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCC--
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPF-- 92 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~-- 92 (284)
+|...+.||+|+||.||.|.+ ++..+|+|.+... +|.
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 466678899999999999998 4556999987653 110
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
...++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||.++.......... .
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~--~ 159 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS--V 159 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec--C
Confidence 1456789999999999999 99999999999999999999999999999876644332211 1
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...++..|+|||++.+..++.++|||||||++|+|++ |..||.... ......... ...... .
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~~--~------ 222 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVS-QGLRLY--R------ 222 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHh-cCCCCC--C------
Confidence 1345678999999988889999999999999999998 888875322 111111111 111000 0
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
.......+.+++.+||+.+|++|||+.+++..|+
T Consensus 223 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0111244789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=243.29 Aligned_cols=141 Identities=22% Similarity=0.289 Sum_probs=118.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|+..+.||+|+||.||++.. ++..+|+|++...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 36788899999999999999999 6788999987543
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||.||| + .+|+|+||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 159 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 159 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc-
Confidence 1111 334578999999999999 6 4799999999999999999999999999876533211
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
....|+..|+|||++.+..++.++|||||||++|++++|..||..
T Consensus 160 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 160 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 125689999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.44 Aligned_cols=182 Identities=25% Similarity=0.320 Sum_probs=138.5
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCC-
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPF- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~- 92 (284)
+.||+|+||.||+|.. +|+.||+|++... +|.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999998 7899999998532 111
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~ 154 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTT 154 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---Ccc
Confidence 1456678999999999999 99999999999999999999999999999865422211 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ... .+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~-~~~--~~~~------ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILH-KPL--VLRP------ 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHc-CCc--cCCC------
Confidence 2578999999999999899999999999999999999999986432 1111221111 100 0000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev 273 (284)
.....+.+++.+||+.+|.+||++.+.
T Consensus 218 --------~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 218 --------GASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred --------CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 122337789999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=240.11 Aligned_cols=198 Identities=21% Similarity=0.280 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc--ceEEEeecCC-----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR--PISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~----------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.. ++. .+++|.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4678889999999999999988 333 4688877632
Q ss_pred --CCC-------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 --FPF-------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 --~~~-------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
++. ....+.++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 000 0234678999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |..||.... ...
T Consensus 159 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~ 226 (297)
T cd05089 159 KIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAE 226 (297)
T ss_pred EECCcCCCccccceec----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 9999999864322111 111223567999999988889999999999999999997 888885432 111
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
...... .+. .+ +.+...+..+.+|+.+||+.+|.+|||+.++++.|+++.+.
T Consensus 227 ~~~~~~-~~~-----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 227 LYEKLP-QGY-----RM----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHHh-cCC-----CC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 110 00 00112234478999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=238.17 Aligned_cols=197 Identities=25% Similarity=0.386 Sum_probs=146.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~--------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.+ .+..||+|.+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577778999999999999985 4568999998742
Q ss_pred ---CCC--------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC
Q 039895 90 ---FPF--------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134 (284)
Q Consensus 90 ---~~~--------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 134 (284)
++. ....+.++.|++.||.||| +.+|+|+||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 110 0123568999999999999 99999999999999999999
Q ss_pred cceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccH
Q 039895 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 135 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~ 213 (284)
.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRV-QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----NQEV 235 (283)
T ss_pred cEEeccccccccccCCcceec-ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence 999999999987644322111 112446778999999988889999999999999999998 888875432 1111
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
...+ ....... .+..++..+.+++.+||+.+|++||++.+|++.|..
T Consensus 236 ~~~~----~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMV----RKRQLLP---------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----HcCCcCC---------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1111110 011223347899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.62 Aligned_cols=197 Identities=20% Similarity=0.267 Sum_probs=141.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +++.||+|++...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3677889999999999999998 8899999987532
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 2211 334568999999999999 999999999999999999999999999998643211000
Q ss_pred ------------c--------------------------------cCCCCcccCccccccccccCCCCCcchhHHHHHHH
Q 039895 154 ------------I--------------------------------NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGAL 189 (284)
Q Consensus 154 ------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~i 189 (284)
. .......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 00012469999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCC--
Q 039895 190 LLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR-- 267 (284)
Q Consensus 190 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R-- 267 (284)
+|||++|..||.... . ............ .+ .++........+.+++.+||. +|.+|
T Consensus 238 l~elltG~~Pf~~~~-----~---~~~~~~i~~~~~--~~-----------~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 238 MFECLIGWPPFCSEN-----S---HETYRKIINWRE--TL-----------YFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred hhhhhcCCCCCCCCC-----H---HHHHHHHHccCC--cc-----------CCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999986432 1 111111111000 00 001111122347789999997 66665
Q ss_pred -CCHHHHHHH
Q 039895 268 -PTIVQVAKQ 276 (284)
Q Consensus 268 -ps~~ev~~~ 276 (284)
+|+.|++..
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 599998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=235.95 Aligned_cols=192 Identities=23% Similarity=0.349 Sum_probs=147.5
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------CCC----
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------FPF---- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------~~~---- 92 (284)
++|...+.||+|+||.||+|..+++.||+|.+... +|.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L 85 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNL 85 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCH
Confidence 45778899999999999999999999999998644 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
....+.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........ .
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~------~ 156 (254)
T cd05083 86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD------N 156 (254)
T ss_pred HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCC------C
Confidence 1456778999999999999 99999999999999999999999999999876433211 1
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...+..|+|||.+.+..++.++|||||||++|+|++ |..||.... ....... ...+....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~-~~~~~~~~---------- 217 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKEC-VEKGYRME---------- 217 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHH-HhCCCCCC----------
Confidence 334678999999988889999999999999999998 888875432 1111111 11110000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.....+..+.+++.+||+.+|+.||++.+++..|++
T Consensus 218 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=257.00 Aligned_cols=199 Identities=21% Similarity=0.232 Sum_probs=155.7
Q ss_pred CCCCCCeeeecCCceEEEEEe-CC-cceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QD-RPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~-~~vavK~~~~~-------------------------------------------- 89 (284)
.....+.|.+|||+.||.+.. .+ ..+|+|++...
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 344567899999999999999 44 89999998644
Q ss_pred -----CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 -----FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 -----~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
||.. ...++|+.|+++|+++||.. ..+|||||||-+||||+.+|..||||||.+...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 4442 67899999999999999954 778999999999999999999999999998654
Q ss_pred CCCCccc------cCCCCcccCccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 148 PEGETHI------NDSNRVIGTFGFMAPEYR---TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 148 ~~~~~~~------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
....... ...-...-|+.|+|||++ .+.+++.|+|||+|||+||.|+....||....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------- 262 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------- 262 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------
Confidence 3322110 111113468999999975 46689999999999999999999999997542
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
-..+++ ..+.+|..+.....+.+||..||+.||++||++-+|+..+.+|..
T Consensus 263 -------~laIln------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 -------KLAILN------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------ceeEEe------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 011111 122334445667779999999999999999999999999988764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.47 Aligned_cols=197 Identities=20% Similarity=0.327 Sum_probs=145.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~------------------------------------- 89 (284)
.++|...+.||+|++|.||+|.+. +..||+|.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467888899999999999999993 357888987533
Q ss_pred -----CC----------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceee
Q 039895 90 -----FP----------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLF 139 (284)
Q Consensus 90 -----~~----------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 139 (284)
++ .....+.++.||+.||.||| +.+++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 11 00335679999999999999 99999999999999998765 58999
Q ss_pred ccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHH
Q 039895 140 DFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 140 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
|||+++.......... ......+..|+|||++.+..++.++|||||||++|||++ |..||.... . .....
T Consensus 162 dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-----~---~~~~~ 232 (277)
T cd05036 162 DFGMARDIYRASYYRK-GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-----N---QEVME 232 (277)
T ss_pred cCccccccCCccceec-CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----H---HHHHH
Confidence 9999987643322211 111334568999999988889999999999999999997 888875432 1 11111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
........ . .+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 233 ~~~~~~~~-~---------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGRL-D---------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCcC-C---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111100 0 01112345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=233.37 Aligned_cols=196 Identities=22% Similarity=0.314 Sum_probs=147.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF-- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~-- 92 (284)
++|.....||+|++|.||+|.+ .+..+|+|.+... ++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG 85 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence 3467778999999999999998 5557999987643 000
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
......++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++...........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~-- 160 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-- 160 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc--
Confidence 0345788999999999999 99999999999999999999999999999977644322111
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||...+..++.++||||||+++|++++ |..||.... . .............
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~---~~~~~~~~~~~~~---------- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----N---REVLEQVERGYRM---------- 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHcCCCC----------
Confidence 11346778999999988889999999999999999999 787775422 1 1111111111000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
+.+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011223458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=241.19 Aligned_cols=207 Identities=22% Similarity=0.247 Sum_probs=149.5
Q ss_pred CCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~---------------------------------------- 89 (284)
.|...+.||+|+||.||.+.+ ++..||+|.+...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356678999999999999974 5778999998633
Q ss_pred ----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ ....++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 01 11456789999999999999 99999999999999999999999999999987654
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------CCccccHHHHHHHHhh
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD-------DGEDYRLQDLVKKYIE 222 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 222 (284)
............++..|+|||++.+..++.++|||||||++||++++..|....... ..........+.. ..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HH
Confidence 332211112245677899999998888999999999999999999987664321100 0000011111110 00
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.+. ..+.....+..+.+|+.+||+.+|++|||+.++++.|+++.
T Consensus 241 ~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 241 EGK---------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred cCc---------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 000 00111123445889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=254.45 Aligned_cols=191 Identities=19% Similarity=0.204 Sum_probs=145.0
Q ss_pred CCCCCeeeecCCceEEEEEe--C-CcceEEEeecCC-----------------------------------------CCC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--Q-DRPISVMKFEDT-----------------------------------------FPF 92 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~-~~~vavK~~~~~-----------------------------------------~~~ 92 (284)
|...+.||+|+||.||+|.. + +..||+|.+... +|.
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 77788999999999999988 4 677888876433 221
Q ss_pred c-------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 93 S-------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 93 ~-------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 1 344568899999999999 999999999999999999999999999999876543221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... +....
T Consensus 226 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~-~~~~~----- 290 (478)
T PTZ00267 226 -DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLY-GKYDP----- 290 (478)
T ss_pred -ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCCCC-----
Confidence 11223579999999999998899999999999999999999999986432 1111211111 11100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+......+.+++.+||+.+|++|||+.+++.
T Consensus 291 ----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ----------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01122334789999999999999999999874
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=239.06 Aligned_cols=191 Identities=23% Similarity=0.326 Sum_probs=143.7
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------C
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------F 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~ 90 (284)
|+..+.||+|+||+||++.. +++.||+|.+... +
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66678999999999999999 7889999987532 1
Q ss_pred C-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 P-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+ .....+.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 1 11345678999999999999 999999999999999999999999999998765433221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....|+..|+|||++.+..++.++|||||||++|+|++|..||..... . ............ .....
T Consensus 159 ----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~--~---~~~~~~~~~~~~--~~~~~--- 224 (285)
T cd05630 159 ----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK--K---IKREEVERLVKE--VQEEY--- 224 (285)
T ss_pred ----cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc--c---chHHHHHhhhhh--hhhhc---
Confidence 124689999999999988999999999999999999999999964321 0 000001111000 00000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
.......+.+|+..||+.||++||| +.|+++
T Consensus 225 -----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 -----------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -----------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0112234789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=234.04 Aligned_cols=190 Identities=25% Similarity=0.354 Sum_probs=140.4
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC-----
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP----- 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~----- 91 (284)
+.||+|+||.||+|.. +++.||+|.+... ++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999998 7899999987543 11
Q ss_pred -----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 92 -----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 92 -----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
.......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccc-cCCCC
Confidence 01445779999999999999 9999999999999999999999999999987654322111 11111
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
.++..|+|||.+.+..++.++|||||||++||+++ |..|+.... ... ......... ..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--------~~~-~~~~~~~~~-~~----------- 215 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--------NQQ-TREAIEQGV-RL----------- 215 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--------HHH-HHHHHHcCC-CC-----------
Confidence 23457999999988889999999999999999998 777764321 011 111111100 00
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
+.+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 ---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 001122345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=239.79 Aligned_cols=200 Identities=20% Similarity=0.297 Sum_probs=149.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------- 89 (284)
.++|...+.||+|+||.||++.. .+..||+|.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35788899999999999999975 2347999987542
Q ss_pred ------CC-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 ------FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 ------~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
++ ...+...++.|++.||.||| +.+|+|+||||+|||++.++.++++|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 11 11456779999999999999 99999999999999999999999999999986
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
......... .....++..|+|||.+....++.++|||||||++||+++ |..||..... ..... .....+.
T Consensus 191 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~----~~~~~~~ 261 (302)
T cd05055 191 IMNDSNYVV-KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFY----KLIKEGY 261 (302)
T ss_pred ccCCCceee-cCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHH----HHHHcCC
Confidence 654332111 112346788999999988889999999999999999998 8888764320 00111 1111110
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
... .+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 262 -~~~--------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -RMA--------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -cCC--------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 0011123478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=237.45 Aligned_cols=191 Identities=22% Similarity=0.317 Sum_probs=142.7
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------C
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------F 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~ 90 (284)
|...+.||+|+||+||+|.+ +++.||+|.+... +
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55567899999999999999 7889999988532 0
Q ss_pred C-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 P-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+ .......++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 1 01356779999999999999 999999999999999999999999999998765432221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....|+..|+|||++.+..++.++|+|||||++|++++|..||.... .......+........ ...
T Consensus 159 ----~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~-----~~~~~~~~~~~~~~~~--~~~--- 224 (285)
T cd05632 159 ----RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK-----EKVKREEVDRRVLETE--EVY--- 224 (285)
T ss_pred ----cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhhhccc--ccc---
Confidence 12468999999999988889999999999999999999999986432 0101111111111110 000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
.......+.+|+..||+.+|++||+ +.+++.
T Consensus 225 -----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 -----------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -----------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0112233678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=250.94 Aligned_cols=209 Identities=24% Similarity=0.368 Sum_probs=156.0
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEe---CC--cc-eEEEeecCC-----------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFL---QD--RP-ISVMKFEDT----------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~---~~--~~-vavK~~~~~----------------------------- 89 (284)
+....+.-...+-...++||+|.||.||+|.+ ++ .. ||||.....
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 33444444555666678999999999999999 22 23 899998852
Q ss_pred ---------------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ---------------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ---------------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
+|.. .+++.++.+.|.||+||| +++++||||-.+|+|++.++.+||
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEe
Confidence 1111 678899999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||+++....- ........-+..|+|||.+....|+.++|||||||++||+++ |..|+.+.. ..+..
T Consensus 304 SDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--------~~~v~ 372 (474)
T KOG0194|consen 304 SDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--------NYEVK 372 (474)
T ss_pred CccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--------HHHHH
Confidence 999998765411 111111234678999999999999999999999999999999 777776543 12211
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.....++ .+. +.+...+..+..++..||..+|++||||.++.+.|+.+..
T Consensus 373 ~kI~~~~-~r~--------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 373 AKIVKNG-YRM--------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred HHHHhcC-ccC--------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1111111 111 1122334457789999999999999999999999998865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=253.75 Aligned_cols=145 Identities=20% Similarity=0.249 Sum_probs=117.8
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
.|...+.||+|+||+||+|.. ++..||+|++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477788999999999999998 7889999998642
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc--
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET-- 152 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~-- 152 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 2211 334567899999999999 99999999999999999999999999999754321000
Q ss_pred ------------------------------------------cccCCCCcccCccccccccccCCCCCcchhHHHHHHHH
Q 039895 153 ------------------------------------------HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALL 190 (284)
Q Consensus 153 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il 190 (284)
.........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 00001124699999999999988999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 039895 191 LELLTGKKISYSS 203 (284)
Q Consensus 191 ~elltg~~p~~~~ 203 (284)
|||++|..||...
T Consensus 239 ~elltG~~Pf~~~ 251 (382)
T cd05625 239 YEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=245.43 Aligned_cols=180 Identities=25% Similarity=0.330 Sum_probs=136.7
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CCCc
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FPFS 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~~~ 93 (284)
++||+|+||.||+|.. ++..||+|++... +|..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999 7889999998532 1111
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~ 154 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTS 154 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---ccc
Confidence 345568999999999999 99999999999999999999999999999875322211 112
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ... . +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~-~~~-~-~-------- 215 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILH-KPL-Q-L-------- 215 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhc-CCC-C-C--------
Confidence 2578999999999988889999999999999999999999986532 1111111111 100 0 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIV 271 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 271 (284)
+......+.+++.+||+.+|.+||++.
T Consensus 216 ------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 ------PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 011223477999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=240.02 Aligned_cols=201 Identities=21% Similarity=0.271 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEeC---------CcceEEEeecCC------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQ---------DRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~------------------------------------ 89 (284)
++|...+.||+|+||.||++... +..+|+|.+...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999862 246999988643
Q ss_pred -------CCC-------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -------FPF-------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -------~~~-------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|. ....+.++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 111 0234578999999999999 99999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~ 210 (284)
.++.++|+|||++........... .....+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhc-cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 999999999999876643222111 111234578999999988889999999999999999998 777764321
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
........ ...... +.+......+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus 248 --~~~~~~~~-~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 --VEELFKLL-KEGHRM---------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHHH-HcCCCC---------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 111100 01112234578999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=231.53 Aligned_cols=189 Identities=23% Similarity=0.326 Sum_probs=142.4
Q ss_pred CeeeecCCceEEEEEe-CCcceEEEeecCC------------------------------------------CC------
Q 039895 61 KVIMKCLFYKLYKGFL-QDRPISVMKFEDT------------------------------------------FP------ 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------------------------------------------~~------ 91 (284)
++||+|+||.||+|.. ++..+|+|.+... ++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998 7788999987644 11
Q ss_pred ----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 92 ----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 92 ----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
.....+.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++............ ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~--~~~ 155 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG--LKQ 155 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC--CCC
Confidence 11455788999999999999 999999999999999999999999999998765433222111 124
Q ss_pred cCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
+++.|+|||++.+..++.++||||||+++|++++ |..||.... ...... .........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--------~~~~~~-~~~~~~~~~------------ 214 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--------NQQARE-QVEKGYRMS------------ 214 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHH-HHHcCCCCC------------
Confidence 4678999999988889999999999999999998 888875432 111111 111111000
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
.....+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 ---CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01112345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=234.62 Aligned_cols=196 Identities=23% Similarity=0.307 Sum_probs=146.0
Q ss_pred CCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC------------------------------C-----------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT------------------------------F----------- 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------------------------------~----------- 90 (284)
|...+.||+|+||.||+|.+ ++..||+|++... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 45567899999999999986 3578999987643 0
Q ss_pred --------C---------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 91 --------P---------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 91 --------~---------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
+ .......++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 0 00234678999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHH
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
|+++........... ....+++.|++||.+....++.++|||||||++|++++ |..||.... ........
T Consensus 158 g~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--------~~~~~~~~ 228 (273)
T cd05074 158 GLSKKIYSGDYYRQG-CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--------NSEIYNYL 228 (273)
T ss_pred cccccccCCcceecC-CCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--------HHHHHHHH
Confidence 999876443322111 11345678999999988889999999999999999999 777765322 11111111
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
........ ....+..+.+++.+||+.+|++|||+.+++..|+++
T Consensus 229 ~~~~~~~~----------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRLKQ----------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcCCC----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111000 011233588999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=240.43 Aligned_cols=163 Identities=25% Similarity=0.340 Sum_probs=116.9
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
..+.++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++........... .....+++.|+|||++..
T Consensus 131 ~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV-QGRAPLPIRWMAWESVLL 206 (296)
T ss_pred HHHHHHHHHHHHHHHHH---HcCccccccchhceeecCCCceEEccccceeecccCcceee-cCcCCCCceecCHHHhhc
Confidence 35678999999999999 99999999999999999999999999999876644322211 122456788999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLT--GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
..++.++|||||||++||+++ +..|+.... ..................... +.....+..+
T Consensus 207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l 269 (296)
T cd05051 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-----DQQVIENAGHFFRDDGRQIYL------------PRPPNCPKDI 269 (296)
T ss_pred CCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-----hHHHHHHHHhccccccccccC------------CCccCCCHHH
Confidence 889999999999999999998 555654221 111111111110000000000 0111223458
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
.+++.+||+.+|++|||+.||++.|+
T Consensus 270 ~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 270 YELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccChhcCCCHHHHHHHhc
Confidence 89999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=252.32 Aligned_cols=186 Identities=21% Similarity=0.315 Sum_probs=146.4
Q ss_pred eeeecCCceEEEEEe--CCcceEEEeecCC----------------------------CCCc------------------
Q 039895 62 VIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------FPFS------------------ 93 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------~~~~------------------ 93 (284)
+||+|.||+||-|++ +...+|||.+... .|++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999999 5667899988655 1111
Q ss_pred -------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCcceeeccccccccCCCCccccCCCC
Q 039895 94 -------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 94 -------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
.+.-.+-.||++||.||| +..|||||||-+|+|++ -.|.+||+|||.++.+..-. +.+.+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin---P~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN---PCTET 735 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC---ccccc
Confidence 445568899999999999 99999999999999997 57899999999998775322 22334
Q ss_pred cccCccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 160 VIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~--~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
+.||..|||||++..++ |+.++|||||||++.||.||++||..... ....+.+- +-
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkV----------------Gm 793 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKV----------------GM 793 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhh----------------cc
Confidence 88999999999998774 88999999999999999999999975431 01111110 01
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+|.+.+...++..++.+|+.++|.+||++.+++.
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11223557788888999999999999999999999874
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=233.43 Aligned_cols=200 Identities=25% Similarity=0.348 Sum_probs=150.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe-C----CcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-Q----DRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~----~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ + ...||+|.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 3577788999999999999997 2 246899987643
Q ss_pred -CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+| ....++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 11 11456778999999999999 99999999999999999999999999999877654432
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.... ...++..|+|||.+....++.++||||||+++||+++ |..||.... .. ...... ..+...
T Consensus 163 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~---~~~~~~-~~~~~~---- 227 (270)
T cd05056 163 YKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NN---DVIGRI-ENGERL---- 227 (270)
T ss_pred eecC--CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HH---HHHHHH-HcCCcC----
Confidence 2111 1334578999999888889999999999999999986 998885432 11 111111 111100
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..++..+.+++.+||..+|++|||+.+++..|+++..+
T Consensus 228 -----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112234588999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=228.84 Aligned_cols=189 Identities=24% Similarity=0.344 Sum_probs=141.7
Q ss_pred CCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------CCCc------------------
Q 039895 60 GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------FPFS------------------ 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------~~~~------------------ 93 (284)
...||.|+-|.||++.+ .|..+|||.+... .|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C 176 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTC 176 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHH
Confidence 45699999999999999 7899999998765 1111
Q ss_pred --------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 94 --------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 94 --------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
...-++...+++||.||-+ .++|+|||+||+|||+|..|++|+||||++-.+-++.... .
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht----r 250 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT----R 250 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc----c
Confidence 1111456778899999997 7899999999999999999999999999997775544332 2
Q ss_pred cccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 160 VIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
..|.+.|||||.+.- ..|+.++||||||+.++||.||+.||.... ........+.. + ..|.+.+
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----tdFe~ltkvln---~------ePP~L~~ 317 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TDFEVLTKVLN---E------EPPLLPG 317 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----ccHHHHHHHHh---c------CCCCCCc
Confidence 568999999998764 368999999999999999999999997533 11111111111 1 1122222
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ...++.+.+++..||..|+.+||...++++
T Consensus 318 ~--------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 H--------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred c--------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2 223445889999999999999999998875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=233.83 Aligned_cols=194 Identities=21% Similarity=0.287 Sum_probs=143.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
.+|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999998 7889999987421
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. ......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 000 0345678999999999999 99999999999999999999999999999876543
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
............++..|+|||.+.+..++.++|||||||++||+++|..||.... ....+........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~~~~---- 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQPT---- 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhcCCC----
Confidence 2211111122457899999999988889999999999999999999999985321 1111111111110
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.+ +......+.+++ +||..+|++||++.||++
T Consensus 227 -~~~~----------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -NPQL----------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCC----------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0110 112223355666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=263.44 Aligned_cols=203 Identities=22% Similarity=0.335 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...++||+|+||.||+|.. +|+.||+|++...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5688889999999999999998 6899999998642
Q ss_pred -CCCc--------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccc
Q 039895 90 -FPFS--------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFT 142 (284)
Q Consensus 90 -~~~~--------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 142 (284)
+|.. ...+.++.||+.||+||| +.+|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 1110 123678899999999999 9999999999999999999999999999
Q ss_pred cccccCCCCc---------------cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 039895 143 LSLSIPEGET---------------HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207 (284)
Q Consensus 143 ~a~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~ 207 (284)
+++....... .........||+.|+|||++.+..++.++|||||||++|||+||..||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~--- 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK--- 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc---
Confidence 9986621110 0001112569999999999999999999999999999999999999986422
Q ss_pred CccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHh
Q 039895 208 GEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-TIVQVAKQLRQIYQ 282 (284)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~ev~~~L~~l~~ 282 (284)
. .... .... ..++... ......+..+.+++.+||+.||++|| +++++++.|+...+
T Consensus 236 ~--~ki~--~~~~--------i~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 236 G--RKIS--YRDV--------ILSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h--hhhh--hhhh--------ccChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0000 0000 0000000 00112234477899999999999996 66778888887654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=231.44 Aligned_cols=191 Identities=24% Similarity=0.347 Sum_probs=147.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||+|++|.||+|.. ++..|++|.+... +
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467778999999999999998 7899999987532 1
Q ss_pred CC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+. ......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 10 0345678999999999999 999999999999999999999999999998876543322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ....|++.|+|||++.+..++.++|||||||++++|++|..||.... ......... .+.....
T Consensus 158 ~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~---- 221 (256)
T cd08529 158 A---NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKII-RGVFPPV---- 221 (256)
T ss_pred h---hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCCCCCC----
Confidence 1 12468899999999998889999999999999999999999986432 111111111 1111110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 -----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -----------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11233448899999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=252.98 Aligned_cols=197 Identities=18% Similarity=0.210 Sum_probs=141.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +++.||+|++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3678889999999999999998 7899999998532
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc-
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET- 152 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~- 152 (284)
+|.. .....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 2211 334567899999999999 99999999999999999999999999999753311000
Q ss_pred ---------------------------------------cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHH
Q 039895 153 ---------------------------------------HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLEL 193 (284)
Q Consensus 153 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~el 193 (284)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001125799999999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC---CH
Q 039895 194 LTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP---TI 270 (284)
Q Consensus 194 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp---s~ 270 (284)
++|..||.... . ............... .+........+.+++.+|+ .+|.+|+ |+
T Consensus 238 l~G~~Pf~~~~-----~---~~~~~~i~~~~~~~~-------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 238 LVGQPPFLADT-----P---AETQLKVINWETTLH-------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred hhCCCCCCCCC-----H---HHHHHHHhccCcccc-------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999996533 1 111111110000000 0001112233667888766 5999999 88
Q ss_pred HHHHHH
Q 039895 271 VQVAKQ 276 (284)
Q Consensus 271 ~ev~~~ 276 (284)
.++++.
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=237.24 Aligned_cols=194 Identities=21% Similarity=0.316 Sum_probs=146.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
..|...+.||+|+||.||+|.. ++..||+|.+... ++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3566778899999999999997 7889999988643 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++......... .
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~ 173 (296)
T cd06654 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---R 173 (296)
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc---c
Confidence 11456789999999999999 999999999999999999999999999998765432211 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ...+.. ..... ....
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~-~~~~~-~~~~-------- 236 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL-IATNG-TPEL-------- 236 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHH-HhcCC-CCCC--------
Confidence 124688999999999888889999999999999999999999864320 011110 10000 0000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+.+......+.+++.+||..+|++|||+.++++.
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011223447899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=242.00 Aligned_cols=215 Identities=16% Similarity=0.207 Sum_probs=148.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|..||+|.+...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788899999999999999998 7899999987532
Q ss_pred -----CC-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -----FP-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -----~~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .......++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 00 00345668999999999999 9999999999999999999999999999987765433
Q ss_pred ccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFK 227 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 227 (284)
..........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .............. .+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCCHHHHH
Confidence 22222223568999999998654 4688999999999999999999999864320 11111111111000 000
Q ss_pred cccccc-------ccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 228 EIVDPA-------IVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 228 ~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+.+.. ........+. ........+.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000000000 001223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=236.65 Aligned_cols=201 Identities=19% Similarity=0.314 Sum_probs=149.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------ 89 (284)
..+.|+..+.||+|+||.||+|.. .+..||+|.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 456788889999999999999975 2447999987533
Q ss_pred ------CCCc-------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ------FPFS-------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ------~~~~-------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
+|.. .....++.|++.||.||| +++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 1110 134568999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||+++.......... .....++..|+|||.+.+..++.++|||||||++||+++ |..||.... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (288)
T cd05061 161 GDFGMTRDIYETDYYRK-GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVL 231 (288)
T ss_pred CcCCccccccccccccc-cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence 99999876644332211 111345778999999988889999999999999999998 677765322 11111
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.... .+.... .+..++..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 232 ~~~~-~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVM-DGGYLD---------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHH-cCCCCC---------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 111110 01122345889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=247.39 Aligned_cols=183 Identities=21% Similarity=0.257 Sum_probs=135.5
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------------CCCc
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------------FPFS 93 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------------~~~~ 93 (284)
||+|+||+||+|.. ++..||+|++... +|..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999998 7899999998532 1110
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.||+.||+||| +.+|+||||||+|||++.++.++|+|||++......... ..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---~~ 154 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TN 154 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC---cc
Confidence 345678999999999999 999999999999999999999999999998754322211 12
Q ss_pred CcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 159 RVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ........ ..+.. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i-~~~~~-~~~~------ 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNI-AFGKV-RFPK------ 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHH-HcCCC-CCCC------
Confidence 25799999999998754 47899999999999999999999986532 11111111 11110 0000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCC----CHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRP----TIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp----s~~ev~~ 275 (284)
......+.+++.+||+.||++|| ++.++++
T Consensus 219 --------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01123467899999999999998 4555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=235.52 Aligned_cols=192 Identities=26% Similarity=0.342 Sum_probs=143.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF------------------------------------------ 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------------------------------------ 90 (284)
++|+..+.||+|+||.||++.. +|..||+|.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4678888999999999999998 78999999886430
Q ss_pred -------------------CCchhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 91 -------------------PFSVSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 91 -------------------~~~~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+.+.....++.|++.||.||| +. +++||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 011345689999999999999 76 9999999999999999999999999998766432
Q ss_pred CccccCCCCcccCccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTT----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
... ....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.... ..... ...... ...
T Consensus 158 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~-~~~~~~-~~~ 225 (283)
T cd06617 158 VAK----TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK------TPFQQ-LKQVVE-EPS 225 (283)
T ss_pred ccc----ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc------cCHHH-HHHHHh-cCC
Confidence 211 12457889999998764 456889999999999999999999985321 11111 111111 000
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... ....+..+.+++.+||..+|++|||+.+++.
T Consensus 226 ~~~~--------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP--------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC--------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0112344789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=239.58 Aligned_cols=198 Identities=22% Similarity=0.278 Sum_probs=146.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc--ceEEEeecCC-----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR--PISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~----------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.+ ++. .+|+|.+...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5778889999999999999997 454 4577776532
Q ss_pred --CCC-------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 --FPF-------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 --~~~-------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
++. ....+.++.|++.||+||| +.+++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 110 1235678999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
||+|||++........ .....++..|+|||++.+..++.++|||||||++||++| |..||.... ...
T Consensus 164 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~ 231 (303)
T cd05088 164 KIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAE 231 (303)
T ss_pred EeCccccCcccchhhh----cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--------hHH
Confidence 9999999864321111 111234667999999988889999999999999999998 888885432 111
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..... ....... .....+..+.+|+.+||+.+|++||++.+++..|+.+.+.
T Consensus 232 ~~~~~-~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 232 LYEKL-PQGYRLE---------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHH-hcCCcCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 1100000 0111223478999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=235.70 Aligned_cols=196 Identities=22% Similarity=0.327 Sum_probs=146.9
Q ss_pred cCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||.||+|... +..||+|.+...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 56777889999999999999983 257999997644
Q ss_pred ----CCCc-------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeec
Q 039895 90 ----FPFS-------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 ----~~~~-------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
++.. ...+.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 1110 135678999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHH
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKK 219 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 219 (284)
||+++.......... .....++..|+|||.+....++.++|||||||++||+++ |..||.... .......
T Consensus 163 fg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~~~~~ 233 (277)
T cd05032 163 FGMTRDIYETDYYRK-GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEVLKF 233 (277)
T ss_pred cccchhhccCccccc-CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--------HHHHHHH
Confidence 999876644332211 112456789999999988889999999999999999998 887775322 1111111
Q ss_pred HhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 220 YIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
. ........ +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ~-~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 V-IDGGHLDL---------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred H-hcCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 11111110 1112345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=259.32 Aligned_cols=210 Identities=20% Similarity=0.240 Sum_probs=138.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--C----CcceEEEeecCC-------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--Q----DRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~----~~~vavK~~~~~------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.+ + +..||+|++...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 567899999999999999999999 5 689999986531
Q ss_pred ------CCCc-----------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcE
Q 039895 90 ------FPFS-----------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTI 128 (284)
Q Consensus 90 ------~~~~-----------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NI 128 (284)
|+.. .....++.||+.||.||| +.+|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence 0000 012358999999999999 99999999999999
Q ss_pred EEec-CCcceeeccccccccCCCCccccCCCCcccCccccccccccCC----------------------CCCcchhHHH
Q 039895 129 VLQE-ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG----------------------DFSEKSDVYS 185 (284)
Q Consensus 129 Ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwS 185 (284)
|++. ++.+||+|||+++.+......... ...+++.|+|||.+... .++.++||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~--~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCc--ccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9985 579999999999876543332222 26789999999965322 1334679999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC----cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhc
Q 039895 186 FGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE----SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLS 261 (284)
Q Consensus 186 ~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 261 (284)
|||++|||+++..++... ...+.......+ .+.....+....+....+...........+|+.+||+
T Consensus 365 lGviL~el~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN---------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHhCcCCCchH---------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999876553211 111111111000 0111111110000000000000111235689999999
Q ss_pred CCCCCCCCHHHHHHH
Q 039895 262 ESEGDRPTIVQVAKQ 276 (284)
Q Consensus 262 ~~p~~Rps~~ev~~~ 276 (284)
.||++|||+.|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999863
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=234.71 Aligned_cols=209 Identities=13% Similarity=0.144 Sum_probs=144.0
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~ 91 (284)
|...+.||+|+||.||+|.. +|..||+|.+... +|
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 66678899999999999999 7899999988532 11
Q ss_pred C---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 F---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
. ......++.||+.||.||| ..+|+|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 155 (284)
T cd07839 82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--- 155 (284)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC---
Confidence 1 1455789999999999999 999999999999999999999999999998765432211
Q ss_pred CCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---c---ccc
Q 039895 157 SNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES---F---KEI 229 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~ 229 (284)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..|+..... ....+ ..+........ + ...
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHH-HHHHHHhCCCChHHhHHhhhc
Confidence 1124578899999988764 478999999999999999999998754321 11111 11111000000 0 000
Q ss_pred ccccccCCCC--CC-ChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEG--LM-WPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~--~~-~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+........ .. ..........+.+++.+||+.||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000 00 0001123445789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=232.06 Aligned_cols=197 Identities=23% Similarity=0.349 Sum_probs=149.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CC-
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FP- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~- 91 (284)
-++|...+.||+|+||.||+|.. ++..||+|.+... ++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 36788889999999999999998 6678999988754 00
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 01345789999999999999 99999999999999999999999999999877654221111
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
. ...++..|+|||.+.+..++.++||||||++++++++ |..||.... ........... ...
T Consensus 162 ~--~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~~~~--~~~------ 223 (261)
T cd05034 162 E--GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQVERG--YRM------ 223 (261)
T ss_pred h--ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC--CCC------
Confidence 1 1334678999999988889999999999999999998 888875321 11111111110 000
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
+.+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=245.95 Aligned_cols=194 Identities=23% Similarity=0.293 Sum_probs=144.9
Q ss_pred CCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------CCCc--------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------FPFS-------------------------------- 93 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------~~~~-------------------------------- 93 (284)
.|+..+.||.||.+.||++.. +.+.+|+|++... ||.+
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 467778899999999999999 6677888876433 1111
Q ss_pred ------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 94 ------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 94 ------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
..+..+..||+.++.++| ..||||.||||.|+|+- .|.+||+|||+|..+....+...
T Consensus 442 Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 442 GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccccee
Confidence 356678999999999999 99999999999999986 57899999999998876655443
Q ss_pred CCCCcccCccccccccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-----------DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
.. ..+||+.||+||.+... ..+.++||||+|||||+|+.|+.||.. +......
T Consensus 518 kd-sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----------~~n~~aK----- 581 (677)
T KOG0596|consen 518 KD-SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----------IINQIAK----- 581 (677)
T ss_pred ec-cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH----------HHHHHHH-----
Confidence 32 37899999999987532 256899999999999999999999842 2222221
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+..+.+|...-+ +|....-. ++.++|..||.+||.+|||+.++++
T Consensus 582 -l~aI~~P~~~Ie----fp~~~~~~-~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 -LHAITDPNHEIE----FPDIPEND-ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHhhcCCCcccc----ccCCCCch-HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 223333322111 11111111 1789999999999999999999985
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.93 Aligned_cols=193 Identities=30% Similarity=0.404 Sum_probs=143.7
Q ss_pred CCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CCC-
Q 039895 59 GGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FPF- 92 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~~- 92 (284)
..+.||+|+||+||++.. ++..+|+|++... +|.
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 456899999999999999 6668999999766 000
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
...+..++.|++.||.+|| +.+|+|+||||+||+++.++.++|+|||.+........ ...
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~---~~~ 156 (260)
T PF00069_consen 83 GSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE---NFN 156 (260)
T ss_dssp EBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS---EBS
T ss_pred ccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc---ccc
Confidence 0566789999999999999 89999999999999999999999999999876421111 111
Q ss_pred CcccCcccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 159 RVIGTFGFMAPEYRT-TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~-~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...++..|+|||++. +..++.++||||+|+++|+|++|..|+.... .....................
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~------- 224 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPLPSSSQ------- 224 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHHHHHTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccccccccc-------
Confidence 256899999999988 7789999999999999999999999987531 011111111111100000000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........+.+++..||+.||++|||+.++++
T Consensus 225 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001145889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=232.29 Aligned_cols=191 Identities=19% Similarity=0.259 Sum_probs=146.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~ 91 (284)
+|...+.||+|+||.||++.. ++..+|+|.+... ++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 366678999999999999998 7889999987532 11
Q ss_pred -----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 92 -----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 -----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
.+...+.++.|++.||.||| +.+|+|+||||+||+++.++.++++|||.+.........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 01345678999999999999 999999999999999999999999999998766432221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ......... .+.....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~----- 220 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVC-QGSYKPL----- 220 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHh-cCCCCCC-----
Confidence 112568899999999988889999999999999999999999986432 111111111 1111110
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+......+.+++.+||+.+|++|||+.+++..
T Consensus 221 ----------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122347899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=235.66 Aligned_cols=202 Identities=23% Similarity=0.301 Sum_probs=151.3
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------- 89 (284)
.++.++..+.+.|+..+.||.|+||.||+|.. ++..+|+|++...
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 46777777888999999999999999999999 7889999987533
Q ss_pred --------------CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 --------------FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 --------------~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
+|.. .....++.|++.||.||| +.+|+|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 1100 235678899999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||.... ..
T Consensus 163 ~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-----~~-- 232 (282)
T cd06636 163 VDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-----PM-- 232 (282)
T ss_pred eeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-----HH--
Confidence 99999876543211 112256899999999875 3457889999999999999999999986432 00
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.. .... ..... +.. .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~-~~~~-~~~~~-----~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 RA-LFLI-PRNPP-----PKL---------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hh-hhhH-hhCCC-----CCC---------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000 00000 000 01122345889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=239.52 Aligned_cols=210 Identities=17% Similarity=0.220 Sum_probs=145.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
+.|...+.||+|+||.||+|.. ++..||+|.+... +
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4577788999999999999998 6889999988632 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
+. ......++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 160 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 160 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--
Confidence 10 1345668899999999999 999999999999999999999999999998765332211
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh---cCccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE---NESFKEIVD 231 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (284)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+..... ...+..+.+
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCChhhchhhhc
Confidence 1114578899999987654 57889999999999999999999986432 1111111111110 011111111
Q ss_pred ccccCCCC-CCC------hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEG-LMW------PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~-~~~------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........ ... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 000 001122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=232.45 Aligned_cols=197 Identities=21% Similarity=0.325 Sum_probs=148.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF-- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~-- 92 (284)
.+|...+.||+|+||.||++.. .+..+|+|.+... ++.
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKG 85 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCC
Confidence 5677889999999999999998 6678999988653 110
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~-- 160 (260)
T cd05073 86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-- 160 (260)
T ss_pred cHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc--
Confidence 0345678999999999999 89999999999999999999999999999876654322211
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||++....++.++|+|||||+++++++ |..||.... ....... ...+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~----~~~~~~~--------- 222 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRA----LERGYRM--------- 222 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH----HhCCCCC---------
Confidence 11345678999999988889999999999999999999 888875322 1111111 1111000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+.....+..+.+++.+||+.+|++||++.++...|+.+
T Consensus 223 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 ------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00112233478999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=232.45 Aligned_cols=199 Identities=20% Similarity=0.310 Sum_probs=148.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CC---cceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QD---RPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. ++ ..+|+|.+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4677789999999999999987 33 36999987643
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.|++.||+||| +.+++|+||||+|||++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 11 01456789999999999999 9999999999999999999999999999998765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
..........++..|+|||++.+..++.++||||||+++||+++ |..||.... ...... ........
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-----~~~~~~---~~~~~~~~---- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-----NQDVIK---AIEEGYRL---- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-----HHHHHH---HHhCCCcC----
Confidence 22221111234568999999988889999999999999999887 998875432 111111 11110000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+.....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11112234578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=235.03 Aligned_cols=198 Identities=21% Similarity=0.323 Sum_probs=148.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------- 89 (284)
.++|+..+.||+|+||.||++.. ++..||+|++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 46788899999999999999986 3578999987643
Q ss_pred -----CCCc-------------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCc
Q 039895 90 -----FPFS-------------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTT 127 (284)
Q Consensus 90 -----~~~~-------------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~N 127 (284)
+|.. ...+.++.|++.||.||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 1110 124679999999999999 9999999999999
Q ss_pred EEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 039895 128 IVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFD 206 (284)
Q Consensus 128 ILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~ 206 (284)
|+++.++.++|+|||++........... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA-SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccc-cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 9999999999999999876543322111 111334678999999988889999999999999999998 777775422
Q ss_pred CCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 207 DGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
....... ...+.... .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 238 ------~~~~~~~-~~~~~~~~---------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ------HEEVIYY-VRDGNVLS---------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHH-HhcCCCCC---------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1121211 11111110 011223458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=239.34 Aligned_cols=164 Identities=24% Similarity=0.339 Sum_probs=116.3
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
..+.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++.......... ......++..|+|||++..
T Consensus 130 ~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 205 (295)
T cd05097 130 NLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMAWESILL 205 (295)
T ss_pred HHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcCCCcEEecccccccccccCccee-ccCcCcCceeecChhhhcc
Confidence 34678999999999999 9999999999999999999999999999987664332211 1112345778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLT--GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
..++.++|||||||++++|++ +..||.... ..................... . .....+..+
T Consensus 206 ~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~------~------~~~~~~~~l 268 (295)
T cd05097 206 GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-----DEQVIENTGEFFRNQGRQIYL------S------QTPLCPSPV 268 (295)
T ss_pred CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-----hHHHHHHHHHhhhhccccccC------C------CCCCCCHHH
Confidence 889999999999999999998 445554321 111111111111110000000 0 011122358
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.+|+.+||+.+|++|||+.+|++.|++
T Consensus 269 ~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 269 FKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=250.70 Aligned_cols=146 Identities=23% Similarity=0.301 Sum_probs=120.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||++.. ++..||+|++...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4678889999999999999998 7889999998532
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 1111 445678999999999999 999999999999999999999999999998755321100
Q ss_pred --------------------------------ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039895 154 --------------------------------INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201 (284)
Q Consensus 154 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~ 201 (284)
........||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 000112579999999999999999999999999999999999999996
Q ss_pred CC
Q 039895 202 SS 203 (284)
Q Consensus 202 ~~ 203 (284)
..
T Consensus 238 ~~ 239 (360)
T cd05627 238 SE 239 (360)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=232.30 Aligned_cols=201 Identities=20% Similarity=0.317 Sum_probs=150.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc----ceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR----PISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~--------------------------------------- 89 (284)
.+|...+.||+|+||.||+|.+ +|. .+|+|.+...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 4566778999999999999997 443 5899987644
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 11 11456789999999999999 8999999999999999999999999999998765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
...... ...++..|+|||.+....++.++||||||+++||+++ |..||.... ..............
T Consensus 164 ~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~---- 230 (279)
T cd05057 164 KEYHAE-GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGERL---- 230 (279)
T ss_pred cceecC-CCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCCC----
Confidence 221111 1234568999999988889999999999999999999 998886432 11111111111100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..+...+.+++.+||..+|+.|||+.++++.|..+...
T Consensus 231 ------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00111223477999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=235.80 Aligned_cols=210 Identities=19% Similarity=0.189 Sum_probs=142.9
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||+|++|.||+|.. ++..||+|++... +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 466778999999999999998 7889999987532 1
Q ss_pred CC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
|. ......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 11 1345668999999999999 999999999999999999999999999998765432211
Q ss_pred ccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--Ccccc--
Q 039895 154 INDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN--ESFKE-- 228 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 228 (284)
.....+++.|+|||++.+. .++.++|||||||++++|++|+.||.... ............... ..+..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 158 ---YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS----EIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ---ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCChhhhhcch
Confidence 1124578899999987654 57899999999999999999999886432 000111111100000 00000
Q ss_pred -ccc--ccccCCCCCC-ChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 -IVD--PAIVGEEGLM-WPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 -~~~--~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+ +......... .........++.+++.+||+.||++|||+.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000000000 0000112345779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=232.13 Aligned_cols=199 Identities=19% Similarity=0.267 Sum_probs=145.6
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------- 89 (284)
|+..+++++.....||+|+||.||+|.+ ++..||+|.+...
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456778888889999999999999997 6778999987643
Q ss_pred ----CC------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccc
Q 039895 90 ----FP------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLS 146 (284)
Q Consensus 90 ----~~------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~ 146 (284)
++ .......++.|++.||.||| ..+|+|+||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 11 11334567889999999999 999999999999999986 67899999999876
Q ss_pred cCCCCccccCCCCcccCccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
....... .....|++.|+|||++.... ++.++||||||+++|++++|..||..... .....+.... ..
T Consensus 159 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~--~~ 228 (268)
T cd06624 159 LAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGM--FK 228 (268)
T ss_pred cccCCCc---cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhh--hc
Confidence 5432211 11245789999999986543 78899999999999999999999853220 0000000000 00
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. .+ ..+......+.+++.+||+.+|++|||+.|++.
T Consensus 229 ~-----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 I-----HP----------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred c-----CC----------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 00 001123344789999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.26 Aligned_cols=206 Identities=21% Similarity=0.238 Sum_probs=149.9
Q ss_pred CCCCCCeeeecCCceEEEEEeC------CcceEEEeecCCC---------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFLQ------DRPISVMKFEDTF--------------------------------------- 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~--------------------------------------- 90 (284)
.|...+.||+|+||.||+|.++ +..+|||++....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4556688999999999999872 6789999886441
Q ss_pred -----CC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 91 -----PF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 91 -----~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
|. ......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 10 0345779999999999999 99999999999999999999999999999987763
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-------cccHHHHHHHHhh
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE-------DYRLQDLVKKYIE 222 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~ 222 (284)
............++..|+|||.+.+..++.++||||||++++||++|..|+......... ......+. ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHHH
Confidence 322211111134566799999998888999999999999999999999887543210000 00011111 1110
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
... ..+....++..+.+++.+||+.+|++|||+.||+++|+++
T Consensus 241 ~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE---------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC---------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 0111223335588999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=237.00 Aligned_cols=159 Identities=24% Similarity=0.346 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
.+.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||+++............ ...++..|+|||++.+.
T Consensus 136 ~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~ 211 (314)
T cd05099 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-NGRLPVKWMAPEALFDR 211 (314)
T ss_pred HHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccc-cCCCCccccCHHHHccC
Confidence 4568899999999999 9999999999999999999999999999998765332211111 12345679999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++|||||||++|++++ |..||.... ........ ....... .+..++..+.+
T Consensus 212 ~~~~~~DiwslG~~l~el~~~g~~p~~~~~--------~~~~~~~~-~~~~~~~---------------~~~~~~~~l~~ 267 (314)
T cd05099 212 VYTHQSDVWSFGILMWEIFTLGGSPYPGIP--------VEELFKLL-REGHRMD---------------KPSNCTHELYM 267 (314)
T ss_pred CcCccchhhHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HcCCCCC---------------CCCCCCHHHHH
Confidence 89999999999999999999 777775322 11111111 1111000 01122334779
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
++.+||+.+|++|||+.++++.|+++..
T Consensus 268 li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 268 LMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=233.65 Aligned_cols=197 Identities=21% Similarity=0.275 Sum_probs=145.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
.++.....||+|+||.||++.. ++..+|+|.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3456678999999999999964 3567899987643
Q ss_pred ---CC------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 ---FP------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 ---~~------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
++ ....++.++.|++.||+||| +.+++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 11 11345678999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
+|+|||++........... .....+++.|+|||++.+..++.++|||||||++||+++ |..||.... . ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~---~~ 232 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-----N---TE 232 (280)
T ss_pred EECCCCceeEcCCCceeec-CCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-----H---HH
Confidence 9999999876543322111 112345788999999988889999999999999999998 888875422 1 11
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
........... . .+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 233 ~~~~~~~~~~~-~---------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGREL-E---------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCccC-C---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111000 0 011223347899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=240.47 Aligned_cols=197 Identities=21% Similarity=0.284 Sum_probs=140.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||++.. +++.||+|++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3677888999999999999998 7889999998531
Q ss_pred -CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. +.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 111 1345678999999999999 99999999999999999999999999999876544322
Q ss_pred cccCCCCcccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
... ....||+.|+|||++.. ..++.++|||||||++|+|++|..||.... ...............
T Consensus 158 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 227 (331)
T cd05597 158 VQS--NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKEHF 227 (331)
T ss_pred ccc--cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCcc
Confidence 111 12468999999999863 457889999999999999999999986432 111111111111000
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCC--CCCCCHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESE--GDRPTIVQVAKQ 276 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p--~~Rps~~ev~~~ 276 (284)
.. . +.....+..+.+++.+|+..++ ..||++.++++.
T Consensus 228 ~~-~-----------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QF-P-----------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-C-----------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0 0011123346788888776543 348899988764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=235.45 Aligned_cols=205 Identities=21% Similarity=0.252 Sum_probs=152.7
Q ss_pred eecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------C---
Q 039895 44 SFSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------F--- 90 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------~--- 90 (284)
.+.++.+..+.++|+..+.||+|+||.||++.. +++.+|+|++... +
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 356677888899999999999999999999998 7889999987542 1
Q ss_pred ---------------CCc-------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 91 ---------------PFS-------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 91 ---------------~~~-------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
|.. .....++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 100 223458899999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY 211 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~ 211 (284)
+|+|||++......... .....|++.|+|||++.. ..++.++||||+||++|||++|..|+.....
T Consensus 164 kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------ 234 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR---RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------ 234 (286)
T ss_pred EEccCCceeecccCCCc---cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------
Confidence 99999998776433211 112468999999998753 4478899999999999999999999864320
Q ss_pred cHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 212 RLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
........ ........+ +......+.+++.+||+.+|++|||+.||++.
T Consensus 235 --~~~~~~~~-~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 --MRALFKIP-RNPPPTLHQ-------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hHHHhhcc-ccCCCcccC-------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000000 000001101 11122347899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=231.53 Aligned_cols=199 Identities=19% Similarity=0.306 Sum_probs=146.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc---ceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR---PISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. ++. .||+|.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 3466788999999999999998 333 5999998643
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++. ....+.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 110 0456788999999999999 9999999999999999999999999999987664332
Q ss_pred ccccCCCCc--ccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 152 THINDSNRV--IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 152 ~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
......... ..+..|+|||.+.+..++.++|||||||++||+++ |..||.... .......+ .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i---~~~~~--- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAI---EQDYR--- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHH---HcCCc---
Confidence 211111111 12457999999998899999999999999999886 888885432 11111111 10000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+....++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 230 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=238.27 Aligned_cols=164 Identities=21% Similarity=0.345 Sum_probs=117.5
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
....++.|++.||+||| +.+++|+||||+|||++.++.++|+|||++..+........ .....+++.|+|||+...
T Consensus 131 ~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 131 TLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI-QGRAVLPIRWMSWESILL 206 (296)
T ss_pred HHHHHHHHHHHHHHHHH---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceec-cCcCcCccccCCHHHHhc
Confidence 46788999999999999 99999999999999999999999999999876644322111 111345678999998888
Q ss_pred CCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLT--GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
..++.++|||||||++|||++ |..||.... ................ .... .+.+..++..+
T Consensus 207 ~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~ 269 (296)
T cd05095 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-----DEQVIENTGEFFRDQG-RQVY-----------LPKPALCPDSL 269 (296)
T ss_pred CCccchhhhhHHHHHHHHHHHhCCCCCccccC-----hHHHHHHHHHHHhhcc-cccc-----------CCCCCCCCHHH
Confidence 889999999999999999998 666764322 1111111111110000 0000 01111233458
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.+++.+||+.||++|||+.+|++.|++
T Consensus 270 ~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 270 YKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=228.75 Aligned_cols=191 Identities=21% Similarity=0.278 Sum_probs=146.4
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|...+.||+|++|.||++.. +++.||+|.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 467778999999999999998 6789999987532
Q ss_pred CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ......++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 111 0345689999999999999 99999999999999999999999999999876643221
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
......+++.|+|||++.+..++.++||||||++++++++|..||.... ......... .+....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~~~---- 221 (257)
T cd08223 158 ---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRII-EGKLPP---- 221 (257)
T ss_pred ---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHH-hcCCCC----
Confidence 1122568899999999998889999999999999999999999886322 112111111 111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
........+.+++.+||+.+|++|||+.+++++
T Consensus 222 -----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -----------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011233458899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=230.86 Aligned_cols=195 Identities=22% Similarity=0.344 Sum_probs=146.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCC-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPF- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~- 92 (284)
.+|...+.||+|+||.||+|.+ ++..+|+|++... ++.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 3566678999999999999998 6889999988753 110
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...........
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~-- 158 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-- 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccccc--
Confidence 1345678999999999999 89999999999999999999999999999876543322111
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||.+.+..++.++||||||+++||+++ |..||.... .......... + .....+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~-~--~~~~~~~--- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINA-G--FRLYKPR--- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhC-C--CCCCCCC---
Confidence 11345678999999988889999999999999999998 888875322 1111211111 0 0001111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
..+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 225 ----------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11234889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=230.23 Aligned_cols=148 Identities=21% Similarity=0.384 Sum_probs=109.8
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc-------ceeeccccccccCCCCccccCCCCcccCccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV-------AQLFDFTLSLSIPEGETHINDSNRVIGTFGF 166 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 166 (284)
..++.++.||+.||+||| +.+|+||||||+|||++.++. ++++|||++....... ...++..|
T Consensus 105 ~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~y 174 (262)
T cd05077 105 PWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-------ECVERIPW 174 (262)
T ss_pred HHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcc-------cccccccc
Confidence 456789999999999999 999999999999999987664 7999999986553221 14578899
Q ss_pred ccccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChh
Q 039895 167 MAPEYRT-TGDFSEKSDVYSFGALLLELL-TGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPE 244 (284)
Q Consensus 167 ~aPE~~~-~~~~~~~~DvwS~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
+|||.+. +..++.++|||||||++|||+ +|..|+.... .... .... .... ...
T Consensus 175 ~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~-~~~~-~~~~-~~~-------------- 229 (262)
T cd05077 175 IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--------LAEK-ERFY-EGQC-MLV-------------- 229 (262)
T ss_pred cChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc--------hhHH-HHHH-hcCc-cCC--------------
Confidence 9999886 456889999999999999998 4766664322 1110 0000 1100 000
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 245 KEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 245 ~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
......+.+|+.+||+.||++||++.+|++.|
T Consensus 230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01123478999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=235.65 Aligned_cols=195 Identities=22% Similarity=0.281 Sum_probs=142.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||+|+||.||+|.. ++..||+|.+... +|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4566667899999999999998 7889999987543 11
Q ss_pred C---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 F---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
. +.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~---~ 162 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA---K 162 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc---c
Confidence 1 1456779999999999999 89999999999999999999999999999876543221 1
Q ss_pred CCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||..... . .. ..... ..... .+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-----~--~~-~~~~~-~~~~~---~~~ 230 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-----M--RA-LFLMT-KSNFQ---PPK 230 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-----h--hh-HHhhh-ccCCC---CCc
Confidence 12257899999999874 45688999999999999999999999864320 0 00 00000 00000 000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ....+..+.+++.+||+.+|++|||+.+|++
T Consensus 231 ~~~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0011233779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=235.26 Aligned_cols=193 Identities=20% Similarity=0.287 Sum_probs=146.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
..|...+.||+|+||.||+|.. +++.||+|.+... ++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5677888999999999999997 7899999998643 00
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||.||| +.+++|+||||+|||++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~ 172 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---R 172 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC---c
Confidence 11466789999999999999 999999999999999999999999999998765433221 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....+++.|+|||.+.+..++.++|||||||++|++++|..||..... ... .. .....+ .+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~--~~~--~~----~~~~~~-~~~--------- 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRA--LY----LIATNG-TPE--------- 234 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--chh--ee----eeccCC-CCC---------
Confidence 124688899999999888899999999999999999999999864321 000 00 000000 000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+......+.+++.+||..+|++|||+.++++
T Consensus 235 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 ----LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011222344778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=241.71 Aligned_cols=217 Identities=15% Similarity=0.218 Sum_probs=149.3
Q ss_pred cHHHHHHHh----cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------
Q 039895 46 SADELKTAT----DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------ 89 (284)
Q Consensus 46 ~~~~l~~~~----~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------ 89 (284)
+.+|+..++ +.|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 445555554 7888889999999999999997 7899999988532
Q ss_pred CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
++ .......++.|++.||+||| +.+|+||||||+||+++.++.++|
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eecccccCCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 00 00334568999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+
T Consensus 159 ~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~~ 227 (342)
T cd07879 159 LDFGLARHADAEM------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQI 227 (342)
T ss_pred eeCCCCcCCCCCC------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence 9999987653321 12467889999998866 4688999999999999999999999864321 1111100
Q ss_pred HHHhhc--Ccccccccc--------cccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 218 KKYIEN--ESFKEIVDP--------AIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 218 ~~~~~~--~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...... ..+.+.... .........+ .........+.+++.+||+.||++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 000000000 0000000000 0001123447899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=235.29 Aligned_cols=203 Identities=21% Similarity=0.266 Sum_probs=151.7
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------- 89 (284)
+...++..++++|...+.||+|+||.||++.. +++.+|+|++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 45567777889999999999999999999998 7889999988532
Q ss_pred -------------CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcce
Q 039895 90 -------------FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 90 -------------~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 137 (284)
++ .+.....++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 00 00334568999999999999 89999999999999999999999
Q ss_pred eeccccccccCCCCccccCCCCcccCccccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcccc
Q 039895 138 LFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYR 212 (284)
Q Consensus 138 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~ 212 (284)
|+|||++.......... ....|+..|+|||++... .++.++|||||||++|||++|..||....
T Consensus 169 l~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-------- 237 (291)
T cd06639 169 LVDFGVSAQLTSTRLRR---NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-------- 237 (291)
T ss_pred Eeecccchhcccccccc---cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--------
Confidence 99999987664332211 124678999999987643 36889999999999999999999986432
Q ss_pred HHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 213 LQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+.... ......+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~-~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 PVKTLFKIP-RNPPPTLLH-------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHh-cCCCCCCCc-------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011111111 111111111 1122334789999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=231.55 Aligned_cols=192 Identities=24% Similarity=0.301 Sum_probs=147.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF------------------------------------------ 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------------------------------------ 90 (284)
++|+..+.||.|++|.||+|.. ++..||+|.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3577778999999999999998 78899999876430
Q ss_pred --------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 91 --------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 91 --------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
........++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~ 154 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---K 154 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc---c
Confidence 111556789999999999999 99999999999999999999999999999987754321 1
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
.....+++.|+|||++.+..++.++||||||+++|++++|..||.... ...... . ......+....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-----~~~~~~---~-~~~~~~~~~~~----- 220 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-----PMRVLF---L-IPKNNPPSLEG----- 220 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-----hHHHHH---H-hhhcCCCCCcc-----
Confidence 122568889999999988889999999999999999999999985432 111111 1 11111111100
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ---------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 ---------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 002334789999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=228.50 Aligned_cols=194 Identities=22% Similarity=0.266 Sum_probs=144.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
.+|...+.||+|+||.||.|.. +|..||+|.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999998 6889999987421
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. ....+.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 000 0345779999999999999 99999999999999999999999999999876543
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
............|+..|+|||++.+..++.++|||||||++|++++|..||.... .... .........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~-~~~~~~~~~---- 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAA-IFKIATQPT---- 226 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHH-HHHHhcCCC----
Confidence 2221112222568899999999988889999999999999999999999985321 1111 111111100
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+ ..+......+.+++.+||. +|++||+++||++
T Consensus 227 -~~----------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 -NP----------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CC----------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 0122333457789999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=233.76 Aligned_cols=192 Identities=19% Similarity=0.313 Sum_probs=146.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC-
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP- 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~- 91 (284)
+|...+.||.|++|.||+|.. +|+.||+|.+... ++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 477778999999999999997 8899999988543 11
Q ss_pred -------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 92 -------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 92 -------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
....+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 100 ~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~ 173 (296)
T cd06655 100 GGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RS 173 (296)
T ss_pred CCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc---CC
Confidence 11566789999999999999 999999999999999999999999999998765443221 11
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...++..|+|||.+.+..++.++|||||||++|++++|..||.... . ..... ...... .....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~-----~--~~~~~-~~~~~~-~~~~~-------- 236 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----P--LRALY-LIATNG-TPELQ-------- 236 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H--HHHHH-HHHhcC-CcccC--------
Confidence 2468899999999988889999999999999999999999986432 0 11111 110000 00000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+......+.+++.+||..+|++|||+.+++.
T Consensus 237 -----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 -----NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01122334778999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=232.11 Aligned_cols=193 Identities=20% Similarity=0.231 Sum_probs=143.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
+.|...+.||.|+||.||+|.. ++..+|+|.+... ++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4567778999999999999998 6889999998644 11
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-- 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc--
Confidence 11455779999999999999 999999999999999999999999999988654322111
Q ss_pred CCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 156 DSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||.... ......... ........
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~~ 236 (292)
T cd06644 167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIA-KSEPPTLS 236 (292)
T ss_pred -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHh-cCCCccCC
Confidence 11246788999999874 3457889999999999999999999885422 111111111 11100100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+......+.+++.+||+.+|++||++.++++
T Consensus 237 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 -------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01122334789999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=230.46 Aligned_cols=157 Identities=24% Similarity=0.319 Sum_probs=117.5
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
.+..++.|++.||+||| +.+++|+||||+|||++.++.+||+|||++....... .......+..|+|||++..
T Consensus 113 ~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~ 185 (270)
T cd05047 113 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY 185 (270)
T ss_pred HHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccchhh----hccCCCCccccCChHHHcc
Confidence 44788999999999999 9999999999999999999999999999985332111 1111233567999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT 253 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
..++.++|||||||++|||++ |..||.... .............. . ........+.
T Consensus 186 ~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~~~~-~---------------~~~~~~~~~~ 241 (270)
T cd05047 186 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLPQGYRL-E---------------KPLNCDDEVY 241 (270)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHhCCCCC-C---------------CCCcCCHHHH
Confidence 889999999999999999997 888885422 11111111110000 0 0111223478
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 254 ELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 254 ~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+++.+||+.+|.+|||+.+++..|+++++
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 242 DLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred HHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=242.63 Aligned_cols=158 Identities=22% Similarity=0.325 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......... .....+++.|+|||.+....
T Consensus 242 ~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 317 (401)
T cd05107 242 VGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTFLPLKWMAPESIFNNL 317 (401)
T ss_pred HHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccccc-CCCcCCCCceeChHHhcCCC
Confidence 457889999999999 99999999999999999999999999999976543222111 11245688999999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHH
Q 039895 177 FSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTEL 255 (284)
Q Consensus 177 ~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (284)
++.++|||||||++||+++ |..||.... ...........+... +.+......+.+|
T Consensus 318 ~~~~~DvwslGvil~e~l~~g~~P~~~~~--------~~~~~~~~~~~~~~~---------------~~p~~~~~~l~~l 374 (401)
T cd05107 318 YTTLSDVWSFGILLWEIFTLGGTPYPELP--------MNEQFYNAIKRGYRM---------------AKPAHASDEIYEI 374 (401)
T ss_pred CCcHhHHHHHHHHHHHHHHcCCCCCCCCC--------chHHHHHHHHcCCCC---------------CCCCCCCHHHHHH
Confidence 9999999999999999998 777875322 011111111111000 0011223458899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 256 AFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 256 ~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
+.+||+.+|+.||++.||++.|+++.
T Consensus 375 i~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 375 MQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=233.16 Aligned_cols=213 Identities=14% Similarity=0.184 Sum_probs=145.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
++++|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457788889999999999999987 7889999998532
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
++. ......++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||+++........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 110 0345678999999999999 899999999999999999999999999998764332211
Q ss_pred ccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc---C-----
Q 039895 154 INDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN---E----- 224 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~----- 224 (284)
.....+++.|+|||++.+. .++.++|||||||++|++++|..||..... ....+.. ....... .
T Consensus 160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 160 ---YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD---VFEQLEK-IWTVLGVPTEDTWPGV 232 (291)
T ss_pred ---CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh---HHHHHHH-HHHHcCCCChhhhhhh
Confidence 1124578899999988754 578899999999999999999999864320 0000110 0000000 0
Q ss_pred -cccccccccccCCCCCCChh---hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 -SFKEIVDPAIVGEEGLMWPE---KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 -~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+................. .......+.+++.+|+..||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000000 0011345779999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.51 Aligned_cols=197 Identities=21% Similarity=0.271 Sum_probs=141.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||++.. .++.+|+|++...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3677788999999999999998 6788999998531
Q ss_pred -CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 1110 345678999999999999 99999999999999999999999999999876543322
Q ss_pred cccCCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
... ....||+.|+|||++. ...++.++|||||||++|||++|..||.... ...............
T Consensus 158 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 227 (332)
T cd05623 158 VQS--SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKERF 227 (332)
T ss_pred cee--cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCccc
Confidence 111 1256999999999886 3467899999999999999999999996432 111121111110000
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAKQ 276 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~~ 276 (284)
. +. .........+.+++.+|+..+|++ |+++.|+++.
T Consensus 228 ~-~p-----------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q-FP-----------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c-CC-----------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00 001122344778999988665444 7899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=229.04 Aligned_cols=193 Identities=22% Similarity=0.367 Sum_probs=146.3
Q ss_pred CCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC-------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~------------------------------------------- 89 (284)
+|+..+.||+|+||.||+|.. .+..+|+|.+...
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 477788999999999999999 3578999976421
Q ss_pred ---------CCC-------------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeec
Q 039895 90 ---------FPF-------------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 ---------~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
++. ......++.|++.||.||| + .+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 110 0345678999999999999 5 6899999999999999999999999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
||++........ .....|+..|+|||++.+..++.++||||||+++|++++|..||.... ........
T Consensus 158 fg~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~ 225 (269)
T cd08528 158 FGLAKQKQPESK----LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKI 225 (269)
T ss_pred ccceeecccccc----cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHH
Confidence 999977654331 122568899999999998889999999999999999999999985432 11111111
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
. ........ .......+.+++.+||+.||++||++.||..+|.
T Consensus 226 ~-~~~~~~~~--------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 V-EAVYEPLP--------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred h-hccCCcCC--------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 11111000 0112234789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=241.24 Aligned_cols=181 Identities=23% Similarity=0.268 Sum_probs=137.3
Q ss_pred CeeeecCCceEEEEEe-----CCcceEEEeecCC-------------------------------------------CCC
Q 039895 61 KVIMKCLFYKLYKGFL-----QDRPISVMKFEDT-------------------------------------------FPF 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~-------------------------------------------~~~ 92 (284)
+.||+|+||.||++.. +|..||+|++... +|.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 5789999998642 111
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~ 155 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---A 155 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc---e
Confidence 1456778999999999999 999999999999999999999999999998765433211 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....||+.|+|||++....++.++|||||||++|||++|+.||.... ......... .... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~-~~~~-~--------- 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMIL-KAKL-G--------- 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHH-cCCC-C---------
Confidence 12578999999999988889999999999999999999999986432 111111111 1100 0
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQ 272 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~e 272 (284)
.+......+.+++.+||+.||++|||+.+
T Consensus 217 ------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 ------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01112234779999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=227.75 Aligned_cols=192 Identities=24% Similarity=0.354 Sum_probs=143.1
Q ss_pred CeeeecCCceEEEEEe-C--Cc--ceEEEeecCCCC--------------------------------------------
Q 039895 61 KVIMKCLFYKLYKGFL-Q--DR--PISVMKFEDTFP-------------------------------------------- 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-~--~~--~vavK~~~~~~~-------------------------------------------- 91 (284)
+.||+|++|.||+|.+ + +. .||+|.+.....
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 3689999999999998 2 22 589999875411
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++..+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 00345678899999999999 9999999999999999999999999999998775433222222
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||.... ..+........... .
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~--~------- 220 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEGER--L------- 220 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcCCc--C-------
Confidence 22457789999999988889999999999999999999 998875322 11111111111100 0
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
+.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001122345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=236.59 Aligned_cols=196 Identities=23% Similarity=0.314 Sum_probs=143.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|.....||+|+||.||++.. ++..||+|.+... +
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 444567899999999999999 7899999988642 1
Q ss_pred CC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 91 PF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 ~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+. ......++.+++.||+|||+ ..+++||||||+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 10 02346789999999999992 3599999999999999999999999999987654332
Q ss_pred ccccCCCCcccCccccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTG---DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.. ....|++.|+|||++... .++.++|||||||++|++++|..||.... ........... ...
T Consensus 163 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~-~~~-- 228 (288)
T cd06616 163 AK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVK-GDP-- 228 (288)
T ss_pred cc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcC-CCC--
Confidence 11 114578999999998766 68899999999999999999999985321 11111111111 110
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+.+... .....+..+.+|+.+||+.+|++|||+.+|+..
T Consensus 229 ---~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ---PILSNS------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CcCCCc------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011000 112234458899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=229.70 Aligned_cols=159 Identities=21% Similarity=0.289 Sum_probs=110.1
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC-
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT- 174 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 174 (284)
.+.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++............ ....+++.|+|||++..
T Consensus 102 ~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05042 102 LQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK-DCHAVPLRWLAPELVEIR 177 (269)
T ss_pred HHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheecc-CCCCCcccccCHHHHhhc
Confidence 4678999999999999 999999999999999999999999999998654332221111 22456778999998642
Q ss_pred ------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHH
Q 039895 175 ------GDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ 247 (284)
Q Consensus 175 ------~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
..++.++|||||||++|||++ |..||.... . ........... ...+..+.+ ...
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~---~~~~~~~~~~~-~~~~~~~~~----------~~~ 238 (269)
T cd05042 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----D---EQVLKQVVREQ-DIKLPKPQL----------DLK 238 (269)
T ss_pred cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----H---HHHHHHHhhcc-CccCCCCcc----------ccc
Confidence 356789999999999999999 666664321 1 11111111111 111111111 112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 248 QLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 248 ~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
....+.+++..|| .||++|||+.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2334667888998 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=231.73 Aligned_cols=190 Identities=20% Similarity=0.217 Sum_probs=140.0
Q ss_pred CCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC---
Q 039895 58 DGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP--- 91 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~--- 91 (284)
+..+.||+|+||.||+|.. ++..+++|.+... ++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 3456799999999999999 6778899987643 11
Q ss_pred -------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 92 -------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 92 -------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.+..+..++.|++.||.||| +.+++|+||||+|||++.++.++|+|||++........ ...
T Consensus 88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~ 161 (282)
T cd06643 88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRD 161 (282)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc---ccc
Confidence 11456779999999999999 99999999999999999999999999999876543221 112
Q ss_pred CcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 159 RVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
...+++.|+|||++. ...++.++|||||||++|+|++|..||.... ....+...... .......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~~~-- 230 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKS-EPPTLAQ-- 230 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhc-CCCCCCC--
Confidence 256899999999874 3457889999999999999999999885422 11111111110 0001000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+...+..+.+++.+||+.+|++|||+.++++
T Consensus 231 -----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 -----------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112334789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=233.28 Aligned_cols=189 Identities=19% Similarity=0.277 Sum_probs=142.8
Q ss_pred CCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC-----
Q 039895 60 GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP----- 91 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~----- 91 (284)
...||+|+||.||++.. ++..||+|.+... ++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999988 7899999998543 11
Q ss_pred ---------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCccc
Q 039895 92 ---------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162 (284)
Q Consensus 92 ---------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g 162 (284)
.......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......... .....|
T Consensus 106 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~ 179 (297)
T cd06659 106 TDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVG 179 (297)
T ss_pred HHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc---ccceec
Confidence 11456789999999999999 999999999999999999999999999998765433211 112568
Q ss_pred CccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCC
Q 039895 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMW 242 (284)
Q Consensus 163 t~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
+..|+|||++.+..++.++|||||||+++||++|..||.... ......... ........
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~~------------ 238 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAMKRLR-DSPPPKLK------------ 238 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh-ccCCCCcc------------
Confidence 999999999988889999999999999999999999986422 111111111 11000000
Q ss_pred hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 243 PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 243 ~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
........+.+++.+||+.+|++||++.++++.
T Consensus 239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 -NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 001122347799999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=235.58 Aligned_cols=140 Identities=19% Similarity=0.223 Sum_probs=111.0
Q ss_pred CCeeeec--CCceEEEEEe--CCcceEEEeecCC-------------------------------------------CCC
Q 039895 60 GKVIMKC--LFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FPF 92 (284)
Q Consensus 60 ~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~~ 92 (284)
..+||+| +|++||++.. +|..||+|++... +|.
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 7889999998 8899999998643 111
Q ss_pred -----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc--
Q 039895 93 -----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH-- 153 (284)
Q Consensus 93 -----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-- 153 (284)
......++.|++.||.||| +.+|+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 1345679999999999999 999999999999999999999999999865443221110
Q ss_pred --ccCCCCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 154 --INDSNRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 154 --~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
........++..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011112356788999999875 4588999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=233.05 Aligned_cols=207 Identities=20% Similarity=0.273 Sum_probs=146.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|+||.||++.. ++..+|+|.+... +
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688889999999999999998 6788999987533 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+. ......++.|++.||.||| + .+++|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc--
Confidence 11 1345689999999999999 6 5899999999999999999999999999866533221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc-------
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK------- 227 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 227 (284)
....|++.|+|||++.+..++.++|||||||++|++++|..||.... ..................
T Consensus 156 ---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 156 ---NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-----AKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ---ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-----hhhHHHhhcCccccccccCCccccc
Confidence 12568999999999888889999999999999999999999985422 111111110000000000
Q ss_pred -------------ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 228 -------------EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 228 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+..+... .......+. ......+.+++.+||+.+|++|||+.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIV-NEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCCccchhhHHHHHHHHh-cCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000000000 0133458899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=253.64 Aligned_cols=175 Identities=21% Similarity=0.269 Sum_probs=116.3
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
...++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+........ ....||+.|+|||++.+.
T Consensus 269 ~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~ 343 (501)
T PHA03210 269 TRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD--YGWVGTVATNSPEILAGD 343 (501)
T ss_pred HHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccccc--ccccCCcCCCCchhhcCC
Confidence 4568999999999999 99999999999999999999999999999987754332211 125799999999999998
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh-hcCcccc-------cccccccCCCCCCChh---
Q 039895 176 DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI-ENESFKE-------IVDPAIVGEEGLMWPE--- 244 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~~~~~~~--- 244 (284)
.++.++|||||||++|||++|..++..... ......+...+.... ....++. .++...........+.
T Consensus 344 ~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~ 422 (501)
T PHA03210 344 GYCEITDIWSCGLILLDMLSHDFCPIGDGG-GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR 422 (501)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH
Confidence 999999999999999999999865543221 111111111111100 0000110 0000000000000000
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 245 KEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 245 ~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++.+||+.||++|||+.|++..
T Consensus 423 ~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 423 NLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred hcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112346788999999999999999999863
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=228.05 Aligned_cols=193 Identities=25% Similarity=0.353 Sum_probs=147.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------CCC-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------FPF- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------~~~- 92 (284)
++|+..+.||+|+||.||+|.. ++..+++|.+... ++.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 6788889999999999999999 4789999988643 110
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~---~ 156 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---R 156 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc---c
Confidence 1455679999999999999 999999999999999999999999999998876543211 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....|+..|+|||++.+..++.++||||||+++|+|++|..||..... . .. ... ..... .+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-----~--~~-~~~-~~~~~-----~~----- 217 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-----M--RA-IFM-IPNKP-----PP----- 217 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-----h--hh-hhh-hccCC-----CC-----
Confidence 124578899999999888899999999999999999999999864320 0 00 000 00000 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+......+.+++.+||+.+|++|||+.||+.
T Consensus 218 ---~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 ---TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00112223345889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=226.82 Aligned_cols=195 Identities=26% Similarity=0.367 Sum_probs=144.2
Q ss_pred CCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------------------------------------- 89 (284)
+|...+.||+|+||+||+|.. +|+.+|+|.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366788999999999999998 8889999987532
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. +.....++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 110 1345568999999999999 89999999999999999999999999999876532111
Q ss_pred c---ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 153 H---INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 153 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
. ........|+..|+|||++.+..++.++|||||||++|++++|..||.... . ..............+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~--~~~~~~~~~~~~~~~~~ 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-----R--LAAMFYIGAHRGLMPRL 230 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-----h--HHHHHHhhhccCCCCCC
Confidence 1 111122568999999999988889999999999999999999999986422 0 11110000000111110
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+......+.+++.+||+.+|++|||+.+++.
T Consensus 231 ---------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 ---------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112334789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=226.32 Aligned_cols=190 Identities=23% Similarity=0.368 Sum_probs=141.6
Q ss_pred CeeeecCCceEEEEEe-CCcceEEEeecCC------------------------------------------CC------
Q 039895 61 KVIMKCLFYKLYKGFL-QDRPISVMKFEDT------------------------------------------FP------ 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------------------------------------------~~------ 91 (284)
++||+|+||.||++.. .++.||+|.+... ++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4799999999999998 5899999987643 00
Q ss_pred ----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 92 ----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 92 ----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
.....+.++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~ 156 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQ 156 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-cccCc
Confidence 00345678999999999999 99999999999999999999999999999876643222111 11123
Q ss_pred cCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
++..|+|||.+.+..++.++||||||+++|++++ |..||.... .......+ .... ..
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-----~~~~~~~~----~~~~--~~----------- 214 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-----NQQTRERI----ESGY--RM----------- 214 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-----HHHHHHHH----hcCC--CC-----------
Confidence 4667999999988889999999999999999999 677764322 01111111 1100 00
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
+.+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 215 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 --PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 001122345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=242.33 Aligned_cols=198 Identities=24% Similarity=0.328 Sum_probs=156.9
Q ss_pred CCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------CCCc---------------
Q 039895 58 DGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------FPFS--------------- 93 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------~~~~--------------- 93 (284)
.-.++||-|.||.||.|.| ..-.||||.++.. .|..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 3457899999999999999 6778999999876 1211
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.-.+.+|.||++|+.||. .+++|||||-.+|+|+.++..+|++|||+++.+..+.+.....
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG- 425 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG- 425 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-
Confidence 345678999999999999 9999999999999999999999999999999886554433222
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
..-++.|.|||.+....++.|+|||+|||+|||+.| |-.|+.+.. +. .+...++.
T Consensus 426 -AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lS-qVY~LLEk-------------- 481 (1157)
T KOG4278|consen 426 -AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LS-QVYGLLEK-------------- 481 (1157)
T ss_pred -ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HH-HHHHHHhc--------------
Confidence 234678999999999999999999999999999998 555654322 11 12222211
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+.+...++-|++.+.+||..||+++|.+||++.|+.+.++.++.+|
T Consensus 482 -gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 482 -GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred -cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 1222335567778999999999999999999999999999998764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=235.81 Aligned_cols=159 Identities=23% Similarity=0.336 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.......... .....++..|+|||++.+.
T Consensus 136 ~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 211 (334)
T cd05100 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK-TTNGRLPVKWMAPEALFDR 211 (334)
T ss_pred HHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCcccceeccccccccc-ccCCCcCceEcCHHHhccC
Confidence 3568899999999999 99999999999999999999999999999876644322111 1113345789999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 176 DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 176 ~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
.++.++||||||+++|||++ |..||.... ......... ...... .+...+..+.+
T Consensus 212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~-~~~~~~---------------~~~~~~~~l~~ 267 (334)
T cd05100 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--------VEELFKLLK-EGHRMD---------------KPANCTHELYM 267 (334)
T ss_pred CcCchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCCCC---------------CCCCCCHHHHH
Confidence 89999999999999999998 777775322 122221111 111000 01122334789
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
++.+||+.+|++|||+.|+++.|+++..
T Consensus 268 li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 268 IMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=226.00 Aligned_cols=190 Identities=27% Similarity=0.377 Sum_probs=145.4
Q ss_pred CeeeecCCceEEEEEeC-----CcceEEEeecCC------------------------------------------CC--
Q 039895 61 KVIMKCLFYKLYKGFLQ-----DRPISVMKFEDT------------------------------------------FP-- 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~------------------------------------------~~-- 91 (284)
+.||+|+||.||+|... +..||+|.+... +|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999999993 789999998754 11
Q ss_pred ----------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 92 ----------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 92 ----------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
.+.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 11345789999999999999 99999999999999999999999999999987765
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.... .......+++.|+|||.+....++.++||||+|++++++++ |..||.... ......... .+...
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~- 226 (262)
T cd00192 158 DDYY-RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLR-KGYRL- 226 (262)
T ss_pred cccc-ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCCC-
Confidence 4321 11222567889999999988889999999999999999999 588875432 111111111 11000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
+.+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 --------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011222445889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=238.88 Aligned_cols=195 Identities=24% Similarity=0.292 Sum_probs=153.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
...|+..+.||.|.||.||++.. +|+.+|+|++.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34577789999999999999999 7999999999765
Q ss_pred ----------------C-CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC----CcceeeccccccccC
Q 039895 90 ----------------F-PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE----NVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ----------------~-~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~Dfg~a~~~~ 148 (284)
. ..+.....++.|++.|+.||| +.+|+||||||+|+|+... +.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 1 333566789999999999999 9999999999999999643 479999999999887
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.+... ...+||+.|+|||++....|+..+||||+|+++|.|++|.+||.... ...... .+..+.+
T Consensus 191 ~~~~~----~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~~~~-----~i~~~~~-- 255 (382)
T KOG0032|consen 191 PGERL----HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFEIFL-----AILRGDF-- 255 (382)
T ss_pred CCceE----eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhHHHH-----HHHcCCC--
Confidence 63222 22789999999999999999999999999999999999999998644 101111 1111111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....+........+.+++..|+..||..|+|+.+++++
T Consensus 256 ----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 00111122334557899999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=237.86 Aligned_cols=144 Identities=17% Similarity=0.251 Sum_probs=121.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..+.|+..+.||+|+||.||+|.. +|+.||+|.+...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899899999999999999998 8899999998532
Q ss_pred --------CC------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 --------FP------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --------~~------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+| .......++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 00 00334568999999999999 99999999999999999999999999999977644
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 171 SFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 322 11246789999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=228.63 Aligned_cols=195 Identities=22% Similarity=0.331 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||+|+||.||+|.. ++..+|+|++... ++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5677888999999999999998 6788999987643 11
Q ss_pred C----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 F----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
. ......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-- 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-- 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc--
Confidence 0 1345679999999999999 999999999999999999999999999998766432211
Q ss_pred CCCCcccCccccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTG---DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.....++..|+|||.+... .++.++||||||+++|+|++|..||.... . ........ ...+. .+
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-----~---~~~~~~~~-~~~~~---~~ 224 (262)
T cd06613 158 -RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-----P---MRALFLIS-KSNFP---PP 224 (262)
T ss_pred -cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHH-hccCC---Cc
Confidence 1125678899999998776 78899999999999999999999986432 0 00010000 00000 00
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+ ......+..+.+++.+||+.+|+.|||+.+|+.
T Consensus 225 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 012233455889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=227.28 Aligned_cols=194 Identities=20% Similarity=0.227 Sum_probs=135.5
Q ss_pred CeeeecCCceEEEEEe----CCcceEEEeecCC------------------------------------------CCCc-
Q 039895 61 KVIMKCLFYKLYKGFL----QDRPISVMKFEDT------------------------------------------FPFS- 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~------------------------------------------~~~~- 93 (284)
+.||+|+||.||+|.+ .+..+|+|.+... ++..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 3689999999999987 2356899987643 1110
Q ss_pred -------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 94 -------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 94 -------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
...+.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 123468899999999999 9999999999999999999999999999987554332211
Q ss_pred cCCCCcccCccccccccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTG-------DFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
......++..|+|||++... .++.++||||||+++|||++ |..||.... ....... .. ....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~~---~~-~~~~ 227 (269)
T cd05087 158 -TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-----DEQVLTY---TV-REQQ 227 (269)
T ss_pred -cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHH---Hh-hccc
Confidence 11224578889999987542 35789999999999999996 988885422 0111111 11 1111
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
.....+.+. ......+.+++..|| .+|++|||+.||+..|.
T Consensus 228 ~~~~~~~~~----------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLK----------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccC----------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111111 011223678999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=226.02 Aligned_cols=199 Identities=20% Similarity=0.208 Sum_probs=150.4
Q ss_pred cHHHHHHHhcCCCCCCee--eecCCceEEEEEe--CCcceEEEeecCC--------------------------------
Q 039895 46 SADELKTATDDFDGGKVI--MKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------- 89 (284)
Q Consensus 46 ~~~~l~~~~~~f~~~~~l--g~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------- 89 (284)
+..++....++|+..+.+ |+|+||.||++.. ++..+|+|.+...
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 345556666777777776 9999999999998 7888999988653
Q ss_pred -----CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccC
Q 039895 90 -----FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIP 148 (284)
Q Consensus 90 -----~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~ 148 (284)
++ .+.....++.|++.||.||| +.+++||||+|+||+++.++ .++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 11 11556789999999999999 99999999999999999998 99999999987654
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.... ..|+..|+|||++.+..++.++||||||+++|+|++|..||.... ........+.... .... .
T Consensus 162 ~~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--~~~~-~ 228 (267)
T PHA03390 162 TPSC-------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQ--QKKL-P 228 (267)
T ss_pred CCcc-------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhh--cccC-C
Confidence 3221 457899999999998889999999999999999999999986432 1111122221111 0000 0
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-IVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~ev~~ 275 (284)
........+.+++.+||+.+|.+||+ ++++++
T Consensus 229 ---------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 ---------------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 01123344789999999999999996 588874
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=239.10 Aligned_cols=197 Identities=21% Similarity=0.278 Sum_probs=142.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||++.. +++.||+|++...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4677888999999999999998 7788999988542
Q ss_pred -CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 1110 345568899999999999 99999999999999999999999999999977654332
Q ss_pred cccCCCCcccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...............
T Consensus 158 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 227 (331)
T cd05624 158 VQS--SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEERF 227 (331)
T ss_pred eee--ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCcc
Confidence 211 12568999999998865 467889999999999999999999996432 111111111110000
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAKQ 276 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~~ 276 (284)
. +.+ .....+..+.+++.+|+..++.+ |+++.++++.
T Consensus 228 ~-~p~-----------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 Q-FPS-----------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c-CCC-----------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 000 01122345778999999866544 5688888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=236.36 Aligned_cols=188 Identities=23% Similarity=0.311 Sum_probs=146.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------CCC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------FPF-- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------~~~-- 92 (284)
+.|..-++||+||||.||-++. +|+.+|.|++.+. .|.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5788889999999999999998 8999999988654 111
Q ss_pred ---------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 93 ---------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 93 ---------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+...+.+|.+|+.||++|| ...||.|||||+|||+|++|.++|+|+|+|..+..+.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 1556679999999999999 9999999999999999999999999999999988766
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.... .+||.+|||||++.+..|+...|-||+||++|||+.|+.||..... ..-..- +|
T Consensus 342 ~~~~----rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~eE-------------vd 399 (591)
T KOG0986|consen 342 PIRG----RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKREE-------------VD 399 (591)
T ss_pred cccc----ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhHHH-------------HH
Confidence 5433 4899999999999999999999999999999999999999964320 000001 11
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
.....+. ..+ +...++++.+|....|+.||++|...
T Consensus 400 rr~~~~~-~ey--~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 400 RRTLEDP-EEY--SDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHhcch-hhc--ccccCHHHHHHHHHHHccCHHHhccC
Confidence 1111110 000 12334457788888999999999754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=257.98 Aligned_cols=199 Identities=21% Similarity=0.267 Sum_probs=144.7
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------- 89 (284)
+.....++|...+.||+|+||+||++.. .+..||+|++...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3344557888899999999999999999 7788999987632
Q ss_pred --------CCC-------------------chhHHHHHHHHHHHHHHhccCC----CCCeeecccccCcEEEecC-----
Q 039895 90 --------FPF-------------------SVSKLKIAIEIASAVAYLHVGF----SRPVVSRDIKPTTIVLQEE----- 133 (284)
Q Consensus 90 --------~~~-------------------~~~~~~i~~~i~~gL~~LH~~~----~~~ivHrDlkp~NILl~~~----- 133 (284)
+|. +...+.|+.||+.||.|||... ..+||||||||+|||++..
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 111 0345678999999999999321 1569999999999999642
Q ss_pred ------------CcceeeccccccccCCCCccccCCCCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCC
Q 039895 134 ------------NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKI 199 (284)
Q Consensus 134 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p 199 (284)
+.+||+|||++..+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~----~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMA----HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccc----cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 34899999999776433221 12578999999999854 4588999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 200 SYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
|.... .....+........++ + ...+..+.+|+..||+.+|.+||++.|++.
T Consensus 243 F~~~~-------~~~qli~~lk~~p~lp------i-----------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKAN-------NFSQLISELKRGPDLP------I-----------KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCC-------cHHHHHHHHhcCCCCC------c-----------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 86422 1112222111110000 0 011234789999999999999999999984
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=231.85 Aligned_cols=211 Identities=20% Similarity=0.302 Sum_probs=147.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.. ++..||+|++...
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3577788999999999999998 6789999987642
Q ss_pred CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
++ .......++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 11 11456678999999999999 8999999999999999999999999999987765443211
Q ss_pred cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--Ccccccc-
Q 039895 155 NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN--ESFKEIV- 230 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~- 230 (284)
. ....++..|+|||++.+. .++.++||||||+++|++++|..||.... ....+.. ....... .......
T Consensus 158 ~--~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 158 L--TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS----DIDQLYL-IQKCLGPLPPSHQELFS 230 (288)
T ss_pred c--cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH-HHHHhCCCCHHHhhhcc
Confidence 1 125678899999999887 78999999999999999999998886432 1000111 0010000 0000000
Q ss_pred -cccccCCC--CCCCh------hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 -DPAIVGEE--GLMWP------EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 -~~~~~~~~--~~~~~------~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
++...... ....+ .+...+..+.+++.+||+.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00000 01112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=230.55 Aligned_cols=190 Identities=26% Similarity=0.362 Sum_probs=143.6
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CCC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FPF 92 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~~ 92 (284)
|+..+.||+|+||.||+|.+ ++..||+|.+... +|.
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 33446799999999999988 6789999988633 111
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
......++.|++.||.||| ..+++|+||+|+||+++.++.++++|||++..+...... ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---~~ 159 (277)
T cd06642 86 GGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RN 159 (277)
T ss_pred CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchh---hh
Confidence 1455678999999999999 999999999999999999999999999998766533211 11
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...|+..|+|||++.+..++.++|||||||++||+++|..|+.... ...... ...... .+.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-----~~~~~~----~~~~~~-----~~~~---- 221 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-----PMRVLF----LIPKNS-----PPTL---- 221 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-----hhhHHh----hhhcCC-----CCCC----
Confidence 2467889999999988889999999999999999999999875322 000000 000000 0100
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....+..+.+++.+||+.+|++|||+.++++.
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11233447899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=229.46 Aligned_cols=150 Identities=20% Similarity=0.337 Sum_probs=109.8
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc--------ceeeccccccccCCCCccccCCCCcccCcc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV--------AQLFDFTLSLSIPEGETHINDSNRVIGTFG 165 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 165 (284)
..++.++.||+.||.||| +.+|+||||||+||+++.++. ++++|||++....... ...+++.
T Consensus 100 ~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~ 169 (258)
T cd05078 100 SWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-------ILLERIP 169 (258)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccccCCch-------hccccCC
Confidence 456778999999999999 999999999999999987765 5899999876543221 1467889
Q ss_pred ccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChh
Q 039895 166 FMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPE 244 (284)
Q Consensus 166 y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
|+|||++.+. .++.++|||||||++|++++|..++.... . .............++
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~----~---~~~~~~~~~~~~~~~----------------- 225 (258)
T cd05078 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL----D---SQKKLQFYEDRHQLP----------------- 225 (258)
T ss_pred ccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc----c---HHHHHHHHHccccCC-----------------
Confidence 9999998764 57899999999999999999964433211 0 111111000000000
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 245 KEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 245 ~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
......+.+++.+||+.+|++|||+.++++.|+
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 -APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011234789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=232.97 Aligned_cols=192 Identities=21% Similarity=0.289 Sum_probs=152.4
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------CCCc--
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------FPFS-- 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------~~~~-- 93 (284)
|+...+||+|+||.||++.+ .|+.||+|.+... ||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 44456899999999999998 8999999987654 3332
Q ss_pred --------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 94 --------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 94 --------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
.....++...+.||+||| ...-+|||||..|||++.+|.+||+|||.|-.+.+.... ..+
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK---RNT 188 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK---RNT 188 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh---hCc
Confidence 445568889999999999 889999999999999999999999999999887655433 234
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
+.|||.|||||++..-.|+.++||||+|++..||..|++|+..... ...++- +...+.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--------------------MRAIFM--IPT~PP 246 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--------------------MRAIFM--IPTKPP 246 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--------------------cceeEe--ccCCCC
Confidence 7899999999999999999999999999999999999999865331 011110 011112
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+-+..++.-+.++.+++..||-.+|++|-|+.++++.
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2223355666778999999999999999999988764
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=228.12 Aligned_cols=199 Identities=23% Similarity=0.339 Sum_probs=147.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|+..+.||.|+||+||+|.. ++..+|+|++... +
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688889999999999999998 7789999988643 1
Q ss_pred C------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 91 P------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
| .+.....++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 1 11234578999999999999 99999999999999999999999999999877654432
Q ss_pred cc-cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 153 HI-NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.. .......|+..|+|||++... .++.++|+|||||++|+|++|..||..... . ..........
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~----~~~~~~~~~~------ 223 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP----M----KVLMLTLQND------ 223 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh----h----hhHHHHhcCC------
Confidence 21 111225689999999998776 788999999999999999999999864321 0 0111111110
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.+... ......+..+.+++.+||+.+|++|||+.+++.
T Consensus 224 ~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETG-----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCc-----cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 001123445789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=230.96 Aligned_cols=189 Identities=23% Similarity=0.302 Sum_probs=143.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
..|+..+.||+|+||.||+|.. +++.||+|++...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4477778999999999999998 7899999987532
Q ss_pred -CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
++ .......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-- 169 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-- 169 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC--
Confidence 11 00445678999999999999 9999999999999999999999999999986654322
Q ss_pred ccCCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
...+++.|+|||++. ...++.++||||||+++||+++|..||.... ........... ....
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--------~~~~~~~~~~~-~~~~-- 233 (307)
T cd06607 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQN-DSPT-- 233 (307)
T ss_pred -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--------HHHHHHHHhcC-CCCC--
Confidence 146788999999874 3568899999999999999999999986432 11111111100 0000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+ ........+.+++.+||+.+|++||++.+|+..
T Consensus 234 ---~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ---L---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---C---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 011233458899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=230.83 Aligned_cols=188 Identities=18% Similarity=0.286 Sum_probs=141.9
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CCC-----
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FPF----- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~~----- 92 (284)
..||+|+||.||++.. ++..||+|.+... ++.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5799999999999998 7889999987543 111
Q ss_pred ---------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccC
Q 039895 93 ---------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGT 163 (284)
Q Consensus 93 ---------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 163 (284)
......++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++......... .....|+
T Consensus 108 ~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~ 181 (292)
T cd06658 108 DIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGT 181 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc---CceeecC
Confidence 1456789999999999999 999999999999999999999999999998765432211 1225688
Q ss_pred ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCCh
Q 039895 164 FGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWP 243 (284)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
..|+|||++.+..++.++||||||+++||+++|..||.... . ........ . ...+....
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~~-~-----~~~~~~~~------- 240 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----P---LQAMRRIR-D-----NLPPRVKD------- 240 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHH-h-----cCCCcccc-------
Confidence 99999999988889999999999999999999999986432 1 11111110 0 00111100
Q ss_pred hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 244 EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 244 ~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++..||..+|++|||+.++++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11122347789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=227.41 Aligned_cols=191 Identities=24% Similarity=0.313 Sum_probs=146.3
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~ 91 (284)
.|+..+.||+|+||.||+|.+ ++..||+|++... ++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 456677899999999999998 6889999987643 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||+||| +.+++|+||+|+||+++.++.++++|||++......... .
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~ 158 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---R 158 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc---c
Confidence 11445678999999999999 999999999999999999999999999998766433211 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....++..|+|||++.+..++.++|+|||||++|||++|..|+.... ...... . ......
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-----~~~~~~---~-~~~~~~----------- 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-----PMRVLF---L-IPKNNP----------- 218 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-----hHhHhh---h-hhcCCC-----------
Confidence 12467889999999988889999999999999999999999986432 000000 0 000000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+..+.+++.+||+.+|++||++.+++..
T Consensus 219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 01123345568899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=229.60 Aligned_cols=185 Identities=21% Similarity=0.269 Sum_probs=138.1
Q ss_pred eeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------------CC-
Q 039895 62 VIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------------FP- 91 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------------~~- 91 (284)
+||+|+||.||++.. +++.+|+|.+... ++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999998 6889999987532 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----- 152 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----- 152 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-----
Confidence 00456678999999999999 99999999999999999999999999999865543221
Q ss_pred CCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....|++.|+|||.+.. ..++.++|||||||+++++++|..||..... .. .. ........ ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~---~~-~~~~~~~~------~~~~--- 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KD---KH-EIDRMTLT------VNVE--- 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC--cC---HH-HHHHHhhc------CCcC---
Confidence 12468999999998864 5688999999999999999999999864321 11 11 11111000 0000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
.+...+..+.+++.+||+.||++|| |+.++++.
T Consensus 218 -------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 -------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112334578999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=225.26 Aligned_cols=192 Identities=23% Similarity=0.350 Sum_probs=143.9
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|.....||+|++|.||+|.. ++..+|+|.+...
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999998 6789999977532
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. ......++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 110 0345679999999999999 99999999999999999999999999999887653
Q ss_pred CCccc---cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 150 GETHI---NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 150 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
..... .......|+..|+|||.+.+..++.++|||||||++|++++|..||.... ... .+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~-~~~~~~-~~-- 227 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------QLQ-AIFKIG-EN-- 227 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------HHH-HHHHHh-cc--
Confidence 22111 11112457889999999988889999999999999999999999986422 011 111100 00
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+.+ +...+..+.+++.+||+.+|++||++.+|++
T Consensus 228 ---~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---ASPEI----------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CCCcC----------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00110 1122344789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=228.35 Aligned_cols=210 Identities=18% Similarity=0.232 Sum_probs=145.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+....||+|+||.||+|.. +|+.||+|++...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3577788999999999999998 6899999987532
Q ss_pred CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
++ .+..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 11 11457789999999999999 899999999999999999999999999999876543321
Q ss_pred cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh----------c
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE----------N 223 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (284)
.....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... ............. .
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD----VDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHhhhccc
Confidence 112457889999998865 4578999999999999999999999864321 0111111110000 0
Q ss_pred Ccc-cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 ESF-KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+ .....+....... ...........+.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREP-LESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccC-HHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000000000000 00000112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=224.27 Aligned_cols=194 Identities=21% Similarity=0.230 Sum_probs=148.1
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|+..+.||.|+||.||++.. ++..||+|.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999998 7789999988532
Q ss_pred -CCCc-------------------hhHHHHHHHHHHHHHHhccCC--CCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 -FPFS-------------------VSKLKIAIEIASAVAYLHVGF--SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 -~~~~-------------------~~~~~i~~~i~~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
+|.. ...+.++.|++.||.|||..+ +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 1110 345678999999999999554 678999999999999999999999999999877
Q ss_pred CCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
....... ....+++.|+|||++....++.++||||||++++++++|..|+.... ...... ........
T Consensus 161 ~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~-~~~~~~~~ 228 (265)
T cd08217 161 GHDSSFA---KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLAS-KIKEGKFR 228 (265)
T ss_pred cCCcccc---cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHH-HHhcCCCC
Confidence 5433211 12468999999999988889999999999999999999999986432 111111 11111111
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. .+......+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ~---------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R---------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 111233457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=232.29 Aligned_cols=214 Identities=15% Similarity=0.186 Sum_probs=145.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|+..+.||+|+||.||+|.. ++..||+|.+...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45688889999999999999998 7899999987432
Q ss_pred ---------CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 90 ---------FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 90 ---------~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
+| .......++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 00 01455679999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCccc-cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh-
Q 039895 146 SIPEGETHI-NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE- 222 (284)
Q Consensus 146 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 222 (284)
......... .......++..|+|||.+.+. .++.++||||||+++|||++|..||.... .......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-----~~~~~~~~~~~~~~ 242 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-----EQHQLTLISQLCGS 242 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCC
Confidence 664332211 111224578899999987654 47889999999999999999998886432 1111111111110
Q ss_pred --cCccccccccc------ccCCCCCCChh---hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 --NESFKEIVDPA------IVGEEGLMWPE---KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 --~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...++...... .........+. .......+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 00000000000 0001234678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=229.26 Aligned_cols=195 Identities=23% Similarity=0.340 Sum_probs=144.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.+ +++.||||.+...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 35677889999999999999999 4899999998643
Q ss_pred -CC---------------CchhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FP---------------FSVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~---------------~~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
++ ....+..++.|++.||+||| + .+|+||||+|+||++++++.++|+|||++..+.....
T Consensus 94 e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 00 00334579999999999999 6 5999999999999999999999999999876643322
Q ss_pred cccCCCCcccCccccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGD----FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.. ...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.... .. .......... ....
T Consensus 171 ~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~-~~~~~~~~~~-~~~~ 238 (296)
T cd06618 171 KT----RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK------TE-FEVLTKILQE-EPPS 238 (296)
T ss_pred cc----CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch------hH-HHHHHHHhcC-CCCC
Confidence 11 135788999999987553 7889999999999999999999985321 00 1111111111 1000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. +........+.+++.+||+.+|++|||+.+++..
T Consensus 239 ~-------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 L-------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0001123347899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=227.19 Aligned_cols=148 Identities=22% Similarity=0.343 Sum_probs=109.0
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-------cceeeccccccccCCCCccccCCCCcccCccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-------VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF 166 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 166 (284)
..++.++.||+.||+||| +.+|+||||||+|||++..+ .++++|||++........ ..++..|
T Consensus 117 ~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~-------~~~~~~~ 186 (274)
T cd05076 117 AWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-------RVERIPW 186 (274)
T ss_pred HHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccc-------cccCCcc
Confidence 556789999999999999 99999999999999998654 379999998755432211 3567889
Q ss_pred cccccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChh
Q 039895 167 MAPEYRTT-GDFSEKSDVYSFGALLLELL-TGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPE 244 (284)
Q Consensus 167 ~aPE~~~~-~~~~~~~DvwS~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
+|||.+.+ ..++.++|||||||++||++ +|..||.... ......... .....+.
T Consensus 187 ~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~---~~~~~~~---------------- 242 (274)
T cd05076 187 IAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-----PSEKERFYE---KKHRLPE---------------- 242 (274)
T ss_pred cCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-----hHHHHHHHH---hccCCCC----------------
Confidence 99998865 46889999999999999985 6888875432 011111110 0000000
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 245 KEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 245 ~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
.....+.+++.+||+.+|++|||+.+|++.|
T Consensus 243 --~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 243 --PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0112378999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=235.81 Aligned_cols=217 Identities=17% Similarity=0.183 Sum_probs=150.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||+||+|.. ++..||+|.+...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688888999999999999998 7899999987542
Q ss_pred ------CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ------FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ------~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .......++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 00 01345678999999999999 99999999999999999999999999999977644
Q ss_pred CCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---c
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---S 225 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 225 (284)
.... .....++..|+|||.+.. ..++.++|||||||++|+|++|..||.... ............... .
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 161 KGDF---MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-----YVHQLKLITELLGSPSEED 232 (337)
T ss_pred Cccc---ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHHHhCCCChHH
Confidence 3211 112467889999998764 468899999999999999999999986432 011111111111000 0
Q ss_pred ccccccccc-------cCCCCCC-ChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHHH
Q 039895 226 FKEIVDPAI-------VGEEGLM-WPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ--LRQIY 281 (284)
Q Consensus 226 ~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~--L~~l~ 281 (284)
+..+.+... ....... ..........+.+++.+||+.+|++|||+.++++. +..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 0000000 00011234557899999999999999999999876 55443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=226.54 Aligned_cols=157 Identities=24% Similarity=0.386 Sum_probs=117.2
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-----cceeeccccccccCCCCccccCCCCcccCcccccc
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-----VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAP 169 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 169 (284)
..+.++.|++.||.||| +.+++|+||+|+||+++.++ .++++|||++............ ....++..|+||
T Consensus 107 ~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aP 182 (269)
T cd05044 107 ELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE-GEGLLPVRWMAP 182 (269)
T ss_pred HHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccC-cccCCCccccCH
Confidence 34568999999999999 89999999999999999877 8999999998766433222111 113457889999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHH
Q 039895 170 EYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQ 248 (284)
Q Consensus 170 E~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (284)
|++.+..++.++|||||||++|||++ |..||.... ....... ...+... ......
T Consensus 183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~~~~~~----~~~~~~~---------------~~~~~~ 238 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQEVLQH----VTAGGRL---------------QKPENC 238 (269)
T ss_pred HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HHHHHHH----HhcCCcc---------------CCcccc
Confidence 99998899999999999999999998 888875322 1111111 1111000 011223
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 249 LLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 249 ~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3457899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=227.31 Aligned_cols=195 Identities=22% Similarity=0.310 Sum_probs=146.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|+..+.||+|++|.||++.. +++.||+|.+... +
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3566778999999999999999 6889999987644 1
Q ss_pred CC----------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PF----------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~----------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
|. ......++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 11 0344578999999999999 8 99999999999999999999999999998665432211
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ..++..|+|||.+.+..++.++||||||+++|++++|..||..... ................. ..
T Consensus 158 ~-----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-~~----- 223 (265)
T cd06605 158 T-----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEPP-PR----- 223 (265)
T ss_pred c-----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCCC-CC-----
Confidence 1 4678899999999888999999999999999999999999864321 11112222222211110 00
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ + .......+.+++.+||..+|++|||+.+++.
T Consensus 224 ~--------~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 L--------P-SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred C--------C-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0 0 0113445889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=232.21 Aligned_cols=211 Identities=15% Similarity=0.174 Sum_probs=147.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|+..+.||+|+||.||+|.. +|..||+|++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46788899999999999999998 7899999988532
Q ss_pred ---CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. +.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 110 0345679999999999999 9999999999999999999999999999998765432
Q ss_pred ccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFK 227 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 227 (284)
.. .....+++.|+|||++.+ ..++.++||||+||++|||++|..||.... .......+....... .++
T Consensus 163 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-----~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 163 KP---MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-----EIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CC---CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChhhch
Confidence 11 111345788999998865 457899999999999999999999986432 111111111111100 000
Q ss_pred ccccc------cccCCCCCCChh-hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 EIVDP------AIVGEEGLMWPE-KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 ~~~~~------~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..-+. .+.......... .......+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000000000 0112445779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=229.27 Aligned_cols=193 Identities=19% Similarity=0.282 Sum_probs=142.7
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~ 91 (284)
+|+..+.||+|+||.||++.. +|..||+|.+... +|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 566778999999999999999 6899999987542 11
Q ss_pred C------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 92 F------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ~------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
. ......++.|++.||.|||+ ..+|+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 1 03457889999999999993 25999999999999999999999999999876543222
Q ss_pred ccCCCCcccCccccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTG------DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
....+++.|+|||.+.+. .++.++|||||||++|++++|..||.... ............ .....
T Consensus 159 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~-~~~~~ 228 (286)
T cd06622 159 ----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSAIV-DGDPP 228 (286)
T ss_pred ----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHHHh-hcCCC
Confidence 124578899999987544 35789999999999999999999986432 111111111111 11100
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. .+......+.+++.+||+.+|++||++.++++.
T Consensus 229 ~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 T---------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C---------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 112234457899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=231.75 Aligned_cols=145 Identities=23% Similarity=0.349 Sum_probs=118.0
Q ss_pred CCCCCeeeecCCceEEEEEe----CCcceEEEeecCC-------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL----QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~------------------------------------------- 89 (284)
|...+.||+|+||.||+|.. .+..||+|.+...
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 66678899999999999999 4689999998761
Q ss_pred ---CCC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec----CCcceeecccc
Q 039895 90 ---FPF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE----ENVAQLFDFTL 143 (284)
Q Consensus 90 ---~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~Dfg~ 143 (284)
+|. ......++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 110 0234578999999999999 999999999999999999 89999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
+.................+++.|+|||++.+. .++.++|||||||++++|++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 98765433222222235678999999987664 57899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=227.66 Aligned_cols=203 Identities=18% Similarity=0.207 Sum_probs=143.5
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||.|++|.||+|.. +|..||||++... +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477788999999999999998 7899999988632 1
Q ss_pred CC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 PF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+. ......++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 10 0345678999999999999 9999999999999999999999999999987654322111
Q ss_pred cCCCCcccCccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---------
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE--------- 224 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 224 (284)
....+++.|+|||++.+.. ++.++|||||||++|+++||+.||.... ................
T Consensus 158 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 158 ---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ---ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCChhhhhhhhH
Confidence 1135688999999876644 6889999999999999999999986432 1111111111100000
Q ss_pred ------cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 ------SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+..+....+. .........+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-------KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH-------HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112334779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=226.61 Aligned_cols=206 Identities=16% Similarity=0.188 Sum_probs=143.5
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 44567899999999999998 7889999988643
Q ss_pred CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
++ .......++.|++.||.||| +.+++|+||+|+||+++. +.+||+|||++.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 00 00456779999999999999 999999999999999999 99999999999776433221
Q ss_pred cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--c-----
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--F----- 226 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~----- 226 (284)
....++..|+|||++.. ..++.++|||||||++|||++|..||.... ................ +
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-----ELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-----HHHHHHHHHHHcCCCCHHHHHhhc
Confidence 11457889999997644 457889999999999999999999986432 1111111111110000 0
Q ss_pred -cccccccccCCCC-CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 -KEIVDPAIVGEEG-LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+........ ...+.....+..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 000111234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=224.26 Aligned_cols=197 Identities=18% Similarity=0.290 Sum_probs=146.1
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|+..+.||+|++|.||+|.. ++..||+|++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999997 8899999988632
Q ss_pred ---CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCC
Q 039895 90 ---FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~ 150 (284)
++ .+.....++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 01 01445678999999999999 99999999999999998776 5899999998776543
Q ss_pred Ccccc-CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHIN-DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
..... ......|+..|+|||.+.+..++.++||||+|++++++++|..||..... ................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~--- 229 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASATTA--- 229 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccCCC---
Confidence 22111 11225688999999999888899999999999999999999999853321 1111111111000000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+......+.+++.+||..+|++|||+.++++
T Consensus 230 ------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 ------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0112233445789999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=223.69 Aligned_cols=149 Identities=23% Similarity=0.321 Sum_probs=122.3
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe----C--CcceEEEeecCC---------CCCc-----------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL----Q--DRPISVMKFEDT---------FPFS----------------------- 93 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~----~--~~~vavK~~~~~---------~~~~----------------------- 93 (284)
+....|+....||+|.||.||+|.- + ...+|+|+++.. .|-+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3345677788999999999999966 2 237999999765 0100
Q ss_pred -------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC----Cccee
Q 039895 94 -------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE----NVAQL 138 (284)
Q Consensus 94 -------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl 138 (284)
....+|+.||+.|+.||| ++=|+||||||.|||+..+ |.+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 455689999999999999 9999999999999999877 89999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
+|||+++.+...-........++-|.+|+|||.+.+. .|+.+.||||+|||+.||+|-.+.|.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999987654433333336789999999998876 5899999999999999999999888654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=224.79 Aligned_cols=195 Identities=26% Similarity=0.376 Sum_probs=145.4
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCC------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPF------------------------------------------ 92 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------------------------------------------ 92 (284)
|...+.||+|+||.||+|.. +++.||+|.+......
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 66778999999999999998 7889999998754111
Q ss_pred ----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 93 ----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 93 ----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
......++.+++.||.||| +.+|+|+||+|+||+++.++.+||+|||++............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 1445678999999999999 999999999999999999999999999998876544332221
Q ss_pred -CCCcccCccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 157 -SNRVIGTFGFMAPEYRTTGD---FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 157 -~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.....+++.|+|||++.... ++.++||||||+++|++++|..||.... .... ...... .... +
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~------~~~~-~~~~~~-~~~~-----~ 225 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD------NEFQ-IMFHVG-AGHK-----P 225 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc------chHH-HHHHHh-cCCC-----C
Confidence 11246788999999988766 8899999999999999999999986432 0111 111100 0100 0
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+ +........+.+++.+||+.+|++|||+.+++.
T Consensus 226 ~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI--------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC--------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 111122344779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=221.63 Aligned_cols=192 Identities=26% Similarity=0.370 Sum_probs=144.1
Q ss_pred CCCCCeeeecCCceEEEEEeC--C----cceEEEeecCCC----------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFLQ--D----RPISVMKFEDTF---------------------------------------- 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~---------------------------------------- 90 (284)
|...+.||.|+||.||++... + ..||+|.+....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345678999999999999993 2 789999987541
Q ss_pred -------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 91 -------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 -------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
........++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 111345678999999999999 9999999999999999999999999999998776543
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
..... ...+++.|+|||.+.+..++.++||||+|++++++++ |..||.... ......... ......
T Consensus 158 ~~~~~--~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~~-- 224 (258)
T smart00219 158 YYKKK--GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLEYLK-KGYRLP-- 224 (258)
T ss_pred ccccc--cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHh-cCCCCC--
Confidence 32221 1336789999999988889999999999999999998 666664321 111111111 111100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
.....+..+.+++.+||..+|++|||+.|+++.|
T Consensus 225 -------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111334588999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=228.63 Aligned_cols=199 Identities=21% Similarity=0.228 Sum_probs=144.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. .++.||+|.+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4678889999999999999998 6789999987643
Q ss_pred -CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
++ .+.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 11 00345678899999999999 999999999999999999999999999988642111000
Q ss_pred ------------ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh
Q 039895 154 ------------INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI 221 (284)
Q Consensus 154 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
........++..|+|||.+....++.++|||||||++||+++|..||.+.. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~~~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFGQVI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 001112457889999999988889999999999999999999999986432 111111111
Q ss_pred hcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 222 ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
.. ... .+.. ....+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 230 ~~-~~~---~~~~----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 230 SD-DIE---WPEG----------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred hc-ccC---CCCc----------cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11 000 0000 0122334789999999999999999765555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=226.10 Aligned_cols=191 Identities=18% Similarity=0.264 Sum_probs=143.3
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC--
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP-- 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~-- 91 (284)
|...+.||+|++|.||++.. ++..+++|++... ++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999987 7789999987422 11
Q ss_pred ------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 92 ------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 92 ------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
....+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+......... ...
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---~~~ 174 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---RKS 174 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc---ccc
Confidence 01345679999999999999 999999999999999999999999999988655432211 112
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
..|++.|+|||.+.+..++.++||||||+++|++++|..||.... .......... .......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~--------- 236 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRD-NLPPKLK--------- 236 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHh-cCCCCCc---------
Confidence 468899999999988889999999999999999999999986422 1111111111 1000000
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+.+++.+||+.+|++|||+.++++
T Consensus 237 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 ----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01112335889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=229.82 Aligned_cols=211 Identities=17% Similarity=0.158 Sum_probs=143.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.+ +++.||+|++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688889999999999999998 7899999986532
Q ss_pred ------CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeecccc
Q 039895 90 ------FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTL 143 (284)
Q Consensus 90 ------~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~ 143 (284)
+| .......++.||+.||.||| +.+|+||||+|+||+++. ++.++|+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 00 11345678999999999999 999999999999999998 88999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
+..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.... ....+.........
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~----~~~~~~~~~~~~~~ 230 (295)
T cd07837 158 GRAFSIPVKS---YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS----ELQQLLHIFKLLGT 230 (295)
T ss_pred ceecCCCccc---cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHHhCC
Confidence 8765332111 111356888999998765 457899999999999999999999886432 11111111110000
Q ss_pred c--CcccccccccccCCCCCCCh-----hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 N--ESFKEIVDPAIVGEEGLMWP-----EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ..+................+ ........+.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000000000000000000 01123445789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=224.57 Aligned_cols=208 Identities=17% Similarity=0.196 Sum_probs=145.8
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|+..+.||+|+||.||+|.. ++..||+|++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 45667899999999999999 5899999998621
Q ss_pred ------CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 ------FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 ------~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
++ ....+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 00 01445679999999999999 899999999999999999999999999998776
Q ss_pred CCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES-- 225 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (284)
....... ...++..|+|||++.+..++.++|||||||++|+|++|..||.... ....+............
T Consensus 158 ~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMALT----SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS----EADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCcccc----cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC----hHHHHHHHHHHcCCCChHh
Confidence 4432211 1357889999999998889999999999999999999988876432 11111111111100000
Q ss_pred ccccc---cccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIV---DPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.... ...........+ .........+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 000000000000 011233456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=227.47 Aligned_cols=194 Identities=22% Similarity=0.247 Sum_probs=144.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||.|+||.||+|.. ++..+|+|.+... ++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4577778899999999999998 6889999998543 11
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-- 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc--
Confidence 11456779999999999999 999999999999999999999999999988665432211
Q ss_pred CCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 156 DSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.....|++.|+|||++. ...++.++||||||+++|+|++|..||.... ........ .........
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~~~~~ 229 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKI-LKSEPPTLD 229 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHH-hcCCCCCcC
Confidence 12256899999999874 3457789999999999999999999986432 11111111 111110000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 230 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011223347899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=228.69 Aligned_cols=200 Identities=24% Similarity=0.306 Sum_probs=146.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|+..+.||+|+||+||++.. +|..||+|++... +
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4566678999999999999998 6889999987533 1
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
+.. .....++.+++.||.|||+ ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~--- 159 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--- 159 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc---
Confidence 100 3456789999999999993 26899999999999999999999999998865432211
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC---ccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDG---EDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....|+..|+|||++.+..++.++|||||||++|++++|..||........ ................ .+
T Consensus 160 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd06620 160 --DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP 231 (284)
T ss_pred --CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence 125689999999999888899999999999999999999999875431111 1111112222111110 00
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+ + ....+..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~--------~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 232 RL--------P-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CC--------C-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0 11233457899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=229.19 Aligned_cols=142 Identities=18% Similarity=0.310 Sum_probs=115.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|++|.||+|.. +++.||+|.+... +
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5677888999999999999998 7899999987532 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
+. ......++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 159 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-- 159 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence 10 1345678899999999999 999999999999999999999999999998654322111
Q ss_pred CCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 156 DSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
.....++..|+|||++.+ ..++.++||||+|+++|+|++|..||..
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 111346888999998865 4588999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=233.08 Aligned_cols=222 Identities=17% Similarity=0.233 Sum_probs=154.2
Q ss_pred cceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------
Q 039895 42 IRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------ 89 (284)
Q Consensus 42 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------ 89 (284)
++.....++..+.++|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 44555677778889999999999999999999987 7899999988642
Q ss_pred C--------------------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcce
Q 039895 90 F--------------------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 90 ~--------------------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 137 (284)
. .....+..++.|++.||+||| +.+|+||||||+||+++.++.++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred eeeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence 0 000345668999999999999 99999999999999999999999
Q ss_pred eeccccccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHH
Q 039895 138 LFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216 (284)
Q Consensus 138 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 216 (284)
|+|||++....... ....++..|+|||++.+ ..++.++|||||||++|++++|..||.... ....+...
T Consensus 161 l~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~----~~~~~~~~ 230 (345)
T cd07877 161 ILDFGLARHTDDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLI 230 (345)
T ss_pred Eecccccccccccc------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Confidence 99999987653322 12467889999998765 468899999999999999999999985422 10111111
Q ss_pred HHHHhhc-Cc-ccccccc-------cccCCCCCCChh-hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 217 VKKYIEN-ES-FKEIVDP-------AIVGEEGLMWPE-KEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 217 ~~~~~~~-~~-~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....... .. ...+.+. .+.......+.. .......+.+++.+||+.+|.+|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1100000 00 0000000 000000000000 00123347899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=232.08 Aligned_cols=213 Identities=15% Similarity=0.245 Sum_probs=149.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC-----------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF----------------------------------------- 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----------------------------------------- 90 (284)
.++|+..+.||+|+||.||+|.. +|..||+|++....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788889999999999999998 78999999876430
Q ss_pred ------C--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 91 ------P--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 91 ------~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+ .......++.||+.||.||| ..+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 0 01456788999999999999 899999999999999999999999999998766433
Q ss_pred Cccc-cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC----
Q 039895 151 ETHI-NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---- 224 (284)
Q Consensus 151 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 224 (284)
.... .......|+..|+|||.+.. ..++.++|||||||++|||++|..||..... ......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY-----VHQLKLILSVLGSPSEEV 235 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh-----HHHHHHHHHHhCCChhHh
Confidence 2211 11122568899999998765 4588999999999999999999999965321 11111111100000
Q ss_pred -------cccccccccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 -------SFKEIVDPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 -------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......+ .........+. .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 00000000000 01123456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=234.04 Aligned_cols=189 Identities=21% Similarity=0.301 Sum_probs=153.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPF---------------------------------------- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---------------------------------------- 92 (284)
.-|+.++.||+|.|+.|-.+.+ +|..||||++.+.-..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999988 9999999999876111
Q ss_pred -------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCcceeeccccccccCCCCc
Q 039895 93 -------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 93 -------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+....+++.||+.|+.|+| ...+|||||||+|+.+. +-|.+||.|||++..+.++..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 0445679999999999999 89999999999998775 568999999999988876654
Q ss_pred cccCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. +.+|++.|-|||++.+..|+ +++||||+|||||-|++|+.||...+ +.+. +..++|
T Consensus 175 L~----TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN--DSET---------------LTmImD 233 (864)
T KOG4717|consen 175 LT----TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN--DSET---------------LTMIMD 233 (864)
T ss_pred hh----cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc--chhh---------------hhhhhc
Confidence 32 37899999999999999987 68999999999999999999997654 2211 122222
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
-. +..+.....++.+||..||..||.+|.|.++|+.
T Consensus 234 CK--------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CK--------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 21 1235566777999999999999999999999874
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=240.05 Aligned_cols=187 Identities=21% Similarity=0.291 Sum_probs=140.6
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CCCc----
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FPFS---- 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~~~---- 93 (284)
.-||.|+||.||++.. .+-..|.|++... ||..
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 4689999999999998 4555666776543 4433
Q ss_pred ------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 94 ------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 94 ------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
.++.-++.|++.||.||| +++|||||||..|||+.-+|.++|+|||.+........ ...++.
T Consensus 118 aimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q---kRDsFI 191 (1187)
T KOG0579|consen 118 AIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ---KRDSFI 191 (1187)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh---hhcccc
Confidence 556678999999999999 99999999999999999999999999999866544332 223489
Q ss_pred cCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 162 GTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 162 gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
|||.|||||+.. ..+|++++||||||++|.||..+.+|-.... .+.. +... .....+-++.
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRV---llKi-aKSePPTLlq----- 257 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRV---LLKI-AKSEPPTLLQ----- 257 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHH---HHHH-hhcCCCcccC-----
Confidence 999999999854 4589999999999999999999998864322 1111 1111 1111111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+......+.+++.+||..||..||++.++++
T Consensus 258 --------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 --------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2233344889999999999999999999975
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=228.73 Aligned_cols=188 Identities=25% Similarity=0.331 Sum_probs=142.6
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------C
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------F 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~ 90 (284)
|+..+.||+|+||.||++.. ++..||+|++... +
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66678999999999999998 7889999988532 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|. ...+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 179 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---- 179 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc----
Confidence 11 1455678999999999999 9999999999999999999999999999886543321
Q ss_pred CCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
...|++.|+|||++. ...++.++|||||||++|+|++|..||.... ............. ..
T Consensus 180 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~-~~---- 243 (317)
T cd06635 180 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-PT---- 243 (317)
T ss_pred ---cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccC-CC----
Confidence 146888999999873 4568899999999999999999999986421 1111111111110 00
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
.........+.+++.+||+.+|.+||++.++++.+
T Consensus 244 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 244 ----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00112233478999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=227.77 Aligned_cols=208 Identities=18% Similarity=0.192 Sum_probs=144.2
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC-------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP------------------------------------------- 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------------------------------------------- 91 (284)
|+..+.||+|++|.||+|.. +|+.||+|.+.....
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 66778999999999999998 688999999864311
Q ss_pred ------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 92 ------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
.......++.||+.||.||| +.+|+|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred cccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 11446789999999999999 999999999999999999999999999999876543221
Q ss_pred ccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccc--
Q 039895 154 INDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFK-- 227 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 227 (284)
. ....+++.|+|||.+.+ ..++.++|||||||+++|+++|.++|.... ............... .+.
T Consensus 159 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 159 M---THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-----DIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred c---cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-----cHHHHHHHHHHcCCCchhhhhhc
Confidence 1 11356788999998754 457899999999999999999976665322 111111111110000 000
Q ss_pred -ccccccccCCCCCCCh---hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 228 -EIVDPAIVGEEGLMWP---EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 228 -~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...+.. ........+ ........+.+++.+||+.+|++|||+.|++..
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 000000000 011234558899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=222.46 Aligned_cols=149 Identities=21% Similarity=0.351 Sum_probs=111.7
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-------cceeeccccccccCCCCccccCCCCcccCccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-------VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF 166 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 166 (284)
..++.++.||+.||+||| +.+|+||||||+|||++.++ .++|+|||++....... ...++..|
T Consensus 101 ~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~y 170 (259)
T cd05037 101 HWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-------ERVERIPW 170 (259)
T ss_pred HHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccccccccc-------ccccCCCc
Confidence 456778999999999999 99999999999999999888 79999999987754311 14567789
Q ss_pred cccccccCC--CCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCCh
Q 039895 167 MAPEYRTTG--DFSEKSDVYSFGALLLELLTG-KKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWP 243 (284)
Q Consensus 167 ~aPE~~~~~--~~~~~~DvwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
+|||++... .++.++||||||+++|++++| ..|+.... ...... ......... . +
T Consensus 171 ~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-----~~~~~~---~~~~~~~~~---------~-----~ 228 (259)
T cd05037 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-----SSEKER---FYQDQHRLP---------M-----P 228 (259)
T ss_pred cChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-----chhHHH---HHhcCCCCC---------C-----C
Confidence 999998876 789999999999999999995 55554321 011111 110000000 0 0
Q ss_pred hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 244 EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 244 ~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
. ...+.+++.+||..+|++|||+.+|++.|.
T Consensus 229 ~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 229 D----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 144789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=227.50 Aligned_cols=194 Identities=19% Similarity=0.282 Sum_probs=146.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
+.|...+.||+|+||.||++.. ++..||+|.+... ++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788889999999999999987 7788999987533 11
Q ss_pred C--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 F--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 ~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
. ......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~---~ 172 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---R 172 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc---c
Confidence 0 1345778999999999999 999999999999999999999999999988765433221 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....|++.|+|||.+....++.++||||||+++|++++|..||...... . .+......+.
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~------~~~~~~~~~~------------ 232 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--R------ALYLIATNGT------------ 232 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--h------heeehhcCCC------------
Confidence 2246888999999998888999999999999999999999998653210 0 0000000000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
..++........+.+++.+||+.+|++||++.+++.+
T Consensus 233 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 --PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112233457899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=229.33 Aligned_cols=195 Identities=22% Similarity=0.282 Sum_probs=145.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|++|+||+|.. ++..||+|.+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3677888999999999999999 6899999988643
Q ss_pred -CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. +.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 111 0345568899999999999 9999999999999999999999999999987653221
Q ss_pred ccc--------------------------cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 039895 152 THI--------------------------NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF 205 (284)
Q Consensus 152 ~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~ 205 (284)
... .......||..|+|||++.+..++.++||||||+++|++++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~- 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN- 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc-
Confidence 100 01112468899999999988889999999999999999999999986432
Q ss_pred CCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHH
Q 039895 206 DDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT----IVQVAK 275 (284)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps----~~ev~~ 275 (284)
. ......... ... .++........+.+++.+||+.+|++||| +.++++
T Consensus 237 ---~----~~~~~~~~~-~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 ---R----DETFSNILK-KEV--------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ---h----HHHHHHHhc-CCc--------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0 111111110 000 00111113445889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=240.05 Aligned_cols=191 Identities=22% Similarity=0.316 Sum_probs=147.8
Q ss_pred CCeeeecCCceEEEEEe---CCc--ceEEEeecCCCCCc-----------------------------------------
Q 039895 60 GKVIMKCLFYKLYKGFL---QDR--PISVMKFEDTFPFS----------------------------------------- 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~---~~~--~vavK~~~~~~~~~----------------------------------------- 93 (284)
.++||+|.||.|++|.| .|+ .||||.+...-...
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 35899999999999999 343 58999998761110
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
...-.++.|||.|+.||- ++++|||||-.+|+|+.....+||+|||+.+.+.........
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 233468999999999999 999999999999999999999999999999998765544332
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
.....-...|.|||.+....++.++|||+|||++|||+| |..||-+.. -.+ + .+.+|.
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~q-I---------L~~iD~--- 330 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQ-I---------LKNIDA--- 330 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHH-H---------HHhccc---
Confidence 222234678999999999999999999999999999999 566775432 111 1 111221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
+.+.+.+..|+..+.++|..||..+|++|||+..|.+.+
T Consensus 331 ---~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 ---GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 112233567788899999999999999999999997443
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=223.93 Aligned_cols=196 Identities=19% Similarity=0.292 Sum_probs=145.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
.+|+....||+|+||.||+|.. ....|++|.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 4677888999999999999996 2467999987543
Q ss_pred ----CC------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 90 ----FP------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 90 ----~~------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
+| ....+..++.|++.||+||| +.+|+|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 11 01335678999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHH
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
|++.......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||.... ....+..
T Consensus 162 ~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--------~~~~~~~- 230 (275)
T cd05046 162 SLSKDVYNSEYYK--LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------DEEVLNR- 230 (275)
T ss_pred ccccccCcccccc--cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------hHHHHHH-
Confidence 9987553322211 112456788999999888888999999999999999999 667764321 1111111
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
...+..... .....+..+.+++.+||+.+|++|||+.|++..|.
T Consensus 231 ~~~~~~~~~--------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELP--------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCC--------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111110 01122335889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=229.47 Aligned_cols=205 Identities=17% Similarity=0.234 Sum_probs=145.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||.|+||.||+|.. +++.+|+|.++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5678888999999999999999 6889999988532
Q ss_pred --CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
++ .......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 01 11456789999999999999 99999999999999999999999999999887654321
Q ss_pred cccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-------
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE------- 224 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 224 (284)
.. ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+.......
T Consensus 162 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 162 PY---TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-----IDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred cc---ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchHHHHH
Confidence 11 124578899999988654 468999999999999999999999864321 11111110000000
Q ss_pred --ccc--------ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 --SFK--------EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 --~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+. ......+... ++.. .....+.+++.+||+.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKK----FPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhcc----cccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0000000000 0000 02444789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=235.64 Aligned_cols=202 Identities=19% Similarity=0.230 Sum_probs=156.7
Q ss_pred CCCeeeecCCceEEEEEeCC-cceEEEeecCCCCCc--------------------------------------------
Q 039895 59 GGKVIMKCLFYKLYKGFLQD-RPISVMKFEDTFPFS-------------------------------------------- 93 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~-------------------------------------------- 93 (284)
..++||+|.||.|..+..+| ..||||.++...|..
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 45689999999999999965 999999998772211
Q ss_pred ---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 94 ---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 ---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
..-++|+.||+.|++||. +.++|||||.++|+|++.++++||+|||+++.+.++.++.....
T Consensus 622 LnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 622 LNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred HHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 345689999999999999 99999999999999999999999999999998888776654332
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT--GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
.+-+..|||||.+..+++++++|||+||+++||+++ ...|+.... .....+........+...-.
T Consensus 699 -~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~~~------- 765 (807)
T KOG1094|consen 699 -AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQVV------- 765 (807)
T ss_pred -eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCccee-------
Confidence 456889999999999999999999999999999876 556664322 11122222222211111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.+.+.-|+..+.++|.+||..+-.+|||++++...|++..
T Consensus 766 -----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 -----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1224456667889999999999999999999999998753
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=227.36 Aligned_cols=209 Identities=21% Similarity=0.328 Sum_probs=144.3
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||+|+||.||+|.+ +++.||+|++... +
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 577788999999999999999 6889999987532 1
Q ss_pred C---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 P---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
+ .....+.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-- 156 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-- 156 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--
Confidence 1 11456778999999999999 899999999999999999999999999998776443221
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--Cccccccc-
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN--ESFKEIVD- 231 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 231 (284)
.....++..|+|||++.+. .++.++||||||+++|||++|..||.... ......... ..... .......+
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS----DIDQLYHII-KCLGNLIPRHQEIFQK 230 (286)
T ss_pred -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHHH-HHhCCCchhhHHHhcc
Confidence 1124678999999988653 47889999999999999999998875432 000000000 00000 00000000
Q ss_pred -----ccccCCCCCCCh---hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 -----PAIVGEEGLMWP---EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 -----~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...........+ .....+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 01123455889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=223.61 Aligned_cols=197 Identities=18% Similarity=0.330 Sum_probs=142.7
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||.||+|.. +|+.||+|.+...
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 55678999999999999987 7889999987421
Q ss_pred ------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 ------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
++. ...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 110 0345678999999999999 8999999999999999999999999999987654
Q ss_pred CCCccccCCCCcccCccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
...... ......|+..|+|||++.... ++.++|+||||+++|++++|..|+.... ...... .... ...
T Consensus 160 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~~~~~-~~~~-~~~ 229 (272)
T cd06629 160 DIYDND-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-------AIAAMF-KLGN-KRS 229 (272)
T ss_pred cccccc-ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-------hHHHHH-Hhhc-ccc
Confidence 321111 112246889999999987654 7899999999999999999999985322 011111 1100 000
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...+.... ....+..+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDV----------SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCccc----------cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111100 11233458899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=229.14 Aligned_cols=214 Identities=16% Similarity=0.176 Sum_probs=146.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------CC----------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------FP---------- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------~~---------- 91 (284)
.++|...+.||+|+||.||+|.. ++..+|+|++... .+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47888899999999999999998 7889999987422 00
Q ss_pred --------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 92 --------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 92 --------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
.......++.|+++||.||| +.+|+|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 00445678999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCccc--------cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHH
Q 039895 146 SIPEGETHI--------NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216 (284)
Q Consensus 146 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 216 (284)
......... .......+++.|+|||.+.+. .++.++|||||||++|||++|.+||.... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~-----~~~~~~~ 238 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS-----DIDQLHL 238 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence 654322111 111224678889999987654 57899999999999999999999886432 1111111
Q ss_pred HHHHhhcC---cc------cccccccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 217 VKKYIENE---SF------KEIVDPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 217 ~~~~~~~~---~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+....... .+ ....+........... .........+.+++.+||+.+|.+|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111000 00 0000000000000000 000112245789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=227.40 Aligned_cols=211 Identities=16% Similarity=0.202 Sum_probs=145.3
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|...+.||+|++|.||+|.. +|..||+|++... +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 366778999999999999998 7899999998643 1
Q ss_pred C---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 P---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
+ ....+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-- 155 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-- 155 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC--
Confidence 1 11446678999999999999 999999999999999999999999999998876543321
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---cccccc-
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEIV- 230 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 230 (284)
......|+..|+|||++.+. .++.++||||+||+++++++|.++|.... .......+....... .+++..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhccC
Confidence 11124688999999988654 46899999999999999999976664322 111111111111000 000000
Q ss_pred --cc---cccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 --DP---AIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 --~~---~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+. .........+ .........+.+++.+||+.+|++|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0011223568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=221.20 Aligned_cols=189 Identities=23% Similarity=0.299 Sum_probs=143.0
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|++|.||+|.. ++..|++|.+...
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 56678999999999999998 6899999987532
Q ss_pred -C---------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -F---------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~---------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+ ........++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~- 157 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF- 157 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccccc-
Confidence 0 011445578999999999999 99999999999999999999999999999876644321
Q ss_pred ccCCCCcccCccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.....|+..|+|||.+.... ++.++|+||||+++|++++|..||.... .................
T Consensus 158 ---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~--- 223 (258)
T cd06632 158 ---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELPPI--- 223 (258)
T ss_pred ---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCCCc---
Confidence 12256889999999987766 8999999999999999999999985422 11111111110111110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+......+.+++.+||+.+|++|||+.+++.
T Consensus 224 ------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 ------------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112234778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=223.90 Aligned_cols=191 Identities=21% Similarity=0.324 Sum_probs=143.6
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
.|+..+.||+|+||.||+|.+ ++..||+|.+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999998 7899999987532
Q ss_pred -CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 -FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 -~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
++ .....+.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 00 00456778999999999999 999999999999999999999999999998776543321
Q ss_pred cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....|+..|+|||.+.++ .++.++||||||+++|+|++|..||.... ....... .... ..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--------~~~~~~~-~~~~-----~~~~ 221 (277)
T cd06917 158 --RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--------AFRAMML-IPKS-----KPPR 221 (277)
T ss_pred --cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--------hhhhhhc-cccC-----CCCC
Confidence 1225688999999987654 57899999999999999999999986432 0111100 0000 0011
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+... .....+.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---------GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1000 12334789999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=259.02 Aligned_cols=198 Identities=22% Similarity=0.268 Sum_probs=150.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
.+-.+..+++||.|.||.||-|.. +|...|+|.+.-.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 445677889999999999999998 8899999987644
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
||.+ .-...+..|++.|++||| ..|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 5544 122357889999999999 99999999999999999999999999999998865531
Q ss_pred c-ccCCCCcccCccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 H-INDSNRVIGTFGFMAPEYRTTGD---FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~-~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
. ...-....||+.|||||++.+.. ...+.||||+||++.||+||+.||.... ..++.+..-. -+..+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d------ne~aIMy~V~--~gh~P- 1460 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD------NEWAIMYHVA--AGHKP- 1460 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc------chhHHHhHHh--ccCCC-
Confidence 1 12223468999999999997653 5578999999999999999999996432 1111111111 11111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+.+.....+-.+++.+||..||..|-++.|+++.
T Consensus 1461 --------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 --------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1233345556799999999999999999888753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=221.28 Aligned_cols=159 Identities=18% Similarity=0.225 Sum_probs=109.4
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC-
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT- 174 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 174 (284)
...++.||+.||.||| +.+++||||||+|||++.++.++|+|||++......... .......++..|+|||++..
T Consensus 101 ~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 176 (268)
T cd05086 101 LQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI-ETEDDKCVPLRWLAPELVGEF 176 (268)
T ss_pred HHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhh-hcccCCcCcccccCchhcccc
Confidence 3568899999999999 999999999999999999999999999987643222111 11122567889999998743
Q ss_pred ------CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHH
Q 039895 175 ------GDFSEKSDVYSFGALLLELLTG-KKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ 247 (284)
Q Consensus 175 ------~~~~~~~DvwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
..++.++|||||||++|||+++ ..||.... ........... ......++.+...
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~-~~~~~~~~~~~~~---------- 237 (268)
T cd05086 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKD-QQVKLFKPQLELP---------- 237 (268)
T ss_pred cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhh-cccccCCCccCCC----------
Confidence 2457899999999999999975 44553221 11112111111 1112222222111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 248 QLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 248 ~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
....+.+++..|| .+|++|||+.+|++.|.
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1233678999999 67999999999988873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=223.95 Aligned_cols=184 Identities=21% Similarity=0.295 Sum_probs=138.5
Q ss_pred eeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------------CCC
Q 039895 62 VIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------------FPF 92 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------------~~~ 92 (284)
+||+|+||.||++.. +++.||+|.+... +|.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999988 6889999987532 110
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
...+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----- 152 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----- 152 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-----
Confidence 0456779999999999999 89999999999999999999999999999876543221
Q ss_pred CCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....|+..|+|||++.++ .++.++||||+||++|+|++|..||....... ... ........ ...+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~-~~~~~~~~------~~~~-- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE-IDRMTLTM------AVEL-- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHH-HHHHhhcc------CCCC--
Confidence 124689999999998754 68999999999999999999999986542110 011 00000000 0000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+...+..+.+++.+||..+|++|| ++.++++
T Consensus 219 --------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 --------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111234478999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=228.51 Aligned_cols=214 Identities=18% Similarity=0.196 Sum_probs=148.5
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------CC--------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------FP-------- 91 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------~~-------- 91 (284)
.+.++|+..+.||+|+||.||+|.. +|..||+|++... .+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999999 6889999998532 00
Q ss_pred ------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 92 ------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 92 ------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
.......++.|++.||+||| +.+|+|+||+|+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 00456788999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
|++.......... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.... .......+...
T Consensus 161 g~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~~~~~~ 233 (302)
T cd07864 161 GLARLYNSEESRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLELISRL 233 (302)
T ss_pred cccccccCCcccc--cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 9987765433211 1113467889999987653 57889999999999999999998886422 11111111111
Q ss_pred hhcC---ccccccccccc----CCCCCCC---hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 221 IENE---SFKEIVDPAIV----GEEGLMW---PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 221 ~~~~---~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... .++.+...... ....... ......+..+.+++..||+.+|++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110 11111000000 0000000 001112445889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=220.51 Aligned_cols=199 Identities=23% Similarity=0.246 Sum_probs=153.5
Q ss_pred HhcCCCC-CCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 53 ATDDFDG-GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
+|++|+. .++||-|-.|.|..+.. ++..+|+|++...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 4566654 35899999999999998 8999999998765
Q ss_pred C------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeeccccccccC
Q 039895 90 F------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ~------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~~ 148 (284)
- ..+...-.|+.||+.|+.||| +.+|.||||||+|+|... |..+||+|||+|+.-.
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 1 111556689999999999999 999999999999999974 4578999999998765
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.... ..+.+.||.|.|||++....|+..+|+||+||++|-|++|.+||++..- ..+..-.+..+.
T Consensus 216 ~~~~----L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~------ 280 (400)
T KOG0604|consen 216 EPGD----LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIR------ 280 (400)
T ss_pred CCcc----ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhh------
Confidence 3221 2236779999999999999999999999999999999999999987541 111111111111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.+...-++..+.+....++++.+|..+|.+|.|+.++++
T Consensus 281 ------~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 ------TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ------ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 12222223445566777889999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=226.03 Aligned_cols=196 Identities=24% Similarity=0.293 Sum_probs=145.8
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
.++++|...+.||+|++|.||+|.. +++.+++|++...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4568899999999999999999999 6788999997643
Q ss_pred -------CCCc-------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccc
Q 039895 90 -------FPFS-------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143 (284)
Q Consensus 90 -------~~~~-------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~ 143 (284)
+|.. .....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 0000 223458999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
+......... .....|+..|+|||++.. ..++.++|||||||+++++++|..||.... . .....
T Consensus 160 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~----~~~~~ 228 (275)
T cd06608 160 SAQLDSTLGR---RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH----P----MRALF 228 (275)
T ss_pred ceecccchhh---hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc----h----HHHHH
Confidence 8765432221 112568899999998753 246789999999999999999999986422 0 01111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ......+ .........+.+++.+||..||++|||+.++++
T Consensus 229 ~~~-~~~~~~~-------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIP-RNPPPTL-------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred Hhh-ccCCCCC-------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 1100010 111223445889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=225.29 Aligned_cols=186 Identities=20% Similarity=0.223 Sum_probs=139.1
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------CC--
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------------FP-- 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------------~~-- 91 (284)
+.||+|+||.||+|.. +|+.||+|.+... +|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999998 7889999988542 11
Q ss_pred -------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 92 -------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 92 -------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-------~ 151 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------K 151 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc-------c
Confidence 11456789999999999999 999999999999999999999999999988764331 1
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...|++.|+|||.+.+..++.++||||||+++|++++|..||.... ......... ..... . ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~-~-~~------ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNIL-SRRIN-W-PE------ 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-hcccC-C-CC------
Confidence 2467889999999988888999999999999999999999986432 111111111 11000 0 00
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
......+..+.+++.+||+.+|++||++.++.+.|
T Consensus 215 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 ----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00112334478999999999999999775544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=224.30 Aligned_cols=191 Identities=21% Similarity=0.280 Sum_probs=146.3
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
.|+..+.||+|+||.||.+.. +|+.||+|.+... +
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 366778999999999999998 7889999987532 1
Q ss_pred CC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+. ....+.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 11 1345788999999999999 899999999999999999999999999998766443221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ....|++.|+|||++.+..++.++|||||||+++++++|..|+.... ....+..... +....
T Consensus 158 ~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~~~----- 220 (256)
T cd08218 158 A---RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIR-GSYPP----- 220 (256)
T ss_pred h---hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhc-CCCCC-----
Confidence 1 12457889999999988889999999999999999999999986422 1122222111 11110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 221 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223347899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=219.71 Aligned_cols=189 Identities=21% Similarity=0.324 Sum_probs=142.9
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|...+.||+|+||.||++.. ++..+|+|.+... +
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 366778999999999999988 7889999987543 0
Q ss_pred C-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-CcceeeccccccccCCCCc
Q 039895 91 P-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~~ 152 (284)
+ .+.....++.+++.||.||| +.+++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 0 01345678999999999999 9999999999999999855 4689999999987654322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ....|+..|+|||.+....++.++||||||+++|++++|..||.... .......... ......
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~--- 221 (256)
T cd08220 158 A----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMS-GTFAPI--- 221 (256)
T ss_pred c----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHHh-cCCCCC---
Confidence 1 12467889999999988888999999999999999999999985432 1111111111 111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+.+++.+||+.+|++|||+.|++.
T Consensus 222 ------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0112334789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=224.92 Aligned_cols=208 Identities=16% Similarity=0.167 Sum_probs=142.3
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~ 91 (284)
|+..+.||.|++|.||+|.. +|..||+|++... ++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678999999999999998 7899999987532 00
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
....++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-- 155 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-- 155 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence 11455789999999999999 899999999999999999999999999998765332111
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--------c
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--------F 226 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 226 (284)
.....+++.|+|||++.+. .++.++||||||+++|+|++|..||.... ................. .
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS----EIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 1113568899999987654 57899999999999999999999986432 11111111111000000 0
Q ss_pred cccccccccCCC-CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPAIVGEE-GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
++... ...... .............+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKP-TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhh-hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000 0000001112245789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=239.65 Aligned_cols=196 Identities=21% Similarity=0.319 Sum_probs=153.1
Q ss_pred CCCeeeecCCceEEEEEe--CC----cceEEEeecCC-----------------------------CCCc----------
Q 039895 59 GGKVIMKCLFYKLYKGFL--QD----RPISVMKFEDT-----------------------------FPFS---------- 93 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~--~~----~~vavK~~~~~-----------------------------~~~~---------- 93 (284)
...+||+|+||+||+|.| .| -+||+|++... .|..
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 356899999999999999 44 47999998765 1111
Q ss_pred ------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 94 ------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 94 ------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
...+.+..|||+||.||| .+.++||||-.+|||+.+-..+||.|||+++.+........
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 567789999999999999 99999999999999999999999999999998876544332
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
... ..-.+.|||-|.+....|+.++|||||||++||++| |..|++... ..-+...++.+
T Consensus 857 ~~~-gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---------~~eI~dlle~g---------- 916 (1177)
T KOG1025|consen 857 APG-GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---------AEEIPDLLEKG---------- 916 (1177)
T ss_pred ccc-cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---------HHHhhHHHhcc----------
Confidence 221 223578999999999999999999999999999998 777876433 11111111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+.+.++.+...+..+|.+||..|+..||+++++...+.++..
T Consensus 917 -----eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 917 -----ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1123345566678999999999999999999999998877653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=219.65 Aligned_cols=192 Identities=25% Similarity=0.285 Sum_probs=146.6
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||.|+||.||.+.. ++..+++|.+... +
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 367778999999999888887 7889999986543 1
Q ss_pred CCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
|.. .....++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 110 345678999999999999 899999999999999999999999999998776443321
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||.... ......... .+.....
T Consensus 158 ---~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~~~~---- 221 (256)
T cd08221 158 ---AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIV-QGNYTPV---- 221 (256)
T ss_pred ---ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCCCCC----
Confidence 122568999999999988888999999999999999999999885422 112222211 1111110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
.......+.+++.+||+.+|++|||+.++++.+
T Consensus 222 -----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112233478999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=221.99 Aligned_cols=190 Identities=24% Similarity=0.340 Sum_probs=144.5
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CCC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FPF 92 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~~ 92 (284)
|+..+.||+|+||.||+|.. ++..||+|++... +|.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 55677899999999999987 7789999987533 111
Q ss_pred --------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCC
Q 039895 93 --------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 --------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+...... ..
T Consensus 86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~---~~ 159 (277)
T cd06641 86 GGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RN 159 (277)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh---hc
Confidence 1456789999999999999 999999999999999999999999999998766432211 12
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...++..|+|||.+.+..++.++|+|||||++|++++|..|+.... . ...... ........ +
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~---~~~~~~-~~~~~~~~-----~---- 221 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----P---MKVLFL-IPKNNPPT-----L---- 221 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----h---HHHHHH-HhcCCCCC-----C----
Confidence 2467889999999988888999999999999999999999885322 1 111111 11111100 0
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....+..+.+++.+||+.+|++||++.++++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223347899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=231.67 Aligned_cols=216 Identities=20% Similarity=0.202 Sum_probs=147.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------CC--------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------FP-------- 91 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------~~-------- 91 (284)
..++|...+.||+|+||.||+|.+ +|..+|+|++... +|
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456788889999999999999998 6889999977431 00
Q ss_pred --------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 92 --------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 92 --------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
....+..++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 00344568999999999999 9999999999999999999999999999998765433
Q ss_pred cc--ccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-----
Q 039895 152 TH--INDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN----- 223 (284)
Q Consensus 152 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (284)
.. ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .............
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST-----LNQLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHH
Confidence 21 111122568999999998754 4578899999999999999999999854321 0000000000000
Q ss_pred ------CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ------ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......++....................+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000000011134558899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=224.84 Aligned_cols=209 Identities=17% Similarity=0.186 Sum_probs=144.5
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC--------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF-------------------------------------------- 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------------------------------------------- 90 (284)
|+..+.||+|++|.||+|.. ++..+|+|++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 45567899999999999998 57899999986430
Q ss_pred ----------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 ----------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ----------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
......+.++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 000355789999999999999 8999999999999999999999999999998765443211
Q ss_pred cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---cccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEIV 230 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 230 (284)
.....++..|+|||.+.+ ..++.++||||||+++||+++|..||.... .......+....... .+....
T Consensus 158 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 158 --YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST-----ELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred --ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCchhhccccc
Confidence 112456888999997664 457899999999999999999999986432 111111111111110 011100
Q ss_pred cc----cccCCCCCCC---hhhHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DP----AIVGEEGLMW---PEKEQ-QLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~----~~~~~~~~~~---~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+. .......... ..... ++..+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000000000 00011 2556889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=226.12 Aligned_cols=188 Identities=21% Similarity=0.251 Sum_probs=151.4
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
.|+..+.||+|.||.|-+++. .|+.||||.+.+.
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 456667899999999999998 8999999998766
Q ss_pred ---------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 ---------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ---------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
...+.....++.||.+|+.|+| .++++|||||.+|||+|.|+++||+|||++..+.......
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 1111566789999999999999 9999999999999999999999999999998877655432
Q ss_pred cCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
+++|++.|.+||++.+.+|. +.+|.||+||+||-|+.|..||++.. ...+++.. ..+...+.-.
T Consensus 211 ----TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQI-s~GaYrEP~~-- 275 (668)
T KOG0611|consen 211 ----TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQI-SRGAYREPET-- 275 (668)
T ss_pred ----HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHh-hcccccCCCC--
Confidence 38899999999999999985 78999999999999999999997643 22233222 2222222111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+....-||.+||-.+|++|.|+.+|...
T Consensus 276 ---------------PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 276 ---------------PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1125579999999999999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=231.09 Aligned_cols=208 Identities=17% Similarity=0.237 Sum_probs=150.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------CCCc------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------FPFS------------ 93 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------~~~~------------ 93 (284)
++.|....++|+|.||.|-++.+ .+..||||+++.. .|..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 56788888999999999999999 6789999998754 0100
Q ss_pred ------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-----------------
Q 039895 94 ------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE----------------- 132 (284)
Q Consensus 94 ------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~----------------- 132 (284)
.....++.|++++++||| +.+++|-||||+|||+.+
T Consensus 168 ivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 168 IVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred EEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 567789999999999999 999999999999999942
Q ss_pred ---CCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 039895 133 ---ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE 209 (284)
Q Consensus 133 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~ 209 (284)
+..+++.|||.|.......+. .+.|..|+|||++.+-.++.++||||+||||.|+.||...|+... +.+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~------iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe--n~E 316 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHST------IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE--NLE 316 (415)
T ss_pred cCCCcceEEEecCCcceeccCcce------eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC--cHH
Confidence 235789999999776554432 678999999999999999999999999999999999999987644 112
Q ss_pred cccHHHHHHHHhhc-----------------Cc--cccccccc-ccCCCCCCCh------hhHHHHHHHHHHHHHhhcCC
Q 039895 210 DYRLQDLVKKYIEN-----------------ES--FKEIVDPA-IVGEEGLMWP------EKEQQLLICTELAFKCLSES 263 (284)
Q Consensus 210 ~~~~~~~~~~~~~~-----------------~~--~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~l~~~cl~~~ 263 (284)
.. .+.+....+ +. +.+...+. .......+-| ....+...+.+|+.+||..|
T Consensus 317 HL---aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 317 HL---AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HH---HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 11 122221111 10 00000000 0000000001 01233445899999999999
Q ss_pred CCCCCCHHHHHH
Q 039895 264 EGDRPTIVQVAK 275 (284)
Q Consensus 264 p~~Rps~~ev~~ 275 (284)
|.+|+|+.|++.
T Consensus 394 P~~RiTl~EAL~ 405 (415)
T KOG0671|consen 394 PARRITLREALS 405 (415)
T ss_pred ccccccHHHHhc
Confidence 999999999975
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=219.90 Aligned_cols=194 Identities=23% Similarity=0.272 Sum_probs=144.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
.+|...+.||+|+||.||+|.. ++..||+|.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3688899999999999999998 7899999986421
Q ss_pred -----CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 00 00345678999999999999 99999999999999999999999999999976643
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
............|+..|+|||++.+..++.++|+|||||+++++++|..||.... .... +....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~-~~~~~~~~-~~~~ 229 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAA-IFKIATQP-TKPM 229 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHH-HHHHHcCC-CCCC
Confidence 2111111122568899999999988888999999999999999999999985321 1111 11111111 0011
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ +......+.+++.+||. +|..|||+.+++.
T Consensus 230 ~--------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 L--------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C--------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 12233447899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=220.02 Aligned_cols=195 Identities=21% Similarity=0.307 Sum_probs=150.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|+..+.||+|++|.||++.. ++..|++|++... +
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 4688889999999999999999 5899999987654 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+. ...++.++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 11 0456789999999999999 8 999999999999999999999999999987765433221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
....++..|+|||.+....++.++||||||+++|++++|..|+..... ............. .....
T Consensus 158 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~-~~~~~----- 223 (264)
T cd06623 158 ---NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDG-PPPSL----- 223 (264)
T ss_pred ---cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcC-CCCCC-----
Confidence 124678899999999888899999999999999999999999865421 1122222222111 11000
Q ss_pred cCCCCCCChhhHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 235 VGEEGLMWPEKEQ-QLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 235 ~~~~~~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
... .+..+.+++.+||+.+|++|||+.++++.
T Consensus 224 ----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 33458899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=228.62 Aligned_cols=212 Identities=18% Similarity=0.213 Sum_probs=148.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP------------------------------------------ 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------------------------------------------ 91 (284)
+|...+.||.|++|.||+|.. ++..||+|++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 366778999999999999998 589999998764310
Q ss_pred --------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 92 --------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 92 --------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
.......++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 00334568999999999999 9999999999999999999999999999998775543
Q ss_pred ccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc-----
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES----- 225 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (284)
..........++..|+|||++.+. .++.++||||||+++|+|++|..||..... ......+........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-----IDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHhcCCCChhHhh
Confidence 211112225678899999999887 789999999999999999999999865431 111111111100000
Q ss_pred ------ccccccccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 226 ------FKEIVDPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 226 ------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....+.. ........+ .........+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000 000000000 0011134557899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=223.88 Aligned_cols=200 Identities=23% Similarity=0.205 Sum_probs=146.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||.|++|.||++.. ++..+|+|.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577788999999999999999 6889999988643
Q ss_pred -CCCc-------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FPFS-------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~~~-------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 1110 234468999999999999 99999999999999999999999999999866543
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... ...++..|+|||.+.+..++.++|||||||++|+|++|..||......... ..+..... .......+
T Consensus 158 ~~~~-----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~-~~~~~~~~ 228 (287)
T cd06621 158 SLAG-----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYI-VNMPNPEL 228 (287)
T ss_pred cccc-----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC---hHHHHHHH-hcCCchhh
Confidence 2211 145788999999998888999999999999999999999998754311111 11111111 11111111
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+. . +........+.+++.+||+.+|++|||+.|++.
T Consensus 229 ~~~-~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDE-P--------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccC-C--------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 0 000122345889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=235.72 Aligned_cols=187 Identities=24% Similarity=0.269 Sum_probs=148.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
++.|.....+|.|+|+.|-++.. ++...+||++...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 45666777899999999999998 8889999998765
Q ss_pred ----------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE-ecCCcceeeccccccccCCCCccccCCC
Q 039895 90 ----------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL-QEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 90 ----------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
......+..|+.+|+.|+.||| ++|+|||||||+|||+ ++.++++|+|||.++.......
T Consensus 401 ~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~------ 471 (612)
T KOG0603|consen 401 GELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD------ 471 (612)
T ss_pred cHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc------
Confidence 0000345569999999999999 9999999999999999 6899999999999988765511
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
+..-|..|.|||++....|+.++|+||||++||+|++|+.||..... + ..+...+..+.+.
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~--~------~ei~~~i~~~~~s----------- 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA--G------IEIHTRIQMPKFS----------- 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc--h------HHHHHhhcCCccc-----------
Confidence 14568899999999988999999999999999999999999975431 1 1122222222222
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+....+|+.+||+.||.+||++.++..
T Consensus 533 -------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 233445789999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=238.99 Aligned_cols=152 Identities=26% Similarity=0.403 Sum_probs=119.3
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCCCccccCCCCcccCccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYR 172 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 172 (284)
.....|+.||++||.|||.. .++|+|||||.+||+|+. .|.+||+|+|+|.......... ..|||.|||||++
T Consensus 143 kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks-----vIGTPEFMAPEmY 216 (632)
T KOG0584|consen 143 KAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS-----VIGTPEFMAPEMY 216 (632)
T ss_pred HHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccce-----eccCccccChHHH
Confidence 44567999999999999976 789999999999999974 5899999999998876543322 6899999999988
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 173 TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 173 ~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
. ..|+..+||||||++++||+|+..|+.... ....+..-+-....+..+..+-|| ++
T Consensus 217 E-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~SGiKP~sl~kV~dP------------------ev 273 (632)
T KOG0584|consen 217 E-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTSGIKPAALSKVKDP------------------EV 273 (632)
T ss_pred h-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHcCCCHHHhhccCCH------------------HH
Confidence 7 789999999999999999999999986432 222222222222233333333332 27
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.++|.+|+.. .+.|||+.|+++
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHhh
Confidence 8999999999 999999999985
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=224.00 Aligned_cols=187 Identities=18% Similarity=0.258 Sum_probs=143.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +++.||+|++...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3577788999999999999999 7899999988532
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ...+..++.|++.||.||| +.+++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~-- 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-- 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence 121 1456678999999999999 9999999999999999999999999999987765431
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....|++.|+|||.+.+...+.++||||||+++|+|++|..||.... ......... .+... +
T Consensus 156 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~--~--- 217 (290)
T cd05580 156 ----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKIL-EGKVR--F--- 217 (290)
T ss_pred ----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh-cCCcc--C---
Confidence 12568899999999988888999999999999999999999986432 111111111 11100 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+......+.+++.+||+.+|.+|| ++.|+++
T Consensus 218 -----------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 -----------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -----------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011123478999999999999999 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=225.98 Aligned_cols=187 Identities=22% Similarity=0.304 Sum_probs=140.8
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------C
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------F 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~ 90 (284)
|+..+.||+|+||.||+|.. ++..+|+|.+... +
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55567899999999999998 7788999987531 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|. ......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---- 169 (308)
T cd06634 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---- 169 (308)
T ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence 11 1455678999999999999 9999999999999999999999999999987654321
Q ss_pred CCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
...|++.|+|||.+. ...++.++|||||||++|++++|..|+.... ......... ....+...
T Consensus 170 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~~-- 235 (308)
T cd06634 170 ---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIA-QNESPALQ-- 235 (308)
T ss_pred ---cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHh-hcCCCCcC--
Confidence 146788999999874 3467889999999999999999999975421 011111111 11111100
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++.+||+.+|++||++.++++.
T Consensus 236 ------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ------------cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11233447899999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=230.55 Aligned_cols=212 Identities=16% Similarity=0.225 Sum_probs=143.8
Q ss_pred CCCCCCeeeecCCceEEEEEe--C--CcceEEEeecCC------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--Q--DRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~--~~~vavK~~~~~------------------------------------------ 89 (284)
+|...+.||+|+||.||++.. . +..||+|++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 366678899999999999999 4 678999987532
Q ss_pred ------CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ------FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ------~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .......++.||+.||.||| ..+|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 00 01455678999999999999 99999999999999999999999999999987654
Q ss_pred CCccc-cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---
Q 039895 150 GETHI-NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE--- 224 (284)
Q Consensus 150 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 224 (284)
..... .......||+.|+|||++.+ ..++.++||||+||++|++++|..||..... ..............
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLGTPDEE 232 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhCCCCHH
Confidence 32211 11122578999999998765 4688999999999999999999998864321 01111000000000
Q ss_pred cccccccc-------cccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDP-------AIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+..+.++ .........++ ........+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00000000000 00112345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=221.88 Aligned_cols=208 Identities=17% Similarity=0.187 Sum_probs=146.2
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~ 91 (284)
|+..+.||+|++|.||+|.. ++..+++|.+... ++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 44567899999999999998 7889999987543 11
Q ss_pred C---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 F---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
. ...+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~--- 154 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--- 154 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc---
Confidence 0 0455679999999999999 999999999999999999999999999998777544311
Q ss_pred CCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccccccc-
Q 039895 157 SNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEIVD- 231 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 231 (284)
.....++..|+|||.+.+. .++.++||||+|+++|++++|+.||.... .......+....... .+....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS-----EIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCchHhcccchhh
Confidence 1114578899999998776 78899999999999999999998885432 111111111110000 0000000
Q ss_pred -----ccccCCCCC-CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 -----PAIVGEEGL-MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 -----~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......... ...........+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000 00112234566889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=229.64 Aligned_cols=213 Identities=17% Similarity=0.198 Sum_probs=148.4
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------- 89 (284)
++..++++|+..+.||.|+||.||++.. ++..||+|++...
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4455788999999999999999999987 7889999987432
Q ss_pred -------CCC-------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -------FPF-------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -------~~~-------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. ......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 000 0334568999999999999 99999999999999999999999999999875432
Q ss_pred CCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-----
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN----- 223 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (284)
.. ....++..|+|||.+.+ ..++.++|||||||+++++++|..||.... .......+......
T Consensus 161 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-----~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 161 QM------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-----HVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred Cc------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCCHHH
Confidence 21 12467889999998765 568999999999999999999999885432 00000001010000
Q ss_pred ------CcccccccccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ------ESFKEIVDPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....+.+. .+......... ........+.+++.+||+.+|++|||+.+++..
T Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccchhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000000000 001123568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=223.45 Aligned_cols=195 Identities=26% Similarity=0.335 Sum_probs=150.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||.|.-|+||.+.. .+..+|+|++.+.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3455567899999999999999 4589999999766
Q ss_pred -CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
||.. .....++.+++.||+||| -.|||.|||||+|||+.++|.+.|+||.++.......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 4443 445568999999999999 9999999999999999999999999999875442100
Q ss_pred c--------------------------------c---------------------ccCCCCcccCccccccccccCCCCC
Q 039895 152 T--------------------------------H---------------------INDSNRVIGTFGFMAPEYRTTGDFS 178 (284)
Q Consensus 152 ~--------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 178 (284)
+ . ......++||-.|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0011247899999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHH
Q 039895 179 EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFK 258 (284)
Q Consensus 179 ~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 258 (284)
.++|-|+|||++|||+.|..||.+.. . ...+.+++-.. ..+|..+.....+.+||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~----~-------------~~Tl~NIv~~~------l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSN----N-------------KETLRNIVGQP------LKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCC----c-------------hhhHHHHhcCC------CcCCCCCcchhHHHHHHHH
Confidence 99999999999999999999998654 1 11122222111 1223333555668999999
Q ss_pred hhcCCCCCCCC----HHHHHH
Q 039895 259 CLSESEGDRPT----IVQVAK 275 (284)
Q Consensus 259 cl~~~p~~Rps----~~ev~~ 275 (284)
.|..||.+|.. +.||.+
T Consensus 371 LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 371 LLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HhccChhhhhccccchHHhhc
Confidence 99999999997 777654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=223.88 Aligned_cols=187 Identities=24% Similarity=0.314 Sum_probs=140.1
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------C
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------F 90 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~ 90 (284)
|...+.||+|+||.||+|.. +|..||+|++... +
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567899999999999998 7889999998532 1
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|.. ..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----- 174 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----- 174 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence 111 455678999999999999 999999999999999999999999999987543221
Q ss_pred CCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....|+..|+|||++. ...++.++|||||||++|+|++|..|+.... .......... ...+....
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~- 242 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQ-NDSPTLQS- 242 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHh-cCCCCCCc-
Confidence 1256889999999874 4568889999999999999999999986432 1111111111 11111100
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......+.+++.+||+.+|++||++.+++..
T Consensus 243 -------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 -------------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112237789999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=230.13 Aligned_cols=214 Identities=16% Similarity=0.171 Sum_probs=143.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------C----------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------F---------------- 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------~---------------- 90 (284)
+.|...+.||.|+||.||+|.. +|..||+|++... +
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5688889999999999999998 7889999987442 0
Q ss_pred -------------C-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCcceeecccc
Q 039895 91 -------------P-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQLFDFTL 143 (284)
Q Consensus 91 -------------~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~ 143 (284)
+ .+.....++.||+.||.||| +.+|+||||||+||+++ .++.++++|||.
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 0 00355678999999999999 89999999999999997 456789999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
+..+..............++..|+|||++.. ..++.++|||||||++|+|++|..||..... .............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~ 237 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE----LEQMQLILESVPV 237 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCC
Confidence 8766432222111122457889999997654 4678899999999999999999999964320 0000000000000
Q ss_pred -----cCccccccccccc-CCCCCCChh---hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 -----NESFKEIVDPAIV-GEEGLMWPE---KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 -----~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+......... .......+. .......+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000 000000000 0122345789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=221.72 Aligned_cols=209 Identities=19% Similarity=0.183 Sum_probs=141.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|++|.||+|.. +|+.||+|++...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4678888999999999999998 7889999987532
Q ss_pred CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCCCc
Q 039895 90 FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~ 152 (284)
++ .......++.||+.||+||| +.+++|+||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 10 00234468899999999999 999999999999999985 55789999999876543211
Q ss_pred cccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc-
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV- 230 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
. .....+++.|+|||++.+. .++.++|||||||++|+|+||..||..... .......... .... .....
T Consensus 159 ~---~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~~~~-~~~~-~~~~~~ 229 (294)
T PLN00009 159 T---FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKIFRI-LGTP-NEETWP 229 (294)
T ss_pred c---cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHH-hCCC-Chhhcc
Confidence 1 1124578899999987654 578999999999999999999999864320 0011111000 0000 00000
Q ss_pred ------cc--cccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 ------DP--AIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ------~~--~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+- .......... .........+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000000000 001112334789999999999999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=222.11 Aligned_cols=210 Identities=15% Similarity=0.219 Sum_probs=144.6
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~~ 91 (284)
+|+..+.||.|++|.||+|.. +|..||+|++... ++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477788999999999999999 7889999987643 01
Q ss_pred -----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 92 -----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 -----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
.......++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 11445679999999999999 899999999999999999999999999998765432111
Q ss_pred cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--Cccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN--ESFKEIVD 231 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 231 (284)
.....+++.|+|||++.+. .++.++||||||+++|++++|..||..... .............. ..+..+.+
T Consensus 157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhHHHHhc
Confidence 1124578899999987654 578899999999999999999999864321 11111111100000 00000000
Q ss_pred -ccccCCCCCCCh-----hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 -PAIVGEEGLMWP-----EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 -~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.+......... ........+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 01123455789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=214.94 Aligned_cols=191 Identities=25% Similarity=0.311 Sum_probs=145.9
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC-----------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF-----------------------------------------PF 92 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----------------------------------------~~ 92 (284)
+|+..+.||+|++|.||++.. ++..+++|++.... +.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 366778999999999999999 58899999886541 11
Q ss_pred ----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 93 ----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 93 ----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
......++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 1445678999999999999 89999999999999999999999999999877654432
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
.....++..|+|||.+....++.++||||||++++++++|..|+.... . ........ .........
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~-~~~~~~~~~----- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----P---MKALFKIA-TNGPPGLRN----- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----h---HHHHHHHH-hcCCCCcCc-----
Confidence 122568899999999988888999999999999999999999986432 0 11111110 011111100
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+.+++.+||+.+|++|||+.+++.
T Consensus 220 --------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 --------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111344889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=219.49 Aligned_cols=190 Identities=23% Similarity=0.256 Sum_probs=144.6
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
+|...+.||.|+||.||+|.. ++..||+|++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 466778999999999999999 6899999988643
Q ss_pred CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+| .......++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 156 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT- 156 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc-
Confidence 11 01456778999999999999 999999999999999999999999999998776543211
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
....|+..|+|||++....++.++|+||||+++|++++|..||...... ........... ....
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~~~----- 220 (258)
T cd05578 157 ---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--ADVL----- 220 (258)
T ss_pred ---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--cccc-----
Confidence 1256788999999998888999999999999999999999998654310 11111111110 0000
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH--HHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI--VQVA 274 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~--~ev~ 274 (284)
.+...+..+.+++.+||+.+|.+||++ .|++
T Consensus 221 ---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 ---------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011223458899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=230.31 Aligned_cols=208 Identities=18% Similarity=0.264 Sum_probs=146.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC---------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP--------------------------------------- 91 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------------------------------------- 91 (284)
..++|...+.||+|++|.||+|.. ++..||+|++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457788889999999999999999 678999998753200
Q ss_pred -----------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 92 -----------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 92 -----------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
.......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 00345678999999999999 9999999999999999999999999999987664
Q ss_pred CCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
... ....++..|+|||.+.+ ..++.++|||||||++|++++|..||.... .......+..... ....
T Consensus 170 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-----~~~~~~~i~~~~~-~~~~ 237 (343)
T cd07851 170 DEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD-----HIDQLKRIMNLVG-TPDE 237 (343)
T ss_pred ccc------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcC-CCCH
Confidence 331 12467889999998765 367899999999999999999999986432 1111111111000 0000
Q ss_pred cccccc-----------ccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 EIVDPA-----------IVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 ~~~~~~-----------~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.... +.......+ .........+.+++.+||+.+|++|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 000000000 000112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=228.45 Aligned_cols=210 Identities=16% Similarity=0.219 Sum_probs=145.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF---------------------------------------- 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---------------------------------------- 90 (284)
..+.|+..+.||+|+||.||++.. +|..||||++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456788889999999999999988 78999999885320
Q ss_pred ---------C-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 91 ---------P-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 91 ---------~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+ .......++.|++.||+||| ..+|+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 0 00345678999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh-cCcc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE-NESF 226 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (284)
.... ...+++.|+|||++.+ ..++.++|+||+|+++|++++|..||..... ............. ...+
T Consensus 170 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 170 SEMT------GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cCcc------ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHH
Confidence 3221 1467889999998875 3588999999999999999999999864320 0001110000000 0000
Q ss_pred ccccccc-----ccCCCCCCC----hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPA-----IVGEEGLMW----PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+... ......... .........+.+++.+|++.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000000000 001122334789999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=217.13 Aligned_cols=191 Identities=25% Similarity=0.317 Sum_probs=144.5
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||+|+||.||+|.. +|..+|+|.+... +
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 466778999999999999999 6889999998532 1
Q ss_pred C-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCCCc
Q 039895 91 P-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~~ 152 (284)
+ .+.....++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 1 11456788999999999999 99999999999999999886 469999999877654322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.. ....|++.|+|||++....++.++||||||++++++++|..||.... ....+.... .......
T Consensus 158 ~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~--- 222 (257)
T cd08225 158 LA---YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKIC-QGYFAPI--- 222 (257)
T ss_pred cc---cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHh-cccCCCC---
Confidence 11 11468899999999988889999999999999999999999985422 122222211 1111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 223 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ------------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112347899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=218.72 Aligned_cols=207 Identities=16% Similarity=0.162 Sum_probs=142.4
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~ 91 (284)
|...+.||+|++|+||+|.. +++.||+|.+... +|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 45678899999999999999 6788999987543 11
Q ss_pred C----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 F----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
. ....+.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 0 0345778999999999999 999999999999999999999999999998766443221
Q ss_pred CCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---------c
Q 039895 156 DSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---------S 225 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 225 (284)
....++..|+|||++.. ..++.++|+||||++++++++|..||..... .............. .
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE-----IDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh-----HHHHHHHHHhcCCCChhhhhhHhh
Confidence 11467889999998754 4578999999999999999999988854320 00000000000000 0
Q ss_pred ccccccccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+........ .........+.+++.+||+.+|++|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000000000 000111345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=219.97 Aligned_cols=195 Identities=21% Similarity=0.321 Sum_probs=147.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------C
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------F 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~ 90 (284)
.++.|+..+.||+|++|.||+|.+ ++..|++|++... +
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456677788999999999999999 5889999998643 1
Q ss_pred C----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 P----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+ ....+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK- 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh-
Confidence 1 11456779999999999999 999999999999999999999999999988665433211
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.....++..|+|||++.+..++.++||||||+++|++++|..|+.... ......... .......
T Consensus 173 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~----- 236 (286)
T cd06614 173 --RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP--------PLRALFLIT-TKGIPPL----- 236 (286)
T ss_pred --hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hcCCCCC-----
Confidence 112457889999999988889999999999999999999999975322 011111111 1111110
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+........+.+++.+||+.+|..|||+.+++.
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 --------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001113345889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=214.56 Aligned_cols=188 Identities=21% Similarity=0.251 Sum_probs=145.7
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..+.||+|+||.||++.. ++..+|+|.+... +
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467778999999999999988 7789999998643 0
Q ss_pred C-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 91 P-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 ~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+ .......++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 0 00234578999999999999 9999999999999999999999999999997765541
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. ...+++.|+|||.+.+..++.++|+||||+++|++++|..||.... ...... .........
T Consensus 158 ~~-----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~-~~~~~~~~~--- 220 (256)
T cd08530 158 AK-----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRY-KVQRGKYPP--- 220 (256)
T ss_pred cc-----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH-HHhcCCCCC---
Confidence 11 1457889999999988889999999999999999999999986432 111111 111111111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........+.+++.+||+.+|++|||+.++++
T Consensus 221 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 ------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233445889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=220.91 Aligned_cols=199 Identities=22% Similarity=0.252 Sum_probs=144.4
Q ss_pred CCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC-----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~----------------------------------------- 89 (284)
+|...+.||+|++|.||++.. ++..||+|.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 356678999999999999885 4678999988532
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. ......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 110 0345568889999999999 99999999999999999999999999999877644
Q ss_pred CCccccCCCCcccCccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
...... ....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||.... ................
T Consensus 158 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~--- 228 (288)
T cd05583 158 EEEERA--YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----EQNSQSEISRRILKSK--- 228 (288)
T ss_pred cccccc--ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc----ccchHHHHHHHHHccC---
Confidence 322211 1246889999999987654 7889999999999999999999985322 1111111111111100
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+ +.+......+.+++.+||+.+|++|||+.++...|+..
T Consensus 229 ----~----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ----P----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----C----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 00111223478999999999999999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=239.70 Aligned_cols=162 Identities=25% Similarity=0.362 Sum_probs=123.7
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
..+.++.|||.|++||+ +.++|||||-.+|||+..+..+||+|||+++................-+..|||||.+..
T Consensus 419 dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 419 DLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred HHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 45789999999999999 999999999999999999999999999999977665554432211112456999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE 254 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
..|+.++||||||++|||++|...++++.- ........ ....+. +...+..|..++.+
T Consensus 496 ~~ft~kSDVWSfGI~L~EifsLG~~PYp~~------~~~~~l~~-~l~~G~---------------r~~~P~~c~~eiY~ 553 (609)
T KOG0200|consen 496 RVFTSKSDVWSFGILLWEIFTLGGTPYPGI------PPTEELLE-FLKEGN---------------RMEQPEHCSDEIYD 553 (609)
T ss_pred CcccccchhhHHHHHHHHHhhCCCCCCCCC------CcHHHHHH-HHhcCC---------------CCCCCCCCCHHHHH
Confidence 999999999999999999999544433221 11122211 222221 12234556677899
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 255 LAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 255 l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
+|..||+.+|++||++.++.+.++..+
T Consensus 554 iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 554 LMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999999999999999999999999864
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=219.74 Aligned_cols=187 Identities=18% Similarity=0.277 Sum_probs=140.4
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CCC-----
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FPF----- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~~----- 92 (284)
..||+|+||.||++.. ++..||+|++... ++.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4799999999999998 7889999987532 111
Q ss_pred ---------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccC
Q 039895 93 ---------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGT 163 (284)
Q Consensus 93 ---------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 163 (284)
......++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......... .....|+
T Consensus 106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~ 179 (292)
T cd06657 106 DIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGT 179 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc---ccccccC
Confidence 1455678999999999999 899999999999999999999999999988765432211 1225688
Q ss_pred ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCCh
Q 039895 164 FGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWP 243 (284)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
+.|+|||.+....++.++|+||||+++|++++|..||.... .......... ... +.+.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--------~~~~~~~~~~--~~~----~~~~-------- 237 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRD--NLP----PKLK-------- 237 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh--hCC----cccC--------
Confidence 99999999888888999999999999999999999986432 1111111100 000 0000
Q ss_pred hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 244 EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 244 ~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00112234778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=216.66 Aligned_cols=215 Identities=15% Similarity=0.213 Sum_probs=149.2
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|....+||+|.||.||+|.. .|+.||+|+..-.
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 44456899999999999998 7888999876431
Q ss_pred ------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 ------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+|.. ....+++.++..||.|+| ...|+|||+||.|+||+.+|.+||+|||+++.+.
T Consensus 99 ~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 99 FYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 1211 566789999999999999 9999999999999999999999999999998775
Q ss_pred CCCccccC-CCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 149 EGETHIND-SNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 149 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
........ .+..+-|.+|++||.+.+. .|+++.|||.-||++.||+|+.+.+.+.. +.....++.........+.+
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccCCcccC
Confidence 44332221 1224569999999988776 68999999999999999999998876432 11112222222222222333
Q ss_pred cccccccccCCC------CCCChhhHHHH------HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 227 KEIVDPAIVGEE------GLMWPEKEQQL------LICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 227 ~~~~~~~~~~~~------~~~~~~~~~~~------~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+++..-.+.... ...+....+.. +..++|+..++..||.+|++++++++.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 332211111000 00000011111 246799999999999999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=243.70 Aligned_cols=193 Identities=22% Similarity=0.313 Sum_probs=148.4
Q ss_pred CCCCCCeeeecCCce-EEEEEeCCcceEEEeecCC------------------------CCCc-----------------
Q 039895 56 DFDGGKVIMKCLFYK-LYKGFLQDRPISVMKFEDT------------------------FPFS----------------- 93 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~------------------------~~~~----------------- 93 (284)
-|+..+++|.|+.|+ ||+|.++|+.||||.+-.. ||.+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL 589 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSL 589 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhH
Confidence 356677899999995 7999999999999998655 3433
Q ss_pred ----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---C--CcceeeccccccccCCCCc
Q 039895 94 ----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---E--NVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 94 ----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~Dfg~a~~~~~~~~ 152 (284)
...+.++.|+++||++|| +.+||||||||.||||+. + ..++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 123568999999999999 999999999999999986 3 4689999999999988776
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG-KKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.........||-+|+|||++....-+.++||||+||++|.+++| .+||.... .....-...+..+..+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~---------~R~~NIl~~~~~L~~L~- 736 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL---------ERQANILTGNYTLVHLE- 736 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH---------HhhhhhhcCccceeeec-
Confidence 66666668899999999999998888899999999999999997 66774321 00000000011111110
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ..++ +..+||.+|++.+|..||++.+|+.
T Consensus 737 ----~--------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 ----P--------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----c--------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 1112 4779999999999999999999975
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=220.32 Aligned_cols=203 Identities=18% Similarity=0.218 Sum_probs=136.5
Q ss_pred eeeec--CCceEEEEEe--CCcceEEEeecCCC-------------------------------------------CC--
Q 039895 62 VIMKC--LFYKLYKGFL--QDRPISVMKFEDTF-------------------------------------------PF-- 92 (284)
Q Consensus 62 ~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~-------------------------------------------~~-- 92 (284)
.||+| +||+||++.. .|+.||+|++.... +.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 8999999998 89999999986430 00
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc----
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH---- 153 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~---- 153 (284)
......++.|++.||+||| +.+|+||||||+|||++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 0233478999999999999 999999999999999999999999999865433211110
Q ss_pred ccCCCCcccCccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc----
Q 039895 154 INDSNRVIGTFGFMAPEYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK---- 227 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 227 (284)
........++..|+|||++.+. .++.++|||||||++|++++|..||..... ..... .........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~-------~~~~~-~~~~~~~~~~~~~ 233 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR-------TQMLL-QKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh-------HHHHH-HHhcCCCCCCccc
Confidence 0111112356779999998764 478999999999999999999999864320 00000 000000000
Q ss_pred -----------------------cccccc---ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 -----------------------EIVDPA---IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 -----------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...... .........+........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000 000001112233445667899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=212.92 Aligned_cols=190 Identities=24% Similarity=0.380 Sum_probs=145.3
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP------------------------------------------ 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------------------------------------------ 91 (284)
+|+..+.||+|++|.||++.. ++..|++|.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 366778999999999999988 678999999865411
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 11445679999999999999 999999999999999999999999999999877543321
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
.....++..|+|||......++.++||||+|++++++++|..|+.... ...... ... ...... +
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~-~~~-~~~~~~-~----- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALF-RIV-QDDHPP-L----- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHH-HHh-ccCCCC-C-----
Confidence 112467889999999887788999999999999999999999986422 111111 111 111100 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+......+.+++.+||..+|++|||+.+++.
T Consensus 220 ---------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112334789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=215.85 Aligned_cols=185 Identities=19% Similarity=0.242 Sum_probs=139.4
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCCCC-------------------------------------------------
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDTFP------------------------------------------------- 91 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------------------------------------------------- 91 (284)
||.|++|.||++.. ++..+|+|++.....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999 489999999864300
Q ss_pred ----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 92 ----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 92 ----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
.......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~----~~~~~ 153 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWTFC 153 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----ccccc
Confidence 00455678899999999999 99999999999999999999999999999987754321 11246
Q ss_pred cCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCC
Q 039895 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLM 241 (284)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
|++.|+|||.+....++.++|+||||+++|++++|..||..... ................
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-------------- 213 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKL-------------- 213 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCC--------------
Confidence 78899999998888899999999999999999999999864331 1111111111000000
Q ss_pred ChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 242 WPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 242 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
..+......+.+++.+||+.+|++||+ +.|+++
T Consensus 214 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 -EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 001111345889999999999999999 677654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=219.12 Aligned_cols=170 Identities=20% Similarity=0.291 Sum_probs=115.5
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc----ccCCCCcccCcccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH----INDSNRVIGTFGFMAP 169 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aP 169 (284)
.....++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||.+......... ........++..|+||
T Consensus 101 ~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 101 LAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177 (314)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence 345678999999999999 999999999999999999999999999988765332211 1111224577889999
Q ss_pred ccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc--------c----
Q 039895 170 EYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI--------V---- 235 (284)
Q Consensus 170 E~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---- 235 (284)
|++... .++.++|||||||++|||++|..||..... ........ .+.....++... .
T Consensus 178 E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA-------TQMLLEKV--RGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH--hccCccccccCchhhhcCCcCcccc
Confidence 998653 588999999999999999999999864320 01111110 000011000000 0
Q ss_pred ----C--CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 236 ----G--EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 236 ----~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ...............+.+++.+||+.+|++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 000001112233456789999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=214.95 Aligned_cols=189 Identities=21% Similarity=0.293 Sum_probs=139.7
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CC-----
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FP----- 91 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~----- 91 (284)
||.|+||.||++.. +|..+|+|++... ++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999 5899999998543 11
Q ss_pred ----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc-----ccC
Q 039895 92 ----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH-----IND 156 (284)
Q Consensus 92 ----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-----~~~ 156 (284)
....+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 11456679999999999999 999999999999999999999999999998765433211 001
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
.....++..|+|||.......+.++||||||++++++++|..||.... .......... +...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~--------- 219 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-GKIE--------- 219 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCcC---------
Confidence 122567889999999888888999999999999999999999986432 1111111111 1100
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
++.....+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 220 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 220 -----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 011111234578999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=233.10 Aligned_cols=191 Identities=21% Similarity=0.304 Sum_probs=147.7
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-CCCc---------------------------------
Q 039895 50 LKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-FPFS--------------------------------- 93 (284)
Q Consensus 50 l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~--------------------------------- 93 (284)
+....+-|. .+.||+|.||+||-|.+ +|+.||||++.+- ++..
T Consensus 560 ~stvYQif~-devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 560 ISTVYQIFA-DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred HHHHHHhhh-HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 344445555 47999999999999999 9999999999765 0000
Q ss_pred -------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeecccccc
Q 039895 94 -------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTLSL 145 (284)
Q Consensus 94 -------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfg~a~ 145 (284)
.....++.||+.||+||| .++|+|+||||+|||+.+.. .+||||||.|+
T Consensus 639 FVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccccee
Confidence 233457899999999999 99999999999999997543 68999999999
Q ss_pred ccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh---h
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI---E 222 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 222 (284)
.+....... +.+|||.|+|||++....|+...|+||+||++|--++|..||... .++.+.++... .
T Consensus 716 iIgEksFRr----sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNAaFMyP 784 (888)
T KOG4236|consen 716 IIGEKSFRR----SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNAAFMYP 784 (888)
T ss_pred ecchhhhhh----hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhccccccC
Confidence 997655432 378999999999999999999999999999999999999998532 22333332211 1
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
...| .+.....++||...|+..-.+|.|.+..+
T Consensus 785 p~PW-------------------~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPW-------------------SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCch-------------------hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1111 23344477899999999999999887654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=217.62 Aligned_cols=185 Identities=18% Similarity=0.259 Sum_probs=136.2
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CCC----
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FPF---- 92 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~~---- 92 (284)
||+|+||+||++.. +|+.||+|++... ++.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999988 7899999987532 110
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~----~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc----cc
Confidence 0345668999999999999 999999999999999999999999999998765432111 12
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
..++..|+|||++.+..++.++||||||++++++++|..||...... ......... .... ..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~~------~~------- 215 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRR-TLEM------AV------- 215 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhc-cccc------cc-------
Confidence 45788999999998888999999999999999999999998643310 001111100 0000 00
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
..+......+.+++.+||+.+|++|| ++.+++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 ---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00111233478999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=233.23 Aligned_cols=215 Identities=20% Similarity=0.270 Sum_probs=153.0
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
+...+.||+|+||.||+|+. .|+.||||.+...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45567899999999999997 9999999999774
Q ss_pred ---CCCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe--cCC--cceeeccccc
Q 039895 90 ---FPFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ--EEN--VAQLFDFTLS 144 (284)
Q Consensus 90 ---~~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~Dfg~a 144 (284)
||.. ...+.++.+++.||.||| +++|+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 4443 677889999999999999 99999999999999985 334 3599999999
Q ss_pred cccCCCCccccCCCCcccCcccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh-
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRT-TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE- 222 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 222 (284)
+.+.++.... +.+||..|.+||++. ...|+..+|.|||||++|+++||..||.+.. .........+....
T Consensus 172 rel~d~s~~~----S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~----~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 172 RELDDNSLFT----SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG----GPKNNKEIMWHIITK 243 (732)
T ss_pred ccCCCCCeee----eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC----Cccccchhhhhhhcc
Confidence 9998776332 389999999999998 4789999999999999999999999997643 11111111111111
Q ss_pred -cCcccccccccccCC----CCCCChh--hHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHHHHHHh
Q 039895 223 -NESFKEIVDPAIVGE----EGLMWPE--KEQQLLICTELAFKCLSESEGDRP--TIVQVAKQLRQIYQ 282 (284)
Q Consensus 223 -~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~Rp--s~~ev~~~L~~l~~ 282 (284)
.....-..++...+. .....|. .......+-..+..+|..+|.+|- ...+....+.+|+.
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111111111111100 0001111 122223355677778889999998 77777777777664
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=216.40 Aligned_cols=192 Identities=20% Similarity=0.247 Sum_probs=139.5
Q ss_pred CCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------CCCc-----
Q 039895 60 GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------FPFS----- 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------~~~~----- 93 (284)
...||.|.||+|++-.+ .|+..|||.+... .|.+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~S 148 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDIS 148 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhh
Confidence 35799999999999988 8999999998755 1111
Q ss_pred ------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 94 ------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 94 ------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.-.-.|..-.+.||.||-+ ...|||||+||+|||++..|.+||||||++-.+..+-....
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 1111344456789999996 78899999999999999999999999999876644322211
Q ss_pred CCCCcccCccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
-.|...|||||.+... .|+.+|||||+|++|+|+.||..|+..-. ...+.+.... .+..+.+..+.
T Consensus 227 ----daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv-~gdpp~l~~~~ 294 (361)
T KOG1006|consen 227 ----DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVV-IGDPPILLFDK 294 (361)
T ss_pred ----ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHH-cCCCCeecCcc
Confidence 4688999999987643 48999999999999999999999975322 1222222221 22222221111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+....+..++.-||..|.+.||...++.+
T Consensus 295 ----------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 ----------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----------cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 12234455889999999999999999998764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=212.18 Aligned_cols=194 Identities=24% Similarity=0.298 Sum_probs=147.6
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC-------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF------------------------------------------- 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------------------------------------- 90 (284)
+|...+.||+|++|.||+|.. ++..|++|++....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 367778999999999999999 58899999875431
Q ss_pred --C---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 --P---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 --~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+ ....+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 0 00455779999999999999 899999999999999999999999999998877654321
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.......++..|+|||.+....++.++||||||++++++++|..||.... .................
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~----- 224 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEPPE----- 224 (260)
T ss_pred -ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCCcC-----
Confidence 01112568899999999988889999999999999999999999986432 11111111110011111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+......+.+++.+||+.+|++||++.+++.
T Consensus 225 ----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ----------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122445889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=215.50 Aligned_cols=193 Identities=21% Similarity=0.273 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3677788999999999999998 7899999998642
Q ss_pred --CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
++ .......++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 11 11467789999999999999 99999999999999999999999999999877654322
Q ss_pred c-----------------ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHH
Q 039895 153 H-----------------INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 153 ~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 215 (284)
. ........++..|+|||+.....++.++||||||++++++++|..||.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~ 229 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--------EYL 229 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------HHH
Confidence 1 011123567889999999888889999999999999999999999986432 011
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHH
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI----VQVAK 275 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~----~ev~~ 275 (284)
....... .. .. .+...+..+.+++.+||+.+|++|||+ .++++
T Consensus 230 ~~~~~~~-~~--~~--------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKILK-LE--YS--------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHh-cC--CC--------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111110 00 00 011113347899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=222.28 Aligned_cols=208 Identities=15% Similarity=0.176 Sum_probs=141.4
Q ss_pred CCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------------
Q 039895 60 GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------------ 89 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------------ 89 (284)
.+.||+|+||.||+|.. .+..||||++...
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 56799999999999997 7899999987421
Q ss_pred -------CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 -------FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 -------~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
++ .......++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 94 FINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred cEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence 00 01455679999999999999 9999999999999999999999999999987664
Q ss_pred CCCc-----------cccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHH
Q 039895 149 EGET-----------HINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216 (284)
Q Consensus 149 ~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 216 (284)
.... .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-----~~~~~~~ 245 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-----EIDQLGR 245 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence 1110 00111123468889999988764 46899999999999999999999986433 1111111
Q ss_pred HHHHhhcC---cccccccccc-----cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 217 VKKYIENE---SFKEIVDPAI-----VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 217 ~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+....... .++...+... .................+.+++.+||+.+|++|||+.|++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111 0111100000 00000000001122445789999999999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=213.42 Aligned_cols=190 Identities=26% Similarity=0.356 Sum_probs=145.9
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|...+.||.|+||.||++.. ++..+|+|++... +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 466778999999999999999 5899999998643 1
Q ss_pred CC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 91 PF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 ~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
|. ......++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 11 0345678999999999999 8999999999999999999999999999987765443
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. .....|++.|+|||.+....++.++||||+|++++++++|..|+.... ......... ......+
T Consensus 158 ~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~-- 223 (258)
T cd08215 158 DL---AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKIL-KGQYPPI-- 223 (258)
T ss_pred ce---ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHh-cCCCCCC--
Confidence 11 112468889999999888889999999999999999999999985422 112221111 1111110
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+......+.+++.+||..+|++|||+.++++
T Consensus 224 -------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 -------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122234789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=214.98 Aligned_cols=208 Identities=19% Similarity=0.218 Sum_probs=143.8
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~ 91 (284)
|+....||+|++|.||+|.. +++.+|+|++... ++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45567899999999999999 6899999988753 00
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
....+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-- 155 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-- 155 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc--
Confidence 01445778999999999999 8999999999999999999999999999987765432211
Q ss_pred CCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc---Ccccccc--
Q 039895 157 SNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN---ESFKEIV-- 230 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 230 (284)
....++..|+|||.+... .++.++|||||||+++|+++|..||.... . ......+...... ..+..+.
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 156 -THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----E-IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----H-HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 113457789999998766 78899999999999999999988885432 0 1111111111000 0000000
Q ss_pred ---cccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 ---DPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ---~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+........... .........+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 000112445889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=217.45 Aligned_cols=194 Identities=22% Similarity=0.291 Sum_probs=140.2
Q ss_pred CCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC-----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~----------------------------------------- 89 (284)
+|+..+.||+|+||.||++.. +|..||+|++...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 466778999999999999986 6788999988642
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. ......++.|++.||.||| +.+++||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 110 0344567779999999999 99999999999999999999999999999877644
Q ss_pred CCccccCCCCcccCccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
..... .....|+..|+|||.+... .++.++||||||+++|++++|..||.... .................
T Consensus 158 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~-- 229 (290)
T cd05613 158 DEVER--AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEP-- 229 (290)
T ss_pred ccccc--cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccCC--
Confidence 32211 1125688999999988653 46789999999999999999999985322 11111222211111000
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+.+......+.+++.+||+.+|++|| ++.+++.
T Consensus 230 ---------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ---------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00111233478999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=196.24 Aligned_cols=211 Identities=15% Similarity=0.202 Sum_probs=145.7
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|+..++||+|.||+||+|.. ++..||+|.+.-. +
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455567899999999999998 7889999998644 3
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|.. ....+++.|+++||.|+| +.+++||||||.|+||+.+|.+|++|||+++.+.-.....
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcy- 158 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY- 158 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence 322 445678999999999999 9999999999999999999999999999998876443211
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH--hhcCcccccc--
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY--IENESFKEIV-- 230 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-- 230 (284)
+..+-|.+|.+|+++.+. -|++..|+||-||++.|+.....|.++.. .....+....+.. .....++.+.
T Consensus 159 --saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~---dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC---cHHHHHHHHHHHhCCCccccCCccccC
Confidence 114568999999998876 48999999999999999988655554332 1111122212111 1122233221
Q ss_pred -cccccCCCCC--CChh-hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 -DPAIVGEEGL--MWPE-KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 -~~~~~~~~~~--~~~~-~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
|-.....+.. .|.. .+.....=.+++++.+.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111000 0000 1111122358899999999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=217.76 Aligned_cols=183 Identities=23% Similarity=0.291 Sum_probs=142.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------CCCc--------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------FPFS-------- 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------~~~~-------- 93 (284)
.+|....+||+|+||.|..|.. +...+|||++++. .|..
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4688889999999999999998 6678999999876 1111
Q ss_pred ---------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 94 ---------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 94 ---------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
...+-+|.+||-||-+|| +++|+.||||.+|||+|.+|.+||+|||+.+.---+
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-- 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-- 503 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC--
Confidence 455678999999999999 999999999999999999999999999998653222
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (284)
..++.+++|||.|+|||++...+|+.++|-|||||+||||+.|++||+++. + .+..+..... ..+
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD----E----~elF~aI~ehnvsy----- 569 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----E----DELFQAIMEHNVSY----- 569 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC----H----HHHHHHHHHccCcC-----
Confidence 222334899999999999999999999999999999999999999998643 1 1112221111 111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT 269 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps 269 (284)
+...+.+..++....|...|.+|..
T Consensus 570 -------------PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 570 -------------PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------------cccccHHHHHHHHHHhhcCCccccC
Confidence 1222334667888888999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=211.09 Aligned_cols=212 Identities=15% Similarity=0.231 Sum_probs=147.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------CCCc-----------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------FPFS----------------------- 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------~~~~----------------------- 93 (284)
.+.+..+.||-|.||.||-.++ +|+.||+|++-.. .|+-
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3567789999999999999999 8999999988544 1100
Q ss_pred -----------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 94 -----------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 94 -----------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
....-++.||++||.||| +.+|+||||||.|+|+++|..+||||||+++.....
T Consensus 133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 334457899999999999 999999999999999999999999999999887654
Q ss_pred CccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-----
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE----- 224 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (284)
.....+. .+-|..|+|||++.+. .|+.+.||||+||++.|++..+..|.... .....+++.......
T Consensus 210 ~~~hMTq--EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-----PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 210 DRLNMTH--EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-----PIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhHH--HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-----hHHHHHHHHHHhCCCcHHHH
Confidence 4433332 4568899999999876 58999999999999999998888776433 111122222211111
Q ss_pred ------ccccccccccc-CCCCCCC--hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 225 ------SFKEIVDPAIV-GEEGLMW--PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 225 ------~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.-..++..... ......+ ......-.+...+...++..||+.|.+..+.+..
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11111111000 0000000 0011222335678888999999999998887654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=208.46 Aligned_cols=188 Identities=18% Similarity=0.223 Sum_probs=138.5
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||.||++.. .+..+++|+++..
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 66678999999999999988 4455666665421
Q ss_pred -CCC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FPF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++. +...+.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 111 1345678999999999999 999999999999999975 5699999999876643
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... .....|++.|+|||.+....++.++|+||||+++|++++|..||.... ......... .+..+.
T Consensus 158 ~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~-~~~~~~- 224 (260)
T cd08222 158 SCDL---ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIV-EGPTPS- 224 (260)
T ss_pred Cccc---ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH-cCCCCC-
Confidence 3221 112467889999999888888999999999999999999999985322 111111111 111110
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+......+.+++.+||..+|++||++.++++
T Consensus 225 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 --------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11223345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=210.44 Aligned_cols=184 Identities=24% Similarity=0.310 Sum_probs=143.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------CCCc
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------FPFS 93 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------~~~~ 93 (284)
.++|+..++||+|.||.|-.+.- .|+.+|+|++++. .|+-
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36899999999999999999988 8999999999876 1110
Q ss_pred ---------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 94 ---------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 94 ---------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
.....+-..|+.||.||| +.+||.||||.+|+|+|.+|.+||+|||+.+.--.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--- 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--- 320 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc---
Confidence 233457789999999999 99999999999999999999999999999865322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
......+++|||.|+|||++....|+.++|-|.+||++|||++|+.||+... ...+..++.. ..-.++.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----h~kLFeLIl~--ed~kFPr---- 389 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----HEKLFELILM--EDLKFPR---- 389 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----hhHHHHHHHh--hhccCCc----
Confidence 2222334899999999999999999999999999999999999999998533 2222222211 1111211
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP 268 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 268 (284)
...++...|+...|..||.+|.
T Consensus 390 --------------~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 390 --------------TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --------------cCCHHHHHHHHHHhhcChHhhc
Confidence 1222366888899999999996
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=224.96 Aligned_cols=193 Identities=23% Similarity=0.263 Sum_probs=155.4
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------- 89 (284)
..-+..|.....||+|.|+.|..|++ ++..||+|++.+.
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34457788999999999999999999 8999999999776
Q ss_pred ----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
|+.. .....++.|+.+|++||| +++|||||||+.|||++.+.++||+|||++..+..+
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 1111 455678999999999999 999999999999999999999999999999988755
Q ss_pred CccccCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... +.+|++.|.|||++.+..|+ +.+|+||+|+++|-|+.|.-||++.. +.++
T Consensus 209 ~~lq----t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------------lk~L 263 (596)
T KOG0586|consen 209 LMLQ----TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------------LKEL 263 (596)
T ss_pred cccc----ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------------cccc
Confidence 4332 27899999999999988775 78999999999999999999997543 2222
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
-++.+.+.....+. ...++.++++++|-.+|.+|++++++..
T Consensus 264 r~rvl~gk~rIp~~----ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cchheeeeecccce----eechhHHHHHHhhccCccccCCHHHhhh
Confidence 22333333222222 2223778999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=220.83 Aligned_cols=184 Identities=20% Similarity=0.268 Sum_probs=144.7
Q ss_pred CCCCCCeeeecCCceEEEEEeCCcc--eEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFLQDRP--ISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~-------------------------------------------- 89 (284)
+++....||-||||.|=....++.. +|+|++++.
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3444457999999999998884444 899998766
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
.|.. .+...++..+++|++||| .++||.|||||+|.+++.+|.+||.|||+|+.+.++....
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence 1111 344567889999999999 9999999999999999999999999999999997765432
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
+++|||.|.|||++.....+.++|.||+|+++|||++|.+||.+.. ++...+.+...+..-.++.
T Consensus 578 ----TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-----pmktYn~ILkGid~i~~Pr------ 642 (732)
T KOG0614|consen 578 ----TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-----PMKTYNLILKGIDKIEFPR------ 642 (732)
T ss_pred ----eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-----hHHHHHHHHhhhhhhhccc------
Confidence 3899999999999999999999999999999999999999997543 3444444444333222221
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT 269 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps 269 (284)
.......+|+.+....+|.+|..
T Consensus 643 ------------~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 ------------RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------------ccchhHHHHHHHHHhcCcHhhhc
Confidence 22223678999999999999975
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=208.29 Aligned_cols=168 Identities=20% Similarity=0.184 Sum_probs=128.9
Q ss_pred cCCceEEEEEe--CCcceEEEeecCC------------------------------------CCC---------------
Q 039895 66 CLFYKLYKGFL--QDRPISVMKFEDT------------------------------------FPF--------------- 92 (284)
Q Consensus 66 G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------~~~--------------- 92 (284)
|.+|.||++.. +++.+|+|.+... ++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 89999999999 8899999998754 111
Q ss_pred chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccc
Q 039895 93 SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYR 172 (284)
Q Consensus 93 ~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 172 (284)
......++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+........ ...++..|+|||.+
T Consensus 84 ~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~y~aPE~~ 154 (237)
T cd05576 84 EECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD------GEAVENMYCAPEVG 154 (237)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc------cCCcCccccCCccc
Confidence 1445678999999999999 99999999999999999999999999998766543221 13457789999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 173 TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 173 ~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
....++.++||||+|+++||+++|..|+...... ........ .+......+
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------------~~~~~~~~----------~~~~~~~~~ 205 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------------INTHTTLN----------IPEWVSEEA 205 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------------cccccccC----------CcccCCHHH
Confidence 8888999999999999999999999876432100 00000000 011123347
Q ss_pred HHHHHHhhcCCCCCCCCHH
Q 039895 253 TELAFKCLSESEGDRPTIV 271 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ 271 (284)
.+++.+||+.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=233.57 Aligned_cols=88 Identities=28% Similarity=0.423 Sum_probs=76.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ +++.||+|++...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5678889999999999999999 6899999998642
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
++. ....+.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 111 1346789999999999999 8999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=219.58 Aligned_cols=198 Identities=23% Similarity=0.344 Sum_probs=146.6
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------CC
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~~ 91 (284)
|-..++||+|||+.||++.+ ..+.||||+-... ||
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 33456899999999999999 8899999986543 22
Q ss_pred ------Cc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeecccccccc
Q 039895 92 ------FS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSI 147 (284)
Q Consensus 92 ------~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~ 147 (284)
.. .....|++||+.||.||.+. +.+|||-||||.|||+-+ -|.+||+|||+++.+
T Consensus 545 TVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 21 55678999999999999976 789999999999999964 467899999999998
Q ss_pred CCCCcccc----CCCCcccCccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHH
Q 039895 148 PEGETHIN----DSNRVIGTFGFMAPEYRTTG----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219 (284)
Q Consensus 148 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 219 (284)
........ -+....||.+|++||.+.-+ .++.++||||+|||+|.++.|+.||.... ..++....
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-------sQQdILqe 696 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-------SQQDILQE 696 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-------hHHHHHhh
Confidence 76543322 22346799999999987644 47899999999999999999999985321 11111111
Q ss_pred HhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 220 YIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
. .+ .......+|..+....+..++|.+||++.-++|....++.
T Consensus 697 N----TI--------lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N----TI--------LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h----ch--------hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 11 1111122333344555678999999999999998887764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=239.79 Aligned_cols=196 Identities=23% Similarity=0.323 Sum_probs=149.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
.-++|...++||+|+||.|..+.+ +++.+|.|++.+-
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 346899999999999999999999 8899999998763
Q ss_pred ----CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ----FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ----~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+| .+.....++..|+.||.-|| +.|+|||||||+|||||.+|.+||+|||....+....
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 00 11455668899999999999 9999999999999999999999999999988877555
Q ss_pred ccccCCCCcccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
...... .+|||.|.+||++.. +.|+..+|-||+||++|||+.|..||+... +..-.......
T Consensus 230 ~V~s~~--aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~KIm~h--- 296 (1317)
T KOG0612|consen 230 TVRSSV--AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYGKIMNH--- 296 (1317)
T ss_pred cEEecc--ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHHHHhch---
Confidence 444433 799999999998752 568999999999999999999999998643 22222222111
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT---IVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~ev~~ 275 (284)
.....+|.....+....+||.+.+. +|+.|.. +.++..
T Consensus 297 ----------k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 ----------KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ----------hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111223333455567788877654 6677776 777654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=204.47 Aligned_cols=179 Identities=24% Similarity=0.310 Sum_probs=136.6
Q ss_pred eeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------CC-----
Q 039895 63 IMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------FP----- 91 (284)
Q Consensus 63 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------~~----- 91 (284)
||.|+||.||++.. ++..+|+|.+... ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999998 6899999987643 11
Q ss_pred ----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcc
Q 039895 92 ----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 92 ----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
.......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~ 154 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFC 154 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccCCc
Confidence 11456778999999999999 99999999999999999999999999999877644321 112256
Q ss_pred cCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCC
Q 039895 162 GTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLM 241 (284)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
++..|+|||...+...+.++|+||||+++|++++|..||.... . ......... ...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~~--------------- 210 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-----R---KEIYEKILK-DPL--------------- 210 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHhc-CCC---------------
Confidence 7889999999988888999999999999999999999985432 1 111111111 000
Q ss_pred ChhhHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 039895 242 WPEKEQQLLICTELAFKCLSESEGDRPTIVQ 272 (284)
Q Consensus 242 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~e 272 (284)
+.+...+..+.+++.+||..||++|||+.+
T Consensus 211 -~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 -RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 001111334789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=206.26 Aligned_cols=210 Identities=20% Similarity=0.264 Sum_probs=149.5
Q ss_pred cHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------
Q 039895 46 SADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 46 ~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------- 89 (284)
+++|+-+.|. .+||+|+++.|--+.. +|..+|||++.+.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3667666664 5899999999999887 9999999999876
Q ss_pred -----------------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeecccc
Q 039895 90 -----------------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTL 143 (284)
Q Consensus 90 -----------------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfg~ 143 (284)
+..+...-++..+|+.||.||| .+||.||||||+|||..+.. -+|||||.+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 2222556689999999999999 99999999999999997654 469999988
Q ss_pred ccccCCC----CccccCCCCcccCcccccccccc---C--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-----Cc
Q 039895 144 SLSIPEG----ETHINDSNRVIGTFGFMAPEYRT---T--GDFSEKSDVYSFGALLLELLTGKKISYSSHFDD-----GE 209 (284)
Q Consensus 144 a~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~-----~~ 209 (284)
+..+.-. ........+.+|+..|||||+.. + ..|+.++|.||+|||+|-|++|.+||.+..-.+ ++
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 7654321 12222334578999999999743 2 358899999999999999999999997654221 11
Q ss_pred cccH-HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 210 DYRL-QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 210 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.-.. ++..-..+..+. +..........+.+..+++...|..++.+|.++.++++
T Consensus 306 ~Cr~CQ~~LFesIQEGk------------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGK------------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccC------------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111 111111111111 11111112344556778999999999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=193.54 Aligned_cols=144 Identities=24% Similarity=0.280 Sum_probs=116.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------CCCc-----------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------FPFS----------------- 93 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------~~~~----------------- 93 (284)
..++......||+|++|.|=+-++ +|...|+|.+... .|.-
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 334555566799999998766665 9999999998755 1111
Q ss_pred ------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 94 ------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 94 ------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
.-.-+||..+..||.|||+ ...++|||+||+||||+.+|.+|+||||.+-.+.+
T Consensus 124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 2233689999999999996 67899999999999999999999999999977765
Q ss_pred CCccccCCCCcccCccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTT----GDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
+..... ..|...|||||.+.. ..|+.++||||+|++++||.+++.|+..
T Consensus 202 SiAkt~----daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SIAKTM----DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhHHHH----hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 433322 357889999998753 3689999999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=217.73 Aligned_cols=160 Identities=16% Similarity=0.215 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (284)
...++.|++.||.||| ..+|+||||||+|||++.++.+||+|||++........... ....+|+.|+|||.+...
T Consensus 311 ~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 311 IKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP--LYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc--cccCCCcceeChhhhcCC
Confidence 3457889999999999 89999999999999999999999999999976543322111 113457899999987532
Q ss_pred C--------------------C--CcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCc----cccHHHHHHHHhhcCcccc
Q 039895 176 D--------------------F--SEKSDVYSFGALLLELLTGKK-ISYSSHFDDGE----DYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 176 ~--------------------~--~~~~DvwS~G~il~elltg~~-p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (284)
. + ..+.||||+||++++|++|.. |+......... ......|.. .....
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~--- 460 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK--- 460 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC---
Confidence 2 1 124799999999999999875 54321100000 000111100 00000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESE---GDRPTIVQVAKQ 276 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p---~~Rps~~ev~~~ 276 (284)
..++..........+|+.++|..+| .+|+|+.|++++
T Consensus 461 -----------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 -----------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -----------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0111112233457899999999766 689999999863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=208.49 Aligned_cols=160 Identities=23% Similarity=0.311 Sum_probs=126.3
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 173 (284)
.+.+.++.|++.|++||| ..+|||.||-.+|.+||+.-.+||+|=.+++.+-+..+..-.. ....+..||+||.+.
T Consensus 396 ~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGD-nEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 396 IQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGD-NENRPVKWMSLEALQ 471 (563)
T ss_pred HHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCC-CCCCcccccCHHHHh
Confidence 456778999999999999 9999999999999999999999999999999886655442211 133477899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 174 TGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 174 ~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
...|+.++||||||+++|||+| |+.|+.... +.... .++..+ .+...+..|++++
T Consensus 472 n~~yssasDvWsfGVllWELmtlg~~PyaeID-----PfEm~----~ylkdG---------------yRlaQP~NCPDeL 527 (563)
T KOG1024|consen 472 NSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----PFEME----HYLKDG---------------YRLAQPFNCPDEL 527 (563)
T ss_pred hhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----HHHHH----HHHhcc---------------ceecCCCCCcHHH
Confidence 9999999999999999999998 677764322 11111 111111 1122345677889
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
..+|..||...|++||+++|++.-|.+..
T Consensus 528 f~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 528 FTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 99999999999999999999999988764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=189.60 Aligned_cols=155 Identities=19% Similarity=0.173 Sum_probs=114.0
Q ss_pred CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccccc
Q 039895 92 FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEY 171 (284)
Q Consensus 92 ~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 171 (284)
.+.....++.|++.||.||| +.+ ||+|||++.++.+++ ||++....... ..||+.|+|||+
T Consensus 15 ~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--------~~g~~~y~aPE~ 75 (176)
T smart00750 15 NEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--------SRVDPYFMAPEV 75 (176)
T ss_pred CHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--------CCCcccccChHH
Confidence 34677899999999999999 666 999999999999999 99987654322 257899999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHH--
Q 039895 172 RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQL-- 249 (284)
Q Consensus 172 ~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (284)
+.+..++.++|||||||++|||++|..||.... .....+........ .. ++.. .+......
T Consensus 76 ~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~---~~~~~~~~~~~~~~-~~------~~~~-------~~~~~~~~~~ 138 (176)
T smart00750 76 IQGQSYTEKADIYSLGITLYEALDYELPYNEER---ELSAILEILLNGMP-AD------DPRD-------RSNLESVSAA 138 (176)
T ss_pred hcCCCCcchhhHHHHHHHHHHHHhCCCCccccc---hhcHHHHHHHHHhc-cC------Cccc-------cccHHHHHhh
Confidence 999999999999999999999999999985432 00111111111100 00 0000 00111222
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 250 LICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 250 ~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
..+.+++.+||+.+|++|||+.|+++.+..+..
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 258899999999999999999999999887754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=217.08 Aligned_cols=204 Identities=25% Similarity=0.311 Sum_probs=159.2
Q ss_pred eecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------
Q 039895 44 SFSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------- 89 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------- 89 (284)
.+.++.+...++-|.....||.|.+|.||+++. +|+.+|||+....
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555566778899999999999999999988 8999999998655
Q ss_pred --------------CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 --------------FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 --------------~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
+|.. ....-|+..++.||.+|| ...++|||+|-.|||++.++.+|+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence 4443 345568999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
+|||++..+.++.... .+.+||+.|||||++... .|+..+|+||+|++..||.-|.+|+..... .
T Consensus 165 vDFGvSaQldsT~grR---nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------m 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRR---NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------M 234 (953)
T ss_pred eeeeeeeeeecccccc---cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------h
Confidence 9999998887654433 347899999999997643 478899999999999999999999865431 0
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..++ .++.-..|.+ -.+..-...+.+++..||..|-++||++.++++
T Consensus 235 raLF-------~IpRNPPPkL--------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 RALF-------LIPRNPPPKL--------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhhc-------cCCCCCCccc--------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0000 0011111111 113455667899999999999999999998875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=211.60 Aligned_cols=210 Identities=21% Similarity=0.209 Sum_probs=149.1
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CCCc-
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FPFS- 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~~~- 93 (284)
|......|+|-||+|.+|.+ .|..||||++... .|.-
T Consensus 434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVF 513 (752)
T KOG0670|consen 434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVF 513 (752)
T ss_pred eEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEe
Confidence 44444578999999999999 6789999999876 1111
Q ss_pred ----------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-CcceeeccccccccCCC
Q 039895 94 ----------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 94 ----------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~~~ 150 (284)
.....++.|+..||..|- ..+|+|.||||+|||+++. ..+||||||.|......
T Consensus 514 E~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 514 EPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccccccc
Confidence 455679999999999999 9999999999999999865 46899999999877654
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHH-----HhhcCc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK-----YIENES 225 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 225 (284)
.... +.-+..|.|||++.+.+|+...|+||+||+||||.||+..|.+.. .+....+..-+.. ++..+.
T Consensus 591 eitP-----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T--NN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 591 EITP-----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT--NNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cccH-----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC--cHHHHHHHHHhcCCCcHHHhhhcc
Confidence 4321 344678999999999999999999999999999999999987644 1111111100000 000011
Q ss_pred cc-ccccccc----------------------cCC---------CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 039895 226 FK-EIVDPAI----------------------VGE---------EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273 (284)
Q Consensus 226 ~~-~~~~~~~----------------------~~~---------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev 273 (284)
+. ..+|..+ .+. ..............+.+|+..||..||++|.|..++
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 00 0001000 000 001122345667778999999999999999999998
Q ss_pred HHH
Q 039895 274 AKQ 276 (284)
Q Consensus 274 ~~~ 276 (284)
+++
T Consensus 744 L~H 746 (752)
T KOG0670|consen 744 LKH 746 (752)
T ss_pred hcC
Confidence 753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=189.79 Aligned_cols=211 Identities=17% Similarity=0.258 Sum_probs=150.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------CC--------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------FP-------------------------- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------~~-------------------------- 91 (284)
.++|+..+++|+|.++.||.|.. +...++||++++. .|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 35677788999999999999996 8889999999765 00
Q ss_pred -------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCCCccccCC
Q 039895 92 -------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 -------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.+++.||.|+| ++||+|||+||.|++||. ...++|.|+|+|.....+.....
T Consensus 117 v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV-- 191 (338)
T KOG0668|consen 117 VNNTDFKQLYPTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-- 191 (338)
T ss_pred hccccHHHHhhhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee--
Confidence 01445668999999999999 999999999999999995 45789999999998877665443
Q ss_pred CCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-------ccccc
Q 039895 158 NRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-------SFKEI 229 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 229 (284)
.+.+..|..||.+... .|+...|+|||||++..|+-.+.||+... .....+...+. .+... ...-.
T Consensus 192 --RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~---dN~DQLVkIak-VLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 192 --RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH---DNYDQLVKIAK-VLGTDELYAYLNKYQID 265 (338)
T ss_pred --eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC---CCHHHHHHHHH-HhChHHHHHHHHHHccC
Confidence 4567788999987654 58999999999999999999999997543 11111111111 11100 01111
Q ss_pred ccccccC----CCCCCChh-----hH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVG----EEGLMWPE-----KE-QQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~----~~~~~~~~-----~~-~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+||.... .....|.. .. -..++..+++.+.|.+|.++|||+.|.+.
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 2222211 11111111 11 12356889999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=202.06 Aligned_cols=115 Identities=18% Similarity=0.226 Sum_probs=73.7
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--CccccHHHHHHHHh-------hcCc-ccccc
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD--GEDYRLQDLVKKYI-------ENES-FKEIV 230 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~-------~~~~-~~~~~ 230 (284)
.-|..|+|||++.+..|++.+||||++|++|||+||-..|.+..-.. .+...+...+.-.. ..+. ..+.+
T Consensus 412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF 491 (590)
T KOG1290|consen 412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF 491 (590)
T ss_pred hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence 34678999999999999999999999999999999999987643111 11112222221110 0111 11111
Q ss_pred ccc--ccCCC-CCCChh----------hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPA--IVGEE-GLMWPE----------KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~--~~~~~-~~~~~~----------~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.. +.... -..||. +.+....+.+++.-||+.+|++||||.+.++
T Consensus 492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 111 00000 012322 4566777999999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=188.57 Aligned_cols=181 Identities=27% Similarity=0.316 Sum_probs=135.7
Q ss_pred CCceEEEEEe--CCcceEEEeecCCC------------------------------------------------------
Q 039895 67 LFYKLYKGFL--QDRPISVMKFEDTF------------------------------------------------------ 90 (284)
Q Consensus 67 ~~g~Vy~~~~--~~~~vavK~~~~~~------------------------------------------------------ 90 (284)
+||.||+|.. +|..+|+|++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999 57899999986430
Q ss_pred ---CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccc
Q 039895 91 ---PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFM 167 (284)
Q Consensus 91 ---~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~ 167 (284)
........++.+++.++.||| ..+++|+||+|+||+++.++.++|+|||.+......... ....++..|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~ 153 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLL----TTFVGTPEYM 153 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccccc----ccccCCcCCC
Confidence 111455679999999999999 899999999999999999999999999999877554211 1256788999
Q ss_pred ccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHH
Q 039895 168 APEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ 247 (284)
Q Consensus 168 aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
+||.+....++.++||||||++++++++|..|+.... . ...... ........... ....
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~---~~~~~~-~~~~~~~~~~~-------------~~~~ 212 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----Q---LLELFK-KIGKPKPPFPP-------------PEWK 212 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----c---HHHHHH-HHhccCCCCcc-------------cccc
Confidence 9999988888999999999999999999999885421 1 111111 11111110000 0000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 248 QLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 248 ~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+.+++.+||..+|++||++.++++
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 2344889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=193.62 Aligned_cols=145 Identities=22% Similarity=0.308 Sum_probs=124.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------CCCc-------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------FPFS------- 93 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------~~~~------- 93 (284)
.++|+..++||+|+|+.|..+.+ +.+.+|+|++++. .|+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 47899999999999999999998 8899999998766 1111
Q ss_pred ----------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 94 ----------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 94 ----------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
.....+...|+.||.||| +.||+.||||.+|+|+|..|.+|++|+|+.+.--...
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 334557889999999999 9999999999999999999999999999886532221
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
..+++++|||.|.|||++.+..|...+|-|++||+++||+.|+.||+--.
T Consensus 406 ---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 406 ---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred ---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 12234899999999999999999999999999999999999999997544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=192.13 Aligned_cols=205 Identities=22% Similarity=0.313 Sum_probs=144.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCCCc----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFPFS---------------------------------------- 93 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---------------------------------------- 93 (284)
.|.....+|.|.- .|-.+.+ .+++||+|+....+-..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3444567888888 6777777 89999999886541111
Q ss_pred ---------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 94 ---------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 94 ---------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
.....|..|++.|++||| +.+|+||||||+||++..++.+||.|||+|+.....
T Consensus 97 y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 97 YLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred HHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc--
Confidence 445578999999999999 999999999999999999999999999999876544
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--------------cccHHHHHH
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE--------------DYRLQDLVK 218 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~--------------~~~~~~~~~ 218 (284)
...+ -.+.|..|.|||++.+..+...+||||+||++.||++|...|.+..-.+.. -..+...++
T Consensus 172 ~~mt--pyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 FMMT--PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccC--chhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 1222 267899999999999888999999999999999999999888643211100 011112222
Q ss_pred HHhhcC------cccccccccccCCCCCCChh----hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 219 KYIENE------SFKEIVDPAIVGEEGLMWPE----KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 219 ~~~~~~------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+..+. .+.+.+.. ..|+. +.-....+.+++.+||-.+|++|.|++++++
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD-------~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPD-------SLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhcChHhhccchhhhCCc-------ccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 222110 01111100 01111 1112233678999999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=225.63 Aligned_cols=154 Identities=16% Similarity=0.193 Sum_probs=107.7
Q ss_pred chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-------------------CCcceeeccccccccCCCCc-
Q 039895 93 SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-------------------ENVAQLFDFTLSLSIPEGET- 152 (284)
Q Consensus 93 ~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-------------------~~~~kl~Dfg~a~~~~~~~~- 152 (284)
....+.++.||+.||.||| +++|+||||||+|||++. ++.+|++|||+++.......
T Consensus 79 ~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~ 155 (793)
T PLN00181 79 AFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSER 155 (793)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccccccc
Confidence 3567889999999999999 999999999999999954 45667777777764321000
Q ss_pred ------------cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 153 ------------HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 153 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
.........||+.|||||++.+..++.++|||||||++|||++|..|+.... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~- 228 (793)
T PLN00181 156 RIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR- 228 (793)
T ss_pred chhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh-
Confidence 0000112458999999999999999999999999999999999877653211 001111000
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+. ..........++.+||+.+|.+|||+.||++
T Consensus 229 --------~~~~~-----------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 229 --------VLPPQ-----------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --------hcChh-----------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 00000 0111223567888999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=191.01 Aligned_cols=152 Identities=24% Similarity=0.278 Sum_probs=118.2
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEe-C----CcceEEEeecCC--------------------------CCCc-----
Q 039895 50 LKTATDDFDGGKVIMKCLFYKLYKGFL-Q----DRPISVMKFEDT--------------------------FPFS----- 93 (284)
Q Consensus 50 l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~----~~~vavK~~~~~--------------------------~~~~----- 93 (284)
+....+.|...++||+|+|++||+++. + ++.||+|.+... .|..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 344556788899999999999999998 3 578999988655 1111
Q ss_pred ---------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCC-
Q 039895 94 ---------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEG- 150 (284)
Q Consensus 94 ---------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~- 150 (284)
..+..++..++.||.++| ..|||||||||+|+|.+. .+.-.|.|||+|......
T Consensus 111 ~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 567789999999999999 999999999999999984 356689999998721100
Q ss_pred ------C------cc---------------------c-------cCCCCcccCccccccccccCC-CCCcchhHHHHHHH
Q 039895 151 ------E------TH---------------------I-------NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGAL 189 (284)
Q Consensus 151 ------~------~~---------------------~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~i 189 (284)
. .. . .......||++|.|||++... ..++++||||.||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 00 0 000124699999999998765 46889999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 039895 190 LLELLTGKKISYSSH 204 (284)
Q Consensus 190 l~elltg~~p~~~~~ 204 (284)
++-++++..||+...
T Consensus 268 ~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAK 282 (418)
T ss_pred eehhhccccccccCc
Confidence 999999999997654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=195.62 Aligned_cols=156 Identities=22% Similarity=0.266 Sum_probs=119.5
Q ss_pred cHHHHHHHh---cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------C
Q 039895 46 SADELKTAT---DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------F 90 (284)
Q Consensus 46 ~~~~l~~~~---~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------~ 90 (284)
+|-.|+.+- ..|...+.||-|+||.|..+.- +...+|.|-+.+. |
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 344444442 3577778899999999999876 5566777766544 0
Q ss_pred -----------------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 91 -----------------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 91 -----------------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
..+.....++.++.+|+++.| ..|+|||||||+|||||.+|.+||+||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeec
Confidence 000233456789999999999 999999999999999999999999999
Q ss_pred ccccccCC---------CCccc------------------------------cCCCCcccCccccccccccCCCCCcchh
Q 039895 142 TLSLSIPE---------GETHI------------------------------NDSNRVIGTFGFMAPEYRTTGDFSEKSD 182 (284)
Q Consensus 142 g~a~~~~~---------~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 182 (284)
|+..-+.- +.... ...-..+||+.|+|||++....|+..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 99754410 00000 0001358999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCC
Q 039895 183 VYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 183 vwS~G~il~elltg~~p~~~~~ 204 (284)
-||.|||||||+.|+.||....
T Consensus 854 wws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCC
Confidence 9999999999999999997544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=175.37 Aligned_cols=198 Identities=21% Similarity=0.224 Sum_probs=138.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|.||.+..+.+ ....+++|.+...
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 35677788999999999999999 6678999987655
Q ss_pred CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec--CCcceeeccccccccCCCCcc
Q 039895 90 FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE--ENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. ....+++.|+++||.|+| ++++||||||.+||||-. ...+|+||||+.+..+.....
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 1110 345679999999999999 999999999999999953 347999999998776544332
Q ss_pred ccCCCCcccCccccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTG-----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.--+..|.|||+.... ..++.+|||.||++++.++||+.|+......+..-..+..|.... ...++.
T Consensus 180 ------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk--~~~~P~ 251 (378)
T KOG1345|consen 180 ------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK--NPALPK 251 (378)
T ss_pred ------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc--CccCch
Confidence 2235668899976533 356889999999999999999999975443222222222222211 111111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
.+. ...+.+..+..+-|..+|++|=-+.++.++.
T Consensus 252 ~F~---------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 252 KFN---------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhc---------------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 1122366788888999999995555555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=190.96 Aligned_cols=140 Identities=17% Similarity=0.294 Sum_probs=121.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
.+|...+.+|+|+||.|+.|.+ +...|+||.+.+.
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4688889999999999999999 6678999988766
Q ss_pred -------------------------CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 90 -------------------------FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 90 -------------------------~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
.-.+....-|+.|++.|+++|| +.+|||||||-+|+.++.+|-+||.|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccch
Confidence 0011455669999999999999 999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~ 202 (284)
....+++... ++||..|.|||++.+.+|- ..-|||++|++||.++....|++.
T Consensus 718 a~~ksgpfd~-----f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDV-----FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcce-----eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8777665543 7899999999999998874 668999999999999999888863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=167.86 Aligned_cols=152 Identities=27% Similarity=0.419 Sum_probs=127.6
Q ss_pred eeecCCceEEEEEeC--CcceEEEeecCCCCC------------------------------------------------
Q 039895 63 IMKCLFYKLYKGFLQ--DRPISVMKFEDTFPF------------------------------------------------ 92 (284)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~------------------------------------------------ 92 (284)
||+|++|.||++... +..+++|++......
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999994 899999998755221
Q ss_pred ----------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCCCccccCCCCcc
Q 039895 93 ----------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGETHINDSNRVI 161 (284)
Q Consensus 93 ----------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 161 (284)
...+..++.+++.+|.+|| ..+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~ 154 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIV 154 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhccc
Confidence 0345678999999999999 899999999999999999 89999999999877654321 111145
Q ss_pred cCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 162 GTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 162 gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
+...|++||.+... .++.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78889999998877 788999999999999998
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 126789999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=190.16 Aligned_cols=196 Identities=21% Similarity=0.280 Sum_probs=146.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
-++|.....+|+|.+|.||++++ .+.+.|+|+++-. |
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46788889999999999999999 8999999998754 3
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|.. .+....+...+.||.||| +++-+|||||-.|||+++.|.+|++|||.+-.+.... .
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati---~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI---A 167 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh---h
Confidence 332 344556888999999999 9999999999999999999999999999987765332 2
Q ss_pred CCCCcccCccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYR---TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....+.||+.|||||+. ..+.|+..+|||++|+...|+---++|.+... .......... ..+++
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTk------S~~qp 234 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTK------SGFQP 234 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhc------cCCCC
Confidence 33347899999999975 35579999999999999999988777754322 1111111111 11111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.-..+ ...-.+.+.+++..|+-.+|.+|||+..++.
T Consensus 235 p~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccC-------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111 1122334779999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=160.95 Aligned_cols=141 Identities=28% Similarity=0.337 Sum_probs=116.2
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC-------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP------------------------------------------- 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------------------------------------------- 91 (284)
|+..+.||+|++|.||++.. ++..+|+|.+.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678999999999999999 478999999875311
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
.......++.+++.+|.+|| ..+++|+||+|.||+++.++.++|+|||.+......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA--L 155 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--c
Confidence 11335678999999999999 889999999999999999999999999998877544311 1
Q ss_pred CCCcccCccccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 039895 157 SNRVIGTFGFMAPEYR-TTGDFSEKSDVYSFGALLLELLTGKKISYS 202 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~G~il~elltg~~p~~~ 202 (284)
.....++..|++||.+ ....++.++|||+||++++++++|+.||+.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1125678889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=161.31 Aligned_cols=136 Identities=21% Similarity=0.244 Sum_probs=91.0
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 173 (284)
..++.+..|+++.+++|| ..|++|+||+|+|++++.+|.+.|+||+........... ...+..|.|||...
T Consensus 145 ~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 145 AARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELES 215 (288)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHH
T ss_pred HHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec------cCCCcccCChhhhh
Confidence 345667789999999999 999999999999999999999999999877655432221 12357789999753
Q ss_pred C--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhh
Q 039895 174 T--------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEK 245 (284)
Q Consensus 174 ~--------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
. -.++.+.|.|++|+++|.+.++..||........... .+. . .
T Consensus 216 ~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~-~-------C 266 (288)
T PF14531_consen 216 CAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFS-R-------C 266 (288)
T ss_dssp HHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGT-T-------S
T ss_pred hhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cch-h-------c
Confidence 3 2478899999999999999999999864331111100 010 1 1
Q ss_pred HHHHHHHHHHHHHhhcCCCCCC
Q 039895 246 EQQLLICTELAFKCLSESEGDR 267 (284)
Q Consensus 246 ~~~~~~~~~l~~~cl~~~p~~R 267 (284)
.+.++.+..||..+|+.+|.+|
T Consensus 267 ~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 267 RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S---HHHHHHHHHHT-SSGGGS
T ss_pred CCcCHHHHHHHHHHccCCcccC
Confidence 1444558899999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=155.42 Aligned_cols=188 Identities=18% Similarity=0.183 Sum_probs=136.3
Q ss_pred CCeeeecCCceEEEEEeCCcceEEEeecCCCCCc----------------------------------------------
Q 039895 60 GKVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFS---------------------------------------------- 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---------------------------------------------- 93 (284)
..+|.+...|..|+|.|+|..+++|++....|..
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3468889999999999999999999987652211
Q ss_pred --------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceee--ccccccccCCCCccccCC
Q 039895 94 --------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLF--DFTLSLSIPEGETHINDS 157 (284)
Q Consensus 94 --------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~--Dfg~a~~~~~~~~~~~~~ 157 (284)
.+.++++.++++|++|||+. +.-|..--|.+..++||++.+++|+ |--++.+. ..
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe--------~g 345 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--------VG 345 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec--------cc
Confidence 67889999999999999964 3445556799999999999988875 32222111 00
Q ss_pred CCcccCccccccccccCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 158 NRVIGTFGFMAPEYRTTGDFS---EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~---~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
..-+|.||+||.+...+-+ .++|+|||++++||+.|...||......+-. ..+.-+.+.--+
T Consensus 346 --r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------mkialeglrv~i---- 410 (448)
T KOG0195|consen 346 --RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------MKIALEGLRVHI---- 410 (448)
T ss_pred --cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------hhhhhccccccC----
Confidence 2347899999998876543 5799999999999999999999754311111 000011111112
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
++.....+.+||.-|++.||.+||.++.|+..|+++.
T Consensus 411 ----------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 ----------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2223334789999999999999999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-21 Score=175.58 Aligned_cols=162 Identities=19% Similarity=0.184 Sum_probs=119.5
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc-ccCCCCcccCcccccccccc
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH-INDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~ 173 (284)
.+-.++.|++.|++|+| +.||.|||+|++|+++..+|.+||+|||.+..+...... ........|+..|+|||++.
T Consensus 421 e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~ 497 (601)
T KOG0590|consen 421 EADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLT 497 (601)
T ss_pred hhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccc
Confidence 34468999999999999 999999999999999999999999999998766433221 11222378999999999999
Q ss_pred CCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 174 TGDFSE-KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 174 ~~~~~~-~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
...|++ ..||||.|+++..|++|+.||......+... .......-..............+...
T Consensus 498 ~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~lp~~~ 561 (601)
T KOG0590|consen 498 GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------------KTNNYSDQRNIFEGPNRLLSLLPRET 561 (601)
T ss_pred ccccCcchhhhhhccceEEEEecCCCccccccccccch----------------hhhccccccccccChHHHHHhchhhH
Confidence 999885 5899999999999999999986543211110 00000000000111122344555667
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..++.++|+.+|.+|.|+.+|++
T Consensus 562 ~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 562 RIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHHHccCChhheecHHHHhh
Confidence 89999999999999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=177.32 Aligned_cols=197 Identities=18% Similarity=0.165 Sum_probs=136.5
Q ss_pred CCCCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------CCCc------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------FPFS------------------ 93 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------~~~~------------------ 93 (284)
++...+.||++.|=.|.+|++....|+||+|.+. .|..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 4556678999999999999995555999999766 1111
Q ss_pred ----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 94 ----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 94 ----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.++..|+.|++.||..+| ..||+|+|||.+||||++=..+.|+||..-+...-........
T Consensus 104 khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 104 KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 567789999999999999 9999999999999999999999999998765542111111111
Q ss_pred CCc----ccCccccccccccCC----------C-CCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccccHHHHHHHHh
Q 039895 158 NRV----IGTFGFMAPEYRTTG----------D-FSEKSDVYSFGALLLELLTG-KKISYSSHFDDGEDYRLQDLVKKYI 221 (284)
Q Consensus 158 ~~~----~gt~~y~aPE~~~~~----------~-~~~~~DvwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
+.+ ..-..|.|||.+... + .+++-||||+||++.|+++- ++||. +.++..-..
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----------LSQL~aYr~ 249 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----------LSQLLAYRS 249 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----------HHHHHhHhc
Confidence 111 123469999976431 2 56789999999999999985 55553 222221111
Q ss_pred hcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 222 ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.+....+.+-..+.. ..+.+++..|++.||++|.++++.++.-..
T Consensus 250 ~~~~~~e~~Le~Ied-------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIED-------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCccCHHHHHHhCcC-------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111111111001100 127899999999999999999999887543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.1e-20 Score=149.89 Aligned_cols=147 Identities=19% Similarity=0.310 Sum_probs=124.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
-+|..+++||+|+||.++.|+. ++.+||||.-...
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLG 107 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLG 107 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhC
Confidence 4789999999999999999998 9999999975433
Q ss_pred --------CCCc----hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-----cceeeccccccccCCCCc
Q 039895 90 --------FPFS----VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-----VAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --------~~~~----~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .+.+.+|.|++.-++|+| ++.+|.|||||+|+||...+ .+.+.|||+|+.+.+..+
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 2322 567789999999999999 99999999999999997544 578999999999876544
Q ss_pred ccc----CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 153 HIN----DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 153 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
... ......||..||+--.-.+...+.+.|+=|+|-++...+-|..||.+..
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 322 2234679999999998888889999999999999999999999998654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=154.42 Aligned_cols=205 Identities=20% Similarity=0.190 Sum_probs=144.8
Q ss_pred CCCCCCeeeecCCceEEEEEeCC---cceEEEeecCC-------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFLQD---RPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~------------------------------------------- 89 (284)
.|...+.||+|+||.||.+.... ..+|+|.....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78899999999999999999833 36888876542
Q ss_pred ---------------CC----CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-----Ccceeecccccc
Q 039895 90 ---------------FP----FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-----NVAQLFDFTLSL 145 (284)
Q Consensus 90 ---------------~~----~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~Dfg~a~ 145 (284)
.+ +..+.++++.|++.+|.+|| +.|++||||||+|+++... ..+.+.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 00 11677889999999999999 9999999999999999865 368999999998
Q ss_pred --ccCCCCcc--c---cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 146 --SIPEGETH--I---NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 146 --~~~~~~~~--~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
.+...... . .......||..|.++.+..+...+.+.|+||++-++.|++.|..|+........ ...+.
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~~~~~ 250 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----KSKFE 250 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----HHHHH
Confidence 33222111 1 111235699999999999999999999999999999999999988854321111 11111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.......... . ....+..+.++...+-..+...+|....+...|+++...
T Consensus 251 ~~~~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 251 KDPRKLLTDR-----F----------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHhhhhcccc-----c----------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111100000 0 011122255566666668999999999999998877653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=145.46 Aligned_cols=155 Identities=21% Similarity=0.262 Sum_probs=124.5
Q ss_pred cHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------
Q 039895 46 SADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 46 ~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------- 89 (284)
+.+++..+ +.|...++||+|+||.+|.|.. +|..||||+-...
T Consensus 7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 34444433 5688889999999999999998 9999999997655
Q ss_pred -----------------CCCc----hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC---Ccceeecccccc
Q 039895 90 -----------------FPFS----VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE---NVAQLFDFTLSL 145 (284)
Q Consensus 90 -----------------~~~~----~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfg~a~ 145 (284)
+|.. .+.+-+|-|++.-++|+| .++.+||||||+|+|..-+ ..+.++|||+|+
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 3332 566778999999999999 9999999999999999743 357899999999
Q ss_pred ccCCCCcccc----CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 146 SIPEGETHIN----DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 146 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
.+.+..+... ......||..|.+--...+...+.+.|+=|+|-++..+.-|.-||.+..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 8865433221 2233679999998877767777889999999999999999999997644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=172.15 Aligned_cols=190 Identities=22% Similarity=0.278 Sum_probs=136.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------CCCchhHH--HHHHHHHHHHHHhc
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------FPFSVSKL--KIAIEIASAVAYLH 111 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------~~~~~~~~--~i~~~i~~gL~~LH 111 (284)
...+|+..++|..|++|.||...+ ..+.+|.|+-+.. .|....+. ..=.+++.+++|||
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~Eylh 160 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAVEYLH 160 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHhHhhc
Confidence 457899999999999999999988 5778888543332 12221111 12234588999999
Q ss_pred cCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc------------ccCCCCcccCccccccccccCCCCCc
Q 039895 112 VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH------------INDSNRVIGTFGFMAPEYRTTGDFSE 179 (284)
Q Consensus 112 ~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 179 (284)
..+|+|||+||+|.+|..-|.+|++|||+++........ .-.....+||+.|+|||++.-..|..
T Consensus 161 ---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygk 237 (1205)
T KOG0606|consen 161 ---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGK 237 (1205)
T ss_pred ---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCC
Confidence 999999999999999999999999999998754221111 01112368999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-cccccccccccCCCCCCChhhHHHHHHHHHHHHH
Q 039895 180 KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFK 258 (284)
Q Consensus 180 ~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 258 (284)
.+|-|++|+++||.+.|+.||++.. ..+++...+... .+++- | ....++..+++..
T Consensus 238 pvdwwamGiIlyeFLVgcvpffGdt--------peelfg~visd~i~wpE~-d--------------ea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 238 PVDWWAMGIILYEFLVGCVPFFGDT--------PEELFGQVISDDIEWPEE-D--------------EALPPEAQDLIEQ 294 (1205)
T ss_pred CccHHHHHHHHHHHheeeeeccCCC--------HHHHHhhhhhhhcccccc-C--------------cCCCHHHHHHHHH
Confidence 9999999999999999999998653 111111111111 11111 1 2223347889999
Q ss_pred hhcCCCCCCC
Q 039895 259 CLSESEGDRP 268 (284)
Q Consensus 259 cl~~~p~~Rp 268 (284)
.|+.+|..|.
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999996
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=156.08 Aligned_cols=122 Identities=16% Similarity=0.213 Sum_probs=93.5
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC-------------------------------------
Q 039895 50 LKTATDDFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 50 l~~~~~~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~------------------------------------- 89 (284)
.....++|...+.||+|+||+||+|.+ ++..||||+....
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~ 92 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGK 92 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCC
Confidence 334557899999999999999999987 4677899985311
Q ss_pred ------CCCc--------hhHHHHHHHHHHHHHHhccCCCCCeeeccc-ccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 ------FPFS--------VSKLKIAIEIASAVAYLHVGFSRPVVSRDI-KPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ------~~~~--------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|.. .....++.+++.||.||| +.+|+|||| ||+|||++.++.++|+|||+++.+.......
T Consensus 93 ~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 93 DGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred cEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 1111 113578999999999999 999999999 9999999999999999999998775432111
Q ss_pred c-----CCCCcccCccccccccccC
Q 039895 155 N-----DSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 155 ~-----~~~~~~gt~~y~aPE~~~~ 174 (284)
. .-....+++.|+|||++..
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccCCh
Confidence 1 1123568888999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-20 Score=159.55 Aligned_cols=95 Identities=35% Similarity=0.564 Sum_probs=80.3
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc---ccCCCCcccCcccccccc
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH---INDSNRVIGTFGFMAPEY 171 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~gt~~y~aPE~ 171 (284)
..+.++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+........+. ....+...||..||+||.
T Consensus 360 ~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQ 433 (516)
T KOG1033|consen 360 LMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQ 433 (516)
T ss_pred HHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHH
Confidence 345678888888887 68999999999999999999999999998776554411 112234689999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh
Q 039895 172 RTTGDFSEKSDVYSFGALLLELLT 195 (284)
Q Consensus 172 ~~~~~~~~~~DvwS~G~il~ellt 195 (284)
+.+..|+.++||||||++++|++.
T Consensus 434 i~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 434 IRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred HhhhhhhhhcchhhHHHHHHHHHH
Confidence 999999999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=145.75 Aligned_cols=159 Identities=22% Similarity=0.258 Sum_probs=107.9
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe--cCC--cceeeccccccccCCCCccc---cCCCCcccCccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ--EEN--VAQLFDFTLSLSIPEGETHI---NDSNRVIGTFGF 166 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~Dfg~a~~~~~~~~~~---~~~~~~~gt~~y 166 (284)
....-++.|+++|+.||| .++|.|||+|++|||+. .++ .+.|+|||+.---....... .......|.-.-
T Consensus 341 r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l 417 (598)
T KOG4158|consen 341 RTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL 417 (598)
T ss_pred HHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence 445568999999999999 99999999999999994 444 45789999864332211110 011113467778
Q ss_pred cccccccCCC-----C-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 167 MAPEYRTTGD-----F-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 167 ~aPE~~~~~~-----~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
||||+....+ . -.++|.|+.|.+.||+++...||+..... ...... ..+..++
T Consensus 418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~r~-----Yqe~qLP------------- 476 (598)
T KOG4158|consen 418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDTRT-----YQESQLP------------- 476 (598)
T ss_pred cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eechhh-----hhhhhCC-------------
Confidence 9999876543 1 25899999999999999999999863300 000000 1111111
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLR 278 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~ 278 (284)
+.+..+++.+.+++...|+.||++|++..-..+.|+
T Consensus 477 --alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 477 --ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred --CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 223344555789999999999999999876665554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-17 Score=139.97 Aligned_cols=204 Identities=24% Similarity=0.288 Sum_probs=140.1
Q ss_pred CCCCCeeeecCCceEEEEEeCCcceEEEeecCCCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDTFP--------------------------------------------- 91 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--------------------------------------------- 91 (284)
|.....||.|+||.||++... ..+++|.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 444567889999999999887 6678887754400
Q ss_pred ------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCCCc
Q 039895 92 ------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 92 ------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~~ 152 (284)
.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 01345678999999999999 99999999999999999988 799999999986654432
Q ss_pred ccc---CCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 153 HIN---DSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 153 ~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
... ......||..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ...............
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~ 232 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELPT 232 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcCC
Confidence 211 1233689999999999887 57889999999999999999999996433210 001111111111111
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. ......... . .......+.+++..|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~----~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPS----N--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCcc----c--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 000000000 0 01222347789999999999999998876653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.9e-18 Score=158.08 Aligned_cols=141 Identities=19% Similarity=0.204 Sum_probs=115.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCCCCCc---------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDTFPFS--------------------------------------- 93 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--------------------------------------- 93 (284)
...|.+.+.||+|+||.||+|.. +|+.||+|+-+...|++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence 34677788999999999999999 99999999988774444
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-------CCcceeeccccccccCC
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-------ENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~Dfg~a~~~~~ 149 (284)
.-.+.+..|++.-+..|| ..+|||+||||+|+||.. +..++|+|||.+..+.-
T Consensus 777 ~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 777 PYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred ccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 345678999999999999 999999999999999952 34689999998865431
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~ 198 (284)
-... .......+|-.+-++|+..+.++++..|.|.++.+++-|+-|+.
T Consensus 854 fp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 854 FPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 1111 11122567889999999999999999999999999999999965
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.1e-18 Score=148.13 Aligned_cols=171 Identities=23% Similarity=0.292 Sum_probs=118.2
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCe-eecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPV-VSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYR 172 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~i-vHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 172 (284)
.-...++.+|+.||.||| ..+| .|+.|++.|.++|..+.+||+|||+.......... .......-...|.|||.+
T Consensus 48 ~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPell 123 (484)
T KOG1023|consen 48 FFILSFIRDISKGLAYLH---NSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELL 123 (484)
T ss_pred HHHHHHHHHHHHHHHHHh---cCcceeeeeeccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHh
Confidence 345678999999999999 5555 99999999999999999999999998766431000 000012234579999998
Q ss_pred cCCC-------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhh
Q 039895 173 TTGD-------FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEK 245 (284)
Q Consensus 173 ~~~~-------~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
.... .+.+.||||||++++|+++...||......... ..+...+.. .....+.|.+... .
T Consensus 124 r~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~-------~ 190 (484)
T KOG1023|consen 124 RGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELL-------N 190 (484)
T ss_pred cccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhh-------h
Confidence 7631 467899999999999999999999764422221 122222221 1111222222111 1
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 246 EQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 246 ~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+..+.+..++..||..+|+.||++.+|-..++.+..
T Consensus 191 -e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 191 -ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred -hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 333358899999999999999999999988877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.1e-18 Score=148.39 Aligned_cols=133 Identities=25% Similarity=0.266 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
..+...++.+++++| +.+|+|||+|++||+++.+|.+++.|||+++..-.... .+||..|||||++. .
T Consensus 100 ~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-------~cgt~eymApEI~~--g 167 (612)
T KOG0603|consen 100 AFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-------ACGTYEYRAPEIIN--G 167 (612)
T ss_pred HHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-------cccchhhhhhHhhh--c
Confidence 346778899999999 99999999999999999999999999999987644332 27899999999988 5
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHH
Q 039895 177 FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELA 256 (284)
Q Consensus 177 ~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (284)
....+|-||||++.+|++||..||... ........ ..+.+.+......+++
T Consensus 168 h~~a~D~ws~gvl~felltg~~pf~~~------------~~~~Il~~-----------------~~~~p~~l~~~a~~~~ 218 (612)
T KOG0603|consen 168 HLSAADWWSFGVLAFELLTGTLPFGGD------------TMKRILKA-----------------ELEMPRELSAEARSLF 218 (612)
T ss_pred cCCcccchhhhhhHHHHhhCCCCCchH------------HHHHHhhh-----------------ccCCchhhhHHHHHHH
Confidence 678999999999999999999998641 11111100 0122445555677888
Q ss_pred HHhhcCCCCCCCCH
Q 039895 257 FKCLSESEGDRPTI 270 (284)
Q Consensus 257 ~~cl~~~p~~Rps~ 270 (284)
..++..+|.+|.-.
T Consensus 219 ~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 219 RQLFKRNPENRLGA 232 (612)
T ss_pred HHHHhhCHHHHhcc
Confidence 89999999998755
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.3e-17 Score=127.77 Aligned_cols=84 Identities=8% Similarity=0.131 Sum_probs=70.2
Q ss_pred CCeeeecCCceEEEEEe-CCcceEEEeecCCC------------------------------------------------
Q 039895 60 GKVIMKCLFYKLYKGFL-QDRPISVMKFEDTF------------------------------------------------ 90 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------------------------------------------------ 90 (284)
...||+|+||.||+|.. +|++||||++....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35899999999999998 89999999984220
Q ss_pred -----------------CCc---------------hhHHHHHHHHHHHHHHh-ccCCCCCeeecccccCcEEEecCCcce
Q 039895 91 -----------------PFS---------------VSKLKIAIEIASAVAYL-HVGFSRPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 91 -----------------~~~---------------~~~~~i~~~i~~gL~~L-H~~~~~~ivHrDlkp~NILl~~~~~~k 137 (284)
|.. .....++.|++.+|.++ | +.+|+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEE
Confidence 100 24567899999999999 7 88999999999999998 57899
Q ss_pred eecccccccc
Q 039895 138 LFDFTLSLSI 147 (284)
Q Consensus 138 l~Dfg~a~~~ 147 (284)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=125.50 Aligned_cols=86 Identities=9% Similarity=0.121 Sum_probs=73.2
Q ss_pred CCeeeecCCceEEEEEe-CCcceEEEeecCCC------------------------------------------------
Q 039895 60 GKVIMKCLFYKLYKGFL-QDRPISVMKFEDTF------------------------------------------------ 90 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------------------------------------------------ 90 (284)
...||+|++|.||+|.. +|+.||||++....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998 79999999976421
Q ss_pred -----------------CCc---------------hhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcce
Q 039895 91 -----------------PFS---------------VSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 91 -----------------~~~---------------~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~k 137 (284)
|.. .....++.|++.+|.++| . .+|+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCCEE
Confidence 000 355789999999999999 7 9999999999999999 88999
Q ss_pred eeccccccccCC
Q 039895 138 LFDFTLSLSIPE 149 (284)
Q Consensus 138 l~Dfg~a~~~~~ 149 (284)
|+|||++.....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-17 Score=130.71 Aligned_cols=122 Identities=13% Similarity=0.124 Sum_probs=92.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCCC-------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDTF------------------------------------------- 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------------------------------------- 90 (284)
.+.|...+++|.|+||.||....++..+|+|++....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4778889999999999999987788899999996430
Q ss_pred -----CCc----------hhH-------HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 91 -----PFS----------VSK-------LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 91 -----~~~----------~~~-------~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+.. .+. .....+++.+|..+| ..|++|+|++|+||+++.+| ++|+|||......
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence 000 111 235679999999999 99999999999999999988 9999999876553
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHH
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELL 194 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ell 194 (284)
..... ..+.....++.++|+||||+++.-+.
T Consensus 186 e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 186 QRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred chhhH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence 21111 11333445677999999999877553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=118.74 Aligned_cols=145 Identities=13% Similarity=0.099 Sum_probs=103.1
Q ss_pred CCCCCeeeecCCceEEEEEeCCcceEEEeecCCCC------------------------------------------Cc-
Q 039895 57 FDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDTFP------------------------------------------FS- 93 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~------------------------------------------~~- 93 (284)
+.....|++|+||+||.+...+.+++.+.+..... ..
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 34567899999999998877888887666544300 00
Q ss_pred -------hhHHHHHHHHHHHHHHhccCCCCCeeeccc-ccCcEEEecCCcceeeccccccccCCCCcc----c-cC----
Q 039895 94 -------VSKLKIAIEIASAVAYLHVGFSRPVVSRDI-KPTTIVLQEENVAQLFDFTLSLSIPEGETH----I-ND---- 156 (284)
Q Consensus 94 -------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~Dfg~a~~~~~~~~~----~-~~---- 156 (284)
.....++.|++.+|.++| ..||+|||| ||+|||++.++.++|+|||++......... . .+
T Consensus 84 ~L~~~~~~~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l 160 (218)
T PRK12274 84 AMYQRPPRGDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL 160 (218)
T ss_pred cHHhhhhhhhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence 123467889999999999 999999999 799999999999999999999865432210 0 00
Q ss_pred -CCCcccCccccccccccCC-CCC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 157 -SNRVIGTFGFMAPEYRTTG-DFS-EKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 157 -~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
......++.|++|+--.-. ..+ ...+-++-|.-+|.++|+..+..+..
T Consensus 161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0001246777777643221 233 45677799999999999998876543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-14 Score=114.18 Aligned_cols=90 Identities=11% Similarity=0.096 Sum_probs=74.5
Q ss_pred CCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------------------------------------- 89 (284)
-|...+.||+|+||.||++.. +|+.||||++...
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 366778999999999999998 8999999974321
Q ss_pred ----------------CCCc---------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 90 ----------------FPFS---------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 90 ----------------~~~~---------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
++.. .....++.+++.++.++| ..+|+|+||+|+||+++.++.++|+|||.+
T Consensus 96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~ 172 (198)
T cd05144 96 PVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQM 172 (198)
T ss_pred CCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCcc
Confidence 0000 223468899999999999 899999999999999999999999999998
Q ss_pred cccC
Q 039895 145 LSIP 148 (284)
Q Consensus 145 ~~~~ 148 (284)
....
T Consensus 173 ~~~~ 176 (198)
T cd05144 173 VSTD 176 (198)
T ss_pred ccCC
Confidence 6554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.6e-14 Score=117.32 Aligned_cols=88 Identities=13% Similarity=0.141 Sum_probs=73.6
Q ss_pred CCCCCCeeeecCCceEEEEE-e--CCcceEEEeecCCC------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGF-L--QDRPISVMKFEDTF------------------------------------------ 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~-~--~~~~vavK~~~~~~------------------------------------------ 90 (284)
.|+..+.||+|++|.||+|. . +|..||+|++....
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 3 89999999875210
Q ss_pred ---------------------CCc---------------hhHHHHHHHHHHHHHHhccCCCCC-eeecccccCcEEEecC
Q 039895 91 ---------------------PFS---------------VSKLKIAIEIASAVAYLHVGFSRP-VVSRDIKPTTIVLQEE 133 (284)
Q Consensus 91 ---------------------~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~-ivHrDlkp~NILl~~~ 133 (284)
+.. .....++.|++.+|.+|| ..+ |+|+||||+||+++ +
T Consensus 109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-C
Confidence 000 234579999999999999 999 99999999999999 8
Q ss_pred Ccceeecccccccc
Q 039895 134 NVAQLFDFTLSLSI 147 (284)
Q Consensus 134 ~~~kl~Dfg~a~~~ 147 (284)
+.++|+|||.+...
T Consensus 185 ~~i~LiDFg~a~~~ 198 (237)
T smart00090 185 GKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEEEEChhhhcc
Confidence 89999999988654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.4e-14 Score=111.55 Aligned_cols=85 Identities=14% Similarity=0.146 Sum_probs=71.2
Q ss_pred CCeeeecCCceEEEEEe-CCcceEEEeecCCCC-----------------------------------------------
Q 039895 60 GKVIMKCLFYKLYKGFL-QDRPISVMKFEDTFP----------------------------------------------- 91 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----------------------------------------------- 91 (284)
.+.||+|+||+||+|.. +|+.||||++.....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999999 699999998764200
Q ss_pred ----------------Cc--------------hhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeec
Q 039895 92 ----------------FS--------------VSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 92 ----------------~~--------------~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
.. .....++.+++.++.++| . .+|+|+||||+||+++ ++.++++|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEE
Confidence 00 234578999999999999 7 9999999999999999 89999999
Q ss_pred cccccccC
Q 039895 141 FTLSLSIP 148 (284)
Q Consensus 141 fg~a~~~~ 148 (284)
||.+....
T Consensus 158 fg~a~~~~ 165 (187)
T cd05119 158 VPQAVEID 165 (187)
T ss_pred Cccccccc
Confidence 99986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.9e-13 Score=108.68 Aligned_cols=82 Identities=21% Similarity=0.255 Sum_probs=68.9
Q ss_pred CeeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------------------CC
Q 039895 61 KVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------------------FP 91 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------------------~~ 91 (284)
+.||+|++|.||+|.+.|..|++|+.... ++
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999999999999975432 00
Q ss_pred Cc-----------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 92 FS-----------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 92 ~~-----------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
.. ..+..++.+++.+|.++| ..+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGMEELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccHHHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 00 124588999999999999 99999999999999999 78899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=109.53 Aligned_cols=82 Identities=20% Similarity=0.203 Sum_probs=67.7
Q ss_pred eeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------------------CCC
Q 039895 62 VIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------------------FPF 92 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------------------~~~ 92 (284)
+||+|+||.||+|.++|..|++|..... ++.
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 4899999999999999999999985421 000
Q ss_pred c---hhH-----HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 93 S---VSK-----LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 93 ~---~~~-----~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
. ... ..++.+++.+|.+|| ..+++|+|++|.||+++ ++.+++.|||++...
T Consensus 81 g~~l~~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGNDELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 0 011 178999999999999 99999999999999999 889999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-13 Score=124.23 Aligned_cols=91 Identities=16% Similarity=0.150 Sum_probs=71.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------- 89 (284)
....|...+.||+|+||+||+|.+.+..+++|+....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445567889999999999999997666666543211
Q ss_pred ------CCCc-------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 ------FPFS-------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 ------~~~~-------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
++.. .....++.+++.+|.+|| +.+++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 0000 224678999999999999 9999999999999999 5788999999998553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.3e-10 Score=97.94 Aligned_cols=182 Identities=19% Similarity=0.173 Sum_probs=119.5
Q ss_pred CCCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccc
Q 039895 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAP 169 (284)
Q Consensus 90 ~~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 169 (284)
.|.....++.+..++.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|-..-.....+.... ..+|...|.+|
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~----cpVg~~eftPP 185 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHL----CPVGVSEFTPP 185 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCCceEe----cccCccccCCH
Confidence 3444778899999999999999 8999999999999999999999998854332222222222 26789999999
Q ss_pred cccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC-CCC
Q 039895 170 EYRT-----TGDFSEKSDVYSFGALLLELLTG-KKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG-LMW 242 (284)
Q Consensus 170 E~~~-----~~~~~~~~DvwS~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (284)
|... +-.-+...|.|.+|+++++++.| ++||.+..........+..-+.. +.+....+........ ..+
T Consensus 186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~----g~f~ya~~~~~g~~p~P~~~ 261 (637)
T COG4248 186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH----GRFAYASDQRRGLKPPPRSI 261 (637)
T ss_pred HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc----ceeeechhccCCCCCCCCCC
Confidence 9754 22346789999999999999887 88886644322222222211211 1111111111111111 111
Q ss_pred hhhHHHHHHHHHHHHHhhcC--CCCCCCCHHHHHHHHHHHHhc
Q 039895 243 PEKEQQLLICTELAFKCLSE--SEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 243 ~~~~~~~~~~~~l~~~cl~~--~p~~Rps~~ev~~~L~~l~~~ 283 (284)
| ..-.++.+..|..+|+.. ++.-|||++..+..|..+.++
T Consensus 262 P-~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 262 P-LSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred C-hhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1 223344577888899865 367899999999999887654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-11 Score=101.64 Aligned_cols=84 Identities=13% Similarity=0.016 Sum_probs=68.1
Q ss_pred CCeee-ecCCceEEEEEeCCcceEEEeecCC-------------------------------------------------
Q 039895 60 GKVIM-KCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------------- 89 (284)
Q Consensus 60 ~~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------------- 89 (284)
...|| .||.|+||.....+..++||.+...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 46898 8999999999998889999877421
Q ss_pred -----------CCCc-hh----------HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 -----------FPFS-VS----------KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 -----------~~~~-~~----------~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
++.. .. ....+.+++.+|.+|| +.||+|+||||.|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 0000 00 1234778999999999 99999999999999999989999999998755
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-11 Score=98.06 Aligned_cols=44 Identities=18% Similarity=0.255 Sum_probs=36.5
Q ss_pred HHHHHHHHHH-HHhccCCCCCeeecccccCcEEEecC----Ccceeeccccc
Q 039895 98 KIAIEIASAV-AYLHVGFSRPVVSRDIKPTTIVLQEE----NVAQLFDFTLS 144 (284)
Q Consensus 98 ~i~~~i~~gL-~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~Dfg~a 144 (284)
.++.+++.++ +||| +.+|+||||||+|||++.. +.++|+||+.+
T Consensus 108 ~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 108 AQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3577888888 9999 9999999999999999743 37999995433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-12 Score=120.86 Aligned_cols=157 Identities=24% Similarity=0.303 Sum_probs=110.8
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCC--CCccccCCCCccc-Ccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPE--GETHINDSNRVIG-TFGFMAP 169 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~--~~~~~~~~~~~~g-t~~y~aP 169 (284)
...-.++.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..+.. +...... ...| ++.|+||
T Consensus 123 ~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~--~~~g~s~~y~a~ 198 (601)
T KOG0590|consen 123 SSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLK--DRCGSSPPYGAP 198 (601)
T ss_pred cchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeee--cccCCCCCCCCc
Confidence 4456789999999999995 67899999999999999999 999999999988765 2222222 2567 9999999
Q ss_pred ccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHH
Q 039895 170 EYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQ 248 (284)
Q Consensus 170 E~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (284)
|...+. ......|+||.|+++.-+++|..|+......... ...|.... ..+... .....
T Consensus 199 E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---~~~~~~~~---~~~~~~--------------~~~~~ 258 (601)
T KOG0590|consen 199 EHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---YSSWKSNK---GRFTQL--------------PWNSI 258 (601)
T ss_pred ccccchhhcCCCcccccccccccccccCCCCcccccccccc---ceeecccc---cccccC--------------ccccC
Confidence 998874 4467899999999999999999998654321111 11111100 000000 00111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 249 LLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 249 ~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
.....++..+++..+|+.|.+.+++.
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ChhhhhcccccccCCchhcccccccc
Confidence 11255788888889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.7e-11 Score=108.09 Aligned_cols=50 Identities=16% Similarity=0.237 Sum_probs=42.5
Q ss_pred HHHHHHHHH-HHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 97 LKIAIEIAS-AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 97 ~~i~~~i~~-gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
..++..++. .+..+| ..|++|+|++|.||+++.++.+++.|||++..+..
T Consensus 259 ~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 259 KALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 456666666 467889 89999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-11 Score=90.71 Aligned_cols=87 Identities=17% Similarity=0.115 Sum_probs=71.6
Q ss_pred CCeeeecCCceEEEEEeCCcceEEEeecCCCC-----------------------------------------Cc-----
Q 039895 60 GKVIMKCLFYKLYKGFLQDRPISVMKFEDTFP-----------------------------------------FS----- 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----------------------------------------~~----- 93 (284)
.+.||+|.++.||++..++..+++|......- ..
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~ 82 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE 82 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeeccc
Confidence 46799999999999999778999999865410 00
Q ss_pred ---hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 94 ---VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 94 ---~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
.....++.+++.+|.++|.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus 83 ~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 83 VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 24567899999999999944335799999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.9e-11 Score=104.22 Aligned_cols=192 Identities=20% Similarity=0.187 Sum_probs=131.3
Q ss_pred CCCCCCeeee--cCCceEEEEEe----CCcceEEEeecCC----------------------------------------
Q 039895 56 DFDGGKVIMK--CLFYKLYKGFL----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~--G~~g~Vy~~~~----~~~~vavK~~~~~---------------------------------------- 89 (284)
.|.....+|. |.+|.||.+.. ++..+|+|.-+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555678999 99999999887 6788999874322
Q ss_pred ------------CCCc-------hhHHHHHHHHHH----HHHHhccCCCCCeeecccccCcEEEecC-Ccceeecccccc
Q 039895 90 ------------FPFS-------VSKLKIAIEIAS----AVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSL 145 (284)
Q Consensus 90 ------------~~~~-------~~~~~i~~~i~~----gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~ 145 (284)
+|.. ........+... ||..+| ..+++|-|+||.||++..+ ..++++|||+..
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeE
Confidence 1111 334456667777 999999 9999999999999999999 889999999998
Q ss_pred ccCCCCccccCC--CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc
Q 039895 146 SIPEGETHINDS--NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 146 ~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
.+.+........ ....|...|++||+.. +.++...|+||+|.++.+..++..++....+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------------------ 332 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------------------ 332 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------------------
Confidence 887655322211 1235677899999765 4678899999999999999998776543210
Q ss_pred CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..|.. ++......+ ........+...+..+++.+|-.|++++.+.+
T Consensus 333 ~~W~~-~r~~~ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 SSWSQ-LRQGYIPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CCccc-cccccCchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 000000000 00011112344778899999999999877653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-10 Score=96.77 Aligned_cols=104 Identities=25% Similarity=0.332 Sum_probs=75.2
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc-cCCCCcccCccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI-NDSNRVIGTFGFMAPEYR 172 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~ 172 (284)
..-.+++.||+.||.|||.. +.+|+|+++..+-|++..+|.+||+--.-...-.+-.... .......+-++|.+||.-
T Consensus 176 ~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 176 KAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred HHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence 34457999999999999954 8999999999999999999988876422111111100000 011113467889999987
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCC
Q 039895 173 TTGDFSEKSDVYSFGALLLELLTGKK 198 (284)
Q Consensus 173 ~~~~~~~~~DvwS~G~il~elltg~~ 198 (284)
.....+.++|||+||+..+||..+..
T Consensus 255 ~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 255 TTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cccccccchhhhhhhHHHHHHHHhee
Confidence 76677889999999999999987754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-11 Score=109.57 Aligned_cols=152 Identities=22% Similarity=0.239 Sum_probs=100.9
Q ss_pred HHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc------CCCCcccCcccccccccc
Q 039895 100 AIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN------DSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 100 ~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~ 173 (284)
+.+++.||.|+|. +.++||++|.|++|.++.++..||+.|+............. -.....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4566789999997 78999999999999999999999999998765543211100 001122346799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHH
Q 039895 174 TGDFSEKSDVYSFGALLLELL-TGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLIC 252 (284)
Q Consensus 174 ~~~~~~~~DvwS~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
....+.++|+||+|+++|.+. .|+..+....... ..... .... +....+ .....+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~-~~~~--------~~~~~~-------~s~~~p~el 241 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFS-RNLL--------NAGAFG-------YSNNLPSEL 241 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhh-hccc--------cccccc-------ccccCcHHH
Confidence 888889999999999999998 4554443322100 00000 0000 000000 012334447
Q ss_pred HHHHHHhhcCCCCCCCCHHHHH
Q 039895 253 TELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 253 ~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
.+-+.+.+..++..||++.++.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 7888899999999999877654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-10 Score=102.77 Aligned_cols=202 Identities=19% Similarity=0.183 Sum_probs=137.0
Q ss_pred ceecHHH-HHHHhcCCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC-----------------------------
Q 039895 43 RSFSADE-LKTATDDFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT----------------------------- 89 (284)
Q Consensus 43 ~~~~~~~-l~~~~~~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~----------------------------- 89 (284)
..|...+ ....+.+|.....||.|.|+.|++... ++..+++|.+...
T Consensus 252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 3344444 333456788888999999999999877 6778898887665
Q ss_pred ---------------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-Cccee
Q 039895 90 ---------------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQL 138 (284)
Q Consensus 90 ---------------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl 138 (284)
+|.. ..++++..|++.++.++| ++.++|+|++|+||++..+ +..++
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhc
Confidence 2211 456788999999999999 9999999999999999986 78899
Q ss_pred eccccccccCCCCccccCCCCcccCccc-cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGF-MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||++..+.-..... ...+..| .+|.......+..+.|++|||..+.+.+++........
T Consensus 409 ~~~~~~t~~~~~~~~~-----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------- 470 (524)
T KOG0601|consen 409 GDFGCWTRLAFSSGVF-----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------- 470 (524)
T ss_pred cccccccccceecccc-----cccccccccchhhccccccccccccccccccccccccCcccCcccc-------------
Confidence 9999986532211110 1123333 35555556678899999999999999999865432211
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+..+..-.+ +........+..+...+...++..||.+.++....+-.
T Consensus 471 -------~~~~i~~~~~--------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 471 -------QSLTIRSGDT--------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------cceeeecccc--------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0001100000 01111113356778888999999999998877655443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.3e-10 Score=100.05 Aligned_cols=35 Identities=17% Similarity=0.243 Sum_probs=31.9
Q ss_pred CCCeeecccccCcEEEecCC----cceeeccccccccCC
Q 039895 115 SRPVVSRDIKPTTIVLQEEN----VAQLFDFTLSLSIPE 149 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~----~~kl~Dfg~a~~~~~ 149 (284)
..|++|+|++|.||+++.++ .+++.|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 78999999999999999888 899999999877754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.4e-09 Score=83.84 Aligned_cols=48 Identities=13% Similarity=0.171 Sum_probs=41.6
Q ss_pred HHHHHHHHHHHHHh-ccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 97 LKIAIEIASAVAYL-HVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 97 ~~i~~~i~~gL~~L-H~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
..+..+++.+|..| | ..+|||+||++.|||++ ++.+.|+|||.+....
T Consensus 127 ~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 127 KNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 45678999999998 8 89999999999999997 5679999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.7e-09 Score=82.25 Aligned_cols=81 Identities=19% Similarity=0.190 Sum_probs=64.8
Q ss_pred CeeeecCCceEEEEEeCCcceEEEeecCCCCC--c--------------------------------------------h
Q 039895 61 KVIMKCLFYKLYKGFLQDRPISVMKFEDTFPF--S--------------------------------------------V 94 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~--------------------------------------------~ 94 (284)
+.|+.|.++.||++...+..+++|+....... . .
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~~ 83 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTEDF 83 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccccc
Confidence 46889999999999998889999997543100 0 1
Q ss_pred hHHHHHHHHHHHHHHhccCCCCC-----eeecccccCcEEEecCCcceeecccccc
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRP-----VVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
....++.+++.+|+.|| ..+ ++|+|++|.||+++ ++.+++.|||.+.
T Consensus 84 ~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 84 SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 12356789999999999 666 59999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.3e-09 Score=100.80 Aligned_cols=148 Identities=25% Similarity=0.337 Sum_probs=104.0
Q ss_pred HHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC------C--C-----------------c
Q 039895 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE------G--E-----------------T 152 (284)
Q Consensus 98 ~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~------~--~-----------------~ 152 (284)
.....+..+++||| ...+.|+|++|.|+|+..++..+++|||....... . . .
T Consensus 908 s~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l 984 (1205)
T KOG0606|consen 908 SPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQL 984 (1205)
T ss_pred chhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccccc
Confidence 35667888999999 88899999999999999999999999984322210 0 0 0
Q ss_pred cc---cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 153 HI---NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 153 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.. .......||+.|.+||...+......+|.|++|++++|.++|.+||.... .+.. +..+
T Consensus 985 ~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t--------pq~~---------f~ni 1047 (1205)
T KOG0606|consen 985 SADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET--------PQQI---------FENI 1047 (1205)
T ss_pred ccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc--------hhhh---------hhcc
Confidence 00 01123578999999999999999999999999999999999999986543 0111 1111
Q ss_pred ccccccCCCCCCChh-hHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 039895 230 VDPAIVGEEGLMWPE-KEQQLLICTELAFKCLSESEGDRPTIV 271 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~~p~~Rps~~ 271 (284)
....+ .|+. .........+++...+..+|.+|..+.
T Consensus 1048 ~~~~~------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1048 LNRDI------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ccCCC------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11111 1111 223344467888889999999998765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-07 Score=72.82 Aligned_cols=85 Identities=18% Similarity=0.227 Sum_probs=67.8
Q ss_pred CCCeeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------CCC---------
Q 039895 59 GGKVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------FPF--------- 92 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------~~~--------- 92 (284)
...+|-+|+-+.|+++.+.|+...||.=... +|.
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678999999999999999999888854332 000
Q ss_pred --------------------c-hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc---ceeeccccccc
Q 039895 93 --------------------S-VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFTLSLS 146 (284)
Q Consensus 93 --------------------~-~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfg~a~~ 146 (284)
+ .....++..|-+.+.-|| ..+|+|+||..+||++..++. +.+.|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 0 223578899999999999 999999999999999987663 47999999743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.2e-07 Score=71.73 Aligned_cols=82 Identities=20% Similarity=0.232 Sum_probs=64.2
Q ss_pred CeeeecCCceEEEEEeCCcceEEEeecCC------------------------------CCCc-----------------
Q 039895 61 KVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------FPFS----------------- 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------~~~~----------------- 93 (284)
..+++|+-+.+|.+.+-|.++.+|.=.+. .|..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 36889999999999998877777764433 0000
Q ss_pred ----------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 94 ----------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 94 ----------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
.....++..+-.-+.-|| ..+|+|+||.++||++...+ +.+.|||++..
T Consensus 82 ~G~~lkd~l~~~~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhcchHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 112457788888899999 99999999999999998665 89999999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.5e-06 Score=68.56 Aligned_cols=49 Identities=18% Similarity=0.308 Sum_probs=37.7
Q ss_pred HHHHHHHHHHHHHH-hccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 96 KLKIAIEIASAVAY-LHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 96 ~~~i~~~i~~gL~~-LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
...++.+++..+.. +| ..||+|+||.+.|||++.+ .+.|.|||.+....
T Consensus 108 ~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 108 PKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 45678888885555 57 8999999999999999977 89999999875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1e-06 Score=79.73 Aligned_cols=49 Identities=18% Similarity=0.261 Sum_probs=38.4
Q ss_pred HHHHHHHHH-HHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 98 KIAIEIASA-VAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 98 ~i~~~i~~g-L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
.++..++.+ +..+- ..|++|.|..|.||+++.+|.+-+.|||+...+.+
T Consensus 268 ~ia~~~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 268 ELAELLVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 455555443 34444 67999999999999999999999999999877653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-05 Score=73.51 Aligned_cols=92 Identities=17% Similarity=0.211 Sum_probs=67.5
Q ss_pred HHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCC
Q 039895 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDF 177 (284)
Q Consensus 98 ~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 177 (284)
.-+.||+.||.|||+ +.+++|++|.-+.|+++..|.-||++|.++........ ......---.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc-
Confidence 458899999999986 78999999999999999999999999988754432211 000011222355665433222
Q ss_pred CcchhHHHHHHHHHHHHhC
Q 039895 178 SEKSDVYSFGALLLELLTG 196 (284)
Q Consensus 178 ~~~~DvwS~G~il~elltg 196 (284)
-..|.|-|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 456999999999999999
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.5e-06 Score=67.90 Aligned_cols=85 Identities=16% Similarity=0.089 Sum_probs=66.1
Q ss_pred CCCCeeeecCCceEEEEEe-CCcceEEEeecCCCC----------------------------------------C----
Q 039895 58 DGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDTFP----------------------------------------F---- 92 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----------------------------------------~---- 92 (284)
..++.||-|.-|.||.|.. .|.++|||.=..+.. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4468999999999999999 799999998654400 0
Q ss_pred ---------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 93 ---------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 93 ---------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
....-.++..|+.-+.-+- ..||||+|+++=||+++++|.+.+.||--+.
T Consensus 174 P~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 174 PKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred CCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 0223345666666666666 6899999999999999999999999987553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.1e-06 Score=67.31 Aligned_cols=102 Identities=11% Similarity=0.075 Sum_probs=76.9
Q ss_pred eecHHHHHHHhcCCCCCCe---eeecCCceEEEEEe-CCcceEEEeecCCCCCc--------------------------
Q 039895 44 SFSADELKTATDDFDGGKV---IMKCLFYKLYKGFL-QDRPISVMKFEDTFPFS-------------------------- 93 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~---lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-------------------------- 93 (284)
..+.+.|....+.-..... |++|.-+.||+|.. ++..+|||++....+..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3456666666555554444 55677778999998 89999999997661110
Q ss_pred ----------------------------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeec
Q 039895 94 ----------------------------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSR 121 (284)
Q Consensus 94 ----------------------------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHr 121 (284)
.....+..++++++.-|-. ..++||+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHg 191 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHG 191 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccc
Confidence 2355677888888888872 4899999
Q ss_pred ccccCcEEEecCCcceeeccccccccC
Q 039895 122 DIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 122 Dlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
||+.=|||+. ++.+.|+|||-|....
T Consensus 192 DLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 192 DLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999 8899999999886654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.3e-06 Score=67.83 Aligned_cols=50 Identities=16% Similarity=0.137 Sum_probs=43.5
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-------CCcceeeccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-------ENVAQLFDFTLSLS 146 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~Dfg~a~~ 146 (284)
..+..++.+++..+.-|| ..||+|+|++++|||++. ++.+.++||+.+..
T Consensus 138 ~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 138 RLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 355688999999999999 999999999999999985 46789999998743
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.1e-05 Score=64.91 Aligned_cols=51 Identities=18% Similarity=0.275 Sum_probs=45.6
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeecccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTLSLSI 147 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfg~a~~~ 147 (284)
..+..++.+++..+.-|| ..||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 118 ~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 456789999999999999 99999999999999999887 7899999977553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.5e-05 Score=60.86 Aligned_cols=50 Identities=18% Similarity=0.087 Sum_probs=43.4
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc--ceeecccccccc
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV--AQLFDFTLSLSI 147 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~Dfg~a~~~ 147 (284)
.+..+..+++..++-|| ..|+.|+|+-+.||+++.++. +.+.||.-++..
T Consensus 129 ~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 129 VRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 34589999999999999 999999999999999986676 899999866543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.88 E-value=7.7e-05 Score=60.31 Aligned_cols=31 Identities=16% Similarity=0.321 Sum_probs=26.1
Q ss_pred CCeeecccccCcEEEec--CCcceeeccccccc
Q 039895 116 RPVVSRDIKPTTIVLQE--ENVAQLFDFTLSLS 146 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~~--~~~~kl~Dfg~a~~ 146 (284)
..++|+|+.|.||+++. ++.+.|.||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 45799999999999998 56688999997743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00028 Score=56.61 Aligned_cols=89 Identities=12% Similarity=0.105 Sum_probs=66.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------------- 89 (284)
.++|...+++-......|.+-..+|..+.+|.....
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 356766667777777778888888999999988765
Q ss_pred ----CCCc----------------hh-HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 ----FPFS----------------VS-KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 ----~~~~----------------~~-~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
++.. .. .-.++..+.+++.-|| ..|++|+|..|+|++++.++ +++.||+..+.
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 0000 00 1135567889999999 99999999999999998655 89999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00043 Score=62.87 Aligned_cols=50 Identities=14% Similarity=0.171 Sum_probs=40.0
Q ss_pred CCCcceecHHHHHHHh------------cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC
Q 039895 39 HNPIRSFSADELKTAT------------DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT 89 (284)
Q Consensus 39 ~~~~~~~~~~~l~~~~------------~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~ 89 (284)
....+.++++|+.... ..|+. +.||.-+.|.||+|+. +|..||||+-.++
T Consensus 134 qD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~ 196 (538)
T KOG1235|consen 134 QDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPG 196 (538)
T ss_pred hccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCc-chhhhcchhheEEEEecCCCEEEEEecCcC
Confidence 3456667888876643 45653 6899999999999999 9999999998777
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0024 Score=50.70 Aligned_cols=82 Identities=20% Similarity=0.193 Sum_probs=64.5
Q ss_pred cCCCCCCeeeecCC-ceEEEEEeCCcceEEEeecCC--------------------------------------------
Q 039895 55 DDFDGGKVIMKCLF-YKLYKGFLQDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~-g~Vy~~~~~~~~vavK~~~~~-------------------------------------------- 89 (284)
.+++..+.||.|.. |.||++..+|+.+|+|++..-
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888899999999 999999999999999994321
Q ss_pred ------CCCc-------------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccC
Q 039895 90 ------FPFS-------------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126 (284)
Q Consensus 90 ------~~~~-------------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~ 126 (284)
.|.. ....+-+.+|.+-|..+| ..+|+-+|+++.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ 193 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILH---KLGIVPRDVKPR 193 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHH---HCCeeeccCccc
Confidence 0100 012234677888899999 999999999999
Q ss_pred cEEEecCCcceeeccccc
Q 039895 127 TIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 127 NILl~~~~~~kl~Dfg~a 144 (284)
|.. + -+|+|||.+
T Consensus 194 ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 194 NYR---G--GKLVDFSSS 206 (207)
T ss_pred ccc---C--CEEEecccC
Confidence 987 3 389999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.048 Score=49.17 Aligned_cols=82 Identities=18% Similarity=0.253 Sum_probs=63.3
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 173 (284)
.....++.|+..||.++| +.|+.-+-|.|.+||++.+..++|+..|....+..+.. |.+.
T Consensus 393 ~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~-----------------~~le 452 (655)
T KOG3741|consen 393 EVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT-----------------EPLE 452 (655)
T ss_pred HHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC-----------------cchh
Confidence 455679999999999999 99999999999999999888888887776654433221 1111
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCC
Q 039895 174 TGDFSEKSDVYSFGALLLELLTGKK 198 (284)
Q Consensus 174 ~~~~~~~~DvwS~G~il~elltg~~ 198 (284)
. -.+-|.=.||.+++.|.||..
T Consensus 453 ~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 453 S---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred H---HhhhhHHHHHHHHHHHhhccc
Confidence 1 246788999999999999954
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0051 Score=52.28 Aligned_cols=52 Identities=23% Similarity=0.245 Sum_probs=33.7
Q ss_pred HHHHHHHHHHHHHHhc-cCCCCCeeecccccCcEEEecCC------------------cceeecccccccc
Q 039895 96 KLKIAIEIASAVAYLH-VGFSRPVVSRDIKPTTIVLQEEN------------------VAQLFDFTLSLSI 147 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH-~~~~~~ivHrDlkp~NILl~~~~------------------~~kl~Dfg~a~~~ 147 (284)
..-+..||+.-.-.+. ..|..+.+|-||||+|||+-... .++|.||.+++..
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 3446777765443342 22357799999999999995332 3566777776543
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0056 Score=52.27 Aligned_cols=48 Identities=25% Similarity=0.309 Sum_probs=31.3
Q ss_pred HHHHHHHHHHHH--hccC-CCCCeeecccccCcEEEecC------------------Ccceeecccccccc
Q 039895 98 KIAIEIASAVAY--LHVG-FSRPVVSRDIKPTTIVLQEE------------------NVAQLFDFTLSLSI 147 (284)
Q Consensus 98 ~i~~~i~~gL~~--LH~~-~~~~ivHrDlkp~NILl~~~------------------~~~kl~Dfg~a~~~ 147 (284)
-+..||| |-| +.+. |..+.+|-||||+|||+-.. -.+++.||.+|+..
T Consensus 279 fifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 279 FIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3555664 444 3222 35679999999999999432 24567788777554
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0042 Score=60.66 Aligned_cols=142 Identities=21% Similarity=0.247 Sum_probs=90.4
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccC---cEEEecCCcceee--ccccccccCCCCccccCCCCcccCccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT---TIVLQEENVAQLF--DFTLSLSIPEGETHINDSNRVIGTFGFMA 168 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~---NILl~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a 168 (284)
...+.+..++.+||.|+| +....|.-|..+ +-..+..+...++ ||+.+..+........ ..-+..+.+
T Consensus 286 ~~~r~~~~~~~~GL~~~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~----~~~~~~~~~ 358 (1351)
T KOG1035|consen 286 ETLRILHQKLLEGLAYLH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS----DLLAEIRNA 358 (1351)
T ss_pred HHHHHHHHHHhhhHHHHH---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh----hcCcccccc
Confidence 344567888999999999 665555444444 3334455556666 8888777655433222 234566788
Q ss_pred cccccCCCCCc--chhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhH
Q 039895 169 PEYRTTGDFSE--KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKE 246 (284)
Q Consensus 169 PE~~~~~~~~~--~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
||......++. ..|+|.+|.....+..|..+..... ....+++....
T Consensus 359 ~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~--------------------~~~~~l~~~~~----------- 407 (1351)
T KOG1035|consen 359 DEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA--------------------VPVSLLDVLST----------- 407 (1351)
T ss_pred ccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc--------------------chhhhhccccc-----------
Confidence 88776655544 4799999999999998876532110 00111111100
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 247 QQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 247 ~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
....+....|+..++++|+++.+++..
T Consensus 408 ---~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 408 ---SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred ---hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 025678889999999999999998764
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0054 Score=47.49 Aligned_cols=84 Identities=13% Similarity=0.071 Sum_probs=57.3
Q ss_pred CCeeeecCCceEEEEEeCCcceEEEeecCCCCCc------------------------------------------hh--
Q 039895 60 GKVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFS------------------------------------------VS-- 95 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~------------------------------------------~~-- 95 (284)
...|++|.+|.||.|.+.|..+|+|+-.....-. ..
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~~~ 106 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEIGG 106 (201)
T ss_pred hhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhhcc
Confidence 4679999999999999999999999876651110 00
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeeccccc-CcEEEecCCcceeeccccccc
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKP-TTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp-~NILl~~~~~~kl~Dfg~a~~ 146 (284)
..+-...+++.---|- ..||-|..|.- ...++..++.+.|+||..|+.
T Consensus 107 ~rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 107 DRKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cHHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 1223344555533344 78899999874 444444455899999998863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0097 Score=48.56 Aligned_cols=28 Identities=7% Similarity=0.099 Sum_probs=24.9
Q ss_pred CCeeecccccCcEEEecCCcceeeccccc
Q 039895 116 RPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..++|+|+.|.||+++.++ +.|.||+.+
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhc
Confidence 3568999999999999888 999999976
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.036 Score=47.63 Aligned_cols=30 Identities=17% Similarity=0.463 Sum_probs=26.0
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.|.|||++.+...-|.||+.+
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 468999999999999997665689999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.018 Score=49.86 Aligned_cols=87 Identities=8% Similarity=0.074 Sum_probs=66.6
Q ss_pred CCCeeeecCCceEEEEEe-CCcceEEEeecCC--------------------CCCc------------------------
Q 039895 59 GGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT--------------------FPFS------------------------ 93 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------------~~~~------------------------ 93 (284)
....|..|.-+-||.++- +|..+|||+++.. ||..
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345799999999999999 9999999998765 3332
Q ss_pred ------------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcce
Q 039895 94 ------------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 94 ------------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 137 (284)
.....+-.+++.-+.-|.+ ...+||.||.-=|+|+- +|.+.
T Consensus 228 IP~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 228 IPCPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CCEEE
Confidence 2334455667777777765 56899999999999986 67799
Q ss_pred eeccccccccC
Q 039895 138 LFDFTLSLSIP 148 (284)
Q Consensus 138 l~Dfg~a~~~~ 148 (284)
|+|.+-+....
T Consensus 305 iIDVSQSVE~D 315 (520)
T KOG2270|consen 305 IIDVSQSVEHD 315 (520)
T ss_pred EEEccccccCC
Confidence 99988765443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.01 Score=46.98 Aligned_cols=56 Identities=16% Similarity=0.150 Sum_probs=47.8
Q ss_pred CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 92 FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 92 ~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
....|.+||.+++..+.+|++.....+.-.|++++|+-+++++.+|+.|...+...
T Consensus 57 ~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 57 PWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 34789999999999999999654456777999999999999999999999866444
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0019 Score=59.15 Aligned_cols=92 Identities=23% Similarity=0.225 Sum_probs=72.7
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
..+...-+++|+|+| +..=+|+| ||+..+ +..+.+||+....+.... ......+|+.++|||+.....
T Consensus 339 ~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~ 406 (829)
T KOG0576|consen 339 AYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENT 406 (829)
T ss_pred hhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCchhhcccc
Confidence 345566678899999 66668888 777665 678999999988776554 223377999999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCC
Q 039895 177 FSEKSDVYSFGALLLELLTGKKIS 200 (284)
Q Consensus 177 ~~~~~DvwS~G~il~elltg~~p~ 200 (284)
+....|+|+.|+--.++.-|.+|-
T Consensus 407 ~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 407 IDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCccCCCcchhhcCCCCCCC
Confidence 999999999998777777776664
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.007 Score=51.47 Aligned_cols=85 Identities=11% Similarity=0.085 Sum_probs=61.3
Q ss_pred CCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------------- 89 (284)
++.++.||-|.-+.||.+-. +|++.++|.-.-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56789999999999999999 7999999975433
Q ss_pred ---------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 90 ---------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 90 ---------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
.|.- ...-.+...+..-+.-|- ..|+||+|..-=||++++++.++++||--.
T Consensus 174 VPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 174 VPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred CCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHH---HcCceecccchheeEEecCCCEEEeechHh
Confidence 0000 111122223333333444 789999999999999999999999999643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.0027 Score=63.82 Aligned_cols=83 Identities=13% Similarity=0.019 Sum_probs=66.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHH
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELL 194 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ell 194 (284)
+.-.+|++||+-|.+|..+..++++++|+.+.......... ...+++.|+.|+....-.++.++|+|..|+.+|+..
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~G---l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFG---LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhhhh---hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 34478999999999999999999999999984433322222 256788899999888888888899999999999987
Q ss_pred hCCCCC
Q 039895 195 TGKKIS 200 (284)
Q Consensus 195 tg~~p~ 200 (284)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776654
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.098 Score=43.86 Aligned_cols=45 Identities=16% Similarity=0.231 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 99 i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
.+..+-.++.-++.. ..-++|.|+.|.|+|.+..+.++|.||.-|
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyA 181 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYA 181 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccC
Confidence 344444555555521 136899999999999999899999999876
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.033 Score=47.66 Aligned_cols=30 Identities=23% Similarity=0.554 Sum_probs=27.1
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.+.||+++.++.+.|.||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 578999999999999998887789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.029 Score=45.25 Aligned_cols=75 Identities=16% Similarity=0.222 Sum_probs=51.0
Q ss_pred HHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhH
Q 039895 104 ASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDV 183 (284)
Q Consensus 104 ~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 183 (284)
+.+|.-.|.. ..+.+|+|..|+||+-|+.|.+||.|=+.-.. .+.-|.--| ....+.++.+
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---------------~~V~~vN~~---Y~~lT~~aE~ 211 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---------------NQVNMVNIE---YESLTQEAEV 211 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh---------------heeeEEeee---ccccChHHHH
Confidence 4567777844 68899999999999999999999999664311 111122211 1234667777
Q ss_pred HHHHHHHHHHHhCC
Q 039895 184 YSFGALLLELLTGK 197 (284)
Q Consensus 184 wS~G~il~elltg~ 197 (284)
-+|=.-+++++...
T Consensus 212 ~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 212 KVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHH
Confidence 77777777776643
|
The function of this family is unknown. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.026 Score=46.25 Aligned_cols=30 Identities=17% Similarity=0.356 Sum_probs=25.8
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+|+.+.|||++.++..-|.||+.+
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a 192 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCL 192 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence 456999999999999987766679999976
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.013 Score=42.64 Aligned_cols=38 Identities=13% Similarity=0.179 Sum_probs=31.6
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~ 89 (284)
.+....|+ .+.||.|+.|.||+|++ +|+.||||+..+.
T Consensus 8 ~~~F~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~ 46 (119)
T PF03109_consen 8 DEIFDEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPG 46 (119)
T ss_pred HHHHHHCC-cchhhheehhhheeeeecccchhhhhhcchH
Confidence 33445666 47999999999999999 8999999998766
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.057 Score=44.08 Aligned_cols=30 Identities=17% Similarity=0.361 Sum_probs=26.4
Q ss_pred CCCeeecccccCcEEEec-CCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQE-ENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a 144 (284)
...++|+|+.+.|||++. ++.+.+.||..+
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 457999999999999997 578999999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.029 Score=45.40 Aligned_cols=30 Identities=17% Similarity=0.412 Sum_probs=21.2
Q ss_pred CCCeeecccccCcEEEe-cCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQ-EENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~a 144 (284)
...++|+|+.|.|||++ .++.+.|.||+.+
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred CcEEEEeccccccceeeeccceeEEEecccc
Confidence 57799999999999999 5565679999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.071 Score=45.43 Aligned_cols=30 Identities=20% Similarity=0.306 Sum_probs=26.8
Q ss_pred CCCeeecccccCcEEEecC----Ccceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEE----NVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~----~~~kl~Dfg~a 144 (284)
...++|+|+.|.|||++.+ +.+.+.||..+
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 5679999999999999975 78999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.80 E-value=0.037 Score=46.98 Aligned_cols=30 Identities=17% Similarity=0.459 Sum_probs=26.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.|.|||++.++.+.|.||+.+
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 357999999999999998877789999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.096 Score=44.74 Aligned_cols=29 Identities=24% Similarity=0.372 Sum_probs=25.1
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.+.||+++. +.+.|.||+.+
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 468999999999999987 56789999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.43 Score=41.62 Aligned_cols=81 Identities=17% Similarity=0.161 Sum_probs=54.0
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 173 (284)
.+.+.++.+.+.-+.-+-. .-+.=|||+.-.||||+ +|.+.|+||-+++.-.+.... .....--|..+.
T Consensus 321 ~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~i--------sy~rldhp~lF~ 389 (488)
T COG5072 321 EEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGII--------SYNRLDHPDLFN 389 (488)
T ss_pred HHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecccCCcee--------eccccCchhhhc
Confidence 5667777777666666653 55688999999999999 999999999999843222111 111122354455
Q ss_pred CCCCCcchhHHHH
Q 039895 174 TGDFSEKSDVYSF 186 (284)
Q Consensus 174 ~~~~~~~~DvwS~ 186 (284)
+ .-+.+-+||-+
T Consensus 390 G-~dd~QFeIYrl 401 (488)
T COG5072 390 G-VDDYQFEIYRL 401 (488)
T ss_pred C-ccceeeeHHHH
Confidence 3 33677788864
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.052 Score=42.68 Aligned_cols=30 Identities=13% Similarity=0.225 Sum_probs=25.5
Q ss_pred CCeeecccccCcEEEecCCcceeeccccccc
Q 039895 116 RPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
...+|+|+.|.|++++.++ ++++||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 4569999999999998877 88999998743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.06 Score=44.72 Aligned_cols=28 Identities=14% Similarity=0.331 Sum_probs=24.9
Q ss_pred CCeeecccccCcEEEecCCcceeeccccc
Q 039895 116 RPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..++|+|+.|.||+++.++ +.+.||..+
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEecccc
Confidence 4689999999999999877 789999876
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.053 Score=44.61 Aligned_cols=30 Identities=13% Similarity=0.134 Sum_probs=26.5
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+|+.|.|||++.++...|.||+.+
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 456899999999999998877889999876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.04 E-value=0.065 Score=43.10 Aligned_cols=29 Identities=21% Similarity=0.489 Sum_probs=20.7
Q ss_pred CCeeecccccCcEEE-ecCCcceeeccccc
Q 039895 116 RPVVSRDIKPTTIVL-QEENVAQLFDFTLS 144 (284)
Q Consensus 116 ~~ivHrDlkp~NILl-~~~~~~kl~Dfg~a 144 (284)
..++|.|+.|.|||+ +.++.++++||..+
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHH
Confidence 467899999999999 88899999999876
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.15 Score=45.18 Aligned_cols=30 Identities=17% Similarity=0.388 Sum_probs=25.8
Q ss_pred CCCeeecccccCcEEEecCCcceeecccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
...++|+|+.|.|||+..+ .+++.||..+.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 5679999999999999876 58999998764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.23 E-value=0.11 Score=41.27 Aligned_cols=30 Identities=23% Similarity=0.341 Sum_probs=25.0
Q ss_pred CCCeeecccccCcEEEecCC-----cceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEEN-----VAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~-----~~kl~Dfg~a 144 (284)
...++|+|+.+.||++..++ .+.+.||..+
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~ 153 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS 153 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence 45789999999999998554 5789999876
|
subfamily of choline kinases |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.12 E-value=0.2 Score=44.31 Aligned_cols=36 Identities=17% Similarity=0.240 Sum_probs=24.5
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 134 (284)
.+++.-.+.||.-+-- -.+.+|.|+.|.||++..+.
T Consensus 347 kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 347 KKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred HHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEecC
Confidence 3455555556544332 57899999999999996443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.93 E-value=0.23 Score=43.92 Aligned_cols=29 Identities=7% Similarity=0.403 Sum_probs=25.1
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+||.|.||+++.++ +|+.|..++
T Consensus 226 ~~aLlHGDlHtGSI~v~~~~-~kvIDpEFA 254 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKNDS-TKVIDPEFA 254 (409)
T ss_pred chhhccCcCCCCCEEecCCc-eEEEccccc
Confidence 67899999999999999764 899997766
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.68 E-value=0.13 Score=43.38 Aligned_cols=32 Identities=25% Similarity=0.420 Sum_probs=25.6
Q ss_pred CCCeeecccccCcEEEecCCc-ceeeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENV-AQLFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~-~kl~Dfg~a~~ 146 (284)
...++|+|+.|.|||++.++. .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 346899999999999997554 46999998733
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.67 E-value=0.26 Score=42.93 Aligned_cols=31 Identities=13% Similarity=0.288 Sum_probs=26.4
Q ss_pred CCCeeecccccCcEEEec-CCcceeecccccc
Q 039895 115 SRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSL 145 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~ 145 (284)
...++|+|+++.|||++. ++.+.+.||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 457899999999999986 4679999998763
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.30 E-value=0.36 Score=41.70 Aligned_cols=27 Identities=15% Similarity=0.543 Sum_probs=24.4
Q ss_pred eeecccccCcEEEecCCc-ceeeccccc
Q 039895 118 VVSRDIKPTTIVLQEENV-AQLFDFTLS 144 (284)
Q Consensus 118 ivHrDlkp~NILl~~~~~-~kl~Dfg~a 144 (284)
+||+|+.|.||+++.+.. +.+.||+-+
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccc
Confidence 999999999999998874 889999965
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.09 E-value=0.12 Score=44.35 Aligned_cols=30 Identities=10% Similarity=0.204 Sum_probs=27.2
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.+.|+|++.++.+.+.||..+
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 457999999999999999988999999876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.29 E-value=0.26 Score=42.28 Aligned_cols=34 Identities=15% Similarity=0.299 Sum_probs=29.3
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
...++|+|+.+.|++++..+.+-+.||+++..-.
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 5679999999999999988888899999885543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=90.17 E-value=0.44 Score=41.64 Aligned_cols=31 Identities=13% Similarity=0.354 Sum_probs=25.9
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
...++|+|+.+.||+++.++ +++.|+..+..
T Consensus 191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 67899999999999997654 78999886643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.14 E-value=0.66 Score=46.50 Aligned_cols=32 Identities=19% Similarity=0.354 Sum_probs=26.1
Q ss_pred CCCeeecccccCcEEEecCC--cce-eeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEEN--VAQ-LFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~--~~k-l~Dfg~a~~ 146 (284)
..++||.|+.+.|||++.++ .+. |.|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 56799999999999999775 444 999997643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.85 E-value=0.43 Score=43.51 Aligned_cols=82 Identities=22% Similarity=0.230 Sum_probs=43.7
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-CcccccccccccCCCCCCChhhHHHHHHHHHHH
Q 039895 178 SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELA 256 (284)
Q Consensus 178 ~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (284)
.+|+||||+|.++.|+.-|...+.... .......+...... .......... ....++...+.++.
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~-----~s~~l~~i~k~~~~d~~~~~~a~e~---------~~~~~~d~~~~~~~ 174 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELT-----ESEYLEILLKYYTDDQELLSTAMEH---------LIQLLADKKRLPLL 174 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHH-----HHHHHHHHHHhccCchhHHHHHHHH---------HHHHhhhHhHHHHh
Confidence 369999999999999998876543211 00011111111100 0000000000 11233444577889
Q ss_pred HHhhcCCCCCCCCHHHH
Q 039895 257 FKCLSESEGDRPTIVQV 273 (284)
Q Consensus 257 ~~cl~~~p~~Rps~~ev 273 (284)
..|+-..|..||...+.
T Consensus 175 ~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 175 KKCLWLEPIIRPLPMEL 191 (725)
T ss_pred ccCCccccccccchhHH
Confidence 99999999998865554
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=87.84 E-value=0.42 Score=41.42 Aligned_cols=29 Identities=21% Similarity=0.331 Sum_probs=24.9
Q ss_pred CeeecccccCcEEEec-CCcceeecccccc
Q 039895 117 PVVSRDIKPTTIVLQE-ENVAQLFDFTLSL 145 (284)
Q Consensus 117 ~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~ 145 (284)
-.+|.|+.+.|||++. ++.+++.||..|.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 4789999999999974 5789999998763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=87.03 E-value=0.83 Score=40.66 Aligned_cols=29 Identities=14% Similarity=0.405 Sum_probs=24.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+||.|.||+++.++ +++.|..++
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 67899999999999999876 788886654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.01 E-value=1 Score=38.90 Aligned_cols=28 Identities=14% Similarity=0.222 Sum_probs=23.9
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.+.|||++ + .+.|.||+-+
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~ 222 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDA 222 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCC
Confidence 56789999999999995 4 5789999976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 284 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 284 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-48 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-47 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-43 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-32 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-23 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-22 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-21 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-21 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-20 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-20 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-19 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-19 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-19 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-19 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-18 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-18 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-18 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-17 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-16 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-16 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-14 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-14 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-14 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-14 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-13 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-13 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-13 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-13 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-13 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-13 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-13 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-12 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-12 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-12 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-12 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-11 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-11 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-11 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-10 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-10 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-10 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-10 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-10 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-10 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-10 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-10 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-10 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-10 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-10 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-10 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-10 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 9e-10 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-09 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-09 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-09 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-09 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-09 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-09 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-09 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-09 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-09 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-09 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-09 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-08 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-08 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-08 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-08 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-08 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-08 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-08 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-08 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-08 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-08 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-08 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-08 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-08 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-08 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-08 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-08 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-08 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-08 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-08 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-08 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-04 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-08 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 9e-08 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-07 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-07 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-07 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-07 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-07 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-07 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-07 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-07 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-07 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-07 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-07 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-07 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-07 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-07 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-07 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-07 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-07 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-07 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-07 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-07 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-07 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-07 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-07 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-07 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-07 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-07 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-07 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-07 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-07 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-07 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-07 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 7e-07 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-07 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-07 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 7e-07 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-07 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-06 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-06 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-06 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-06 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-06 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-06 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-06 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-06 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-06 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-06 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-06 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-06 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-06 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-06 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-06 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-06 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-06 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 7e-06 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-06 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-05 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-05 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-05 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-05 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-05 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-05 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-04 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-04 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-04 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-48
Identities = 61/188 (32%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG-ETHIN 155
L+I I A + YLH ++ RD+K I+L E V ++ DF +S E +TH+
Sbjct: 142 LEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL- 197
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK-ISYSSHFDDGEDYRLQ 214
S V GT G++ PEY G +EKSDVYSFG +L E+L + I S E L
Sbjct: 198 -STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL---PREMVNLA 253
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274
+ + N ++IVDP + + + L + A KCL+ S DRP++ V
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADK----IRPES--LRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 275 KQLRQIYQ 282
+L +
Sbjct: 308 WKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-47
Identities = 60/181 (33%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+IA+ A +AYLH ++ RD+K I+L EE A + DF L+ + +TH+
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-- 191
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ V GT G +APEY +TG SEK+DV+ +G +LLEL+TG++ + + +D L D
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
VK ++ + + +VD + G + ++E + LI ++A C S +RP + +V +
Sbjct: 252 VKGLLKEKKLEALVDVDLQGN----YKDEEVEQLI--QVALLCTQSSPMERPKMSEVVRM 305
Query: 277 L 277
L
Sbjct: 306 L 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 52/189 (27%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE-THIN 155
KIA A+ + +LH + RDIK I+L E A++ DF L+ + + T +
Sbjct: 136 CKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM- 191
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
++R++GT +MAPE G+ + KSD+YSFG +LLE++TG + L D
Sbjct: 192 -TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQL-LLD 245
Query: 216 LVKKYI-ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274
+ ++ E ++ ++ +D + + +A +CL E + RP I +V
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND-----ADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 275 KQLRQIYQS 283
+ L+++ S
Sbjct: 299 QLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 39/228 (17%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLH------VGFSRP-VVSRDIKPTT 127
FL+ +S + IA +A +AYLH +P + RDIK
Sbjct: 112 FLKANVVSWNEL----------CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
Query: 128 IVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEY-----RTTGDFSEKSD 182
++L+ A + DF L+L G++ D++ +GT +MAPE D + D
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAG-DTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 183 VYSFGALLLELLTGKKISYSSHFDDGEDYRL--QDLVKKYIENESFKEIV-----DPAIV 235
+Y+ G +L EL + + ++Y L ++ + ++ E +E+V P +
Sbjct: 221 MYAMGLVLWELASRCTAADGPV----DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
W + ++C E +C R + V +++ Q+ +
Sbjct: 277 DY----WQKHAGMAMLC-ETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-23
Identities = 36/214 (16%), Positives = 75/214 (35%), Gaps = 31/214 (14%)
Query: 95 SKLKIAIEIASAVAYLH------VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL--- 145
S ++A + +AYLH + + RD+ ++++ + + DF LS+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 146 --SIPEGETHINDSNRVIGTFGFMAPEY-------RTTGDFSEKSDVYSFGALLLELLTG 196
+ N + +GT +MAPE R ++ D+Y+ G + E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 197 KKISYSSHFDDGEDYRL--QDLVKKYIENESFKEIVD-----PAIVGEEGLMWPEKEQQL 249
+ + +Y++ Q V + E + +V P W E +
Sbjct: 232 CTDLF--PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----WKENSLAV 285
Query: 250 LICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
E C + R T +++ ++
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 42/233 (18%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLH-----VGFSRPVVSRDIKP 125
L+ +L ++V +K+A+ AS +A+LH + RD+K
Sbjct: 127 LFD-YLNRYTVTVEGM----------IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHIND-SNRVIGTFGFMAPE------YRTTGDFS 178
I++++ + D L++ I+ N +GT +MAPE +
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 179 EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL--QDLVKKYIENESFKEIVDPAIVG 236
+++D+Y+ G + E+ I EDY+L DLV + S +E+ +V
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIH-----EDYQLPYYDLVP---SDPSVEEMRK--VVC 285
Query: 237 EEGL------MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
E+ L W E ++ ++ +C + R T +++ K L Q+ Q
Sbjct: 286 EQKLRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 42/233 (18%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLH-----VGFSRPVVSRDIKP 125
LY +L+ + LK+A S + +LH + RD+K
Sbjct: 122 LYD-YLKSTTLDAKSM----------LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHIND-SNRVIGTFGFMAPE------YRTTGDFS 178
I++++ + D L++ ++ N +GT +M PE R
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 179 EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL--QDLVKKYIENESFKEIVDPAIVG 236
+D+YSFG +L E+ E+Y+L DLV + S++++ + IV
Sbjct: 231 IMADMYSFGLILWEVARRC-----VSGGIVEEYQLPYHDLVP---SDPSYEDMRE--IVC 280
Query: 237 EEGL------MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
+ L W E + +L +C + + R T ++V K L ++ +S
Sbjct: 281 IKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 43/219 (19%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
LY L E F + IA + A + YLH ++ ++ RD+K I L
Sbjct: 106 LYH-HLHAS-------ETKFEMKK-LIDIARQTARGMDYLH---AKSIIHRDLKSNNIFL 153
Query: 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE---YRTTGDFSEKSDVYSFG 187
E+N ++ DF L+ + + + ++ G+ +MAPE + + +S +SDVY+FG
Sbjct: 154 HEDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 188 ALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ 247
+L EL+TG ++ YS+ + +I+ +VG L P+ +
Sbjct: 213 IVLYELMTG-QLPYSNI-------------------NNRDQII--EMVGRGSLS-PDLSK 249
Query: 248 QLLIC----TELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282
C L +CL + +RP+ ++ ++ ++ +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 48/230 (20%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLH-----VGFSRPVVSRDIKP 125
LY +LQ + + S L+I + IAS +A+LH + RD+K
Sbjct: 93 LYD-YLQLTTLDTV----------SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHIND-SNRVIGTFGFMAPE------YRTTGDFS 178
I++++ + D L++ + ++ +N +GT +MAPE D
Sbjct: 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 179 EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL--QDLVKKYIENESFKEIVDPAIVG 236
++ D+++FG +L E+ EDY+ D+V + SF+++ +V
Sbjct: 202 KRVDIWAFGLVLWEVARRM-----VSNGIVEDYKPPFYDVVP---NDPSFEDMRK--VVC 251
Query: 237 EEGL------MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280
+ W + +L +C ++ R T +++ K L +I
Sbjct: 252 VDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHI 154
+ ++ + VAYLH + ++ RD+KP ++L V ++ DF + I T
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-- 161
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198
G+ +MAPE ++SEK DV+S+G +L E++T +K
Sbjct: 162 ----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 21/105 (20%), Positives = 46/105 (43%), Gaps = 12/105 (11%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+K A+++A +A+LH + + ++++ E+ A++ + S
Sbjct: 113 AVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------- 163
Query: 156 DSNRVIGTFGFMAPE---YRTTGDFSEKSDVYSFGALLLELLTGK 197
S + ++APE + +D++SF LL EL+T +
Sbjct: 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-19
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 12/101 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +EI A++YLH S +V D+KP I+L EE + +L D + IN
Sbjct: 185 IAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAV-------SRINS 233
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ GT GF APE + +D+Y+ G L L
Sbjct: 234 FGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-19
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 24/135 (17%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
L + L + I + A++IA + YLH P++ RD+K + I++
Sbjct: 93 LNR-VLSGKRIPPDI----------LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141
Query: 131 QEENVAQLF--------DFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSD 182
++ DF L+ E H G + +MAPE FS+ SD
Sbjct: 142 LQKVENGDLSNKILKITDFGLA-----REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSD 196
Query: 183 VYSFGALLLELLTGK 197
V+S+G LL ELLTG+
Sbjct: 197 VWSYGVLLWELLTGE 211
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+L +A ++A + YLH + P+V R++K +++ ++ ++ DF LS
Sbjct: 139 RLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--- 194
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
S GT +MAPE +EKSDVYSFG +L EL T +
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-18
Identities = 45/198 (22%), Positives = 83/198 (41%), Gaps = 47/198 (23%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLF-----DFTLSLSIPEG 150
KL++ ++IA + Y+ + P+V RD++ I LQ + DF LS
Sbjct: 124 KLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS------ 176
Query: 151 ETHINDSNRVIGTFGFMAPE--YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDG 208
+ ++ + ++G F +MAPE ++EK+D YSF +L +LTG + +
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG-EGPF------- 228
Query: 209 EDYRLQDLVKKYIENESFKEIVDPAIVGEEGL------MWPEKEQQLLICTELAFKCLSE 262
+ S+ +I ++ EEGL P + + ++ C S
Sbjct: 229 -------------DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIE------LCWSG 269
Query: 263 SEGDRPTIVQVAKQLRQI 280
RP + K+L ++
Sbjct: 270 DPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 38/202 (18%), Positives = 69/202 (34%), Gaps = 42/202 (20%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
++ A +IAS +AYLH S ++ RD+ +++E + DF L+ + + +T
Sbjct: 110 RVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166
Query: 156 DSNR-----------VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
V+G +MAPE + EK DV+SFG +L E++
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----- 221
Query: 205 FDDGEDYRLQDLVKKYIENESFKEI---VDPAIVGEEGLMWPEKEQQLLICTELAFKCLS 261
D + + P+ + +C
Sbjct: 222 DPDYLP--RTMDFGLNVRGFLDRYCPPNCPPSFF------------------PITVRCCD 261
Query: 262 ESEGDRPTIVQVAKQLRQIYQS 283
RP+ V++ L +
Sbjct: 262 LDPEKRPSFVKLEHWLETLRMH 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-18
Identities = 27/101 (26%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ I +I SA+ H + RD+KP I++ ++ A L DF ++ + + +
Sbjct: 137 VAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQ 191
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+GT +MAPE + + ++D+Y+ +L E LTG
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 24/138 (17%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
LY ++D + + +IA EI + YLH ++ ++ +D+K +
Sbjct: 116 LYS-VVRDA-------KIVLDVNK-TRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY 163
Query: 131 QEENVAQLFDFTLS--LSIPEGETHINDSNRVIGTFGFMAPE-YRTTGD--------FSE 179
+ + DF L + + + G +APE R FS+
Sbjct: 164 -DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222
Query: 180 KSDVYSFGALLLELLTGK 197
SDV++ G + EL +
Sbjct: 223 HSDVFALGTIWYELHARE 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 21/150 (14%), Positives = 47/150 (31%), Gaps = 12/150 (8%)
Query: 55 DDFDGGKVIMKCLFYKLYKGFLQD--RPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHV 112
D V+ + Y + LQ + ++L++ +++ +A LH
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH- 228
Query: 113 GFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE-- 170
+V ++P IVL + L F + +G + ++ R A
Sbjct: 229 --HYGLVHTYLRPVDIVLDQRGGVFLTGF--EHLVRDGASAVSPIGRGFAPPETTAERML 284
Query: 171 ---YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ D ++ G + +
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+++ + A+ + H ++ RD+KP I++ N ++ DF ++ +I + +
Sbjct: 119 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ VIGT +++PE +SDVYS G +L E+LTG+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +I + + H +V RDIKP I++ ++FDF ++ ++ ET +
Sbjct: 114 INFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQ 168
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+N V+GT + +PE E +D+YS G +L E+L G+
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 29/182 (15%), Positives = 61/182 (33%), Gaps = 27/182 (14%)
Query: 66 CLFYKLYKGF-LQDRPISVMKFEDTFPFS-VSKLKIAIEIASAVAYLHVGFSRPVVSRDI 123
L +LY L + I++ K + A+ + + +H ++ DI
Sbjct: 143 VLVGELYSYGTLLNA-INLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDI 198
Query: 124 KPTTIVLQEENVA-----------QLFDFTLSL---SIPEGETHINDSNRVIGTFGFMAP 169
KP +L + L D S+ P+G T GF
Sbjct: 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK----CETSGFQCV 254
Query: 170 EYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229
E + ++ + D + A + +L G + ++G + + + L ++ + + E
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK---NEGGECKPEGLFRRLPHLDMWNEF 311
Query: 230 VD 231
Sbjct: 312 FH 313
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHIND 156
+I + +LH + P++ RD+K I + ++ D L+ +
Sbjct: 133 SWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-----TLKRASF 186
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ VIGT FMAPE + E DVY+FG +LE+ T +
Sbjct: 187 AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 32/125 (25%), Positives = 51/125 (40%), Gaps = 15/125 (12%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A+A+LH S+ +V D+KP I L +L DF L + +
Sbjct: 160 WGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGA 212
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
G +MAPE G + +DV+S G +LE+ + GE + Q L
Sbjct: 213 GEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVACNME-----LPHGGEGW--QQL 264
Query: 217 VKKYI 221
+ Y+
Sbjct: 265 RQGYL 269
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 18/113 (15%), Positives = 38/113 (33%), Gaps = 21/113 (18%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
+L++ +++ +A LH +V ++P IVL + L F + +G
Sbjct: 208 RLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF--EHLVRDGARV-- 260
Query: 156 DSNRVIGTFGFMAPEY-----------RTTGDFSEKSDVYSFGALLLELLTGK 197
+ GF PE + D ++ G ++ +
Sbjct: 261 ---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 9e-14
Identities = 17/147 (11%), Positives = 38/147 (25%), Gaps = 13/147 (8%)
Query: 55 DDFDGGKVIMKCLFYKLYKGFLQD--RPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHV 112
D V L L+ + + ++ + ++ A L
Sbjct: 153 PGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ- 211
Query: 113 GFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEY- 171
S+ +V P + + + L D S G + E+
Sbjct: 212 --SKGLVHGHFTPDNLFIMPDGRLMLGDV--SALWKVGTR----GPASSVPVTYAPREFL 263
Query: 172 -RTTGDFSEKSDVYSFGALLLELLTGK 197
+T F+ + + G + +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 12/111 (10%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS---------LSI 147
L I I+IA AV +LH S+ ++ RD+KP+ I ++V ++ DF L ++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK 198
+GT +M+PE ++S K D++S G +L ELL
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-13
Identities = 33/151 (21%), Positives = 63/151 (41%), Gaps = 31/151 (20%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-----------L 145
++ +I A++Y+H S+ ++ RD+KP I + E ++ DF L+ L
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 146 SIPEGETHINDSNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTG-------- 196
++ IGT ++A E TG ++EK D+YS G + E++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 197 --------KKISYSSHFDDGEDYRLQDLVKK 219
I + FDD + + +++
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 25/137 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L++ +I V Y+H S+ +++RD+KP+ I L + ++ DF L S+ +
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----KNDGK 177
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG--------------KKISYS 202
R GT +M+PE ++ D+ ++ D+Y+ G +L ELL + S
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIIS 237
Query: 203 SHFDDGEDYRLQDLVKK 219
FD + + L++K
Sbjct: 238 DIFDK----KEKTLLQK 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 40/197 (20%), Positives = 69/197 (35%), Gaps = 42/197 (21%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF---------TLSLSI 147
LKI + AV ++H P++ RD+K ++L + +L DF
Sbjct: 139 LKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 148 PEGETHINDSNRVIGTFGFMAPE----YRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203
+ + + T + PE Y EK D+++ G +L L +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQ-----H 251
Query: 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSES 263
F+DG R I N + P + Q + L L +
Sbjct: 252 PFEDGAKLR--------IVNGKYS--------------IPPHDTQYTVFHSLIRAMLQVN 289
Query: 264 EGDRPTIVQVAKQLRQI 280
+R +I +V QL++I
Sbjct: 290 PEERLSIAEVVHQLQEI 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-13
Identities = 40/193 (20%), Positives = 75/193 (38%), Gaps = 35/193 (18%)
Query: 97 LKIAIEIASAVAYLH--VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154
L++ ++ A+ H V+ RD+KP + L + +L DF L+ +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDT 170
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
+ + +GT +M+PE ++EKSD++S G LL EL F +
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----F-TAFS--QK 222
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQ-- 272
+L K I F+ I P +E E+ + L+ + RP++ +
Sbjct: 223 ELAGK-IREGKFRRI--PYRYSDE-------------LNEIITRMLNLKDYHRPSVEEIL 266
Query: 273 ----VAKQLRQIY 281
+ + +
Sbjct: 267 ENPLILEHHHHHH 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 37/185 (20%), Positives = 66/185 (35%), Gaps = 34/185 (18%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-----VAQLFDFTLSLSIPEGET 152
+ + S +A+LH S +V RD+KP I++ N A + DF L + G
Sbjct: 122 TLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 153 HINDSNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLELLTGKKISYSSH-FDDG 208
+ + V GT G++APE + + D++S G + +++ H F
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKS 233
Query: 209 EDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP 268
+ L+ S + + LI K ++ RP
Sbjct: 234 LQRQANILLGAC----SLDCLHPEKHEDVIA--------RELIE-----KMIAMDPQKRP 276
Query: 269 TIVQV 273
+ V
Sbjct: 277 SAKHV 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 30/177 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L ++I A+ ++H R ++ RDIK I L ++ QL DF ++ + + +
Sbjct: 128 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVEL 181
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ IGT +++PE ++ KSD+++ G +L EL T K F+ G +++L
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH-----AFEAGS---MKNL 233
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
V K I + SF + + L + + DRP++ +
Sbjct: 234 VLK-IISGSFPPV--SLHYSYD-------------LRSLVSQLFKRNPRDRPSVNSI 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 16/111 (14%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+ AV +H +V D+KP ++ + + +L DF ++ + T +
Sbjct: 131 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 186
Query: 158 NRVIGTFGFMAPE-----------YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ +GT +M PE ++ S KSDV+S G +L + GK
Sbjct: 187 S-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 27/177 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
K +++ SA+ ++H SR V+ RDIKP + + V +L D L +
Sbjct: 139 WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTA 192
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
++ ++GT +M+PE ++ KSD++S G LL E+ + G+ L L
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYSL 246
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
KK IE + + E +L C++ RP + V
Sbjct: 247 CKK-IEQCDYPPLPSDHYSEE--------------LRQLVNMCINPDPEKRPDVTYV 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 38/196 (19%), Positives = 69/196 (35%), Gaps = 40/196 (20%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF---TLSLSIPEGETH 153
L + + I + +H ++ RD+KPT I+L +E L D + EG
Sbjct: 137 LWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 154 IN---DSNRVIGTFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
D T + APE + E++DV+S G +L ++ G+
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE-----GP 245
Query: 205 FDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESE 264
+D + + +S V + L P+ + +L ++
Sbjct: 246 YDM-----------VFQKGDSVALAV------QNQLSIPQSPRHSSALWQLLNSMMTVDP 288
Query: 265 GDRPTIVQVAKQLRQI 280
RP I + QL +
Sbjct: 289 HQRPHIPLLLSQLEAL 304
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 16/111 (14%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+ AV +H +V D+KP ++ + + +L DF ++ + T +
Sbjct: 112 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 167
Query: 158 NRVIGTFGFMAPE-----------YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ +GT +M PE ++ S KSDV+S G +L + GK
Sbjct: 168 S-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 25/111 (22%), Positives = 46/111 (41%), Gaps = 16/111 (14%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+ AV +H +V D+KP ++ + + +L DF ++ + T +
Sbjct: 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 214
Query: 158 NRVIGTFGFMAPE-----------YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ +G +M PE ++ S KSDV+S G +L + GK
Sbjct: 215 S-QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 38/186 (20%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS---------LSI 147
L I ++IA AV +LH S+ ++ RD+KP+ I ++V ++ DF L ++
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 148 PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207
+GT +M+PE +S K D++S G +L ELL F
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFST 229
Query: 208 GEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR 267
+ + + N F + + +++ LS S +R
Sbjct: 230 QME--RVRTLTD-VRNLKFPPLFTQKY----------PCEYVMVQ-----DMLSPSPMER 271
Query: 268 PTIVQV 273
P + +
Sbjct: 272 PEAINI 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K++I + + YL ++ RD+KP+ I++ +L DF +S G+ + +
Sbjct: 135 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 187
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N +GT +M+PE +S +SD++S G L+E+ G+
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
FL+ ++ + +A +IAS +AY+ V RD++ I++ E
Sbjct: 351 FLKGETGKYLRLPQL-------VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENL 400
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELL 194
V ++ DF L+ I + E + + APE G F+ KSDV+SFG LL EL
Sbjct: 401 VCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 195 TGKKISY 201
T ++ Y
Sbjct: 459 TKGRVPY 465
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
FL+ ++ + +A +IAS +AY+ V RD++ I++ E
Sbjct: 268 FLKGETGKYLRLPQL-------VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENL 317
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELL 194
V ++ DF L+ I + E + + APE G F+ KSDV+SFG LL EL
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 195 TGKKISY 201
T ++ Y
Sbjct: 376 TKGRVPY 382
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 23/132 (17%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
L Y L + F + + A EI + ++H +R VV RD+KP
Sbjct: 279 LHYHLSQ-------------HGVFSEADMRFYAA-EIILGLEHMH---NRFVVYRDLKPA 321
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKS-DVYS 185
I+L E ++ D L+ + + H V GT G+MAPE G + S D +S
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKKPH----ASV-GTHGYMAPEVLQKGVAYDSSADWFS 376
Query: 186 FGALLLELLTGK 197
G +L +LL G
Sbjct: 377 LGCMLFKLLRGH 388
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 36/134 (26%), Positives = 54/134 (40%), Gaps = 24/134 (17%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
L Y L + F KL I E+ A+ YL ++ ++ RD+KP
Sbjct: 102 LRYHLQQ-------------NVHFKEETVKLFIC-ELVMALDYLQ---NQRIIHRDMKPD 144
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE---YRTTGDFSEKSDV 183
I+L E + DF ++ +P + GT +MAPE R +S D
Sbjct: 145 NILLDEHGHVHITDFNIAAMLPRETQI----TTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 184 YSFGALLLELLTGK 197
+S G ELL G+
Sbjct: 201 WSLGVTAYELLRGR 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L +A +I+SA+ YL + + R++ ++ E ++ ++ DF LS + +
Sbjct: 321 LYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ + APE FS KSDV++FG LL E+ T Y
Sbjct: 378 GAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 11/103 (10%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154
I ++ S V YLH +V RD+KP ++L+ ++ + ++ DF LS +
Sbjct: 140 VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM- 195
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+GT ++APE + EK DV+S G +L LL G
Sbjct: 196 ---KERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 12/110 (10%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
L++ + A+ + YL S+ + RD+ ++ E+NV ++ DF +S +G +
Sbjct: 215 LLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271
Query: 156 DSNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
G APE G +S +SDV+SFG LL E + Y
Sbjct: 272 G-----GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 37/142 (26%), Positives = 59/142 (41%), Gaps = 34/142 (23%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
E+A+A++Y H S+ V+ RDIKP ++L ++ DF S H S
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSS 162
Query: 158 NR--VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG-------------KKI--- 199
R + GT ++ PE EK D++S G L E L G K+I
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222
Query: 200 --SYSSHFDDGEDYRLQDLVKK 219
++ +G +DL+ +
Sbjct: 223 EFTFPDFVTEG----ARDLISR 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 35/125 (28%), Positives = 60/125 (48%), Gaps = 16/125 (12%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154
+I ++ S + Y+H +V RD+KP ++L+ ++ ++ DF LS +
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
IGT ++APE G + EK DV+S G +L LL+G F+ +Y +
Sbjct: 186 ---KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSG-----CPPFNGANEYDIL 236
Query: 215 DLVKK 219
V+K
Sbjct: 237 KKVEK 241
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 36/148 (24%), Positives = 57/148 (38%), Gaps = 31/148 (20%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
F S + E+A A+ Y H R V+ RDIKP +++ + ++ DF S+ P
Sbjct: 111 FDEQRSATFME-ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG------------- 196
+ GT ++ PE EK D++ G L E L G
Sbjct: 167 LRRRT-----MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
Query: 197 KKI-----SYSSHFDDGEDYRLQDLVKK 219
++I + DG +DL+ K
Sbjct: 222 RRIVNVDLKFPPFLSDG----SKDLISK 245
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 11/102 (10%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154
I +I S + YLH +V RDIKP I+L+ ++ DF LS +
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+GT ++APE ++EK DV+S G ++ LL G
Sbjct: 206 ---RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 17/114 (14%), Positives = 38/114 (33%), Gaps = 16/114 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE----- 151
+ +++ + Y+H S +V DIKP+ I + ++
Sbjct: 118 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 152 -------THINDSNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGK 197
T I+ G F+A E + K+D+++ ++ +
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHINDSNRV 160
+I + YLH +V RDIK +++ + V ++ DF S +
Sbjct: 130 QILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---F 183
Query: 161 IGTFGFMAPE--YRTTGDFSEKSDVYSFGALLLELLTGK 197
GT +MAPE + + + +D++S G ++E+ TGK
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 24/99 (24%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEGETHINDSNR- 159
+ + YLH +R ++ D+K ++L + + A L DF +L + +
Sbjct: 158 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 160 -VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ GT MAPE K D++S ++L +L G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 16/107 (14%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
KIA+ I A+ +LH V+ RD+KP+ +++ ++ DF +S ++ D
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDD 163
Query: 158 ---NRVIGTFGFMAPE----YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ G +MAPE +S KSD++S G ++EL +
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-10
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 46/221 (20%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
+L I + + L A +I +AYLH ++ + RD+ ++L +
Sbjct: 125 YLPRHSIGLAQL----------LLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDR 171
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALL 190
+ ++ DF L+ ++PEG + RV APE F SDV+SFG L
Sbjct: 172 LVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 191 LELLTGKKISYSSHFDDGEDYRLQDLVKKY--IENESFKEIVDPAIVGEEG--LMWPEKE 246
ELLT + L+ + + E++ E G L P+K
Sbjct: 228 YELLT-----HCDSSQSPPTKFLELIGIAQGQMTVLRLTELL------ERGERLPRPDK- 275
Query: 247 QQLLICT----ELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283
C L C RPT + L+ +++
Sbjct: 276 -----CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 17/108 (15%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
K+ + I A+ YL V+ RD+KP+ I+L E +L DF +S + D
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLVDD 178
Query: 158 ---NRVIGTFGFMAPE-----YRTTGDFSEKSDVYSFGALLLELLTGK 197
+R G +MAPE T D+ ++DV+S G L+EL TG+
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 14/102 (13%), Positives = 25/102 (24%), Gaps = 35/102 (34%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
++ +A+A H V P V ++
Sbjct: 132 IRAMQSLAAAADAAH---RAGVALSIDHP-------SRV-----------------RVSI 164
Query: 157 SNRV-IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
V + M + + D+ GA L LL +
Sbjct: 165 DGDVVLAYPATMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 19/131 (14%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
L + +Y + FP + + A EI + LH +V RD+KP
Sbjct: 271 LKFHIYH-----------MGQAGFPEARAVFYAA-EICCGLEDLH---RERIVYRDLKPE 315
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSF 186
I+L + ++ D L++ +PEG+T +GT G+MAPE ++ D ++
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 187 GALLLELLTGK 197
G LL E++ G+
Sbjct: 372 GCLLYEMIAGQ 382
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 28/99 (28%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + ++A + +L SR + RD+ I+L E+NV ++ DF L+ I + ++
Sbjct: 196 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ + +MAPE ++ +SDV+SFG LL E+ +
Sbjct: 253 GDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 46/221 (20%), Positives = 85/221 (38%), Gaps = 45/221 (20%)
Query: 76 LQDRPISVMKFEDTFPFSVSKLKIAI--EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE 133
LQD S ++ I++ +IAS VA+LH S ++ RD+KP I++
Sbjct: 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTS 151
Query: 134 NVAQLF-------------DFTLSLSIPEGETHINDS-NRVIGTFGFMAPE-------YR 172
+ DF L + G++ + N GT G+ APE +
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ 211
Query: 173 TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232
T + D++S G + +L+ K H + R ++++ + K + D
Sbjct: 212 TKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDKYSRESNIIRGIFSLDEMKCLHDR 266
Query: 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+++ E T+L + + RPT ++V
Sbjct: 267 SLIAE--------------ATDLISQMIDHDPLKRPTAMKV 293
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 52/197 (26%), Positives = 77/197 (39%), Gaps = 32/197 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + +I + YL SR V RD+ I+++ E ++ DF L+ +P + D
Sbjct: 130 LLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----D 182
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYR 212
V APE + FS +SDV+SFG +L EL T S S E R
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS---AEFLR 239
Query: 213 LQDLVKKYIENESFKEIVDPAIVGEEG--LMWPEKEQQLLICT----ELAFKCLSESEGD 266
+ + E++ EEG L P C EL C + S D
Sbjct: 240 MMGCERDVPALSRLLELL------EEGQRLPAPPA------CPAEVHELMKLCWAPSPQD 287
Query: 267 RPTIVQVAKQLRQIYQS 283
RP+ + QL ++
Sbjct: 288 RPSFSALGPQLDMLWSG 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154
+I ++ S + Y+H +V RD+KP I+L+ ++ ++ DF LS +
Sbjct: 125 RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM- 180
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
IGT ++APE G + EK DV+S G +L LL+G
Sbjct: 181 ---KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSG 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 8/105 (7%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL--FDFTLSLSIPEGETHIN 155
I +I SA+ YLH ++ + RDIKP + ++ DF LS +
Sbjct: 172 NIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 156 DS-NRVIGTFGFMAPE--YRTTGDFSEKSDVYSFGALLLELLTGK 197
GT F+APE T + K D +S G LL LL G
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 16/107 (14%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
KI + A+ +L + ++ RDIKP+ I+L +L DF +S + DS
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-------GQLVDS 179
Query: 158 ---NRVIGTFGFMAPE----YRTTGDFSEKSDVYSFGALLLELLTGK 197
R G +MAPE + + +SDV+S G L EL TG+
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 22/134 (16%)
Query: 83 VMKF----------EDTFPFSVSKLKIAI---EIASAVAYLHVGFSRPVVSRDIKPTTIV 129
V F F +++L IA + A+ Y+H V R +K + I+
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHIL 160
Query: 130 LQEENVAQLFDFTLSLSIPEG----ETHINDSNRVIGTFGFMAPE--YRTTGDFSEKSDV 183
+ + L +LS+ + + +++PE + + KSD+
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220
Query: 184 YSFGALLLELLTGK 197
YS G EL G
Sbjct: 221 YSVGITACELANGH 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 35/158 (22%), Positives = 67/158 (42%), Gaps = 20/158 (12%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
+ Y +Y V + F + A +I S + +LH R ++ RD+KP
Sbjct: 272 IRYHIYN---------VDEDNPGFQEPRAIFYTA-QIVSGLEHLH---QRNIIYRDLKPE 318
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSF 186
++L ++ ++ D L++ + G+T GT GFMAPE ++ D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 187 GALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224
G L E++ + GE ++L ++ +E
Sbjct: 376 GVTLYEMIAAR----GPFRARGEKVENKELKQRVLEQA 409
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 32/159 (20%), Positives = 61/159 (38%), Gaps = 19/159 (11%)
Query: 71 LYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
+ K F + + + P V K I + ++ +Y+H + + RD+KP+ I++
Sbjct: 130 ILK-FDEYFFVLDKNYTCFIPIQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILM 185
Query: 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE--YRTTGDFSEKSDVYSFGA 188
+ +L DF S + + + GT+ FM PE + K D++S G
Sbjct: 186 DKNGRVKLSDFGESEYMVDKKIK-----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
Query: 189 LLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227
L + F L +L I ++ +
Sbjct: 241 CLYVMFYNV-----VPFSL--KISLVELFNN-IRTKNIE 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 6e-09
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTLSLSIPEGETH 153
+ +I+SA+ YLH ++ RD+KP IVLQ + ++ D + + +GE
Sbjct: 124 RTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL- 179
Query: 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+GT ++APE ++ D +SFG L E +TG
Sbjct: 180 ---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 38/193 (19%), Positives = 70/193 (36%), Gaps = 39/193 (20%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L ++IA + YL R +V RD+ ++++ ++ DF L+ + E +
Sbjct: 120 LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
G MA E ++ +SDV+S+G + EL+T Y +
Sbjct: 177 EG---GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------DGIPAS 226
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT----ELAFKCLSESEGDRPTI 270
+ + +E GE L P ICT + KC RP
Sbjct: 227 E-ISSILEK------------GER-LPQPP------ICTIDVYMIMRKCWMIDADSRPKF 266
Query: 271 VQVAKQLRQIYQS 283
++ + ++ +
Sbjct: 267 RELIIEFSKMARD 279
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 15/129 (11%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131
K +L+ ++ P S+SK+ ++A EIA +AYL+ + V RD+ ++
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA 172
Query: 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGDFSEKSDVYSF 186
E+ ++ DF ++ I E + + G G M+PE G F+ SDV+SF
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 187 GALLLELLT 195
G +L E+ T
Sbjct: 227 GVVLWEIAT 235
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 39/196 (19%), Positives = 72/196 (36%), Gaps = 29/196 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L+ +I + YL ++ + RD+ I+++ EN ++ DF L+ +P+ + +
Sbjct: 148 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 204
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
G APE T FS SDV+SFG +L EL T Y +
Sbjct: 205 KEP--GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---------------YIEK 247
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQL---LICT----ELAFKCLSESEGDR 267
++ + + +L C + +C + + R
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307
Query: 268 PTIVQVAKQLRQIYQS 283
P+ +A ++ QI
Sbjct: 308 PSFRDLALRVDQIRDQ 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 39/196 (19%), Positives = 72/196 (36%), Gaps = 29/196 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L+ +I + YL ++ + RD+ I+++ EN ++ DF L+ +P+ +
Sbjct: 117 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
G APE T FS SDV+SFG +L EL T Y +
Sbjct: 174 KEP--GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---------------YIEK 216
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQL---LICT----ELAFKCLSESEGDR 267
++ + + +L C + +C + + R
Sbjct: 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276
Query: 268 PTIVQVAKQLRQIYQS 283
P+ +A ++ QI +
Sbjct: 277 PSFRDLALRVDQIRDN 292
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 36/198 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
LK A++I + YL SR V RD+ ++++ E+ ++ DF L+ +I + +
Sbjct: 129 LKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----E 181
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYR 212
V APE F SDV+SFG L ELLT Y
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALF 236
Query: 213 LQDLVKKY--IENESFKEIVDPAIVGEEG--LMWPEKEQQLLICT----ELAFKCLSESE 264
L+ + + + + +EG L P C +L KC
Sbjct: 237 LKMIGPTHGQMTVTRLVNTL------KEGKRLPCPPN------CPDEVYQLMRKCWEFQP 284
Query: 265 GDRPTIVQVAKQLRQIYQ 282
+R + + + + +
Sbjct: 285 SNRTSFQNLIEGFEALLK 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 32/207 (15%), Positives = 61/207 (29%), Gaps = 33/207 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ----LFDFTLSLSIPEGET 152
L + ++ + +L +V R+IKP I+ Q L DF + + + E
Sbjct: 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 153 HINDSNRVIGTFGFMAPE--------YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
+ GT ++ P+ + D++S G TG
Sbjct: 172 ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS-----LP 222
Query: 205 FDDGEDYRL-QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQ--------LLICTEL 255
F E R ++++ K I + I + W ++ T +
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282
Query: 256 AFKCLSESEGDRPTIVQVAKQLRQIYQ 282
L + Q + I
Sbjct: 283 LANILEADQEKCWGFDQFFAETSDILH 309
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 11/117 (9%)
Query: 85 KFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144
KFED P +++ +A E+ A+ +H V RDIKP I++ +L DF
Sbjct: 167 KFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKS-----DVYSFGALLLELLTG 196
L + E T S+ +GT +++PE + + D +S G + E+L G
Sbjct: 223 LKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 28/155 (18%), Positives = 47/155 (30%), Gaps = 24/155 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ----LFDFTLSLSIPEGET 152
L + ++ + +L +V R+IKP I+ Q L DF + + + E
Sbjct: 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 153 HINDSNRVIGTFGFMAPE--------YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
+ GT ++ P+ + D++S G TG
Sbjct: 172 ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS-----LP 222
Query: 205 FDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239
F E R V I + E G
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 32/121 (26%), Positives = 51/121 (42%), Gaps = 15/121 (12%)
Query: 84 MKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143
KF + P +++ +A EI A+ +H V RDIKP I+L +L DF
Sbjct: 153 SKFGERIPAEMARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 144 SL-SIPEGETHINDSNRVIGTFGFMAPE-------YRTTGDFSEKSDVYSFGALLLELLT 195
L +G S +GT +++PE TG + + D ++ G E+
Sbjct: 209 CLKLRADGTVR---SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 196 G 196
G
Sbjct: 266 G 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 35/131 (26%), Positives = 59/131 (45%), Gaps = 20/131 (15%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
FL+ S + + +IA +A++ R + RD++ I++
Sbjct: 272 FLKSDEGSKQPLPKL-------IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 321
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALL 190
V ++ DF L+ I + E + + F APE G F+ KSDV+SFG LL
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAK------FPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 191 LELLTGKKISY 201
+E++T +I Y
Sbjct: 376 MEIVTYGRIPY 386
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 3e-08
Identities = 44/132 (33%), Positives = 63/132 (47%), Gaps = 22/132 (16%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
LF +L K E F K +A E+A A+ +LH S ++ RD+KP
Sbjct: 113 LFTRLSK-------------EVMFTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPE 155
Query: 127 TIVLQEENVAQLFDFTLS-LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYS 185
I+L EE +L DF LS SI + + GT +MAPE ++ +D +S
Sbjct: 156 NILLDEEGHIKLTDFGLSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWS 211
Query: 186 FGALLLELLTGK 197
FG L+ E+LTG
Sbjct: 212 FGVLMFEMLTGT 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 31/120 (25%), Positives = 50/120 (41%), Gaps = 14/120 (11%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHINDSNR 159
I AVAYLH +V RD+KP ++ + ++ DF LS +
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KT 209
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219
V GT G+ APE + + D++S G + LL G + +D+ D + +
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG----FEPFYDERGDQFMFRRILN 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 99 IAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
IA E+ + YLH + RD+K I+L E+ Q+ DF +S + G
Sbjct: 123 IATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 156 DSNR--VIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ R +GT +MAPE + K+D++SFG +EL TG
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 9/102 (8%)
Query: 99 IAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
IA EI + YLH S + RDIK ++L E +L DF ++ + +
Sbjct: 121 IATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QI 174
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N +GT +MAPE + K+D++S G +EL G+
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 14/105 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +++A + YL S+ V RD+ +L E+ ++ DF L+ + + +
Sbjct: 131 IGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KE 182
Query: 157 SNRVIGTFGF------MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
V G MA E T F+ KSDV+SFG LL EL+T
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-08
Identities = 33/109 (30%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L +A +IA +A++ R + RD++ I++ + ++ DF L+ I + E +
Sbjct: 112 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ F APE G F+ KSDV+SFG LL E++T +I Y
Sbjct: 169 GAK------FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 4e-08
Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
LF +L + E F + +A EI+ A+ +LH + ++ RD+KP
Sbjct: 108 LFMQLER-------------EGIFMEDTACFYLA-EISMALGHLH---QKGIIYRDLKPE 150
Query: 127 TIVLQEENVAQLFDFTLS-LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYS 185
I+L + +L DF L SI +G ++ GT +MAPE + D +S
Sbjct: 151 NIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWS 206
Query: 186 FGALLLELLTGK 197
GAL+ ++LTG
Sbjct: 207 LGALMYDMLTGA 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 38/191 (19%), Positives = 76/191 (39%), Gaps = 34/191 (17%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
++ +++ + YL + V R++ ++L + A++ DF LS ++ +++
Sbjct: 439 AELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ + APE FS +SDV+S+G + E L+ + Y + + +
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY-------KKMKGPE- 547
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT----ELAFKCLSESEGDRPTIVQ 272
V +IE G+ + P + C L C DRP +
Sbjct: 548 VMAFIEQ------------GKR-MECPPE------CPPELYALMSDCWIYKWEDRPDFLT 588
Query: 273 VAKQLRQIYQS 283
V +++R Y S
Sbjct: 589 VEQRMRACYYS 599
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A ++++A+AYL S+ V RDI +++ + +L DF LS + + +
Sbjct: 494 ILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
++ +MAPE F+ SDV+ FG + E+L
Sbjct: 551 KGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-08
Identities = 38/171 (22%), Positives = 72/171 (42%), Gaps = 40/171 (23%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
L + K +F + ++ A EI SA+ YLH + ++ RD+KP
Sbjct: 117 LLKYIRK-------------IGSFDETCTRFYTA-EIVSALEYLH---GKGIIHRDLKPE 159
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSF 186
I+L E+ Q+ DF + + E+ +N +GT +++PE T + SD+++
Sbjct: 160 NILLNEDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 218
Query: 187 GALLLELLTG------------------KKISYSSHFDDGEDYRLQDLVKK 219
G ++ +L+ G + + F + +DLV+K
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 25/101 (24%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L ++IA + YL R +V RD+ ++++ ++ DF L+ + E +
Sbjct: 120 LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
G MA E ++ +SDV+S+G + EL+T
Sbjct: 177 EG---GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-08
Identities = 33/125 (26%), Positives = 54/125 (43%), Gaps = 16/125 (12%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154
++ ++ +A+AY H S+ VV +D+KP I+ Q + ++ DF L+ E
Sbjct: 128 ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS- 183
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
GT +MAPE D + K D++S G ++ LLTG F +Q
Sbjct: 184 ---TNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTG-----CLPFTGTSLEEVQ 234
Query: 215 DLVKK 219
Sbjct: 235 QKATY 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 8/112 (7%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
E F ++ A EI SA+ YLH + VV RD+K ++L ++ ++ DF L
Sbjct: 242 ERVFSEDRARFYGA-EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
I +G T GT ++APE D+ D + G ++ E++ G+
Sbjct: 299 GIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 13/100 (13%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ + LH +V RD+KP I+L ++ +L DF S + GE V G
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCG 185
Query: 163 TFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTG 196
T ++APE + ++ D++S G ++ LL G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 5e-08
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 16/120 (13%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHINDSNR 159
+ SAVAY H V RD+KP + ++ +L DF L+ G+
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RT 167
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219
+GT +++P+ G + + D +S G ++ LL G F D + +++
Sbjct: 168 KVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCG-----YPPFSAPTDSEVMLKIRE 221
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 7e-08
Identities = 27/109 (24%), Positives = 52/109 (47%), Gaps = 13/109 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + +++ +AYL V+ RD+ ++ E V ++ DF ++ + + + +
Sbjct: 107 LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ F +PE + +S KSDV+SFG L+ E+ + KI Y
Sbjct: 164 GTK------FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 25/101 (24%), Positives = 48/101 (47%), Gaps = 8/101 (7%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L ++IA + YL +V R++ ++L+ + Q+ DF ++ +P + +
Sbjct: 118 LNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
S MA E G ++ +SDV+S+G + EL+T
Sbjct: 175 SE---AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-08
Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 19/129 (14%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131
FL I E+ F + L + ++IA + YL SR + RD+ +L
Sbjct: 119 HAFLLASRIG----ENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLA 171
Query: 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGDFSEKSDVYSF 186
E+ + DF LS I G+ + G +A E ++ SDV++F
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYY------RQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 187 GALLLELLT 195
G + E++T
Sbjct: 226 GVTMWEIMT 234
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 8e-08
Identities = 40/323 (12%), Positives = 95/323 (29%), Gaps = 76/323 (23%)
Query: 8 RKSLEKAEKRKF-----MLGNGKILLEKLIASSNG--KHNPIRSF--SADELKTATDDFD 58
R++L + K +LG+GK + + S + F + + +
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 59 GGKVIMKCLFYKLYKGFLQ--DRPISV-MKFEDTFP-----FSVSKLKIAIEI------A 104
+++ L Y++ + D ++ ++ + + + A
Sbjct: 201 ----MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256
Query: 105 SAVAYLHVGFSRPVV-SRDIKPTTIV----------------LQEENVAQLFDFTLSLSI 147
A ++ + ++ +R + T + L + V L L
Sbjct: 257 KAWNAFNLS-CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 148 ---PEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSH 204
P N R + + T D + + ++ + S +
Sbjct: 316 QDLPREVLTTNP--RRLSIIAESIRDGLATWDNWKHVNCDKLTTII-------ESSL-NV 365
Query: 205 FDDGEDYRL-QDLVKKYIENESFKEIVD-PAIVGEEGLMWPEKEQQ--LLICTELAFKCL 260
+ E ++ L + F P I+ L+W + + +++ +L L
Sbjct: 366 LEPAEYRKMFDRLS---V----FPPSAHIPTILLS--LIWFDVIKSDVMVVVNKLHKYSL 416
Query: 261 SESEGDRPTIVQVAKQLRQIYQS 283
E + TI + IY
Sbjct: 417 VEKQPKESTI-----SIPSIYLE 434
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 4e-04
Identities = 52/328 (15%), Positives = 99/328 (30%), Gaps = 100/328 (30%)
Query: 1 MGSCLRSRKSLEKAEKRKFMLGNGKILLEKLIASSNG-------KHNPIR-SFSADELKT 52
+ + + SL+ K LL K + NP R S A+ ++
Sbjct: 281 LSAATTTHISLDHHSM-TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 53 ATDDFDG---------GKVIMKCL-------FYKLYKG---FLQDRPISVMKFEDTFPFS 93
+D +I L + K++ F I P
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI---------PTI 390
Query: 94 V-SKL---KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---------QEENVAQL-- 138
+ S + I ++ V LH +V + K +TI + + EN L
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLH---KYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 139 -----------FDFTLSLSIPEGE----THI-------------NDSNRVIGTFGFMAPE 170
FD L P + +HI V F F+ +
Sbjct: 448 SIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 171 YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF--DDGEDYRLQDLVKKYIENES--- 225
R + + S L +L K Y + +D + RL + + ++
Sbjct: 507 IRHDS--TAWNASGSILNTLQQL---KF--YKPYICDNDPKYERLVNAILDFLPKIEENL 559
Query: 226 ----FKEIVDPAIVGEEGLMWPEKEQQL 249
+ +++ A++ E+ ++ E +Q+
Sbjct: 560 ICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 8e-08
Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 16/120 (13%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGETHINDSNR 159
+ SAV YLH +V RD+KP ++ +E + + DF LS G
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-----T 166
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219
GT G++APE +S+ D +S G + LL G Y F + + +L + +K+
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG----YPP-FYEETESKLFEKIKE 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 9e-08
Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 14/100 (14%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI-NDSNR- 159
+I + + YLH S ++ RD+ + ++L ++ DF L+ T + +
Sbjct: 120 QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKH 169
Query: 160 --VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ GT +++PE T +SDV+S G + LL G+
Sbjct: 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 9e-08
Identities = 40/194 (20%), Positives = 72/194 (37%), Gaps = 37/194 (19%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A+++A + YL S+ + RD+ ++L ++ ++ DF L ++P+ + H
Sbjct: 124 SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
F APE T FS SD + FG L E+ T + +
Sbjct: 181 QEH--RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-------IGLNGS 231
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT----ELAFKCLSESEGDRPTI 270
+ I+ E + L PE C + +C + DRPT
Sbjct: 232 Q-ILHKIDKEGER------------LPRPE------DCPQDIYNVMVQCWAHKPEDRPTF 272
Query: 271 VQVAKQLRQIYQSN 284
V + L + ++
Sbjct: 273 VALRDFLLEAQPTD 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 14/104 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
LK ++IA + YL +R + RD+ +L+++ + DF LS I G+ +
Sbjct: 150 LKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY--- 203
Query: 157 SNRVIGTFGF-----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
G +A E ++ KSDV++FG + E+ T
Sbjct: 204 ---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ E A+ +LH S V+ RDIK I+L + +L DF I + +
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRS 174
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
++GT +MAPE T + K D++S G + +E++ G+
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
F + A EIA + +L S+ ++ RD+K ++L E ++ DF +
Sbjct: 436 VGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+I +G T + GT ++APE + + D ++FG LL E+L G+
Sbjct: 492 NIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 24/101 (23%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
++ +++ + YL + V RD+ ++L + A++ DF LS ++ +++
Sbjct: 113 AELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ G + APE FS +SDV+S+G + E L+
Sbjct: 170 RSA--GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 23/109 (21%), Positives = 50/109 (45%), Gaps = 13/109 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L++ ++ +A+L S + RD+ ++ + ++ DF ++ + + + +
Sbjct: 107 LEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ F APE +S KSDV++FG L+ E+ + K+ Y
Sbjct: 164 GTK------FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 20/131 (15%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
+L++ + L +A +I+SA+ YL + + RD+ ++ E +
Sbjct: 99 YLRECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENH 148
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALL 190
+ ++ DF LS + + + F APE FS KSDV++FG LL
Sbjct: 149 LVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 191 LELLTGKKISY 201
E+ T Y
Sbjct: 203 WEIATYGMSPY 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 35/125 (28%), Positives = 59/125 (47%), Gaps = 16/125 (12%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154
+I ++ S + Y+H +V RD+KP I+L+ ++ ++ DF LS +
Sbjct: 125 RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM- 180
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
IGT ++APE G + EK DV+S G +L LL+G + F +Y +
Sbjct: 181 ---KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDIL 231
Query: 215 DLVKK 219
V+
Sbjct: 232 KRVET 236
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 27/109 (24%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L++ ++ A+ YL S+ + RD+ ++ ++ V ++ DF LS + + E +
Sbjct: 123 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
++ F PE FS KSD+++FG L+ E+ + K+ Y
Sbjct: 180 GSK------FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+++ +++ + YL V RD+ ++L ++ A++ DF LS ++ E +
Sbjct: 120 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 174
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ G + APE FS KSDV+SFG L+ E +
Sbjct: 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 34/134 (25%), Positives = 59/134 (44%), Gaps = 19/134 (14%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKL------KIAIEIASAVAYLHVGFSRPVVSRDIKP 125
FL+ P +++ + + +L IA +IAS + YL S+ V RD+
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLAT 161
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKS 181
++ + ++ DF +S + + + RV G M PE F+ +S
Sbjct: 162 RNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTES 216
Query: 182 DVYSFGALLLELLT 195
DV+SFG +L E+ T
Sbjct: 217 DVWSFGVILWEIFT 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 14/105 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +++A + YL + V RD+ +L E ++ DF L+ I + +
Sbjct: 127 ISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----RE 178
Query: 157 SNRVIGTFG------FMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
V + A E T F+ KSDV+SFG LL ELLT
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 27/99 (27%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ + A+AYLH ++ V+ RDIK +I+L + +L DF I + +
Sbjct: 146 VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRK 199
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
++GT +MAPE + ++ + D++S G +++E++ G+
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 23/148 (15%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
+ P ++ A EI+ A+ YLH R ++ RD+K ++L E +L D+ +
Sbjct: 147 QRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK---KISYS 202
+ G+T ++ GT ++APE D+ D ++ G L+ E++ G+ I S
Sbjct: 203 GLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
Query: 203 SHFDDGEDYRLQDLVKKYIENESFKEIV 230
S D E+ F+ I+
Sbjct: 259 SDNPDQNT-----------EDYLFQVIL 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A ++++A+AYL S+ V RDI +++ + +L DF LS + + +
Sbjct: 119 ILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
++ +MAPE F+ SDV+ FG + E+L
Sbjct: 176 KGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 12/103 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + ++A +A+L S+ + RD+ I+L + ++ DF L+ I ++
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
N MAPE ++ +SDV+S+G L EL +
Sbjct: 205 GNAR-----LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 11/98 (11%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ----LFDFTLSLSIPEGETHINDSN 158
I + V YLH S + D+KP I+L + NV + + DF L+ I G
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----K 175
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+ GT F+APE ++D++S G + LL+G
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 11/98 (11%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHINDSN 158
+I +A+ +LH S + RD+KP ++ ++ V +L DF + +
Sbjct: 136 DIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----- 187
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
T ++APE + + D++S G ++ LL G
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
F + A EIA + +L S+ ++ RD+K ++L E ++ DF +
Sbjct: 115 VGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+I +G T + GT ++APE + + D ++FG LL E+L G+
Sbjct: 171 NIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 36/123 (29%), Positives = 57/123 (46%), Gaps = 20/123 (16%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
+L+ R SV+ + LK ++++ A+ YL V RD+ +++ E+N
Sbjct: 277 YLRSRGRSVLGGDC-------LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDN 326
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLE 192
VA++ DF L+ S + G APE FS KSDV+SFG LL E
Sbjct: 327 VAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 378
Query: 193 LLT 195
+ +
Sbjct: 379 IYS 381
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ AV++LH + +V RD+KP I+L + +L DF S + GE + G
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCG 261
Query: 163 TFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTG 196
T G++APE T + ++ D+++ G +L LL G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 23/148 (15%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
+ P ++ A EI+ A+ YLH R ++ RD+K ++L E +L D+ +
Sbjct: 104 QRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK---KISYS 202
+ G+T ++ GT ++APE D+ D ++ G L+ E++ G+ I S
Sbjct: 160 GLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
Query: 203 SHFDDGEDYRLQDLVKKYIENESFKEIV 230
S D E+ F+ I+
Sbjct: 216 SDNPDQNT-----------EDYLFQVIL 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR-- 159
+I YLH V+ RD+K + L E+ ++ DF L+ + D R
Sbjct: 149 QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE------YDGERKK 199
Query: 160 -VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ GT ++APE + S + DV+S G ++ LL GK
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 14/105 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +++A + +L S+ V RD+ +L E+ ++ DF L+ + + +
Sbjct: 195 IGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----KE 246
Query: 157 SNRVIGTFG------FMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ V G +MA E T F+ KSDV+SFG LL EL+T
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQL--FDFTLSLSIPEGETHINDSNR 159
+ SAV+++H VV RD+KP ++ E + ++ DF + P +
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--- 168
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
T + APE + E D++S G +L +L+G
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 14/120 (11%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVA-QLFDFTLSLSIPEGETHINDSNR 159
I AV + H VV R++KP ++L + + A +L DF L++ + +
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--- 172
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219
GT G+++PE + + D+++ G +L LL G F D + +RL +K
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-----YPPFWDEDQHRLYQQIKA 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 102 EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR-- 159
+I YLH V+ RD+K + L E+ ++ DF L+ + D R
Sbjct: 123 QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE------YDGERKK 173
Query: 160 -VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ GT ++APE + S + DV+S G ++ LL GK
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
E F ++ A EI SA+ YLH SR VV RDIK ++L ++ ++ DF L
Sbjct: 99 ERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
I +G T GT ++APE D+ D + G ++ E++ G+
Sbjct: 155 GISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 23/96 (23%), Positives = 39/96 (40%), Gaps = 9/96 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL--FDFTLSLSIPEGETHINDSNRV 160
+ + ++H V D+KP I+ + +L DF L+ + ++
Sbjct: 264 VCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVT 316
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
GT F APE +D++S G L LL+G
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQL--FDFTLSLSIPEGETHINDSNR 159
I A+ Y H ++ RD+KP ++L +EN A + F +++ + E
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--- 192
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+GT FMAPE + + DV+ G +L LL+G
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 31/133 (23%), Positives = 52/133 (39%), Gaps = 18/133 (13%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSKL------KIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
FL+ + L +A ++A+ + YL V RD+
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATR 187
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKSD 182
++ + V ++ DF +S I + + RV G M PE F+ +SD
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESD 242
Query: 183 VYSFGALLLELLT 195
V+SFG +L E+ T
Sbjct: 243 VWSFGVVLWEIFT 255
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 9/96 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL--FDFTLSLSIPEGETHINDSNRV 160
+ ++H +V DIKP I+ + + + + DF L+ + E
Sbjct: 158 ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVT 210
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
T F APE +D+++ G L LL+G
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 9/102 (8%)
Query: 99 IAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
IA + YLH + RDIK I+L E A+L DF ++ + + +
Sbjct: 127 IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT---MA 180
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
N VIGT +MAPE ++ +D++S G +E+ GK
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 5e-07
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +++I A+AYL S V RDI I++ +L DF LS I + + +
Sbjct: 116 VLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
R M+PE F+ SDV+ F + E+L+
Sbjct: 173 VTR------LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 15/120 (12%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVA-QLFDFTLSLSIPEGETHINDSNR 159
I ++AY H S +V R++KP ++L + + A +L DF L++ + + E +
Sbjct: 137 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HG 189
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219
GT G+++PE +S+ D+++ G +L LL G Y F D + +RL +K
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG----YPP-FWDEDQHRLYAQIKA 244
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 33/132 (25%), Positives = 55/132 (41%), Gaps = 22/132 (16%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
L + + K F + ++ A EI SA+ +LH + ++ RD+K
Sbjct: 111 LMFHIQK-------------SRRFDEARARFYAA-EIISALMFLH---DKGIIYRDLKLD 153
Query: 127 TIVLQEENVAQLFDFTLS-LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYS 185
++L E +L DF + I G T + GT ++APE + D ++
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYIAPEILQEMLYGPAVDWWA 209
Query: 186 FGALLLELLTGK 197
G LL E+L G
Sbjct: 210 MGVLLYEMLCGH 221
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-07
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 15/106 (14%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQL--FDFTLSLSIPEGETHINDSNR 159
+ASA+ +LH ++ + RD+KP I+ + V+ + DF L I S
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 160 ----VIGTFGFMAPE-----YRTTGDFSEKSDVYSFGALLLELLTG 196
G+ +MAPE + ++ D++S G +L LL+G
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 11/98 (11%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ----LFDFTLSLSIPEGETHINDSN 158
I V YLH S+ + D+KP I+L ++NV L DF ++ I G
Sbjct: 117 ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----K 169
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+ GT F+APE ++D++S G + LL+G
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 24/101 (23%), Positives = 42/101 (41%), Gaps = 7/101 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + + + + YL V RD+ +++ V ++ DF LS + +
Sbjct: 154 VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ G APE FS SDV+SFG ++ E+L
Sbjct: 211 TTG--GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 41/132 (31%), Positives = 58/132 (43%), Gaps = 22/132 (16%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
LFY L + E F ++ A EIASA+ YLH S +V RD+KP
Sbjct: 126 LFYHLQR-------------ERCFLEPRARFYAA-EIASALGYLH---SLNIVYRDLKPE 168
Query: 127 TIVLQEENVAQLFDFTLS-LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYS 185
I+L + L DF L +I T ++ GT ++APE + D +
Sbjct: 169 NILLDSQGHIVLTDFGLCKENIEHNST----TSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 186 FGALLLELLTGK 197
GA+L E+L G
Sbjct: 225 LGAVLYEMLYGL 236
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 10/98 (10%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVAQL--FDFTLSLSIPEGETHINDSN 158
I V YLH ++ VV RD+KP+ I+ + N + DF + + +
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-- 179
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
T F+APE + D++S G LL +LTG
Sbjct: 180 -PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 9/96 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL--FDFTLSLSIPEGETHINDSNRV 160
+ A+ +LH S + DI+P I+ Q + + +F + + G+ +
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RLL 163
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+ APE S +D++S G L+ LL+G
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 9e-07
Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 15/120 (12%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVA-QLFDFTLSLSIPEGETHINDSNR 159
I ++AY H S +V R++KP ++L + + A +L DF L++ + + E +
Sbjct: 114 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HG 166
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219
GT G+++PE +S+ D+++ G +L LL G Y F D + +RL +K
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG----YPP-FWDEDQHRLYAQIKA 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 9/111 (8%)
Query: 87 EDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS-L 145
F S + A EI + +LH S+ +V RD+K I+L ++ ++ DF +
Sbjct: 112 CHKFDLSRATFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167
Query: 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
++ +N GT ++APE ++ D +SFG LL E+L G
Sbjct: 168 NMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 14/104 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + ++A +A+L S+ + RD+ ++L +VA++ DF L+ I +ND
Sbjct: 167 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MND 217
Query: 157 SNRVIGTFGF-----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
SN ++ MAPE ++ +SDV+S+G LL E+ +
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 11/98 (11%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ--EENVAQL--FDFTLSLSIPEGETHINDSN 158
I V YLH ++ + D+KP I+L + + DF L+ I +G
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----K 176
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+ GT F+APE ++D++S G + LL+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 23/97 (23%), Positives = 40/97 (41%), Gaps = 10/97 (10%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHINDSNR 159
I A+ YLH S + RD+KP ++ + +L DF + +
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TT 222
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
T ++APE + + D++S G ++ LL G
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A ++A + YL S+ + RD+ +++ E+NV ++ DF L+ I + +
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+N MAPE ++ +SDV+SFG LL E+ T
Sbjct: 251 TNGR-----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 99 IAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
IA +AYLH S ++ RD+K I+L E + +L DF + + +
Sbjct: 156 IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMA 205
Query: 156 DSNRVIGTFGFMAPE---YRTTGDFSEKSDVYSFGALLLELLTGK 197
+N +GT +MAPE G + K DV+S G +EL K
Sbjct: 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 34/135 (25%), Positives = 55/135 (40%), Gaps = 21/135 (15%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKL------KIAIEIASAVAYLHVGFSRPVVSRDIKP 125
+L+ R V L + ++A + +L SR + RD+
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 176
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGDFSEK 180
I+L E+NV ++ DF L+ I D + V MAPE ++ +
Sbjct: 177 RNILLSEKNVVKICDFGLARDI------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230
Query: 181 SDVYSFGALLLELLT 195
SDV+SFG LL E+ +
Sbjct: 231 SDVWSFGVLLWEIFS 245
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 11/98 (11%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ----LFDFTLSLSIPEGETHINDSN 158
I V YLH ++ + D+KP I+L ++N+ L DF L+ I +G
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----K 176
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
+ GT F+APE ++D++S G + LL+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ + YLH + ++ RDIKP+ +++ E+ ++ DF +S + ++++ G
Sbjct: 146 LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV---G 199
Query: 163 TFGFMAPE--YRTTGDFS-EKSDVYSFGALLLELLTGK 197
T FMAPE T FS + DV++ G L + G+
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 20/123 (16%)
Query: 75 FLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN 134
+L+ R SV+ + LK ++++ A+ YL V RD+ +++ E+N
Sbjct: 105 YLRSRGRSVLGGDCL-------LKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDN 154
Query: 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLE 192
VA++ DF L+ E G APE FS KSDV+SFG LL E
Sbjct: 155 VAKVSDFGLT-----KEASSTQDT---GKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 206
Query: 193 LLT 195
+ +
Sbjct: 207 IYS 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 10/96 (10%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL-QEENVAQLFDFTLSLSIPEGETHINDSNRVI 161
+ +A+ + H SR VV RDIK I++ A+L DF + + D
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----- 199
Query: 162 GTFGFMAPEY-RTTGDFSEKSDVYSFGALLLELLTG 196
GT + PE+ + + V+S G LL +++ G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 35/143 (24%), Positives = 53/143 (37%), Gaps = 41/143 (28%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
LF L + + F ++ + EI A+ +LH ++ RDIK
Sbjct: 146 LFTHLSQ-------------RERFTEHEVQIYVG-EIVLALEHLH---KLGIIYRDIKLE 188
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTF-G---FMAPE--------YRTT 174
I+L L DF LS + + D F G +MAP+ +
Sbjct: 189 NILLDSNGHVVLTDFGLS------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 175 GDFSEKSDVYSFGALLLELLTGK 197
D+ +S G L+ ELLTG
Sbjct: 243 VDW------WSLGVLMYELLTGA 259
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 7/101 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + IAS + YL V RD+ I++ V ++ DF L + +
Sbjct: 150 VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 157 SNRVIGTFGF--MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
+ G +PE F+ SDV+S+G +L E+++
Sbjct: 207 TRG--GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 17/123 (13%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHINDSNR 159
+ AV YLH ++ RD+KP ++L E+ + ++ DF S + E
Sbjct: 248 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RT 300
Query: 160 VIGTFGFMAPE---YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ GT ++APE T ++ D +S G +L L+G Y + L+D
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----YPPFSEHRTQVSLKDQ 356
Query: 217 VKK 219
+
Sbjct: 357 ITS 359
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL--FDFTLSLSIPEGETHINDSNRV 160
I + ++H ++ D+KP I+ + Q+ DF L+ E
Sbjct: 196 ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL----KVN 248
Query: 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
GT F+APE S +D++S G + LL+G
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + IA+ + YL + V RD+ I++ V ++ DF LS + +
Sbjct: 150 VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 157 SNRVIGTF--GFMAPEYRTTGDFSEKSDVYSFGALLLELLT 195
++ G + APE + F+ SDV+SFG ++ E++T
Sbjct: 207 TSG--GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 25/97 (25%), Positives = 41/97 (42%), Gaps = 10/97 (10%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHINDSNR 159
I V YLH +V D+KP I+L ++ DF +S I
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----RE 192
Query: 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
++GT ++APE + +D+++ G + LLT
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 31/134 (23%), Positives = 58/134 (43%), Gaps = 19/134 (14%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKL------KIAIEIASAVAYLHVGFSRPVVSRDIKP 125
+ +L+ RP + D ++ ++A + YL S+ + RD+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 185
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKS 181
+++ E NV ++ DF L+ I + + +N MAPE ++ +S
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR-----LPVKWMAPEALFDRVYTHQS 240
Query: 182 DVYSFGALLLELLT 195
DV+SFG L+ E+ T
Sbjct: 241 DVWSFGVLMWEIFT 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 14/107 (13%)
Query: 99 IAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
IA EI +++LH V+ RDIK ++L E +L DF +S + +
Sbjct: 131 IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VG 184
Query: 156 DSNRVIGTFGFMAPE-----YRTTGDFSEKSDVYSFGALLLELLTGK 197
N IGT +MAPE + KSD++S G +E+ G
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 21/135 (15%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKLK------IAIEIASAVAYLHVGFSRPVVSRDIKP 125
FL P S + D S L+ + +IA+ + YL S VV +D+
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLAT 156
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGDFSEK 180
+++ ++ ++ D L + + + + MAPE G FS
Sbjct: 157 RNVLVYDKLNVKISDLGLFREVYAADYY------KLLGNSLLPIRWMAPEAIMYGKFSID 210
Query: 181 SDVYSFGALLLELLT 195
SD++S+G +L E+ +
Sbjct: 211 SDIWSYGVVLWEVFS 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 12/103 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L A ++A + +L + V RD+ +++ V ++ DF L+ I ++
Sbjct: 175 LCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
N MAPE G ++ KSDV+S+G LL E+ +
Sbjct: 232 GNAR-----LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 27/102 (26%), Positives = 44/102 (43%), Gaps = 10/102 (9%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+I SAV Y H + +V RD+K ++L + ++ DF S G
Sbjct: 118 SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK----L 170
Query: 158 NRVIGTFGFMAPEYRTTGDFSE--KSDVYSFGALLLELLTGK 197
+ G + APE G + + DV+S G +L L++G
Sbjct: 171 DAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
P ++ A E+ A+ +H S + RD+KP ++L + +L DF + + +
Sbjct: 165 VPEKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 150 GETHINDSNRVIGTFGFMAPE----YRTTGDFSEKSDVYSFGALLLELLTG 196
+ +GT +++PE G + + D +S G L E+L G
Sbjct: 221 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 7e-06
Identities = 31/148 (20%), Positives = 61/148 (41%), Gaps = 32/148 (21%)
Query: 90 FPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149
F ++ A +I YLH S ++ RD+KP +++ ++ Q+ DF + +
Sbjct: 138 FSEPHARFYAA-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG------------- 196
+ + GT +APE + +++ D ++ G L+ E+ G
Sbjct: 194 R------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 197 -----KKISYSSHFDDGEDYRLQDLVKK 219
K+ + SHF L+DL++
Sbjct: 248 EKIVSGKVRFPSHFSS----DLKDLLRN 271
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 34/133 (25%), Positives = 53/133 (39%), Gaps = 23/133 (17%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
K FL++ RP + ++ L +A +IA YL + RDI +L
Sbjct: 121 KSFLRETRP----RPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLL 173
Query: 131 Q---EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGDFSEKSD 182
VA++ DF ++ I + G M PE G F+ K+D
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRASYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTD 227
Query: 183 VYSFGALLLELLT 195
+SFG LL E+ +
Sbjct: 228 TWSFGVLLWEIFS 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-06
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 13/100 (13%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVA-QLFDFTLSLSIPEGETHINDSNR 159
+ AV YLH ++ RD+KP ++L QEE+ ++ DF S + E
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RT 175
Query: 160 VIGTFGFMAPE---YRTTGDFSEKSDVYSFGALLLELLTG 196
+ GT ++APE T ++ D +S G +L L+G
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 34/133 (25%), Positives = 53/133 (39%), Gaps = 23/133 (17%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKL-KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130
K FL++ RP + ++ L +A +IA YL + RDI +L
Sbjct: 162 KSFLRETRP----RPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLL 214
Query: 131 Q---EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF-----MAPEYRTTGDFSEKSD 182
VA++ DF ++ I + G M PE G F+ K+D
Sbjct: 215 TCPGPGRVAKIGDFGMARDIYRAGYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTD 268
Query: 183 VYSFGALLLELLT 195
+SFG LL E+ +
Sbjct: 269 TWSFGVLLWEIFS 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 12/98 (12%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEE--NVAQLFDFTLSLSIPEGETHINDSNRV 160
+ AV + H + V+ RDIK I++ + +L DF + + D
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL-KLIDFGSGALLKDTVYTDFD---- 209
Query: 161 IGTFGFMAPEY-RTTGDFSEKSDVYSFGALLLELLTGK 197
GT + PE+ R + V+S G LL +++ G
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 31/134 (23%), Positives = 58/134 (43%), Gaps = 19/134 (14%)
Query: 73 KGFLQD-RPISVMKFEDTFPFSVSKL------KIAIEIASAVAYLHVGFSRPVVSRDIKP 125
+ +L+ RP + D ++ ++A + YL S+ + RD+
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 231
Query: 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGF----MAPEYRTTGDFSEKS 181
+++ E NV ++ DF L+ I + + +N MAPE ++ +S
Sbjct: 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR-----LPVKWMAPEALFDRVYTHQS 286
Query: 182 DVYSFGALLLELLT 195
DV+SFG L+ E+ T
Sbjct: 287 DVWSFGVLMWEIFT 300
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 27/100 (27%), Positives = 43/100 (43%), Gaps = 18/100 (18%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ SAV YL + ++ RDIK IV+ E+ +L DF + + G+ G
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYTFCG 191
Query: 163 TFGFMAPE------YRTTGDFSEKSDVYSFGALLLELLTG 196
T + APE YR + +++S G L L+
Sbjct: 192 TIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFE 226
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A +I+ + YL +V RD+ I++ E ++ DF LS + E ++++
Sbjct: 153 ISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 157 SNRVIGTFGF----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
S MA E ++ +SDV+SFG LL E++T
Sbjct: 210 SQGR-----IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 14/104 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L IA ++A+ +AYL R V RD+ ++ E V ++ DF LS +I + +
Sbjct: 177 LCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--- 230
Query: 157 SNRVIGTFGF-----MAPEYRTTGDFSEKSDVYSFGALLLELLT 195
M PE ++ +SDV+++G +L E+ +
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 19/117 (16%), Positives = 44/117 (37%), Gaps = 23/117 (19%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDI--------KPTTIVLQEENVAQLFDFTLSLSI 147
KL++A ++A+A+ +L ++ ++ + +L D +S+++
Sbjct: 115 KLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 148 PEGETHINDSNRVIGTFGF--MAPE-YRTTGDFSEKSDVYSFGALLLELLTGKKISY 201
+ I + PE + + +D +SFG L E+ +G
Sbjct: 172 LPKD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 26/107 (24%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 99 IAI---EIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
I + ++ A+ +LH S+ ++ RD+K +++ E +L DF +S + +
Sbjct: 119 IQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---LQ 172
Query: 156 DSNRVIGTFGFMAPE-----YRTTGDFSEKSDVYSFGALLLELLTGK 197
+ IGT +MAPE + K+D++S G L+E+ +
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 25/102 (24%), Positives = 44/102 (43%), Gaps = 27/102 (26%)
Query: 106 AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFG 165
+ +LH S ++ RD+KP+ IV++ + ++ DF L+ R GT
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGTSF 218
Query: 166 FM----------APEYRTTGDFSEKSDVYSFGALLLELLTGK 197
M APE + E D++S G ++ E++ K
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 25/102 (24%), Positives = 44/102 (43%), Gaps = 27/102 (26%)
Query: 106 AVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFG 165
+ +LH S ++ RD+KP+ IV++ + ++ DF L+ R GT
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGTSF 181
Query: 166 FM----------APEYRTTGDFSEKSDVYSFGALLLELLTGK 197
M APE + E D++S G ++ E++ G
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 7e-05
Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 45/171 (26%)
Query: 67 LFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPT 126
LF L K FP V+K A E+ A+ YLH S+ ++ RD+KP
Sbjct: 93 LFSLLRK-------------SQRFPNPVAKFYAA-EVCLALEYLH---SKDIIYRDLKPE 135
Query: 127 TIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSF 186
I+L + ++ DF + +P+ + + GT ++APE +T +++ D +SF
Sbjct: 136 NILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSF 189
Query: 187 GALLLELLTG------------------KKISYSSHFDDGEDYRLQDLVKK 219
G L+ E+L G ++ + F++ ++DL+ +
Sbjct: 190 GILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE----DVKDLLSR 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 23/107 (21%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L A ++A + YL + + RD+ I++ E VA++ DF LS
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQ 192
Query: 157 SNRVIGTFGF-----MAPE---YRTTGDFSEKSDVYSFGALLLELLT 195
V T G MA E Y ++ SDV+S+G LL E+++
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVS 236
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 24/94 (25%), Positives = 39/94 (41%), Gaps = 25/94 (26%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
I A+ YLH S + RD+KP EN+ L+ + ++ +
Sbjct: 126 IGEAIQYLH---SINIAHRDVKP-------ENL--LY-----------TSKRPNAILKLT 162
Query: 163 TFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTG 196
FGF A E + + D++S G ++ LL G
Sbjct: 163 DFGF-AKETTGEK-YDKSCDMWSLGVIMYILLCG 194
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 27/135 (20%), Positives = 57/135 (42%), Gaps = 29/135 (21%)
Query: 73 KGFLQDRPISVMKFEDTFPFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131
G L + + F++S++K + + + + Y+H ++ RD+K +++
Sbjct: 111 AGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLIT 158
Query: 132 EENVAQLFDFTL--SLSIPEGETHINDSNRVIGTFGFMAPE-------YRTTGDFSEKSD 182
+ V +L DF L + S+ + +NRV+ T + PE Y D
Sbjct: 159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPID 211
Query: 183 VYSFGALLLELLTGK 197
++ G ++ E+ T
Sbjct: 212 LWGAGCIMAEMWTRS 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 23/97 (23%), Positives = 39/97 (40%), Gaps = 6/97 (6%)
Query: 103 IASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG 162
+ + YLH S+ +V +DIKP ++L ++ ++ + G
Sbjct: 118 LIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADDTCRTSQG 173
Query: 163 TFGFMAPE-YRTTGDFS-EKSDVYSFGALLLELLTGK 197
+ F PE FS K D++S G L + TG
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 284 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 93.32 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 91.11 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 90.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 88.72 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.21 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 84.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.61 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=334.80 Aligned_cols=204 Identities=23% Similarity=0.319 Sum_probs=151.2
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------------------------CCC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------FPF 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------~~~ 92 (284)
+++...+.||+|+||+||+|.+.+ .||||+++.. ||.
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~ 114 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCE 114 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCC
Confidence 456667889999999999999865 4999998643 221
Q ss_pred c----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 93 S----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 93 ~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
. ..++.++.|||.||+||| +++||||||||+|||+++++.+||+|||+|+......... .
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~-~ 190 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ-Q 190 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce-e
Confidence 1 567889999999999999 8999999999999999999999999999998765432211 1
Q ss_pred CCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|||||++.+ .+|+.++|||||||++|||+||+.||.... . ...+......+. ..+.
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~---~~~~~~~~~~~~----~~p~ 258 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----N---RDQIIFMVGRGY----ASPD 258 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C---HHHHHHHHHTTC----CCCC
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhcCC----CCCC
Confidence 223689999999999863 468999999999999999999999996432 1 111111111111 1111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.. ....++..+.+|+.+||+.||++|||+.||++.|+.|..
T Consensus 259 ~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 LSK-------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp STT-------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ccc-------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 110 112344558899999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=330.64 Aligned_cols=218 Identities=20% Similarity=0.303 Sum_probs=156.5
Q ss_pred CCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------------~~ 91 (284)
++...+.||+|+||+||+|.++|+.||||++... ||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 3455678999999999999999999999998654 22
Q ss_pred Cc--------------hhHHHHHHHHHHHHHHhccC-----CCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 92 FS--------------VSKLKIAIEIASAVAYLHVG-----FSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 92 ~~--------------~~~~~i~~~i~~gL~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
.. ..+++++.|++.||+|||+. +..+||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 163 (303)
T 3hmm_A 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence 11 56788999999999999932 123999999999999999999999999999987755433
Q ss_pred ccc-CCCCcccCccccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-------ccccHHHHHH
Q 039895 153 HIN-DSNRVIGTFGFMAPEYRTTG------DFSEKSDVYSFGALLLELLTGKKISYSSHFDDG-------EDYRLQDLVK 218 (284)
Q Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~ 218 (284)
... ......||+.|||||++.+. .++.++|||||||++|||+||..|+........ ..........
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 243 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHH
Confidence 221 22236799999999998754 367899999999999999999887643221100 0111122111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
...... .+|.+... ....+++..+.+|+.+||+.||++||||.||++.|++|.++
T Consensus 244 -~~~~~~----~rp~~p~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 244 -VVCEQK----LRPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp -HHTTSC----CCCCCCGG-----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHhccc----CCCCCCcc-----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111111 11111110 11235566788999999999999999999999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=332.59 Aligned_cols=201 Identities=20% Similarity=0.274 Sum_probs=155.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ ++..||||++...
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4566678999999999999986 3678999999754
Q ss_pred ---CCCc----------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ---FPFS----------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ---~~~~----------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
||.. ..++.++.||+.||.||| +++||||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 2221 356789999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||+|+.......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..+..
T Consensus 170 ~DFGla~~~~~~~~~~~-~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~ 240 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI 240 (299)
T ss_dssp CCCSCHHHHTGGGCEEE-TTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHH
T ss_pred CCcccceecCCCCceee-cCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999987654433222 122568999999999999999999999999999999999 899986432 11222
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
... ..+.... .+..++..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 241 ~~i-~~~~~~~---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECI-TQGRVLQ---------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHH-HHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-HcCCCCC---------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 221 1111111 1122344588999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=332.72 Aligned_cols=196 Identities=23% Similarity=0.337 Sum_probs=152.2
Q ss_pred CCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC----------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~---------------------------------------- 89 (284)
+...+.||+|+||+||+|.+ +++.||||++...
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 33456899999999999997 4578999998654
Q ss_pred --CCCc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 --FPFS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 --~~~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
||.. ..++.++.|||.||.||| +.+||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 2211 246789999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
||+|||+++.+....... ......||+.|||||++.+..|+.++|||||||++|||+| |..||.+.. ..+
T Consensus 185 Ki~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~~ 255 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 255 (308)
T ss_dssp EECCSCCBCGGGGGGCBC-SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HHH
T ss_pred EECCcccceeccCCCcee-EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 999999998765433221 1223679999999999999999999999999999999999 888886432 122
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.+.. +..+... +.+..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 256 ~~~~-i~~~~~~---------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEM-IRNRQVL---------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH-HHTTCCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH-HHcCCCC---------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222 1122111 11223445688999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=332.45 Aligned_cols=201 Identities=20% Similarity=0.238 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
.+|...+.||+|+||+||+|.+ ++..||||++...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3556667899999999999986 3678999999754
Q ss_pred ---CCCc------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 ---FPFS------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 ---~~~~------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
||.. ..++.++.|||.||.||| +++||||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 2211 346789999999999999 8999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
||+|||+++.+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~-~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE 268 (329)
T ss_dssp EECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred EEcccccceeccCCCccee-cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 9999999987754432221 122579999999999999999999999999999999999 899986432 112
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+.... .+... +.+..+++.+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 269 ~~~~i~-~g~~~---------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 AIDCIT-QGREL---------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHH-HTCCC---------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHH-cCCCC---------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222211 11100 01122344588999999999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=329.91 Aligned_cols=203 Identities=17% Similarity=0.145 Sum_probs=154.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------CCCc---
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------FPFS--- 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------~~~~--- 93 (284)
+.|...+.||+|+||.||+|.+ +|+.||||++... ||..
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 4566677899999999999998 7999999999755 2221
Q ss_pred ------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCCCccc--cCCC
Q 039895 94 ------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHI--NDSN 158 (284)
Q Consensus 94 ------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~~--~~~~ 158 (284)
.....++.||+.||.||| +++||||||||+|||++.+| .+||+|||+|+.+....... ....
T Consensus 138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~ 214 (336)
T 4g3f_A 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214 (336)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence 567789999999999999 99999999999999999998 59999999998875432211 1223
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
..+||+.|||||++.+..|+.++|||||||++|||++|..||..... ..+...+.. ....+.+
T Consensus 215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~--~~~~~~~---------- 277 (336)
T 4g3f_A 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-----GPLCLKIAS--EPPPIRE---------- 277 (336)
T ss_dssp CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-----SCCHHHHHH--SCCGGGG----------
T ss_pred ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHc--CCCCchh----------
Confidence 36799999999999999999999999999999999999999975431 111111111 0101111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+...++.+.+|+.+||+.||++|||+.|+++.|...++
T Consensus 278 -----~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 -----IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp -----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 012233457899999999999999999999999988764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=337.97 Aligned_cols=211 Identities=21% Similarity=0.308 Sum_probs=163.1
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC------------------------------
Q 039895 47 ADELKTATDDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT------------------------------ 89 (284)
Q Consensus 47 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~------------------------------ 89 (284)
..+++...++|...+.||+|+||+||+|.+. ++.||||++...
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 3445445577888899999999999999972 257999998654
Q ss_pred --------------CCCc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccc
Q 039895 90 --------------FPFS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIK 124 (284)
Q Consensus 90 --------------~~~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlk 124 (284)
||.. ..++.++.|||.||.||| +++|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccC
Confidence 2211 345689999999999999 9999999999
Q ss_pred cCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 039895 125 PTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSS 203 (284)
Q Consensus 125 p~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~ 203 (284)
|+|||+++++.+||+|||+|+.+........ .....||+.|||||++.+..|+.++|||||||++|||+| |..||...
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~-~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCcee-eccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999988765443222 123678999999999999999999999999999999998 89998653
Q ss_pred CCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. ....+.. .+..+.... .+..+++.+.+++.+||+.||++|||+.||+++|++++++
T Consensus 292 ~----~~~~~~~----~i~~g~~~~---------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 K----IDEEFCR----RLKEGTRMR---------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp C----CSHHHHH----HHHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----HHHHHHH----HHHcCCCCC---------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2 1111111 111111111 1122334588999999999999999999999999999886
Q ss_pred C
Q 039895 284 N 284 (284)
Q Consensus 284 ~ 284 (284)
|
T Consensus 349 ~ 349 (353)
T 4ase_A 349 N 349 (353)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=325.19 Aligned_cols=193 Identities=18% Similarity=0.248 Sum_probs=152.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
..|+..+.||+|+||+||+|.+ +|+.||||++... ||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 3477778899999999999999 7999999998643 22
Q ss_pred Cc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 FS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 ~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.. .....++.||+.||.||| +++||||||||+|||++.+|.+||+|||+|+.+...... .
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~ 227 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---R 227 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC---B
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc---c
Confidence 21 567789999999999999 999999999999999999999999999999887544322 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
.+.+||+.|||||++.+..|+.++|||||||++|||++|..||.... ............ ... +
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~~~-----~--- 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNL-PPR-----L--- 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSS-CCC-----C---
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-CCC-----C---
Confidence 23689999999999999999999999999999999999999997532 111121111110 000 0
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus 291 -----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 -----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223345889999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=314.89 Aligned_cols=186 Identities=21% Similarity=0.312 Sum_probs=142.2
Q ss_pred CCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------------
Q 039895 59 GGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------------- 89 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------------- 89 (284)
....||+|+||+||+|.+ ++..||+|++...
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 345799999999999998 7889999998643
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEec-CCcceeeccccccccCCCC
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+......
T Consensus 110 y~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 2211 456789999999999999 777 999999999999984 7999999999997654332
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
. .+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ........ ...+..+...
T Consensus 187 ~-----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~-i~~~~~~~~~- 251 (290)
T 3fpq_A 187 A-----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRR-VTSGVKPASF- 251 (290)
T ss_dssp B-----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHH-HTTTCCCGGG-
T ss_pred c-----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHH-HHcCCCCCCC-
Confidence 2 22689999999998865 69999999999999999999999996432 11111111 1111111111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 252 -------------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 -------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112234789999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=328.43 Aligned_cols=191 Identities=23% Similarity=0.292 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5688888999999999999998 7999999998654
Q ss_pred CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
||.. ...+.++.||+.||.||| +++||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 2221 356679999999999999 99999999999999999999999999999987754321
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......... +.++..
T Consensus 181 ~---~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~~~~~~--- 245 (350)
T 4b9d_A 181 L---ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIIS-GSFPPV--- 245 (350)
T ss_dssp H---HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-TCCCCC---
T ss_pred c---ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHc-CCCCCC---
Confidence 1 112579999999999999999999999999999999999999996532 2222222221 111110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 ------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 ------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122344789999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=311.56 Aligned_cols=189 Identities=20% Similarity=0.268 Sum_probs=139.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +|+.||+|++...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999998 7999999998654
Q ss_pred -CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 -FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 -~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|.. .....++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~- 168 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL- 168 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc-
Confidence 2211 567789999999999999 999999999999999999999999999999876543321
Q ss_pred cCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.+.+||+.|||||++.+..+ +.++||||+||++|||++|+.||.... ......... .+... +
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~-~~~~~--~--- 231 (275)
T 3hyh_A 169 ---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNIS-NGVYT--L--- 231 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCCC--C---
T ss_pred ---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCCC--C---
Confidence 22689999999999998876 579999999999999999999996432 122222221 11110 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 -----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 -----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0112234789999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=325.76 Aligned_cols=193 Identities=19% Similarity=0.259 Sum_probs=152.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
+.|+..+.||+|+||.||+|.+ +|+.||||++... ||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4578888999999999999999 7999999998644 33
Q ss_pred Cc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 FS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 ~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.. .....++.||+.||.||| +++||||||||+||||+.+|.+||+|||+|+.+...... .
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~---~ 304 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---R 304 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC---B
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc---c
Confidence 22 566789999999999999 999999999999999999999999999999887543322 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...+||+.|||||++.+..|+.++|||||||++|||++|..||.... ............ . +.+.
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~-----~~~~-- 368 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNL-P-----PRLK-- 368 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-C-----CCCS--
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-C-----CCCc--
Confidence 23789999999999999999999999999999999999999996532 112122111111 0 0000
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 369 ------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 ------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01122344789999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=316.81 Aligned_cols=191 Identities=22% Similarity=0.337 Sum_probs=151.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688999999999999999998 8999999998643
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 2221 556779999999999999 999999999999999999999999999999887543222
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ...+.+||+.|||||++.+..|+.++||||+||++|||++|..||.... .......... ..+.
T Consensus 189 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~-~~~~------ 252 (311)
T 4aw0_A 189 A-RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIK-LEYD------ 252 (311)
T ss_dssp C-CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-TCCC------
T ss_pred c-cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-CCCC------
Confidence 1 1223789999999999999999999999999999999999999996532 1222222211 1110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
+ +...++.+.+|+.+||+.||++|||+.|++
T Consensus 253 ~----------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 F----------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C----------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C----------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0 011223478999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=309.90 Aligned_cols=190 Identities=23% Similarity=0.272 Sum_probs=146.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.. .++.||+|++...
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688889999999999999986 4678999998643
Q ss_pred ---CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 2221 566789999999999999 9999999999999999999999999999998764432
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. ..+.+||+.|||||++.+..|+.++||||+||++|||+||..||.+.. .......... ....
T Consensus 181 ~~---~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~~~~---- 244 (304)
T 3ubd_A 181 KK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILK-AKLG---- 244 (304)
T ss_dssp CC---CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCC----
T ss_pred cc---ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHc-CCCC----
Confidence 21 123689999999999999999999999999999999999999997532 1222222211 1110
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI-----VQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~ev~~ 275 (284)
.+...++.+.+|+.+||+.||++|||+ +|+++
T Consensus 245 ------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 011123347899999999999999985 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=308.48 Aligned_cols=192 Identities=24% Similarity=0.336 Sum_probs=137.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.+ +|+.||||++...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688889999999999999998 7999999998543
Q ss_pred -----------CCCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeec
Q 039895 90 -----------FPFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 -----------~~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
+|.. ...+.++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 1211 125679999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCccc---------cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 039895 141 FTLSLSIPEGETHI---------NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY 211 (284)
Q Consensus 141 fg~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~ 211 (284)
||+|+.+....... ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~ 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------M 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------c
Confidence 99998875432211 11223579999999999999999999999999999999996 65321 0
Q ss_pred cHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 212 RLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........ .....+ ++......+.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~-~~~~~~---------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTD-VRNLKF---------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-HHTTCC---------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-HhcCCC---------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 111111 1223344455678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=308.25 Aligned_cols=213 Identities=15% Similarity=0.197 Sum_probs=150.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4577778999999999999998 8999999998644
Q ss_pred ------CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ------FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ------~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 1111 567789999999999999 99999999999999999999999999999987754
Q ss_pred CCcc-ccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 150 GETH-INDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 150 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
.... .......+||+.|||||++.+. .++.++||||+||++|||++|..||.+.. .......+..........
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-----~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-----YVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHHCCCCGG
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhcCCCChH
Confidence 3221 2222347899999999998775 46899999999999999999999997532 111222221111111100
Q ss_pred cc--cc--------ccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 EI--VD--------PAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 ~~--~~--------~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+ .. ..+.......+. ........+.+|+.+||..||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 000000000000 00112345789999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=301.28 Aligned_cols=232 Identities=31% Similarity=0.521 Sum_probs=186.1
Q ss_pred CCcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC-----------------------------
Q 039895 40 NPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------- 89 (284)
Q Consensus 40 ~~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------- 89 (284)
...+.|++.++..++++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4578899999999999999999999999999999998 7899999998654
Q ss_pred -------------CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcce
Q 039895 90 -------------FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 90 -------------~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 137 (284)
+| ....+..++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 11 1145678999999999999932222999999999999999999999
Q ss_pred eeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 138 LFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 138 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
|+|||++............. ..||+.|+|||++.+..++.++|||||||++|+|++|..||...............++
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp ECCCSSCEECCSSSSCEECC--CCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred eccCccccccCccccccccc--ccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999998775443332222 5699999999999888899999999999999999999999964332234445566666
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
.............+..+... .....+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTS------CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccc------cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 55555555555555444332 245667789999999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.38 Aligned_cols=152 Identities=22% Similarity=0.326 Sum_probs=123.4
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------- 89 (284)
.+....+.|...+.||+|+||+||+|+. .++.||+|++...
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 3344567899999999999999999986 3678999988654
Q ss_pred ------CCCc------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-CcceeeccccccccCCC
Q 039895 90 ------FPFS------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ------~~~~------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. .....++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 2221 566789999999999999 9999999999999999977 79999999999866443
Q ss_pred Cccc-------------------------cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 151 ETHI-------------------------NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 151 ~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2110 011235799999999998876 4899999999999999999999999754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.47 Aligned_cols=231 Identities=31% Similarity=0.456 Sum_probs=181.3
Q ss_pred CCcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC-----------------------------
Q 039895 40 NPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------- 89 (284)
Q Consensus 40 ~~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------- 89 (284)
.....+++.++..++++|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 24 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 24 FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp ------CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred CcceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3445667777788899999999999999999999999 7899999987644
Q ss_pred ------------CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ------------FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ------------~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
+| ....++.++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEE
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEE
Confidence 11 11467789999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
+|||++.......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........+..
T Consensus 181 ~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~--~~~~~~~~~~~~ 257 (321)
T 2qkw_B 181 TDFGISKKGTELDQTH-LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PREMVNLAEWAV 257 (321)
T ss_dssp CCCTTCEECSSSSCCC-CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS--SSSCCCHHHHTH
T ss_pred eecccccccccccccc-cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC--cHHHHHHHHHhh
Confidence 9999997654322211 1122568999999999988899999999999999999999999997654 233344555554
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.....+.+...+++.+... .....+..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTC------SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccccHHHhcChhhccc------cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4445555555555544322 245677789999999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=284.83 Aligned_cols=229 Identities=28% Similarity=0.440 Sum_probs=175.1
Q ss_pred CCCcceecHHHHHHHhcCCCCC------CeeeecCCceEEEEEeCCcceEEEeecCC-----------------------
Q 039895 39 HNPIRSFSADELKTATDDFDGG------KVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------- 89 (284)
Q Consensus 39 ~~~~~~~~~~~l~~~~~~f~~~------~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------- 89 (284)
......|++.++..++++|+.. +.||+|+||.||+|..++..||||++...
T Consensus 9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 3467899999999999999988 89999999999999999999999998642
Q ss_pred ----------------------CCC------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEE
Q 039895 90 ----------------------FPF------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIV 129 (284)
Q Consensus 90 ----------------------~~~------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NIL 129 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence 110 1456789999999999999 899999999999999
Q ss_pred EecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 039895 130 LQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE 209 (284)
Q Consensus 130 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~ 209 (284)
++.++.+||+|||++........... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---- 239 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVM-TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE---- 239 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEE-CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS----
T ss_pred EcCCCcEEEeeccccccccccccccc-ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc----
Confidence 99999999999999987654322211 122578999999998764 588999999999999999999999875331
Q ss_pred cccHHHHHHHHh-hcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 210 DYRLQDLVKKYI-ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 210 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
......+..... ....+...+++.+.. .....+..+.+++.+||+.||.+|||+.+|++.|+++..|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp SSBTTHHHHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred hHHHHHHHHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 111112221111 112233333333221 2455667789999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=315.41 Aligned_cols=190 Identities=21% Similarity=0.279 Sum_probs=149.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...++||+|+||.||+|.. +|+.||+|++.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6788899999999999999999 8999999998533
Q ss_pred ----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
||.. .....++.||+.||.||| +.+||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 2221 556779999999999999 999999999999999999999999999999887544
Q ss_pred CccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Ccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKE 228 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 228 (284)
.. .+.+||+.|||||++.. ..|+.++|+||+||++|||++|..||.... .............. ..++
T Consensus 346 ~~-----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~-----~~~~~~i~~~i~~~~~~~p- 414 (689)
T 3v5w_A 346 KP-----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTMAVELP- 414 (689)
T ss_dssp CC-----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG-----CCCHHHHHHHHHHCCCCCC-
T ss_pred CC-----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhhcCCCCCCC-
Confidence 32 23689999999999974 579999999999999999999999996432 11122222221111 1111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
...++.+.+|+.+||+.||++|++ +.||++
T Consensus 415 -----------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 112234789999999999999998 677754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=292.41 Aligned_cols=215 Identities=22% Similarity=0.270 Sum_probs=160.2
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------------~ 90 (284)
++|...+.||+|+||+||+|.+.++.||||++... +
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 67888899999999999999999999999998643 1
Q ss_pred CCc--------------hhHHHHHHHHHHHHHHhccCCCC----------CeeecccccCcEEEecCCcceeeccccccc
Q 039895 91 PFS--------------VSKLKIAIEIASAVAYLHVGFSR----------PVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 91 ~~~--------------~~~~~i~~~i~~gL~~LH~~~~~----------~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
|.. ..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 104 HEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 111 456789999999999999 88 999999999999999999999999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc--------ccH
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTG-----DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED--------YRL 213 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~--------~~~ 213 (284)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||.......... ...
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 181 FEAGKSAG-DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp ECTTSCCC-CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred cccccCcc-ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 65443321 12225789999999998763 45678999999999999999999997643211111 011
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..+...... ......+.. .......+..+.+|+.+||+.||++|||+.||++.|++|.+.
T Consensus 260 ~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 260 EDMQEVVVH-KKKRPVLRD---------YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHTT-SCCCCCCCG---------GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhc-ccCCCCccc---------cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 111100000 011234556689999999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=309.60 Aligned_cols=193 Identities=18% Similarity=0.165 Sum_probs=152.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.++|...+.||+|+||.||+|.. +|+.||+|++... +
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36788889999999999999999 8999999998654 2
Q ss_pred CCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC--CcceeeccccccccCCCCc
Q 039895 91 PFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE--NVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~Dfg~a~~~~~~~~ 152 (284)
|.. .....++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 221 456789999999999999 9999999999999999854 8899999999998765443
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (284)
.. ..+||+.|||||++.+..|+.++||||+||++|||++|..||.+.. ........... ..+..
T Consensus 313 ~~----~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~--- 377 (573)
T 3uto_A 313 VK----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDD--- 377 (573)
T ss_dssp EE----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCCCCCS---
T ss_pred ee----eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCCCCCCc---
Confidence 22 2579999999999999999999999999999999999999997533 11222211111 11111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 378 -----------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122344789999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=288.41 Aligned_cols=219 Identities=19% Similarity=0.306 Sum_probs=160.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------------- 89 (284)
.++|...+.||+|+||.||+|..+++.||||++...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 367888899999999999999999999999998543
Q ss_pred -CCCc--------------hhHHHHHHHHHHHHHHhccCCCC---------CeeecccccCcEEEecCCcceeecccccc
Q 039895 90 -FPFS--------------VSKLKIAIEIASAVAYLHVGFSR---------PVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 90 -~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~---------~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
+|.. .....++.||+.||.||| +. +|+||||||+|||++.++.+||+|||++.
T Consensus 92 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 1111 456789999999999999 77 99999999999999999999999999998
Q ss_pred ccCCCCcc-----ccCCCCcccCccccccccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 146 SIPEGETH-----INDSNRVIGTFGFMAPEYRTT-------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 146 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
.+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|++............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 76543211 111123579999999999876 356778999999999999999988876544222211111
Q ss_pred HH---------HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 214 QD---------LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 214 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.. ........... .......++.....+..+.+|+.+||+.||++|||+.|+++.|+++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQ--------RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCC--------CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcccCCCchHHHHHhhhccccc--------CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10 01111111100 0111111222345666799999999999999999999999999999853
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=277.72 Aligned_cols=211 Identities=16% Similarity=0.220 Sum_probs=158.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------C
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------F 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~ 90 (284)
..+.|...+.||+|+||.||+|.. +++.||||++... +
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 457899999999999999999997 8899999986543 1
Q ss_pred C---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccCCCCc
Q 039895 91 P---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
| ....+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++........
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 1 11567789999999999999 9999999999999999 7889999999999987755432
Q ss_pred cc----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 HI----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........+...........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--ATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC--SSSSSHHHHHHHHHHHSCHHH
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch--hhhhhhhhhhhcccccchhhh
Confidence 11 112236789999999999999999999999999999999999999976431 222222222211111111000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. ....+..+.+++..||+.||++|||+.+|++.|+++.++
T Consensus 242 ~---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 242 L---------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp H---------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred h---------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0 011134588999999999999999999999999998864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=279.28 Aligned_cols=214 Identities=23% Similarity=0.322 Sum_probs=158.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------------- 89 (284)
.++|...+.||+|+||+||+|.++|+.||||++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 467888899999999999999999999999998654
Q ss_pred CCCc--------------hhHHHHHHHHHHHHHHhccC-----CCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 FPFS--------------VSKLKIAIEIASAVAYLHVG-----FSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ~~~~--------------~~~~~i~~~i~~gL~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. ...+.++.|++.||.|||.. ++.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 166 (301)
T 3q4u_A 87 YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166 (301)
T ss_dssp CCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred hccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccc
Confidence 1111 56678999999999999932 1578999999999999999999999999999776543
Q ss_pred Cccc-cCCCCcccCccccccccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCCCCCccccH
Q 039895 151 ETHI-NDSNRVIGTFGFMAPEYRTTG------DFSEKSDVYSFGALLLELLTG----------KKISYSSHFDDGEDYRL 213 (284)
Q Consensus 151 ~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~G~il~elltg----------~~p~~~~~~~~~~~~~~ 213 (284)
.... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||....... ...
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~---~~~ 243 (301)
T 3q4u_A 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND---PSF 243 (301)
T ss_dssp TTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS---CCH
T ss_pred cccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC---cch
Confidence 3322 112235799999999998876 455799999999999999999 77775433111 112
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
................ ... ......+..+.+|+.+||+.||++|||+.||++.|++|
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNI-PNR---------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHTTSCCCCCC-CGG---------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhHHHhccCCCCCC-Chh---------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211111111111111 000 01234566789999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=277.14 Aligned_cols=209 Identities=13% Similarity=0.162 Sum_probs=159.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~- 91 (284)
++|...+.||+|+||.||+|.. +|+.||||++... +|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 89 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 89 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecC
Confidence 5688889999999999999997 8999999988643 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc-----ceeeccccccccCCCCc
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV-----AQLFDFTLSLSIPEGET 152 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~Dfg~a~~~~~~~~ 152 (284)
....+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||++........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 90 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 11567789999999999999 999999999999999987776 99999999987754432
Q ss_pred cc----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 HI----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ..........+...........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--AATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC--SCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh--ccccHHHHHHHHhhccCccHHH
Confidence 11 11233679999999999999999999999999999999999999997543 1111111111111111111111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. ....+..+.+++.+||+.||++|||+.+|++.|+++.++
T Consensus 245 ~---------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 245 L---------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp H---------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H---------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 011234588999999999999999999999999998864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=280.59 Aligned_cols=202 Identities=23% Similarity=0.265 Sum_probs=149.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------- 89 (284)
..++|...+.||+|+||+||+|.++|..||||++...
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 4467888889999999999999999999999998654
Q ss_pred CCC------------------chhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 FPF------------------SVSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ~~~------------------~~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ...++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 111 1456779999999999999 888 99999999999999999999999999976543
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ................
T Consensus 192 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~- 259 (309)
T 3p86_A 192 TFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKRLE- 259 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHSCCCCC-
T ss_pred cccc---cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCC-
Confidence 3211 122578999999999999999999999999999999999999986432 1111111111111000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+..+.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus 260 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 --------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0112233478999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=279.44 Aligned_cols=222 Identities=20% Similarity=0.274 Sum_probs=160.2
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------
Q 039895 47 ADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 47 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------- 89 (284)
...-....++|...+.||+|+||.||+|.+.++.||||++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3333445578999999999999999999999999999998543
Q ss_pred -------CCCc--------------hhHHHHHHHHHHHHHHhccCCCC--------CeeecccccCcEEEecCCcceeec
Q 039895 90 -------FPFS--------------VSKLKIAIEIASAVAYLHVGFSR--------PVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 -------~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~--------~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
+|.. ...+.++.|++.||.||| +. +|+||||||+|||++.++.+||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 1111 456789999999999999 77 999999999999999999999999
Q ss_pred cccccccCCCCcccc-CCCCcccCccccccccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 039895 141 FTLSLSIPEGETHIN-DSNRVIGTFGFMAPEYRTTGDFSEK------SDVYSFGALLLELLTG----------KKISYSS 203 (284)
Q Consensus 141 fg~a~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwS~G~il~elltg----------~~p~~~~ 203 (284)
||++........... ......||+.|+|||++.+...+.. +|||||||++|||++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999977654332211 1123579999999999987766654 9999999999999999 4444332
Q ss_pred CCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.. ........ ................ .....++..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 266 ~~---~~~~~~~~-~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 266 VP---SDPSYEDM-REIVCIKKLRPSFPNR---------WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SC---SSCCHHHH-HHHHTTSCCCCCCCGG---------GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cC---CCCchhhh-HHHHhhhccCcccccc---------chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 21 11111111 1111111111110000 11236677799999999999999999999999999999876
Q ss_pred C
Q 039895 284 N 284 (284)
Q Consensus 284 ~ 284 (284)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.84 Aligned_cols=210 Identities=16% Similarity=0.221 Sum_probs=160.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
.++|...+.||+|+||.||+|.. +|+.||||++... +|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 46788889999999999999997 8999999987644 11
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccCCCCcc
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
....+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 11556789999999999999 9999999999999999 48899999999999877554321
Q ss_pred c----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 154 I----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 154 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........+............
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--ATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC--SSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc--hhhhhhhhhhcccccCCchHHH
Confidence 1 112236799999999999999999999999999999999999999975431 2222222222111111110000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
....+..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 243 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 243 ---------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp ---------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 011223488999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.15 Aligned_cols=187 Identities=18% Similarity=0.172 Sum_probs=144.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...++||+|+||+||+|.+ +|+.||||++...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5677788999999999999999 7899999998543
Q ss_pred -CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+| ....+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 11 11467789999999999999 899999999999999999999999999998776543322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . .. .........
T Consensus 214 ----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~-~~-~~~~~~~~~----- 271 (311)
T 3p1a_A 214 ----EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------G-WQ-QLRQGYLPP----- 271 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------H-HH-HHTTTCCCH-----
T ss_pred ----cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------H-HH-HHhccCCCc-----
Confidence 12568999999998875 78999999999999999999987764311 0 01 111111110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.........+.+++.+||+.||++|||+.|+++
T Consensus 272 ---------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ---------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011122345889999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=275.73 Aligned_cols=205 Identities=19% Similarity=0.277 Sum_probs=158.5
Q ss_pred ceecHHHHHHHhcC----------CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------
Q 039895 43 RSFSADELKTATDD----------FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------- 89 (284)
Q Consensus 43 ~~~~~~~l~~~~~~----------f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------- 89 (284)
..++++++.++++. |+..+.||+|+||.||+|.. +|+.||||++...
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46889999998875 55566899999999999998 7999999998643
Q ss_pred --------------------CCC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc
Q 039895 90 --------------------FPF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV 135 (284)
Q Consensus 90 --------------------~~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 135 (284)
+|. ...+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCc
Confidence 111 1567789999999999999 899999999999999999999
Q ss_pred ceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHH
Q 039895 136 AQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 136 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 215 (284)
+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ...
T Consensus 180 ~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--------~~~ 248 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQ 248 (321)
T ss_dssp EEECCCTTCEECCSSSCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHH
T ss_pred EEEeeeeeeeecccCccc---cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHH
Confidence 999999998876543221 122579999999999999999999999999999999999999986432 111
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....... ...... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~-~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 AMKRLRD-SPPPKL-------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHH-SSCCCC-------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhc-CCCCCc-------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 111110 001122334789999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=273.24 Aligned_cols=194 Identities=20% Similarity=0.300 Sum_probs=151.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.+.|...+.||+|+||+||+|.. +|+.||||++... +
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788899999999999999987 8899999998543 2
Q ss_pred CC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 91 PF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 91 ~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 173 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB--
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc--
Confidence 21 1456789999999999999 8999999999999999999999999999988765433221
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ............. ....
T Consensus 174 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~-~~~~------ 237 (297)
T 3fxz_A 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGT-PELQ------ 237 (297)
T ss_dssp -CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCS-CCCS------
T ss_pred -CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-CCCC------
Confidence 22579999999999999999999999999999999999999986432 1111111111111 0100
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+...+..+.+++.+||+.||++|||+.|+++
T Consensus 238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 -------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11223344789999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=275.10 Aligned_cols=202 Identities=22% Similarity=0.333 Sum_probs=153.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||+|+||+||+|.+ ++..||+|++... +|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5677788999999999999998 6899999987543 11
Q ss_pred Cc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 FS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.. ..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 11 566789999999999999 99999999999999999999999999999987654332211
Q ss_pred -----------CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-cccHHHHHHHHhhc
Q 039895 156 -----------DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE-DYRLQDLVKKYIEN 223 (284)
Q Consensus 156 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 223 (284)
......||+.|+|||++.+..++.++|||||||++|||++|..|+......... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--- 243 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT---
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc---
Confidence 111357999999999999999999999999999999999999988653311111 11111111110
Q ss_pred CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 224 ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
..+ .++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 244 ------~~~--------------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 244 ------CPP--------------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------CCT--------------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCC--------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001 111237899999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=284.84 Aligned_cols=213 Identities=17% Similarity=0.153 Sum_probs=158.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-C------CcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-Q------DRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~------~~~vavK~~~~~------------------------------------- 89 (284)
.++|...+.||+|+||.||+|.+ . ++.||||++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45788889999999999999988 2 478999996532
Q ss_pred -------------------CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe--cC
Q 039895 90 -------------------FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ--EE 133 (284)
Q Consensus 90 -------------------~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~--~~ 133 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCT
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCC
Confidence 11 11567789999999999999 89999999999999999 88
Q ss_pred CcceeeccccccccCCCCccc----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 039895 134 NVAQLFDFTLSLSIPEGETHI----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE 209 (284)
Q Consensus 134 ~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~ 209 (284)
+.+||+|||+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... .
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~----~ 266 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL----K 266 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT----T
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc----c
Confidence 999999999998765432211 11123569999999999999999999999999999999999999997432 1
Q ss_pred cccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
........... ....+..++++.+.. ...+..+.+++..||+.+|++||++.+|++.|+++++.
T Consensus 267 ~~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKIR-YRENIASLMDKCFPA---------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHHH-HHHCHHHHHHHHSCT---------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHH-hhhhHHHHHHHhccc---------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11111111111 111222222222110 11234588999999999999999999999999998763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=277.85 Aligned_cols=201 Identities=19% Similarity=0.289 Sum_probs=152.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CC---cceEEEeecCC-----------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QD---RPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~----------------------------------------- 89 (284)
.|...+.||+|+||.||+|.+ ++ ..||||++...
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 455568899999999999998 33 35999998754
Q ss_pred -CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 111 1467789999999999999 99999999999999999999999999999987755433
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.........+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..............
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~~----- 273 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYRL----- 273 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCC-----
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCCC-----
Confidence 2222222456788999999998899999999999999999999 999986432 11122111111100
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..++..+.+|+..||+.||++|||+.+|++.|+.+.++
T Consensus 274 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 -----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 01112334588999999999999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=276.05 Aligned_cols=208 Identities=17% Similarity=0.194 Sum_probs=157.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CCC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FPF 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~~ 92 (284)
++|...+.||+|+||.||+|.. +|+.||||++... +|.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCC
Confidence 5688889999999999999997 8899999998643 111
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc-----ceeeccccccccCCCCc
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV-----AQLFDFTLSLSIPEGET 152 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~Dfg~a~~~~~~~~ 152 (284)
...++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++.+.....
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 89 PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 1566789999999999999 899999999999999998887 99999999987654332
Q ss_pred ccc----CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 HIN----DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ..........+......... +
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~--~~~~~~~~~~i~~~~~~~~~-~ 242 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK--ADTLKERYQKIGDTKRATPI-E 242 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CSSHHHHHHHHHHHHHHSCH-H
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc--cccHHHHHHHHHhhhccCCH-H
Confidence 111 1123679999999999999999999999999999999999999997543 11111111111111110000 0
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
... ...+ .+.+++..||+.||.+||++.+|++.|+++.+.
T Consensus 243 ~~~--------------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 243 VLC--------------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHT--------------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHh--------------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 000 0012 588999999999999999999999999988753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.76 Aligned_cols=209 Identities=18% Similarity=0.260 Sum_probs=160.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
.+.|...+.||+|+||.||+|.+ ++..||||++... +|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 36789999999999999999998 7899999987643 11
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccCCCCcc
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
....++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 11567789999999999999 8999999999999999 68899999999999877654322
Q ss_pred c----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 154 I----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 154 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ..........+...........+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK--AGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC--CSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc--chhHHHHHHHHhhccccccHHHH
Confidence 1 11123679999999999999999999999999999999999999997543 11111111111111111111110
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
...++..+.+|+..||+.+|++||++.+|++.|++++.
T Consensus 241 ---------------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 241 ---------------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp ---------------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 01123458899999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.14 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=155.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 45677778999999999999999 6899999998643
Q ss_pred CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. ...+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 1110 456789999999999999 999999999999999999999999999999875443222
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ......+++.|+|||++....++.++|||||||++|||++ |..||.... ... +......+...
T Consensus 270 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--------~~~-~~~~~~~~~~~----- 334 (377)
T 3cbl_A 270 A-SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQ-TREFVEKGGRL----- 334 (377)
T ss_dssp C-CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--------HHH-HHHHHHTTCCC-----
T ss_pred e-cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHH-HHHHHHcCCCC-----
Confidence 1 1111346778999999988889999999999999999998 888876432 111 11111111100
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 335 ----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 ----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11112334588999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=273.55 Aligned_cols=211 Identities=21% Similarity=0.274 Sum_probs=151.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~--------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.+ +++.||||++...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5677788999999999999984 6789999998654
Q ss_pred ----CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ----FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ----~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ....+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 111 1456789999999999999 99999999999999999999999999999987755
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------CCccccHHHHHHHHhh
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD-------DGEDYRLQDLVKKYIE 222 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 222 (284)
............+|+.|+|||++.+..++.++||||||+++|||++|..|+...... ................
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 433222222345788899999999889999999999999999999999887532100 0000000000001110
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
... ..+.+..++..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 247 ~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 247 NNG---------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TTC---------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccC---------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000 0111223345588999999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.99 Aligned_cols=163 Identities=23% Similarity=0.367 Sum_probs=124.7
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
..+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........... .....||+.|+|||++.+
T Consensus 194 ~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 194 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFD 269 (359)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE-C--CEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh-ccccCCCceeEChhhhcC
Confidence 35668999999999999 89999999999999999999999999999987644332211 122568999999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT 253 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
..++.++|||||||++|||++ |..||..... ...... .......... +......+.
T Consensus 270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~----~~~~~~~~~~---------------~~~~~~~l~ 326 (359)
T 3vhe_A 270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCR----RLKEGTRMRA---------------PDYTTPEMY 326 (359)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHHHH----HHHHTCCCCC---------------CTTCCHHHH
T ss_pred CCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHHHH----HHHcCCCCCC---------------CCCCCHHHH
Confidence 899999999999999999998 9999865331 111111 1111110000 111223478
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 254 ELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 254 ~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+++.+||+.||++|||+.||++.|+++.++|
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=277.08 Aligned_cols=200 Identities=20% Similarity=0.313 Sum_probs=148.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcc----eEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRP----ISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ ++.. ||+|.+...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 5678888999999999999998 5554 588876432
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 00 11456789999999999999 8999999999999999999999999999998775443
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ...+...+. .....
T Consensus 172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~----~~~~~--- 238 (327)
T 3poz_A 172 KEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE----KGERL--- 238 (327)
T ss_dssp C--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH----TTCCC---
T ss_pred cccc-ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-----HHHHHHHHH----cCCCC---
Confidence 2221 112456889999999999999999999999999999999 999986432 112222111 11000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+..+...+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 239 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 ------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011223347899999999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=267.89 Aligned_cols=200 Identities=20% Similarity=0.307 Sum_probs=156.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FP-- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~-- 91 (284)
++|...+.||+|+||+||+|.+ ++..||+|++... +|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 4677778999999999999999 8889999998754 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-- 164 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-- 164 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST--
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccc--
Confidence 11456789999999999999 99999999999999999999999999999987654322211
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.... ............. ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~~---~~~----- 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR---LYK----- 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC---CCC-----
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCcc---CCC-----
Confidence 22557888999999998899999999999999999999 888886432 1122222111100 000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 229 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 --------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011123478999999999999999999999999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=275.36 Aligned_cols=190 Identities=22% Similarity=0.299 Sum_probs=149.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788889999999999999998 8999999998643
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 1211 456789999999999999 999999999999999999999999999999876544322
Q ss_pred ccCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....||+.|+|||++.+..++ .++||||+||++|+|++|..||.... ......... .+...
T Consensus 171 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~-~~~~~----- 232 (328)
T 3fe3_A 171 ----DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVL-RGKYR----- 232 (328)
T ss_dssp ----GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCC-----
T ss_pred ----ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hCCCC-----
Confidence 226799999999999888765 79999999999999999999996532 122222211 11110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 233 -----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 -----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00112234789999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=271.64 Aligned_cols=200 Identities=21% Similarity=0.329 Sum_probs=150.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcc----eEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRP----ISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ ++.. ||+|.+...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 4577778999999999999998 5555 777776432
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ....+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 111 0457789999999999999 8999999999999999999999999999998875443
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .......+. ......
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~----~~~~~~-- 237 (325)
T 3kex_A 170 KQLL-YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLE----KGERLA-- 237 (325)
T ss_dssp TCCC------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHH----TTCBCC--
T ss_pred cccc-ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHH----cCCCCC--
Confidence 2211 122567889999999998899999999999999999999 999986532 111222111 111000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+. .++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 238 ~~~-------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 QPQ-------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCT-------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCC-------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 011126789999999999999999999999998864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.95 Aligned_cols=195 Identities=21% Similarity=0.269 Sum_probs=145.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 36788889999999999999998 7889999998643
Q ss_pred ---CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 1111 456679999999999999 9999999999999999999999999999997643222
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||...........................
T Consensus 208 ~~---~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 280 (396)
T 4dc2_A 208 DT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 280 (396)
T ss_dssp CC---BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----
T ss_pred Cc---cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----
Confidence 11 22368999999999999999999999999999999999999999654321211111111111111111110
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+ +......+.+|+.+||+.||++||++
T Consensus 281 ----------~--p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 ----------I--PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----------C--CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----------C--CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 01122347899999999999999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=279.84 Aligned_cols=202 Identities=19% Similarity=0.299 Sum_probs=142.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ .+..||||++...
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 4688899999999999999987 3667999998643
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 111 1457789999999999999 8999999999999999999999999999998775443
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
..........+|+.|+|||++.+..++.++|||||||++||+++ |..||.... ......... .+...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~-~~~~~--- 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVD-EGYRL--- 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHH-TTEEC---
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH-cCCCC---
Confidence 22222222345788999999998899999999999999999998 999986432 111111111 11000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 270 ------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 ------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00112334588999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=266.31 Aligned_cols=200 Identities=18% Similarity=0.250 Sum_probs=155.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FP-- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~-- 91 (284)
++|...+.||+|+||.||+|.+ ++..||+|++... +|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 5677788999999999999998 6668999998754 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
....+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++............
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~- 163 (268)
T 3sxs_A 88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV- 163 (268)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC-
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc-
Confidence 11566789999999999999 899999999999999999999999999999877554433222
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......... .. ....+
T Consensus 164 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~-~~--~~~~~---- 227 (268)
T 3sxs_A 164 -GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQ-GH--RLYRP---- 227 (268)
T ss_dssp -SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHT-TC--CCCCC----
T ss_pred -CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHc-CC--CCCCC----
Confidence 2456788999999988889999999999999999999 888886432 1111111111 11 00000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
...+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 228 ---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 ---------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11123478999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=287.88 Aligned_cols=204 Identities=21% Similarity=0.339 Sum_probs=157.6
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------
Q 039895 50 LKTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 50 l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------------------------------- 89 (284)
+....++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e 262 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 262 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence 344456677788999999999999999 6788999998754
Q ss_pred CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. ...+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 1111 356679999999999999 89999999999999999999999999999987654322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. .....+|+.|+|||++....++.++|||||||++|||++ |..||.... ..............
T Consensus 340 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~~~----- 404 (454)
T 1qcf_A 340 TA--REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRM----- 404 (454)
T ss_dssp HT--TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHTCCC-----
T ss_pred ec--cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC-----
Confidence 11 112456789999999998899999999999999999999 998886432 11111111111000
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+..++..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 405 -----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 -----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1112234458899999999999999999999999998864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=270.37 Aligned_cols=204 Identities=18% Similarity=0.293 Sum_probs=151.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4677788999999999999998 7899999987432
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 111 1567789999999999999 999999999999999999999999999999876543322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......... ....... ..
T Consensus 168 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~-~~~~~~~-~~ 235 (294)
T 4eqm_A 168 QT--NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQ-DSVPNVT-TD 235 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHS-SCCCCHH-HH
T ss_pred cc--CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhh-ccCCCcc-hh
Confidence 21 22579999999999999999999999999999999999999996532 1111111111 1111100 00
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHhc
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-TIVQVAKQLRQIYQS 283 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~ev~~~L~~l~~~ 283 (284)
.....+..+.+++.+||+.||++|| ++.++.+.|+.+..+
T Consensus 236 ----------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 ----------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ----------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ----------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0112234588999999999999999 999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=277.32 Aligned_cols=200 Identities=21% Similarity=0.279 Sum_probs=152.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe---------CCcceEEEeecCC------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL---------QDRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~------------------------------------ 89 (284)
++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 4667778899999999999986 2346999998653
Q ss_pred -------CCC-------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -------FPF-------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -------~~~-------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|. ....+.++.||+.||.||| +.+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence 111 1234678999999999999 99999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~ 210 (284)
.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-----~ 311 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 311 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCT-TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----G
T ss_pred CCCCEEEccccCCcccCcccceec-ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----H
Confidence 999999999999987654332211 122457889999999999999999999999999999999 888886432 1
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
..+...+ ..+.... .+..++..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 312 ~~~~~~~----~~~~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 312 EELFKLL----KEGHRMD---------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GGHHHHH----HTTCCCC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHH----hcCCCCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122111 1111000 011233458899999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=284.08 Aligned_cols=197 Identities=23% Similarity=0.292 Sum_probs=154.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------------CC--
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------------------------FP-- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------------------------~~-- 91 (284)
.++|...+.||+|+||.||+|.+.|+.||||++... +|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 356777889999999999999999999999999764 11
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
....++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 344 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 344 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc----
Confidence 11456789999999999999 99999999999999999999999999999976533221
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
...+++.|+|||++.+..++.++|||||||++|||++ |..||.... .......+ ..+..
T Consensus 345 --~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i----~~~~~--------- 404 (450)
T 1k9a_A 345 --TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRV----EKGYK--------- 404 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-----TTTHHHHH----HTTCC---------
T ss_pred --CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----HcCCC---------
Confidence 1356889999999999999999999999999999998 998886433 11121111 11100
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+.+..++..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 405 ------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 ------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 011122344588999999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.27 Aligned_cols=204 Identities=23% Similarity=0.373 Sum_probs=145.5
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------------------------CCC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------FPF 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------~~~ 92 (284)
+.|...+.||+|+||+||+|.+.+ .||+|++... +|.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~ 102 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCE 102 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecC
Confidence 568888899999999999999855 4999998643 111
Q ss_pred c----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 93 S----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 93 ~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
. ...+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~ 178 (289)
T 3og7_A 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH-Q 178 (289)
T ss_dssp EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccc-c
Confidence 0 456789999999999999 8999999999999999999999999999997654322111 1
Q ss_pred CCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++. ...++.++||||||+++|+|++|..||.... ....... .............
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~----~~~~~~~~~~~~~- 249 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIE----MVGRGSLSPDLSK- 249 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHHHHHH----HHHHTSCCCCTTS-
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHHHHHH----HhcccccCcchhh-
Confidence 12256899999999986 5678899999999999999999999986432 1111111 1111111111000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
....++..+.+|+.+||+.+|++|||+.++++.|+++.+
T Consensus 250 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 ----------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011223458899999999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=268.23 Aligned_cols=200 Identities=21% Similarity=0.339 Sum_probs=148.0
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC-------------------------------------CCC-----
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------FPF----- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------~~~----- 92 (284)
++|...+.||+|+||.||+|.+.++.||+|++... +|.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLY 87 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHH
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHH
Confidence 46777889999999999999999999999998654 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc-ceeeccccccccCCCCccccCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV-AQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
....+.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++........
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~------ 161 (307)
T 2eva_A 88 NVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT------ 161 (307)
T ss_dssp HHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------
T ss_pred HHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc------
Confidence 1456788999999999999322289999999999999998886 79999999976543221
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... ........... .......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~~--------- 225 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVH-NGTRPPL--------- 225 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHH-TTCCCCC---------
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHh-cCCCCCc---------
Confidence 1468999999999999899999999999999999999999986432 11111111111 1111110
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
....+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 226 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 ------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11122347899999999999999999999999998864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=266.46 Aligned_cols=196 Identities=25% Similarity=0.365 Sum_probs=150.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ +++.||+|++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 6788888999999999999999 7899999998432
Q ss_pred ---CCC----------------chhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEecCCc-----ceeecccc
Q 039895 90 ---FPF----------------SVSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQEENV-----AQLFDFTL 143 (284)
Q Consensus 90 ---~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~-----~kl~Dfg~ 143 (284)
+|. ...++.++.|++.||.||| +.+ |+||||||+|||++.++. +||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 111 1556789999999999999 888 999999999999988776 99999999
Q ss_pred ccccCCCCccccCCCCcccCcccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRT--TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI 221 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
++....... ...||+.|+|||++. ...++.++|||||||++|+|++|..||.... ...........
T Consensus 176 ~~~~~~~~~------~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~ 243 (287)
T 4f0f_A 176 SQQSVHSVS------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFINMIR 243 (287)
T ss_dssp CBCCSSCEE------CCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHHHHHH
T ss_pred ccccccccc------ccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHHHHHh
Confidence 975543221 257899999999983 4567899999999999999999999996433 11111111111
Q ss_pred hcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 222 ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
.... .... +...+..+.+++.+||+.||++|||+.|+++.|++|
T Consensus 244 ~~~~-~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGL-RPTI--------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCC-CCCC--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCC-CCCC--------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 1111 112234488999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=278.18 Aligned_cols=155 Identities=23% Similarity=0.245 Sum_probs=131.6
Q ss_pred CCCcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------
Q 039895 39 HNPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------- 89 (284)
Q Consensus 39 ~~~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------- 89 (284)
......+++.+.....++|...+.||+|+||+||+|.. +++.||||++...
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34555667777777778999999999999999999999 8899999998643
Q ss_pred ------------------CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---
Q 039895 90 ------------------FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE--- 132 (284)
Q Consensus 90 ------------------~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~--- 132 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred ecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence 11 11456789999999999999 999999999999999975
Q ss_pred ----------------------CCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHH
Q 039895 133 ----------------------ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALL 190 (284)
Q Consensus 133 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il 190 (284)
++.+||+|||++........ ...||+.|+|||++.+..++.++|||||||++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG------SIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC------SCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCCc------CccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 78899999999976543222 25789999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 039895 191 LELLTGKKISYS 202 (284)
Q Consensus 191 ~elltg~~p~~~ 202 (284)
|+|++|..||..
T Consensus 250 ~ell~g~~pf~~ 261 (360)
T 3llt_A 250 AELYTGSLLFRT 261 (360)
T ss_dssp HHHHHSSCSCCC
T ss_pred HHHHHCCCCCCC
Confidence 999999999965
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=270.52 Aligned_cols=191 Identities=23% Similarity=0.291 Sum_probs=149.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 6788889999999999999998 7899999998542
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 111 1456678999999999999 899999999999999999999999999999764332211
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ....
T Consensus 162 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~-~~~~------ 223 (337)
T 1o6l_A 162 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM-EEIR------ 223 (337)
T ss_dssp ---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCC------
T ss_pred ---ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHc-CCCC------
Confidence 123679999999999999999999999999999999999999996432 1111211111 1100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
+ +...+..+.+|+.+||+.||++|| ++.|+++.
T Consensus 224 ~----------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 F----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 011223478999999999999999 89998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=275.51 Aligned_cols=189 Identities=17% Similarity=0.220 Sum_probs=148.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.+ +++.||+|++...
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788889999999999999998 8899999988532
Q ss_pred -CCC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 -FPF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 -~~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 89 E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~- 164 (336)
T 3h4j_B 89 EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL- 164 (336)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT-
T ss_pred ECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc-
Confidence 111 1567789999999999999 899999999999999999999999999999876544322
Q ss_pred cCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... +....
T Consensus 165 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------------~~~~i 220 (336)
T 3h4j_B 165 ---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------------LFKKV 220 (336)
T ss_dssp ---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------------CBCCC
T ss_pred ---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------------HHHHH
Confidence 22579999999999988776 689999999999999999999997533110 00000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... +..+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 221 ~~~~----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSCV----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSC----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcCC----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000 0011122344789999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.15 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=143.7
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC---------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+.|..||||++...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 56777889999999999999999999999997543
Q ss_pred CCC--------------chhHHHHHHHHHHHHHHhccCCCCC---eeecccccCcEEEec--------CCcceeeccccc
Q 039895 90 FPF--------------SVSKLKIAIEIASAVAYLHVGFSRP---VVSRDIKPTTIVLQE--------ENVAQLFDFTLS 144 (284)
Q Consensus 90 ~~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~---ivHrDlkp~NILl~~--------~~~~kl~Dfg~a 144 (284)
+|. ......++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||++
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 87 FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp CCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred cCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 111 1557789999999999999 777 999999999999986 678999999999
Q ss_pred cccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
......... ...||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...........
T Consensus 164 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~- 229 (271)
T 3dtc_A 164 REWHRTTKM-----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAMN- 229 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHTS-
T ss_pred ccccccccc-----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhcC-
Confidence 766543221 2568999999999998889999999999999999999999986432 11111111111
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
..... .+...+..+.+++.+||+.||++|||+.|+++.|++|
T Consensus 230 ~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLALP--------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCC--------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCC--------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11000 0112234488999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=270.71 Aligned_cols=227 Identities=19% Similarity=0.287 Sum_probs=164.5
Q ss_pred eecHHHHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------
Q 039895 44 SFSADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---------------------------------- 89 (284)
..++.--....++|...+.||+|+||.||+|.++|+.||||++...
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3344444455678999999999999999999999999999998644
Q ss_pred ----------CCC--------------chhHHHHHHHHHHHHHHhccCC-----CCCeeecccccCcEEEecCCcceeec
Q 039895 90 ----------FPF--------------SVSKLKIAIEIASAVAYLHVGF-----SRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 ----------~~~--------------~~~~~~i~~~i~~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
+|. ...++.++.|++.||.|||... +.+|+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 111 0456789999999999999321 47899999999999999999999999
Q ss_pred cccccccCCCCccc-cCCCCcccCccccccccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCC
Q 039895 141 FTLSLSIPEGETHI-NDSNRVIGTFGFMAPEYRTTG------DFSEKSDVYSFGALLLELLTG----------KKISYSS 203 (284)
Q Consensus 141 fg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~G~il~elltg----------~~p~~~~ 203 (284)
||++.......... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99998765443221 112235799999999998765 234789999999999999999 5666543
Q ss_pred CCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
... ......+..... .......+... .....+...+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 271 ~~~---~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 271 VPS---DPSVEEMRKVVC-EQKLRPNIPNR---------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SCS---SCCHHHHHHHHT-TSCCCCCCCGG---------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcC---cccHHHHHHHHH-HHHhCCCCccc---------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 211 111222222211 11111111000 01235666789999999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=270.24 Aligned_cols=211 Identities=15% Similarity=0.199 Sum_probs=150.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC-------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------------------------------------------- 89 (284)
.+.|...+.||+|+||+||+|.+ +|+.||+|++...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788889999999999999999 8899999998643
Q ss_pred CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+| .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 100 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 100 FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp CCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 11 11456789999999999999 9999999999999999999999999999998765332221
Q ss_pred cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---ccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES---FKEIV 230 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (284)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... . ......+........ +....
T Consensus 177 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~-~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 177 ---THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT----D-DDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----T-TTHHHHHHHHHCCCCTTTSGGGT
T ss_pred ---cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC----h-HHHHHHHHHHHCCCChHHhhhhh
Confidence 12568999999999876 468999999999999999999999997533 1 112222222111111 11100
Q ss_pred c------ccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 D------PAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~------~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ ..........+ .........+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00000000000 001122345789999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.28 Aligned_cols=194 Identities=22% Similarity=0.289 Sum_probs=150.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46788889999999999999999 7899999998643
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC----cceeecccccc
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN----VAQLFDFTLSL 145 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg~a~ 145 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 111 1567789999999999999 89999999999999998777 79999999998
Q ss_pred ccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
........ ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... ...
T Consensus 168 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~-~~~ 234 (361)
T 2yab_A 168 EIEDGVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANIT-AVS 234 (361)
T ss_dssp ECCTTCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHH-TTC
T ss_pred EcCCCCcc----ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hcC
Confidence 77553321 22579999999999998899999999999999999999999996532 111111111 111
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.. +++ +.....+..+.+|+.+||..||++|||+.|+++
T Consensus 235 ~~--~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDE----------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCc----------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000 001122345789999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.66 Aligned_cols=204 Identities=20% Similarity=0.270 Sum_probs=154.1
Q ss_pred HhcCCCCCC-eeeecCCceEEEEEe----CCcceEEEeecCC--------------------------------------
Q 039895 53 ATDDFDGGK-VIMKCLFYKLYKGFL----QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-------------------------------------- 89 (284)
..+.|.... .||+|+||+||+|.+ .+..||||++...
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 345566666 899999999999965 4678999998653
Q ss_pred ----CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ----FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ----~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+| .....+.++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 11 11457789999999999999 899999999999999999999999999999877554
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ..... ...........
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~-~~~~~~~~~~~ 241 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVT-AMLEKGERMGC 241 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTCCCCC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHH-HHHHcCCCCCC
Confidence 433222222456789999999988889999999999999999999 999986432 11111 11111111100
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+...+..+.+++.+||+.||++|||+.++++.|++++.+
T Consensus 242 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 242 ---------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ---------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 112234488999999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=265.46 Aligned_cols=211 Identities=12% Similarity=0.157 Sum_probs=150.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +++.||+|++...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4677788999999999999999 7899999998643
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 111 1456789999999999999 899999999999999999999999999999876533221
Q ss_pred cCCCCcccCccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---cccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEIV 230 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 230 (284)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.... ........+....... .+....
T Consensus 158 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 12257899999999987765 8999999999999999999998875432 1111111111111111 011100
Q ss_pred c---c---cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 D---P---AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~---~---~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. . ...................+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 0000000000111223445789999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=268.51 Aligned_cols=201 Identities=21% Similarity=0.292 Sum_probs=143.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC---------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~--------------------------------------- 89 (284)
.+.|...+.||+|+||.||+|.+ .+..||+|++...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 35677788999999999999998 2346999997643
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ....+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 111 1456788999999999999 8999999999999999999999999999998765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... ....+|+.|+|||++....++.++|||||||++|||++ |..||.... .......+. ......
T Consensus 171 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-----~~~~~~~i~----~~~~~~-- 237 (281)
T 1mp8_A 171 YYKA--SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRIE----NGERLP-- 237 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH----TTCCCC--
T ss_pred cccc--ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-----HHHHHHHHH----cCCCCC--
Confidence 2221 12456789999999988899999999999999999997 888886432 111211111 111000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 238 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 -------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0112234578999999999999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=267.77 Aligned_cols=215 Identities=15% Similarity=0.210 Sum_probs=157.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 4577788999999999999999 6899999998643
Q ss_pred -CC------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE----ecCCcceeeccccccc
Q 039895 90 -FP------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL----QEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 -~~------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfg~a~~ 146 (284)
+| .......++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 11 11456789999999999999 9999999999999999 7778899999999987
Q ss_pred cCCCCccccCCCCcccCcccccccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRT--------TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
........ ...||+.|+|||++. +..++.++|||||||++|||++|..||....... .......
T Consensus 166 ~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~ 237 (319)
T 4euu_A 166 LEDDEQFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMY 237 (319)
T ss_dssp CCTTCCBC----CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG----GCHHHHH
T ss_pred cCCCCcee----ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc----hhHHHHH
Confidence 75543221 256899999999875 5678999999999999999999999997533111 1112222
Q ss_pred HHhhcC---ccccccc---ccc--cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 219 KYIENE---SFKEIVD---PAI--VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 219 ~~~~~~---~~~~~~~---~~~--~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
...... .+..+.. ..+ .................+.+++.+||+.||++|||+.|+++...+-
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 222111 1111000 000 0011111123456677789999999999999999999999987753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=282.75 Aligned_cols=196 Identities=19% Similarity=0.274 Sum_probs=148.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.. +|..+|+|++...
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456788889999999999999998 8899999998654
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe---cCCcceeeccccccccCC
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 221 1556789999999999999 99999999999999998 457899999999987654
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
..... ....||+.|+|||++.+..++.++||||+||++|+|++|..||.... . ........ .+... .
T Consensus 166 ~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~---~~~~~~i~-~~~~~-~ 232 (444)
T 3soa_A 166 EQQAW---FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----Q---HRLYQQIK-AGAYD-F 232 (444)
T ss_dssp TCCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H---HHHHHHHH-HTCCC-C
T ss_pred CCcee---ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----H---HHHHHHHH-hCCCC-C
Confidence 33221 22579999999999999899999999999999999999999996432 1 11111111 11110 0
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.. +.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PS-----------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CT-----------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Cc-----------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 001122344789999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=279.97 Aligned_cols=209 Identities=16% Similarity=0.195 Sum_probs=147.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788889999999999999998 7899999998643
Q ss_pred -------CCC------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -------FPF------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -------~~~------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 000 0456679999999999999 899999999999999999999999999999876543
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh--------
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE-------- 222 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (284)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+...+.....
T Consensus 218 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~----~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 218 FMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp CCC--------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccc----CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHHHHHH
Confidence 221 22679999999999999999999999999999999999999996532 11111111111000
Q ss_pred ----------cC------cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 223 ----------NE------SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 223 ----------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.. .+...+...+.. ............+.+|+.+||+.||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFP---ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSC---CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccc---cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000000 0001122335668999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.30 Aligned_cols=200 Identities=20% Similarity=0.308 Sum_probs=145.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcce----EEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPI----SVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~v----avK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ ++..+ |+|.+...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 5688889999999999999998 56655 66766432
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
++ .....+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 00 01456789999999999999 8999999999999999999999999999998765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ...+...+. .....
T Consensus 172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~----~~~~~--- 238 (327)
T 3lzb_A 172 KEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE----KGERL--- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH----TTCCC---
T ss_pred cccc-ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHH----cCCCC---
Confidence 2211 112456889999999999999999999999999999999 999986432 112222111 11100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 239 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 ------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0011223347899999999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=268.52 Aligned_cols=211 Identities=16% Similarity=0.172 Sum_probs=151.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..+.|...+.||+|+||+||+|.+ +++.||||++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999997 8899999998521
Q ss_pred -------------C----------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeec
Q 039895 90 -------------F----------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 -------------~----------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
+ ........++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence 0 111456789999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+...
T Consensus 164 fg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~ 234 (308)
T 3g33_A 164 FGLARIYSYQMAL----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIFDL 234 (308)
T ss_dssp CSCTTTSTTCCCS----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHHHHHHHH
T ss_pred CccccccCCCccc----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHH
Confidence 9999876543322 12578999999999999999999999999999999999999986532 11111111111
Q ss_pred hhcC---ccccccc---ccccCCCCC-CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 221 IENE---SFKEIVD---PAIVGEEGL-MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 221 ~~~~---~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... .+..... ......... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111 1111000 000000000 00001123345789999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=265.92 Aligned_cols=201 Identities=18% Similarity=0.269 Sum_probs=152.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPF 92 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~ 92 (284)
.++|...+.||+|+||+||+|.+ ++..||+|++... +|.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 35677778999999999999999 6678999998754 111
Q ss_pred ----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 93 ----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 93 ----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-- 177 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-- 177 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS--
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccccc--
Confidence 1567789999999999999 9999999999999999999999999999998765432221
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ......... ... . ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~-~~~-~-~~~---- 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIA-QGL-R-LYR---- 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHH-TTC-C-CCC----
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHh-ccc-C-CCC----
Confidence 122457888999999998889999999999999999998 998886432 111111111 110 0 000
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+......+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 243 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 ---------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 011123478999999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=271.41 Aligned_cols=209 Identities=21% Similarity=0.226 Sum_probs=155.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~--------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.+ +++.||+|++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3467778999999999999983 6889999998643
Q ss_pred -----CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 -----FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 -----~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 111 0456789999999999999 9999999999999999999999999999998876
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------CCCccccHHHHHHHHh
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF-------DDGEDYRLQDLVKKYI 221 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 221 (284)
.............||..|+|||++.+..++.++||||||+++|+|++|..|+..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL- 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH-
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH-
Confidence 554333333336788899999999888899999999999999999999988642110 000001111111111
Q ss_pred hcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 222 ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.... ..+.+...+..+.+|+.+||+.||++|||+.++++.|+++++
T Consensus 257 ~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 257 KEGK---------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HTTC---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred hccC---------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 1100 001112233458899999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=278.22 Aligned_cols=198 Identities=20% Similarity=0.262 Sum_probs=143.7
Q ss_pred cCCCCC-CeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 55 DDFDGG-KVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
++|... ++||+|+||+||+|.. +|+.||||++... +
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 445443 6899999999999998 7889999998643 1
Q ss_pred CC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeeccccccccCCC
Q 039895 91 PF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 91 ~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~~~~ 150 (284)
|. +.....++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 11 1456789999999999999 899999999999999997 788999999999876533
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... ....||+.|+|||++.+..++.++|||||||++|||++|..||......... ......+.. +.+. ..
T Consensus 218 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~----~~~~-~~ 287 (400)
T 1nxk_A 218 NSL----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRM----GQYE-FP 287 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHH----TCCC-CC
T ss_pred Ccc----ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHc----Cccc-CC
Confidence 221 2267899999999999999999999999999999999999999754321111 111111111 1100 00
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. +........+.+|+.+||+.||++|||+.|+++.
T Consensus 288 ~-----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 N-----------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T-----------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C-----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0011223447899999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.33 Aligned_cols=194 Identities=15% Similarity=0.220 Sum_probs=151.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
.+.|...+.||+|+||.||+|.. ++..||+|++... +|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 46788889999999999999999 7889999998644 22
Q ss_pred C----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec--CCcceeeccccccccCCCCcc
Q 039895 92 F----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE--ENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
. +.....++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++.........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 1 1567789999999999999 999999999999999987 789999999999887554332
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ...||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........... .... +
T Consensus 161 ~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~-~~~~--~-- 223 (321)
T 1tki_A 161 R----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNA-EYTF--D-- 223 (321)
T ss_dssp E----EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT-CCCC--C--
T ss_pred c----cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcC-CCCC--C--
Confidence 2 1568999999999998889999999999999999999999996532 11222221111 1000 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 224 --------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 --------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001122345889999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=276.07 Aligned_cols=196 Identities=20% Similarity=0.299 Sum_probs=150.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456788899999999999999998 7899999998643
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeeccccccccCC
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfg~a~~~~~ 149 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 111 1566789999999999999 89999999999999998654 599999999987754
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... . ........ .+....
T Consensus 184 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~---~~~~~~i~-~~~~~~- 249 (362)
T 2bdw_A 184 SEAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----Q---HRLYAQIK-AGAYDY- 249 (362)
T ss_dssp CCSC----CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHH-HTCCCC-
T ss_pred Cccc----ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHH-hCCCCC-
Confidence 3321 22579999999999999899999999999999999999999986432 1 11111111 111100
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. .+.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 P-----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C-----------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C-----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00111223457899999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=277.80 Aligned_cols=200 Identities=20% Similarity=0.276 Sum_probs=150.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 5677788999999999999995 4568999998643
Q ss_pred ----CCCc----------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeec
Q 039895 90 ----FPFS----------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFD 140 (284)
Q Consensus 90 ----~~~~----------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 140 (284)
+|.. ...+.++.||+.||.||| +.+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 1111 346679999999999999 99999999999999999555 599999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHH
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKK 219 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 219 (284)
||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.... .......
T Consensus 228 FG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~ 298 (367)
T 3l9p_A 228 FGMARDIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF 298 (367)
T ss_dssp CHHHHHHHHHSSCT-TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred Cccccccccccccc-cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH
Confidence 99997653222111 1122567899999999988899999999999999999998 888886432 1122221
Q ss_pred HhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 220 YIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.. .+.... .+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus 299 i~-~~~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VT-SGGRMD---------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HH-TTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-cCCCCC---------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11 111000 011223347899999999999999999999999998875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.85 Aligned_cols=194 Identities=17% Similarity=0.199 Sum_probs=151.2
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC---------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+.+..||||++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 56777889999999999999999999999998643
Q ss_pred CC-----------------CchhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+| ....++.++.|++.||.||| +.+ |+||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 11 11567889999999999999 888 999999999999999999999999887543221
Q ss_pred CccccCCCCcccCccccccccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSE---KSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK 227 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
...||+.|+|||++.+..++. ++|||||||++|||++|..||.... ...............
T Consensus 167 --------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 167 --------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGLRP 230 (271)
T ss_dssp --------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSCCCC
T ss_pred --------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcCCCC
Confidence 146899999999988765544 7999999999999999999986432 111111111111111
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 228 EIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
. . +...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 231 ~-~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 T-I--------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C-C--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C-C--------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 0 11123348899999999999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.37 Aligned_cols=190 Identities=21% Similarity=0.254 Sum_probs=145.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999998 7899999998642
Q ss_pred ---CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 1211 456679999999999999 8999999999999999999999999999997643322
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-cccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-SFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (284)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ............ .++
T Consensus 179 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~p--- 244 (353)
T 3txo_A 179 VT---TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVYP--- 244 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC---
T ss_pred cc---ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCC---
Confidence 11 122679999999999988889999999999999999999999997532 122222221111 011
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI------VQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~------~ev~~ 275 (284)
......+.+|+.+||+.||++||++ .|+++
T Consensus 245 ---------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 ---------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122347899999999999999998 66654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.86 Aligned_cols=203 Identities=18% Similarity=0.290 Sum_probs=153.4
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------
Q 039895 48 DELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 48 ~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------ 89 (284)
.++....++|...+.||+|+||+||+|.. +++.||+|++...
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34444567899999999999999999999 7889999998542
Q ss_pred --------CCCc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 --------FPFS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 --------~~~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 2211 456779999999999999 999999999999999999999999999999877
Q ss_pred CCCCccccCCCCcccCccccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGD----FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
........ ....||+.|+|||++.... ++.++|||||||++|||++|..||.... ...........
T Consensus 219 ~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~ 288 (410)
T 3v8s_A 219 NKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMNH 288 (410)
T ss_dssp CTTSEEEC--CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTH
T ss_pred ccCCcccc--cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHHHHhc
Confidence 55433222 2368999999999987665 7899999999999999999999997532 11112211111
Q ss_pred CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 039895 224 ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAKQ 276 (284)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~~ 276 (284)
..... +|.....+..+.+|+.+||..+|.+ ||++.||+++
T Consensus 289 ~~~~~-------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 KNSLT-------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHCC-------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccc-------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000 0001112234789999999999988 9999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=275.78 Aligned_cols=148 Identities=26% Similarity=0.327 Sum_probs=114.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457888889999999999999998 7899999988543
Q ss_pred -----CCCc-------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -----FPFS-------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -----~~~~-------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. ..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 1110 456678999999999999 9999999999999999999999999999998764311
Q ss_pred cc------------------ccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 152 TH------------------INDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 152 ~~------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 10 111123579999999999876 57899999999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=264.06 Aligned_cols=210 Identities=20% Similarity=0.265 Sum_probs=146.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC-------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------------------------------------------~ 90 (284)
++|...+.||+|+||+||+|.. +|+.||+|++... +
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4577778999999999999999 7899999998543 1
Q ss_pred C---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 P---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
| .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 1 01456789999999999999 899999999999999999999999999999876432211
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccccc--
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEI-- 229 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 229 (284)
.....||+.|+|||++.+. .++.++|||||||++|||++|..||.... .......+....... .++..
T Consensus 157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHCCCChhhchhhhc
Confidence 1124689999999998764 58999999999999999999999986432 111111111111111 01110
Q ss_pred ---ccccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 ---VDPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ---~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.++.........+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100000000 01122345789999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=286.77 Aligned_cols=200 Identities=22% Similarity=0.319 Sum_probs=154.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
..+|...+.||+|+||.||+|.+ .+..||||++... +|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 34566678899999999999999 5889999998754 11
Q ss_pred C-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 92 F-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 ~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
. ...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 1 0456788999999999999 9999999999999999999999999999998775433222
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ....+|+.|+|||++....++.++|||||||++|||++ |..||.... .......+. .+..
T Consensus 376 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~~------- 437 (495)
T 1opk_A 376 H--AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE----KDYR------- 437 (495)
T ss_dssp C--TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHH----TTCC-------
T ss_pred c--CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----cCCC-------
Confidence 1 12456789999999998899999999999999999999 888886432 112222111 1100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus 438 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 --------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred --------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 00112233458899999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.47 Aligned_cols=203 Identities=21% Similarity=0.325 Sum_probs=143.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCc---ceEEEeecCC--------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDR---PISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~-------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.+ ++. .||||++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456788889999999999999998 332 7999998643
Q ss_pred -----------CC---------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcce
Q 039895 90 -----------FP---------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ 137 (284)
Q Consensus 90 -----------~~---------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 137 (284)
+| ....+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 01 00346789999999999999 89999999999999999999999
Q ss_pred eeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHH
Q 039895 138 LFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDL 216 (284)
Q Consensus 138 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 216 (284)
|+|||++........... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... .......
T Consensus 178 l~Dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQ-GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIYNY 251 (323)
T ss_dssp ECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHH
T ss_pred Eeeccccccccccccccc-cccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hHHHHHH
Confidence 999999987654432211 112456889999999998899999999999999999999 888886432 1111111
Q ss_pred HHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+ ..... .. .+...+..+.+++.+||+.||++|||+.++++.|+++++.
T Consensus 252 ~---~~~~~-~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 252 L---IGGNR-LK---------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp H---HTTCC-CC---------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H---hcCCC-CC---------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1 11110 00 0112234488999999999999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=261.92 Aligned_cols=201 Identities=20% Similarity=0.305 Sum_probs=155.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FP-- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~-- 91 (284)
++|...+.||+|+||.||+|.+ ++..||+|++... +|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 4577778999999999999999 7889999998754 11
Q ss_pred --------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 --------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 --------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......... .
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~ 162 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--S 162 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS--T
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccc--c
Confidence 11456789999999999999 9999999999999999999999999999998764432211 1
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......... +. ... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~-~~-~~~-~----- 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDIST-GF-RLY-K----- 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHT-TC-CCC-C-----
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhc-CC-cCC-C-----
Confidence 22457889999999988889999999999999999999 888876432 1122211111 10 000 0
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+...+..+.+++.+||+.||++|||+.++++.|+++.+++
T Consensus 227 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 227 --------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0111234789999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=282.53 Aligned_cols=202 Identities=23% Similarity=0.305 Sum_probs=150.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF 92 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~ 92 (284)
..++|...+.||+|+||.||+|.+ .+..||||++... +|.
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 345566778899999999999999 5567999998754 111
Q ss_pred -----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 93 -----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 93 -----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 1456789999999999999 99999999999999999999999999999987654322211
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
....+|+.|+|||++....++.++|||||||++|||++ |..||.... ........ ..+..
T Consensus 339 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i-~~~~~-------- 399 (452)
T 1fmk_A 339 --QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQV-ERGYR-------- 399 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHH-HTTCC--------
T ss_pred --cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HcCCC--------
Confidence 12456889999999988899999999999999999999 888886432 11111111 11100
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+.+..++..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 400 -------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 011122344588999999999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.67 Aligned_cols=194 Identities=21% Similarity=0.283 Sum_probs=144.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688889999999999999998 6899999998643
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 111 1456779999999999999 99999999999999999999999999999976432221
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||...........................
T Consensus 166 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 237 (345)
T 3a8x_A 166 T---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 237 (345)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred c---ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence 1 12367999999999999999999999999999999999999999653311111111111111111111110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 270 (284)
+ +......+.+|+.+||+.||++||++
T Consensus 238 -~----------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -I----------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -C----------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -C----------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0 01122347899999999999999996
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=273.93 Aligned_cols=200 Identities=22% Similarity=0.276 Sum_probs=154.2
Q ss_pred cCCCCCCeeeecCCceEEEEEeC---------CcceEEEeecCC------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQ---------DRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~------------------------------------ 89 (284)
+.|...+.||+|+||+||+|.+. +..||||++...
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 56777789999999999999972 246999998654
Q ss_pred -------CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -------FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -------~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence 11 12356789999999999999 89999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~ 210 (284)
.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------ 298 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 298 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTC-CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred CCCcEEEcccCcccccccccccc-cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence 99999999999998775433221 1122467889999999999999999999999999999999 888886432
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
......... ....... +..++..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 299 --~~~~~~~~~-~~~~~~~---------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 299 --VEELFKLLK-EGHRMDK---------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HHHHHHHHH-TTCCCCC---------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHH-cCCCCCC---------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 122222211 1111000 11123348899999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.04 Aligned_cols=187 Identities=21% Similarity=0.300 Sum_probs=148.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +|+.||+|++...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5788889999999999999998 7899999998542
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-- 160 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence 2211 456678999999999999 9999999999999999999999999999998764322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....||+.|+|||++.+..++.++|||||||++|||++|..||.... ........... ...
T Consensus 161 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~-~~~------ 221 (318)
T 1fot_A 161 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNA-ELR------ 221 (318)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHC-CCC------
T ss_pred ----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCC------
Confidence 12679999999999999999999999999999999999999996532 11222222111 100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+ +......+.+++.+||+.||++|| ++.|+++
T Consensus 222 ~----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 F----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 011123478999999999999999 8888874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.66 Aligned_cols=201 Identities=21% Similarity=0.332 Sum_probs=151.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEeC-----CcceEEEeecCC---------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQ-----DRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~--------------------------------------- 89 (284)
.++|...+.||+|+||.||+|.+. +..||+|++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 467888899999999999999972 235999998753
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 111 1456788999999999999 9999999999999999999999999999998765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+.. .....
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~~---~~~~~--- 234 (281)
T 3cc6_A 168 YYKA--SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLEK---GDRLP--- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHHH---TCCCC---
T ss_pred cccc--ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHhc---CCCCC---
Confidence 2221 12457889999999988899999999999999999998 999986432 1122222111 10000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 235 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 -------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0111223478999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=267.23 Aligned_cols=204 Identities=18% Similarity=0.326 Sum_probs=144.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||.||+|.+ +++.||||++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788889999999999999997 8899999998653
Q ss_pred ------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 ------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 111 0456789999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.............||+.|+|||++.+..++.++|||||||++|+|++|..||.... ................
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDPIPP 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCCCCH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCCCCCc
Confidence 44333222233578999999999999999999999999999999999999986432 1111112111111110
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHH-HHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV-AKQLRQIY 281 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev-~~~L~~l~ 281 (284)
. ......+..+.+++.+||+.||++||++.++ .+.|..+.
T Consensus 240 ~-------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 S-------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H-------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c-------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0 0011123447899999999999999966554 45555543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.92 Aligned_cols=210 Identities=22% Similarity=0.254 Sum_probs=156.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~--------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5677788999999999999984 6788999998654
Q ss_pred ----CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ----FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ----~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 111 1456789999999999999 89999999999999999999999999999988765
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC------CCccccHHHHHHHHhhc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD------DGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 223 (284)
............||+.|+|||++.+..++.++|||||||++|+|++|..||...... .................
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 443333333356888999999998888999999999999999999999998542100 00000000011111111
Q ss_pred CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 224 ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+. ..+.+...+..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 260 ~~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 260 GQ---------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cc---------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 001112234458899999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=262.79 Aligned_cols=192 Identities=17% Similarity=0.252 Sum_probs=145.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +++.||||++...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6788889999999999999998 7899999987421
Q ss_pred --------------------------CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEE
Q 039895 90 --------------------------FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIV 129 (284)
Q Consensus 90 --------------------------~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NIL 129 (284)
+| .......++.||+.||.||| +.+|+||||||+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEE
Confidence 11 01567889999999999999 899999999999999
Q ss_pred EecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 039895 130 LQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD---FSEKSDVYSFGALLLELLTGKKISYSSHFD 206 (284)
Q Consensus 130 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~G~il~elltg~~p~~~~~~~ 206 (284)
++.++.+||+|||++.......... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-- 244 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALL---SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEE---CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred ECCCCCEEEecCCCccccccccccc---cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--
Confidence 9999999999999998765433221 1257899999999987665 4788999999999999999999986432
Q ss_pred CCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 207 DGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......... ...... +.....+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ------~~~~~~~~~-~~~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ------IMCLHSKIK-SQALEF--------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HHHHHHHHH-HCCCCC--------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HHHHHHHHh-cccCCC--------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111111 111100 001112234789999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=281.11 Aligned_cols=204 Identities=21% Similarity=0.260 Sum_probs=153.4
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------
Q 039895 47 ADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------- 89 (284)
Q Consensus 47 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------- 89 (284)
+.++...+++|...++||+|+||+||+|.. +++.||+|++...
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 445555668899999999999999999999 6789999998642
Q ss_pred ---------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 90 ---------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 90 ---------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 1211 456679999999999999 999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHH
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 219 (284)
+.......... ....||+.|+|||++. ...++.++|||||||++|||++|..||.... .......+..
T Consensus 223 ~~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~ 295 (437)
T 4aw2_A 223 LKLMEDGTVQS--SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMN 295 (437)
T ss_dssp EECCTTSCEEC--CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHT
T ss_pred hhcccCCCccc--ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-----hhHHHHhhhh
Confidence 87655433222 2267999999999986 5678999999999999999999999997532 1111111111
Q ss_pred HhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 039895 220 YIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGD--RPTIVQVAK 275 (284)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~--Rps~~ev~~ 275 (284)
......++... ......+.+|+.+||..+|++ ||++.|+++
T Consensus 296 ~~~~~~~p~~~---------------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 HKERFQFPTQV---------------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHCCCCSSC---------------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccccCCccc---------------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00011111110 012234789999999888888 999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.06 Aligned_cols=140 Identities=23% Similarity=0.269 Sum_probs=120.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
..|...+.||+|+||+||+|.. +++.||||++...
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4577788999999999999998 6899999998654
Q ss_pred ---CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc--ceeeccccccccC
Q 039895 90 ---FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV--AQLFDFTLSLSIP 148 (284)
Q Consensus 90 ---~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~Dfg~a~~~~ 148 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++.++. +||+|||++....
T Consensus 177 v~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 177 TFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 11 11456789999999999999 899999999999999999887 9999999997654
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.... ...||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 254 ~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 254 QRVY------TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCCC------SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cccc------ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 3322 257899999999999999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=270.61 Aligned_cols=192 Identities=21% Similarity=0.270 Sum_probs=149.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4577788999999999999999 7899999998642
Q ss_pred ----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC----cceeeccccccc
Q 039895 90 ----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN----VAQLFDFTLSLS 146 (284)
Q Consensus 90 ----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg~a~~ 146 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 111 1567789999999999999 99999999999999999887 799999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ES 225 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 225 (284)
....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........... ..
T Consensus 168 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 168 IDFGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNYE 235 (326)
T ss_dssp CCTTSCC----CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHTCCC
T ss_pred CCCCCcc----ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhcCCC
Confidence 7543221 12579999999999998899999999999999999999999986432 11111111110 00
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FED--------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCH--------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCc--------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 001122344789999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=263.44 Aligned_cols=195 Identities=20% Similarity=0.276 Sum_probs=152.7
Q ss_pred eeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------CC-----
Q 039895 62 VIMKCLFYKLYKGFL----QDRPISVMKFEDT-----------------------------------------FP----- 91 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-----------------------------------------~~----- 91 (284)
.||+|+||.||+|.+ ++..||+|++... +|
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L 96 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 96 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCH
Confidence 899999999999986 5778999999763 11
Q ss_pred -----------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 92 -----------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 92 -----------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
....+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++................
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 173 (287)
T 1u59_A 97 HKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173 (287)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred HHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccc
Confidence 11567789999999999999 8999999999999999999999999999998876544333333335
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
.||+.|+|||++.+..++.++||||||+++|+|++ |..||.... ....... ...+....
T Consensus 174 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~----i~~~~~~~----------- 233 (287)
T 1u59_A 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAF----IEQGKRME----------- 233 (287)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHHHHH----HHTTCCCC-----------
T ss_pred cccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHH----HhcCCcCC-----------
Confidence 67899999999988889999999999999999999 999986432 1111111 11111100
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+..+.+++..||+.||++|||+.++++.|+++..+
T Consensus 234 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 234 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0112234588999999999999999999999999999865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=271.76 Aligned_cols=212 Identities=14% Similarity=0.154 Sum_probs=156.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-C---------CcceEEEeecCC-----------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-Q---------DRPISVMKFEDT----------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~---------~~~vavK~~~~~----------------------------------- 89 (284)
++|...+.||+|+||.||+|.. . ++.||+|++...
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 5788889999999999999998 2 789999998543
Q ss_pred -----------------CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC--
Q 039895 90 -----------------FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-- 134 (284)
Q Consensus 90 -----------------~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-- 134 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~ 198 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQS 198 (352)
T ss_dssp CCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEE
T ss_pred hhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCc
Confidence 11 11556789999999999999 89999999999999999998
Q ss_pred cceeeccccccccCCCCccc----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 135 VAQLFDFTLSLSIPEGETHI----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 135 ~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
.+||+|||+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ...
T Consensus 199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~ 275 (352)
T 2jii_A 199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL---PNT 275 (352)
T ss_dssp EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT---TCH
T ss_pred eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC---cCH
Confidence 89999999998765432111 11123579999999999999899999999999999999999999986432 011
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
............ ......+.... ....+..+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 276 ~~~~~~~~~~~~--~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 276 EDIMKQKQKFVD--KPGPFVGPCGH---------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHHHHHHHHHHH--SCCCEECTTSC---------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccC--Chhhhhhhccc---------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 112222211111 11111111000 001123488999999999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=264.96 Aligned_cols=197 Identities=23% Similarity=0.289 Sum_probs=149.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------------CCCc
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------------------------FPFS 93 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------------------------~~~~ 93 (284)
.++|...+.||+|+||.||+|...|+.||||++... +|..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 467888889999999999999999999999998754 1110
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---- 172 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 172 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccccc----
Confidence 345789999999999999 89999999999999999999999999999876543322
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
...+++.|+|||++.+..++.++||||||+++|+|++ |..||.... ....... ...+.. ..
T Consensus 173 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~~~----~~~~~~-----~~-- 234 (278)
T 1byg_A 173 --TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR----VEKGYK-----MD-- 234 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHH----HTTTCC-----CC--
T ss_pred --CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH----HhcCCC-----CC--
Confidence 1457889999999988889999999999999999998 888886432 1111111 111100 00
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 --------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0112234588999999999999999999999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.99 Aligned_cols=200 Identities=21% Similarity=0.350 Sum_probs=143.8
Q ss_pred CCCCCeeeecCCceEEEEEe--CC----cceEEEeecCC-----------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QD----RPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~----~~vavK~~~~~----------------------------------------- 89 (284)
|...+.||+|+||.||+|.+ ++ ..||||++...
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 33457899999999999998 22 35999998754
Q ss_pred -CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 126 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 126 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 111 1457789999999999999 89999999999999999999999999999987654332
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.........+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..............
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~~----- 269 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFRL----- 269 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCC-----
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCcC-----
Confidence 2222222456788999999998899999999999999999999 999986432 11112111111000
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 270 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 -----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00112234478999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.16 Aligned_cols=201 Identities=21% Similarity=0.320 Sum_probs=155.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC-
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF- 92 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~- 92 (284)
.++|...+.||+|+||.||+|.. ++..||+|++... +|.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCC
Confidence 35677788999999999999999 6678999998754 111
Q ss_pred ----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 93 ----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 93 ----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
....+.++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++...........
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 167 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR- 167 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC-
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc-
Confidence 1456789999999999999 99999999999999999999999999999987755432221
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
....+++.|+|||++.+..++.++||||||+++|||++ |..||.... ......... .+. ...
T Consensus 168 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~-~~~-~~~------ 230 (279)
T 1qpc_A 168 -EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLE-RGY-RMV------ 230 (279)
T ss_dssp -TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHH-TTC-CCC------
T ss_pred -cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHh-ccc-CCC------
Confidence 12457889999999988889999999999999999999 888886432 111111111 110 000
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 231 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 --------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0111233488999999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=271.23 Aligned_cols=191 Identities=21% Similarity=0.298 Sum_probs=148.6
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
...++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3557899999999999999999999 7899999998642
Q ss_pred -----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 2211 456679999999999999 89999999999999999999999999999976533
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-cccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-SFKE 228 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 228 (284)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ............ .++
T Consensus 171 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 171 GDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDNPFYP- 238 (345)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC-
T ss_pred CCCc---ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCCCCCC-
Confidence 2221 123679999999999999999999999999999999999999996432 112222211111 111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIV-QVA 274 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-ev~ 274 (284)
......+.+|+.+||+.||++||++. +++
T Consensus 239 -----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 -----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01223478999999999999999997 654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=270.77 Aligned_cols=191 Identities=21% Similarity=0.300 Sum_probs=146.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +++.||+|++...
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688889999999999999998 7889999988533
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 111 1456789999999999999 999999999999999999999999999999876543222
Q ss_pred ccCCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEI 229 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (284)
....||+.|+|||++.. ..++.++|||||||++|||++|..||.... .............. ..+
T Consensus 172 ----~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~--- 239 (384)
T 4fr4_A 172 ----TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETTVVTY--- 239 (384)
T ss_dssp ----CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHCCCCC---
T ss_pred ----eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhcccCC---
Confidence 22679999999999864 458999999999999999999999996433 11122222221111 001
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-IVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~ev~~ 275 (284)
+...+..+.+|+.+||+.||++||+ +.+|++
T Consensus 240 ---------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ---------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112234789999999999999998 666653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.53 Aligned_cols=196 Identities=21% Similarity=0.281 Sum_probs=148.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||+||+|.. +++.||||++...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 36788889999999999999998 7899999998533
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 121 1567889999999999999 9999999999999999999999999999997664322211
Q ss_pred cCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .......+ .......
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~----~~~~~~~------ 228 (323)
T 3tki_A 163 -LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDW----KEKKTYL------ 228 (323)
T ss_dssp -CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT---TSHHHHHH----HTTCTTS------
T ss_pred -ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHH----hcccccC------
Confidence 1122679999999999987765 7789999999999999999999965331 11111111 1110000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+........+.+|+.+||+.||++|||+.|+++
T Consensus 229 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001122334779999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=269.69 Aligned_cols=196 Identities=19% Similarity=0.242 Sum_probs=128.7
Q ss_pred CCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------CCC------
Q 039895 60 GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------FPF------ 92 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------~~~------ 92 (284)
.+.||+|+||+||+|.. +++.||||++... +|.
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 57899999999999999 6899999998654 111
Q ss_pred ---------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeeccccccccCCCCccccCCCCc
Q 039895 93 ---------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 93 ---------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
+.....++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++.......... ...
T Consensus 96 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~ 169 (325)
T 3kn6_A 96 RIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTP 169 (325)
T ss_dssp HHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc---ccc
Confidence 1567789999999999999 99999999999999998765 79999999998665432221 125
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
.||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........... ..+.. ..
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i-~~~~~------------~~ 235 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKI-KKGDF------------SF 235 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHH-TTTCC------------CC
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHH-HcCCC------------CC
Confidence 689999999999999999999999999999999999999975431110 11112222111 11111 00
Q ss_pred CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 241 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11112234456889999999999999999998863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=274.01 Aligned_cols=216 Identities=15% Similarity=0.132 Sum_probs=156.6
Q ss_pred ccCchHHHHHHHHhhCCCC-CCcceecHHHHHHH---------------------hcCCCCCCeeeecCCceEEEEEe--
Q 039895 21 LGNGKILLEKLIASSNGKH-NPIRSFSADELKTA---------------------TDDFDGGKVIMKCLFYKLYKGFL-- 76 (284)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~---------------------~~~f~~~~~lg~G~~g~Vy~~~~-- 76 (284)
...|....++.++...+.. .........++... .+.|...+.||+|+||+||+|.+
T Consensus 17 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~ 96 (377)
T 3byv_A 17 QGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQE 96 (377)
T ss_dssp CCTTHHHHHHHHHHCGGGCCCSTTC-CHHHHHHHHHHHTCC-CCEEEEEESSSCCCEEEEEEEEEEEETTEEEEEEEC-C
T ss_pred CCCchHHHHHHHHhCcccccccccccccchhhhhhHHHhcCCCCcEEEEeecCCCCceEEEcceeecCCCEEEEEEEECC
Confidence 3445566677776655544 44444555555443 23455568899999999999997
Q ss_pred CCcceEEEeecCC--------------------------------C--CC----------------------------c-
Q 039895 77 QDRPISVMKFEDT--------------------------------F--PF----------------------------S- 93 (284)
Q Consensus 77 ~~~~vavK~~~~~--------------------------------~--~~----------------------------~- 93 (284)
+|+.||||++... + +. .
T Consensus 97 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 176 (377)
T 3byv_A 97 TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176 (377)
T ss_dssp CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEE
T ss_pred CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEE
Confidence 7999999998521 0 00 0
Q ss_pred -----------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 94 -----------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 94 -----------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 177 lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a 253 (377)
T 3byv_A 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253 (377)
T ss_dssp EEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred EEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence 224468999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccCCCCcccCccccccccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTG-----------DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
+...... ....| +.|+|||++.+. .++.++|||||||++|||++|..||.......
T Consensus 254 ~~~~~~~------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~------ 320 (377)
T 3byv_A 254 VRDGARV------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------ 320 (377)
T ss_dssp EETTCEE------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------C------
T ss_pred eecCCcc------cCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccccc------
Confidence 8643311 12567 999999999877 79999999999999999999999986432100
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+.. .. ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 321 -----------~~~~~~~-~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 321 -----------GSEWIFR-SC-----------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp -----------CSGGGGS-SC-----------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred -----------chhhhhh-hc-----------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 0111110 00 011234789999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.72 Aligned_cols=189 Identities=23% Similarity=0.308 Sum_probs=146.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4477778999999999999997 8899999998643
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-- 208 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-- 208 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC--
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC--
Confidence 111 1456789999999999999 8999999999999999999999999999997664321
Q ss_pred ccCCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
...||+.|+|||++. ...++.++|||||||++|||++|..||.... ............ .....
T Consensus 209 -----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~-~~~~~ 274 (348)
T 1u5q_A 209 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE-SPALQ 274 (348)
T ss_dssp -----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCCCC
T ss_pred -----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC-CCCCC
Confidence 257899999999874 5678999999999999999999999986432 111122221111 11110
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. ...+..+.+++.+||+.||++|||+.++++.
T Consensus 275 ~--------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 S--------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 1112347899999999999999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=279.75 Aligned_cols=142 Identities=18% Similarity=0.169 Sum_probs=111.1
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccc--
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYR-- 172 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~-- 172 (284)
.++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++
T Consensus 212 ~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~ 281 (413)
T 3dzo_A 212 ARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAE 281 (413)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhc
Confidence 45678899999999999 999999999999999999999999999998765433 112567 999999998
Q ss_pred --------cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChh
Q 039895 173 --------TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPE 244 (284)
Q Consensus 173 --------~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
....++.++|||||||++|||++|+.||..... ......+ +....
T Consensus 282 ~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-----------------~~~~~~~----~~~~~------ 334 (413)
T 3dzo_A 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA-----------------LGGSEWI----FRSCK------ 334 (413)
T ss_dssp HTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGG-----------------GSCSGGG----GSSCC------
T ss_pred cccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcch-----------------hhhHHHH----Hhhcc------
Confidence 555688999999999999999999999864321 0001111 11110
Q ss_pred hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 245 KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 245 ~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+..+.+|+.+||+.||++|||+.++++
T Consensus 335 --~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 335 --NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp --CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11234889999999999999999888754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=277.42 Aligned_cols=190 Identities=21% Similarity=0.279 Sum_probs=148.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36788889999999999999998 7899999998632
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ......++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 111 1456679999999999999 7 899999999999999999999999999997643322
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-cccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-SFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (284)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ............ .++
T Consensus 304 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p--- 369 (446)
T 4ejn_A 304 AT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFP--- 369 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC---
T ss_pred cc---cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCCC---
Confidence 21 122679999999999999999999999999999999999999996532 111222111111 111
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
......+.+|+.+||+.||++|| |+.|+++
T Consensus 370 ---------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 ---------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11223478999999999999999 9999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=264.12 Aligned_cols=202 Identities=23% Similarity=0.324 Sum_probs=157.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------C
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------F 90 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~ 90 (284)
..++|...+.||+|+||+||+|.+ ++..||+|++... +
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 456778888999999999999999 5889999998754 1
Q ss_pred CC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 91 PF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 91 ~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
|. ...++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 11 1456789999999999999 899999999999999999999999999999877544332
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
... ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+.. ....
T Consensus 168 ~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-----~~~~~~~~~~----~~~~----- 231 (288)
T 3kfa_A 168 AHA--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK----DYRM----- 231 (288)
T ss_dssp EET--TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHT----TCCC-----
T ss_pred ccc--CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhc----cCCC-----
Confidence 222 2567889999999998899999999999999999999 888876432 1112221111 0000
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+...+..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 232 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 ----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 00112234488999999999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=270.45 Aligned_cols=209 Identities=21% Similarity=0.250 Sum_probs=154.7
Q ss_pred CCCCCeeeecCCceEEEEEe------CCcceEEEeecCC-----------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~----------------------------------------- 89 (284)
|...+.||+|+||+||++.+ +++.||||++...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 37778999999999988865 6788999998754
Q ss_pred ---CCC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 ---FPF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ---~~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 111 1567789999999999999 89999999999999999999999999999988765543
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC------CCccccHHHHHHHHhhcCcc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFD------DGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 226 (284)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...................
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE- 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC-
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc-
Confidence 323333356888999999999888999999999999999999999998532100 0000000000001111100
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. .+.+..++..+.+|+.+||+.||++|||+.|+++.|+.+.+.
T Consensus 269 --------~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 269 --------R------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp --------C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------C------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 0 011122334588999999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.99 Aligned_cols=195 Identities=22% Similarity=0.294 Sum_probs=146.7
Q ss_pred CeeeecCCceEEEEEe----CCcceEEEeecCC------------------------------------------CCC--
Q 039895 61 KVIMKCLFYKLYKGFL----QDRPISVMKFEDT------------------------------------------FPF-- 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~------------------------------------------~~~-- 92 (284)
+.||+|+||.||+|.+ .+..||||++... +|.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 3699999999999976 4578999998753 111
Q ss_pred -------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 93 -------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 93 -------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+............
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 1456789999999999999 899999999999999999999999999999877654432222223
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
..+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..... .....+....
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--------~~~~~-~~i~~~~~~~---------- 592 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVT-AMLEKGERMG---------- 592 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTCCCC----------
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCCCCC----------
Confidence 457889999999998899999999999999999998 999986533 11111 1111111110
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+..++..+.+|+..||+.||++|||+.+|++.|+++..
T Consensus 593 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011233458899999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=268.86 Aligned_cols=196 Identities=22% Similarity=0.302 Sum_probs=141.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------CC
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------FP 91 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------~~ 91 (284)
..+.|...+.||+|+||.||+|.. +++.||||++... +|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 456688889999999999999999 6788999998654 11
Q ss_pred ---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeeccccccccCCCCcc
Q 039895 92 ---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
.......++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++........
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 11567789999999999999 899999999999999975 889999999999876443221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....||+.|+|||++.+..++.++|||||||++|||++|..||.... . ......... ..... ...
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~---~~~~~~~i~-~~~~~-~~~-- 272 (349)
T 2w4o_A 208 ----KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----G---DQFMFRRIL-NCEYY-FIS-- 272 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----C---HHHHHHHHH-TTCCC-CCT--
T ss_pred ----ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----c---cHHHHHHHH-hCCCc-cCC--
Confidence 12578999999999999899999999999999999999999986432 1 111111111 11110 000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 273 ---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 ---------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001122334789999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=278.46 Aligned_cols=205 Identities=20% Similarity=0.246 Sum_probs=153.0
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------- 89 (284)
+.+.++....++|...+.||+|+||.||++.. +|+.||+|++...
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34555556678999999999999999999998 7899999998642
Q ss_pred -----------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccc
Q 039895 90 -----------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFT 142 (284)
Q Consensus 90 -----------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 142 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 1211 445678999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCcccCcccccccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHH
Q 039895 143 LSLSIPEGETHINDSNRVIGTFGFMAPEYRT-------TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 143 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~ 215 (284)
+++.......... ....||+.|+|||++. ...++.++|||||||++|||++|..||.... ......
T Consensus 208 la~~~~~~~~~~~--~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~ 280 (412)
T 2vd5_A 208 SCLKLRADGTVRS--LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-----TAETYG 280 (412)
T ss_dssp TCEECCTTSCEEC--SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHH
T ss_pred hheeccCCCcccc--ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 9987755433221 2267999999999987 4568999999999999999999999997532 111111
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHH
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR---PTIVQVAK 275 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R---ps~~ev~~ 275 (284)
.+........++.. ....+..+.+|+.+||. +|.+| |++.|+++
T Consensus 281 ~i~~~~~~~~~p~~---------------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHYKEHLSLPLV---------------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTHHHHCCCC-------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhcccCcCCCcc---------------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11110000011100 11123347899999999 99998 58988864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=272.70 Aligned_cols=193 Identities=22% Similarity=0.313 Sum_probs=147.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5688889999999999999998 7899999987421
Q ss_pred ---CCC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc---ceeeccccc
Q 039895 90 ---FPF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFTLS 144 (284)
Q Consensus 90 ---~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfg~a 144 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 221 1345678999999999999 999999999999999987654 999999999
Q ss_pred cccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
.......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... +
T Consensus 181 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~-~ 247 (351)
T 3c0i_A 181 IQLGESGLVA---GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIK-G 247 (351)
T ss_dssp EECCTTSCBC---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHH-T
T ss_pred eEecCCCeee---cCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHc-C
Confidence 8775533221 22579999999999999899999999999999999999999996421 111111111 1
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... .+ ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~--~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKM--NP----------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCC--CH----------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC--Cc----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1000 00 001122345789999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=260.45 Aligned_cols=201 Identities=23% Similarity=0.322 Sum_probs=151.3
Q ss_pred CCCCCeeeecCCceEEEEEe--CCc---ceEEEeecCC------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDR---PISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~------------------------------------------ 89 (284)
|...++||+|+||+||+|.+ ++. .||+|++...
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 44457899999999999997 333 6999998653
Q ss_pred -CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
++ .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 11 00456789999999999999 89999999999999999999999999999986654322
Q ss_pred c-ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 H-INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
. ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+.... ........+.. ....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~~~~~~~~~~----~~~~---- 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHFLAQ----GRRL---- 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CGGGHHHHHHT----TCCC----
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CHHHHHHHhhc----CCCC----
Confidence 1 112223567899999999999999999999999999999999777665322 12222222111 1000
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 248 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 -----------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111223488999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=270.35 Aligned_cols=205 Identities=20% Similarity=0.324 Sum_probs=155.6
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEeCC-------cceEEEeecCC----------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFLQD-------RPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~---------------------------------- 89 (284)
....++|...+.||+|+||.||+|.+.+ ..||||++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3345788889999999999999999843 78999998754
Q ss_pred --------CCCc---------------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecc
Q 039895 90 --------FPFS---------------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRD 122 (284)
Q Consensus 90 --------~~~~---------------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrD 122 (284)
+|.. ..++.++.||+.||.||| +.+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 1111 234569999999999999 99999999
Q ss_pred cccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 039895 123 IKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISY 201 (284)
Q Consensus 123 lkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~ 201 (284)
|||+|||++.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcccc-ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 99999999999999999999997764332211 1122567899999999988899999999999999999999 888886
Q ss_pred CCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 202 SSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
... ....... ...+..... +..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 279 ~~~--------~~~~~~~-~~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 279 GMA--------HEEVIYY-VRDGNILAC---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TSC--------HHHHHHH-HHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC--------hHHHHHH-HhCCCcCCC---------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 432 1111111 111111110 1122334889999999999999999999999999986
Q ss_pred hc
Q 039895 282 QS 283 (284)
Q Consensus 282 ~~ 283 (284)
+.
T Consensus 335 ~~ 336 (343)
T 1luf_A 335 ER 336 (343)
T ss_dssp C-
T ss_pred hh
Confidence 53
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=262.53 Aligned_cols=194 Identities=21% Similarity=0.311 Sum_probs=149.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788889999999999999998 7899999998643
Q ss_pred -CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc---ceeeccccccccCCC
Q 039895 90 -FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfg~a~~~~~~ 150 (284)
+| .......++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 11 11556789999999999999 899999999999999986655 999999999776543
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... . ........ .+.... .
T Consensus 162 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~---~~~~~~~~-~~~~~~-~ 227 (284)
T 3kk8_A 162 EAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----Q---HRLYAQIK-AGAYDY-P 227 (284)
T ss_dssp CBC----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHH-HTCCCC-C
T ss_pred ccc----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----h---hHHHHHHH-hccccC-C
Confidence 322 12578999999999999999999999999999999999999986432 1 11111111 111100 0
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. +.....+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 S-----------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-----------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-----------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 001122344789999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=270.62 Aligned_cols=195 Identities=18% Similarity=0.192 Sum_probs=141.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDTF------------------------------------------- 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------------------------------------------- 90 (284)
+.|...+.||+|+||.||++.. +++.||||++....
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4577788999999999999998 88899999986430
Q ss_pred ----------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 ----------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ----------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
.....+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.........
T Consensus 89 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 89 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 011467789999999999999 89999999999999997 6789999999998775433221
Q ss_pred cCCCCcccCccccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-----------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.... . ...........
T Consensus 165 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~-~~~~~~~~~~~ 236 (343)
T 3dbq_A 165 V-KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------N-QISKLHAIIDP 236 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------S-HHHHHHHHHCT
T ss_pred c-CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------h-HHHHHHHHhcC
Confidence 1 122579999999999854 678899999999999999999999986432 1 11111111111
Q ss_pred CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.. .... +......+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~---------~~~~------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NH---------EIEF------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TS---------CCCC------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc---------ccCC------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 10 0000 00112347899999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=266.84 Aligned_cols=212 Identities=21% Similarity=0.320 Sum_probs=161.1
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC----------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT---------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~---------------------------- 89 (284)
+...++....++|...+.||+|+||.||+|.+ +++.||||++...
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455555668899999999999999999984 4578999998654
Q ss_pred ----------------CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecc
Q 039895 90 ----------------FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRD 122 (284)
Q Consensus 90 ----------------~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrD 122 (284)
+| ....+..++.|++.||.||| +.+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 11 11346679999999999999 89999999
Q ss_pred cccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 039895 123 IKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISY 201 (284)
Q Consensus 123 lkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~ 201 (284)
|||+|||++.++.+||+|||++........... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEECCCCCEEECCCccccccccCcccee-ccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999987654332211 122567899999999988899999999999999999998 888886
Q ss_pred CCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 202 SSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
.... ....... ...+..... +......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 253 ~~~~----~~~~~~~----~~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 253 GVKI----DEEFCRR----LKEGTRMRA---------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp TCCC----SHHHHHH----HHHTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccch----hHHHHHH----hccCccCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 4321 1111111 111110000 0112234789999999999999999999999999998
Q ss_pred hc
Q 039895 282 QS 283 (284)
Q Consensus 282 ~~ 283 (284)
++
T Consensus 310 ~~ 311 (316)
T 2xir_A 310 QA 311 (316)
T ss_dssp HH
T ss_pred hh
Confidence 75
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=273.10 Aligned_cols=196 Identities=10% Similarity=0.023 Sum_probs=146.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------CCC----------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------FPF---------------- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------~~~---------------- 92 (284)
..|...+.||+|+||.||+|.+ +|+.||||++... .+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3477788999999999999998 7899999998752 000
Q ss_pred -------------------c--------------------------hhH------HHHHHHHHHHHHHhccCCCCCeeec
Q 039895 93 -------------------S--------------------------VSK------LKIAIEIASAVAYLHVGFSRPVVSR 121 (284)
Q Consensus 93 -------------------~--------------------------~~~------~~i~~~i~~gL~~LH~~~~~~ivHr 121 (284)
. ..+ +.++.||+.||+||| +.+|+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccC
Confidence 0 223 567799999999999 9999999
Q ss_pred ccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCC
Q 039895 122 DIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKI 199 (284)
Q Consensus 122 Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p 199 (284)
||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGP------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEE------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCcc------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999987643221 1457799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 200 SYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
|......... .+.... ..........++.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~---------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKG---------------SWKRPS-LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTT---------------CCCBCC-TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCccccc---------------chhhhh-hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9754311100 000000 00000011111111233445889999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=263.48 Aligned_cols=203 Identities=17% Similarity=0.247 Sum_probs=145.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999998 7889999998643
Q ss_pred ---CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ......++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 111 1456789999999999999 8999999999999999999999999999987765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc-ccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES-FKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (284)
.... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ............ .....
T Consensus 189 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~ 257 (309)
T 2h34_A 189 LTQL--GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---------LSVMGAHINQAIPRPSTV 257 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---------HHHHHHHHHSCCCCGGGT
T ss_pred cccc--cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---------HHHHHHHhccCCCCcccc
Confidence 2211 12568999999999998899999999999999999999999986422 111111111111 01111
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-TIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~ev~~~L~~l~~~ 283 (284)
. ...+..+.+++.+||+.||++|| |+.++++.|++++..
T Consensus 258 ~--------------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 258 R--------------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp S--------------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred C--------------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1 11223478999999999999999 999999999987643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=273.22 Aligned_cols=195 Identities=18% Similarity=0.204 Sum_probs=142.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDTF------------------------------------------- 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------------------------------------------- 90 (284)
..|...+.||+|+||.||+|.. .++.||||++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3488889999999999999998 78899999985430
Q ss_pred --C--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 --P--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 --~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+ ....+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+.......
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 0 00357789999999999999 99999999999999995 6889999999998775433221
Q ss_pred cCCCCcccCccccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-----------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ............
T Consensus 212 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~~~~~~ 283 (390)
T 2zmd_A 212 V-KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHAIIDP 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHCT
T ss_pred c-CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHHHHhCc
Confidence 1 122579999999999865 368899999999999999999999996432 111111111111
Q ss_pred CcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. ..... + ......+.+|+.+||+.||++|||+.|+++.
T Consensus 284 ~---------~~~~~----~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 N---------HEIEF----P--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp T---------SCCCC----C--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c---------ccCCC----C--ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 00000 0 0012347899999999999999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.21 Aligned_cols=211 Identities=17% Similarity=0.217 Sum_probs=136.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46788899999999999999998 7899999998643
Q ss_pred CCC--------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 FPF--------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ~~~--------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 111 1345678889999999999 89999999999999999999999999999987653
Q ss_pred CCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---c
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---S 225 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 225 (284)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.... .......+....... .
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 161 PVNT---FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp CCCC---CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCTTT
T ss_pred Cccc---CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhH
Confidence 3221 1125789999999998764 68999999999999999999999986432 111111111111110 0
Q ss_pred ccccc-----cccccCCCCCCCh------hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIV-----DPAIVGEEGLMWP------EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.... .+.+......... ........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 0000000000000 00112345889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=272.86 Aligned_cols=212 Identities=14% Similarity=0.168 Sum_probs=152.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.. +++.||||++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 6788889999999999999988 7889999998653
Q ss_pred ---------CC----------------CchhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCC---------
Q 039895 90 ---------FP----------------FSVSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEEN--------- 134 (284)
Q Consensus 90 ---------~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~--------- 134 (284)
+| .......++.||+.||.||| ++ +|+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 117 GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 00 01456789999999999999 87 999999999999999775
Q ss_pred ----------------------------------------cceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 135 ----------------------------------------VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 135 ----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
.+||+|||++........ ...||+.|+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~------~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT------EDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC------SCCSCGGGCCHHHHHT
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc------cCCCCCcccCChhhcC
Confidence 799999999987653321 2578999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-cccHHHHHHHHhhc--------Cccc-cccccc--ccCCCC-C-
Q 039895 175 GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE-DYRLQDLVKKYIEN--------ESFK-EIVDPA--IVGEEG-L- 240 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~--------~~~~-~~~~~~--~~~~~~-~- 240 (284)
..++.++|||||||++|||++|..||......... .......+...... .... ...... +..... .
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999754421111 01111111111100 0000 000000 000000 0
Q ss_pred ---------CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 241 ---------MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 241 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.........+.+|+.+||+.||++|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01123456677899999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=267.46 Aligned_cols=187 Identities=17% Similarity=0.238 Sum_probs=148.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +|+.||+|++...
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6788889999999999999998 7899999998532
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 221 1456779999999999999 9999999999999999999999999999998765432
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... +...
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~-~~~~------ 256 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVS-GKVR------ 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCC------
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHc-CCCC------
Confidence 12679999999999999999999999999999999999999996432 1122222211 1110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
+ +...+..+.+++.+||+.||++||+ +.||++
T Consensus 257 ~----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 F----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 0112234789999999999999998 788764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=267.96 Aligned_cols=144 Identities=19% Similarity=0.275 Sum_probs=121.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||+||+|.. +++.||||++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 457888889999999999999998 7889999998654
Q ss_pred -----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe--cCCcceeeccccccc
Q 039895 90 -----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ--EENVAQLFDFTLSLS 146 (284)
Q Consensus 90 -----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~Dfg~a~~ 146 (284)
+| .......++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||++..
T Consensus 132 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 11 1145678999999999999932 47899999999999995 477899999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
...... ...||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 211 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 211 LGQRIY------QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCCCC------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc------cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 257899999999999999999999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=272.72 Aligned_cols=210 Identities=20% Similarity=0.178 Sum_probs=147.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ .+..||+|++...
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 4677888999999999999998 4578999987542
Q ss_pred ----------------CC--------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC--cce
Q 039895 90 ----------------FP--------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN--VAQ 137 (284)
Q Consensus 90 ----------------~~--------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~--~~k 137 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEE
Confidence 11 11567889999999999999 89999999999999999887 999
Q ss_pred eeccccccccCCCCccc----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 138 LFDFTLSLSIPEGETHI----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 138 l~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
|+|||+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~ 270 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL---KDPVAV 270 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---TCHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---cccHHH
Confidence 99999998764322111 11123579999999999999899999999999999999999999995322 111111
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIY 281 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~ 281 (284)
........ ..++..+..... ....+..+.+++..||+.||++|||+.+|++.|+++.
T Consensus 271 ~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLL--DELPQSVLKWAP---------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHH--HTTTHHHHHHSC---------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhc--ccccHHHHhhcc---------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111 111111100000 0022335889999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.28 Aligned_cols=191 Identities=20% Similarity=0.257 Sum_probs=147.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 46788899999999999999999 6789999998642
Q ss_pred ---CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 1111 456779999999999999 8999999999999999999999999999997643222
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ........... ... +
T Consensus 176 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-~~~--~- 240 (353)
T 2i0e_A 176 VT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEH-NVA--Y- 240 (353)
T ss_dssp CC---BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC--C-
T ss_pred cc---cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhC-CCC--C-
Confidence 11 123679999999999999999999999999999999999999996432 11222222111 100 0
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
+...+..+.+|+.+||+.||++||+ +.++++
T Consensus 241 -------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 -------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0112234789999999999999995 466654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=264.47 Aligned_cols=202 Identities=22% Similarity=0.301 Sum_probs=155.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------- 89 (284)
.++|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46677788999999999999986 3478999998653
Q ss_pred -----CCC---------------------------------------chhHHHHHHHHHHHHHHhccCCCCCeeeccccc
Q 039895 90 -----FPF---------------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKP 125 (284)
Q Consensus 90 -----~~~---------------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp 125 (284)
+|. ...++.++.||+.||.||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 111 1245689999999999999 89999999999
Q ss_pred CcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 039895 126 TTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSH 204 (284)
Q Consensus 126 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~ 204 (284)
+|||++.++.+||+|||++........... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEEC-SSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEcccccccccccccccee-ccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987654433221 222467889999999988889999999999999999999 998886432
Q ss_pred CCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 205 FDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
...+...+. ...... .+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 258 -----~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 -----PERLFNLLK----TGHRME---------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp -----GGGHHHHHH----TTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HHHHHHHhh----cCCcCC---------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 112222111 111000 0112233488999999999999999999999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=273.16 Aligned_cols=206 Identities=24% Similarity=0.328 Sum_probs=147.2
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
.|...+.||+|+||.||+|.+ +|+.||||++... +
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 477788999999999999999 7899999988643 1
Q ss_pred CCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-CcceeeccccccccCCCC
Q 039895 91 PFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 ~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~ 151 (284)
+.. .....++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 135 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp CCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 100 235678999999999999 9999999999999999965 578999999998765432
Q ss_pred ccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh--------
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE-------- 222 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (284)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+...+.....
T Consensus 212 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~----~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 212 PN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CC----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHHHHHH
T ss_pred Cc----eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHHh
Confidence 21 125789999999998765 78999999999999999999999997532 11112222211100
Q ss_pred -cCcccccccccccCCCCCCChh--hHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 -NESFKEIVDPAIVGEEGLMWPE--KEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+.+...+.+.. ..|.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKA---HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCC---CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCC---CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 01111111111100 00100 1122345889999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=269.58 Aligned_cols=204 Identities=20% Similarity=0.259 Sum_probs=153.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------ 89 (284)
..++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788889999999999999996 3457999998643
Q ss_pred -------CC--------------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccc
Q 039895 90 -------FP--------------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIK 124 (284)
Q Consensus 90 -------~~--------------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlk 124 (284)
+| ....++.++.||+.||.||| +.+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 11 11235679999999999999 8999999999
Q ss_pred cCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 039895 125 PTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSS 203 (284)
Q Consensus 125 p~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~ 203 (284)
|+|||++.++.+||+|||++........... .....||+.|+|||++.+..++.++|||||||++|+|+| |..||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCcccee-ccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999987654332211 122567889999999988899999999999999999998 99898653
Q ss_pred CCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.. ...... ......... .+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 279 ~~----~~~~~~----~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PV----DANFYK----LIQNGFKMD---------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CC----SHHHHH----HHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred Cc----HHHHHH----HHhcCCCCC---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 31 111111 111110000 0111234488999999999999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.11 Aligned_cols=218 Identities=14% Similarity=0.190 Sum_probs=159.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 4577788999999999999999 6899999998643
Q ss_pred -CC------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE----ecCCcceeeccccccc
Q 039895 90 -FP------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL----QEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 -~~------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfg~a~~ 146 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 11 11557789999999999999 9999999999999999 7777899999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTT--------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
....... ....||+.|+|||++.. ..++.++|||||||++|||++|..||......... .....
T Consensus 166 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~----~~~~~ 237 (396)
T 4eut_A 166 LEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----KEVMY 237 (396)
T ss_dssp CCCGGGS----SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----HHHHH
T ss_pred ccCCCcc----ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----HHHHH
Confidence 6543322 12579999999998764 46788999999999999999999999754321111 12222
Q ss_pred HHhhcCc---ccccc---ccc--ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 219 KYIENES---FKEIV---DPA--IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 219 ~~~~~~~---~~~~~---~~~--~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
....... +.... ... ..................+.+++.+||+.||++|||+.|+++.++++++.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2221111 11000 000 00011111123456677788999999999999999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=265.44 Aligned_cols=200 Identities=19% Similarity=0.218 Sum_probs=137.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
..+|...+.||+|+||.||+|.+ +++.||||++...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35678889999999999999998 8899999987433
Q ss_pred --------CC-----------------CchhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEecCCcceeeccc
Q 039895 90 --------FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQEENVAQLFDFT 142 (284)
Q Consensus 90 --------~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfg 142 (284)
+| ....++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 00 00456789999999999999 888 9999999999999999999999999
Q ss_pred cccccCCCCccc---------cCCCCcccCccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 143 LSLSIPEGETHI---------NDSNRVIGTFGFMAPEYR---TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 143 ~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
++.......... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----- 258 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----- 258 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-----
Confidence 998775432211 011124689999999998 566789999999999999999999999864320
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..... ....... .......+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 259 ---~~~~~-----~~~~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 259 ---LRIVN-----GKYSIPP--------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ---------------CCCCT--------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHhhc-----CcccCCc--------------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 0000000 001112267899999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=269.12 Aligned_cols=210 Identities=16% Similarity=0.214 Sum_probs=144.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|+||+||+|.. +++.||+|++... +
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4577788999999999999999 7899999988643 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~- 157 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY- 157 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc-
Confidence 11 1456778999999999999 9999999999999999999999999999997654332211
Q ss_pred CCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC---ccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE---SFKEIVD 231 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (284)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+....... .+.....
T Consensus 158 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 158 --DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhhhc
Confidence 12568999999999876 568999999999999999999999986532 111222222211111 1111111
Q ss_pred ccc------cCC-CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAI------VGE-EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~------~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 000 00000011122345789999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=261.77 Aligned_cols=203 Identities=20% Similarity=0.311 Sum_probs=155.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------- 89 (284)
.++|...+.||+|+||.||+|.+ ++..||+|++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35677888999999999999985 4578999998643
Q ss_pred ------CC---------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE
Q 039895 90 ------FP---------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130 (284)
Q Consensus 90 ------~~---------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl 130 (284)
+| .....+.++.||+.||.||| +.+|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 11 11345679999999999999 8999999999999999
Q ss_pred ecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 039895 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGE 209 (284)
Q Consensus 131 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~ 209 (284)
+.++.+||+|||++........... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 253 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---- 253 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----
T ss_pred cCCCCEEEcccccccccccccccee-ccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc----
Confidence 9999999999999987765433221 122567889999999988899999999999999999999 8888864321
Q ss_pred cccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.......+.. . ..... +...+..+.+++.+||+.||.+|||+.|+++.|+++.++
T Consensus 254 ~~~~~~~~~~----~-~~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKE----G-FRMLS--------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHH----T-CCCCC--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhcc----C-CCCCC--------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111111 1 00000 111223478999999999999999999999999998864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=262.73 Aligned_cols=203 Identities=24% Similarity=0.353 Sum_probs=144.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688889999999999999998 7899999998642
Q ss_pred --CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 --FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 --~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+| .......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 11 11356689999999999999 8999999999999999999999999999987664
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
...... ....|++.|+|||++.+..++.++||||||+++|+|++|..||.... .......... .......
T Consensus 188 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~~ 257 (310)
T 2wqm_A 188 SKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKI-EQCDYPP 257 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHH-HTTCSCC
T ss_pred CCCccc---cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHh-hcccCCC
Confidence 432211 12568999999999999899999999999999999999999986432 1222222221 1111111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
... ...+..+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 258 ~~~--------------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 LPS--------------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CCT--------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Ccc--------------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 110 11223478999999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=270.68 Aligned_cols=206 Identities=17% Similarity=0.227 Sum_probs=150.7
Q ss_pred CcceecHHHHHHHhcCCCCC-CeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------
Q 039895 41 PIRSFSADELKTATDDFDGG-KVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------- 89 (284)
Q Consensus 41 ~~~~~~~~~l~~~~~~f~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------- 89 (284)
....+.+.......+.|... +.||+|+||.||+|.. +++.||+|++...
T Consensus 14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 33344444455555556655 7899999999999998 6899999998653
Q ss_pred ----------------CC-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---C
Q 039895 90 ----------------FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---E 133 (284)
Q Consensus 90 ----------------~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~ 133 (284)
+| ....+..++.|++.||.||| +.+|+||||||+|||++. +
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTB
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCC
Confidence 11 11567889999999999999 899999999999999997 7
Q ss_pred CcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 134 NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 134 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
+.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .
T Consensus 171 ~~~kL~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~ 238 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHACEL----REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------N 238 (327)
T ss_dssp CCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------H
T ss_pred CcEEEeeCccccccCCcccc----ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------c
Confidence 89999999999876543221 12578999999999999999999999999999999999999986532 1
Q ss_pred HHHHHHHhh-cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 214 QDLVKKYIE-NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......... ...... +........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~i~~~~~~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 239 QETYLNISQVNVDYSE--------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHHHTCCCCCT--------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHhcccccCc--------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111111 000000 001122344789999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=265.06 Aligned_cols=217 Identities=18% Similarity=0.177 Sum_probs=146.9
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------
Q 039895 50 LKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 50 l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------- 89 (284)
+....+.|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 344557899999999999999999999 6899999998632
Q ss_pred --------CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 --------FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 --------~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+| .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 11 11567789999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-- 223 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 223 (284)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.... ....+..........
T Consensus 162 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 162 FGSPNRA---YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTSCCCC---CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCT
T ss_pred ccCCccc---CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHcCCCCh
Confidence 6543221 1225789999999998764 58899999999999999999998886432 111111111111100
Q ss_pred Ccccccccc-c-ccCCCCCCCh---hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ESFKEIVDP-A-IVGEEGLMWP---EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ~~~~~~~~~-~-~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
..+...... . .........+ ........+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111111000 0 0000000000 011223558899999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=269.04 Aligned_cols=189 Identities=26% Similarity=0.307 Sum_probs=146.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36788889999999999999999 7889999998543
Q ss_pred ---CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 111 0445678999999999999 9999999999999999999999999999997643322
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ........... ... +.
T Consensus 194 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-~~~--~~ 259 (373)
T 2r5t_A 194 S---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PLQ--LK 259 (373)
T ss_dssp C---CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHS-CCC--CC
T ss_pred C---ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc-ccC--CC
Confidence 1 1223679999999999999999999999999999999999999996432 12222222111 100 00
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev 273 (284)
+ .....+.+|+.+||+.||.+||++.+.
T Consensus 260 ~--------------~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 260 P--------------NITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp S--------------SSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred C--------------CCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 0 112347899999999999999998543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=275.20 Aligned_cols=139 Identities=20% Similarity=0.332 Sum_probs=104.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------CC-----------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------FP----------- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------~~----------- 91 (284)
+.|...+.||+|+||+||+|.+ +++.||||++... ++
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6788899999999999999988 7899999998653 00
Q ss_pred ---------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 92 ---------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 92 ---------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
.+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 11456789999999999999 999999999999999999999999999999876432
Q ss_pred Cccc------------------------cCCCCcccCccccccccc-cCCCCCcchhHHHHHHHHHHHHhC
Q 039895 151 ETHI------------------------NDSNRVIGTFGFMAPEYR-TTGDFSEKSDVYSFGALLLELLTG 196 (284)
Q Consensus 151 ~~~~------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~G~il~elltg 196 (284)
.... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 2110 112235789999999976 456799999999999999999994
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=256.93 Aligned_cols=189 Identities=24% Similarity=0.357 Sum_probs=145.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||+||+|.. ++..||+|++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46788889999999999999998 6778999988432
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ......++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++........
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 111 1456789999999999999 99999999999999999999999999999866543322
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (284)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ........... ..++
T Consensus 165 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~---- 227 (279)
T 3fdn_A 165 -----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTFP---- 227 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCC----
T ss_pred -----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCCCCCC----
Confidence 12578999999999999899999999999999999999999986432 11111111110 0111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......+.+|+.+||+.||++|||+.|+++.
T Consensus 228 --------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 --------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1122347899999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=285.16 Aligned_cols=194 Identities=19% Similarity=0.260 Sum_probs=145.4
Q ss_pred eeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------CCC----
Q 039895 62 VIMKCLFYKLYKGFL----QDRPISVMKFEDT-----------------------------------------FPF---- 92 (284)
Q Consensus 62 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-----------------------------------------~~~---- 92 (284)
.||+|+||.||+|.+ ++..||||++... +|.
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 699999999999987 3457999998753 111
Q ss_pred ------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCc
Q 039895 93 ------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRV 160 (284)
Q Consensus 93 ------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 160 (284)
...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.............
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 1567789999999999999 8999999999999999999999999999998775433222222223
Q ss_pred ccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCC
Q 039895 161 IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEG 239 (284)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
.+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ....... +..+...
T Consensus 500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~~~~~~----i~~~~~~------------ 558 (613)
T 2ozo_A 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAF----IEQGKRM------------ 558 (613)
T ss_dssp --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SHHHHHH----HHTTCCC------------
T ss_pred CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH----HHcCCCC------------
Confidence 46789999999998899999999999999999998 999986532 1111111 1111100
Q ss_pred CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 240 LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+..++..+.+|+..||+.+|++|||+.+|++.|+.+..
T Consensus 559 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 559 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0112233458899999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.76 Aligned_cols=222 Identities=16% Similarity=0.203 Sum_probs=154.9
Q ss_pred cHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------
Q 039895 46 SADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 46 ~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------- 89 (284)
...++....+.|...+.||+|+||.||+|.. ++..||||++...
T Consensus 18 ~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 18 VRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp CC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred EccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 3333334456788889999999999999998 7889999998643
Q ss_pred -------------CC-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccc
Q 039895 90 -------------FP-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143 (284)
Q Consensus 90 -------------~~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~ 143 (284)
++ .......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp STTTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CccccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 00 01456789999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
+.................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.....
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGILG 249 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHHHC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHHhC
Confidence 9876544332222233679999999998654 458999999999999999999999986532 1222222221111
Q ss_pred cCccc---cccc-------ccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NESFK---EIVD-------PAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~~~---~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..... ...+ ..+.......+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11000 0000 000000000000 01122345789999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=267.65 Aligned_cols=198 Identities=14% Similarity=0.160 Sum_probs=150.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEE-----e--CCcceEEEeecCC------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGF-----L--QDRPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~-----~--~~~~vavK~~~~~------------------------------------ 89 (284)
..+.|...+.||+|+||+||+|. . .++.||||++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 34567777889999999999993 2 7899999998754
Q ss_pred -----CCCc--------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-----------C
Q 039895 90 -----FPFS--------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-----------E 133 (284)
Q Consensus 90 -----~~~~--------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-----------~ 133 (284)
+|.. ..++.++.||+.||.||| +.+|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccccc
Confidence 2211 347789999999999999 999999999999999998 8
Q ss_pred CcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccH
Q 039895 134 NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213 (284)
Q Consensus 134 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~ 213 (284)
+.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------- 290 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGT-IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTE-EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET--------
T ss_pred CCEEEeeCchhhhhhccCCCc-eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC--------
Confidence 999999999997653221111 11225799999999999999999999999999999999999999853220
Q ss_pred HHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHHHHHHhc
Q 039895 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR-PTIVQVAKQLRQIYQS 283 (284)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R-ps~~ev~~~L~~l~~~ 283 (284)
+. ......+.. .+ ....+.+++..|++.+|.+| |++.++.+.|+++++.
T Consensus 291 ----------~~--~~~~~~~~~-----~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 291 ----------GE--CKPEGLFRR-----LP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ----------TE--EEECSCCTT-----CS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------Cc--eeechhccc-----cC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00 000000000 01 12236689999999999998 5888899999888754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=271.90 Aligned_cols=199 Identities=21% Similarity=0.260 Sum_probs=149.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------CCC
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------FPF 92 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------~~~ 92 (284)
..++|...+.||+|+||.||+|.. +|+.||+|++... +|.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 346788889999999999999999 7889999998654 221
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC----CcceeeccccccccCCCCcc
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE----NVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+.....++.||+.||.||| +.+|+||||||+|||+... +.+||+|||++.........
T Consensus 100 gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 100 GGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp SCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 1556789999999999999 9999999999999998533 35999999999876543322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||.... . ........... .+.+...
T Consensus 177 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~---~~~~~~~~~i~-~~~~~~~---- 243 (342)
T 2qr7_A 177 L---MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--D---DTPEEILARIG-SGKFSLS---- 243 (342)
T ss_dssp B---CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--T---SCHHHHHHHHH-HCCCCCC----
T ss_pred e---eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--c---CCHHHHHHHHc-cCCcccC----
Confidence 1 22578999999999988788999999999999999999999996432 1 11222222211 1111100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 --~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 --G------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --S------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --c------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001122334789999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.96 Aligned_cols=194 Identities=18% Similarity=0.315 Sum_probs=146.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CC-------cceEEEeecCC------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QD-------RPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~-------~~vavK~~~~~------------------------------------ 89 (284)
++|...+.||+|+||+||+|.. ++ ..||+|++...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 5677788999999999999998 34 46999998543
Q ss_pred -----CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc--------ceeec
Q 039895 90 -----FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV--------AQLFD 140 (284)
Q Consensus 90 -----~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~D 140 (284)
+|. ...+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 111 1456789999999999999 999999999999999998887 99999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHH
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKK 219 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 219 (284)
||++........ ..||+.|+|||++.+ ..++.++|||||||++|||++|..|+.... ........
T Consensus 165 fg~~~~~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-------~~~~~~~~ 230 (289)
T 4fvq_A 165 PGISITVLPKDI-------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-------DSQRKLQF 230 (289)
T ss_dssp CCSCTTTSCHHH-------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-------CHHHHHHH
T ss_pred CcccccccCccc-------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-------chHHHHHH
Confidence 999866543221 457899999999887 678999999999999999999766654322 11111111
Q ss_pred HhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 220 YIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.......+... +..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 231 ~~~~~~~~~~~------------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YEDRHQLPAPK------------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHTTCCCCCCS------------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hhccCCCCCCC------------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11111111111 11277999999999999999999999999988653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=266.82 Aligned_cols=196 Identities=19% Similarity=0.228 Sum_probs=151.8
Q ss_pred ceecHHHHHH----HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------
Q 039895 43 RSFSADELKT----ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------- 89 (284)
Q Consensus 43 ~~~~~~~l~~----~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------- 89 (284)
..++++.+.. ..+.|...+.||+|+||.||+|.. ++..||||++...
T Consensus 8 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 87 (335)
T 3dls_A 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87 (335)
T ss_dssp -CEECCHHHHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC
T ss_pred ccccccccccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC
Confidence 3444444443 346788889999999999999987 8899999988643
Q ss_pred ----------------------CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 ----------------------FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 ----------------------~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|. ...+..++.||+.||.||| +.+|+||||||+|||++
T Consensus 88 h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIA 164 (335)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred CCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEc
Confidence 110 0456789999999999999 89999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
.++.+||+|||++.......... ...||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------ 234 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGKLFY----TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ 234 (335)
T ss_dssp TTSCEEECCCTTCEECCTTCCBC----EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------
T ss_pred CCCcEEEeecccceECCCCCcee----ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------
Confidence 99999999999998775443221 2568999999999988876 789999999999999999999985321
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......... +...+..+.+|+.+||+.||++|||+.++++.
T Consensus 235 -----------------~~~~~~~~~--------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 235 -----------------ETVEAAIHP--------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------------GGTTTCCCC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------------HHHhhccCC--------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00122347899999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.80 Aligned_cols=194 Identities=16% Similarity=0.165 Sum_probs=149.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.+.|...+.||+|+||.||+|.. +|+.||+|++... +
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46788889999999999999998 7899999998643 1
Q ss_pred CC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec--CCcceeeccccccccCCCCc
Q 039895 91 PF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE--ENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|. +.....++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 11 1567789999999999999 999999999999999974 46799999999987754432
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.. ...||+.|+|||++.+..++.++|||||||++|||++|..||.... .......... ..+. .++
T Consensus 207 ~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~-~~~~--~~~ 271 (387)
T 1kob_A 207 VK----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKR-CDWE--FDE 271 (387)
T ss_dssp EE----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHH-CCCC--CCS
T ss_pred ee----eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCCC--CCc
Confidence 21 1468999999999999999999999999999999999999996532 1111111111 1100 000
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 272 ~----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 D----------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp S----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 01122334789999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=265.02 Aligned_cols=203 Identities=23% Similarity=0.301 Sum_probs=145.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC--------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~-------------------------------------- 89 (284)
..+.|...+.||+|+||.||+|.+ .+..||+|++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 345677778899999999999987 2347999998633
Q ss_pred ----------CC---------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCccee
Q 039895 90 ----------FP---------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQL 138 (284)
Q Consensus 90 ----------~~---------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 138 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 11 01456789999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||++........... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+
T Consensus 189 ~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQ-GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEMYDYL 262 (313)
T ss_dssp CSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHH
T ss_pred eecCcceecccccccCc-ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHHHH
Confidence 99999987654332211 122457889999999999899999999999999999999 777875432 11111111
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. .+.... .+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 263 ---~-~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 263 ---L-HGHRLK---------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ---H-TTCCCC---------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---H-cCCCCC---------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 111000 0112234488999999999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=261.73 Aligned_cols=193 Identities=23% Similarity=0.296 Sum_probs=137.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||+||+|.. +|+.||+|++...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 36788888999999999999999 8899999998654
Q ss_pred -CCC------------------chhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FPF------------------SVSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~~------------------~~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ......++.|++.||.||| +. +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 111 1456689999999999999 87 999999999999999999999999999977654
Q ss_pred CCccccCCCCcccCccccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYR----TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
..... ...||+.|+|||++ ....++.++|||||||++|+|++|..||.... ..... .........
T Consensus 163 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~-~~~~~~~~~ 231 (290)
T 3fme_A 163 DVAKD----IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------TPFQQ-LKQVVEEPS 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------CHHHH-HHHHHHSCC
T ss_pred ccccc----ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------chHHH-HHHHhccCC
Confidence 32221 14689999999996 45678999999999999999999999986422 11111 111111111
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -PQLP--------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCC--------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCcc--------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1100 0112234789999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=257.11 Aligned_cols=194 Identities=24% Similarity=0.385 Sum_probs=153.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.+ +++.||+|++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 35688889999999999999999 6899999998643
Q ss_pred -----------CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 90 -----------FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 90 -----------~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
+|.. ..+..++.||+.||.||| +.+|+|+||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcc
Confidence 0100 346789999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI 221 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
|++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..|+... ...... .
T Consensus 167 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~~-~ 231 (284)
T 2a19_B 167 GLVTSLKNDGKR----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFTD-L 231 (284)
T ss_dssp TTCEESSCCSCC----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHHH-H
T ss_pred hhheeccccccc----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHHH-h
Confidence 999877554322 1256899999999999889999999999999999999998876321 111111 1
Q ss_pred hcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 222 ENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
....+... .+..+.+++.+||+.||++|||+.|+++.|..+..+
T Consensus 232 ~~~~~~~~------------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 RDGIISDI------------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HTTCCCTT------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hccccccc------------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111111 112377999999999999999999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.90 Aligned_cols=210 Identities=18% Similarity=0.246 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||+|+||+||+|.. +++.||||++... +|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 5677888999999999999988 8899999998744 11
Q ss_pred C------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCCCccccCCC
Q 039895 92 F------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 92 ~------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
. ......++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++......... .
T Consensus 116 ~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----~ 188 (330)
T 3nsz_A 116 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----N 188 (330)
T ss_dssp CCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC----C
T ss_pred CchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc----c
Confidence 1 1556789999999999999 99999999999999999777 8999999999876543322 1
Q ss_pred CcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc-------
Q 039895 159 RVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV------- 230 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 230 (284)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+.... ...........+
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~---~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH---DNYDQLVRIA-KVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS---SHHHHHHHHH-HHHCHHHHHHHHHHTTCCC
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC---chHHHHHHHH-HhcCCchhhhHHHHhcccc
Confidence 2568999999999877 578999999999999999999999986432 1111111111 100000000000
Q ss_pred ccc----ccCCCCC------CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPA----IVGEEGL------MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~----~~~~~~~------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
++. +...... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000 00011123455889999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=263.38 Aligned_cols=204 Identities=22% Similarity=0.282 Sum_probs=153.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CC-----cceEEEeecCC------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QD-----RPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~-----~~vavK~~~~~------------------------------------ 89 (284)
..++|...+.||+|+||.||+|.. .+ ..||+|++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 446788889999999999999998 33 36999998653
Q ss_pred -------CCC-----------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC
Q 039895 90 -------FPF-----------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE 133 (284)
Q Consensus 90 -------~~~-----------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 133 (284)
+|. ....+.++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence 111 1235678999999999999 8999999999999999999
Q ss_pred CcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcccc
Q 039895 134 NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYR 212 (284)
Q Consensus 134 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~ 212 (284)
+.+||+|||++........... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.... ....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~~ 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIV-KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----VNSK 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEE-CSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----SSHH
T ss_pred CeEEECccccccccccccceee-cCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----hhHH
Confidence 9999999999987644322211 122567889999999988899999999999999999999 888886432 1111
Q ss_pred HHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 213 LQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
....+.. .. ... . +...+..+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 276 ~~~~~~~----~~-~~~-~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYKLVKD----GY-QMA-Q-------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHH----TC-CCC-C-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhc----CC-CCC-C-------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 10 000 0 011123478999999999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=268.58 Aligned_cols=210 Identities=19% Similarity=0.311 Sum_probs=158.9
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC----------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT---------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~---------------------------- 89 (284)
+..+++....++|...+.||+|+||.||+|.+. +..||+|++...
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444555666788988999999999999999873 578999998643
Q ss_pred --------------CCC-------------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE
Q 039895 90 --------------FPF-------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130 (284)
Q Consensus 90 --------------~~~-------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl 130 (284)
+|. ...++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence 111 1245678999999999999 8999999999999999
Q ss_pred ecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 039895 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGE 209 (284)
Q Consensus 131 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~ 209 (284)
+.++.+||+|||++........... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEG-GGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----
T ss_pred cCCCeEEECcCcccccccccccccc-ccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----
Confidence 9999999999999976644322211 112467889999999988889999999999999999999 778875432
Q ss_pred cccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
........ ........ ....+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 246 ---~~~~~~~~-~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 ---NEQVLRFV-MEGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---HHHHHHHH-HTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHHHHHHH-HcCCcCCC---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11112111 11111110 11223347899999999999999999999999988754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=268.21 Aligned_cols=208 Identities=15% Similarity=0.204 Sum_probs=142.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35678888999999999999998 7899999998543
Q ss_pred -------CC-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -------FP-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -------~~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
++ .......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 00 00446678999999999999 99999999999999999999999999999987643
Q ss_pred CCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--c
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--F 226 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (284)
.. ....||+.|+|||++.+ ..++.++||||+||+++||++|+.||.+.. .......+........ +
T Consensus 181 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 181 EM------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp SC------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCHHH
T ss_pred cc------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCCHHH
Confidence 22 12578999999999877 679999999999999999999999997532 1111111111110000 0
Q ss_pred -ccccc-------ccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 -KEIVD-------PAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 -~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+.. ..+.......+ .........+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000 00000000000 001122345789999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=265.85 Aligned_cols=205 Identities=17% Similarity=0.219 Sum_probs=143.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +++.||||++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36788889999999999999998 7899999998643
Q ss_pred -------CCC------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -------FPF------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -------~~~------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 010 0446679999999999999 899999999999999999999999999999776433
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-------
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN------- 223 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (284)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...........
T Consensus 181 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 181 FMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--------HIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHC-CCCCCHH
T ss_pred ccc----CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCCHH
Confidence 211 12578999999999999899999999999999999999999996532 11111111100
Q ss_pred ---------------C-cc-----cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 ---------------E-SF-----KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ---------------~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. .+ ......... .............+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF---PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS---CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccC---cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 00 000000000 00011123345678999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=267.88 Aligned_cols=197 Identities=20% Similarity=0.239 Sum_probs=140.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
.+.|...+.||+|+||+||++.. +++.||||++... +|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 35788889999999999999999 7899999998754 22
Q ss_pred Cc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc--ceeeccccccccCCCCccc
Q 039895 92 FS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV--AQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 ~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~Dfg~a~~~~~~~~~~ 154 (284)
.. .....++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++.......
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-- 173 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 173 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC--
Confidence 11 566789999999999999 999999999999999987765 99999999875432221
Q ss_pred cCCCCcccCccccccccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEK-SDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ................ ..
T Consensus 174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~~~~~~~-~~------ 240 (361)
T 3uc3_A 174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPRDYRKTIQRILSVK-YS------ 240 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTC-CC------
T ss_pred --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhcCC-CC------
Confidence 122579999999999988887655 899999999999999999996532 1122222222222111 00
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.+.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 241 --------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 --------IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00011122347899999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=269.48 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=138.9
Q ss_pred CCCCCeeeecCCceEEEEEe--CC---cceEEEeecCC------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QD---RPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~------------------------------------------ 89 (284)
|...+.||+|+||.||+|.+ ++ ..||+|.+...
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 33456899999999999997 22 36899988643
Q ss_pred -CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|. ....+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 110 0456789999999999999 89999999999999999999999999999987644322
Q ss_pred cc-cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 153 HI-NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.... .......+. .+.. ..
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~~----~~~~--~~ 316 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLL----QGRR--LL 316 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHHH----TTCC--CC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHHH----cCCC--CC
Confidence 11 11122457889999999998899999999999999999999 455554322 112222111 1110 00
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. +..++..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 317 ~-------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 317 Q-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp C-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 112233488999999999999999999999999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=266.85 Aligned_cols=207 Identities=15% Similarity=0.199 Sum_probs=149.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CC-cceEEEeecCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QD-RPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~-~~vavK~~~~~------------------------------------------ 89 (284)
++|...+.||+|+||+||+|.. ++ ..||+|++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 5788889999999999999998 44 68999998753
Q ss_pred ----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE-------------------
Q 039895 90 ----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL------------------- 130 (284)
Q Consensus 90 ----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl------------------- 130 (284)
+| .......++.||+.||.||| +.+|+||||||+|||+
T Consensus 99 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 99 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 11 11456789999999999999 9999999999999999
Q ss_pred ecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 131 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
+.++.+||+|||++........ ...||+.|+|||++.+..++.++|||||||++|||++|..||.... .
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~ 244 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHT------TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE-----N 244 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCC------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H
T ss_pred cCCCcEEEeecCcccccccccc------CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----H
Confidence 6788999999999976543322 2578999999999999999999999999999999999999996432 1
Q ss_pred ccHHHHHHHHhhcCc--------ccccc-cccccCCC---------------CCCChhhHHHHHHHHHHHHHhhcCCCCC
Q 039895 211 YRLQDLVKKYIENES--------FKEIV-DPAIVGEE---------------GLMWPEKEQQLLICTELAFKCLSESEGD 266 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 266 (284)
......+........ ..... ........ .............+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111111111111000 00000 00000000 0000011233456889999999999999
Q ss_pred CCCHHHHHH
Q 039895 267 RPTIVQVAK 275 (284)
Q Consensus 267 Rps~~ev~~ 275 (284)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=260.89 Aligned_cols=203 Identities=21% Similarity=0.307 Sum_probs=145.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe---CCc--ceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL---QDR--PISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~---~~~--~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+ ++. .||||++...
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 5688888999999999999986 223 5899988643
Q ss_pred ---CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ---FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|. ......++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 111 1456789999999999999 899999999999999999999999999999887654
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ...............
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~-- 244 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEGERL-- 244 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSCCCC--
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccCCCC--
Confidence 433222233567889999999988889999999999999999999 999986432 122222221111100
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.....+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 245 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 -------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01112234588999999999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=261.93 Aligned_cols=209 Identities=18% Similarity=0.247 Sum_probs=144.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +|+.||+|++...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5677888999999999999999 6899999988543
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 111 1456789999999999999 8999999999999999999999999999998765432221
Q ss_pred cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc----------
Q 039895 155 NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN---------- 223 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 223 (284)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... .......+......
T Consensus 160 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 160 ---DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-----DVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ---CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhcccccccccccc
Confidence 12578999999999876 568999999999999999999999986532 11111111111100
Q ss_pred -Cc-ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 -ES-FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.. ......+... ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 232 TNQYFSGVKIPDPE-DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCGGGTTCCCCCCS-SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccCcCCCcc-ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000000 000000001123445789999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.36 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=155.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF 92 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~ 92 (284)
..++|...+.||+|+||.||+|.+ .+..||||++... +|.
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~ 344 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 344 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhc
Confidence 345566778899999999999999 5577999998754 111
Q ss_pred -----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 93 -----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 93 -----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
...++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~- 420 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 420 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT-
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec-
Confidence 1456789999999999999 9999999999999999999999999999998765422111
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.....++..|+|||++....++.++|||||||++|||++ |..||.... ........ ..+..
T Consensus 421 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i-~~~~~-------- 482 (535)
T 2h8h_A 421 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQV-ERGYR-------- 482 (535)
T ss_dssp -TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHH-HTTCC--------
T ss_pred -ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HcCCC--------
Confidence 112456889999999988899999999999999999999 888886432 11111111 11100
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+.+..++..+.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 483 -------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 001112334588999999999999999999999999988653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=265.00 Aligned_cols=220 Identities=17% Similarity=0.247 Sum_probs=145.8
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------
Q 039895 47 ADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------- 89 (284)
Q Consensus 47 ~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------- 89 (284)
-.+.....++|...+.||+|+||.||+|.. +|..||||++...
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667788999999999999999999998 6899999988543
Q ss_pred ------------CCCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCccee
Q 039895 90 ------------FPFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQL 138 (284)
Q Consensus 90 ------------~~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl 138 (284)
+|.. .....++.|++.||.|||.. +.+|+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEE
Confidence 1110 33567899999999999943 689999999999999997 899999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||++......... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ....+....
T Consensus 174 ~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~~~ 245 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN----SAGQLHEIV 245 (360)
T ss_dssp CCCTTCBCCCTTSCC----CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH
T ss_pred eeCCCceecCCCCCc----ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC----hHHHHHHHH
Confidence 999999877544322 1256899999999986654 8999999999999999999999996532 111111111
Q ss_pred HHHhhcC-cccc-----cccccccCCCCCCCh-----hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 218 KKYIENE-SFKE-----IVDPAIVGEEGLMWP-----EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 218 ~~~~~~~-~~~~-----~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....... .... ..+..........+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1110000 0000 000000000000010 01123456889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=267.84 Aligned_cols=197 Identities=22% Similarity=0.326 Sum_probs=149.4
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------- 89 (284)
....++|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34456788889999999999999998 6899999987532
Q ss_pred -----------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccc
Q 039895 90 -----------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143 (284)
Q Consensus 90 -----------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~ 143 (284)
+|. ......++.||+.||.||| +.+|+|+||||+|||++.++.++|+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 111 0456789999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+..+...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....
T Consensus 247 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~~ 314 (365)
T 2y7j_A 247 SCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QILML 314 (365)
T ss_dssp CEECCTTCCB----CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred ccccCCCccc----ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 9877543322 22579999999998753 358899999999999999999999986432 11111
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... .+.... ..+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 315 ~~i~-~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIM-EGQYQF------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHH-HTCCCC------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH-hCCCCC------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 111000 00111122344789999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=272.52 Aligned_cols=197 Identities=18% Similarity=0.230 Sum_probs=143.1
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
...+.|...+.||+|+||+||+|.. +++.||||++...
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3457888899999999999999998 7889999998642
Q ss_pred --------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---cceeecccc
Q 039895 90 --------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQLFDFTL 143 (284)
Q Consensus 90 --------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfg~ 143 (284)
+|. +.....++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 110 1567789999999999999 89999999999999997544 599999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+...+.
T Consensus 289 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i~-- 358 (419)
T 3i6u_A 289 SKILGETSLM----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQIT-- 358 (419)
T ss_dssp TTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHHH--
T ss_pred ceecCCCccc----cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHHh--
Confidence 9876543221 22679999999999853 568889999999999999999999996532 1112222211
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+..... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 359 --~~~~~~~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 --SGKYNFI------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --TTCCCCC------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --cCCCCCC------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1110000 0011123345889999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=264.60 Aligned_cols=211 Identities=21% Similarity=0.263 Sum_probs=155.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe------CCcceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL------QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~--------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577778999999999999984 6889999998654
Q ss_pred ----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+| .....+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 11 11456789999999999999 89999999999999999999999999999988765
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------CCCccccHHHHHHHHhh
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHF-------DDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 222 (284)
............++..|+|||++.+..++.++|||||||++|+|++|..|+..... ...........+.....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 44322222234678889999999888899999999999999999999988753210 00000000000111111
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.... .+.+..++..+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 278 ~~~~---------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 278 NNGR---------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TTCC---------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCC---------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1000 011122334588999999999999999999999999998763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=265.46 Aligned_cols=196 Identities=21% Similarity=0.264 Sum_probs=147.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +++.||||++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788889999999999999998 6789999998532
Q ss_pred ------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 ------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 111 1456678999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccCCCCcccCccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|..||..... ................
T Consensus 211 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~- 283 (355)
T 1vzo_A 211 ADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEP- 283 (355)
T ss_dssp GGGGGGG--CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCCC-
T ss_pred cCCCCcc--cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhccCC-
Confidence 3322222 125799999999998853 478999999999999999999999965331 1122222222211100
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAKQ 276 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~~ 276 (284)
.. +......+.+|+.+||+.||++|| |+.|+++.
T Consensus 284 ------~~----------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 284 ------PY----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ------CC----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------CC----------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 00 111223478999999999999999 99998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.34 Aligned_cols=202 Identities=20% Similarity=0.198 Sum_probs=148.2
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------
Q 039895 50 LKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 50 l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------- 89 (284)
+....+.|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445567788899999999999999998 7889999987422
Q ss_pred --------CCC-------------------------------------------------------chhHHHHHHHHHHH
Q 039895 90 --------FPF-------------------------------------------------------SVSKLKIAIEIASA 106 (284)
Q Consensus 90 --------~~~-------------------------------------------------------~~~~~~i~~~i~~g 106 (284)
+|. ......++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 221 12245689999999
Q ss_pred HHHhccCCCCCeeecccccCcEEEecCC--cceeeccccccccCCCCccc-cCCCCcccCccccccccccC--CCCCcch
Q 039895 107 VAYLHVGFSRPVVSRDIKPTTIVLQEEN--VAQLFDFTLSLSIPEGETHI-NDSNRVIGTFGFMAPEYRTT--GDFSEKS 181 (284)
Q Consensus 107 L~~LH~~~~~~ivHrDlkp~NILl~~~~--~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 181 (284)
|.||| +.+|+||||||+|||++.++ .+||+|||++..+....... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 89999999999999998776 89999999998654322111 11123578999999999865 5789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhc
Q 039895 182 DVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLS 261 (284)
Q Consensus 182 DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 261 (284)
|||||||++|||++|..||.... ............... ..+........+.+|+.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLCF-------------ENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCT-------------TSGGGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhccccc-------------CCcccccCCHHHHHHHHHHcC
Confidence 99999999999999999986432 112222221111000 001111233458899999999
Q ss_pred CCCCCCCCHHHHHH
Q 039895 262 ESEGDRPTIVQVAK 275 (284)
Q Consensus 262 ~~p~~Rps~~ev~~ 275 (284)
.||.+|||+.|+++
T Consensus 317 ~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 317 RNVDERFDAMRALQ 330 (345)
T ss_dssp SCTTTSCCHHHHHH
T ss_pred CChhHCCCHHHHhc
Confidence 99999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=263.18 Aligned_cols=194 Identities=22% Similarity=0.280 Sum_probs=149.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||.||+|.. +|..||+|++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35677888999999999999998 7899999998643
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC----cceeecccccc
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN----VAQLFDFTLSL 145 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg~a~ 145 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 111 0567789999999999999 89999999999999999888 79999999998
Q ss_pred ccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
........ ....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......... ..
T Consensus 168 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~-~~ 234 (321)
T 2a2a_A 168 EIEDGVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITS-VS 234 (321)
T ss_dssp ECCTTCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHT-TC
T ss_pred ecCccccc----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh-cc
Confidence 76543321 12568999999999998899999999999999999999999986432 1111111111 10
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ..++. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--DFDEE----------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCCHH----------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--ccChh----------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00000 01122344789999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.78 Aligned_cols=203 Identities=22% Similarity=0.308 Sum_probs=149.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--C---CcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--Q---DRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~---------------------------------------- 89 (284)
..|...+.||+|+||+||+|.+ + ...||+|.+...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 3466678999999999999997 1 225899988653
Q ss_pred ---CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ---FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|. ....+.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 111 1456789999999999999 999999999999999999999999999999876543
Q ss_pred Cccc-cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHI-NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... .......||+.|+|||.+.+..++.++||||||+++|+|++|..|++... ........... ... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~~~~----~~~--~ 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLLQ----GRR--L 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS----CTTTHHHHHHT----TCC--C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC----CHHHHHHHHhc----CCC--C
Confidence 3211 12223567889999999998899999999999999999999655544322 11111111111 100 0
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.. +...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 252 ~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 LQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC-------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 011223488999999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=265.70 Aligned_cols=213 Identities=15% Similarity=0.207 Sum_probs=150.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688889999999999999998 7899999987543
Q ss_pred --------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 --------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 --------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 111 0457789999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccc-cCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-
Q 039895 147 IPEGETHI-NDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN- 223 (284)
Q Consensus 147 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 223 (284)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLCGSI 248 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCC
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCC
Confidence 65322211 11223578999999998876 458999999999999999999999986432 11122222221111
Q ss_pred --Cccccccccccc----CCCCCCChhhH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 --ESFKEIVDPAIV----GEEGLMWPEKE-----QQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 --~~~~~~~~~~~~----~~~~~~~~~~~-----~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+......... ........... ...+.+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111000000 00000000000 11345789999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.58 Aligned_cols=211 Identities=18% Similarity=0.239 Sum_probs=148.0
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------CC-------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------FP------------- 91 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------~~------------- 91 (284)
....+.|...+.||+|+||+||+|.. +|+.||||++... ++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 34567888899999999999999998 8899999987543 00
Q ss_pred --------------------------------------Cc------------------hhHHHHHHHHHHHHHHhccCCC
Q 039895 92 --------------------------------------FS------------------VSKLKIAIEIASAVAYLHVGFS 115 (284)
Q Consensus 92 --------------------------------------~~------------------~~~~~i~~~i~~gL~~LH~~~~ 115 (284)
.. .....++.||+.||.||| +
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---S 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 00 345678999999999999 9
Q ss_pred CCeeecccccCcEEEe-cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHH
Q 039895 116 RPVVSRDIKPTTIVLQ-EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLEL 193 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~el 193 (284)
.+|+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++||||+||++|||
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC----CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC----cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 9999999999999998 6889999999999876543322 125689999999998765 489999999999999999
Q ss_pred HhCCCCCCCCCCCCCccccHHHHHHHHhhc---------CcccccccccccCCCCCCCh--hhHHHHHHHHHHHHHhhcC
Q 039895 194 LTGKKISYSSHFDDGEDYRLQDLVKKYIEN---------ESFKEIVDPAIVGEEGLMWP--EKEQQLLICTELAFKCLSE 262 (284)
Q Consensus 194 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~ 262 (284)
++|..||.... ....+...+...... .......-+... ...+. .+...+..+.+|+.+||+.
T Consensus 236 l~g~~pf~~~~----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 236 ILGKPLFSGET----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK---AKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC---CCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HhCCCCCCCCC----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC---cccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999997532 111111111111000 000000000000 00000 0112334588999999999
Q ss_pred CCCCCCCHHHHHH
Q 039895 263 SEGDRPTIVQVAK 275 (284)
Q Consensus 263 ~p~~Rps~~ev~~ 275 (284)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=263.03 Aligned_cols=201 Identities=21% Similarity=0.283 Sum_probs=153.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe---------CCcceEEEeecCC-----------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL---------QDRPISVMKFEDT----------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~----------------------------------- 89 (284)
.++|...+.||+|+||.||+|.+ ++..||+|++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 36788889999999999999986 3467999998653
Q ss_pred --------CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE
Q 039895 90 --------FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL 130 (284)
Q Consensus 90 --------~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl 130 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 11 11345778999999999999 8999999999999999
Q ss_pred ecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 039895 131 QEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGE 209 (284)
Q Consensus 131 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~ 209 (284)
+.++.+||+|||++........... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----- 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEEC-CSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred cCCCCEEEccccccccccccccccc-cCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----
Confidence 9999999999999987654432221 122457889999999988889999999999999999999 888886432
Q ss_pred cccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
......... ....... +..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 265 ---~~~~~~~~~-~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 265 ---VEELFKLLK-EGHRMDK---------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ---HHHHHHHHH-HTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHh-cCCCCCC---------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112221111 1110000 11223347899999999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.22 Aligned_cols=207 Identities=17% Similarity=0.246 Sum_probs=147.8
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC---------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------- 89 (284)
++....++|...+.||+|+||.||+|.+.+ .||+|++...
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 333345788899999999999999999865 4999998643
Q ss_pred ----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+| ....+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 11 11567889999999999999 89999999999999998 68999999999876532
Q ss_pred CCcc--ccCCCCcccCccccccccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 150 GETH--INDSNRVIGTFGFMAPEYRTT---------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 150 ~~~~--~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
.... ........||+.|+|||++.. ..++.++|||||||++|||++|..||.... ......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~ 253 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------AEAIIW 253 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------HHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 2111 111122468999999999864 357899999999999999999999986432 111111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.. ..+.......... +..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 254 ~~-~~~~~~~~~~~~~--------------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 254 QM-GTGMKPNLSQIGM--------------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HH-HTTCCCCCCCSSC--------------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred Hh-ccCCCCCCCcCCC--------------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111111111111 12278999999999999999999999999988754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=264.82 Aligned_cols=208 Identities=18% Similarity=0.211 Sum_probs=150.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~------------------------------------------ 89 (284)
+.|...+.||+|+||.||+|.. +++.||||++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 5688888999999999999987 6789999998653
Q ss_pred ----CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-----------------
Q 039895 90 ----FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE----------------- 132 (284)
Q Consensus 90 ----~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~----------------- 132 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++.
T Consensus 94 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 94 IVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 11 11456789999999999999 899999999999999987
Q ss_pred --CCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 133 --ENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 133 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
++.+||+|||++........ ...||+.|+|||++.+..++.++|||||||++|||++|..||.... .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~ 239 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHS------TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-----S 239 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCC------SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-----H
T ss_pred ccCCCceEeeCcccccCccccc------cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----h
Confidence 66899999999976543221 2578999999999998899999999999999999999999986432 1
Q ss_pred ccHHHHHHHHhhcCc--------ccccccc-cccCCC---------------CCCChhhHHHHHHHHHHHHHhhcCCCCC
Q 039895 211 YRLQDLVKKYIENES--------FKEIVDP-AIVGEE---------------GLMWPEKEQQLLICTELAFKCLSESEGD 266 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~---------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 266 (284)
......+........ ....... ...... .............+.+|+.+||+.||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111111111111000 0000000 000000 0000012244567889999999999999
Q ss_pred CCCHHHHHHH
Q 039895 267 RPTIVQVAKQ 276 (284)
Q Consensus 267 Rps~~ev~~~ 276 (284)
|||+.|+++.
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.17 Aligned_cols=188 Identities=17% Similarity=0.202 Sum_probs=139.3
Q ss_pred CCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CCCc---
Q 039895 60 GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FPFS--- 93 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~~~--- 93 (284)
.+.||+|+||.||+|.. +|..||+|++... +|..
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 45799999999999998 7899999998754 1211
Q ss_pred -------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE--ecCCcceeeccccccccCCCCccccCCC
Q 039895 94 -------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 94 -------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.....++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++........ .
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~----~ 246 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL----K 246 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC----C
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc----c
Confidence 456678999999999999 8999999999999999 45678999999999877543322 1
Q ss_pred CcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
...||+.|+|||++.+..++.++|||||||++|||++|..||.... ............ +. ...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~-~~-~~~------- 309 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACR-WD-LED------- 309 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC-CC-SCS-------
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcc-CC-CCh-------
Confidence 2569999999999998899999999999999999999999996532 111122211110 00 000
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 310 ----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 ----EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001122345889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=269.74 Aligned_cols=208 Identities=18% Similarity=0.277 Sum_probs=136.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC-----------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF----------------------------------------- 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----------------------------------------- 90 (284)
.+.|...+.||+|+||.||+|.. +|+.||||++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788889999999999999998 78999999985430
Q ss_pred ---------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 91 ---------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 91 ---------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
........++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 001456789999999999999 99999999999999999999999999999977543
Q ss_pred CCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--- 225 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 225 (284)
.. ....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. .......+........
T Consensus 185 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 185 EM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHH
T ss_pred cC------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCCHHH
Confidence 22 12578999999999876 678999999999999999999999996532 1111111111111100
Q ss_pred cccccc-------ccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVD-------PAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+..+.. ..+.......++ ........+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000 000000000000 00112345789999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=268.47 Aligned_cols=209 Identities=19% Similarity=0.248 Sum_probs=147.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC-------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------------------------------------------~ 90 (284)
..|...+.||+|+||+||+|.. .+..||+|++... +
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 3577788999999999999999 6666999987543 1
Q ss_pred CCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCcceeeccccccccCCCC
Q 039895 91 PFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 ~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~ 151 (284)
|.. .....++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 111 345678999999999999 99999999999999999 79999999999998764433
Q ss_pred ccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc----
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF---- 226 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 226 (284)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.. ....+...+... .....
T Consensus 197 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~l~~i~~~~-g~p~~~~~~ 267 (394)
T 4e7w_A 197 PN----VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES----GIDQLVEIIKVL-GTPSREQIK 267 (394)
T ss_dssp CC----CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHH-CCCCHHHHH
T ss_pred CC----cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHh-CCCCHHHHH
Confidence 22 125789999999998765 58999999999999999999999997532 111111111111 00000
Q ss_pred ---cccccccccCCCCCCCh--hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 ---KEIVDPAIVGEEGLMWP--EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+.......+. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000000 01113345889999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=266.72 Aligned_cols=219 Identities=17% Similarity=0.226 Sum_probs=151.2
Q ss_pred ecHHHHHHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------
Q 039895 45 FSADELKTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------- 89 (284)
Q Consensus 45 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------- 89 (284)
....++....++|...+.||+|+||.||+|.. +|..||||++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34678888899999999999999999999998 8899999988431
Q ss_pred -----------------------CC---------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -----------------------FP---------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -----------------------~~---------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence 00 11457789999999999999 89999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
.++.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~ 239 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADANK----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-----F 239 (362)
T ss_dssp TTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H
T ss_pred CCCCEEEEecCccccccccccc----ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-----H
Confidence 9999999999999755433221 12568999999998876 678999999999999999999999986532 1
Q ss_pred ccHHHHHHHHhhcCccc-----------ccccccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 211 YRLQDLVKKYIENESFK-----------EIVDPAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......+.......... ..+...........+ .........+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111111100 000011111000000 011122345889999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=269.67 Aligned_cols=147 Identities=18% Similarity=0.202 Sum_probs=121.7
Q ss_pred hcCCCCCCeeeec--CCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 54 TDDFDGGKVIMKC--LFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
.++|...+.||+| +||+||+|.. +|+.||||++...
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568888999999 9999999999 7899999998644
Q ss_pred ---CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ---FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ---~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 111 1456789999999999999 99999999999999999999999999998865532
Q ss_pred CCc----cccCCCCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 150 GET----HINDSNRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 150 ~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 211 1111222578999999999987 57999999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=271.29 Aligned_cols=189 Identities=24% Similarity=0.286 Sum_probs=148.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5678888999999999999998 7999999998532
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 221 1567789999999999999 999999999999999999999999999999876543321
Q ss_pred ccCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... . ........ .+... .
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~---~~~~~~i~-~~~~~---~- 235 (476)
T 2y94_A 173 ----RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----V---PTLFKKIC-DGIFY---T- 235 (476)
T ss_dssp ----CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----S---HHHHHHHH-TTCCC---C-
T ss_pred ----cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----H---HHHHHHHh-cCCcC---C-
Confidence 12579999999999988765 689999999999999999999996432 1 11111111 11110 0
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+......+.+|+.+||+.||++|||+.|+++
T Consensus 236 ------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 ------------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0111234789999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=284.75 Aligned_cols=191 Identities=20% Similarity=0.268 Sum_probs=149.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +++.||||++...
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46788889999999999999999 7888999998642
Q ss_pred ---CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ---FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ---~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 111 1456789999999999999 9999999999999999999999999999998643322
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||.... ........... ...
T Consensus 497 ~~---~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~-~~~---- 560 (674)
T 3pfq_A 497 VT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEH-NVA---- 560 (674)
T ss_dssp CC---BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSS-CCC----
T ss_pred cc---cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhC-CCC----
Confidence 21 223679999999999999999999999999999999999999997532 12222222211 100
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI-----VQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~ev~~ 275 (284)
+ +......+.+|+.+||+.||++||++ .||++
T Consensus 561 ----------~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 ----------Y--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----------C--CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----------C--CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 01123347899999999999999997 66653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=266.69 Aligned_cols=145 Identities=23% Similarity=0.376 Sum_probs=106.5
Q ss_pred CCC-CCeeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------C
Q 039895 57 FDG-GKVIMKCLFYKLYKGFL----QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 57 f~~-~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-----------------------------------------~ 90 (284)
|.. +++||+|+||+||+|.+ ++..||||++... +
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 443 56899999999999996 4788999998754 1
Q ss_pred CC-----------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE----ecCCcceeecccc
Q 039895 91 PF-----------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL----QEENVAQLFDFTL 143 (284)
Q Consensus 91 ~~-----------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfg~ 143 (284)
|. ......++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 102 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp CSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 11 1235679999999999999 8999999999999999 6778999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSH 204 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~ 204 (284)
++................||+.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 98775433222222336789999999998874 58999999999999999999999996543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.47 Aligned_cols=191 Identities=23% Similarity=0.239 Sum_probs=140.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
+.|...+.||+|+||.||++.. ++..||+|++... +
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4677789999999999999998 7889999998644 1
Q ss_pred CCc-------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccC
Q 039895 91 PFS-------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 91 ~~~-------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~ 148 (284)
|.. .....++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 111 346789999999999999 9999999999999999 456789999999997765
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
..... ....||+.|+|||++. ..++.++|||||||++|+|++|..||.... ................
T Consensus 179 ~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~ 245 (285)
T 3is5_A 179 SDEHS----TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEPNYA 245 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCC
T ss_pred CcccC----cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCcccc
Confidence 43221 1256899999999875 568999999999999999999999986432 1111111111110000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. . .....+.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~-------~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 V-------E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C----------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-------c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0001234779999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.36 Aligned_cols=151 Identities=28% Similarity=0.412 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc---------cCCCCcccCccc
Q 039895 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI---------NDSNRVIGTFGF 166 (284)
Q Consensus 96 ~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~gt~~y 166 (284)
.+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.......... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 5789999999999999 9999999999999999999999999999998776542111 112235799999
Q ss_pred cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhH
Q 039895 167 MAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKE 246 (284)
Q Consensus 167 ~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
+|||++.+..++.++|||||||++|||++|..|+.. ....... ...... .....
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~-~~~~~~---------------~~~~~ 296 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITD-VRNLKF---------------PLLFT 296 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHH-HHTTCC---------------CHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHH-hhccCC---------------Ccccc
Confidence 999999999999999999999999999998765421 1111111 111111 11233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 247 QQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 247 ~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 44556789999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=276.68 Aligned_cols=194 Identities=23% Similarity=0.304 Sum_probs=146.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||+||+|.. +++.||||++...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 35688889999999999999998 7899999998432
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe---cCCcceeeccccccccCCC
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 2211 456789999999999999 99999999999999995 4567999999999876543
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... ....||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ......... .+....
T Consensus 178 ~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~~~-- 241 (486)
T 3mwu_A 178 TKM----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVE-TGKYAF-- 241 (486)
T ss_dssp --------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCCCS--
T ss_pred Ccc----CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hCCCCC--
Confidence 321 12579999999999875 58999999999999999999999997532 111121111 111100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
..+.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 ----------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011112233457899999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=263.22 Aligned_cols=215 Identities=16% Similarity=0.178 Sum_probs=144.5
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------
Q 039895 51 KTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 51 ~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------- 89 (284)
....++|...+.||+|+||+||+|.. +++.||||++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34557899999999999999999987 8899999998643
Q ss_pred ----CCC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-----cCCcceeeccccccc
Q 039895 90 ----FPF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-----EENVAQLFDFTLSLS 146 (284)
Q Consensus 90 ----~~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-----~~~~~kl~Dfg~a~~ 146 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||++..
T Consensus 110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 111 1456789999999999999 89999999999999995 455699999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc--
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-- 223 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 223 (284)
........ ....||+.|+|||++.+. .++.++|||||||++|||++|..||.... ....+..........
T Consensus 187 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 187 FGIPIRQF---THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----EIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCT
T ss_pred cCCccccc---CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----HHHHHHHHHHHhCCCch
Confidence 65332211 125689999999998775 48999999999999999999999986432 111111111111000
Q ss_pred Cccccccc-c----cccCCCCCCCh--hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 ESFKEIVD-P----AIVGEEGLMWP--EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 ~~~~~~~~-~----~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+..... + ........... ........+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 0 00000000000 01113345789999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=267.01 Aligned_cols=208 Identities=17% Similarity=0.218 Sum_probs=145.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35787888999999999999998 7899999998653
Q ss_pred -------CC------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -------FP------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -------~~------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 00 11556789999999999999 899999999999999999999999999999765433
Q ss_pred CccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--cc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--FK 227 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 227 (284)
.. ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+........ +.
T Consensus 198 ~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 198 MT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCHHHH
T ss_pred cC------CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCcHHHH
Confidence 22 2578999999999877 678999999999999999999999996532 1111111111100000 00
Q ss_pred cccc--------ccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 EIVD--------PAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 ~~~~--------~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+. ..+.......+ .........+.+|+.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 00000000000 001122455889999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=272.42 Aligned_cols=145 Identities=17% Similarity=0.293 Sum_probs=116.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.+ +++.||||++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 36788889999999999999998 7889999998653
Q ss_pred ------C--------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 ------F--------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ------~--------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+ ........++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 0 011566789999999999999 99999999999999999999999999999987754
Q ss_pred CCccc-------------------cCCCCcccCccccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039895 150 GETHI-------------------NDSNRVIGTFGFMAPEYR-TTGDFSEKSDVYSFGALLLELLTGKKISY 201 (284)
Q Consensus 150 ~~~~~-------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~G~il~elltg~~p~~ 201 (284)
..... .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32110 112336799999999986 45569999999999999999998655543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.42 Aligned_cols=193 Identities=23% Similarity=0.348 Sum_probs=149.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688888999999999999999 7999999998532
Q ss_pred --CC-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 --FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 --~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+| .+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 11 11556789999999999999 899999999999999999999999999999877544
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (284)
.... ...||+.|+|||++.+..++.++|||||||++|||++|..||...... ............. ..++
T Consensus 340 ~~~~----~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i~~~i~~~~~~~p-- 409 (576)
T 2acx_A 340 QTIK----GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEVPEEYS-- 409 (576)
T ss_dssp CCEE----CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHHHHHHHHCCCCCC--
T ss_pred cccc----ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHHHHHhhcccccCC--
Confidence 3221 257999999999999989999999999999999999999999754311 1111111111111 1111
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
...+..+.+|+.+||+.||++|| ++.||++
T Consensus 410 ----------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ----------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11123478999999999999999 7788864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=265.15 Aligned_cols=198 Identities=22% Similarity=0.278 Sum_probs=128.4
Q ss_pred HhcCCCC-CCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 53 ATDDFDG-GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
..++|.. .++||+|+||+||+|.. +|+.||||++...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 3467777 45799999999999999 6899999998654
Q ss_pred -CC-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeeccccccccC
Q 039895 90 -FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 -~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~~ 148 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 11 11567789999999999999 899999999999999986 4559999999997664
Q ss_pred CCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
..... ...||+.|+|||++.+..++.++|||||||++|+|++|..||........ .............
T Consensus 183 ~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~-- 250 (336)
T 3fhr_A 183 QNALQ-----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-----SPGMKRRIRLGQY-- 250 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ccccc-----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-----hhhHHHhhhcccc--
Confidence 33221 25689999999999888899999999999999999999999865331100 0000000000000
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
....+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 ----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 ----------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111123345789999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=258.75 Aligned_cols=190 Identities=21% Similarity=0.279 Sum_probs=143.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||++.. +|+.||+|++...
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 6788889999999999999987 6789999998643
Q ss_pred -----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 111 1456678999999999999 89999999999999999999999999999876433
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........... ...
T Consensus 174 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~~-- 239 (327)
T 3a62_A 174 DGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKC-KLN-- 239 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHT-CCC--
T ss_pred CCcc---ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhC-CCC--
Confidence 2221 122579999999999998899999999999999999999999996432 11112211111 000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+ +......+.+++.+||+.||++|| ++.|+++
T Consensus 240 ~--------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 L--------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C--------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C--------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 011223478999999999999999 7777765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=265.19 Aligned_cols=209 Identities=12% Similarity=0.143 Sum_probs=147.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +++.||||++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5688888999999999999998 8899999998633
Q ss_pred ------------CC----------------CchhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEec------CC
Q 039895 90 ------------FP----------------FSVSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQE------EN 134 (284)
Q Consensus 90 ------------~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~------~~ 134 (284)
++ .......++.||+.||.||| +. +|+||||||+|||++. .+
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcc
Confidence 11 01456789999999999999 87 9999999999999954 34
Q ss_pred cceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--cccc
Q 039895 135 VAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDG--EDYR 212 (284)
Q Consensus 135 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~--~~~~ 212 (284)
.+||+|||++........ ...||+.|+|||++.+..++.++|||||||++|||++|..||........ ....
T Consensus 176 ~~kl~Dfg~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYT------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEECCCTTCEETTBCCC------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred eEEEcccccccccCCCCC------CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 799999999977653321 25789999999999999999999999999999999999999975431110 0011
Q ss_pred HHHHHHHHhhcCcccc-----------ccccc--ccCC-CCC----------CChhhHHHHHHHHHHHHHhhcCCCCCCC
Q 039895 213 LQDLVKKYIENESFKE-----------IVDPA--IVGE-EGL----------MWPEKEQQLLICTELAFKCLSESEGDRP 268 (284)
Q Consensus 213 ~~~~~~~~~~~~~~~~-----------~~~~~--~~~~-~~~----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 268 (284)
+...... . +..+. .+... .... ... ....+......+.+|+.+||+.||++||
T Consensus 250 ~~~~~~~-~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 250 IAQIIEL-L--GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHH-H--CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHh-c--CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111110 0 00000 00000 0000 000 0112345677789999999999999999
Q ss_pred CHHHHHH
Q 039895 269 TIVQVAK 275 (284)
Q Consensus 269 s~~ev~~ 275 (284)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=256.59 Aligned_cols=191 Identities=19% Similarity=0.305 Sum_probs=128.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788889999999999999998 8899999998532
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+| .......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 11 11567789999999999999 8999999999999999999999999999998765332
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||....... . . .....
T Consensus 167 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~---~---------~~~~~ 226 (278)
T 3cok_A 167 EKH---YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----T---L---------NKVVL 226 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred Ccc---eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----H---H---------HHHhh
Confidence 211 12568999999999998889999999999999999999999986533110 0 0 00000
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY--------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC--------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc--------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 001112234789999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=277.61 Aligned_cols=193 Identities=23% Similarity=0.329 Sum_probs=148.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35677888999999999999999 7899999998533
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccCC
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 1111 456789999999999999 8999999999999999 4678999999999987755
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
...... ..||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ......... .+...
T Consensus 182 ~~~~~~----~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~~-- 245 (484)
T 3nyv_A 182 SKKMKD----KIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVE-KGKYT-- 245 (484)
T ss_dssp CCSHHH----HTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCC--
T ss_pred cccccc----CCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCCC--
Confidence 432211 568999999999876 68999999999999999999999996532 111121111 11110
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 ----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 ----------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 001111223445889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=262.89 Aligned_cols=205 Identities=22% Similarity=0.277 Sum_probs=146.1
Q ss_pred cceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------
Q 039895 42 IRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------ 89 (284)
Q Consensus 42 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------ 89 (284)
.+.+.+.++....+.|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 44555556666778899999999999999999999 8899999998543
Q ss_pred -----------------CCC-----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc
Q 039895 90 -----------------FPF-----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV 135 (284)
Q Consensus 90 -----------------~~~-----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 135 (284)
+|. ......++.||+.||.||| +.+|+|+||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence 110 0345679999999999999 899999999999999999999
Q ss_pred ceeeccccccccCCCCccccCCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 136 AQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 136 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
+||+|||++......... .....||+.|+|||++. ...++.++|||||||++|+|++|..||....
T Consensus 168 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------ 238 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------ 238 (326)
T ss_dssp EEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------
T ss_pred EEEeeCcCceecCcCccc---cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------
Confidence 999999998776432211 12257899999999986 4568899999999999999999999986432
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......... .......... ..+..+.+++.+||+.||++|||+.++++
T Consensus 239 --~~~~~~~~~-~~~~~~~~~~--------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 --PMRALFLIP-RNPAPRLKSK--------------KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HHHHHHHHH-HSCCCCCSCS--------------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHhh-cCccccCCcc--------------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111 1111111110 11234789999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=273.80 Aligned_cols=193 Identities=19% Similarity=0.310 Sum_probs=148.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5677778899999999999998 7899999998532
Q ss_pred -CCC-------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -FPF-------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.+|.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 111 1456678999999999999 99999999999999999999999999999987654
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-cccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-SFKE 228 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 228 (284)
..... ....||+.|+|||++.+..++.++|||||||++|||++|..||.... ................ .++
T Consensus 342 ~~~~~---~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~----~~~~~~~~~~~i~~~~~~~p- 413 (543)
T 3c4z_A 342 GQTKT---KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQAVTYP- 413 (543)
T ss_dssp TCCCB---CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT----CCCCHHHHHHHHHHCCCCCC-
T ss_pred CCccc---ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc----cchhHHHHHHHHhhcccCCC-
Confidence 43221 22579999999999999999999999999999999999999997542 1111222222221110 010
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI-----VQVAK 275 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~ev~~ 275 (284)
...+..+.+|+.+||+.||++||++ .+|++
T Consensus 414 -----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 414 -----------------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----------------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1122347899999999999999975 56653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.14 Aligned_cols=193 Identities=19% Similarity=0.205 Sum_probs=147.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.+.|...+.||+|+||.||+|.. ++..||+|++... +
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45688888999999999999999 6778999998643 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccCCCCc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|. ......++.|++.||.||| +.+|+|+||||+|||+ +.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 11 1567789999999999999 9999999999999999 7888999999999987654432
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.... ......... .+.....
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~--- 227 (277)
T 3f3z_A 165 M----RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIR-EGTFTFP--- 227 (277)
T ss_dssp B----CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCCCC---
T ss_pred h----hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-hCCCCCC---
Confidence 2 125689999999988654 8999999999999999999999986432 111111111 1110000
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+..+.+++.+||+.||++|||+.++++
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 ---------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000122345889999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=252.27 Aligned_cols=188 Identities=21% Similarity=0.304 Sum_probs=142.0
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||+||+|.+ ++..||+|++...
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 44456899999999999998 7788999988643
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEe-cCCcceeeccccccccCC
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQ-EENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.||+.||.||| +.+ |+|+||||+|||++ .++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 1100 456789999999999999 888 99999999999997 789999999999976544
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... ...||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......... .+.....
T Consensus 185 ~~~~-----~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~-~~~~~~~ 250 (290)
T 1t4h_A 185 SFAK-----AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVT-SGVKPAS 250 (290)
T ss_dssp TSBE-----ESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHT-TTCCCGG
T ss_pred cccc-----cccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHHHHHh-ccCCccc
Confidence 3222 156899999999876 458999999999999999999999986432 1111111111 1111111
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ....++.+.+++.+||+.||++|||+.|+++
T Consensus 251 ~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 F--------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1111234789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=254.01 Aligned_cols=192 Identities=23% Similarity=0.323 Sum_probs=149.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
+.|...+.||+|+||.||+|.. +++.||+|++... +
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577788999999999999998 7899999998643 1
Q ss_pred CC--------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccC
Q 039895 91 PF--------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156 (284)
Q Consensus 91 ~~--------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 156 (284)
|. ......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++..........
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 176 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-- 176 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB--
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccccc--
Confidence 11 1567789999999999999 8999999999999999999999999999997765433211
Q ss_pred CCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....... ....... .+.
T Consensus 177 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~~-----~~~- 240 (303)
T 3a7i_A 177 -NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFL-IPKNNPP-----TLE- 240 (303)
T ss_dssp -CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHH-HHHSCCC-----CCC-
T ss_pred -CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHH-hhcCCCC-----CCc-
Confidence 22578999999999999999999999999999999999999986432 1111111 1111111 010
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
...+..+.+|+.+||+.||++|||+.++++.
T Consensus 241 ---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 ---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0112337899999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.99 Aligned_cols=198 Identities=21% Similarity=0.274 Sum_probs=150.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcc--eEEEeecCC-----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRP--ISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~----------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. ++.. ||+|.+...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5677888999999999999998 5654 499988642
Q ss_pred --CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 --FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 --~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 11 11345679999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQD 215 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 215 (284)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... ...
T Consensus 182 kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~ 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAE 249 (327)
T ss_dssp EECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHH
T ss_pred EEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHH
Confidence 999999987443211 1112456889999999988889999999999999999998 999986432 112
Q ss_pred HHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..... ..+.. .. .+...+..+.+|+.+||+.||++|||+.|+++.|+++.++
T Consensus 250 ~~~~~-~~~~~-----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 250 LYEKL-PQGYR-----LE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHG-GGTCC-----CC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHh-hcCCC-----CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 22111 11100 00 0112233488999999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.92 Aligned_cols=193 Identities=21% Similarity=0.274 Sum_probs=148.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.+.|...+.||+|+||.||++.. +|+.||+|++... +
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 35677888999999999999998 7899999998643 1
Q ss_pred CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEE---ecCCcceeeccccccccCCCCc
Q 039895 91 PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|. ......++.|++.||.||| +.+|+|+||||+|||+ +.++.++|+|||++........
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 11 1456779999999999999 8999999999999999 7788999999999876543221
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... .+... ...
T Consensus 165 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~-~~~~~-~~~- 228 (304)
T 2jam_A 165 -----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIK-EGYYE-FES- 228 (304)
T ss_dssp -----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH-HCCCC-CCT-
T ss_pred -----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCCC-CCc-
Confidence 11468999999999999999999999999999999999999986432 111111111 11100 000
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 ----------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122344789999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=260.84 Aligned_cols=207 Identities=18% Similarity=0.229 Sum_probs=145.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF------------------------------------------ 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------------------------------------ 90 (284)
++|...+.||+|+||.||+|.. +|+.||||++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5678888999999999999998 78999999986430
Q ss_pred -------C------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 91 -------P------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 -------~------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+ .......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 180 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180 (353)
T ss_dssp CEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc
Confidence 0 11456789999999999999 8999999999999999999999999999997654322
Q ss_pred ccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--c-c
Q 039895 152 THINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--F-K 227 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~ 227 (284)
. ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+........ + .
T Consensus 181 ~------~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 181 T------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-----HHHHHHHHHHHHCBCCHHHHT
T ss_pred c------ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCCHHHHH
Confidence 1 2578999999999876 678999999999999999999999997532 1111111111100000 0 0
Q ss_pred cccc-------ccccCCCCCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 228 EIVD-------PAIVGEEGLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 228 ~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.+ ..+.......+ .........+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000000000 011123445889999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=262.32 Aligned_cols=210 Identities=20% Similarity=0.312 Sum_probs=144.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5677788999999999999999 6899999988543
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 111 1456789999999999999 8999999999999999999999999999997765432221
Q ss_pred cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH-----------hh
Q 039895 155 NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY-----------IE 222 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 222 (284)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+....... ..
T Consensus 182 ---~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 182 ---DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS----DIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ---CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCChhhhhHhhh
Confidence 125689999999998775 68999999999999999999999986532 111111111000 00
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+.....+.+.... .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKERE-PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccc-hhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0001111111110000 000001123456889999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.22 Aligned_cols=199 Identities=21% Similarity=0.297 Sum_probs=148.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||+|++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4577788999999999999999 6899999988643
Q ss_pred ----CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC----cceeeccccccc
Q 039895 90 ----FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN----VAQLFDFTLSLS 146 (284)
Q Consensus 90 ----~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg~a~~ 146 (284)
+|. ......++.|++.||.||| +.+|+|+||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 111 1567789999999999999 89999999999999998877 799999999987
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ......... ....
T Consensus 162 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~ 228 (283)
T 3bhy_A 162 IEAGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNIS-AVNY 228 (283)
T ss_dssp CC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TTCC
T ss_pred ccCCCcc----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhH-hccc
Confidence 6543221 12568999999999998899999999999999999999999986432 111111111 1100
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK--QLRQIY 281 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~--~L~~l~ 281 (284)
. .+. ......+..+.+++.+||+.||++|||+.|+++ .++.+.
T Consensus 229 ~--~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 D--FDE----------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp C--CCH----------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred C--Ccc----------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0 000 001122344789999999999999999999986 345443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=251.12 Aligned_cols=188 Identities=23% Similarity=0.302 Sum_probs=147.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. ++..||+|++...
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 6788889999999999999999 6788999998432
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 169 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR- 169 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB-
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccccc-
Confidence 111 1456789999999999999 99999999999999999999999999999876543221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
....|++.|+|||++.+..++.++||||||+++|+|++|..||.... ......... .... .
T Consensus 170 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~-~~~~------~ 230 (284)
T 2vgo_A 170 ----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIV-NVDL------K 230 (284)
T ss_dssp ----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TTCC------C
T ss_pred ----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHh-cccc------C
Confidence 12578999999999999899999999999999999999999986432 111111111 1110 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ +......+.+++.+||+.||++|||+.++++
T Consensus 231 ~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 F----------PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 0111234789999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=259.78 Aligned_cols=196 Identities=23% Similarity=0.290 Sum_probs=128.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36788889999999999999999 6899999998654
Q ss_pred -CCC-------------------chhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 -FPF-------------------SVSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 -~~~-------------------~~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+|. ......++.|++.||.||| +. +|+||||||+|||++.++.+||+|||++....
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 111 1345689999999999999 87 99999999999999999999999999997765
Q ss_pred CCCccccCCCCcccCccccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYR----TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
..... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||...... .....
T Consensus 178 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~------ 240 (327)
T 3aln_A 178 DSIAK----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLT------ 240 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C------
T ss_pred ccccc----ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHH------
Confidence 43221 114689999999998 4566899999999999999999999998643200 00000
Q ss_pred cccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 225 SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+.+... ........+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDPPQLSNS------EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCCCCCCCC------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCCCCCCCc------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000001000 01112334889999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=273.77 Aligned_cols=193 Identities=22% Similarity=0.267 Sum_probs=143.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||+||+|.. ++..||+|++...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34577788999999999999999 7889999998643
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC---CcceeeccccccccCCC
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE---NVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.. +.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 2211 456789999999999999 8999999999999999764 45999999999876543
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
... ....||+.|+|||++. ..++.++||||+||++|+|++|..||.... ......... .+.... .
T Consensus 193 ~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~~~-~ 257 (494)
T 3lij_A 193 KKM----KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVE-KGKYTF-D 257 (494)
T ss_dssp BCB----CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCCCC-C
T ss_pred ccc----cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hCCCCC-C
Confidence 321 2257999999999886 569999999999999999999999996532 112222211 111100 0
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 258 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 -----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0111122344789999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=261.58 Aligned_cols=214 Identities=19% Similarity=0.167 Sum_probs=148.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46788889999999999999998 6899999998643
Q ss_pred -----CC-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -----FP-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -----~~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+| .......++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 00 01456789999999999999 8999999999999999999999999999998765332
Q ss_pred cccc-------CCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc
Q 039895 152 THIN-------DSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 152 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
.... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.... .......+......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD-----YRHQLLLIFGIIGT 241 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCC
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHHHhCC
Confidence 1111 1122578999999998754 678999999999999999999999986532 11111111111110
Q ss_pred Ccccc----cccc-------cccCCCCCC-ChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 224 ESFKE----IVDP-------AIVGEEGLM-WPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 224 ~~~~~----~~~~-------~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..... .... .+....... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0000 000000000 0001123445789999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.25 Aligned_cols=206 Identities=19% Similarity=0.241 Sum_probs=141.5
Q ss_pred cCCCC-CCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 55 DDFDG-GKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 55 ~~f~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
+.|.. .++||+|+||+||+|.. +++.||||++...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34544 47899999999999998 7899999998643
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc---ceeeccccccccCCCC
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfg~a~~~~~~~ 151 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++. +||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 121 1456779999999999999 899999999999999998776 8999999987664321
Q ss_pred cc----ccCCCCcccCccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc------cHHHH
Q 039895 152 TH----INDSNRVIGTFGFMAPEYRTT-----GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY------RLQDL 216 (284)
Q Consensus 152 ~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~------~~~~~ 216 (284)
.. ........||+.|+|||++.. ..++.++|||||||++|||++|..||......+.... .....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 11 111122468999999999865 4588999999999999999999999976432111000 00011
Q ss_pred HHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.......+... .. .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~i~~~~~~-~~-----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGKYE-FP-----------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCCCC-CC-----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccCcc-cC-----------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111111100 00 0001122345889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=262.80 Aligned_cols=141 Identities=22% Similarity=0.299 Sum_probs=119.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|...+.||+|+||+||+|.+ ++..||+|++... +
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5678888999999999999999 6899999998643 1
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
|.. .....++.|++.||.||| +. +|+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 111 456689999999999999 75 89999999999999999999999999986553221
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11257899999999999999999999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=280.65 Aligned_cols=201 Identities=21% Similarity=0.292 Sum_probs=150.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--C---CcceEEEeecCC---------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--Q---DRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~--------------------------------------- 89 (284)
.+.|...+.||+|+||.||+|.+ . +..||+|.+...
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv 468 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 468 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEE
Confidence 35566778899999999999998 2 346999987643
Q ss_pred --CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 111 1456788999999999999 8999999999999999999999999999998775443
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... .......... +....
T Consensus 546 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~-~~~~~-- 612 (656)
T 2j0j_A 546 YYKA--SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIEN-GERLP-- 612 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHH-TCCCC--
T ss_pred ceec--cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHc-CCCCC--
Confidence 2221 12457889999999988899999999999999999997 888886432 1112211111 11000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+..++..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 613 -------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 613 -------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112234588999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=253.32 Aligned_cols=195 Identities=23% Similarity=0.252 Sum_probs=144.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------CC
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------FP 91 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------~~ 91 (284)
..+.|...+.||+|+||.||+|.. +|+.||+|++... +|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 346788889999999999999999 6899999998654 11
Q ss_pred C----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 F----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
. ......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.........
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 181 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-- 181 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--
Confidence 1 1456789999999999999 999999999999999999999999999999776543221
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ........... .....
T Consensus 182 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~------ 245 (314)
T 3com_A 182 -RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTN-PPPTF------ 245 (314)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-CCCCC------
T ss_pred -cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcC-CCccc------
Confidence 122578999999999998899999999999999999999999986432 11111111111 10000
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......+..+.+++.+||+.||++|||+.++++
T Consensus 246 -------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001112334789999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.58 Aligned_cols=194 Identities=21% Similarity=0.274 Sum_probs=147.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||++.. +|+.||+|++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35677888999999999999999 7899999998643
Q ss_pred ---CC-------------------CchhHHHHHHHHHHHHHHhccCCCCC-----eeecccccCcEEEecCCcceeeccc
Q 039895 90 ---FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRP-----VVSRDIKPTTIVLQEENVAQLFDFT 142 (284)
Q Consensus 90 ---~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~Dfg 142 (284)
+| .......++.|++.||.||| +.+ |+|+||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 11 11456789999999999999 777 9999999999999999999999999
Q ss_pred cccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 143 LSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 143 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
++........... ...||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....... ..
T Consensus 162 ~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-i~ 229 (279)
T 2w5a_A 162 LARILNHDTSFAK---TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGK-IR 229 (279)
T ss_dssp HHHHC---CHHHH---HHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HH
T ss_pred hheeecccccccc---ccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHH-Hh
Confidence 9987654322111 1468999999999998899999999999999999999999986432 1111111 11
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L 277 (284)
.+....+ +...+..+.+++.+||+.||++|||+.||++.+
T Consensus 230 ~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 EGKFRRI---------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HTCCCCC---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hcccccC---------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1111111 011223478999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.97 Aligned_cols=201 Identities=20% Similarity=0.269 Sum_probs=147.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------- 89 (284)
.++|...+.||+|+||.||+|.+ ++..||||++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36788889999999999999984 5668999998543
Q ss_pred -----CCC----------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceee
Q 039895 90 -----FPF----------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLF 139 (284)
Q Consensus 90 -----~~~----------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 139 (284)
+|. ...++.++.|++.||.||| +.+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 111 1346789999999999999 899999999999999984 4469999
Q ss_pred ccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHH
Q 039895 140 DFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 140 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.... ......
T Consensus 186 Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~ 256 (327)
T 2yfx_A 186 DFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLE 256 (327)
T ss_dssp CCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHH
T ss_pred ccccccccccccccc-cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHHH
Confidence 999997654332211 1122567899999999988899999999999999999998 888875432 111111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.. ........ ....+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 257 ~~-~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FV-TSGGRMDP---------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HH-HTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-hcCCCCCC---------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11 11111000 11122347899999999999999999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=254.30 Aligned_cols=186 Identities=16% Similarity=0.204 Sum_probs=142.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||+||+|.. +++.||+|++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 346788889999999999999999 7999999998753
Q ss_pred ---CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC--------------
Q 039895 90 ---FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-------------- 133 (284)
Q Consensus 90 ---~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-------------- 133 (284)
+| .......++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 11 11456789999999999999 8999999999999999844
Q ss_pred -----CcceeeccccccccCCCCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 039895 134 -----NVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207 (284)
Q Consensus 134 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~ 207 (284)
..+||+|||++........ ..||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~-------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV-------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC-------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred ccCCceEEEEcccccccccCCccc-------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 4789999999987654322 4589999999998766 56689999999999999999987764211
Q ss_pred CccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 208 GEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ....+..... +...+..+.+++.+||+.||++|||+.|+++
T Consensus 236 -----~~~----~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -----QWH----EIRQGRLPRI---------------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHH----HHHTTCCCCC---------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHH----HHHcCCCCCC---------------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 1111111111 0112234789999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=250.06 Aligned_cols=196 Identities=21% Similarity=0.281 Sum_probs=148.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46688889999999999999998 7899999998533
Q ss_pred CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|. ......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 111 1567889999999999999 8999999999999999999999999999997654322111
Q ss_pred cCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... .......+ .......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~~~------ 228 (276)
T 2yex_A 163 -LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDW----KEKKTYL------ 228 (276)
T ss_dssp -CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT---TSHHHHHH----HTTCTTS------
T ss_pred -cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHh----hhccccc------
Confidence 1122578999999999987765 6789999999999999999999965331 11111111 1110000
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+........+.+++.+||+.||++|||+.|+++
T Consensus 229 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122334789999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.27 Aligned_cols=193 Identities=21% Similarity=0.313 Sum_probs=142.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
+.|....+||+|+||.||+|.. ++..||+|++... +|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999998 7889999998643 11
Q ss_pred C------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-CCcceeeccccccccCCCCc
Q 039895 92 F------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-ENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 92 ~------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~ 152 (284)
. ......++.|++.||.||| +.+|+|+||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 1 1345568999999999999 899999999999999997 89999999999987654321
Q ss_pred cccCCCCcccCccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
. .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.... ............ ..
T Consensus 179 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~-~~----- 243 (295)
T 2clq_A 179 C---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG------EPQAAMFKVGMF-KV----- 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS------SHHHHHHHHHHH-CC-----
T ss_pred c---ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC------chhHHHHhhccc-cc-----
Confidence 1 12257899999999987653 7899999999999999999999986422 111111111000 00
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.+ +...+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEI----------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC----------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc----------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 1112234789999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.05 Aligned_cols=196 Identities=22% Similarity=0.326 Sum_probs=134.1
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
...++|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 3456788888999999999999999 7899999998654
Q ss_pred ---CCC---------------chhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ---FPF---------------SVSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|. ......++.|++.||.||| +. +|+|+||||+|||++.++.+||+|||++......
T Consensus 102 v~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 111 1456689999999999999 75 9999999999999999999999999998766443
Q ss_pred CccccCCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
... ....||+.|+|||++. ...++.++|||||||++|+|++|..||.... . ............
T Consensus 179 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~-~~~~~~~~~~~~- 246 (318)
T 2dyl_A 179 KAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------T-DFEVLTKVLQEE- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------S-HHHHHHHHHHSC-
T ss_pred ccc----cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------c-cHHHHHHHhccC-
Confidence 221 1256899999999984 4568899999999999999999999986422 1 111122221111
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... +.....+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPLL-------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC-------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC-------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 000112234789999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.26 Aligned_cols=195 Identities=17% Similarity=0.177 Sum_probs=147.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||++.. ++..||+|++...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 347899999999999999999998 7889999998532
Q ss_pred ------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 ------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 ------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 1110 456789999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccCCCCcccCccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 148 PEGETHINDSNRVIGTFGFMAPEYRTTGD--FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.... ......... ...
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~-~~~ 229 (305)
T 2wtk_C 160 HPFAADDT-CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIG-KGS 229 (305)
T ss_dssp CTTCSSCE-ECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHH-HCC
T ss_pred Cccccccc-cccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHh-cCC
Confidence 53221111 11256899999999987643 4789999999999999999999986432 122221111 111
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.. + +......+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~------~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YA------I----------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC------C----------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC------C----------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 0 01122347899999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.88 Aligned_cols=209 Identities=17% Similarity=0.191 Sum_probs=145.0
Q ss_pred CcceecHHHHHHHhcCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCCCC----------------------------
Q 039895 41 PIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDTFP---------------------------- 91 (284)
Q Consensus 41 ~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---------------------------- 91 (284)
+.+.+.+..+....+.|...+.||+|+||.||++.. +++.||||++.....
T Consensus 14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp ------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 334444444444557788889999999999999998 788999999854300
Q ss_pred -------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeec
Q 039895 92 -------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 92 -------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
....+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp EEEEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECC
T ss_pred EEEeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEee
Confidence 01467789999999999999 89999999999999996 48899999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT-----------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE 209 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~ 209 (284)
||++........... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 170 fg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----- 243 (313)
T 3cek_A 170 FGIANQMQPDTTSVV-KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----- 243 (313)
T ss_dssp CSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----
T ss_pred ccccccccCcccccc-ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----
Confidence 999987654322111 112568999999999865 468889999999999999999999986432
Q ss_pred cccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. ................ . +......+.+++.+||+.||++|||+.|+++.
T Consensus 244 -~-~~~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 244 -N-QISKLHAIIDPNHEIE-----F----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -S-HHHHHHHHHCTTSCCC-----C----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -H-HHHHHHHHHhcccccC-----C----------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 1111111111110000 0 00112347899999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.29 Aligned_cols=212 Identities=19% Similarity=0.238 Sum_probs=151.1
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC---------------------------------C-----
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT---------------------------------F----- 90 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---------------------------------~----- 90 (284)
.+.+.|...+.||+|+||.||+|.. +|+.||+|++... +
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3557888899999999999999997 5788999987532 0
Q ss_pred -----------------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecc
Q 039895 91 -----------------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141 (284)
Q Consensus 91 -----------------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 141 (284)
.....+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 011456789999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh
Q 039895 142 TLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI 221 (284)
Q Consensus 142 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+....
T Consensus 165 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~ 235 (326)
T 1blx_A 165 GLARIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVI 235 (326)
T ss_dssp CSCCCCCGGGG----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred cccccccCCCC----ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHHHc
Confidence 99976643221 122578999999999998899999999999999999999999986432 111111111111
Q ss_pred hcC---ccccccc-c--cccCCC-CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 222 ENE---SFKEIVD-P--AIVGEE-GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 222 ~~~---~~~~~~~-~--~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... .+..... + ...... .............+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 110 1110000 0 000000 0000001123345789999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=251.63 Aligned_cols=191 Identities=21% Similarity=0.269 Sum_probs=148.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||++.. +++.||+|++...
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 5677788999999999999999 6889999987543
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ...+..++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++.........
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 111 1567789999999999999 899999999999999999999999999999876433221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......... ....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~------ 233 (294)
T 2rku_A 172 ---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKK-NEYS------ 233 (294)
T ss_dssp ---BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHT-TCCC------
T ss_pred ---cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhh-ccCC------
Confidence 122568999999999998889999999999999999999999986432 1111111111 1100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+ +......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 I----------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 01112347899999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.79 Aligned_cols=195 Identities=19% Similarity=0.231 Sum_probs=146.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +++.||||++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35688889999999999999998 7889999987532
Q ss_pred ------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc---ceeecccccc
Q 039895 90 ------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFTLSL 145 (284)
Q Consensus 90 ------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfg~a~ 145 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 110 1456789999999999999 899999999999999987664 9999999998
Q ss_pred ccCCCCccccCCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 146 SIPEGETHINDSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 146 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
......... ...||+.|+|||++. ...++.++|||||||++|+|++|..||.... ....+...+..
T Consensus 166 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~--- 234 (322)
T 2ycf_A 166 ILGETSLMR----TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQITS--- 234 (322)
T ss_dssp ECCCCHHHH----HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHHHH---
T ss_pred ecccccccc----cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHHHh---
Confidence 765432211 146899999999863 5678999999999999999999999986533 11122222211
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.... .+ ......+..+.+++.+||+.||++|||+.++++
T Consensus 235 -~~~~~--~~----------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 -GKYNF--IP----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -TCCCC--CH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Ccccc--Cc----------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11000 00 001122345789999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=271.93 Aligned_cols=194 Identities=22% Similarity=0.255 Sum_probs=146.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..+.|...+.||+|+||+||+|.. ++..||+|++...
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456788889999999999999998 7889999998532
Q ss_pred -------------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC---ccee
Q 039895 90 -------------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---VAQL 138 (284)
Q Consensus 90 -------------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl 138 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 2211 456789999999999999 89999999999999998776 6899
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
+|||++......... ....||+.|+|||++. ..++.++||||+||++|+|++|..||.... ......
T Consensus 191 ~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 257 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKL----RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDIIK 257 (504)
T ss_dssp CCCTTCEECCTTSCB----CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred EECCCCEEcCCCCcc----ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 999999877543322 1257999999999986 468999999999999999999999997532 112222
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... .+.... ..+.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~i~-~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVE-KGKYYF------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHH-HCCCCC------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH-cCCCCC------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 211 111100 00111122345889999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=258.20 Aligned_cols=185 Identities=21% Similarity=0.328 Sum_probs=145.2
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------
Q 039895 52 TATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 52 ~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------------------------------- 89 (284)
...+.|...+.||+|+||.||+|.. +++.||||++...
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3456788889999999999999998 8899999987532
Q ss_pred ---------CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCcceeecccc
Q 039895 90 ---------FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQLFDFTL 143 (284)
Q Consensus 90 ---------~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~ 143 (284)
++. ......++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 111 0456679999999999999 99999999999999999 789999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
+......... ...||+.|+|||++.+..+ +.++|||||||++|||++|..||.... .. ..
T Consensus 197 ~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~----~~ 257 (320)
T 3a99_A 197 GALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI----IR 257 (320)
T ss_dssp CEECCSSCBC-----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH----HH
T ss_pred cccccccccc-----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hh----hc
Confidence 9876543221 2568999999999877665 688999999999999999999985311 00 00
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 258 -~~~--~~~--------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 -GQV--FFR--------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -CCC--CCS--------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccc--ccc--------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 011234789999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=256.56 Aligned_cols=190 Identities=22% Similarity=0.269 Sum_probs=148.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||.||++.. +++.||+|++...
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5677788999999999999999 6789999998543
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 111 1567789999999999999 899999999999999999999999999999876533221
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......... ....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~-~~~~------ 259 (335)
T 2owb_A 198 ---KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKK-NEYS------ 259 (335)
T ss_dssp ---BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-TCCC------
T ss_pred ---ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhc-CCCC------
Confidence 122578999999999998889999999999999999999999986432 1111111111 1100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ +......+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 I----------PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C----------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011234789999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=266.79 Aligned_cols=196 Identities=22% Similarity=0.320 Sum_probs=137.4
Q ss_pred cCCCCCCeeeecCCce-EEEEEeCCcceEEEeecCC---------------------------------------CCCc-
Q 039895 55 DDFDGGKVIMKCLFYK-LYKGFLQDRPISVMKFEDT---------------------------------------FPFS- 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~---------------------------------------~~~~- 93 (284)
.+|...++||+|+||+ ||++..+|+.||||++... +|..
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~ 103 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT 103 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCC
Confidence 4578888999999998 5555569999999998654 1111
Q ss_pred --------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CC--cceeeccccccccCCCCccc
Q 039895 94 --------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---EN--VAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 94 --------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~--~~kl~Dfg~a~~~~~~~~~~ 154 (284)
...+.++.||+.||.||| +.+|+||||||+|||++. ++ .+||+|||+++.........
T Consensus 104 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp HHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred HHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 356789999999999999 899999999999999953 23 57799999998876543322
Q ss_pred cCCCCcccCcccccccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRT---TGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||.... ... ............ .
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~------~~~---~~~~~~~~~~~~-~ 250 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QRQ---ANILLGACSLDC-L 250 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT------THH---HHHHTTCCCCTT-S
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh------HHH---HHHHhccCCccc-c
Confidence 2233367999999999987 4567889999999999999999 777774321 111 111111111000 0
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.........+.+|+.+||+.||++|||+.||++
T Consensus 251 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 ------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 011233444789999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=255.98 Aligned_cols=204 Identities=18% Similarity=0.158 Sum_probs=148.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||++.. +|+.||||++...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36788889999999999999997 8899999987432
Q ss_pred ---CC-------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 90 ---FP-------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 90 ---~~-------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 11 11456779999999999999 899999999999999999999999999988765
Q ss_pred CCCCccc------cCCCCcccCccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 148 PEGETHI------NDSNRVIGTFGFMAPEYRTTGD---FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 148 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
....... .......||+.|+|||++.... ++.++|||||||++|+|++|..||..... ..........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ---KGDSVALAVQ 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH---TTSCHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc---ccchhhHHhh
Confidence 3211100 0001135799999999987654 68999999999999999999999842110 0001111110
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
. ... .+.....+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 262 ----~-~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 ----N-QLS--------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ----C-C----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ----c-cCC--------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 000 00011223348899999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=267.10 Aligned_cols=195 Identities=23% Similarity=0.290 Sum_probs=137.6
Q ss_pred CCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCCc----
Q 039895 58 DGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPFS---- 93 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~~---- 93 (284)
...++||+|+||+||.+.. +|+.||||++... +|..
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~ 97 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQD 97 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHH
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHH
Confidence 3457899999999976544 9999999987544 2211
Q ss_pred -----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-------------Ccceeecccc
Q 039895 94 -----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-------------NVAQLFDFTL 143 (284)
Q Consensus 94 -----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~Dfg~ 143 (284)
...+.++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~ 174 (434)
T 2rio_A 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174 (434)
T ss_dssp HHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence 123569999999999999 8999999999999999764 4799999999
Q ss_pred ccccCCCCcccc-CCCCcccCccccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHH
Q 039895 144 SLSIPEGETHIN-DSNRVIGTFGFMAPEYRTT-------GDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQ 214 (284)
Q Consensus 144 a~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 214 (284)
++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.... ....
T Consensus 175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~~~~ 248 (434)
T 2rio_A 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY------SRES 248 (434)
T ss_dssp CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT------THHH
T ss_pred ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch------hhHH
Confidence 988765432211 1223579999999999865 568999999999999999999 888885422 1111
Q ss_pred HHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..... ....... ........+..+.+|+.+||+.||++|||+.||++
T Consensus 249 ~i~~~---~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRG---IFSLDEM-----------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHT---CCCCCCC-----------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcC---CCCcccc-----------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110 0000000 00112345667899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=253.06 Aligned_cols=194 Identities=19% Similarity=0.235 Sum_probs=143.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.+.|...+.||+|+||.||+|.+ ++..||+|++... +
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 35677888999999999999999 6889999998643 1
Q ss_pred CC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 91 PF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 91 ~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
|. ......++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-- 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--
Confidence 11 1456789999999999999 89999999999999999999999999998754321111
Q ss_pred cCCCCcccCccccccccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 155 NDSNRVIGTFGFMAPEYR-----TTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
......||+.|+|||++ ....++.++||||||+++|+|++|..||.... ............ ....
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~ 242 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSD-PPTL 242 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCCC
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccC-Cccc
Confidence 11125689999999987 46678999999999999999999999986432 111111111111 1111
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. .+...+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 L-------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S-------------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-------------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 01122334789999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=252.11 Aligned_cols=195 Identities=19% Similarity=0.275 Sum_probs=149.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346788889999999999999999 7899999998521
Q ss_pred ----------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccc
Q 039895 90 ----------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 90 ----------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
+|. ......++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 111 1466789999999999999 999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCcccCcccccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHH
Q 039895 145 LSIPEGETHINDSNRVIGTFGFMAPEYRT------TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218 (284)
Q Consensus 145 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||.... ......
T Consensus 172 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~ 239 (298)
T 1phk_A 172 CQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 239 (298)
T ss_dssp EECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred hhcCCCccc----ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHHH
Confidence 876543322 1256899999999874 4568899999999999999999999986432 111111
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... ...... . .+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~-~~~~~~-~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIM-SGNYQF-G-----------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-HTCCCC-C-----------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-cCCccc-C-----------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 111100 0 0111223345889999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=246.86 Aligned_cols=190 Identities=25% Similarity=0.319 Sum_probs=139.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 5677888999999999999998 7899999998532
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ......++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 111 1456789999999999999 899999999999999999999999999999876543321
Q ss_pred ccCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... ......... ..... .
T Consensus 168 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~--~-- 230 (276)
T 2h6d_A 168 ----RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIR-GGVFY--I-- 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCC--C--
T ss_pred ----ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhh-cCccc--C--
Confidence 12568999999999987765 589999999999999999999986432 111111111 11100 0
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01112347899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=254.39 Aligned_cols=210 Identities=16% Similarity=0.192 Sum_probs=140.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------CC-------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------FP------------- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------~~------------- 91 (284)
+.|...+.||+|+||.||+|.. +|+.||+|++... ++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 5677788999999999999999 5899999987533 00
Q ss_pred ---------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCcceeecccc
Q 039895 92 ---------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQLFDFTL 143 (284)
Q Consensus 92 ---------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfg~ 143 (284)
.......++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 01456789999999999999 89999999999999998 567999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
+.................+|+.|+|||++.. ..++.++|||||||++|||++|..||.... . .........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~---~~~~~~~~~ 239 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-----E---LEQMQLILE 239 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHH
Confidence 9876543222222223567999999998765 678999999999999999999999987532 1 111111111
Q ss_pred cCc-------------ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NES-------------FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
... +......................+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 00000000000000000001123445889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=251.68 Aligned_cols=205 Identities=20% Similarity=0.270 Sum_probs=139.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..++|...+.||+|+||.||+|.. ++..||||++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 347888899999999999999998 7899999987532
Q ss_pred -CC-----------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccc
Q 039895 90 -FP-----------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 90 -~~-----------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
+| ....+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 11 11346679999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCcc--ccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 146 SIPEGETH--INDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 146 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
........ ........||+.|+|||++.. ..++.++|||||||++|+|++|..||.... ...... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~---~~~~ 241 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-----PMKVLM---LTLQ 241 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC-----GGGHHH---HHHT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc-----hhhHHH---HHhc
Confidence 76543211 111122578999999999865 468999999999999999999999986532 111111 1111
Q ss_pred cCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 223 NESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ............. .....+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~-~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 N-DPPSLETGVQDKE------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp S-SCCCTTC-----C------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-CCCccccccccch------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 1000000000000 00112234789999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=249.25 Aligned_cols=194 Identities=23% Similarity=0.292 Sum_probs=146.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 53 ATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 53 ~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
..+.|...+.||+|+||.||+|.. +++.||+|++...
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 346788889999999999999999 7899999998543
Q ss_pred --CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC---CcceeeccccccccCC
Q 039895 90 --FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE---NVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 --~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfg~a~~~~~ 149 (284)
+|. ......++.||+.||.||| +.+|+|+||||+||+++.+ +.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 111 1556789999999999999 8999999999999999754 4699999999987654
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ......... .+.....
T Consensus 177 ~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~ 242 (287)
T 2wei_A 177 NTKM----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVE-TGKYAFD 242 (287)
T ss_dssp CSSC----SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCCCC
T ss_pred CCcc----ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCCCCCC
Confidence 3221 12468999999998865 48999999999999999999999986532 111121111 1111100
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 ------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0111122344789999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=249.26 Aligned_cols=188 Identities=19% Similarity=0.303 Sum_probs=142.8
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------- 89 (284)
+.....++|...+.||+|+||.||+|.. +++.||||++...
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3444567899999999999999999998 7889999998432
Q ss_pred --------------C-CC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe-cCCccee
Q 039895 90 --------------F-PF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ-EENVAQL 138 (284)
Q Consensus 90 --------------~-~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl 138 (284)
+ +. ......++.||+.||.||| +.+|+||||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 1 11 0456779999999999999 89999999999999999 8899999
Q ss_pred eccccccccCCCCccccCCCCcccCccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHH
Q 039895 139 FDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFS-EKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217 (284)
Q Consensus 139 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
+|||++........ ....||+.|+|||++.+..+. .++|||||||++|+|++|..||.... ...
T Consensus 182 ~dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~ 246 (312)
T 2iwi_A 182 IDFGSGALLHDEPY-----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EIL 246 (312)
T ss_dssp CCCSSCEECCSSCB-----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHH
T ss_pred EEcchhhhcccCcc-----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHh
Confidence 99999987654332 125689999999998776664 58999999999999999999985311 100
Q ss_pred HHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ....+ .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~---~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 E---AELHF------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H---TCCCC------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h---hccCC------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 0112234789999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=245.21 Aligned_cols=196 Identities=20% Similarity=0.325 Sum_probs=138.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||.||+|.. +|+.||||++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45688889999999999999998 7899999998543
Q ss_pred -----------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccc
Q 039895 90 -----------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFT 142 (284)
Q Consensus 90 -----------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 142 (284)
+|.. .....++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 1100 345679999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCcc-----------ccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 039895 143 LSLSIPEGETH-----------INDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210 (284)
Q Consensus 143 ~a~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~ 210 (284)
++......... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------- 231 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------- 231 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-------
Confidence 99776432110 1111235689999999998765 68999999999999999998 44211
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........... .... ...+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~-~~~~--~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNILKKLR-SVSI--EFPPDF----------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHHH-STTC--CCCTTC----------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhcc-cccc--ccCccc----------cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111111111 1100 000000 1122334789999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=247.71 Aligned_cols=206 Identities=17% Similarity=0.201 Sum_probs=148.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------------------------------------------- 89 (284)
.++|...+.||+|+||.||+|..+|+.||||++...
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 367888899999999999999999999999987421
Q ss_pred --------------CCC-----------------------chhHHHHHHHHHHHHHHhccCCC-CCeeecccccCcEEEe
Q 039895 90 --------------FPF-----------------------SVSKLKIAIEIASAVAYLHVGFS-RPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 --------------~~~-----------------------~~~~~~i~~~i~~gL~~LH~~~~-~~ivHrDlkp~NILl~ 131 (284)
+|. ...+..++.|++.||.||| + .+|+|+||||+|||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEc
Confidence 110 1456789999999999999 7 9999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG-DFSE-KSDVYSFGALLLELLTGKKISYSSHFDDGE 209 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwS~G~il~elltg~~p~~~~~~~~~~ 209 (284)
.++.+||+|||++........ ....||+.|+|||++.+. .++. ++|||||||++|+|++|..||.....
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 257 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKI-----KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---- 257 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEE-----CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC----
T ss_pred CCCcEEEeccccccccccccc-----cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc----
Confidence 999999999999987654311 125789999999999877 6666 99999999999999999999865331
Q ss_pred cccHHHHHHHHhhcCccccccc--ccccCCCC-CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 210 DYRLQDLVKKYIENESFKEIVD--PAIVGEEG-LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ....... .........+ ........ .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~---~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 L---VELFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp S---HHHHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H---HHHHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1111111 1111110000 00000000 000001223445889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=262.32 Aligned_cols=215 Identities=19% Similarity=0.216 Sum_probs=148.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999998 7899999987643
Q ss_pred ------CCC------------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc---ceeeccc
Q 039895 90 ------FPF------------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV---AQLFDFT 142 (284)
Q Consensus 90 ------~~~------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfg 142 (284)
+|. ......++.|++.||.||| +.+|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 110 1456789999999999999 899999999999999997764 8999999
Q ss_pred cccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh
Q 039895 143 LSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE 222 (284)
Q Consensus 143 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....|......
T Consensus 170 ~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~ 238 (676)
T 3qa8_A 170 YAKELDQGELC----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVRE 238 (676)
T ss_dssp CCCBTTSCCCC----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC-
T ss_pred ccccccccccc----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhc
Confidence 99877544322 22578999999999999999999999999999999999999996532 00110000000
Q ss_pred cCcccccccccccCC----CC--CCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHH-----HHHHHHHHHh
Q 039895 223 NESFKEIVDPAIVGE----EG--LMWPEKEQQLLICTELAFKCLSESEGDRPTIVQ-----VAKQLRQIYQ 282 (284)
Q Consensus 223 ~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~e-----v~~~L~~l~~ 282 (284)
.............+. .. .........+..+.+++.+||+.||++|||+.| ..+.++.+.+
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000000000000 00 000112334566889999999999999999988 5566666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=233.62 Aligned_cols=177 Identities=21% Similarity=0.262 Sum_probs=129.5
Q ss_pred hcCCCCC-CeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 54 TDDFDGG-KVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
.++|... +.||+|+||.||+|.. +++.||+|++...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 3556554 6799999999999998 7899999998654
Q ss_pred CC-----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeeccccccccCC
Q 039895 90 FP-----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ~~-----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~~~ 149 (284)
+| .......++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 11 11556789999999999999 999999999999999998 7889999999885432
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
+..++.++|||||||++|||++|..||....... .....
T Consensus 172 ------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----------------~~~~~ 210 (299)
T 3m2w_A 172 ------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------------ISPGM 210 (299)
T ss_dssp ------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------------CCS
T ss_pred ------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----------------hhHHH
Confidence 2346789999999999999999999996532100 00000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.............+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000001111234456889999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=258.21 Aligned_cols=184 Identities=22% Similarity=0.280 Sum_probs=144.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe---CCcceEEEeecCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL---QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~------------------------------------------ 89 (284)
+.|...+.||+|+||.||+|.+ +|+.||||++...
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 6788888999999999999998 5789999988533
Q ss_pred -----CC-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 -----FP-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 -----~~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+| ....++.++.||+.||.||| +.+|+||||||+|||++.+ .+||+|||+++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 11 01567889999999999999 8999999999999999975 8999999999876543
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
....||+.|+|||++.+.. +.++|||||||++|+|++|..|+..... ..+.
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------------~~~~---- 285 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------------DGLP---- 285 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------------SSCC----
T ss_pred ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------------cccc----
Confidence 1257999999999987654 8999999999999999999887653210 0000
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-TIVQVAKQLRQIY 281 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~ev~~~L~~l~ 281 (284)
. ..........+.+|+.+||+.||++|| +++++.+.|..+.
T Consensus 286 ----~-----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 ----E-----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----T-----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----c-----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 001122345588999999999999999 5667777777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=231.66 Aligned_cols=176 Identities=13% Similarity=0.069 Sum_probs=132.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTF------------------------------------------ 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------------------------------------------ 90 (284)
+.|...+.||+|+||.||+|.+ +|+.||||++....
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5688888999999999999999 58999999997541
Q ss_pred --CCc-------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 --PFS-------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 --~~~-------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|.. ...+.++.|++.||.||| +.+|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 110 456789999999999999 9999999999999999999999998443
Q ss_pred CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
|++ +++.++|||||||++|||++|..||......... . .......
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----------------~-~~~~~~~ 219 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----------------A-PAERDTA 219 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----------------E-ECCBCTT
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----------------H-HHHHHhc
Confidence 333 2688999999999999999999999754311100 0 0000000
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.............+..+.+++.+||+.||++| |+.|+++.|+++..
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000000112234458899999999999999 99999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=228.72 Aligned_cols=148 Identities=18% Similarity=0.116 Sum_probs=108.0
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC--------------------cceeeccccccccCCCCcc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN--------------------VAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~Dfg~a~~~~~~~~~ 153 (284)
.....++.||+.||.|||+ +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 161 ~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--- 235 (336)
T 2vuw_A 161 ATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---
T ss_pred HHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---
Confidence 5677899999999999993 47899999999999999887 8999999999876532
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGAL-LLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.... ................
T Consensus 236 -----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~----- 297 (336)
T 2vuw_A 236 -----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFK----- 297 (336)
T ss_dssp -----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCS-----
T ss_pred -----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccC-----
Confidence 157999999999998766 899999998777 677888888863100 0000111111010000
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
.....+.....++.+.+|+.+||+.| |+.|++
T Consensus 298 -----~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 298 -----TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp -----SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred -----cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11112334567778999999999976 999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-24 Score=193.94 Aligned_cols=95 Identities=17% Similarity=0.160 Sum_probs=64.5
Q ss_pred HHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCC
Q 039895 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD 176 (284)
Q Consensus 97 ~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 176 (284)
.+|+.||+.||+|+| ++|||||||||+|||++.+|.+||+|||+|+........ ..+.+||+.|||||++.+ .
T Consensus 342 ~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~---~~t~vGTp~YmAPE~l~g-~ 414 (569)
T 4azs_A 342 EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW---PTNLVQSFFVFVNELFAE-N 414 (569)
T ss_dssp HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC---SHHHHHHHHHHHHHHC----
T ss_pred HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc---ccCceechhhccHHHhCC-C
Confidence 468999999999999 999999999999999999999999999999877544322 122679999999999875 4
Q ss_pred CCcchhHHHHHHHHHHHHhCCC
Q 039895 177 FSEKSDVYSFGALLLELLTGKK 198 (284)
Q Consensus 177 ~~~~~DvwS~G~il~elltg~~ 198 (284)
+..++|+||+|++++++.++..
T Consensus 415 ~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 415 KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --------------CCCCTTHH
T ss_pred CCCcccccccccchhhhccccc
Confidence 6778999999998877655543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-22 Score=182.78 Aligned_cols=138 Identities=15% Similarity=0.112 Sum_probs=102.9
Q ss_pred CCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------------------------------
Q 039895 58 DGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------------ 89 (284)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------------ 89 (284)
...++||+|+||.||+|...+..+++|+....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 34578999999999999889999999986432
Q ss_pred -CCCc-------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc----CC
Q 039895 90 -FPFS-------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN----DS 157 (284)
Q Consensus 90 -~~~~-------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~----~~ 157 (284)
+|.. ...+.++.|++.||.||| +.+|+||||||+|||++. .+||+|||+++.......... ..
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~ 493 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFK 493 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhh
Confidence 2211 124589999999999999 999999999999999998 999999999988765322110 01
Q ss_pred CCcccCccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 039895 158 NRVIGTFGFMAPEYRTT--GDFSEKSDVYSFGALLLELLTGKKIS 200 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~G~il~elltg~~p~ 200 (284)
....||+.|||||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 494 ~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 494 KAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 12679999999999876 56788899999999888887776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-19 Score=151.00 Aligned_cols=99 Identities=14% Similarity=0.008 Sum_probs=81.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC--------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------------------------------------------- 89 (284)
..|...+.||+|+||.||+|.+ +|+.||+|++...
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~ 169 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 169 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeE
Confidence 3444558999999999999999 7899999998421
Q ss_pred -----------CCCc--------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 -----------FPFS--------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 -----------~~~~--------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.
T Consensus 170 ~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~---- 241 (282)
T 1zar_A 170 YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---- 241 (282)
T ss_dssp EEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE----
T ss_pred EeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE----
Confidence 1111 345689999999999999 99999999999999999 99999999999843
Q ss_pred CccccCCCCcccCcccccccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~ 173 (284)
+..++|||++.
T Consensus 242 ------------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ------------VGEEGWREILE 252 (282)
T ss_dssp ------------TTSTTHHHHHH
T ss_pred ------------CCCCCHHHHHH
Confidence 34468898764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=128.89 Aligned_cols=49 Identities=14% Similarity=0.187 Sum_probs=44.0
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccccccc
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSI 147 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~ 147 (284)
....++.|++.||.|||. ..+|+||||||+|||++. .++|+|||+|...
T Consensus 171 ~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 171 DVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 457899999999999994 579999999999999998 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-15 Score=129.08 Aligned_cols=89 Identities=10% Similarity=0.065 Sum_probs=73.9
Q ss_pred CCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------------------------------------- 89 (284)
-|.....||+|++|.||+|.. +|+.||||+++..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 377788999999999999998 8999999987532
Q ss_pred ----------------CCC---------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC----------
Q 039895 90 ----------------FPF---------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN---------- 134 (284)
Q Consensus 90 ----------------~~~---------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---------- 134 (284)
++. ......++.|++.+|.+|| ..|||||||||.|||++.++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~ 252 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITL 252 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCccccccccc
Confidence 000 0345678999999999999 89999999999999999877
Q ss_pred cceeecccccccc
Q 039895 135 VAQLFDFTLSLSI 147 (284)
Q Consensus 135 ~~kl~Dfg~a~~~ 147 (284)
.+.|+||+-+...
T Consensus 253 ~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 253 TPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECCCTTCEET
T ss_pred ceEEEEeCCcccC
Confidence 3789999976544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.7e-07 Score=77.04 Aligned_cols=96 Identities=18% Similarity=0.099 Sum_probs=72.3
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC---------------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------- 89 (284)
.+.....+|.....++.|+.+.||+....+..+++|+....
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 34455667776677888889999999988889999998641
Q ss_pred ---CCC----------chhHHHHHHHHHHHHHHhccCC------------------------------------------
Q 039895 90 ---FPF----------SVSKLKIAIEIASAVAYLHVGF------------------------------------------ 114 (284)
Q Consensus 90 ---~~~----------~~~~~~i~~~i~~gL~~LH~~~------------------------------------------ 114 (284)
+.. ......++.+++.+|..||...
T Consensus 88 v~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 000 0123478899999999999510
Q ss_pred --------------CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 --------------SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 --------------~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+|++|.|||++.+..+.|.||+.+
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 145899999999999987666679999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.34 E-value=3.2e-07 Score=74.91 Aligned_cols=27 Identities=15% Similarity=0.160 Sum_probs=24.4
Q ss_pred eeecccccCcEEEecCCcceeeccccc
Q 039895 118 VVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 118 ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
++|+|++|.|||++.++.+.|.||+.+
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987766779999976
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.08 E-value=2.1e-06 Score=72.11 Aligned_cols=83 Identities=13% Similarity=0.192 Sum_probs=48.7
Q ss_pred CCeeecccccCcEEEec--CCcceeeccccccccCCCCccccCCCCc--cc---------Cccccc-cccccCCCCCcch
Q 039895 116 RPVVSRDIKPTTIVLQE--ENVAQLFDFTLSLSIPEGETHINDSNRV--IG---------TFGFMA-PEYRTTGDFSEKS 181 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--~g---------t~~y~a-PE~~~~~~~~~~~ 181 (284)
..++|+|++|.||+++. ...+.|.||+.+................ .+ ..+... |+... ......
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~ 268 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLE--KYRMKE 268 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHH--HHHHHH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHH--HHHHHH
Confidence 35799999999999998 5567899999876543211100000000 00 001111 22111 011236
Q ss_pred hHHHHHHHHHHHHhCCCCC
Q 039895 182 DVYSFGALLLELLTGKKIS 200 (284)
Q Consensus 182 DvwS~G~il~elltg~~p~ 200 (284)
+.|++|.++|.+.+|..++
T Consensus 269 ~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHcCCHHH
Confidence 8999999999999997664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.05 E-value=6.4e-06 Score=70.79 Aligned_cols=87 Identities=11% Similarity=0.071 Sum_probs=65.6
Q ss_pred CCeeeecCCceEEEEEeCCcceEEEeec--CC-------------------------------CCC--------------
Q 039895 60 GKVIMKCLFYKLYKGFLQDRPISVMKFE--DT-------------------------------FPF-------------- 92 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~-------------------------------~~~-------------- 92 (284)
.+.|+.|.++.||+....+..+++|+.. .. +|.
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 3468899999999999877889999876 22 000
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCC-------------------------------------------
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGF------------------------------------------- 114 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~------------------------------------------- 114 (284)
...+..++.+++..|..||...
T Consensus 123 v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (359)
T 3dxp_A 123 VSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMD 202 (359)
T ss_dssp CCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHH
T ss_pred cCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHH
Confidence 1345678999999999999520
Q ss_pred ------------CCCeeecccccCcEEEecCCc--ceeeccccccc
Q 039895 115 ------------SRPVVSRDIKPTTIVLQEENV--AQLFDFTLSLS 146 (284)
Q Consensus 115 ------------~~~ivHrDlkp~NILl~~~~~--~kl~Dfg~a~~ 146 (284)
...++|+|++|.|||++.++. +.|.||+.+..
T Consensus 203 ~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 203 WLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.013 Score=48.26 Aligned_cols=30 Identities=20% Similarity=0.188 Sum_probs=25.2
Q ss_pred CCCeeeecCCceEEEEEe-CCcceEEEeecC
Q 039895 59 GGKVIMKCLFYKLYKGFL-QDRPISVMKFED 88 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~ 88 (284)
....+|.|..+.||+.+. +|+.|.||+...
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~ 49 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPD 49 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCT
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCC
Confidence 345689999999999999 889999998543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.015 Score=48.41 Aligned_cols=30 Identities=13% Similarity=0.286 Sum_probs=24.2
Q ss_pred CeeecccccCcEEEec---CCc-ceeeccccccc
Q 039895 117 PVVSRDIKPTTIVLQE---ENV-AQLFDFTLSLS 146 (284)
Q Consensus 117 ~ivHrDlkp~NILl~~---~~~-~kl~Dfg~a~~ 146 (284)
.++|+|+.|.|||++. ++. +.|.||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4699999999999987 344 47999997633
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0046 Score=52.10 Aligned_cols=30 Identities=17% Similarity=0.199 Sum_probs=27.3
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+|+.+.|||++.++.+.|.||+.+
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 578999999999999988888999999965
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.81 E-value=0.082 Score=41.59 Aligned_cols=90 Identities=11% Similarity=0.011 Sum_probs=53.9
Q ss_pred CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccc
Q 039895 91 PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPE 170 (284)
Q Consensus 91 ~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 170 (284)
..+.+...++.|.+.+|.-+-. ...-..+=+.|..|++..+|.+.+.+ +.+. .....+.|||
T Consensus 46 lsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------------~~~~~~~~pe 107 (229)
T 2yle_A 46 INEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------------AGEPPPVAGK 107 (229)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------------------C
T ss_pred cCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------------ccccCCCChh
Confidence 3457788899999999877620 11111223456889999999887764 2110 0122356888
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 039895 171 YRTTGDFSEKSDVYSFGALLLELLTGKKI 199 (284)
Q Consensus 171 ~~~~~~~~~~~DvwS~G~il~elltg~~p 199 (284)
... ...+.+.=|||+|+++|.-+--..|
T Consensus 108 ~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 108 LGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp CSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred hcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 653 3446778899999999998875544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.34 E-value=0.017 Score=50.41 Aligned_cols=77 Identities=16% Similarity=0.211 Sum_probs=46.7
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCccc--CccccccccccCC---CCCcchhHHHHHHH
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIG--TFGFMAPEYRTTG---DFSEKSDVYSFGAL 189 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwS~G~i 189 (284)
...++|+|++|.|||++.++ +.+.||+.+........... ..+ ...|.+|+..... .-....++.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA----YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH----HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH----HHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 78899999999999998776 99999988754321110000 010 1235666544311 11223455577777
Q ss_pred HHHHHhC
Q 039895 190 LLELLTG 196 (284)
Q Consensus 190 l~elltg 196 (284)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.22 E-value=0.051 Score=45.62 Aligned_cols=33 Identities=18% Similarity=0.176 Sum_probs=27.7
Q ss_pred CCCeeecccccCcEEEecC----Ccceeecccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEE----NVAQLFDFTLSLSI 147 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~----~~~kl~Dfg~a~~~ 147 (284)
...++|+|+.+.|||++.+ +.+.|.||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 67899999977543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.81 E-value=0.024 Score=46.01 Aligned_cols=27 Identities=15% Similarity=0.231 Sum_probs=24.3
Q ss_pred eeecccccCcEEEecCCcceeeccccc
Q 039895 118 VVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 118 ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
++|+|+.+.|||++.++.+-|.||+.+
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred EEcCCCCCCeEEEECCeEEEEEECccc
Confidence 799999999999998777779999976
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.59 E-value=0.024 Score=47.35 Aligned_cols=30 Identities=17% Similarity=0.386 Sum_probs=25.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
..+++|+|+.+.|||++.++.+.|.||+.+
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 356899999999999998766689999865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=93.32 E-value=0.032 Score=47.31 Aligned_cols=30 Identities=7% Similarity=0.211 Sum_probs=25.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+|+.+.|||++.+..+.|.||+.+
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a 250 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMV 250 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGC
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccc
Confidence 467999999999999996555789999976
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.11 E-value=0.092 Score=43.84 Aligned_cols=30 Identities=10% Similarity=0.109 Sum_probs=25.3
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
...++|+|+++.|||++ + .+.|.||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 56689999999999998 4 789999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=91.11 E-value=0.22 Score=41.06 Aligned_cols=31 Identities=10% Similarity=-0.005 Sum_probs=25.7
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
...++|+|+.+.||+ ..++.+.+.||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 456899999999999 6667789999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.66 E-value=0.11 Score=44.35 Aligned_cols=30 Identities=20% Similarity=0.292 Sum_probs=24.1
Q ss_pred CCCeeecccccCcEEEecCCcceeecccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
...++|+|+.+.|||++.++ +.+.||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 35689999999999998654 7899998663
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.41 E-value=0.11 Score=43.94 Aligned_cols=32 Identities=13% Similarity=0.261 Sum_probs=27.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999986644
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=90.38 E-value=0.31 Score=41.85 Aligned_cols=31 Identities=13% Similarity=0.333 Sum_probs=26.0
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
...++|+|+.|.|||++.++ +.+.||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 57899999999999998654 88999977643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.15 E-value=0.13 Score=44.97 Aligned_cols=17 Identities=18% Similarity=0.374 Sum_probs=14.8
Q ss_pred CeeecccccCcEEEecC
Q 039895 117 PVVSRDIKPTTIVLQEE 133 (284)
Q Consensus 117 ~ivHrDlkp~NILl~~~ 133 (284)
.++|+|+.+.|||++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 48999999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.97 E-value=0.28 Score=43.30 Aligned_cols=17 Identities=12% Similarity=0.149 Sum_probs=15.1
Q ss_pred CCCeeecccccCcEEEe
Q 039895 115 SRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~ 131 (284)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 35689999999999998
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=88.72 E-value=0.22 Score=42.83 Aligned_cols=30 Identities=30% Similarity=0.388 Sum_probs=25.8
Q ss_pred CCCeeecccccCcEEEecC----Ccceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEE----NVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~----~~~kl~Dfg~a 144 (284)
...++|+|+.+.|||++.+ +.+.+.||..+
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 3468999999999999876 68899999876
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.67 E-value=0.97 Score=35.44 Aligned_cols=76 Identities=16% Similarity=0.215 Sum_probs=52.8
Q ss_pred hhHHHHHHHHHHHHH-HhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccc
Q 039895 94 VSKLKIAIEIASAVA-YLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYR 172 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~-~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 172 (284)
..+++++..|+.-.. +++ .-+|--|.|+||+++.++.++|.-.|+-..+ +|.-
T Consensus 85 ~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l--------------------pP~e- 138 (219)
T 4ano_A 85 LSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKESL--------------------PPDE- 138 (219)
T ss_dssp HHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTTB--------------------SSCS-
T ss_pred HHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCcccC--------------------CCCC-
Confidence 678888888887666 444 4467778899999999999999988864222 2221
Q ss_pred cCCCCCcchh-HHHHHHHHHHHHhCCCCC
Q 039895 173 TTGDFSEKSD-VYSFGALLLELLTGKKIS 200 (284)
Q Consensus 173 ~~~~~~~~~D-vwS~G~il~elltg~~p~ 200 (284)
.+ ..| .-.+=|++..++.++..|
T Consensus 139 ----~~-ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 139 ----WD-DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ----CC-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred ----CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence 11 122 236677888888887665
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.12 E-value=0.42 Score=41.30 Aligned_cols=28 Identities=29% Similarity=0.367 Sum_probs=23.2
Q ss_pred eeecccccCcEEEe------cCCcceeecccccc
Q 039895 118 VVSRDIKPTTIVLQ------EENVAQLFDFTLSL 145 (284)
Q Consensus 118 ivHrDlkp~NILl~------~~~~~kl~Dfg~a~ 145 (284)
++|+|+.+.|||+. ++..+.+.||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 57999999999993 45678999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=84.11 E-value=0.44 Score=39.71 Aligned_cols=27 Identities=0% Similarity=0.056 Sum_probs=23.5
Q ss_pred CCCeeecccccCcEEEecCCcceeeccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFT 142 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg 142 (284)
...++|+|+.+.|++++.++ +.|.|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 56799999999999999887 8888874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.68 E-value=0.6 Score=40.72 Aligned_cols=30 Identities=20% Similarity=0.376 Sum_probs=25.7
Q ss_pred CCCeeecccccCcEEEecCCcceeecccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~ 145 (284)
...++|+|+.+.||+ +.++.+.+.||..+.
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 345899999999999 778889999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.61 E-value=1.6 Score=34.08 Aligned_cols=78 Identities=14% Similarity=0.120 Sum_probs=55.1
Q ss_pred hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCcccccccccc
Q 039895 94 VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRT 173 (284)
Q Consensus 94 ~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 173 (284)
..+++++..|+.-..+++ .-+|--|.|+||+++.++.+++.-.|+...+ +|.
T Consensus 81 ~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l--------------------~P~--- 132 (215)
T 4ann_A 81 NEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFFTRDGLPIAKTRGLQNVV--------------------DPL--- 132 (215)
T ss_dssp HHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEECTTSCEEESCCEETTTB--------------------SCC---
T ss_pred HHHHHHHHHHHHHHHHhc-----CceEEEEecceEEEcCCCCEEEEEccCccCC--------------------CCC---
Confidence 678899999988776555 2467789999999999999999988864322 221
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039895 174 TGDFSEKSDVYSFGALLLELLTGKKISY 201 (284)
Q Consensus 174 ~~~~~~~~DvwS~G~il~elltg~~p~~ 201 (284)
..+...=.-.+=|++..+++++..|.
T Consensus 133 --~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 133 --PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp --CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred --CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 11111123367788888999987763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 284 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-25 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-24 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-23 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-22 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-21 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-20 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-19 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-19 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-18 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-18 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-18 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-17 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-16 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-15 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-15 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-15 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-14 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-14 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-14 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-14 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-14 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-13 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-13 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-12 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-12 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-12 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-10 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-10 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-10 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-28
Identities = 41/190 (21%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ IA + A + YLH + ++ RD+K I L E+ ++ DF L+ +
Sbjct: 107 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQ 162
Query: 157 SNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
++ G+ +MAPE + +S +SDVY+FG +L EL+TG+ + + ++
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQI 218
Query: 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+V + + ++ P+ L +CL + +RP Q+
Sbjct: 219 IFMVGRGYLSPDLSKVRSN---------CPKA------MKRLMAECLKKKRDERPLFPQI 263
Query: 274 AKQLRQIYQS 283
+ + +S
Sbjct: 264 LASIELLARS 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 9e-27
Identities = 34/187 (18%), Positives = 70/187 (37%), Gaps = 26/187 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
++ +++ + YL + V RD+ ++L + A++ DF LS ++ +++
Sbjct: 112 AELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ + APE FS +SDV+S+G + E L+ + + + +
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ----KPYKKMKGPEVMAF 224
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+++ E E L C DRP + V ++
Sbjct: 225 IEQGKRMECPPECPPELY-------------------ALMSDCWIYKWEDRPDFLTVEQR 265
Query: 277 LRQIYQS 283
+R Y S
Sbjct: 266 MRACYYS 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-26
Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 28/187 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L +A +IA +A++ R + RD++ I++ + ++ DF L+ I + E
Sbjct: 112 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-- 166
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ APE G F+ KSDV+SFG LL E++T +I Y ++
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-------PGMTNPEV 219
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
++ +V P EE +L C E DRPT +
Sbjct: 220 IQNLERGY---RMVRPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 277 LRQIYQS 283
L + +
Sbjct: 264 LEDFFTA 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-26
Identities = 39/199 (19%), Positives = 81/199 (40%), Gaps = 15/199 (7%)
Query: 97 LKIAIEIASAVAYLHVGF-----SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151
+K+A+ AS +A+LH+ + RD+K I++++ + D L++
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162
Query: 152 THIN-DSNRVIGTFGFMAPEYRTT------GDFSEKSDVYSFGALLLELLTGKKISYSSH 204
I+ N +GT +MAPE + +++D+Y+ G + E+ I
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI---GG 219
Query: 205 FDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESE 264
+ DLV E +++V + + + L + ++ +C +
Sbjct: 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279
Query: 265 GDRPTIVQVAKQLRQIYQS 283
R T +++ K L Q+ Q
Sbjct: 280 AARLTALRIKKTLSQLSQQ 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-26
Identities = 39/187 (20%), Positives = 69/187 (36%), Gaps = 26/187 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+++ +++ + YL V RD+ ++L ++ A++ DF LS ++ E +
Sbjct: 110 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ APE FS KSDV+SFG L+ E + + Y + ++
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY-------RGMKGSEV 219
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ E PA E +L C + +RP V +
Sbjct: 220 TAMLEKGERMG---CPAGCPRE-------------MYDLMNLCWTYDVENRPGFAAVELR 263
Query: 277 LRQIYQS 283
LR Y
Sbjct: 264 LRNYYYD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-26
Identities = 39/187 (20%), Positives = 76/187 (40%), Gaps = 28/187 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L + +++ +AYL V+ RD+ ++ E V ++ DF ++ + + +
Sbjct: 104 LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--S 158
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
S + +PE + +S KSDV+SFG L+ E+ + KI Y E+ ++
Sbjct: 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-------ENRSNSEV 211
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
V+ + P + ++ C E DRP ++ +Q
Sbjct: 212 VEDISTGF---RLYKPRLASTH-------------VYQIMNHCWKERPEDRPAFSRLLRQ 255
Query: 277 LRQIYQS 283
L +I +S
Sbjct: 256 LAEIAES 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 6e-25
Identities = 40/204 (19%), Positives = 80/204 (39%), Gaps = 27/204 (13%)
Query: 82 SVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDF 141
+ ++ E P + +++A + +L + V RD+ +L E+ ++ DF
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 142 TLSLSIPEGETH-INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKIS 200
L+ + + E +++ +MA E T F+ KSDV+SFG LL EL+T
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 201 YSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCL 260
Y D D+ ++ + ++ P + E+ KC
Sbjct: 235 Y-------PDVNTFDITVYLLQG---RRLLQPEYCPDP-------------LYEVMLKCW 271
Query: 261 SESEGDRPTIVQVAKQLRQIYQSN 284
RP+ ++ ++ I+ +
Sbjct: 272 HPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.2 bits (244), Expect = 9e-25
Identities = 44/188 (23%), Positives = 73/188 (38%), Gaps = 28/188 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +A +IAS +AY+ V RD++ I++ E V ++ DF L+ I + E
Sbjct: 116 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-- 170
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ APE G F+ KSDV+SFG LL EL T + + + + D
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR----VPYPGMVNREVLDQ 226
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
V++ E + +L +C + +RPT +
Sbjct: 227 VERGYRMPCPPECPESLH-------------------DLMCQCWRKEPEERPTFEYLQAF 267
Query: 277 LRQIYQSN 284
L + S
Sbjct: 268 LEDYFTST 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 9e-25
Identities = 30/187 (16%), Positives = 69/187 (36%), Gaps = 26/187 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + IA+ + YL + V RD+ I++ V ++ DF LS + +
Sbjct: 113 VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
++ + APE + F+ SDV+SFG ++ E++T + + + ++ +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE----RPYWELSNHEVMKA 225
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ + + +L +C + RP +
Sbjct: 226 INDGFRLPTPMDCPSAIY-------------------QLMMQCWQQERARRPKFADIVSI 266
Query: 277 LRQIYQS 283
L ++ ++
Sbjct: 267 LDKLIRA 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 1e-24
Identities = 41/177 (23%), Positives = 65/177 (36%), Gaps = 33/177 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
E+A+A++Y H S+ V+ RDIKP ++L ++ DF S+ P
Sbjct: 109 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--- 162
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ GT ++ PE EK D++S G L E L GK F+
Sbjct: 163 --TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-----PPFEANTYQETYKR 215
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ + E P V E +L + L + RP + +V
Sbjct: 216 ISR-------VEFTFPDFVTEG-------------ARDLISRLLKHNPSQRPMLREV 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 2e-24
Identities = 48/284 (16%), Positives = 99/284 (34%), Gaps = 44/284 (15%)
Query: 8 RKSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCL 67
++ +E R M E I G H + + K VI++
Sbjct: 52 KEGATHSEHRALMS-------ELKILIHIGHHLNVVNLLGACTKPGGPLM----VIVEFC 100
Query: 68 FYKLYKGFLQDRPISVMKFEDTFPFSVSK-------LKIAIEIASAVAYLHVGFSRPVVS 120
+ +L+ + + ++ + + ++A + +L SR +
Sbjct: 101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIH 157
Query: 121 RDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEK 180
RD+ I+L E+NV ++ DF L+ I + ++ +MAPE ++ +
Sbjct: 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQ 216
Query: 181 SDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGL 240
SDV+SFG LL E+ + Y ++ + + ++ + D
Sbjct: 217 SDVWSFGVLLWEIFSLGASPY-------PGVKIDEEFCRRLKEGTRMRAPDY-------- 261
Query: 241 MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284
+ + C RPT ++ + L + Q+N
Sbjct: 262 -TTPE------MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.1 bits (238), Expect = 8e-24
Identities = 40/184 (21%), Positives = 74/184 (40%), Gaps = 27/184 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L IA ++A+ +AYL R V RD+ ++ E V ++ DF LS +I + +
Sbjct: 143 LCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA- 198
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+M PE ++ +SDV+++G +L E+ + Y
Sbjct: 199 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--------------- 243
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ +E++ + L PE L L C S+ DRP+ + +
Sbjct: 244 -----YGMAHEEVIY-YVRDGNILACPENCPLELY--NLMRLCWSKLPADRPSFCSIHRI 295
Query: 277 LRQI 280
L+++
Sbjct: 296 LQRM 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 2e-23
Identities = 33/183 (18%), Positives = 70/183 (38%), Gaps = 28/183 (15%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
++ ++ A+ YL + + RD+ ++ ++ V ++ DF LS + + E S
Sbjct: 104 EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--S 158
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217
+ PE FS KSD+++FG L+ E+ + K+ Y E + +
Sbjct: 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETA 211
Query: 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQL 277
+ + + P + E+ + + C E +RPT + +
Sbjct: 212 EHIAQG---LRLYRPHLASEK-------------VYTIMYSCWHEKADERPTFKILLSNI 255
Query: 278 RQI 280
+
Sbjct: 256 LDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 2e-23
Identities = 35/172 (20%), Positives = 71/172 (41%), Gaps = 12/172 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
K++I + + YL ++ RD+KP+ I++ +L DF +S + +
Sbjct: 107 GKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---- 160
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
N +GT +M+PE +S +SD++S G L+E+ G+ + L+ +
Sbjct: 161 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP-----IPPPDAKELELM 214
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP 268
+E ++ + P G + + + EL ++E P
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.8 bits (235), Expect = 2e-23
Identities = 35/189 (18%), Positives = 72/189 (38%), Gaps = 28/189 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + IA+ + YL V RD+ I++ V ++ DF LS + + +
Sbjct: 131 VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 157 SNRV--IGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
++ + + APE F+ SDV+S+G ++ E+++ + Y D Q
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-------WDMTNQ 240
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274
D++ ++ +D P +L C + RP Q+
Sbjct: 241 DVINAIEQDYRLPPPMD----------CPSA------LHQLMLDCWQKDRNHRPKFGQIV 284
Query: 275 KQLRQIYQS 283
L ++ ++
Sbjct: 285 NTLDKMIRN 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 3e-23
Identities = 34/181 (18%), Positives = 67/181 (37%), Gaps = 26/181 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L A ++A + +L + V RD+ +++ V ++ DF L+ I ++
Sbjct: 167 LCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
N +MAPE G ++ KSDV+S+G LL E+ + Y
Sbjct: 224 GN-ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI------------ 270
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ +F +++ ++ E+ + C + RP+ +
Sbjct: 271 ----PVDANFYKLIQNGFKMDQPFYATEE------IYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 277 L 277
L
Sbjct: 321 L 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 4e-23
Identities = 32/186 (17%), Positives = 67/186 (36%), Gaps = 27/186 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L ++IA + YL R +V RD+ ++++ ++ DF L+ + E +
Sbjct: 114 LNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH- 169
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ +MA E ++ +SDV+S+G + EL+T Y + ++
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------DGIPASEI 222
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ E P I + + KC RP ++ +
Sbjct: 223 SSILEKGERLP---QPPICTID-------------VYMIMVKCWMIDADSRPKFRELIIE 266
Query: 277 LRQIYQ 282
++ +
Sbjct: 267 FSKMAR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 5e-23
Identities = 37/227 (16%), Positives = 78/227 (34%), Gaps = 26/227 (11%)
Query: 56 DFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFS 115
++ ++ L K ++M+ ++ L + ++A +A+L S
Sbjct: 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---S 163
Query: 116 RPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTG 175
+ + RD+ I+L + ++ DF L+ I ++ +MAPE
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNC 222
Query: 176 DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIV 235
++ +SDV+S+G L EL + Y D F +++
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----------------SKFYKMIKEGFR 266
Query: 236 GEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282
P + ++ C RPT Q+ + + +
Sbjct: 267 MLSPEHAPAE------MYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 8e-23
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 32/184 (17%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
LK ++++ A+ YL V RD+ +++ E+NVA++ DF L+ +
Sbjct: 106 LKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--- 159
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ APE FS KSDV+SFG LL E+ + ++ Y L+D+
Sbjct: 160 ---GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------PRIPLKDV 209
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
V + + P E+ C RP+ +Q+ +Q
Sbjct: 210 VPRVEKGYKMDA---PDGCPPA-------------VYEVMKNCWHLDAAMRPSFLQLREQ 253
Query: 277 LRQI 280
L I
Sbjct: 254 LEHI 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.9 bits (230), Expect = 9e-23
Identities = 40/189 (21%), Positives = 75/189 (39%), Gaps = 28/189 (14%)
Query: 96 KLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155
L +A +I+SA+ YL + + RD+ ++ E ++ ++ DF LS +
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA- 172
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ APE FS KSDV++FG LL E+ T S + + ++ +
Sbjct: 173 -HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDLSQVYE 227
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
L++K E + + EL C + DRP+ ++ +
Sbjct: 228 LLEKDYRMERPEGCPEKVY-------------------ELMRACWQWNPSDRPSFAEIHQ 268
Query: 276 QLRQIYQSN 284
++Q +
Sbjct: 269 AFETMFQES 277
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 1e-22
Identities = 39/184 (21%), Positives = 71/184 (38%), Gaps = 25/184 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A+++A + YL S+ + RD+ ++L ++ ++ DF L ++P+ + H
Sbjct: 114 SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
F + APE T FS SD + FG L E+ T + + +
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-------IGLNGSQI 223
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ K + +EG P E + +C + DRPT V +
Sbjct: 224 LHK---------------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
Query: 277 LRQI 280
L +
Sbjct: 269 LLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 5e-22
Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 27/180 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ ++ + V YLH + RDIKP ++L E + ++ DF L+
Sbjct: 106 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL- 161
Query: 157 SNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
N++ GT ++APE +F +E DV+S G +L +L G+ D
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE---LPWDQPSDSCQEYSD 218
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275
+K +K+I + L K L E+ R TI + K
Sbjct: 219 WKEKKTYLNPWKKIDSAPL-------------------ALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 9e-22
Identities = 37/179 (20%), Positives = 71/179 (39%), Gaps = 29/179 (16%)
Query: 97 LKIAIEIASAVAYLH--VGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154
L++ ++ A+ H V+ RD+KP + L + +L DF L+ + +
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF- 170
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
+ +GT +M+PE ++EKSD++S G LL EL + +
Sbjct: 171 --AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------- 221
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ I F+ I P +E E+ + L+ + RP++ ++
Sbjct: 222 --LAGKIREGKFRRI--PYRYSDE-------------LNEIITRMLNLKDYHRPSVEEI 263
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 1e-21
Identities = 36/178 (20%), Positives = 69/178 (38%), Gaps = 30/178 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHIN 155
+I + +LH + P++ RD+K I + ++ D L+
Sbjct: 115 RSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-- 171
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
VIGT FMAPE + E DVY+FG +LE+ T + + + ++
Sbjct: 172 ---AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYR 223
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
V ++ SF ++ P + E+ C+ +++ +R +I +
Sbjct: 224 RVTSGVKPASFDKVAIPEVK------------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 1e-21
Identities = 36/186 (19%), Positives = 71/186 (38%), Gaps = 30/186 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
L A ++A + YL + + RD+ I++ E VA++ DF LS
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+MA E ++ SDV+S+G LL E+++ Y +L
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-------CGMTCAEL 235
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+K + ++ ++ ++ +L +C E +RP+ Q+
Sbjct: 236 YEKLPQGYRLEKPLN----------CDDE------VYDLMRQCWREKPYERPSFAQILVS 279
Query: 277 LRQIYQ 282
L ++ +
Sbjct: 280 LNRMLE 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 5e-21
Identities = 37/177 (20%), Positives = 68/177 (38%), Gaps = 28/177 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ E A+ +LH S V+ RDIK I+L + +L DF I ++
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 172
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ ++GT +MAPE T + K D++S G + +E++ G+ + + R L
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-----YLNENPLRALYL 227
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
I E+ +P + + +CL R + ++
Sbjct: 228 ----IATNGTPELQNPEKLSAI-------------FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 2e-20
Identities = 39/184 (21%), Positives = 71/184 (38%), Gaps = 27/184 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A ++A + YL S+ + RD+ +++ E+NV ++ DF L+ I + +
Sbjct: 138 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK- 193
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ +MAPE ++ +SDV+SFG LL E+ T S + L L
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG----SPYPGVPVEELFKL 249
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+K+ + + + C RPT Q+ +
Sbjct: 250 LKEGHRMDKPSNCTNELY-------------------MMMRDCWHAVPSQRPTFKQLVED 290
Query: 277 LRQI 280
L +I
Sbjct: 291 LDRI 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 5e-20
Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 28/186 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ A ++++A+AYL S+ V RDI +++ + +L DF LS + + +
Sbjct: 111 ILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-- 165
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+++ +MAPE F+ SDV+ FG + E+L + + + D+
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-------QGVKNNDV 218
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
+ + E M P L L KC + RP ++ Q
Sbjct: 219 IGRIENGERLP-------------MPPNCPPTLY---SLMTKCWAYDPSRRPRFTELKAQ 262
Query: 277 LRQIYQ 282
L I +
Sbjct: 263 LSTILE 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 84.4 bits (208), Expect = 1e-19
Identities = 34/186 (18%), Positives = 77/186 (41%), Gaps = 25/186 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+++ + A+ + H ++ RD+KP I++ N ++ DF ++ +I + +
Sbjct: 114 IEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ VIGT +++PE +SDVYS G +L E+LTG+ F +
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSP---VSV 222
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-TIVQVAK 275
+++ + + + + K L+++ +R T ++
Sbjct: 223 AYQHVREDPIPPSARHEGLSAD-------------LDAVVLKALAKNPENRYQTAAEMRA 269
Query: 276 QLRQIY 281
L +++
Sbjct: 270 DLVRVH 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (205), Expect = 3e-19
Identities = 35/182 (19%), Positives = 61/182 (33%), Gaps = 33/182 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ + A+ YLH ++ RD+K I+ + +L DF +S
Sbjct: 113 QVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--- 166
Query: 157 SNRVIGTFGFMAPEY-----RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY 211
+ IGT +MAPE + K+DV+S G L+E+ + +
Sbjct: 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE-----PPHHELNPM 221
Query: 212 RLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIV 271
R+ I + P+ + KCL ++ R T
Sbjct: 222 RVL----LKIAKSEPPTLAQPSRWSSN-------------FKDFLKKCLEKNVDARWTTS 264
Query: 272 QV 273
Q+
Sbjct: 265 QL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 5e-19
Identities = 54/277 (19%), Positives = 111/277 (40%), Gaps = 37/277 (13%)
Query: 9 KSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLF 68
K++ +A + + + L E + H+ +R T VIM+ +
Sbjct: 56 KTVNEAASMRERI---EFLNEASVMKEFNCHHVVRLLGVVSQGQPTL------VIMELMT 106
Query: 69 YKLYKGFLQDRPISVMKFEDTFPFSVSKLK-IAIEIASAVAYLHVGFSRPVVSRDIKPTT 127
K +L+ ++ P S+SK+ +A EIA +AYL+ + V RD+
Sbjct: 107 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARN 163
Query: 128 IVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFG 187
++ E+ ++ DF ++ I E + + + + +M+PE G F+ SDV+SFG
Sbjct: 164 CMVAEDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 222
Query: 188 ALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ 247
+L E+ T + Y + + +++ +E P+
Sbjct: 223 VVLWEIATLAEQPY-------QGLSNEQVLRFVMEGGLLD--------------KPDNCP 261
Query: 248 QLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284
+L EL C + RP+ +++ +++ +
Sbjct: 262 DMLF--ELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 80.4 bits (198), Expect = 4e-18
Identities = 41/180 (22%), Positives = 64/180 (35%), Gaps = 36/180 (20%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +AYLH S ++ RD+K I+L E + +L DF + + +
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAP 167
Query: 157 SNRVIGTFGFMAPEY---RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
+N +GT +MAPE G + K DV+S G +EL K + +
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--------NMNA 219
Query: 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ +NES W E CL + DRPT +
Sbjct: 220 MSALYHIAQNESPALQSGH---------WSEY------FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.9 bits (196), Expect = 5e-18
Identities = 37/195 (18%), Positives = 73/195 (37%), Gaps = 27/195 (13%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE---NVAQLFDFTLSLSIPEGETH 153
L +A ++ S + Y+H S+ + RD+KP ++ N+ + DF L+ + TH
Sbjct: 106 LLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 154 IND----SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGE 209
+ + + GT + + + S + D+ S G +L+ G
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-- 220
Query: 210 DYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT 269
++ E S K++ P V +G +P + L C S D+P
Sbjct: 221 -------KRQKYERISEKKMSTPIEVLCKG--YPSEFATYLN------FCRSLRFDDKPD 265
Query: 270 IVQVAKQLRQIYQSN 284
+ + R ++
Sbjct: 266 YSYLRQLFRNLFHRQ 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 6e-18
Identities = 35/180 (19%), Positives = 70/180 (38%), Gaps = 11/180 (6%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ ++ + +LH S VV RD+KP I++ +L DF L+
Sbjct: 119 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--- 172
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
V+ T + APE ++ D++S G + E+ K + + D + ++ D+
Sbjct: 173 -TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL-FRGSSDVDQLGKILDV 230
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI---CTELAFKCLSESEGDRPTIVQV 273
+ E + +++ P P ++ I +L KCL+ + R +
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (193), Expect = 2e-17
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 29/177 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
EI SA+ YLH + ++ RD+KP I+L E+ Q+ DF + + E+
Sbjct: 111 RFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA-KVLSPESKQAR 166
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+N +GT +++PE T + SD+++ G ++ +L+ G F G +Y +
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL-----PPFRAGNEYLIFQK 221
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ K F E P +L K L R ++
Sbjct: 222 IIK--LEYDFPEKFFPK------------------ARDLVEKLLVLDATKRLGCEEM 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 77.2 bits (189), Expect = 5e-17
Identities = 25/197 (12%), Positives = 66/197 (33%), Gaps = 29/197 (14%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-----ENVAQLFDFTLSLSIPEGE 151
A ++ + V +H + +V RDIKP ++ N+ + DF + +
Sbjct: 104 AMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 152 T----HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDD 207
T + + GT +M+ + S + D+ + G + + L G
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKA 218
Query: 208 GEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDR 267
+ + + + + ++ +E+ +PE+ + + + +
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAG---------FPEEFYKYM------HYARNLAFDAT 263
Query: 268 PTIVQVAKQLRQIYQSN 284
P + ++ +
Sbjct: 264 PDYDYLQGLFSKVLERL 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 76.3 bits (187), Expect = 1e-16
Identities = 36/179 (20%), Positives = 60/179 (33%), Gaps = 30/179 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVAQLFDFTLSLSIPEGETHI 154
++ ++ + ++H V D+KP I+ + N +L DF L+ + ++
Sbjct: 127 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
GT F APE +D++S G L LL+G S F D
Sbjct: 184 V----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETL 234
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
VK + + + I + + K L R TI Q
Sbjct: 235 RNVKS--CDWNMDDSAFSGISED--------------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 74.7 bits (183), Expect = 3e-16
Identities = 36/183 (19%), Positives = 64/183 (34%), Gaps = 34/183 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
KI + + LH +V RD+KP I+L ++ +L DF S + GE
Sbjct: 113 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--- 166
Query: 157 SNRVIGTFGFMAPEYRTTGD------FSEKSDVYSFGALLLELLTGKKISYSSHFDDGED 210
V GT ++APE + ++ D++S G ++ LL G F +
Sbjct: 167 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQ 220
Query: 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTI 270
+ ++ E D + + + L+ + L R T
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDD----------YSDTVKDLVS------RFLVVQPQKRYTA 264
Query: 271 VQV 273
+
Sbjct: 265 EEA 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-15
Identities = 48/272 (17%), Positives = 93/272 (34%), Gaps = 25/272 (9%)
Query: 9 KSLEKAEKRKFMLGNGKILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLF 68
K + E + + + L E I N I D ++ T + ++ L
Sbjct: 39 KKISPFEHQTYCQ---RTLREIKILLRFRHENIIGIN--DIIRAPTIEQMKDVYLVTHLM 93
Query: 69 YKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTI 128
L+ + +S +I + Y+H S V+ RD+KP+ +
Sbjct: 94 GADLYKLLKTQHLSNDH----------ICYFLYQILRGLKYIH---SANVLHRDLKPSNL 140
Query: 129 VLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFG 187
+L ++ DF L+ H + T + APE +++ D++S G
Sbjct: 141 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200
Query: 188 ALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQ 247
+L E+L+ + I H+ D ++ L L E+ + + +
Sbjct: 201 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 260
Query: 248 QLLI------CTELAFKCLSESEGDRPTIVQV 273
L +L K L+ + R + Q
Sbjct: 261 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 72.0 bits (176), Expect = 5e-15
Identities = 32/179 (17%), Positives = 59/179 (32%), Gaps = 30/179 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL--QEENVAQLFDFTLSLSIPEGETHI 154
+ + + ++H +V DIKP I+ ++ + ++ DF L+ + E
Sbjct: 130 INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV- 185
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
T F APE +D+++ G L LL+G F +D
Sbjct: 186 ---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETL 237
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
VK+ + F E ++ E + L + R T+
Sbjct: 238 QNVKR--CDWEFDEDAFSSVSPE--------------AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (174), Expect = 6e-15
Identities = 32/185 (17%), Positives = 58/185 (31%), Gaps = 20/185 (10%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
+ + YLH ++ RD+KP ++L E V +L DF L+ S
Sbjct: 104 AYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT-- 158
Query: 158 NRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ T + APE + D+++ G +L ELL D
Sbjct: 159 -HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF-----LPGDSDLDQLTR 212
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI--------CTELAFKCLSESEGDRP 268
+ + + + ++ D + + L +L + R
Sbjct: 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
Query: 269 TIVQV 273
T Q
Sbjct: 273 TATQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.5 bits (172), Expect = 1e-14
Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 31/180 (17%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
A EI + +LH S+ +V RD+K I+L ++ ++ DF + G+ N
Sbjct: 106 TFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN- 161
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
GT ++APE ++ D +SFG LL E+L G+ S F ++ L
Sbjct: 162 --TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ-----SPFHGQDEEELFHS 214
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276
++ +N + ++ +L K R + +Q
Sbjct: 215 IRM--DNPFYPRWLEKE------------------AKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (170), Expect = 2e-14
Identities = 30/179 (16%), Positives = 61/179 (34%), Gaps = 30/179 (16%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ--LFDFTLSLSIPEGETHI 154
+ ++ A+ +LH S + DI+P I+ Q + + +F + + G+
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF- 160
Query: 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
+ + APE S +D++S G L+ LL+G F + ++
Sbjct: 161 ---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-----FLAETNQQII 212
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ + +F E I E + + L + R T +
Sbjct: 213 ENIMN--AEYTFDEEAFKEISIE--------------AMDFVDRLLVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.4 bits (169), Expect = 3e-14
Identities = 38/186 (20%), Positives = 68/186 (36%), Gaps = 34/186 (18%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
A EI + ++H +R VV RD+KP I+L E ++ D L+ + + H
Sbjct: 110 RFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 163
Query: 157 SNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+GT G+MAPE G + +D +S G +L +LL G F + +
Sbjct: 164 --ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS-----PFRQHKTKDKHE 216
Query: 216 LVKKYIENE-SFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV- 273
+ + + + P L L R +
Sbjct: 217 IDRMTLTMAVELPDSFSPE------------------LRSLLEGLLQRDVNRRLGCLGRG 258
Query: 274 AKQLRQ 279
A+++++
Sbjct: 259 AQEVKE 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.0 bits (168), Expect = 4e-14
Identities = 32/123 (26%), Positives = 58/123 (47%), Gaps = 14/123 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
A E+ A+ YLH S+ ++ RD+KP I+L + ++ DF + +P+
Sbjct: 107 KFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY---- 159
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ GT ++APE +T +++ D +SFG L+ E+L G F D + +
Sbjct: 160 --TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT-----PFYDSNTMKTYEK 212
Query: 217 VKK 219
+
Sbjct: 213 ILN 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (167), Expect = 4e-14
Identities = 26/181 (14%), Positives = 58/181 (32%), Gaps = 10/181 (5%)
Query: 98 KIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157
++ + + H R V+ RD+KP +++ +L +F L+ + S
Sbjct: 105 SFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YS 159
Query: 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV 217
V+ + +S D++S G + EL + + + D + R+ L+
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 218 KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI-----CTELAFKCLSESEGDRPTIVQ 272
E + P ++ +L L + R + +
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 273 V 273
Sbjct: 280 A 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 6e-14
Identities = 29/187 (15%), Positives = 62/187 (33%), Gaps = 21/187 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
++ +A+ H S V+ RD+KP +++ E +L DF L+ +
Sbjct: 105 KSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 157 SNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ T + APE +S D++S G + E++T + + F +
Sbjct: 162 ---EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL-----FPGDSEIDQLF 213
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI---------CTELAFKCLSESEGD 266
+ + + + + +P+ +Q L + L
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
Query: 267 RPTIVQV 273
R +
Sbjct: 274 RISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 1e-13
Identities = 39/185 (21%), Positives = 72/185 (38%), Gaps = 17/185 (9%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHIN 155
++ ++AY+H S + RDIKP ++L + V +L DF + + GE +++
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 156 DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ + D++ DV+S G +L ELL G+ I D ++
Sbjct: 182 ---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 216 LVKKYIE-----NESFKEIVDPAIVGE--EGLMWPEKEQQLLICTELAFKCLSESEGDRP 268
L E N ++ E P I + P + + L + L + R
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI---ALCSRLLEYTPTARL 295
Query: 269 TIVQV 273
T ++
Sbjct: 296 TPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (162), Expect = 3e-13
Identities = 34/180 (18%), Positives = 61/180 (33%), Gaps = 27/180 (15%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGETH 153
+I I A+ YLH S + RD+KP ++ + + +L DF + +
Sbjct: 114 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
T ++APE + + D++S G ++ LL G F +
Sbjct: 171 ----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAI 221
Query: 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+K I ++ W E +++ L L R TI +
Sbjct: 222 SPGMKTRIRMGQYEFPNPE---------WSEVSEEVK---MLIRNLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 65.3 bits (158), Expect = 5e-13
Identities = 41/216 (18%), Positives = 75/216 (34%), Gaps = 9/216 (4%)
Query: 62 VIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSR 121
VI L L ++ + SV+ +++ + +AY H R V+ R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 122 DIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKS 181
D+KP +++ E ++ DF L+ + + ++ + + +S
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 182 DVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLV---KKYIENESFKEIVDPAIVGEE 238
D++S G + E++ G + D + L K N + DP E
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 239 GLMWPEKEQQL-LICTELAFKCLSESEGDRPTIVQV 273
L W + L +L K L R T Q
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (156), Expect = 1e-12
Identities = 40/181 (22%), Positives = 62/181 (34%), Gaps = 32/181 (17%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQ----LFDFTLSLSIPEGET 152
+ +I + V YLH S + D+KP I+L + NV + + DF L+ I G
Sbjct: 116 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYR 212
+ GT F+APE ++D++S G + LL+G E
Sbjct: 173 F----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLA 226
Query: 213 LQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQ 272
V E+E F A + + L + R TI
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAK-------------------DFIRRLLVKDPKKRMTIQD 267
Query: 273 V 273
Sbjct: 268 S 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (156), Expect = 1e-12
Identities = 33/121 (27%), Positives = 53/121 (43%), Gaps = 11/121 (9%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
EI SA+ YLH SR VV RDIK ++L ++ ++ DF L
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 163
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218
GT ++APE D+ D + G ++ E++ G+ F + + RL +L+
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR-----LPFYNQDHERLFELIL 218
Query: 219 K 219
Sbjct: 219 M 219
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.8 bits (154), Expect = 2e-12
Identities = 36/259 (13%), Positives = 81/259 (31%), Gaps = 23/259 (8%)
Query: 26 ILLEKLIASSNGKHNPIRSFSADELKTATDDFDGGKVIMKCLFYKLYKGFLQDRPISVMK 85
L E I N + K + + G + + F + L +
Sbjct: 56 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT 115
Query: 86 FEDTFPFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSL 145
+ ++ + + L+ ++ RD+K +++ + V +L DF L+
Sbjct: 116 LSEI-------KRVMQMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165
Query: 146 SIPEGE-THINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSS 203
+ + + N + T + PE D+ D++ G ++ E+ T I +
Sbjct: 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225
Query: 204 HFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI---------CTE 254
+ L + I E + + + + + L+ +K + +
Sbjct: 226 --TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 255 LAFKCLSESEGDRPTIVQV 273
L K L R
Sbjct: 284 LIDKLLVLDPAQRIDSDDA 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 63.1 bits (153), Expect = 4e-12
Identities = 39/180 (21%), Positives = 63/180 (35%), Gaps = 31/180 (17%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL---QEENVAQLFDFTLSLSIPEGETH 153
++ ++ AV YLH +V RD+KP ++ E++ + DF LS G
Sbjct: 110 SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166
Query: 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRL 213
+ GT G++APE +S+ D +S G + LL G F D D +L
Sbjct: 167 ----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKL 217
Query: 214 QDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ + K F I + + + R T Q
Sbjct: 218 FEQILK--AEYEFDSPYWDDISDS--------------AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.6 bits (149), Expect = 8e-12
Identities = 35/179 (19%), Positives = 60/179 (33%), Gaps = 41/179 (22%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVL-QEENVAQLFDFTLSLSIPEGETHIN 155
++ AV + H + V+ RDIK I++ +L DF + +
Sbjct: 113 RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----T 164
Query: 156 DSNRVIGTFGFMAPEY-RTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
GT + PE+ R + V+S G LL +++ G F+ E+
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-----IPFEHDEEIIRG 219
Query: 215 DLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV 273
+ F++ V C L CL+ DRPT ++
Sbjct: 220 QVF--------FRQRVSSE------------------CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.2 bits (145), Expect = 4e-11
Identities = 23/101 (22%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
A +I YLH S ++ RD+KP +++ ++ Q+ DF + +
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGR 194
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
+ + GT +APE + +++ D ++ G L+ E+ G
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (142), Expect = 1e-10
Identities = 37/194 (19%), Positives = 74/194 (38%), Gaps = 24/194 (12%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ ++ + +LH S ++ RD+KP+ IV++ + ++ DF L+ +
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--- 175
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK-------------KISYSS 203
+ T + APE + E D++S G ++ E++ K K+
Sbjct: 176 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 204 HFDDGEDYR-LQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTE---LAFKC 259
E + LQ V+ Y+EN + + + L + E L ++ L K
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 260 LSESEGDRPTIVQV 273
L R ++
Sbjct: 295 LVIDPAKRISVDDA 308
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (138), Expect = 3e-10
Identities = 35/182 (19%), Positives = 57/182 (31%), Gaps = 22/182 (12%)
Query: 99 IAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSN 158
+ I + V L ++ RDIK I+L L DF LS ET
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 159 RVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVK 218
+ + D +S G L+ ELLTG S F + Q +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQAEIS 245
Query: 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQV-AKQL 277
+ I +P++ L +L + L + R A ++
Sbjct: 246 RRILKSEPP--------------YPQEMSALAK--DLIQRLLMKDPKKRLGCGPRDADEI 289
Query: 278 RQ 279
++
Sbjct: 290 KE 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (136), Expect = 5e-10
Identities = 32/187 (17%), Positives = 67/187 (35%), Gaps = 22/187 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ ++ + Y+H + ++ RD+KP + + E+ ++ DF L+ +
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS------E 174
Query: 157 SNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQD 215
+ T + APE +++ D++S G ++ E++TGK D D +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK---TLFKGSDHLDQLKEI 231
Query: 216 LVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLL---------ICTELAFKCLSESEGD 266
+ F + + PE E++ + L K L
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 267 RPTIVQV 273
R T +
Sbjct: 292 RVTAGEA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 57.0 bits (136), Expect = 6e-10
Identities = 18/101 (17%), Positives = 42/101 (41%), Gaps = 2/101 (1%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+I+ ++ + Y+H ++ DIKP ++++ + + + +
Sbjct: 128 KQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGK 197
I T + +PE + +D++S L+ EL+TG
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 56.8 bits (136), Expect = 6e-10
Identities = 34/192 (17%), Positives = 69/192 (35%), Gaps = 22/192 (11%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHIN 155
EI A+ Y H S ++ RD+KP +++ E+ +L D+ L+ G+ +
Sbjct: 132 RFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 186
Query: 156 DSNRVIGTFGFMAPE-YRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQ 214
N + + F PE + D++S G +L ++ K+ + H + + R+
Sbjct: 187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 215 DLV-----------KKYIENESFKEIVDPAIVGEEGLMWPEKEQQLL--ICTELAFKCLS 261
++ + F +I+ + Q L+ + K L
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 262 ESEGDRPTIVQV 273
R T +
Sbjct: 305 YDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (113), Expect = 4e-07
Identities = 32/183 (17%), Positives = 64/183 (34%), Gaps = 14/183 (7%)
Query: 97 LKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIND 156
+ +I + Y+H S ++ RD+KP+ + + E+ ++ DF L+ T
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEM 175
Query: 157 SNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216
+ V + +++ D++S G ++ ELLTG+ + + D L+ +
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLI------CTELAFKCLSESEGDRPTI 270
E + P+ + +L K L R T
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 271 VQV 273
Q
Sbjct: 296 AQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 40.9 bits (95), Expect = 5e-05
Identities = 21/138 (15%), Positives = 50/138 (36%), Gaps = 18/138 (13%)
Query: 61 KVIMKCLFYKLYKGFLQDRPISVMKFEDTFPFSVSKL----KIAIEIASAVAYLHVGFSR 116
+ + K + K + + +M+ D ++ ++ I VA + R
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HR 122
Query: 117 PVVSRDIKPTTIVLQEENVAQLFDFTLSLSI--PEGETHINDSNRVIGTFGFMAPEYRTT 174
+V D+ +++ EE + + DF S+ + + R I T+ +
Sbjct: 123 GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITY------FS-- 173
Query: 175 GDFSEKSDVYSFGALLLE 192
+ + D+ S +L+
Sbjct: 174 RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 284 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.52 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 93.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 80.81 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=323.54 Aligned_cols=206 Identities=24% Similarity=0.361 Sum_probs=152.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC------------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT------------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------------------------------------------~~ 91 (284)
.++|...+.||+|+||+||+|++.+ .||||++... +|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 3678889999999999999999865 4999998644 11
Q ss_pred Cc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 FS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.. ..++.++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.........
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~- 161 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH- 161 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc-
Confidence 11 567889999999999999 8999999999999999999999999999998765432221
Q ss_pred CCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
......||+.|||||++.+ ..++.++|||||||++|||+||+.||.... ....+...+. .+... +
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~----~~~~~~~~~~----~~~~~----p 229 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIFMVG----RGYLS----P 229 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHH----HTSCC----C
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC----hHHHHHHHHh----cCCCC----C
Confidence 1223679999999999864 358999999999999999999999986432 1111111111 11111 1
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+.. ....+++.+.+|+.+||+.||++|||+.||++.|+.|.++
T Consensus 230 ~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLSK-------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CGGG-------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cchh-------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0000 0122344588999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=319.13 Aligned_cols=202 Identities=20% Similarity=0.324 Sum_probs=148.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCCc
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPFS 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~~ 93 (284)
++|+..+.||+|+||+||+|.+ ++..||||++... +|..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 3567778999999999999999 7788999998765 1111
Q ss_pred ----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 94 ----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 94 ----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
..++.++.|||.||.||| +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~- 160 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST- 160 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeec-
Confidence 567789999999999999 999999999999999999999999999999877554332222
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...||+.|+|||++.+..++.++|||||||++|||+|+..|++... . ............. ...
T Consensus 161 -~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~---~~~~~~~i~~~~~---~~~------ 223 (263)
T d1sm2a_ 161 -GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----S---NSEVVEDISTGFR---LYK------ 223 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----C---HHHHHHHHHHTCC---CCC------
T ss_pred -ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----C---HHHHHHHHHhcCC---CCC------
Confidence 2578999999999999999999999999999999999766654321 1 1222222111110 001
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+..++..+.+|+.+||+.||++|||++||++.|++|.++.
T Consensus 224 -------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~esg 263 (263)
T d1sm2a_ 224 -------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263 (263)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhCC
Confidence 1122345789999999999999999999999999999873
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=320.45 Aligned_cols=202 Identities=21% Similarity=0.333 Sum_probs=158.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCCc-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPFS- 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~~- 93 (284)
++|...+.||+|+||+||+|.+ ++..||||++... +|..
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENG 92 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTC
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCC
Confidence 4667778899999999999999 6678999999755 1111
Q ss_pred ----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 94 ----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 94 ----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+.........
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~- 168 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE- 168 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT-
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcccccc-
Confidence 567899999999999999 899999999999999999999999999999887654433222
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
...||+.|+|||++.+..++.++|||||||++|||+||..|++... .......... .+...
T Consensus 169 -~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~~~~~i~-~~~~~---------- 229 (272)
T d1qpca_ 169 -GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLE-RGYRM---------- 229 (272)
T ss_dssp -TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHH-TTCCC----------
T ss_pred -ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHHHHHHHHH-hcCCC----------
Confidence 2578999999999998899999999999999999999777665322 1112222111 11100
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
+.+..++..+.+|+.+||+.||++|||++||++.|++++.++
T Consensus 230 -----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 230 -----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 001122345889999999999999999999999999988653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=323.80 Aligned_cols=213 Identities=20% Similarity=0.332 Sum_probs=150.8
Q ss_pred eecHHHHHHHhcCCCC---------CCeeeecCCceEEEEEe--CCc---ceEEEeecCC--------------------
Q 039895 44 SFSADELKTATDDFDG---------GKVIMKCLFYKLYKGFL--QDR---PISVMKFEDT-------------------- 89 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~---------~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~-------------------- 89 (284)
-++++|+.+++.+|+. .++||+|+||+||+|.+ +++ .||||.+...
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 4567777777766643 46899999999999998 333 5899987654
Q ss_pred ----------------------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 ----------------------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 ----------------------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|.. ..++.++.||+.||.||| +++|+||||||+|||++
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEEC
Confidence 2211 567889999999999999 89999999999999999
Q ss_pred cCCcceeeccccccccCCCCcccc--CCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 039895 132 EENVAQLFDFTLSLSIPEGETHIN--DSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDG 208 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~ 208 (284)
.++.+||+|||+++.+........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---- 238 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---- 238 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----
Confidence 999999999999987754332211 1122457999999999999999999999999999999998 788886432
Q ss_pred ccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 209 EDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
..+.......... .+.+..++..+.+|+.+||+.||++|||+.||++.|++++++
T Consensus 239 ----~~~~~~~i~~~~~----------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 239 ----NQDVINAIEQDYR----------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----HHHHHHHHHTTCC----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHHcCCC----------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1122221111110 011223344588999999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=319.83 Aligned_cols=203 Identities=21% Similarity=0.323 Sum_probs=148.3
Q ss_pred cCCCCCCeeeecCCceEEEEEeC--C----cceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQ--D----RPISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~--------------------------------------- 89 (284)
+.|+..++||+|+||+||+|.+. + ..||||++...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45777889999999999999982 2 36999998654
Q ss_pred ---CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ---FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. ..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 1111 567889999999999999 999999999999999999999999999999887654
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
...........||+.|+|||++.+..++.++|||||||++|||++|..|+.... ......... ..+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i-~~~~~---- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAI-NDGFR---- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHH-HTTCC----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHH-hccCC----
Confidence 433333333568999999999999999999999999999999999877765322 111222111 11110
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+.+..++..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 232 -----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 -----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 011122344588999999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=321.41 Aligned_cols=204 Identities=21% Similarity=0.296 Sum_probs=149.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC-------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~------------------------------------- 89 (284)
-++|...+.||+|+||.||+|.+ +++.||||++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 36788889999999999999997 2357999998654
Q ss_pred -------CCCc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -------FPFS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -------~~~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|.. ..++.++.||+.||.||| +++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence 2211 346789999999999999 99999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK-ISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~-p~~~~~~~~~~~ 210 (284)
.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+||.. ||.... ..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~----~~ 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----ID 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSC-CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----CS
T ss_pred CCCcEEEccCcchhhcccccccc-ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC----HH
Confidence 99999999999998765443322 2223679999999999999999999999999999999999865 443221 11
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhcC
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQSN 284 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~~ 284 (284)
..+.. ....+..... +...++.+.+|+.+||+.||++|||+.||+++|++++++|
T Consensus 244 ~~~~~----~~~~~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 EEFCR----RLKEGTRMRA---------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHH----HHHHTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHH----HHhcCCCCCC---------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 11111 1111111111 1122334889999999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=321.51 Aligned_cols=202 Identities=23% Similarity=0.336 Sum_probs=158.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
.++|...+.||+|+||+||+|.+ +|+.||||++... +|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 45677788999999999999999 6889999998755 22
Q ss_pred Cc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 92 FS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 ~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
.. ..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 11 567789999999999999 8999999999999999999999999999998876544332
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.. ...||+.|+|||++.+..++.++|||||||++|||++|..|+.... . ..... .....+...
T Consensus 173 ~~--~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~---~~~~~-~~i~~~~~~------- 235 (287)
T d1opja_ 173 HA--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----D---LSQVY-ELLEKDYRM------- 235 (287)
T ss_dssp ET--TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----C---HHHHH-HHHHTTCCC-------
T ss_pred ec--cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----h---HHHHH-HHHhcCCCC-------
Confidence 22 2568999999999999999999999999999999999887765422 1 11111 111111100
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..++..+.+|+.+||+.||++|||+.||++.|+.+.++
T Consensus 236 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 --------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01112334588999999999999999999999999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=310.05 Aligned_cols=197 Identities=18% Similarity=0.261 Sum_probs=156.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC----------------------------------------CCCc
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT----------------------------------------FPFS 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----------------------------------------~~~~ 93 (284)
++|+..+.||+|+||+||+|++ +++.||||++... +|..
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 6889999999999999999999 6779999998765 1111
Q ss_pred ----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 94 ----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 94 ----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
..+.+++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-- 158 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-- 158 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC--
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee--
Confidence 567889999999999999 89999999999999999999999999999987765443322
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
....||+.|+|||++....++.++|||||||++|||+| |+.||.... ..+..... ..+.. ...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i-~~~~~--~~~----- 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHI-AQGLR--LYR----- 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHH-HTTCC--CCC-----
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHH-HhCCC--CCC-----
Confidence 22578999999999999999999999999999999998 788875432 11112111 11110 001
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+...+..+.+|+.+||+.||++|||+.+|++.|.+|
T Consensus 223 --------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 --------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112234588999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=312.48 Aligned_cols=195 Identities=22% Similarity=0.289 Sum_probs=150.7
Q ss_pred CeeeecCCceEEEEEe----CCcceEEEeecCC------------------------------------------CCCc-
Q 039895 61 KVIMKCLFYKLYKGFL----QDRPISVMKFEDT------------------------------------------FPFS- 93 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~------------------------------------------~~~~- 93 (284)
+.||+|+||+||+|.+ .++.||||++... +|..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 4799999999999987 2467999998643 1111
Q ss_pred --------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCC
Q 039895 94 --------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNR 159 (284)
Q Consensus 94 --------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 159 (284)
..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+............
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 567899999999999999 899999999999999999999999999999887665444444444
Q ss_pred cccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCC
Q 039895 160 VIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEE 238 (284)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
..||+.|+|||++.+..++.++|||||||++|||+| |..||.... ..+... .+..+....
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~-~i~~~~~~~---------- 230 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTA-MLEKGERMG---------- 230 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHH-HHHTTCCCC----------
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHH-HHHcCCCCC----------
Confidence 678999999999999999999999999999999998 888886432 111111 111111111
Q ss_pred CCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 239 GLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+..++..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus 231 -----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 112233458899999999999999999999999988753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=314.79 Aligned_cols=200 Identities=19% Similarity=0.256 Sum_probs=156.5
Q ss_pred CCCCCC-eeeecCCceEEEEEe----CCcceEEEeecCC-----------------------------------------
Q 039895 56 DFDGGK-VIMKCLFYKLYKGFL----QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~----------------------------------------- 89 (284)
+|...+ .||+|+||+||+|.+ ++..||||++...
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE 88 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 88 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence 344445 499999999999987 3457999998754
Q ss_pred CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. ...++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 111 1567889999999999999 999999999999999999999999999999988765544
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
........||+.|+|||++....++.++|||||||++|||+| |..||.... ...+...+ ..+....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~~~~~~i----~~~~~~~---- 232 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAFI----EQGKRME---- 232 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHHHHHH----HTTCCCC----
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHH----HcCCCCC----
Confidence 444444678999999999998999999999999999999998 899986432 11122211 1211111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 233 -----------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 -----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233458899999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=311.16 Aligned_cols=193 Identities=20% Similarity=0.305 Sum_probs=152.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
+.|...+.||+|+||+||+|.. +|+.||||++... +|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 3588889999999999999998 7999999998644 22
Q ss_pred Cc--------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 92 FS--------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 92 ~~--------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
.. .....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~--- 173 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 173 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB---
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc---
Confidence 21 567789999999999999 9999999999999999999999999999998875443222
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ............. ...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~-~~~-------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGT-PEL-------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCS-CCC--------
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCC-CCC--------
Confidence 22679999999999999999999999999999999999999996432 1111111111111 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011223345889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=309.10 Aligned_cols=188 Identities=24% Similarity=0.361 Sum_probs=150.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +|+.||+|++...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688889999999999999999 7889999998532
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 2221 567789999999999999 999999999999999999999999999999876544322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .....
T Consensus 163 -----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~-~~~~~------ 222 (263)
T d2j4za1 163 -----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRIS-RVEFT------ 222 (263)
T ss_dssp -----ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TTCCC------
T ss_pred -----ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCCC------
Confidence 2579999999999999999999999999999999999999996432 122222211 11110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ +...++.+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 F----------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 0112334789999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=309.72 Aligned_cols=195 Identities=21% Similarity=0.301 Sum_probs=149.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------C
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------F 90 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------~ 90 (284)
++|+..+.||+|+||+||+|.+ +|+.||||++... +
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688889999999999999998 7899999998644 2
Q ss_pred CCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 91 PFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 91 ~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
|.. .....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~- 160 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER- 160 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC-
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc-
Confidence 211 567789999999999999 9999999999999999999999999999998775433221
Q ss_pred CCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 156 DSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
......||+.|||||++.+..+ +.++||||+||++|||++|+.||.... ....... ..........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~---~~~~~~~~~~------ 227 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYS---DWKEKKTYLN------ 227 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS----TTSHHHH---HHHTTCTTST------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC----hHHHHHH---HHhcCCCCCC------
Confidence 1223689999999999988876 578999999999999999999996433 1111111 1111111000
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ---------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01122334779999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=311.01 Aligned_cols=194 Identities=21% Similarity=0.260 Sum_probs=140.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.. +|+.||||++...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688889999999999999998 7899999998654
Q ss_pred --CCCc-------------------hhHHHHHHHHHHHHHHhccCC--CCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 --FPFS-------------------VSKLKIAIEIASAVAYLHVGF--SRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 --~~~~-------------------~~~~~i~~~i~~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+|.. .....++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 2211 456789999999999999321 13499999999999999999999999999988
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
+....... ....||+.|+|||++.+..++.++|||||||++|||+||..||.... ..+.... +..+..
T Consensus 164 ~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~-i~~~~~ 231 (269)
T d2java1 164 LNHDTSFA---KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGK-IREGKF 231 (269)
T ss_dssp C--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-HHHTCC
T ss_pred cccCCCcc---ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHH-HHcCCC
Confidence 75433221 22679999999999999999999999999999999999999986432 1122221 112222
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
..+ +...++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~---------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 RRI---------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCC---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC---------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 1112334889999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=316.67 Aligned_cols=206 Identities=20% Similarity=0.304 Sum_probs=157.4
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC--------------------------------
Q 039895 49 ELKTATDDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT-------------------------------- 89 (284)
Q Consensus 49 ~l~~~~~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~-------------------------------- 89 (284)
+++...++|+..+.||+|+||+||+|++. +..||||++...
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999873 368999998654
Q ss_pred ----------CCC---------------------------------------chhHHHHHHHHHHHHHHhccCCCCCeee
Q 039895 90 ----------FPF---------------------------------------SVSKLKIAIEIASAVAYLHVGFSRPVVS 120 (284)
Q Consensus 90 ----------~~~---------------------------------------~~~~~~i~~~i~~gL~~LH~~~~~~ivH 120 (284)
+|. ...++.++.|++.||+||| +++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 110 0357889999999999999 999999
Q ss_pred cccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-C
Q 039895 121 RDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKK-I 199 (284)
Q Consensus 121 rDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~-p 199 (284)
|||||+|||++.++.+||+|||+++...+..... ......||+.|+|||++.+..++.++|||||||++|||++|.. |
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcccc-ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999998765433222 1223578999999999999999999999999999999999975 4
Q ss_pred CCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 200 SYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
|.... ..+.... +..+..... +..++..+.+|+.+||+.+|++||||.||++.|++
T Consensus 243 ~~~~~--------~~e~~~~-v~~~~~~~~---------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 243 YYGMA--------HEEVIYY-VRDGNILAC---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp TTTSC--------HHHHHHH-HHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC--------HHHHHHH-HHcCCCCCC---------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 43221 1222222 222221111 11223458899999999999999999999999999
Q ss_pred HHh
Q 039895 280 IYQ 282 (284)
Q Consensus 280 l~~ 282 (284)
|.+
T Consensus 299 i~~ 301 (301)
T d1lufa_ 299 MCE 301 (301)
T ss_dssp TTC
T ss_pred hcC
Confidence 864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-45 Score=310.06 Aligned_cols=187 Identities=23% Similarity=0.304 Sum_probs=147.1
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC--------------------------------------------
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------- 89 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------- 89 (284)
.|+..+.||+|+||+||+|.. +|+.||||++...
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 377788999999999999998 7899999998644
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
+|.. ..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~--- 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--- 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC---
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCCC---
Confidence 2221 567789999999999999 9999999999999999999999999999997754322
Q ss_pred cCCCCcccCccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTT---GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
...||+.|||||++.+ ..|+.++|||||||++|||++|..||.... ........... ..+....
T Consensus 170 ----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~-~~~~~~~ 236 (309)
T d1u5ra_ 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQN-ESPALQS 236 (309)
T ss_dssp ----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-CCCCCSC
T ss_pred ----ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhC-CCCCCCC
Confidence 2579999999999864 468999999999999999999999986432 11222222111 1111111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...++.+.+|+.+||+.||++|||+.|+++
T Consensus 237 --------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112234889999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=312.06 Aligned_cols=200 Identities=21% Similarity=0.331 Sum_probs=150.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc----ceEEEeecCC---------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR----PISVMKFEDT--------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~--------------------------------------- 89 (284)
.+|+..++||+|+||+||+|.+ +|+ .||+|.+...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 4588889999999999999998 454 5888887643
Q ss_pred --CC----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 --FP----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 --~~----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+| ....++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 11 01567889999999999999 8999999999999999999999999999998876543
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |..||.... ...+...+.. +...
T Consensus 166 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~----~~~~--- 232 (317)
T d1xkka_ 166 KEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK----GERL--- 232 (317)
T ss_dssp C---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHH----TCCC---
T ss_pred cccc-ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc----CCCC---
Confidence 3221 122568999999999999999999999999999999999 666665322 1222222221 1100
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+..++..+.+|+.+||+.||++|||+.||++.|..+..
T Consensus 233 ------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112233458899999999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=308.26 Aligned_cols=201 Identities=22% Similarity=0.316 Sum_probs=151.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCC---------------------------------------CCC--
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT---------------------------------------FPF-- 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---------------------------------------~~~-- 92 (284)
++|...+.||+|+||+||+|.+ ++..||||++... +|.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g 96 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 96 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCC
Confidence 5678888999999999999999 6678999998755 111
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
+..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-- 171 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-- 171 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceee--
Confidence 1578899999999999999 89999999999999999999999999999987754433222
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGE 237 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
....||+.|+|||++....++.++|||||||++|||++|..|+.... ........... +...
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~i~~-~~~~---------- 233 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVER-GYRM---------- 233 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHT-TCCC----------
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHHHHHHh-cCCC----------
Confidence 22578999999999999999999999999999999999877765422 11222222111 1100
Q ss_pred CCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 238 EGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+.+..++..+.+|+.+||+.||++|||+++|++.|++.+.+
T Consensus 234 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11122334588999999999999999999999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=306.87 Aligned_cols=218 Identities=20% Similarity=0.309 Sum_probs=157.4
Q ss_pred CCCCCCeeeecCCceEEEEEeCCcceEEEeecCC--------------------------------------------CC
Q 039895 56 DFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT--------------------------------------------FP 91 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--------------------------------------------~~ 91 (284)
++...+.||+|+||+||+|+++|+.||||++... +|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 3445678999999999999999999999998655 11
Q ss_pred Cc--------------hhHHHHHHHHHHHHHHhccC-----CCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 92 FS--------------VSKLKIAIEIASAVAYLHVG-----FSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 92 ~~--------------~~~~~i~~~i~~gL~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
.. ..++.++.|++.||.|||+. ..++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~ 163 (303)
T d1vjya_ 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred cCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence 11 56688999999999999932 136999999999999999999999999999988755433
Q ss_pred ccc-CCCCcccCccccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-------ccccHHHHHH
Q 039895 153 HIN-DSNRVIGTFGFMAPEYRTTG------DFSEKSDVYSFGALLLELLTGKKISYSSHFDDG-------EDYRLQDLVK 218 (284)
Q Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~ 218 (284)
... ......||+.|+|||++... .++.++|||||||++|||+||..|+........ ....... ..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (303)
T d1vjya_ 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE-MR 242 (303)
T ss_dssp EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-HH
T ss_pred ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH-HH
Confidence 222 22336799999999998754 267799999999999999999887743221110 0111111 11
Q ss_pred HHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 219 KYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
........ +|.+... .........+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 243 ~~~~~~~~----~p~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 243 KVVCEQKL----RPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHTTSCC----CCCCCGG-----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcccc----CCCCCcc-----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 11111111 1111110 11334556688999999999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=299.78 Aligned_cols=186 Identities=21% Similarity=0.305 Sum_probs=141.6
Q ss_pred CCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------------
Q 039895 59 GGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------------- 89 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------------- 89 (284)
....||+|+||+||+|.+ ++..||+|++...
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 345799999999999998 7889999998644
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCC--eeecccccCcEEEe-cCCcceeeccccccccCCCC
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRP--VVSRDIKPTTIVLQ-EENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||+||| +++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 1111 456789999999999999 777 99999999999996 57899999999997654332
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. ...||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ......... ..+..+..+
T Consensus 170 ~~-----~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i-~~~~~~~~~- 234 (270)
T d1t4ha_ 170 AK-----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRV-TSGVKPASF- 234 (270)
T ss_dssp BE-----ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHH-TTTCCCGGG-
T ss_pred cC-----CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHH-HcCCCCccc-
Confidence 21 2679999999999865 69999999999999999999999986422 111111111 111111111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+....+.+.+|+.+||+.||++|||+.|+++
T Consensus 235 -------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 -------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112234789999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-44 Score=301.72 Aligned_cols=202 Identities=19% Similarity=0.334 Sum_probs=151.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688889999999999999998 7999999998654
Q ss_pred -----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. ...+.++.||+.||.||| +.+|+||||||+|||++.++..+++|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 1111 567789999999999999 99999999999999999999999999999877655
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccc-c
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFK-E 228 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 228 (284)
............||+.|+|||++.+..++.++|||||||++|||+||..||.... ............... .
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDPIPPS 235 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCCCCGG
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcCCCCCc
Confidence 4433333344689999999999999999999999999999999999999996432 122222222222111 1
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHH
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-TIVQVAKQLRQIY 281 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~ev~~~L~~l~ 281 (284)
... ...+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 236 ~~~--------------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ARH--------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GTS--------------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred hhc--------------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111 12234488999999999999999 8999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=305.56 Aligned_cols=200 Identities=22% Similarity=0.293 Sum_probs=144.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--C---CcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--Q---DRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~---------------------------------------- 89 (284)
++|...+.||+|+||.||+|.+ + +..||||.+...
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 4677788999999999999988 2 246889888644
Q ss_pred -CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 -FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 -~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. ..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 1111 567889999999999999 99999999999999999999999999999987654433
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.... ...||+.|+|||++.+..++.++|||||||++|||++ |.+||.... ...+...+. .+....
T Consensus 164 ~~~~--~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-----~~~~~~~i~----~~~~~~--- 229 (273)
T d1mp8a_ 164 YKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRIE----NGERLP--- 229 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH----TTCCCC---
T ss_pred eecc--ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-----HHHHHHHHH----cCCCCC---
Confidence 2222 2568999999999999999999999999999999998 777776432 122222221 111111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+..++..+.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus 230 ------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 ------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1122334588999999999999999999999999998763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=309.79 Aligned_cols=158 Identities=22% Similarity=0.288 Sum_probs=122.5
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCCCCcccCccccccccccC
Q 039895 95 SKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTT 174 (284)
Q Consensus 95 ~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (284)
.++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+........... ....||+.|||||++.+
T Consensus 165 ~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 165 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR-GNARLPVKWMAPESLFE 240 (325)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEE-TTEEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeee-ccccCCCccCChHHHcC
Confidence 46679999999999999 999999999999999999999999999999876554332211 22568999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHH
Q 039895 175 GDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICT 253 (284)
Q Consensus 175 ~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
..++.++|||||||++|||+| |..||.... ....+... ...+.. .+.+..++..+.
T Consensus 241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~----~~~~~~~~----~~~~~~---------------~~~p~~~~~~l~ 297 (325)
T d1rjba_ 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP----VDANFYKL----IQNGFK---------------MDQPFYATEEIY 297 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----CSHHHHHH----HHTTCC---------------CCCCTTCCHHHH
T ss_pred CCCCcceeccchhHHHHHHHhCCCCCCCCCC----HHHHHHHH----HhcCCC---------------CCCCCcCCHHHH
Confidence 999999999999999999998 888886432 11111111 111110 011122334588
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHH
Q 039895 254 ELAFKCLSESEGDRPTIVQVAKQLRQ 279 (284)
Q Consensus 254 ~l~~~cl~~~p~~Rps~~ev~~~L~~ 279 (284)
+|+.+||+.||++|||++||+++|..
T Consensus 298 ~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 298 IIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=311.56 Aligned_cols=142 Identities=22% Similarity=0.297 Sum_probs=122.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|+..+.||+|+||+||+|.+ +|..||+|++...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788889999999999999998 7899999998644
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCC-CeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSR-PVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||.||| ++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 2211 556789999999999999 64 89999999999999999999999999998764322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSS 203 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~ 203 (284)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 12368999999999999999999999999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=305.95 Aligned_cols=193 Identities=20% Similarity=0.226 Sum_probs=148.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
+.|+..+.||+|+||+||+|.+ +|..||||++... +|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3577778999999999999998 7899999998654 22
Q ss_pred Cc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 FS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.. .....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~-- 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-- 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH--
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc--
Confidence 11 567789999999999999 999999999999999999999999999999765432111
Q ss_pred CCCCcccCcccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 156 DSNRVIGTFGFMAPEYRT-----TGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.....||+.|+|||++. ...|+.++|||||||++|||++|..||.... .......+ .. ...+..
T Consensus 167 -~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-----~~~~~~~i---~~-~~~~~~- 235 (288)
T d2jfla1 167 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-----PMRVLLKI---AK-SEPPTL- 235 (288)
T ss_dssp -HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----GGGHHHHH---HH-SCCCCC-
T ss_pred -ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-----HHHHHHHH---Hc-CCCCCC-
Confidence 12267999999999874 4568999999999999999999999986532 11121111 11 111111
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223345889999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=305.63 Aligned_cols=192 Identities=22% Similarity=0.336 Sum_probs=148.0
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.. +|+.||||++...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688889999999999999998 7899999998643
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 2221 556789999999999999 999999999999999999999999999999887543222
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
.. .....||+.|+|||++.+..++.++||||+||++|||++|..||.... ......... .....
T Consensus 165 ~~-~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~-~~~~~------ 228 (288)
T d1uu3a_ 165 AR-ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKII-KLEYD------ 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-TTCCC------
T ss_pred cc-cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHH-cCCCC------
Confidence 11 122579999999999999999999999999999999999999996432 111122111 11110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+ +...++.+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 F----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C----------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 0112234789999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=298.64 Aligned_cols=195 Identities=23% Similarity=0.291 Sum_probs=148.8
Q ss_pred cCCCCCCeeeecCCceEEEEEeCCcceEEEeecCC----------------------------------------CCCc-
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQDRPISVMKFEDT----------------------------------------FPFS- 93 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----------------------------------------~~~~- 93 (284)
++|+..+.||+|+||.||+|.+.|..||||+++.. +|..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 45667789999999999999999999999999765 1111
Q ss_pred ----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 94 ----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 94 ----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
..+++++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++........
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~---- 159 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---- 159 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCCcc----
Confidence 557889999999999999 999999999999999999999999999999876443221
Q ss_pred CCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccccC
Q 039895 158 NRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAIVG 236 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
..+|+.|+|||++.+..++.++|||||||++|||+| |..|+... ....+...+. .+...
T Consensus 160 --~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i~----~~~~~--------- 219 (262)
T d1byga_ 160 --GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE----KGYKM--------- 219 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHT----TTCCC---------
T ss_pred --ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH----cCCCC---------
Confidence 467899999999998999999999999999999999 56665432 2222322221 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 237 EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
+.+...++.+.+|+.+||+.||++|||+.+|+++|++|..
T Consensus 220 ------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 ------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1112233458899999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-45 Score=309.43 Aligned_cols=194 Identities=20% Similarity=0.280 Sum_probs=139.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35688889999999999999998 7899999998644
Q ss_pred CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe---cCCcceeeccccccccCCCC
Q 039895 90 FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||+. .++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 2221 567789999999999999 99999999999999995 57899999999998765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccc
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVD 231 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
.. ....||+.|||||++.+..++.++|||||||++|||++|..||.... .......... ....
T Consensus 165 ~~----~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~-~~~~---- 227 (307)
T d1a06a_ 165 VL----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILK-AEYE---- 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHT-TCCC----
T ss_pred ee----eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-cCCC----
Confidence 22 12679999999999999999999999999999999999999996432 1111111111 1100
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus 228 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 --------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000111223345889999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=302.63 Aligned_cols=200 Identities=21% Similarity=0.304 Sum_probs=146.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe---CC--cceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL---QD--RPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~---~~--~~vavK~~~~~---------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.+ ++ ..||||++...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 4577778899999999999987 22 36899998754
Q ss_pred ---CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ---FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ---~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. ..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 1111 567789999999999999 899999999999999999999999999999988665
Q ss_pred CccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
...........||..|+|||++.+..++.++|||||||++|||+| |..||.... ...........+...
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~~~~~i~~~~~~~-- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEGERL-- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSCCCC--
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--------HHHHHHHHHhCCCCC--
Confidence 544444444668899999999999999999999999999999998 888886432 222222222221111
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQI 280 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l 280 (284)
+.+...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 235 -------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112234588999999999999999999999988864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-43 Score=300.52 Aligned_cols=187 Identities=21% Similarity=0.298 Sum_probs=149.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|+. +|+.||||++...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688889999999999999998 7999999998643
Q ss_pred -CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|.. .....++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~- 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY- 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC-
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccccc-
Confidence 2211 455678999999999999 99999999999999999999999999999988754332
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
...||+.|+|||++.+..++.++||||+||++|||++|..||.... .......... +... .
T Consensus 160 -----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~-~~~~--~--- 220 (316)
T d1fota_ 160 -----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILN-AELR--F--- 220 (316)
T ss_dssp -----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-CCCC--C---
T ss_pred -----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHc-CCCC--C---
Confidence 2679999999999999999999999999999999999999996532 1222222211 1100 0
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+...+..+.+++.+||+.||.+|| |++++++
T Consensus 221 -----------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 -----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011223478999999999999996 8999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-44 Score=308.91 Aligned_cols=194 Identities=18% Similarity=0.165 Sum_probs=152.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.++|...+.||+|+||.||+|.. +|+.||||++... +
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46788889999999999999998 7999999998655 2
Q ss_pred CCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec--CCcceeeccccccccCCCCc
Q 039895 91 PFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE--ENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|.. .....++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 211 567789999999999999 999999999999999964 57899999999988765433
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (284)
.. ...||+.|||||++.+..++.++|||||||++|||++|..||.+.. ........... ..+..
T Consensus 182 ~~----~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~--- 246 (350)
T d1koaa2 182 VK----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDD--- 246 (350)
T ss_dssp EE----EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSCC---
T ss_pred cc----eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCc---
Confidence 22 2578999999999999999999999999999999999999996432 12222222111 11111
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
......+..+.+|+.+||+.||++|||+.|++++
T Consensus 247 -----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111223447899999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-44 Score=302.30 Aligned_cols=198 Identities=22% Similarity=0.327 Sum_probs=151.2
Q ss_pred CCeeeecCCceEEEEEe-C--C--cceEEEeecCC-------------------------------------------CC
Q 039895 60 GKVIMKCLFYKLYKGFL-Q--D--RPISVMKFEDT-------------------------------------------FP 91 (284)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~-~--~--~~vavK~~~~~-------------------------------------------~~ 91 (284)
.++||+|+||+||+|.+ + + ..||||++... +|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999998 2 2 25899998643 11
Q ss_pred Cc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc-
Q 039895 92 FS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI- 154 (284)
Q Consensus 92 ~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~- 154 (284)
.. ..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 11 567899999999999999 9999999999999999999999999999998875543322
Q ss_pred cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccccc
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPAI 234 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
.......||+.|+|||++....++.++||||||+++|||+||..||.... ........+ ..+... ..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~~~~~~~~i----~~g~~~--~~--- 255 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYL----LQGRRL--LQ--- 255 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHH----HTTCCC--CC---
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----CHHHHHHHH----HcCCCC--CC---
Confidence 12223578999999999999999999999999999999999888876432 111111111 111110 01
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 235 VGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+..++..+.+|+.+||+.||++|||+.||++.|+.++++
T Consensus 256 ----------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112234588999999999999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=299.20 Aligned_cols=208 Identities=17% Similarity=0.241 Sum_probs=155.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CCC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FPF 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~~ 92 (284)
+.|...+.||+|+||+||+|.+ +|+.||||++... +|.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 3578889999999999999998 7899999987654 111
Q ss_pred c---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe---cCCcceeeccccccccCCCCccc
Q 039895 93 S---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ---EENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 93 ~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
. ...+.++.|++.||+||| +++|+||||||+|||++ .+..+||+|||+|+.+.......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 1 667889999999999999 99999999999999986 34579999999999876543221
Q ss_pred ----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccc
Q 039895 155 ----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIV 230 (284)
Q Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
.......||+.|+|||++.+..++.++|||||||++|||++|..||......... ........... .......
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~- 240 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKM-STPIEVL- 240 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHH-HSCHHHH-
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccC-CCChhHh-
Confidence 1223467999999999999999999999999999999999999999754311111 11111111110 0110000
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 231 DPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
...++.++.+++..||+.+|++||++.++.+.|+++..
T Consensus 241 --------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 241 --------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11223458899999999999999999999999988754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=302.59 Aligned_cols=199 Identities=21% Similarity=0.244 Sum_probs=152.1
Q ss_pred hcCCCCC-CeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------
Q 039895 54 TDDFDGG-KVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------- 89 (284)
.++|... ++||+|+||+||+|.+ +|+.||||++...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 4677764 4699999999999998 7899999998765
Q ss_pred CCCc-----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec---CCcceeeccccccccCC
Q 039895 90 FPFS-----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE---ENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 ~~~~-----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg~a~~~~~ 149 (284)
||.. .....++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccC
Confidence 2221 567789999999999999 999999999999999985 45799999999987765
Q ss_pred CCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.... ....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.... .....+
T Consensus 167 ~~~~----~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~------------ 225 (335)
T d2ozaa1 167 HNSL----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGM------------ 225 (335)
T ss_dssp CCCC----CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------------
T ss_pred CCcc----ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHH------------
Confidence 4332 2267999999999999999999999999999999999999999653310 000000
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
.............+.....++.+.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00001111111112234456678999999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=306.45 Aligned_cols=191 Identities=20% Similarity=0.275 Sum_probs=148.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||+|+. +|+.||||++...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6788899999999999999998 7999999998532
Q ss_pred ----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCC
Q 039895 90 ----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEG 150 (284)
Q Consensus 90 ----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~ 150 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 2211 466789999999999999 999999999999999999999999999999877544
Q ss_pred CccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc
Q 039895 151 ETHINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI 229 (284)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
.. ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ........... .... .
T Consensus 161 ~~-----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~-~~~~--~ 227 (364)
T d1omwa3 161 KP-----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTL-TMAV--E 227 (364)
T ss_dssp CC-----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSS-SCCC--C
T ss_pred cc-----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcc-cCCC--C
Confidence 32 22579999999999875 4689999999999999999999999975331 11111111111 1000 0
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 230 VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
. +...++.+.+|+.+||+.||++||| ++|+++
T Consensus 228 ~--------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 L--------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C--------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C--------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 1112234789999999999999999 688865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-43 Score=304.61 Aligned_cols=187 Identities=17% Similarity=0.230 Sum_probs=149.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||.||+|.+ +|+.||||++...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788889999999999999998 7999999998533
Q ss_pred -CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 -FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 -~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.||+.||.||| +.+||||||||+|||++.++.+||+|||+++.+.....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~- 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW- 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC-
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc-
Confidence 111 1567789999999999999 99999999999999999999999999999988754322
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDPA 233 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
...||+.|||||++.+..++.++|||||||++|||+||..||.... .......... .....
T Consensus 197 -----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~-~~~~~----- 257 (350)
T d1rdqe_ 197 -----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVS-GKVRF----- 257 (350)
T ss_dssp -----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCCC-----
T ss_pred -----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhc-CCCCC-----
Confidence 2679999999999999999999999999999999999999996432 1222222111 11100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 039895 234 IVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRP-----TIVQVAK 275 (284)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~ev~~ 275 (284)
+...++.+.+|+.+||+.||.+|+ |+.|+++
T Consensus 258 -----------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011223478999999999999994 8999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=300.91 Aligned_cols=191 Identities=23% Similarity=0.286 Sum_probs=150.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.++|+..+.||+|+||.||+|.. +|+.||+|++...
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36788899999999999999998 8999999998643
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 2211 456678999999999999 99999999999999999999999999999987654332
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
. ....+||+.|+|||++.+..|+.++||||+||++|||++|..||.... .......... ....
T Consensus 161 ~---~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~-~~~~----- 223 (337)
T d1o6la_ 161 T---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM-EEIR----- 223 (337)
T ss_dssp C---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCC-----
T ss_pred c---cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhc-CCCC-----
Confidence 2 123689999999999999999999999999999999999999997533 1222222111 1110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
+ +...++.+.+|+.+||+.||++||+ +.|+++
T Consensus 224 -~----------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -F----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -C----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -C----------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 0112334789999999999999995 788875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=300.14 Aligned_cols=193 Identities=20% Similarity=0.258 Sum_probs=150.7
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688889999999999999998 7899999998543
Q ss_pred ----CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC----cceeeccccccc
Q 039895 90 ----FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN----VAQLFDFTLSLS 146 (284)
Q Consensus 90 ----~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg~a~~ 146 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++ .+|++|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 2211 556789999999999999 99999999999999998777 489999999988
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
....... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ......... ....
T Consensus 167 ~~~~~~~----~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~-~~~~ 233 (293)
T d1jksa_ 167 IDFGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVS-AVNY 233 (293)
T ss_dssp CTTSCBC----SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-TTCC
T ss_pred cCCCccc----cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHH-hcCC
Confidence 7554322 22578999999999999999999999999999999999999997532 111111111 1110
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. ...+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000111223445789999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-44 Score=307.80 Aligned_cols=193 Identities=17% Similarity=0.159 Sum_probs=152.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------C
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------F 90 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~ 90 (284)
.+.|...+.||+|+||.||+|.. +|+.||||++... +
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46788889999999999999998 7999999998654 2
Q ss_pred CC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe--cCCcceeeccccccccCCCCc
Q 039895 91 PF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ--EENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 91 ~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
|. +.....++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|..+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 22 1567789999999999999 99999999999999998 578999999999988765433
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc-Cccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN-ESFKEIVD 231 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (284)
... ..||+.|+|||++.+..++.++||||+||++|||++|..||.+.. ........... ..++..
T Consensus 185 ~~~----~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~-- 250 (352)
T d1koba_ 185 VKV----TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDED-- 250 (352)
T ss_dssp EEE----ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCCCCSS--
T ss_pred eee----ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCcc--
Confidence 221 578999999999999999999999999999999999999996432 11222211111 111110
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 232 PAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 251 ------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 ------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122334789999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=299.28 Aligned_cols=200 Identities=23% Similarity=0.303 Sum_probs=149.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CC-------cceEEEeecCC------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QD-------RPISVMKFEDT------------------------------------ 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~-------~~vavK~~~~~------------------------------------ 89 (284)
++|...+.||+|+||.||+|+. .+ ..||||++...
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 5677778999999999999987 21 36999998765
Q ss_pred -------CC-------------------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -------FP-------------------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -------~~-------------------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+| ....++.++.||+.||+||| +.+||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 11 11457899999999999999 99999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLT-GKKISYSSHFDDGED 210 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~ellt-g~~p~~~~~~~~~~~ 210 (284)
.++.+||+|||+++.......... .....||+.|+|||++.+..|+.++|||||||++|||++ |..||....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------ 242 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 242 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCC-CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred CCCCeEeccchhhccccccccccc-cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------
Confidence 999999999999987765433322 223678999999999999999999999999999999998 566664322
Q ss_pred ccHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHh
Q 039895 211 YRLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQ 282 (284)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~ 282 (284)
..... ..+..+..... +...+..+.+|+.+||+.||++|||+.||++.|++|..
T Consensus 243 --~~~~~-~~i~~~~~~~~---------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 --VEELF-KLLKEGHRMDK---------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --HHHHH-HHHHTTCCCCC---------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHH-HHHHcCCCCCC---------------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 12222111110 11223348899999999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=297.76 Aligned_cols=211 Identities=18% Similarity=0.228 Sum_probs=150.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--C-CcceEEEeecCC-----------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--Q-DRPISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~-~~~vavK~~~~~----------------------------------------- 89 (284)
.++|+..+.||+|+||+||+|.+ + ++.||||++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46788889999999999999998 3 567999998532
Q ss_pred ----------CCCc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeecccc
Q 039895 90 ----------FPFS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTL 143 (284)
Q Consensus 90 ----------~~~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~ 143 (284)
+|.. .....++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 1110 456679999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhc
Q 039895 144 SLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIEN 223 (284)
Q Consensus 144 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
++....... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .......+......
T Consensus 163 ~~~~~~~~~----~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 163 ARIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIGL 233 (305)
T ss_dssp CCCCCGGGG----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCC
T ss_pred hhhhccccc----CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCC
Confidence 876543322 123679999999999999999999999999999999999999996432 11111111111111
Q ss_pred C---ccccccc---ccccCCCCC-CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 224 E---SFKEIVD---PAIVGEEGL-MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 224 ~---~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. .+..... ......... .........+.+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000 000000000 000111223457899999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=300.68 Aligned_cols=202 Identities=19% Similarity=0.319 Sum_probs=155.2
Q ss_pred cCCCCCCeeeecCCceEEEEEeC-------CcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFLQ-------DRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||+||+|.+. +..||||++...
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56777789999999999999873 468999999754
Q ss_pred ----CCCc-------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeec
Q 039895 90 ----FPFS-------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFD 140 (284)
Q Consensus 90 ----~~~~-------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 140 (284)
+|.. ..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence 1111 346789999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 141 FTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 141 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
||+++.+........ .....||+.|+|||.+.+..++.++|||||||++|||+||..|++... .........
T Consensus 177 FGla~~~~~~~~~~~-~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~~i 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLRFV 248 (308)
T ss_dssp TTCCCGGGGGGCEEG-GGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHHHH
T ss_pred cccceeccCCcceee-ccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH
Confidence 999987754433222 223578999999999999999999999999999999999965443211 122222222
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
. .+..... +..++..+.+|+.+||+.+|++|||+.||++.|++..+.
T Consensus 249 ~-~~~~~~~---------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 249 M-EGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp H-TTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred H-hCCCCCC---------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1 2211111 112234588999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=294.32 Aligned_cols=204 Identities=18% Similarity=0.182 Sum_probs=144.8
Q ss_pred CeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------------CCC
Q 039895 61 KVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------------FPF 92 (284)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------------~~~ 92 (284)
++||+|+||+||+|.+ +|+.||||++... +|.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999998 7899999998533 111
Q ss_pred ---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccccCC
Q 039895 93 ---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHINDS 157 (284)
Q Consensus 93 ---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 157 (284)
+.....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~--- 157 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--- 157 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC---
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcccc---
Confidence 1567789999999999999 9999999999999999999999999999998765543222
Q ss_pred CCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---cccccccc
Q 039895 158 NRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES---FKEIVDPA 233 (284)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 233 (284)
....||+.|+|||++... .++.++|||||||++|||++|..||.... .......+........ +.......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhccchhccc
Confidence 125799999999988654 57999999999999999999999986432 1112222222111111 11100000
Q ss_pred ----ccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 234 ----IVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 234 ----~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
........+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000 00122345889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-42 Score=291.54 Aligned_cols=209 Identities=13% Similarity=0.163 Sum_probs=157.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CCC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FPF 92 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~~ 92 (284)
++|...+.||+|+||+||+|.+ +|+.||||++... +|.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~ 84 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecC
Confidence 4678888999999999999998 7899999998543 111
Q ss_pred c---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEec-----CCcceeeccccccccCCCCc
Q 039895 93 S---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQE-----ENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 93 ~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~Dfg~a~~~~~~~~ 152 (284)
. .....++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+|+.......
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 1 567789999999999999 999999999999999974 56799999999988754322
Q ss_pred cc----cCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccc
Q 039895 153 HI----NDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKE 228 (284)
Q Consensus 153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
.. .......||+.|||||++.+..++.++|||||||++|||++|..||..... .........+..........+
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA--ATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS--CCHHHHHHHHHHHHHHSCHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc--hhHHHHHHHHHhccCCCChHH
Confidence 11 122336799999999999999999999999999999999999999975431 111111111111111111111
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 229 IVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
+ ....+.++.+++..|+..+|++||+.+.+.+.|+++.+.
T Consensus 240 l---------------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 240 L---------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp H---------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred h---------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1 011234488999999999999999999999999987653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=294.08 Aligned_cols=182 Identities=21% Similarity=0.321 Sum_probs=143.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688889999999999999998 7899999987532
Q ss_pred ------CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC-Ccceeeccccccc
Q 039895 90 ------FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE-NVAQLFDFTLSLS 146 (284)
Q Consensus 90 ------~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg~a~~ 146 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 111 0556789999999999999 9999999999999999954 7999999999977
Q ss_pred cCCCCccccCCCCcccCccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTTGDF-SEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES 225 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
...... ....||+.|+|||++.+..+ +.++||||+||++|||++|..||.... . .. ...
T Consensus 161 ~~~~~~-----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~----i~-~~~ 220 (273)
T d1xwsa_ 161 LKDTVY-----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E----II-RGQ 220 (273)
T ss_dssp CCSSCB-----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----HH-HCC
T ss_pred cccccc-----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------H----Hh-hcc
Confidence 644322 22679999999999887765 567899999999999999999985311 1 00 110
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
. .+.+ ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 221 ~--~~~~--------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V--FFRQ--------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C--CCSS--------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c--CCCC--------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0011 11234789999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=298.70 Aligned_cols=199 Identities=21% Similarity=0.268 Sum_probs=151.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCc--ceEEEeecCC-----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDR--PISVMKFEDT----------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~----------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.+ +|. .||||++...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6777888999999999999999 444 5788887533
Q ss_pred --CCCc-------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcc
Q 039895 90 --FPFS-------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVA 136 (284)
Q Consensus 90 --~~~~-------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 136 (284)
+|.. ..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 1111 346789999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHH
Q 039895 137 QLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDL 216 (284)
Q Consensus 137 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 216 (284)
||+|||+++........ ....||+.|+|||.+....++.++|||||||++|||++|..|++... .....
T Consensus 167 kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-------~~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAEL 235 (309)
T ss_dssp EECCTTCEESSCEECCC--------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHH
T ss_pred EEccccccccccccccc----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-------CHHHH
Confidence 99999999765433222 22568999999999999999999999999999999999876543211 12222
Q ss_pred HHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 217 VKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.... ..+... +.+..+++.+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 236 ~~~i-~~~~~~---------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 236 YEKL-PQGYRL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHG-GGTCCC---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHH-HhcCCC---------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2221 111100 11122334588999999999999999999999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=295.15 Aligned_cols=203 Identities=19% Similarity=0.285 Sum_probs=155.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-------CCcceEEEeecCC--------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-------QDRPISVMKFEDT-------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~-------------------------------------- 89 (284)
++|...+.||+|+||.||+|++ +++.||||++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677788999999999999986 3458999999754
Q ss_pred -----CCCc---------------------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEe
Q 039895 90 -----FPFS---------------------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQ 131 (284)
Q Consensus 90 -----~~~~---------------------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~ 131 (284)
+|.. ..++.++.||+.||+||| +++|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 2211 457789999999999999 99999999999999999
Q ss_pred cCCcceeeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 039895 132 EENVAQLFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDY 211 (284)
Q Consensus 132 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~ 211 (284)
.++.+|++|||+++.......... .....||+.|+|||++....++.++|||||||++|||+|+..|+.... ....
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~---~~~~ 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---PVDS 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CSSH
T ss_pred ccCcccccccchheeccCCCcceE-eeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC---CHHH
Confidence 999999999999988765443322 233689999999999999999999999999999999999655554322 1111
Q ss_pred cHHHHHHHHhhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHhc
Q 039895 212 RLQDLVKKYIENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQLRQIYQS 283 (284)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~L~~l~~~ 283 (284)
.+...+.. +.... .+...+..+.+|+.+||+.||.+|||+.||++.|+++..+
T Consensus 256 ~~~~~i~~----~~~~~---------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKMIKE----GFRML---------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHH----TCCCC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhc----CCCCC---------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 12222211 11000 0112234488999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=297.00 Aligned_cols=190 Identities=21% Similarity=0.287 Sum_probs=149.8
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788889999999999999999 8999999998532
Q ss_pred --CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 --FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 --~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+|.. .....++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 2211 567789999999999999 99999999999999999999999999999987654332
Q ss_pred cccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcccccccc
Q 039895 153 HINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEIVDP 232 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ......... .+..
T Consensus 159 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~-~~~~------ 220 (320)
T d1xjda_ 159 KT---NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIR-MDNP------ 220 (320)
T ss_dssp CB---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCC------
T ss_pred cc---cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCCC------
Confidence 21 22679999999999999999999999999999999999999997532 112121111 1110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIV-QVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-ev~~ 275 (284)
.+ +...+..+.+|+.+||+.||++|||+. |+++
T Consensus 221 ~~----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FY----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 00 011233478999999999999999995 6653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.8e-43 Score=290.44 Aligned_cols=194 Identities=19% Similarity=0.293 Sum_probs=150.3
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.. +|+.||||++...
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788889999999999999998 8899999998542
Q ss_pred --------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 --------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 --------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+|.. .....++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 1111 667889999999999999 99999999999999999999999999999988
Q ss_pred cCCCCccccCCCCcccCccccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHH
Q 039895 147 IPEGETHINDSNRVIGTFGFMAPEYRTT------GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKY 220 (284)
Q Consensus 147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
+...... ....||+.|+|||++.+ ..++.++||||+||++|||++|..||.... ........
T Consensus 160 ~~~~~~~----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~~i 227 (277)
T d1phka_ 160 LDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRMI 227 (277)
T ss_dssp CCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH
T ss_pred ccCCCce----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHHHH
Confidence 7654322 22679999999998752 357889999999999999999999997532 11111111
Q ss_pred hhcCcccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 221 IENESFKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. .+... . ..+.....++++.+|+.+||+.||++|||+.||++.
T Consensus 228 ~-~~~~~-~-----------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 M-SGNYQ-F-----------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp H-HTCCC-C-----------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred H-hCCCC-C-----------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 11110 0 001122334458899999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=289.94 Aligned_cols=212 Identities=17% Similarity=0.193 Sum_probs=150.6
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.+ +|+.||||++...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788889999999999999998 7999999998543
Q ss_pred CCC----------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcc
Q 039895 90 FPF----------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 90 ~~~----------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 153 (284)
+|. +.....++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 111 1667789999999999999 999999999999999999999999999999877544332
Q ss_pred ccCCCCcccCccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC--cccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE--SFKEIV 230 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 230 (284)
. ....||+.|+|||++.... ++.++||||+||++|+|++|+.||.... ....+........... .+....
T Consensus 159 ~---~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 159 Y---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp T---TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred c---eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC----HHHHHHHHHHhcCCCchhhccccc
Confidence 2 2257999999999877665 5789999999999999999999996432 1111111111111100 000000
Q ss_pred c-ccccCCC----CCCC-hhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 231 D-PAIVGEE----GLMW-PEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 231 ~-~~~~~~~----~~~~-~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. +...... .... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0000000 0000 0011223457899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-42 Score=288.06 Aligned_cols=210 Identities=20% Similarity=0.267 Sum_probs=147.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-CCcceEEEeecCCCC------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-QDRPISVMKFEDTFP------------------------------------------ 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------------------------------------------ 91 (284)
+.|...+.||+|+||+||+|.+ +|+.||||++.....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4677778999999999999999 889999999865411
Q ss_pred ----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCcccc
Q 039895 92 ----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHIN 155 (284)
Q Consensus 92 ----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 155 (284)
.+.....++.||+.||+||| +.+|+||||||+|||++.++.+|++|||.+..........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY- 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc-
Confidence 11667789999999999999 8999999999999999999999999999998775443221
Q ss_pred CCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---ccccc-
Q 039895 156 DSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES---FKEIV- 230 (284)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 230 (284)
....|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.. .......+........ +....
T Consensus 158 --~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 158 --THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCCCChhhccchhh
Confidence 125689999999998754 57899999999999999999999996432 1111111111111111 11000
Q ss_pred ----cccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 231 ----DPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 231 ----~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
...........++ ........+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 01122345789999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=292.24 Aligned_cols=214 Identities=15% Similarity=0.191 Sum_probs=149.1
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|+..+.||+|+||+||+|.+ +|+.||||++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5688888999999999999998 7899999997533
Q ss_pred --------CCCc---------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccc
Q 039895 90 --------FPFS---------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 90 --------~~~~---------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
+|.. .....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 1110 556789999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccc-cCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC
Q 039895 147 IPEGETHI-NDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE 224 (284)
Q Consensus 147 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.. .......+.......
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLCGSI 241 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCC
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHhcCCC
Confidence 65433221 122235799999999998765 68999999999999999999999986432 122222222221110
Q ss_pred ---cccccccc----cccCCCCCCChhh-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 225 ---SFKEIVDP----AIVGEEGLMWPEK-----EQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 225 ---~~~~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
........ .+........+.. ....+.+.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000 0000000011111 1123356789999999999999999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=292.42 Aligned_cols=193 Identities=16% Similarity=0.242 Sum_probs=150.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC----------------------------------------CC
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT----------------------------------------FP 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------------------------------~~ 91 (284)
.+.|...+.||+|+||+||+|.+ +|+.||||++... +|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 35677888999999999999998 7889999999755 22
Q ss_pred Cc----------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecC--CcceeeccccccccCCCCcc
Q 039895 92 FS----------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEE--NVAQLFDFTLSLSIPEGETH 153 (284)
Q Consensus 92 ~~----------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~Dfg~a~~~~~~~~~ 153 (284)
.. .....++.||+.||.||| +.+|+||||||+|||++.+ ..+||+|||+++........
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 21 567789999999999999 9999999999999999854 47899999999877554332
Q ss_pred ccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcC-cccccccc
Q 039895 154 INDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENE-SFKEIVDP 232 (284)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (284)
. ...||+.|+|||.+.+..++.++||||+||++|+|++|..||.... ............ .+...
T Consensus 161 ~----~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~--- 225 (321)
T d1tkia_ 161 R----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp E----EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCHH---
T ss_pred c----ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCChh---
Confidence 2 1578999999999999999999999999999999999999997533 122222221111 11110
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 233 AIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+.+|+.+||..||++|||+.|+++
T Consensus 226 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -----------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122345789999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=289.21 Aligned_cols=208 Identities=22% Similarity=0.288 Sum_probs=147.0
Q ss_pred CCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------C
Q 039895 56 DFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-------------------------------------------F 90 (284)
Q Consensus 56 ~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------------------------------------------~ 90 (284)
+|...++||+|+||+||+|++ +|+.||||++... +
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 466678899999999999999 7899999998654 1
Q ss_pred CCc------------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCCC
Q 039895 91 PFS------------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 91 ~~~------------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~ 151 (284)
|.. .....++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||++.......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 211 355679999999999999 99999999999999999775 89999999998775443
Q ss_pred ccccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc-----
Q 039895 152 THINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES----- 225 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 225 (284)
.. ....||+.|+|||.+.+ ..++.++||||+||++|||++|..||.... ....+..... ......
T Consensus 178 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~----~~~~l~~i~~-~~g~~~~~~~~ 248 (350)
T d1q5ka_ 178 PN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIK-VLGTPTREQIR 248 (350)
T ss_dssp CC----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHH-HHCCCCHHHHH
T ss_pred cc----ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC----HHHHHHHHHH-HhCCChHHhhh
Confidence 22 22579999999998765 468999999999999999999999996432 1111111111 000000
Q ss_pred --ccccccccccCCCCCCCh--hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 --FKEIVDPAIVGEEGLMWP--EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 --~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.....+..+.......+. ......+.+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000000 01122344789999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=291.29 Aligned_cols=214 Identities=16% Similarity=0.213 Sum_probs=148.2
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
..|...+.||+|+||+||+|.. +|+.||||++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4577778999999999999998 7999999998643
Q ss_pred ----CC-------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCc
Q 039895 90 ----FP-------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGET 152 (284)
Q Consensus 90 ----~~-------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 152 (284)
+| .+.....++.||+.||+||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 00 00566789999999999999 99999999999999999999999999999987755444
Q ss_pred cccCCCCcccCccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCccccc--
Q 039895 153 HINDSNRVIGTFGFMAPEYRTT-GDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESFKEI-- 229 (284)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
.........||+.|+|||++.. ..++.++||||+||++|||++|..||.... ....................
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHHHHT
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC-----HHHHHHHHhhhccCCChhhhhh
Confidence 3333344679999999999854 467899999999999999999999986532 11111111111100000000
Q ss_pred -c-------cccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 230 -V-------DPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 230 -~-------~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
. ...........+. ........+.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000000000 001122347899999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=286.84 Aligned_cols=209 Identities=16% Similarity=0.193 Sum_probs=143.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC------------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------ 89 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------ 89 (284)
.+.|...+.||+|+||+||+|.+ +|+.||||++...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35677778999999999999998 7999999998754
Q ss_pred -------CCCc-------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 90 -------FPFS-------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 90 -------~~~~-------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
+|.. .....++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCC
Confidence 1111 567789999999999999 99999999999999999999999999999987754
Q ss_pred CCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--c
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--F 226 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (284)
... ...||+.|+|||++.+. .++.++||||+||++|+|++|..||.... ................ +
T Consensus 174 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 174 EMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp SCC------SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCHHH
T ss_pred ccc------cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-----hHHHHHHHHhccCCCcHHH
Confidence 332 26799999999998764 57899999999999999999999986532 1111111111000000 0
Q ss_pred ccc--------ccccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 227 KEI--------VDPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 227 ~~~--------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
... ....+.......++ ......+.+.+|+.+||..||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000000000 011223347899999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=278.75 Aligned_cols=211 Identities=11% Similarity=0.142 Sum_probs=150.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC-----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP----------------------------------------- 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----------------------------------------- 91 (284)
+.|+..+.||+|+||+||+|++ +|+.||||+++....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4577788999999999999998 789999999864410
Q ss_pred -----------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 92 -----------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 92 -----------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
.+.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 00567789999999999999 9999999999999999999999999999998876543322
Q ss_pred cCCCCcccCccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc---cccc-
Q 039895 155 NDSNRVIGTFGFMAPEYRTTGD-FSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES---FKEI- 229 (284)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 229 (284)
. ...+++.|+|||++.... ++.++||||+||++|||++|+.||.... ........+........ +...
T Consensus 159 ~---~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 159 S---AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C---SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred e---eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC----CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 245788899999987665 6899999999999999999999986432 11111121222111110 0000
Q ss_pred -----ccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 230 -----VDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 230 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
......................+.+|+.+||+.||.+|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000111112223345789999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=281.07 Aligned_cols=195 Identities=22% Similarity=0.261 Sum_probs=147.5
Q ss_pred cCCCCCCeeeecCCceEEEEEe-----CCcceEEEeecCC----------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL-----QDRPISVMKFEDT---------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------------- 89 (284)
++|+..+.||+|+||+||+|.. +|+.||||++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6688899999999999999986 4788999998533
Q ss_pred ------CCC---------------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccC
Q 039895 90 ------FPF---------------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIP 148 (284)
Q Consensus 90 ------~~~---------------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~ 148 (284)
+|. +.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 111 1556678999999999999 9999999999999999999999999999998775
Q ss_pred CCCccccCCCCcccCccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCcc
Q 039895 149 EGETHINDSNRVIGTFGFMAPEYRTTG--DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENESF 226 (284)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
........ ...|++.|+|||.+.+. .++.++|||||||++|||++|..||..... ............... .
T Consensus 181 ~~~~~~~~--~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~----~~~~~~i~~~~~~~~-~ 253 (322)
T d1vzoa_ 181 ADETERAY--DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE-P 253 (322)
T ss_dssp GGGGGGGC--GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC-C
T ss_pred cccccccc--ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcccCC-C
Confidence 44333222 26799999999998754 467899999999999999999999975431 112222222211110 0
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 039895 227 KEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPT-----IVQVAK 275 (284)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~ev~~ 275 (284)
+.+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 254 ----------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001123345889999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=282.88 Aligned_cols=210 Identities=18% Similarity=0.225 Sum_probs=150.4
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-----------------------------------------CC
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT-----------------------------------------FP 91 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------------------------------------~~ 91 (284)
++|...+.||+|+||+||+|+. +|+.||||++... +|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5688889999999999999998 7999999998765 11
Q ss_pred Cc------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCC-cceeeccccccccCCCCccccCCC
Q 039895 92 FS------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEEN-VAQLFDFTLSLSIPEGETHINDSN 158 (284)
Q Consensus 92 ~~------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 158 (284)
.. .....++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 115 ~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~----~ 187 (328)
T d3bqca1 115 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----N 187 (328)
T ss_dssp CSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC----C
T ss_pred CCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCcc----c
Confidence 11 567789999999999999 99999999999999999655 6899999999877654322 2
Q ss_pred CcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhh---------cCc---
Q 039895 159 RVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIE---------NES--- 225 (284)
Q Consensus 159 ~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~--- 225 (284)
...||+.|+|||.+.+. .++.++||||+||+++|+++|..||..... .......+..... ...
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~----~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD----NYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS----HHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch----hHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 25789999999998765 479999999999999999999999875431 1111111111000 000
Q ss_pred ---ccccccccccC--CCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 226 ---FKEIVDPAIVG--EEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 226 ---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
+.......... ......+......+++.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 000011112233455789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=279.62 Aligned_cols=208 Identities=16% Similarity=0.189 Sum_probs=144.9
Q ss_pred cCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCC-------------------------------------------
Q 039895 55 DDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT------------------------------------------- 89 (284)
Q Consensus 55 ~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------------------------------------------- 89 (284)
+.|...++||+|+||+||+|.+ +|+.||||++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5688888999999999999998 7999999998644
Q ss_pred ------CCCc------------hhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCC
Q 039895 90 ------FPFS------------VSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGE 151 (284)
Q Consensus 90 ------~~~~------------~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~ 151 (284)
+|.. .....++.||+.||.||| +.||+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccccc
Confidence 1111 567789999999999999 9999999999999999999999999999987765433
Q ss_pred ccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHh----------
Q 039895 152 THINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYI---------- 221 (284)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 221 (284)
.. ....||+.|+|||++.+..++.++||||+||++++|++|+.||.+.. .............
T Consensus 174 ~~----~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 174 MM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cc----ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC----HHHHHHHHHHhccCCCHHHHHHh
Confidence 22 22578999999999999999999999999999999999999986432 1111111111000
Q ss_pred --------hcC-c-----ccccccccccCCCCCCChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 039895 222 --------ENE-S-----FKEIVDPAIVGEEGLMWPEKEQQLLICTELAFKCLSESEGDRPTIVQVAKQ 276 (284)
Q Consensus 222 --------~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~~ 276 (284)
... . ........ ...............+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDS---LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGG---GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccc---cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 00000000 0111122344566778999999999999999999999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-39 Score=276.80 Aligned_cols=212 Identities=13% Similarity=0.140 Sum_probs=147.1
Q ss_pred CCCCCeeeecCCceEEEEEe--CCcceEEEeecCC---------------------------------------------
Q 039895 57 FDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDT--------------------------------------------- 89 (284)
Q Consensus 57 f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------------------------------------------- 89 (284)
|...+.||+|+||+||+|+. +|+.||||++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 77788999999999999998 7999999998754
Q ss_pred --------C------------------CCchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCc------ce
Q 039895 90 --------F------------------PFSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENV------AQ 137 (284)
Q Consensus 90 --------~------------------~~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~------~k 137 (284)
+ ........++.||+.||+|||+ ..+|+||||||+|||++.++. ++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceee
Confidence 0 0004567799999999999993 389999999999999987653 89
Q ss_pred eeccccccccCCCCccccCCCCcccCccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc--ccHHH
Q 039895 138 LFDFTLSLSIPEGETHINDSNRVIGTFGFMAPEYRTTGDFSEKSDVYSFGALLLELLTGKKISYSSHFDDGED--YRLQD 215 (284)
Q Consensus 138 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~--~~~~~ 215 (284)
++|||.+........ ...||+.|+|||++....++.++||||+||++++|++|+.||.......... ..+..
T Consensus 173 l~dfg~s~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 173 IADLGNACWYDEHYT------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp ECCCTTCEETTBCCC------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred Eeecccccccccccc------cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999876543322 2679999999999999999999999999999999999999987543111110 01111
Q ss_pred HHHHHhh-------cCc-ccccccc-----cccCCCCC--------CChhhHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 039895 216 LVKKYIE-------NES-FKEIVDP-----AIVGEEGL--------MWPEKEQQLLICTELAFKCLSESEGDRPTIVQVA 274 (284)
Q Consensus 216 ~~~~~~~-------~~~-~~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~ 274 (284)
.+..... ... .....+. .+...... ...........+.+|+.+||..||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111000 000 0000000 00000000 1112345667789999999999999999999998
Q ss_pred HH
Q 039895 275 KQ 276 (284)
Q Consensus 275 ~~ 276 (284)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 63
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=276.47 Aligned_cols=208 Identities=17% Similarity=0.259 Sum_probs=144.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEe--CCcceEEEeecCCCC----------------------------------------
Q 039895 54 TDDFDGGKVIMKCLFYKLYKGFL--QDRPISVMKFEDTFP---------------------------------------- 91 (284)
Q Consensus 54 ~~~f~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---------------------------------------- 91 (284)
.+.|...+.||+|+||+||+|.+ +|+.||||++.....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35688888999999999999998 799999999864400
Q ss_pred ----------------------CchhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCC
Q 039895 92 ----------------------FSVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPE 149 (284)
Q Consensus 92 ----------------------~~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~ 149 (284)
.+.....++.||+.||.||| +++|+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc
Confidence 00567789999999999999 99999999999999999999999999999876543
Q ss_pred CCccccCCCCcccCccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccccHHHHHHHHhhcCc--c
Q 039895 150 GETHINDSNRVIGTFGFMAPEYRTTG-DFSEKSDVYSFGALLLELLTGKKISYSSHFDDGEDYRLQDLVKKYIENES--F 226 (284)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (284)
.. ....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.. .......+........ .
T Consensus 174 ~~------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 174 EM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp GG------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCHHH
T ss_pred cc------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChHH
Confidence 22 126789999999987665 46899999999999999999999996532 1111111111111000 0
Q ss_pred cccc--------cccccCCCCCCCh-hhHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 039895 227 KEIV--------DPAIVGEEGLMWP-EKEQQLLICTELAFKCLSESEGDRPTIVQVAK 275 (284)
Q Consensus 227 ~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~ev~~ 275 (284)
.... ...+.......+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 0000000000000 00112345789999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.2e-23 Score=161.56 Aligned_cols=116 Identities=16% Similarity=0.135 Sum_probs=86.5
Q ss_pred CCCeeeecCCceEEEEEe-CCcceEEEeecCC------------------------------------------------
Q 039895 59 GGKVIMKCLFYKLYKGFL-QDRPISVMKFEDT------------------------------------------------ 89 (284)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------------------------------------------------ 89 (284)
.++.||+|+||+||+|.. +|+.||||++...
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 357899999999999998 8999999987532
Q ss_pred -------CCC--------chhHHHHHHHHHHHHHHhccCCCCCeeecccccCcEEEecCCcceeeccccccccCCCCccc
Q 039895 90 -------FPF--------SVSKLKIAIEIASAVAYLHVGFSRPVVSRDIKPTTIVLQEENVAQLFDFTLSLSIPEGETHI 154 (284)
Q Consensus 90 -------~~~--------~~~~~~i~~~i~~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 154 (284)
++. ......++.|++.||.||| ..+|+||||||+|||+++++ ++|+|||.|.........
T Consensus 84 ~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~- 158 (191)
T d1zara2 84 GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR- 158 (191)
T ss_dssp TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHH-
T ss_pred CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcH-
Confidence 000 0455689999999999999 99999999999999999655 889999998765432211
Q ss_pred cCCCCcccCcccccc------ccccCCCCCcchhHHHHHHHH
Q 039895 155 NDSNRVIGTFGFMAP------EYRTTGDFSEKSDVYSFGALL 190 (284)
Q Consensus 155 ~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwS~G~il 190 (284)
.|... +.+ ...|+.++|+||..--+
T Consensus 159 ----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 159 ----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 11111 111 34678899999975433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.52 E-value=0.00031 Score=56.96 Aligned_cols=46 Identities=15% Similarity=0.260 Sum_probs=34.3
Q ss_pred eecHHHHHHHhcCCCCCCeee-----ecCCceEEEEEeCCcceEEEeecCC
Q 039895 44 SFSADELKTATDDFDGGKVIM-----KCLFYKLYKGFLQDRPISVMKFEDT 89 (284)
Q Consensus 44 ~~~~~~l~~~~~~f~~~~~lg-----~G~~g~Vy~~~~~~~~vavK~~~~~ 89 (284)
.++.+|+......|..+++.. .|---+.|+.+.++..+++|++...
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~ 52 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR 52 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCC
Confidence 578899999999998877654 4545678999997677999998653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.11 E-value=0.00047 Score=54.09 Aligned_cols=27 Identities=19% Similarity=0.345 Sum_probs=24.1
Q ss_pred eeecccccCcEEEecCCcceeeccccc
Q 039895 118 VVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 118 ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
++|+|+.|.|||++.++.+-|.||+.+
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred EEEeeccCcceeecCCceEEEeechhc
Confidence 799999999999998776779999876
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.28 E-value=0.019 Score=46.33 Aligned_cols=49 Identities=10% Similarity=0.055 Sum_probs=31.1
Q ss_pred CcceecHHHHHHHhcCC--C-CCCeeeecC-CceEEEEEe-CCcceEEEeecCC
Q 039895 41 PIRSFSADELKTATDDF--D-GGKVIMKCL-FYKLYKGFL-QDRPISVMKFEDT 89 (284)
Q Consensus 41 ~~~~~~~~~l~~~~~~f--~-~~~~lg~G~-~g~Vy~~~~-~~~~vavK~~~~~ 89 (284)
....++.+.+..+...+ . ...++--++ --.||+... +|..+++|+....
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~ 57 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE 57 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT
T ss_pred CccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC
Confidence 34566777776655433 2 223322233 348999998 8889999998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=93.92 E-value=0.0096 Score=45.94 Aligned_cols=30 Identities=13% Similarity=0.106 Sum_probs=25.6
Q ss_pred CCCeeecccccCcEEEecCCcceeeccccc
Q 039895 115 SRPVVSRDIKPTTIVLQEENVAQLFDFTLS 144 (284)
Q Consensus 115 ~~~ivHrDlkp~NILl~~~~~~kl~Dfg~a 144 (284)
...++|+|+.|.|||++.+..+-|.||+.+
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 345899999999999998777789999865
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.09 E-value=0.016 Score=48.11 Aligned_cols=30 Identities=13% Similarity=0.331 Sum_probs=25.2
Q ss_pred CCeeecccccCcEEEecCCcceeeccccccc
Q 039895 116 RPVVSRDIKPTTIVLQEENVAQLFDFTLSLS 146 (284)
Q Consensus 116 ~~ivHrDlkp~NILl~~~~~~kl~Dfg~a~~ 146 (284)
..++|+|+.|.|||++.++ ++|.||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4689999999999998765 89999987643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=80.81 E-value=0.33 Score=39.70 Aligned_cols=17 Identities=18% Similarity=0.389 Sum_probs=13.4
Q ss_pred eeecccccCcEEEecCC
Q 039895 118 VVSRDIKPTTIVLQEEN 134 (284)
Q Consensus 118 ivHrDlkp~NILl~~~~ 134 (284)
++|.|+.+.||++....
T Consensus 220 ~CHnDL~~~NiL~~~~~ 236 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKAS 236 (395)
T ss_dssp EECSCCCGGGEEEEC--
T ss_pred EEecCCCcccEeecccc
Confidence 57999999999996543
|